data_1ppx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ppx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.91 0.386 . . . . 0.44 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.48 122.02 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.44 110.717 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 pp -109.65 125.08 52.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.44 110.957 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 42.6 mt-30 -102.52 150.43 23.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.317 0.58 . . . . 0.44 111.54 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 mt -141.21 131.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.188 -0.914 . . . . 0.44 110.046 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.622 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.01 124.8 43.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.687 -0.486 . . . . 0.44 109.687 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -128.52 156.96 41.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.322 0.582 . . . . 0.44 111.85 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -148.6 118.16 0.94 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.074 -0.967 . . . . 0.44 111.262 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.613 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.11 108.96 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.446 -0.576 . . . . 0.44 109.446 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.82 128.28 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.44 111.386 -178.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -91.75 126.22 36.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.44 111.074 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.486 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 9.6 t-20 -87.6 -172.31 3.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.983 0.897 . . . . 0.44 112.346 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -77.9 -3.0 39.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.926 -1.488 . . . . 0.44 111.878 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -133.46 49.06 2.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.371 . . . . 0.44 111.203 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.85 28.88 0.39 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.099 -0.5 . . . . 0.44 111.451 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -118.17 149.53 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.042 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -120.4 146.65 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.44 111.599 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.434 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -95.85 116.58 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.725 . . . . 0.44 110.525 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.62 162.15 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.202 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.408 ' CB ' ' OE1' ' A' ' 98' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 0.44 110.74 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 111.587 0.217 . . . . 0.44 111.587 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -114.47 26.01 10.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.079 0.466 . . . . 0.44 111.512 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.97 94.58 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.44 110.507 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -111.69 -166.46 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.44 111.652 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.82 163.04 29.94 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.747 -0.661 . . . . 0.44 111.426 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 35.5 Cg_endo -63.48 168.17 11.86 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.525 2.816 . . . . 0.44 112.003 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.32 58.83 0.77 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.122 -1.037 . . . . 0.44 113.927 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -120.95 138.57 12.74 Favored Glycine 0 C--N 1.313 -0.701 0 CA-C-N 114.756 -0.722 . . . . 0.44 111.974 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 2.7 ttpm? 92.45 6.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.981 0.513 . . . . 0.44 112.047 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.588 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -55.82 -27.14 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.49 0.662 . . . . 0.44 110.533 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.2 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.728 -1.124 . . . . 0.44 111.039 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.9 mmm 37.92 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.438 0.461 . . . . 0.44 111.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.76 32.71 0.12 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.8 -0.714 . . . . 0.44 112.418 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt-10 -89.68 -175.02 4.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.782 0.325 . . . . 0.44 111.244 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.536 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.45 155.18 36.67 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.323 -0.399 . . . . 0.44 110.387 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.9 Cg_endo -44.62 -24.91 1.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.819 2.346 . . . . 0.44 112.593 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -104.09 -41.66 5.77 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.003 0.371 . . . . 0.44 112.003 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.4 mm-40 -79.04 -19.21 51.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.628 0.233 . . . . 0.44 111.628 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.481 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -58.41 -47.73 82.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.654 0.264 . . . . 0.44 111.303 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -78.11 -45.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.44 110.883 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.496 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 41.8 t -53.95 -36.94 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.44 111.65 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.38 -52.02 9.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 0.44 110.92 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.79 -22.93 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.23 -0.441 . . . . 0.44 110.811 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 6.2 tp -54.46 -44.81 72.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.812 0.339 . . . . 0.44 110.736 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.76 -28.38 68.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.311 -0.625 . . . . 0.44 109.311 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.27 -25.34 51.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.368 -0.833 . . . . 0.44 111.179 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 6.9 mm-40 -108.52 0.95 21.17 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.127 0.417 . . . . 0.44 112.127 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 60' ' ' ILE . 2.1 t -134.79 -44.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.44 109.786 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -33.91 0.29 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.44 113.906 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.3 OUTLIER -77.69 -175.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.88 0.371 . . . . 0.44 111.084 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.23 89.02 13.52 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.904 -0.589 . . . . 0.44 110.209 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.623 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.8 Cg_endo -109.55 145.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.308 2.672 . . . . 0.44 114.104 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -74.74 79.93 2.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.621 -1.992 . . . . 0.44 105.621 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.32 136.93 54.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.377 -1.283 . . . . 0.44 111.252 -175.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.5 t80 179.16 -144.71 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.404 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 57.02 157.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.336 0.589 . . . . 0.44 112.536 178.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.0 tt -121.33 108.69 14.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.164 -0.926 . . . . 0.44 109.923 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -41.95 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.44 110.518 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.6 tt0 -171.25 160.28 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.44 110.721 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.3 131.41 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.556 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tp -122.73 137.13 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.44 110.853 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -125.82 109.8 12.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.44 110.444 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.4 153.1 47.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.497 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.22 132.7 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.44 111.482 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.9 162.95 21.24 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.44 110.012 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_endo -46.31 80.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.194 2.596 . . . . 0.44 112.58 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t0 85.7 11.85 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.442 -0.799 . . . . 0.44 111.786 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.35 97.25 3.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.661 0.267 . . . . 0.44 111.148 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.0 OUTLIER -74.9 106.56 6.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.484 -0.325 . . . . 0.44 110.951 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 tt -102.11 116.43 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.051 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.32 132.49 49.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.724 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.14 114.61 18.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.47 -0.332 . . . . 0.44 111.064 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.509 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -106.47 123.84 48.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.473 -0.331 . . . . 0.44 110.23 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 2.0 m-85 -105.93 109.9 22.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.879 0.371 . . . . 0.44 110.832 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.4 m95 -97.27 149.36 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.117 -0.492 . . . . 0.44 111.444 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.4 tp -99.89 102.84 14.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.253 0.549 . . . . 0.44 111.914 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 12.2 t -84.12 146.16 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.344 -0.844 . . . . 0.44 111.124 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.55 -26.47 8.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.528 1.307 . . . . 0.44 114.528 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 5.4 ttp180 -162.78 159.8 24.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.885 0.766 . . . . 0.44 111.73 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.623 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -152.18 125.89 8.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.204 -0.453 . . . . 0.44 111.329 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -74.37 146.04 43.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.958 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.47 -119.24 14.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.822 -0.704 . . . . 0.44 112.558 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -135.07 145.77 55.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.571 0.224 . . . . 0.44 110.792 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.7 Cg_exo -76.44 128.84 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.847 2.364 . . . . 0.44 111.241 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 42.2 p-90 -130.42 -64.25 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.342 -0.543 . . . . 0.44 112.43 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . 49.13 -107.68 0.32 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.559 -0.829 . . . . 0.44 112.477 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 164.45 67.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.917 0.389 . . . . 0.44 110.389 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' OE1' ' CB ' ' A' ' 21' ' ' THR . 2.3 pt-20 -86.36 -37.4 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.44 110.767 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.07 -6.67 10.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.556 -0.83 . . . . 0.44 113.507 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -140.06 97.03 7.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.134 0.467 . . . . 0.44 111.483 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -43.79 145.64 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.44 112.586 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.34 177.11 19.43 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.546 -0.835 . . . . 0.44 112.964 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.82 157.43 45.41 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.289 -0.263 . . . . 0.44 110.289 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -70.3 106.65 3.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.44 110.307 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -120.06 163.62 17.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 0.44 110.977 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 93.3 p -89.01 127.97 35.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 18' ' ' ILE . 5.1 tp -78.48 -18.9 54.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.44 111.184 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.93 -24.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.348 -0.387 . . . . 0.44 111.38 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.72 39.64 2.37 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.602 -0.809 . . . . 0.44 112.95 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.71 140.03 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.944 -0.391 . . . . 0.44 109.944 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.1 134.5 54.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.092 0.775 . . . . 0.44 113.092 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.37 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.26 -0.882 . . . . 0.44 110.278 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.0 -49.15 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.158 -0.474 . . . . 0.44 111.556 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -36.28 81.91 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.519 -0.31 . . . . 0.44 111.239 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.7 172.66 8.99 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.387 -0.37 . . . . 0.44 110.273 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.48 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 60.5 Cg_endo -72.77 127.76 12.64 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.139 1.893 . . . . 0.44 111.526 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.27 -14.75 31.01 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.701 2.267 . . . . 0.44 113.28 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.74 -9.73 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.436 0.532 . . . . 0.44 112.436 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -130.62 42.37 3.26 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.759 0.314 . . . . 0.44 111.725 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.424 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.43 -49.74 5.01 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 111.728 0.27 . . . . 0.44 111.728 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.4 Cg_exo -44.94 -33.95 8.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.461 2.107 . . . . 0.44 112.591 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.35 -48.72 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.44 110.427 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.539 HG13 ' CE2' ' A' ' 115' ' ' PHE . 8.7 mm -66.33 -31.93 55.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.817 -0.628 . . . . 0.44 110.719 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.66 -26.87 36.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.932 0.396 . . . . 0.44 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -53.17 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.44 111.864 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.409 ' CD2' HG21 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.24 -29.66 48.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.694 0.283 . . . . 0.44 111.47 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -55.17 -42.52 73.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.17 0.509 . . . . 0.44 110.74 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -65.13 -11.65 42.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.44 109.585 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.231 0.1 0 CA-C-N 115.86 -0.609 . . . . 0.44 111.055 179.749 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.8 0.333 . . . . 0.44 110.957 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 145.5 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.41 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.5 pp -146.01 128.33 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.44 110.99 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -106.95 153.3 22.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.301 0.572 . . . . 0.44 112.029 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 81' ' ' THR . 5.3 mp -146.44 131.37 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.148 -0.933 . . . . 0.44 109.836 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.28 124.75 43.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.184 -0.302 . . . . 0.44 110.184 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -121.25 162.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.44 111.904 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.25 113.31 0.58 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.126 -0.943 . . . . 0.44 111.559 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.91 105.8 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.225 -0.657 . . . . 0.44 109.225 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -70.97 122.17 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.44 111.28 -178.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -93.17 127.72 38.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.167 -0.469 . . . . 0.44 110.342 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 2.5 t-20 -75.33 -172.09 1.65 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 122.219 1.009 . . . . 0.44 113.107 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.04 -17.81 41.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.446 -1.706 . . . . 0.44 112.859 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -120.33 -82.39 0.65 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.724 0.297 . . . . 0.44 111.559 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -158.8 16.05 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.44 111.677 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.404 ' HG2' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -100.91 155.14 18.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.716 -0.476 . . . . 0.44 109.716 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -124.34 144.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.327 0.584 . . . . 0.44 111.957 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.416 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 59.6 t80 -83.65 90.17 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.217 -0.901 . . . . 0.44 110.584 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.464 HG12 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -104.44 162.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.44 110.298 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 100' ' ' GLN . 5.5 p . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.372 -0.376 . . . . 0.44 110.402 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.845 0.355 . . . . 0.44 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.41 26.22 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.388 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 16.2 tp -69.18 63.88 0.14 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.807 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -106.85 -177.65 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.44 111.192 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.53 162.9 30.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.44 111.648 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.94 167.99 7.96 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.538 2.826 . . . . 0.44 111.857 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.28 59.07 0.77 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.365 -0.922 . . . . 0.44 113.255 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.76 121.43 3.43 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.355 -0.922 . . . . 0.44 111.978 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.45 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.306 0.642 . . . . 0.44 111.866 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.603 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -53.81 -27.98 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.541 0.686 . . . . 0.44 110.683 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.58 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.72 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.44 111.147 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mmt 34.96 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.362 0.414 . . . . 0.44 111.755 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.77 30.16 0.16 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.96 -0.638 . . . . 0.44 112.452 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.9 mp0 -93.59 -176.6 4.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.733 0.301 . . . . 0.44 111.127 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.563 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.84 158.94 33.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.44 110.202 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.76 -24.66 0.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.839 2.359 . . . . 0.44 112.525 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -89.86 -60.58 1.9 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.205 0.446 . . . . 0.44 112.205 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -4.84 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.589 0.589 . . . . 0.44 112.589 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -63.14 -55.29 26.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.44 111.103 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -78.25 -45.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.44 110.904 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.473 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 58.0 t -55.52 -36.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.121 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.37 -49.1 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 0.44 111.225 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -68.31 -22.6 64.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.44 111.212 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.455 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -56.52 -45.04 81.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 0.44 110.659 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -27.12 68.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.16 -0.681 . . . . 0.44 109.16 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.43 -30.63 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.307 -0.861 . . . . 0.44 111.279 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.408 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -109.08 5.78 24.37 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.832 0.678 . . . . 0.44 112.832 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 60' ' ' ILE . 2.6 t -134.02 -44.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.26 0.552 . . . . 0.44 110.24 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.57 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.55 7.02 1.25 Allowed Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.424 -0.807 . . . . 0.44 114.563 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.506 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -115.39 -172.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 117.902 0.851 . . . . 0.44 110.033 179.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 p -114.45 87.59 14.21 Favored Pre-proline 0 N--CA 1.438 -1.074 0 CA-C-N 116.326 -0.397 . . . . 0.44 110.537 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.627 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.4 Cg_endo -113.95 142.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.631 2.887 . . . . 0.44 113.598 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 8.8 mt-30 -74.87 79.94 2.12 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.202 -2.147 . . . . 0.44 105.202 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.598 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.15 129.12 53.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.809 -1.541 . . . . 0.44 111.407 -175.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -176.44 -141.69 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.44 110.07 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.73 159.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.334 0.588 . . . . 0.44 112.053 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.4 tt -122.18 113.0 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.345 -0.843 . . . . 0.44 110.318 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.44 -48.32 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.093 0.473 . . . . 0.44 110.017 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.39 166.31 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.637 -0.71 . . . . 0.44 110.216 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.34 132.02 22.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.809 0.338 . . . . 0.44 110.977 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 18.2 tp -113.78 120.77 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.44 110.64 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.68 109.93 16.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.44 110.664 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.86 146.46 37.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.717 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.14 120.13 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.072 0.463 . . . . 0.44 111.278 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -69.95 163.18 63.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.625 -0.716 . . . . 0.44 110.505 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -51.76 83.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.024 2.483 . . . . 0.44 112.058 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 26.2 m-20 95.59 15.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.259 -0.882 . . . . 0.44 111.323 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -137.38 150.17 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.44 110.526 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 5.5 t-160 -124.9 94.1 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.44 110.9 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -99.0 118.21 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.44 110.76 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.95 127.12 55.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.846 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 mt -126.28 114.71 18.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.506 -0.315 . . . . 0.44 111.074 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.544 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -106.32 123.02 47.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.405 -0.361 . . . . 0.44 110.553 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -99.72 116.07 30.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.82 0.343 . . . . 0.44 110.893 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.3 m95 -100.59 149.18 24.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.463 . . . . 0.44 111.257 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tm? -103.04 103.14 13.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.365 0.602 . . . . 0.44 112.04 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 64' ' ' HIS . 22.2 t -81.01 145.87 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.108 -0.951 . . . . 0.44 111.095 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 1.9 pm0 -119.63 -14.53 9.07 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.204 1.187 . . . . 0.44 114.204 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 11.3 tpp85 -162.9 154.91 18.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.611 0.641 . . . . 0.44 111.523 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.627 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -157.55 120.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.44 111.539 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.65 144.28 37.53 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.608 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 -124.57 36.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.644 -0.789 . . . . 0.44 112.201 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 45.4 mt-10 -135.11 143.08 44.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.519 0.199 . . . . 0.44 110.992 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.6 Cg_exo -75.92 128.77 11.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.747 2.298 . . . . 0.44 111.041 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.57 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 62.9 p-90 -129.72 -59.85 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.326 -0.549 . . . . 0.44 112.471 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 43.73 -96.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.921 -0.657 . . . . 0.44 112.795 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 175.65 35.98 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.677 0.275 . . . . 0.44 110.999 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.09 -38.22 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.361 . . . . 0.44 110.685 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.1 58.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.794 -0.717 . . . . 0.44 113.43 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.415 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 50.6 tt0 -140.13 97.02 7.9 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.087 0.443 . . . . 0.44 111.384 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.56 143.03 2.8 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.078 2.519 . . . . 0.44 112.828 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.27 19.31 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.833 -0.698 . . . . 0.44 112.851 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -142.89 157.38 44.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.326 -0.249 . . . . 0.44 110.326 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.64 105.84 5.92 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.679 -0.408 . . . . 0.44 110.24 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.4 ptm -120.75 163.15 18.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.44 110.857 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.04 114.83 17.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.44 110.543 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.3 tp -70.34 -18.86 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 0.44 111.342 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -53.42 -19.25 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 0.44 111.486 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.67 49.73 0.91 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.878 -0.677 . . . . 0.44 111.971 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.18 150.3 39.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.44 110.665 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -106.86 104.14 13.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.719 0.637 . . . . 0.44 112.719 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.524 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.81 61.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.938 -0.573 . . . . 0.44 110.077 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.29 -43.42 23.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.022 -0.535 . . . . 0.44 110.982 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -1.87 31.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.923 -0.58 . . . . 0.44 112.201 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.543 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -117.53 170.55 6.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.268 -0.271 . . . . 0.44 110.268 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.1 Cg_endo -54.4 127.88 27.78 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.099 1.866 . . . . 0.44 112.427 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.94 -20.41 45.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.612 2.208 . . . . 0.44 112.452 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.77 51.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.418 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.481 ' HB3' ' CE2' ' A' ' 115' ' ' PHE . 1.5 m-20 -114.71 -2.36 13.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.44 111.399 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -47.84 -48.29 61.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.717 -0.219 . . . . 0.44 111.519 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.9 Cg_exo -44.95 -34.88 9.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.27 1.98 . . . . 0.44 112.28 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.29 -51.14 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.805 -0.634 . . . . 0.44 110.618 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 115' ' ' PHE . 41.8 mm -64.89 -33.5 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.44 110.996 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.83 -27.04 39.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.44 111.073 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.19 -52.47 8.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.44 111.632 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.19 -30.14 48.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.44 111.509 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HB2' HG23 ' A' ' 123' ' ' ILE . 42.2 tttm -56.69 -42.8 79.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.44 111.017 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -66.67 -10.09 42.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.767 -0.651 . . . . 0.44 109.721 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.231 0.113 0 CA-C-N 115.925 -0.58 . . . . 0.44 111.004 179.693 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.786 0.327 . . . . 0.44 110.949 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 132.52 43.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.44 110.86 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -128.29 123.2 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.44 110.958 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.433 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.0 mt-30 -102.46 152.13 21.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.486 0.66 . . . . 0.44 112.0 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.1 pt -146.56 134.72 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.965 -1.016 . . . . 0.44 109.836 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.59 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.4 124.29 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.797 -0.361 . . . . 0.44 110.087 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.44 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -120.51 160.44 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.249 0.547 . . . . 0.44 111.661 -179.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.53 115.29 0.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.283 -0.872 . . . . 0.44 111.645 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.78 109.33 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.078 -0.712 . . . . 0.44 109.078 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.78 120.23 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.44 111.048 -178.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.34 118.25 23.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.345 -0.843 . . . . 0.44 111.696 -179.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.457 ' CA ' ' CZ3' ' A' ' 90' ' ' TRP . 20.3 t30 -76.09 -172.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 114.834 -1.076 . . . . 0.44 111.873 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.57 3.89 30.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.241 -1.345 . . . . 0.44 112.315 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -139.22 51.28 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.44 111.524 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.09 22.83 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.659 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -117.38 153.29 33.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.734 -0.839 . . . . 0.44 108.734 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 19' ' ' PHE . 1.4 mp -117.0 143.4 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.26 0.552 . . . . 0.44 111.963 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.476 ' N ' HG22 ' A' ' 18' ' ' ILE . 44.7 t80 -87.98 92.84 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.44 110.12 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.417 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.62 159.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.44 110.774 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 13.1 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.44 110.526 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.638 0.256 . . . . 0.44 111.35 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.34 26.24 10.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.733 0.301 . . . . 0.44 111.593 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 22.2 tp -59.63 76.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.903 -0.59 . . . . 0.44 110.735 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -106.86 -172.65 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.44 111.679 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.6 160.56 41.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.731 -0.668 . . . . 0.44 111.901 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.402 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 36.7 Cg_endo -64.2 168.41 12.59 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.594 2.863 . . . . 0.44 111.657 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 59.5 0.74 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.037 -1.077 . . . . 0.44 114.082 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -126.92 117.39 2.73 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.655 -0.772 . . . . 0.44 112.039 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 121.62 4.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.395 0.678 . . . . 0.44 111.678 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.59 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -58.7 -26.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.444 0.64 . . . . 0.44 110.753 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.99 -83.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 0.44 111.332 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 33.45 -85.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.465 0.478 . . . . 0.44 111.889 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.46 34.05 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.848 -0.691 . . . . 0.44 112.516 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -88.18 -173.94 4.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.797 0.332 . . . . 0.44 111.231 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.52 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.2 154.6 37.61 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.435 . . . . 0.44 110.396 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.11 -26.21 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.89 2.393 . . . . 0.44 112.458 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.19 -39.35 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.44 111.779 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -80.23 -12.61 59.61 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.873 0.323 . . . . 0.44 111.873 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.2 -52.95 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.44 111.196 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -78.15 -43.84 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.293 -0.412 . . . . 0.44 111.161 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 48.7 t -53.66 -39.42 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.44 111.528 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.35 -52.02 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.563 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -67.19 -22.26 65.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.295 -0.411 . . . . 0.44 111.32 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.451 ' CD2' ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -54.33 -44.44 72.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.44 110.205 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -33.88 71.92 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.136 -0.69 . . . . 0.44 109.136 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.68 -25.79 49.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.268 -0.878 . . . . 0.44 111.358 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.1 mp0 -108.69 6.1 25.45 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.49 0.552 . . . . 0.44 112.49 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.498 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 15.3 t -134.14 -44.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.166 0.507 . . . . 0.44 110.26 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.572 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.27 3.55 1.42 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.387 -0.824 . . . . 0.44 114.705 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.539 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -117.88 -173.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 117.999 0.9 . . . . 0.44 110.431 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.5 p -114.21 87.59 13.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 116.061 -0.518 . . . . 0.44 110.245 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.592 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -115.25 145.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.578 2.852 . . . . 0.44 114.217 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.84 79.94 2.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.205 -2.146 . . . . 0.44 105.205 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.6 131.67 54.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.22 -1.354 . . . . 0.44 112.018 -175.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -178.92 -140.97 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.611 -0.722 . . . . 0.44 110.251 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 58.26 158.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.248 0.547 . . . . 0.44 112.116 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -120.97 110.69 16.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.362 -0.836 . . . . 0.44 110.296 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.59 -46.3 26.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.44 110.182 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.53 157.49 4.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.44 110.269 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 115.34 8.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.44 110.836 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -109.19 136.55 48.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.44 110.594 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -130.44 115.54 16.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.44 110.775 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -135.47 147.66 48.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.44 110.633 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 4.8 pt-20 -120.07 127.06 52.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.105 0.479 . . . . 0.44 111.284 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.06 163.51 59.65 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.553 -0.749 . . . . 0.44 110.439 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.1 Cg_endo -53.8 82.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.992 2.461 . . . . 0.44 112.404 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER 101.57 11.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.959 0.904 . . . . 0.44 111.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.29 150.01 47.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.44 110.773 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.42 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 4.6 m170 -124.0 101.53 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.44 110.891 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.64 128.31 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.44 111.081 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.75 118.94 28.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.486 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -126.15 115.17 19.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.44 111.439 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.565 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -106.81 122.87 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.44 110.509 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.439 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 7.3 m-30 -98.61 119.03 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.837 0.351 . . . . 0.44 111.095 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 21.4 m95 -101.25 149.2 24.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.161 -0.472 . . . . 0.44 111.069 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.2 tm? -102.49 102.91 13.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.441 0.639 . . . . 0.44 112.053 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.655 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 17.0 t -80.19 146.0 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 115.091 -0.959 . . . . 0.44 111.027 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.71 -23.24 9.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.625 1.343 . . . . 0.44 114.625 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.25 160.05 26.4 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.873 0.761 . . . . 0.44 111.606 -178.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.592 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -156.92 124.3 5.31 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.152 -0.477 . . . . 0.44 111.381 179.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -82.78 127.6 33.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.274 -0.421 . . . . 0.44 110.7 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.52 -125.18 6.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 0.44 112.324 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 69.4 mt-10 -135.08 138.43 29.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.44 110.928 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.11 128.74 10.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.76 2.307 . . . . 0.44 111.132 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.572 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.3 p-90 -135.5 -57.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.454 -0.498 . . . . 0.44 112.268 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 46.77 -94.29 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.927 -0.654 . . . . 0.44 112.868 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -178.87 34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.687 0.28 . . . . 0.44 111.156 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.29 -34.9 78.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.889 0.376 . . . . 0.44 110.412 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.26 68.57 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.909 -0.662 . . . . 0.44 113.342 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -140.28 95.95 8.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.44 111.325 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.6 133.44 7.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.989 2.459 . . . . 0.44 112.789 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.33 177.44 19.18 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.824 -0.703 . . . . 0.44 112.762 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -147.55 157.05 43.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.258 -0.275 . . . . 0.44 110.258 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.68 106.29 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.66 -0.416 . . . . 0.44 110.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 22.0 ptm -120.38 150.96 39.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.44 110.755 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.1 p -70.59 114.65 8.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.44 110.408 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -65.16 -21.54 66.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.44 111.213 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.89 -17.79 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 0.44 111.509 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.42 35.04 4.95 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.663 -0.78 . . . . 0.44 112.816 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 tp -62.5 125.7 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.027 -0.36 . . . . 0.44 110.027 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 139.5 54.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.49 0.552 . . . . 0.44 112.49 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -15.76 61.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.44 110.395 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.94 -48.56 14.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.24 -0.436 . . . . 0.44 111.456 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -40.38 88.13 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.626 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.99 174.17 6.53 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.571 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.1 Cg_endo -76.18 130.26 11.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.263 1.975 . . . . 0.44 111.457 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.76 -14.5 17.87 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.886 2.391 . . . . 0.44 113.556 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -10.57 13.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.729 0.64 . . . . 0.44 112.729 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -134.99 45.43 2.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.765 0.317 . . . . 0.44 111.553 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.09 -49.38 7.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.877 0.325 . . . . 0.44 111.877 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.2 Cg_exo -44.89 -36.74 11.33 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.455 2.103 . . . . 0.44 112.871 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.439 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 20.3 t -77.46 -51.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.431 . . . . 0.44 110.984 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' CE2' ' A' ' 115' ' ' PHE . 10.7 mm -65.36 -32.1 56.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.44 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.8 -27.9 45.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.997 0.427 . . . . 0.44 110.725 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -48.49 13.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.509 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.04 -28.87 49.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.44 111.476 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -55.5 -42.64 74.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.821 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -69.96 -7.72 42.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.44 109.804 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.986 -0.552 . . . . 0.44 111.216 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 tptt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.837 0.351 . . . . 0.44 110.905 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -113.98 145.16 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.44 110.679 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.0 pp -146.09 122.15 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.44 111.02 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -102.37 154.0 19.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.336 0.588 . . . . 0.44 111.869 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 81' ' ' THR . 3.4 mp -146.12 130.93 11.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.05 -0.977 . . . . 0.44 109.74 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.39 124.29 42.02 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.472 -0.566 . . . . 0.44 109.472 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -114.63 162.17 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.421 0.629 . . . . 0.44 111.913 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.54 106.01 0.43 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.086 -0.961 . . . . 0.44 111.985 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 2.8 mp -70.29 100.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.001 -0.74 . . . . 0.44 109.001 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -71.14 126.51 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.197 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -96.42 140.61 30.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.691 -0.686 . . . . 0.44 110.504 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.554 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -107.88 -172.39 2.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.89 0.853 . . . . 0.44 112.666 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.26 -18.26 63.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.948 -1.478 . . . . 0.44 112.259 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.15 39.12 2.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.885 0.374 . . . . 0.44 110.891 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.17 28.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.556 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -106.6 145.42 31.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.44 110.328 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -106.7 127.19 62.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 0.44 111.872 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' N ' HD11 ' A' ' 18' ' ' ILE . 51.0 t80 -78.09 87.49 4.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.599 -0.728 . . . . 0.44 109.753 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.494 HG12 HG13 ' A' ' 18' ' ' ILE . 1.2 pt -112.79 162.29 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.249 -0.432 . . . . 0.44 110.735 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.2 p . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 110.099 -0.334 . . . . 0.44 110.099 178.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t30 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.57 0.224 . . . . 0.44 111.565 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.28 26.16 10.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.89 0.376 . . . . 0.44 111.3 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 6.6 tt -39.58 93.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.655 -0.702 . . . . 0.44 111.307 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.1 tt0 -120.62 -168.88 1.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.44 111.164 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.75 158.16 50.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.44 111.713 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 18.0 Cg_endo -58.17 167.83 4.23 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.513 2.809 . . . . 0.44 111.496 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.56 59.24 0.75 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.143 -1.027 . . . . 0.44 113.692 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.626 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -125.15 120.7 4.02 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 114.447 -0.876 . . . . 0.44 112.026 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.55 5.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.329 0.652 . . . . 0.44 111.751 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.599 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.8 -26.03 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.486 0.66 . . . . 0.44 110.733 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.31 -82.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.79 -1.096 . . . . 0.44 111.185 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 33.67 -86.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.507 0.504 . . . . 0.44 111.86 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.24 31.87 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.44 112.503 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.99 -175.64 4.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.809 0.338 . . . . 0.44 111.16 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.579 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.04 159.58 28.84 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.463 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 7.0 Cg_endo -47.79 -24.44 4.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.628 2.218 . . . . 0.44 112.468 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.8 -47.45 5.57 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.213 0.449 . . . . 0.44 112.213 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -80.13 -25.57 39.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.813 0.301 . . . . 0.44 111.813 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -55.63 -47.54 76.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.809 0.337 . . . . 0.44 110.988 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 2.8 m -78.14 -45.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.44 111.194 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 53.7 t -62.58 -35.79 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.868 -0.605 . . . . 0.44 111.449 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -41.68 33.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.421 -0.354 . . . . 0.44 111.458 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -78.13 -26.23 47.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.637 -0.256 . . . . 0.44 111.318 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.465 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -57.57 -45.11 85.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.799 0.333 . . . . 0.44 110.572 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -26.85 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.311 0.577 . . . . 0.44 109.489 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.11 -26.76 53.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.328 -0.851 . . . . 0.44 111.117 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -108.32 5.16 25.29 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.33 0.492 . . . . 0.44 112.33 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' CG1' HG13 ' A' ' 60' ' ' ILE . 1.3 t -134.78 -44.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.282 0.563 . . . . 0.44 109.603 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 59.78 0.48 1.0 Allowed Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.166 -0.925 . . . . 0.44 114.412 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -105.51 -173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.605 0.702 . . . . 0.44 110.375 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -114.55 88.04 15.28 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.44 110.374 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HG2' ' HB3' ' A' ' 64' ' ' HIS . 98.3 Cg_endo -112.11 152.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.927 3.084 . . . . 0.44 113.478 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 35.5 mt-30 -74.76 78.67 2.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 103.433 -2.802 . . . . 0.44 103.433 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.566 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -111.19 120.25 41.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.555 -1.657 . . . . 0.44 112.089 -174.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -178.55 -148.19 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.44 110.666 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.99 161.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.163 0.506 . . . . 0.44 112.006 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -125.31 116.98 22.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.475 -0.784 . . . . 0.44 110.377 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -76.54 -56.55 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.44 109.924 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mt-10 -172.05 131.66 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.44 110.171 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.38 132.01 56.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.44 110.987 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.78 134.67 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.44 110.5 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.4 109.87 15.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.44 110.772 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -126.24 153.05 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.44 110.522 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.09 133.91 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.52 . . . . 0.44 111.412 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -96.6 162.92 21.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.483 -0.78 . . . . 0.44 110.146 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.442 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 5.7 Cg_endo -47.6 80.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.166 2.577 . . . . 0.44 112.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' PHE . 5.0 t0 86.45 12.73 0.15 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.485 -0.779 . . . . 0.44 111.641 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.41 94.82 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.733 0.302 . . . . 0.44 111.112 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -74.84 109.31 8.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.751 0.31 . . . . 0.44 110.844 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -106.99 111.97 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.44 111.029 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.55 125.71 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.44 110.655 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.45 114.88 18.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.69 0.281 . . . . 0.44 111.467 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.551 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -108.54 122.76 47.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.416 -0.356 . . . . 0.44 110.378 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 9.8 m-30 -101.67 121.0 41.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.44 111.086 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.5 m95 -101.64 149.23 24.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.103 -0.499 . . . . 0.44 111.448 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 65' ' ' PHE . 26.1 tp -100.18 103.44 14.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.613 0.597 . . . . 0.44 112.613 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 10.3 t -86.29 145.29 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.793 -0.639 . . . . 0.44 110.408 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.03 -32.83 9.51 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.372 1.249 . . . . 0.44 114.372 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.26 165.5 26.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.49 0.586 . . . . 0.44 111.59 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.554 ' CZ2' ' ND2' ' A' ' 13' ' ' ASN . 1.2 p90 -152.04 128.71 10.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.325 -0.398 . . . . 0.44 111.554 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -77.0 135.18 38.67 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.077 -0.51 . . . . 0.44 110.883 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.85 -125.84 20.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.661 -0.781 . . . . 0.44 112.431 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -132.92 143.22 47.68 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.527 0.203 . . . . 0.44 110.864 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.27 128.86 10.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.83 2.353 . . . . 0.44 111.408 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.582 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -125.36 -61.26 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.446 -0.502 . . . . 0.44 112.179 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.26 -103.64 0.04 OUTLIER Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.819 -0.705 . . . . 0.44 113.04 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 173.27 38.39 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.556 0.217 . . . . 0.44 111.093 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.48 -41.73 73.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.744 0.307 . . . . 0.44 110.793 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 110.79 -19.63 25.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.685 -0.769 . . . . 0.44 113.143 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.54 99.14 30.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.036 0.446 . . . . 0.44 111.477 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.62 146.43 1.39 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.172 2.581 . . . . 0.44 112.663 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.12 177.39 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.82 -0.705 . . . . 0.44 112.758 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -143.21 157.17 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.452 -0.203 . . . . 0.44 110.452 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.488 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -74.08 106.39 5.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.892 0.377 . . . . 0.44 110.211 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.1 ptm -120.42 163.0 18.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.937 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.95 114.89 23.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.44 110.814 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -64.32 -18.96 65.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.257 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.0 p -54.44 -20.46 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.379 -0.373 . . . . 0.44 111.682 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.74 42.57 1.43 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.369 -0.92 . . . . 0.44 113.222 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.94 150.29 42.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.806 0.303 . . . . 0.44 110.204 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.88 131.16 53.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.657 0.614 . . . . 0.44 112.657 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -14.84 61.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.449 -0.796 . . . . 0.44 110.538 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -49.22 13.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.408 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -38.82 86.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.887 0.375 . . . . 0.44 111.07 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.81 174.4 6.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.434 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.424 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 71.6 Cg_endo -75.21 127.76 10.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.176 1.917 . . . . 0.44 111.489 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.71 -15.0 39.31 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.667 2.245 . . . . 0.44 113.049 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.52 -9.76 57.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.982 0.364 . . . . 0.44 111.982 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.443 ' ND2' ' CE2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -122.64 28.67 7.22 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.44 111.755 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -70.64 -39.72 9.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.868 0.321 . . . . 0.44 111.868 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -53.5 -42.19 67.57 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.988 1.792 . . . . 0.44 112.308 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.43 -51.36 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.526 . . . . 0.44 110.849 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.42 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.31 -29.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.682 -0.69 . . . . 0.44 110.961 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -34.3 64.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.44 110.432 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.17 -49.63 66.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 0.44 110.91 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.416 HD21 ' CE1' ' A' ' 68' ' ' PHE . 9.2 tp -78.19 -28.63 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.44 111.271 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -57.08 -42.67 81.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.44 110.998 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -72.72 -5.09 35.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 0.44 109.983 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-N 116.018 -0.537 . . . . 0.44 111.059 179.682 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.847 0.355 . . . . 0.44 110.905 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 136.26 54.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.836 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.41 128.49 20.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.44 110.969 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -102.45 154.16 19.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.331 0.586 . . . . 0.44 111.777 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.2 mm -146.31 129.39 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.253 -0.885 . . . . 0.44 109.892 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.67 124.5 42.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 110.104 -0.332 . . . . 0.44 110.104 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.534 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.13 161.95 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.445 0.64 . . . . 0.44 111.972 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.04 121.43 1.19 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.968 -1.015 . . . . 0.44 111.642 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -73.77 108.85 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.618 -0.512 . . . . 0.44 109.618 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.482 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.26 127.79 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 0.44 111.709 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.09 131.67 43.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.364 -0.835 . . . . 0.44 111.123 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.752 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p-10 -87.8 -173.04 4.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.357 0.599 . . . . 0.44 111.909 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 22.1 tt0 -73.54 6.29 3.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.057 -0.974 . . . . 0.44 113.391 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 21.5 t-20 -130.33 45.06 2.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.048 -0.407 . . . . 0.44 112.052 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.9 p30 46.92 25.48 0.47 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.918 0.39 . . . . 0.44 111.369 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.53 161.61 18.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.197 -0.668 . . . . 0.44 109.197 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.471 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -116.3 144.37 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.058 0.456 . . . . 0.44 111.88 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.98 102.66 14.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.797 -0.638 . . . . 0.44 111.09 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.402 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.01 162.14 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.44 110.334 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . 10.1 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.328 . . . . 0.44 110.928 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t-20 . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 111.448 0.166 . . . . 0.44 111.448 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.33 26.35 10.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.056 0.391 . . . . 0.44 112.056 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -52.55 84.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.991 -0.549 . . . . 0.44 110.766 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -123.15 176.5 6.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.44 111.177 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.81 166.43 14.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 0.44 112.075 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.4 Cg_endo -47.44 168.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.924 3.083 . . . . 0.44 112.628 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.64 59.46 0.75 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.534 -0.841 . . . . 0.44 113.099 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.68 112.09 1.15 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 114.262 -0.969 . . . . 0.44 112.045 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.02 6.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.4 0.68 . . . . 0.44 111.853 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.602 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -55.06 -27.59 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.595 0.712 . . . . 0.44 110.271 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.9 -80.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.486 -1.234 . . . . 0.44 111.206 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.3 mmm 38.64 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.355 0.41 . . . . 0.44 111.662 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.68 33.79 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.44 112.67 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.487 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -96.94 -170.26 2.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.65 0.262 . . . . 0.44 111.019 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.581 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.9 159.04 30.68 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 116.567 -0.288 . . . . 0.44 110.287 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.581 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.91 -24.66 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.777 2.318 . . . . 0.44 112.5 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.91 -58.1 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.302 0.482 . . . . 0.44 112.302 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 8.0 pt20 -80.66 -4.88 55.9 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.497 0.554 . . . . 0.44 112.497 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -63.16 -57.27 11.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.44 111.013 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.427 HG12 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -78.78 -42.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.44 111.77 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.65 -35.65 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.551 -0.295 . . . . 0.44 111.203 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -78.21 -52.12 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.778 -0.369 . . . . 0.44 110.685 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -62.17 -20.09 63.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.44 110.625 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 2.1 tp -57.46 -44.67 85.0 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.575 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.93 -27.6 68.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.631 . . . . 0.44 109.914 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.19 -30.4 54.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.44 111.282 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.49 6.4 26.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.44 112.388 -178.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.572 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 43.4 t -133.43 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.811 -0.44 . . . . 0.44 109.811 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.78 -40.17 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.594 -0.73 . . . . 0.44 114.006 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.519 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.53 -177.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.06 0.457 . . . . 0.44 111.112 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.71 88.72 14.29 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 115.616 -0.72 . . . . 0.44 109.998 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.0 Cg_endo -111.55 146.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.404 2.736 . . . . 0.44 114.211 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.1 mt-30 -74.85 79.73 2.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.416 -2.068 . . . . 0.44 105.416 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.566 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.21 128.45 52.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.228 -1.351 . . . . 0.44 111.058 -176.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.11 -139.53 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.961 -0.563 . . . . 0.44 110.622 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.45 158.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.12 0.486 . . . . 0.44 111.85 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.6 tt -121.07 109.89 15.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.44 110.577 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.447 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -76.75 -43.39 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.977 0.418 . . . . 0.44 110.139 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt-10 -171.3 166.02 7.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.44 110.516 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.17 132.12 22.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.386 -0.37 . . . . 0.44 110.942 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 tp -117.4 124.55 49.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -122.28 110.16 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.649 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -140.67 153.16 45.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.686 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.25 140.22 48.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.296 0.569 . . . . 0.44 111.284 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.33 163.85 16.64 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.177 -0.919 . . . . 0.44 110.534 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 53.8 Cg_exo -41.58 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.458 2.772 . . . . 0.44 112.534 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.3 t0 73.56 20.67 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.44 110.597 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -137.31 93.87 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.44 110.317 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.54 98.61 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.44 110.94 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.62 111.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.44 110.885 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.98 133.83 43.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.1 mt -126.22 114.36 18.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.44 111.489 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.51 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.14 122.7 48.23 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.686 -0.487 . . . . 0.44 109.686 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.6 125.2 50.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.44 111.21 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 67.5 m95 -107.57 148.56 29.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.127 -0.488 . . . . 0.44 111.149 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.2 tp -98.97 103.01 14.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.326 0.584 . . . . 0.44 111.261 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.566 HG13 ' HA ' ' A' ' 64' ' ' HIS . 13.3 t -81.84 145.61 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.231 -0.895 . . . . 0.44 111.845 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.63 -35.34 6.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.602 1.334 . . . . 0.44 114.602 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.56 165.66 25.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.843 0.747 . . . . 0.44 112.014 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.752 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.5 p90 -151.02 130.76 13.16 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.63 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.6 139.67 40.73 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.2 -0.454 . . . . 0.44 110.815 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.43 -121.84 23.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.666 -0.778 . . . . 0.44 112.442 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -131.94 145.59 58.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.558 0.218 . . . . 0.44 110.835 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.63 128.71 10.4 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.841 2.361 . . . . 0.44 111.363 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.6 p-90 -133.34 -60.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.397 -0.521 . . . . 0.44 112.133 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.572 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.05 -100.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.921 -0.657 . . . . 0.44 113.001 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.56 32.85 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.61 0.243 . . . . 0.44 111.248 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.433 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.3 pt-20 -64.79 -27.04 68.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.35 . . . . 0.44 110.688 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.14 31.6 81.28 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.926 -0.654 . . . . 0.44 112.729 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.423 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 5.9 mm-40 -140.42 91.96 9.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.045 0.45 . . . . 0.44 111.253 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -43.6 126.51 5.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.025 2.483 . . . . 0.44 112.854 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 177.2 19.35 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.676 -0.773 . . . . 0.44 112.762 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.34 157.16 42.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.429 -0.211 . . . . 0.44 110.429 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -68.83 106.28 2.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.44 110.047 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.9 ptm -120.39 147.41 45.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.079 -0.51 . . . . 0.44 111.042 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.0 p -70.76 115.08 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.44 111.072 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -18.65 61.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.984 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.414 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 12.1 p -59.02 -9.94 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.31 -0.405 . . . . 0.44 111.783 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.13 50.36 0.89 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.834 -0.698 . . . . 0.44 112.164 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -62.11 142.27 57.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.44 110.404 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' N ' HD11 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -119.2 114.77 22.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.295 0.479 . . . . 0.44 112.295 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.27 61.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 0.44 110.242 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.94 -49.11 13.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.276 -0.42 . . . . 0.44 111.273 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -68.44 -33.43 74.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.768 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.06 174.03 6.63 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.434 -0.348 . . . . 0.44 110.406 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 64.4 Cg_endo -74.23 127.78 11.54 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.134 1.889 . . . . 0.44 111.387 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.86 -14.85 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.742 2.295 . . . . 0.44 113.285 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.4 -9.82 37.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.376 0.509 . . . . 0.44 112.376 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.16 37.82 3.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.833 0.308 . . . . 0.44 111.833 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -72.19 -43.99 10.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.53 0.196 . . . . 0.44 111.53 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -54.78 -38.96 91.76 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.106 1.871 . . . . 0.44 112.169 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.447 HG11 ' CE1' ' A' ' 68' ' ' PHE . 2.2 t -77.45 -51.31 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.793 -0.64 . . . . 0.44 111.01 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.518 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.36 -29.85 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.617 -0.719 . . . . 0.44 110.974 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.72 -31.06 57.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.393 . . . . 0.44 110.443 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -69.62 -52.43 25.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.44 110.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 2.7 tp -78.21 -19.53 53.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.44 111.585 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 123' ' ' ILE . 18.1 ttpp -72.41 -42.62 64.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.44 110.892 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -76.02 -3.65 36.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.44 110.131 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.38 -0.373 . . . . 0.44 110.849 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.841 0.353 . . . . 0.44 110.919 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 132.76 56.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.44 110.864 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -138.38 128.06 25.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.913 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -102.48 154.19 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.275 0.559 . . . . 0.44 111.792 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.9 mm -146.33 129.04 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.303 -0.862 . . . . 0.44 109.923 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.67 124.54 42.41 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 110.12 -0.326 . . . . 0.44 110.12 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.43 162.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.339 0.59 . . . . 0.44 111.893 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.95 120.85 1.12 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.44 111.688 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.479 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.76 108.94 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.536 -0.542 . . . . 0.44 109.536 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.48 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.32 127.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.44 111.796 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.03 132.37 42.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.349 -0.841 . . . . 0.44 111.081 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.752 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.7 p-10 -88.95 -173.01 3.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.368 0.604 . . . . 0.44 111.931 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 23.1 tt0 -73.29 5.8 3.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.005 -0.998 . . . . 0.44 113.391 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 19.7 t-20 -129.92 44.93 2.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.673 -0.411 . . . . 0.44 111.982 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.7 p30 46.76 25.61 0.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.427 . . . . 0.44 111.396 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.42 161.62 18.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.227 -0.657 . . . . 0.44 109.227 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.47 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -116.55 144.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.032 0.444 . . . . 0.44 111.828 -178.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.48 102.18 13.96 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.715 -0.675 . . . . 0.44 111.099 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.14 162.08 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.44 110.362 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.42 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . 11.0 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.44 110.981 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.8 t-20 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.551 0.215 . . . . 0.44 111.412 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -114.41 26.32 10.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.009 0.374 . . . . 0.44 112.009 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -52.66 84.71 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.925 -0.58 . . . . 0.44 110.752 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -124.03 176.72 6.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.44 111.108 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.76 166.25 15.37 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.062 0.458 . . . . 0.44 112.014 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.5 Cg_endo -47.62 168.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.85 3.033 . . . . 0.44 112.527 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.54 59.47 0.75 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.485 -0.864 . . . . 0.44 113.112 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.84 110.33 0.95 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.252 -0.974 . . . . 0.44 112.039 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.627 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 118.14 4.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.344 0.658 . . . . 0.44 111.734 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.602 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.65 -27.91 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.561 0.696 . . . . 0.44 110.343 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.54 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.521 -1.218 . . . . 0.44 111.26 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 78.4 mmm 39.13 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.304 0.377 . . . . 0.44 111.586 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.67 33.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.649 -0.786 . . . . 0.44 112.702 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.488 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -96.92 -170.15 1.99 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.555 0.217 . . . . 0.44 111.055 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.58 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.55 158.97 30.85 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 110.272 -0.27 . . . . 0.44 110.272 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.88 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.902 2.402 . . . . 0.44 112.496 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.66 -58.29 2.4 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.259 0.466 . . . . 0.44 112.259 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -80.72 -4.78 55.68 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.462 0.541 . . . . 0.44 112.462 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.488 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -62.85 -57.24 11.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.792 0.329 . . . . 0.44 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -78.76 -42.75 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.165 -0.47 . . . . 0.44 111.783 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -50.66 -35.55 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.525 -0.307 . . . . 0.44 111.225 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -52.15 9.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.379 . . . . 0.44 110.926 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.0 mm-40 -63.34 -19.84 64.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.693 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.452 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 2.7 tp -56.76 -44.68 82.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.071 0.462 . . . . 0.44 110.541 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.73 -27.02 68.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.778 -0.647 . . . . 0.44 109.899 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.2 tm-20 -77.2 -30.63 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.44 111.23 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.44 6.69 26.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.414 0.524 . . . . 0.44 112.414 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.574 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 43.8 t -133.48 -44.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.754 -0.461 . . . . 0.44 109.754 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -40.1 0.25 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.7 -0.682 . . . . 0.44 113.951 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.519 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.46 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.014 0.435 . . . . 0.44 111.095 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.55 88.7 13.85 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.659 -0.701 . . . . 0.44 109.996 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.606 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.8 Cg_endo -111.48 146.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 123.394 2.729 . . . . 0.44 114.219 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.414 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.8 mt-30 -74.74 79.64 2.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.45 -2.056 . . . . 0.44 105.45 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.567 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.94 128.64 52.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.234 -1.348 . . . . 0.44 111.006 -176.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.04 -139.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.44 110.587 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.83 157.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.099 0.476 . . . . 0.44 111.86 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.3 tt -119.71 109.44 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.814 -0.63 . . . . 0.44 110.614 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.448 ' HD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -76.79 -43.54 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.44 110.151 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 2.7 mt-10 -171.24 165.66 7.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.44 110.624 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 132.11 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.386 -0.37 . . . . 0.44 110.882 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 tp -116.89 123.75 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.736 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -121.5 109.99 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.44 110.638 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -140.89 153.25 45.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.44 110.706 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -114.22 140.2 48.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.273 0.558 . . . . 0.44 111.307 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.75 163.84 16.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.257 -0.883 . . . . 0.44 110.475 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 54.1 Cg_exo -41.36 81.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.338 2.692 . . . . 0.44 112.554 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.6 t0 73.62 20.48 3.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.44 110.607 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -137.23 93.92 2.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.44 110.36 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.6 98.82 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.44 110.942 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.64 111.87 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.064 -0.517 . . . . 0.44 110.887 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.52 133.76 44.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.475 . . . . 0.44 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.1 mt -126.16 114.39 18.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.44 111.453 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.506 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.08 122.66 48.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.786 -0.45 . . . . 0.44 109.786 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.46 125.73 51.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.348 . . . . 0.44 111.269 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 67.6 m95 -107.86 148.5 29.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.115 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.7 tp -98.74 102.81 14.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.297 0.57 . . . . 0.44 111.332 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 64' ' ' HIS . 13.9 t -81.5 145.65 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.44 111.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -109.53 -35.17 6.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.584 1.327 . . . . 0.44 114.584 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.44 165.64 26.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.845 0.748 . . . . 0.44 112.017 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.752 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.4 p90 -151.47 130.54 12.63 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 0.44 111.572 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -76.35 140.87 41.62 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.827 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.16 -121.94 25.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.665 -0.779 . . . . 0.44 112.468 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -131.84 145.81 59.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.536 0.208 . . . . 0.44 110.779 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.484 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.72 128.76 10.36 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.836 2.357 . . . . 0.44 111.362 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.554 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.8 p-90 -133.51 -60.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.355 -0.538 . . . . 0.44 112.124 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.84 -99.66 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.904 -0.665 . . . . 0.44 113.02 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.46 33.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.554 0.216 . . . . 0.44 111.278 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.437 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.8 pt-20 -65.57 -26.81 68.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 0.44 110.608 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.54 32.04 82.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.926 -0.654 . . . . 0.44 112.836 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.42 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 6.5 mm-40 -140.38 92.2 9.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.44 111.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -43.57 126.37 5.38 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.091 2.527 . . . . 0.44 112.817 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.27 177.17 19.37 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.749 -0.738 . . . . 0.44 112.853 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.92 157.14 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.459 -0.2 . . . . 0.44 110.459 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -69.01 106.23 2.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.887 0.375 . . . . 0.44 110.031 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.6 ptm -120.47 148.12 44.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.036 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.4 p -70.89 114.97 9.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.436 -0.347 . . . . 0.44 111.058 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -18.7 60.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.032 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 11.9 p -59.3 -9.63 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.36 -0.382 . . . . 0.44 111.836 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.45 49.62 0.92 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.44 112.276 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -62.22 142.11 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.674 0.273 . . . . 0.44 110.42 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' N ' HD11 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -120.04 115.87 24.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.367 0.506 . . . . 0.44 112.367 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.16 61.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.821 -0.627 . . . . 0.44 110.211 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -49.03 13.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.228 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -68.39 -33.51 74.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.297 -0.41 . . . . 0.44 111.76 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.14 174.02 6.64 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.448 -0.342 . . . . 0.44 110.394 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.47 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.5 Cg_endo -73.95 127.81 11.78 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.107 1.871 . . . . 0.44 111.363 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.02 -14.83 30.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.738 2.292 . . . . 0.44 113.266 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -9.75 39.58 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.392 0.516 . . . . 0.44 112.392 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.07 37.82 3.86 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.827 0.306 . . . . 0.44 111.827 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.84 -43.87 11.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 111.528 0.195 . . . . 0.44 111.528 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.2 Cg_exo -54.76 -38.92 91.62 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.134 1.889 . . . . 0.44 112.244 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 68' ' ' PHE . 2.3 t -77.55 -51.31 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.44 111.036 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.521 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.41 -29.87 47.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.7 . . . . 0.44 111.027 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.66 -30.95 56.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.987 0.422 . . . . 0.44 110.409 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -69.8 -52.52 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.821 -0.627 . . . . 0.44 110.868 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 2.9 tp -78.16 -19.52 53.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.44 111.568 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.23 -42.74 65.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.114 0.483 . . . . 0.44 110.882 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -75.58 -3.92 37.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.44 110.176 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.821 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttp . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.829 0.347 . . . . 0.44 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 121.94 19.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.44 110.833 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.51 125.99 54.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.761 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 10.8 mt-30 -102.95 160.05 14.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.09 0.472 . . . . 0.44 111.482 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.8 mt -144.8 135.2 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.44 110.461 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.618 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.39 150.11 45.95 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.735 -0.468 . . . . 0.44 109.735 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.99 149.95 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.938 0.399 . . . . 0.44 111.143 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.6 111.35 0.5 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.614 -0.803 . . . . 0.44 112.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.528 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -81.13 109.62 15.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.849 -0.797 . . . . 0.44 108.849 178.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.449 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -71.03 119.38 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.228 0.537 . . . . 0.44 111.82 -178.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 1.4 mmt85 -83.22 124.31 30.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.518 -0.765 . . . . 0.44 111.756 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.507 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -78.05 -172.92 2.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.22 -0.9 . . . . 0.44 110.528 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 3.0 tt0 -85.74 16.46 3.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.871 -0.604 . . . . 0.44 112.553 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -142.63 50.59 1.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.785 -0.366 . . . . 0.44 111.919 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.0 25.6 0.5 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.142 0.496 . . . . 0.44 111.217 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' ' HA ' ' A' ' 106' ' ' SER . 39.4 mt-10 -120.54 161.47 21.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.754 -0.832 . . . . 0.44 108.754 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 HG21 ' N ' ' A' ' 19' ' ' PHE . 13.0 mt -122.26 139.25 49.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.211 0.529 . . . . 0.44 111.356 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -86.19 94.36 9.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.406 -0.816 . . . . 0.44 110.869 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -114.48 148.59 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.44 109.688 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 1.8 t . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.809 -0.356 . . . . 0.44 110.433 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.832 0.349 . . . . 0.44 111.08 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -114.11 26.3 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.44 111.112 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 21.5 tp -64.04 70.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.44 110.89 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -118.37 178.08 4.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.009 0.433 . . . . 0.44 111.508 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.468 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.03 162.36 33.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.886 -0.597 . . . . 0.44 112.187 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 8.0 Cg_endo -48.02 169.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.941 3.094 . . . . 0.44 111.482 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.48 59.97 0.71 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 119.742 -1.218 . . . . 0.44 113.664 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -144.42 107.64 0.45 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 114.222 -0.989 . . . . 0.44 111.67 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.96 -10.79 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.516 0.726 . . . . 0.44 110.513 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.533 ' O ' ' C ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -43.75 -78.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.044 0.449 . . . . 0.44 110.961 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 5.38 -80.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.862 -1.063 . . . . 0.44 112.344 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttm 37.29 -133.43 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.416 -0.356 . . . . 0.44 111.378 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.32 14.81 5.6 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.576 -0.821 . . . . 0.44 113.033 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.417 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -71.09 -164.56 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.44 110.805 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.523 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.62 154.41 37.49 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 110.146 -0.316 . . . . 0.44 110.146 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.29 -24.82 1.07 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.696 2.264 . . . . 0.44 112.321 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.28 -47.97 4.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.99 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.37 -7.15 58.97 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.884 0.328 . . . . 0.44 111.884 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -65.53 -55.62 16.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.565 0.221 . . . . 0.44 111.216 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.27 -40.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.007 -0.277 . . . . 0.44 111.06 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -50.58 -35.4 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.44 110.432 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -42.76 31.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.457 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -67.26 -26.12 66.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.44 110.251 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.468 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.1 tp -52.55 -44.35 65.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.993 -0.549 . . . . 0.44 110.452 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.54 -33.08 74.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.44 110.1 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -77.36 -25.57 51.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.732 -0.667 . . . . 0.44 111.149 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.18 5.19 25.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.895 0.332 . . . . 0.44 111.895 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.499 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 18.4 t -135.22 -44.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.319 0.581 . . . . 0.44 110.309 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.605 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.48 4.62 1.39 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.234 -0.894 . . . . 0.44 114.604 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -122.07 -173.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 117.897 0.848 . . . . 0.44 110.831 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.9 p -113.72 87.48 12.24 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-N 115.843 -0.617 . . . . 0.44 109.545 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.629 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.1 Cg_endo -115.27 149.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.643 2.895 . . . . 0.44 114.22 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.02 79.82 2.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.366 -2.087 . . . . 0.44 105.366 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.573 ' CD2' ' CG2' ' A' ' 87' ' ' VAL . 1.3 t-160 -123.5 130.5 52.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.553 -1.203 . . . . 0.44 111.244 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.55 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -177.86 -139.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.872 -0.604 . . . . 0.44 110.794 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.79 175.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.44 111.847 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.726 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -143.11 123.96 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.813 -0.631 . . . . 0.44 110.926 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.55 -44.61 34.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.498 . . . . 0.44 109.796 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.45 164.83 6.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.465 -0.789 . . . . 0.44 110.036 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 127.69 17.49 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.995 -0.282 . . . . 0.44 110.914 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.7 tp -106.63 121.09 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.44 110.503 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -122.22 112.01 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.44 110.92 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -141.04 148.06 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.44 110.45 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -121.08 139.97 52.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.44 111.457 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -105.04 162.76 18.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.485 -0.78 . . . . 0.44 110.285 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 7.6 Cg_endo -49.72 82.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.099 2.533 . . . . 0.44 112.25 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.2 m-20 87.74 11.35 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.361 -0.836 . . . . 0.44 111.595 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.28 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 0.44 110.866 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -80.34 107.15 12.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 0.44 111.094 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 tt -100.42 111.74 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.601 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.71 135.11 42.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.44 110.924 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.401 ' CD2' ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -126.26 114.44 18.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.429 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.454 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -116.15 122.79 46.12 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.322 -0.251 . . . . 0.44 110.322 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.7 m-85 -113.6 113.44 25.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.877 0.37 . . . . 0.44 110.273 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.726 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 44.0 m95 -94.77 148.59 22.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.011 -0.541 . . . . 0.44 111.452 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 65' ' ' PHE . 50.4 tp -104.8 102.73 12.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.391 0.615 . . . . 0.44 111.251 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.573 ' CG2' ' CD2' ' A' ' 64' ' ' HIS . 12.6 t -80.88 145.8 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 115.162 -0.926 . . . . 0.44 111.291 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.77 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.674 1.361 . . . . 0.44 114.674 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -161.78 165.52 27.82 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.868 0.758 . . . . 0.44 112.065 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.629 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 2.1 p90 -149.84 131.49 14.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.058 -0.519 . . . . 0.44 111.489 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.53 136.38 33.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.401 -0.363 . . . . 0.44 110.921 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -140.82 19.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.44 112.526 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.0 tt0 -115.1 129.82 24.75 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.383 0.135 . . . . 0.44 110.731 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.556 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.55 128.78 10.51 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.649 2.233 . . . . 0.44 111.721 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.605 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.1 p-90 -135.3 -57.74 0.8 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.458 -0.497 . . . . 0.44 111.866 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.502 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 43.51 -104.07 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.762 -0.732 . . . . 0.44 113.137 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 166.57 40.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.798 0.332 . . . . 0.44 110.885 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -41.26 91.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.44 110.981 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.97 -104.03 0.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.532 -0.842 . . . . 0.44 112.932 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -92.95 120.61 66.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.44 111.59 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -43.62 146.14 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.066 2.511 . . . . 0.44 112.682 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.31 19.23 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.85 -0.69 . . . . 0.44 112.808 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.5 157.23 29.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.621 0.248 . . . . 0.44 110.735 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.447 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.1 m0 -60.39 106.87 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.44 110.426 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -120.19 156.73 30.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.325 -0.398 . . . . 0.44 111.043 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 5.0 t -81.1 116.86 21.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.865 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 6.3 tp -72.66 -18.7 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.347 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t -49.67 -21.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.72 0.295 . . . . 0.44 111.452 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.23 50.51 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.958 -0.639 . . . . 0.44 111.886 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.12 150.31 38.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.44 110.686 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -104.11 101.22 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.457 0.54 . . . . 0.44 112.457 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -16.89 61.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.27 0.557 . . . . 0.44 110.083 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.51 -48.81 13.24 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.053 -0.522 . . . . 0.44 111.073 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -35.64 80.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.911 -0.586 . . . . 0.44 112.008 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.523 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.6 169.19 21.87 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.545 -0.298 . . . . 0.44 110.415 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.4 Cg_endo -54.63 131.8 47.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.55 2.167 . . . . 0.44 112.93 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.504 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.17 -14.07 37.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.072 2.515 . . . . 0.44 112.627 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.04 58.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.971 0.36 . . . . 0.44 111.971 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 82' ' ' LEU . 1.7 m-20 -121.38 25.89 9.18 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.915 0.709 . . . . 0.44 112.915 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.02 -38.84 3.94 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 112.124 0.416 . . . . 0.44 112.124 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.9 Cg_exo -44.82 -41.9 15.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.181 1.921 . . . . 0.44 113.204 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.463 HG22 ' CE1' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -77.42 -51.34 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 0.44 111.071 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.523 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.1 mm -65.37 -29.93 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.44 111.222 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.64 -32.23 63.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.13 0.49 . . . . 0.44 110.35 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -71.06 -48.58 51.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.44 111.212 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.456 ' CB ' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -78.24 -30.8 48.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.44 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -54.9 -42.64 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.974 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -67.16 -10.1 46.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.653 . . . . 0.44 109.8 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.968 -0.56 . . . . 0.44 111.069 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.791 0.329 . . . . 0.44 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.79 131.88 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.801 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.5 pp -125.57 123.02 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.048 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.4 153.75 19.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.339 0.59 . . . . 0.44 111.658 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' THR . 89.3 mt -146.36 131.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.44 110.107 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.6 124.46 42.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.28 -0.267 . . . . 0.44 110.28 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.467 HG23 ' CD1' ' A' ' 35' ' ' PHE . 1.5 m -117.13 162.68 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.45 . . . . 0.44 111.697 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.46 115.0 0.83 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.811 -0.709 . . . . 0.44 112.606 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.593 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.5 mp -70.61 95.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.938 -0.764 . . . . 0.44 108.938 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.625 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -71.0 111.82 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.387 0.613 . . . . 0.44 112.47 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -85.51 136.26 33.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.231 -0.895 . . . . 0.44 111.046 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.629 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 23.5 p30 -105.94 -172.89 2.17 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.766 0.793 . . . . 0.44 112.687 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -68.21 -4.4 13.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.44 113.693 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 56.2 t30 -124.19 42.51 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.638 -0.425 . . . . 0.44 112.087 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 46.22 27.05 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.44 111.613 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HG3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -123.29 160.85 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.444 -0.576 . . . . 0.44 109.444 178.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -118.85 146.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.378 0.608 . . . . 0.44 112.295 -178.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t80 -90.04 95.79 10.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.44 109.86 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.513 HG12 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -108.34 162.19 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.284 -0.416 . . . . 0.44 110.052 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 110.063 -0.347 . . . . 0.44 110.063 179.356 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.665 0.269 . . . . 0.44 111.374 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.5 26.18 10.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.717 0.294 . . . . 0.44 111.65 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.0 tt -54.15 83.71 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.986 -0.552 . . . . 0.44 110.757 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.78 -179.08 3.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.84 0.353 . . . . 0.44 111.412 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 160.98 40.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.962 -0.563 . . . . 0.44 111.648 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 29.0 Cg_endo -61.5 168.09 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.484 2.789 . . . . 0.44 111.528 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.45 59.34 0.75 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 119.806 -1.188 . . . . 0.44 113.98 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.94 121.02 3.43 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.777 -0.711 . . . . 0.44 112.05 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 115.02 6.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.382 0.673 . . . . 0.44 111.817 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.596 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -58.24 -25.92 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.582 0.706 . . . . 0.44 110.573 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -45.1 -85.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.738 -1.119 . . . . 0.44 111.24 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 38.29 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.312 0.383 . . . . 0.44 111.615 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.57 32.68 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 0.44 112.541 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.7 mp0 -91.6 -176.46 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.86 0.362 . . . . 0.44 111.222 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.543 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.64 156.17 35.62 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.314 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.99 -24.77 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.797 2.331 . . . . 0.44 112.715 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.32 -48.27 5.39 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.019 0.378 . . . . 0.44 112.019 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -80.27 -14.01 58.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.944 0.35 . . . . 0.44 111.944 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.93 -52.97 62.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.44 111.073 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.1 m -77.93 -44.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.936 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.496 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 46.6 t -57.77 -35.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 0.44 111.127 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -52.09 9.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 40' ' ' ILE . 2.1 mm-40 -65.42 -24.21 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.839 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.481 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -52.2 -44.27 64.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.88 0.371 . . . . 0.44 110.345 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -36.6 78.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.144 -0.688 . . . . 0.44 109.144 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.86 -25.03 48.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.243 -0.89 . . . . 0.44 111.493 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 76.4 mm-40 -108.44 5.94 25.79 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.478 0.547 . . . . 0.44 112.478 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.458 ' CG1' HG13 ' A' ' 60' ' ' ILE . 14.5 t -134.37 -44.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.44 110.543 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.504 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 60.59 5.29 4.88 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.623 -0.717 . . . . 0.44 114.353 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -122.5 -166.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 117.859 0.829 . . . . 0.44 110.852 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.419 HG22 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -112.57 88.08 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.44 110.73 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 16.4 Cg_endo -113.57 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.49 2.793 . . . . 0.44 114.462 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 27.8 mt-30 -74.65 79.39 2.01 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.508 -2.404 . . . . 0.44 104.508 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.536 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -113.04 132.9 55.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.12 -1.4 . . . . 0.44 110.684 -175.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -177.12 -143.1 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.025 -0.534 . . . . 0.44 110.829 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m 52.14 171.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.44 112.245 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.8 tt -134.24 114.48 13.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.445 -0.798 . . . . 0.44 110.452 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CD2' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.49 -56.04 4.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.44 109.811 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -171.51 131.84 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 0.44 110.241 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -114.59 132.08 56.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.812 0.339 . . . . 0.44 110.893 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HB2' HG21 ' A' ' 122' ' ' VAL . 7.5 tp -107.34 141.44 38.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.44 110.804 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -131.32 109.72 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.44 110.683 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 80' ' ' ILE . 1.8 p90 -141.02 138.25 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.44 110.296 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 8.3 pt-20 -107.41 140.11 40.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.262 0.553 . . . . 0.44 111.718 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -101.34 163.05 18.65 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.324 -0.853 . . . . 0.44 110.053 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 4.2 Cg_endo -46.6 81.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.196 2.598 . . . . 0.44 112.532 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.3 m-20 85.61 11.87 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.418 -0.81 . . . . 0.44 111.689 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -137.42 94.89 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.44 111.03 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 12.6 t-160 -74.84 97.92 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.44 110.997 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.43 HG22 ' CE2' ' A' ' 73' ' ' TYR . 3.0 tt -94.47 111.93 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.44 110.9 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.03 129.43 54.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.44 110.84 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.45 114.75 18.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.44 111.425 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -110.29 122.88 48.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.463 -0.335 . . . . 0.44 110.464 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 11.7 m-30 -103.22 113.08 26.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.839 0.352 . . . . 0.44 110.778 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.9 m95 -95.07 148.86 21.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.162 -0.472 . . . . 0.44 111.548 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.2 tm? -90.9 102.87 15.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.225 0.536 . . . . 0.44 111.551 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.593 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 20.9 t -89.53 144.87 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 115.529 -0.759 . . . . 0.44 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.52 ' C ' ' HG2' ' A' ' 89' ' ' ARG . 4.7 pm0 -121.28 -13.5 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.46 1.652 . . . . 0.44 115.46 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -160.94 160.05 30.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.044 1.293 . . . . 0.44 112.357 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -158.0 122.17 4.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.764 -0.653 . . . . 0.44 110.73 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.419 ' CB ' HG22 ' A' ' 61' ' ' THR . 1.5 mm-40 -83.33 117.98 23.37 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.882 0.372 . . . . 0.44 111.096 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.3 -125.61 8.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.44 112.531 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.13 136.12 28.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.577 -0.156 . . . . 0.44 110.577 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.99 128.91 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.766 2.311 . . . . 0.44 111.285 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 50.8 p-90 -140.95 -58.09 0.5 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.429 -0.509 . . . . 0.44 112.129 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 47.87 -93.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.679 -0.772 . . . . 0.44 112.501 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -171.93 33.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.761 0.315 . . . . 0.44 110.787 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -62.0 -47.09 86.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.585 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.46 -24.4 32.36 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.735 -0.745 . . . . 0.44 113.277 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -112.27 95.67 31.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.44 111.574 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.5 146.14 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.173 2.582 . . . . 0.44 112.767 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.71 18.95 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.835 -0.698 . . . . 0.44 112.76 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.43 154.39 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.289 -0.263 . . . . 0.44 110.289 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.518 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -66.83 105.62 1.64 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.663 -0.415 . . . . 0.44 110.073 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.419 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.1 ptm -121.06 153.38 37.48 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.108 -0.496 . . . . 0.44 111.378 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 5.4 p -74.21 114.96 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 0.44 111.146 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.405 ' HB2' HG23 ' A' ' 18' ' ' ILE . 1.9 tm? -60.78 -24.45 65.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.914 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.49 -19.78 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.44 111.617 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.96 35.15 4.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.555 -0.831 . . . . 0.44 113.025 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.8 tp -62.83 130.23 43.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.44 110.012 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.12 136.07 54.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.684 0.624 . . . . 0.44 112.684 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.38 -15.43 61.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.425 -0.807 . . . . 0.44 110.657 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -78.85 -49.1 13.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.299 -0.409 . . . . 0.44 111.624 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -35.26 77.96 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.488 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -82.82 174.02 6.67 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.473 -0.33 . . . . 0.44 110.636 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 68.4 Cg_endo -74.75 127.99 11.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.256 1.971 . . . . 0.44 111.488 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.13 -14.74 25.03 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.774 2.316 . . . . 0.44 113.35 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.99 -9.9 25.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.382 0.512 . . . . 0.44 112.382 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.86 41.0 3.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.78 0.324 . . . . 0.44 111.439 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.29 -46.3 7.85 Favored Pre-proline 0 N--CA 1.464 0.241 0 N-CA-C 112.205 0.446 . . . . 0.44 112.205 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.1 Cg_exo -47.83 -40.27 31.98 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.218 1.945 . . . . 0.44 112.816 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 71' ' ' LEU . 2.3 t -77.52 -51.42 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.504 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.4 mm -65.45 -29.96 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.44 110.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.27 -31.61 63.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.987 0.423 . . . . 0.44 110.627 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -50.06 36.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.44 111.11 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.17 -26.39 47.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.297 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.25 -42.67 86.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.44 110.814 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.04 -8.6 46.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.44 109.779 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-N 115.952 -0.567 . . . . 0.44 111.004 179.696 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.758 0.313 . . . . 0.44 110.983 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 121.92 13.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.4 pp -100.36 121.02 40.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.751 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -102.61 151.32 22.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.44 111.153 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.422 ' N ' ' O ' ' A' ' 81' ' ' THR . 2.8 mp -140.06 139.0 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.503 -0.771 . . . . 0.44 110.486 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.716 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.78 140.8 52.6 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.469 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -144.49 149.78 17.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.427 -0.509 . . . . 0.44 111.167 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.67 125.52 1.88 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.712 -0.756 . . . . 0.44 112.402 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.8 109.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.284 -0.636 . . . . 0.44 109.284 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.521 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -71.16 121.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.157 0.503 . . . . 0.44 111.318 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.632 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -85.94 120.06 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.732 . . . . 0.44 111.129 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 27.5 p-10 -74.62 -171.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.313 -0.858 . . . . 0.44 111.914 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 8.3 tp10 -86.81 19.0 3.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.467 -1.242 . . . . 0.44 112.067 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -144.5 27.73 1.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.746 0.308 . . . . 0.44 111.663 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.61 3.86 4.72 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.754 0.279 . . . . 0.44 111.754 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 1.5 mm-40 -100.76 159.89 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.134 -0.691 . . . . 0.44 109.134 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 19' ' ' PHE . 7.0 mt -125.28 141.78 44.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.44 111.496 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.442 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -90.38 113.47 25.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.44 110.793 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.01 162.05 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.44 110.398 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.44 110.315 179.266 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.67 0.271 . . . . 0.44 111.295 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -114.29 26.05 10.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.012 0.434 . . . . 0.44 111.515 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.02 87.73 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.77 -0.65 . . . . 0.44 110.316 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -169.42 2.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.44 111.526 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.478 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.95 165.44 17.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.44 111.792 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.6 Cg_endo -47.83 168.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.788 2.992 . . . . 0.44 111.844 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.716 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.15 59.84 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.91 -1.138 . . . . 0.44 114.249 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.92 109.44 0.66 Allowed Glycine 0 C--N 1.312 -0.761 0 CA-C-N 114.473 -0.864 . . . . 0.44 111.697 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 122.32 -8.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.463 0.705 . . . . 0.44 110.853 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.2 -65.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.256 0.55 . . . . 0.44 111.41 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -13.6 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.473 -1.24 . . . . 0.44 112.472 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 43.0 -94.0 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.421 -0.354 . . . . 0.44 111.598 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.23 18.11 0.09 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.479 -0.867 . . . . 0.44 113.579 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -79.55 -163.0 0.46 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.842 -0.211 . . . . 0.44 110.801 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.535 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.86 154.76 38.39 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.097 -0.334 . . . . 0.44 110.097 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.8 -24.86 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.702 2.268 . . . . 0.44 112.399 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.65 -52.22 4.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.358 -0.383 . . . . 0.44 112.015 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -80.51 -4.93 55.76 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.867 0.321 . . . . 0.44 111.867 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -66.19 -57.01 8.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.711 -0.222 . . . . 0.44 111.101 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.32 -40.65 25.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.44 111.264 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.7 t -50.46 -35.48 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.44 110.935 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -52.12 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 0.44 111.118 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.89 -25.59 67.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.44 110.65 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.408 ' CD2' ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -54.61 -44.43 73.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.192 -0.458 . . . . 0.44 110.576 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -27.41 67.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.44 109.734 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -77.14 -25.58 52.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.682 -0.69 . . . . 0.44 111.233 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -108.42 5.74 25.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.431 0.53 . . . . 0.44 112.431 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.549 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 16.4 t -134.53 -44.55 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.263 0.554 . . . . 0.44 110.286 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.622 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 56.79 3.41 0.7 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.393 -0.821 . . . . 0.44 114.577 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -119.75 -173.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.926 0.863 . . . . 0.44 110.392 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -113.96 87.5 12.87 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 116.093 -0.503 . . . . 0.44 109.901 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.595 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.9 Cg_endo -115.11 149.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.761 2.974 . . . . 0.44 113.924 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 83.2 mt-30 -74.81 79.62 2.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.546 -2.02 . . . . 0.44 105.546 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.519 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.57 127.57 49.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.505 -1.225 . . . . 0.44 111.061 -176.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.79 -136.98 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.776 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 56.6 163.26 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.219 0.533 . . . . 0.44 112.116 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.5 tt -126.19 113.18 16.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.44 110.289 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.65 -53.24 8.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.44 110.293 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.697 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.41 131.68 0.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.418 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 132.07 53.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.728 0.299 . . . . 0.44 111.023 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.424 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -106.54 159.34 16.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.289 -0.414 . . . . 0.44 110.922 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -140.08 109.92 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.485 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -133.33 153.01 51.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.44 110.679 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -121.24 140.05 52.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.197 0.522 . . . . 0.44 111.425 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -103.41 162.86 18.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.486 -0.779 . . . . 0.44 110.156 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.1 Cg_endo -45.8 80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.334 2.689 . . . . 0.44 112.815 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.5 t0 85.45 9.95 0.31 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.479 -0.782 . . . . 0.44 111.947 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 3.9 ttp-105 -137.39 101.39 4.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.44 111.087 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -74.89 115.84 14.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.44 110.829 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 1.1 tt -107.14 112.04 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.44 110.955 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.88 129.92 53.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.44 111.004 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.3 mt -126.37 114.43 18.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.58 -0.282 . . . . 0.44 111.146 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -111.95 122.43 47.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.367 -0.379 . . . . 0.44 111.044 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.697 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.4 m-30 -104.5 115.06 29.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.134 -0.485 . . . . 0.44 110.491 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 36.6 m95 -94.72 148.72 21.99 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.344 -0.389 . . . . 0.44 111.058 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.2 tm? -101.08 102.68 13.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.452 0.644 . . . . 0.44 111.361 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 t -82.11 145.77 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 115.105 -0.952 . . . . 0.44 111.658 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.97 -45.87 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.896 1.443 . . . . 0.44 114.896 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.8 ptm85 -163.13 165.93 24.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.839 0.745 . . . . 0.44 112.383 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.595 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 8.4 p90 -139.59 136.19 34.13 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.125 -0.488 . . . . 0.44 111.68 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.35 108.72 19.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.199 -0.455 . . . . 0.44 110.814 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.35 -121.47 6.86 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.74 -0.743 . . . . 0.44 112.427 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.5 tt0 -135.08 135.06 22.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.467 0.175 . . . . 0.44 110.917 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.56 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.47 128.73 10.54 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.796 2.331 . . . . 0.44 111.58 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.622 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.4 p-90 -133.47 -58.18 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.298 -0.561 . . . . 0.44 112.09 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.572 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 37.89 -92.39 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.026 -0.607 . . . . 0.44 113.257 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 95' ' ' TRP . 5.2 tmtm? 179.88 -69.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.812 0.339 . . . . 0.44 110.747 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 42.21 26.06 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.009 -0.541 . . . . 0.44 111.605 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.21 -65.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.013 -0.613 . . . . 0.44 113.545 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 98' ' ' GLU . 28.5 mt-30 -108.02 99.23 29.81 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.402 0.519 . . . . 0.44 112.402 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.47 146.55 3.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.139 2.559 . . . . 0.44 112.469 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.04 21.4 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.515 -0.85 . . . . 0.44 113.189 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.84 157.62 25.31 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.448 -0.205 . . . . 0.44 110.448 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.83 106.36 3.11 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.949 0.404 . . . . 0.44 110.609 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.6 mtp -120.87 164.11 17.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.962 -0.563 . . . . 0.44 111.384 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -70.75 116.96 11.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.44 110.339 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -18.71 50.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.44 111.62 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.12 -14.25 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.906 0.336 . . . . 0.44 111.906 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.79 35.24 4.7 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.536 -0.84 . . . . 0.44 113.153 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.74 135.91 57.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.079 -0.341 . . . . 0.44 110.079 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.09 131.48 53.71 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.676 0.621 . . . . 0.44 112.676 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.63 -15.3 61.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.298 -0.864 . . . . 0.44 110.975 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.71 -49.14 13.62 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.421 -0.354 . . . . 0.44 111.809 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -36.46 77.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.42 -0.354 . . . . 0.44 111.775 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.541 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -78.77 173.98 6.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.597 -0.274 . . . . 0.44 110.731 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.4 Cg_endo -76.46 137.17 18.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.358 2.039 . . . . 0.44 112.089 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 27.6 Cg_endo -62.01 -14.29 36.44 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.842 2.361 . . . . 0.44 113.202 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.3 -9.7 19.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 0.44 112.621 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.432 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -135.9 44.12 2.5 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.443 0.534 . . . . 0.44 112.443 -178.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.2 OUTLIER -76.05 -50.77 2.98 Favored Pre-proline 0 N--CA 1.463 0.186 0 N-CA-C 111.833 0.308 . . . . 0.44 111.833 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.461 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 79.6 Cg_exo -44.74 -38.02 12.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.447 2.098 . . . . 0.44 112.792 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.5 t -77.25 -49.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.611 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.541 HG13 ' CE2' ' A' ' 115' ' ' PHE . 11.3 mm -64.75 -29.97 48.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.44 110.747 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.05 -29.75 63.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.44 110.653 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.28 -48.52 15.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.44 111.629 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -78.19 -30.25 48.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.34 . . . . 0.44 111.425 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 123' ' ' ILE . 12.0 ttpt -55.58 -42.47 74.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.44 110.817 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -68.42 -7.47 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.636 . . . . 0.44 109.639 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 C--O 1.233 0.199 0 CA-C-N 116.012 -0.54 . . . . 0.44 111.073 179.743 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.833 0.349 . . . . 0.44 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -126.93 141.89 51.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.825 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.61 117.59 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.44 111.08 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.6 mt-30 -102.29 151.74 21.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.569 . . . . 0.44 111.841 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' A' ' 81' ' ' THR . 4.3 mt -142.68 128.28 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.44 109.869 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.54 124.68 42.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.081 -0.34 . . . . 0.44 110.081 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.503 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.7 m -115.39 162.18 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.283 0.563 . . . . 0.44 111.924 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.42 102.08 0.23 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.335 -0.848 . . . . 0.44 111.957 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.91 110.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.094 -0.335 . . . . 0.44 110.094 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.561 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.55 115.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.44 111.066 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 3.7 mmt85 -82.14 133.7 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.969 -0.382 . . . . 0.44 109.969 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.452 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 10.3 p-10 -84.17 -172.01 3.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.44 113.062 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -56.61 -16.06 5.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.721 -1.581 . . . . 0.44 113.275 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -127.71 -83.0 0.6 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.839 0.311 . . . . 0.44 111.839 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.16 17.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.44 111.687 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HB2' ' ND2' ' A' ' 13' ' ' ASN . 19.8 mt-10 -100.89 160.11 14.64 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.765 -0.457 . . . . 0.44 109.765 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -135.08 145.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.44 111.997 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 14.0 t80 -84.48 89.63 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.44 110.79 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.478 HG12 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -113.29 162.17 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.44 110.038 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.327 -0.391 0 N-CA-C 109.979 -0.378 . . . . 0.44 109.979 178.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.791 0.329 . . . . 0.44 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.03 26.37 10.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.44 111.507 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.8 tt -57.74 77.37 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.44 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -108.58 -170.65 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.091 0.472 . . . . 0.44 111.636 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.9 154.13 55.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.746 -0.661 . . . . 0.44 111.395 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.457 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 11.1 Cg_endo -53.84 167.47 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.233 2.622 . . . . 0.44 111.677 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 59.25 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.896 -1.145 . . . . 0.44 114.137 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.06 117.04 2.48 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 114.84 -0.68 . . . . 0.44 112.059 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 3.5 tttt 115.76 4.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.322 0.649 . . . . 0.44 111.513 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -53.98 -27.61 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.569 0.699 . . . . 0.44 110.665 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.22 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.581 -1.191 . . . . 0.44 111.161 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mmt 33.38 -85.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.558 0.537 . . . . 0.44 111.878 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.31 31.11 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.927 -0.654 . . . . 0.44 112.553 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.0 mp0 -91.61 -175.07 4.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.74 0.305 . . . . 0.44 111.168 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.563 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -111.92 159.0 35.14 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.313 -0.403 . . . . 0.44 110.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.95 -24.65 0.88 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.904 2.403 . . . . 0.44 112.696 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -58.08 2.61 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.61 0.596 . . . . 0.44 112.61 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -80.4 -20.07 44.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.44 112.39 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.3 -49.76 73.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.833 0.349 . . . . 0.44 111.148 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.505 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 2.6 m -76.03 -46.86 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.44 110.912 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 42.3 t -60.46 -35.85 65.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.44 111.087 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -70.91 -49.14 49.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.312 -0.404 . . . . 0.44 111.022 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.33 -27.97 63.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.44 111.028 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.446 ' CD2' ' ND1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -55.06 -44.08 74.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.44 110.55 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -61.44 -35.09 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 0.44 109.816 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.53 -33.54 54.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.44 111.339 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 20.5 mm-40 -100.05 4.83 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.15 0.426 . . . . 0.44 112.15 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.542 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 3.3 t -135.48 -43.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.115 0.483 . . . . 0.44 110.245 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.64 9.39 6.61 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.747 -0.661 . . . . 0.44 114.504 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.833 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 13.5 tt -115.88 162.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 117.46 0.63 . . . . 0.44 110.289 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.462 ' N ' HG12 ' A' ' 60' ' ' ILE . 1.5 p -98.82 88.44 0.72 Allowed Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 109.017 -0.735 . . . . 0.44 109.017 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.833 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 58.4 Cg_endo -113.31 156.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 124.236 3.291 . . . . 0.44 114.096 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -75.85 78.38 2.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 102.47 -3.159 . . . . 0.44 102.47 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -111.94 120.7 42.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.656 -1.611 . . . . 0.44 112.786 -173.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.535 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -177.95 -153.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.608 -0.724 . . . . 0.44 110.629 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m 59.56 154.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.44 111.874 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -118.39 120.02 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.44 110.437 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.71 -44.12 34.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.44 110.064 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 tt0 -171.44 162.81 6.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.44 110.187 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 132.16 22.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.3 . . . . 0.44 111.092 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' HB2' HG23 ' A' ' 122' ' ' VAL . 34.5 tp -113.77 122.32 46.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.822 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -116.86 109.85 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.44 110.723 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.19 143.41 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.44 110.497 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.13 124.52 44.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.44 111.547 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -85.24 163.23 46.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.44 110.089 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -51.56 81.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.921 2.414 . . . . 0.44 112.225 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 90.54 11.61 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.377 -0.829 . . . . 0.44 111.53 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -137.29 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.772 0.32 . . . . 0.44 111.007 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.46 106.96 10.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.44 111.101 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.09 112.63 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.44 110.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.93 128.76 54.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.44 110.665 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.4 ' CD2' ' CG2' ' A' ' 6' ' ' ILE . 9.4 mt -126.34 114.64 18.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.297 . . . . 0.44 111.472 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.536 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -108.84 122.86 48.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.352 . . . . 0.44 110.107 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 12.1 m-30 -103.43 112.04 24.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 0.44 110.888 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.739 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 34.9 m95 -95.12 149.23 21.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.44 111.437 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 65' ' ' PHE . 5.3 tp -106.3 103.18 12.59 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.684 0.624 . . . . 0.44 112.684 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 11.3 t -82.63 145.45 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.44 110.326 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -102.84 -35.23 8.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.358 1.244 . . . . 0.44 114.358 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.3 165.42 26.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.53 0.604 . . . . 0.44 112.0 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 9.2 p90 -138.93 157.96 45.08 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.103 -0.499 . . . . 0.44 111.289 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.469 ' N ' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -104.78 101.29 10.9 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.239 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.67 -115.02 5.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.596 -0.812 . . . . 0.44 112.065 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.5 tt0 -135.25 122.83 15.17 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.504 0.192 . . . . 0.44 111.432 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.0 Cg_exo -74.17 128.82 12.5 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.624 2.216 . . . . 0.44 110.794 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.539 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 20.8 p-90 -123.5 -60.85 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.44 111.833 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 57.2 -117.79 10.69 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.774 -0.727 . . . . 0.44 113.261 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.54 37.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.44 111.06 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -53.82 -24.52 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.44 111.012 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.42 -15.03 39.07 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.689 -0.767 . . . . 0.44 113.315 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.06 105.38 6.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.44 111.392 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.56 143.77 2.44 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.006 2.471 . . . . 0.44 112.727 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.31 19.29 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.774 -0.727 . . . . 0.44 112.971 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.15 157.17 44.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.257 -0.275 . . . . 0.44 110.257 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.27 106.52 0.54 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.872 0.368 . . . . 0.44 110.177 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.53 139.57 52.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.44 111.027 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.8 p -59.66 114.77 2.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.352 . . . . 0.44 110.825 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.72 -24.49 65.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.095 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.73 -18.23 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.44 111.575 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.73 35.89 4.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.631 -0.795 . . . . 0.44 112.789 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.412 ' CG ' HD12 ' A' ' 123' ' ' ILE . 12.3 tp -62.8 135.52 57.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.44 110.304 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.22 133.41 54.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.554 0.575 . . . . 0.44 112.554 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.53 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.35 61.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.503 -0.772 . . . . 0.44 110.779 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.85 -49.29 13.16 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.345 -0.389 . . . . 0.44 111.742 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -30.6 69.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.441 -0.345 . . . . 0.44 111.386 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -88.67 174.43 5.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.341 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 50.5 Cg_endo -69.61 127.97 15.49 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.968 1.779 . . . . 0.44 111.649 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.71 -14.81 45.06 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.228 . . . . 0.44 113.097 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.32 -9.79 44.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.144 0.424 . . . . 0.44 112.144 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.417 ' O ' HG21 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -124.21 27.22 7.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.475 0.179 . . . . 0.44 111.432 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.467 ' HA ' ' CG2' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -58.05 -49.07 95.71 Favored Pre-proline 0 N--CA 1.463 0.195 0 N-CA-C 112.278 0.473 . . . . 0.44 112.278 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 87.0 Cg_exo -46.86 -35.92 18.91 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.437 2.091 . . . . 0.44 113.176 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG13 ' CD2' ' A' ' 84' ' ' PHE . 21.3 t -77.54 -51.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.44 111.627 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.514 ' CG2' ' CZ ' ' A' ' 115' ' ' PHE . 2.5 tp -68.07 -30.6 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.44 110.788 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.99 -26.99 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.877 0.37 . . . . 0.44 110.672 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -49.07 12.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.002 -0.545 . . . . 0.44 111.446 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -29.53 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.489 -0.323 . . . . 0.44 111.432 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -56.04 -42.49 76.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.44 110.86 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.27 -3.9 29.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.44 109.892 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.935 -0.575 . . . . 0.44 111.194 179.702 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.808 0.337 . . . . 0.44 111.034 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.38 143.41 53.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.798 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.71 129.32 17.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.376 . . . . 0.44 111.074 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.423 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.4 mt-30 -102.57 153.62 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.442 0.639 . . . . 0.44 112.342 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -146.48 132.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.079 -0.964 . . . . 0.44 109.671 178.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.26 124.97 43.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.087 -0.245 . . . . 0.44 110.469 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -117.86 162.55 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.406 0.622 . . . . 0.44 112.101 -179.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.08 114.29 0.63 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.126 -0.943 . . . . 0.44 111.851 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.25 107.27 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.717 -0.475 . . . . 0.44 109.717 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.2 mt -71.42 123.29 25.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.446 . . . . 0.44 111.676 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.61 119.97 25.39 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.647 -0.706 . . . . 0.44 111.829 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.552 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.8 t-20 -77.72 -172.32 2.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.172 -0.922 . . . . 0.44 111.766 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 59.6 tt0 -82.45 -2.99 54.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.511 -1.222 . . . . 0.44 112.583 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -131.95 40.61 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.868 -0.333 . . . . 0.44 111.802 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.6 9.29 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.517 -0.31 . . . . 0.44 111.506 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.6 pt-20 -100.86 149.67 23.62 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.949 -0.76 . . . . 0.44 108.949 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.4 mp -115.11 141.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.238 0.542 . . . . 0.44 111.718 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 26.7 t80 -80.65 99.9 8.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.399 -0.819 . . . . 0.44 110.758 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.13 162.12 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.44 110.446 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.448 -0.342 . . . . 0.44 110.551 179.63 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.587 0.232 . . . . 0.44 111.274 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.37 10.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.39 . . . . 0.44 111.423 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.5 tt -50.85 89.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.44 110.95 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -119.94 -177.18 3.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.379 . . . . 0.44 111.234 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.74 160.76 41.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 0.44 111.734 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.29 168.43 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.813 3.008 . . . . 0.44 112.068 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.71 59.24 0.75 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.132 -1.032 . . . . 0.44 114.129 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.77 116.57 1.91 Allowed Glycine 0 C--N 1.315 -0.622 0 CA-C-N 114.71 -0.745 . . . . 0.44 112.097 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 119.13 4.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.517 0.727 . . . . 0.44 111.783 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -57.2 -26.06 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.515 0.674 . . . . 0.44 110.71 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.533 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.16 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.678 -1.146 . . . . 0.44 111.32 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 mtm 31.59 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.455 0.472 . . . . 0.44 112.072 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -167.66 28.98 0.17 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.806 -0.712 . . . . 0.44 112.664 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.2 mp0 -92.43 -175.0 3.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.313 . . . . 0.44 111.101 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.537 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.71 154.94 38.94 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.303 -0.408 . . . . 0.44 110.226 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.92 -24.74 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.79 2.327 . . . . 0.44 112.601 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -50.84 5.04 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.21 0.448 . . . . 0.44 112.21 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.2 -22.03 42.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.44 111.84 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.415 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.58 -48.26 77.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.44 111.112 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.02 -46.82 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.44 110.829 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.506 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 44.6 t -56.28 -35.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.921 -0.581 . . . . 0.44 110.958 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -76.96 -50.19 13.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.44 110.728 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -23.71 66.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.44 110.746 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.452 ' CD2' ' CE1' ' A' ' 64' ' ' HIS . 4.2 tp -52.88 -44.48 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.44 110.54 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -33.05 74.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.581 . . . . 0.44 109.827 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 -24.85 50.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.44 111.197 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 4.0 mm-40 -108.66 5.5 24.94 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.048 0.388 . . . . 0.44 112.048 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.459 ' CG1' HG13 ' A' ' 60' ' ' ILE . 38.8 t -134.74 -44.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.388 0.613 . . . . 0.44 109.944 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.46 4.16 1.22 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.119 -0.946 . . . . 0.44 115.038 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -117.55 -172.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.157 0.979 . . . . 0.44 110.46 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.82 87.94 10.9 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 116.079 -0.509 . . . . 0.44 109.896 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.634 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.5 Cg_endo -114.34 144.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.579 2.852 . . . . 0.44 114.24 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 30.6 mt-30 -75.02 80.04 2.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.44 105.619 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.645 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -119.78 126.05 50.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.071 -1.422 . . . . 0.44 110.947 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 177.37 173.25 0.51 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.44 111.349 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 92.12 148.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.806 -0.633 . . . . 0.44 110.855 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -97.71 137.13 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.44 111.158 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -103.07 -47.71 4.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.44 110.299 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -171.43 157.81 5.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.44 110.566 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.4 127.93 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.445 -0.343 . . . . 0.44 110.977 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.25 124.47 38.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.44 110.497 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -116.91 118.11 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.44 110.755 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -137.37 136.37 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.44 110.685 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.13 120.38 42.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.498 . . . . 0.44 111.338 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.92 162.85 65.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.54 -0.755 . . . . 0.44 110.519 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.8 Cg_endo -41.74 82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.655 2.903 . . . . 0.44 112.587 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' PHE . 2.9 t70 98.43 -27.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.182 -0.917 . . . . 0.44 111.19 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 75' ' ' PHE . 6.1 ttp180 -90.45 150.11 21.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.44 110.824 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -120.32 101.65 7.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.934 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.85 124.95 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.093 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.98 118.58 32.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.44 110.117 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.8 OUTLIER -126.14 114.99 19.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.085 0.469 . . . . 0.44 111.898 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -104.74 122.7 46.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.843 -0.617 . . . . 0.44 110.405 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.427 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.2 m-30 -95.38 109.63 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.44 110.486 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.451 ' CD2' HG21 ' A' ' 50' ' ' VAL . 28.6 m95 -96.78 148.63 22.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.109 0.481 . . . . 0.44 111.853 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.5 tm? -95.15 138.56 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.44 111.713 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 64' ' ' HIS . 21.2 t -123.74 146.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.33 -0.85 . . . . 0.44 110.031 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.08 -22.04 9.15 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.732 1.382 . . . . 0.44 114.732 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.558 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 3.9 tpp85 -162.48 160.51 26.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 119.018 0.826 . . . . 0.44 111.661 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.634 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -157.06 125.42 5.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.063 -0.517 . . . . 0.44 111.178 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.62 149.37 34.77 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 116.291 -0.413 . . . . 0.44 111.03 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.46 -127.13 44.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.44 112.598 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.0 mt-10 -129.57 141.91 43.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.431 0.157 . . . . 0.44 110.689 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.549 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.1 Cg_exo -76.6 128.59 10.35 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.766 2.311 . . . . 0.44 111.607 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.675 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.2 p-90 -125.87 -58.72 1.38 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.443 -0.503 . . . . 0.44 111.63 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 97' ' ' LYS . . . 49.86 -76.26 0.0 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.901 -0.666 . . . . 0.44 112.806 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 95' ' ' TRP . 3.8 tptt 115.91 60.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.993 0.917 . . . . 0.44 110.488 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -33.32 35.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.71 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.17 -1.68 9.75 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.57 -0.824 . . . . 0.44 113.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -140.25 94.59 8.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 117.088 0.444 . . . . 0.44 111.45 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -43.61 145.64 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.063 2.509 . . . . 0.44 112.672 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.29 177.42 19.19 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.721 -0.752 . . . . 0.44 112.992 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.36 157.19 43.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.135 -0.32 . . . . 0.44 110.135 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.13 106.45 1.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.44 110.082 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 3.3 mtp -120.01 159.57 24.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.0 -0.546 . . . . 0.44 110.611 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.0 p -78.47 114.34 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.44 110.809 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.5 -19.54 45.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.44 111.052 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.6 t -56.66 -18.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.622 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.63 50.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.541 -0.838 . . . . 0.44 112.792 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 111' ' ' ASN . 6.4 tt -62.6 150.2 41.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.198 -0.297 . . . . 0.44 110.198 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.432 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -117.02 132.27 56.74 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.57 0.582 . . . . 0.44 112.57 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.17 61.9 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.293 -0.867 . . . . 0.44 110.448 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.6 -49.24 13.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.44 111.556 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.53 -0.305 . . . . 0.44 111.182 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.92 172.38 10.05 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.44 110.301 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.2 Cg_endo -75.76 128.15 10.69 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.327 2.018 . . . . 0.44 111.523 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.31 -14.69 16.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.777 2.318 . . . . 0.44 113.474 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.93 -11.47 18.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 0.44 112.515 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -132.67 43.71 2.95 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.776 0.322 . . . . 0.44 111.533 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.8 tt0 -76.07 -47.11 3.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.874 0.324 . . . . 0.44 111.874 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.7 Cg_exo -45.83 -39.14 18.7 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.031 . . . . 0.44 112.837 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.423 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.6 t -77.27 -48.52 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.44 110.594 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.566 HG13 ' CE2' ' A' ' 115' ' ' PHE . 5.5 mm -65.18 -29.96 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.731 -0.668 . . . . 0.44 110.982 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.928 0.394 . . . . 0.44 110.485 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -46.24 16.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.902 -0.59 . . . . 0.44 111.47 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 129' ' ' LEU . 3.2 tm? -78.17 -28.71 48.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.44 111.266 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -63.85 -42.28 97.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.44 110.416 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -64.07 -9.66 17.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.528 -0.76 . . . . 0.44 110.04 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 126' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.344 -0.389 . . . . 0.44 111.088 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 tttm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.805 0.336 . . . . 0.44 110.846 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -89.04 135.45 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.44 110.928 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.1 127.05 14.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.44 111.046 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.69 154.99 18.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.216 0.532 . . . . 0.44 111.418 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.1 mm -146.2 127.43 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.417 -0.81 . . . . 0.44 110.006 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.38 124.59 42.68 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 120.995 -0.282 . . . . 0.44 110.288 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -129.8 162.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.178 0.513 . . . . 0.44 111.375 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 123.69 1.54 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.546 -0.752 . . . . 0.44 112.095 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.527 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.79 110.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.325 -0.621 . . . . 0.44 109.325 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -71.61 125.93 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 0.44 110.963 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -93.0 126.83 38.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.231 -0.441 . . . . 0.44 111.346 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 5.9 t30 -89.5 -172.02 3.43 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.899 0.857 . . . . 0.44 112.088 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.79 -2.14 34.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.006 -1.452 . . . . 0.44 112.103 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -136.01 50.2 2.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 0.44 111.283 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 p30 45.38 26.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.44 111.44 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.404 ' HG3' ' CB ' ' A' ' 13' ' ' ASN . 11.5 pt-20 -112.36 150.29 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.44 109.258 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -121.99 144.76 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.447 0.642 . . . . 0.44 112.292 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CE1' ' CA ' ' A' ' 102' ' ' GLY . 36.3 t80 -82.5 91.5 6.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.44 110.127 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.9 162.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.497 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 100' ' ' GLN . 7.1 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.44 111.067 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.489 0.185 . . . . 0.44 111.406 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.32 26.06 10.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.44 111.505 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.0 tp -52.12 92.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.44 110.857 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.54 -176.43 3.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.886 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.56 168.24 10.53 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.44 111.615 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.7 Cg_endo -47.5 168.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.602 2.868 . . . . 0.44 112.249 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.42 59.22 0.76 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.502 -0.856 . . . . 0.44 112.666 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.58 112.02 1.27 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.23 -0.985 . . . . 0.44 112.384 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER 113.97 5.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.168 0.587 . . . . 0.44 112.096 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.22 -29.47 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.742 0.782 . . . . 0.44 110.148 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.98 -79.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.305 -1.316 . . . . 0.44 111.25 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.4 mmt 41.35 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.376 -0.375 . . . . 0.44 111.539 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.27 33.22 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.754 -0.736 . . . . 0.44 112.762 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.24 -169.19 1.93 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.673 0.273 . . . . 0.44 111.019 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.548 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.96 156.24 36.17 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.44 110.301 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.3 Cg_endo -44.01 -24.8 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.766 2.31 . . . . 0.44 112.465 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -99.59 -48.34 4.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.443 -0.344 . . . . 0.44 111.912 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.32 -7.56 59.11 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.949 0.352 . . . . 0.44 111.949 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.477 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -63.68 -56.98 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 0.44 110.864 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' LEU . 1.4 p -78.3 -40.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.44 111.716 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.2 t -50.67 -37.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.896 -0.322 . . . . 0.44 110.995 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.87 -52.38 8.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.4 . . . . 0.44 111.306 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 9.3 tm-20 -66.35 -19.92 65.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.364 -0.38 . . . . 0.44 110.694 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 50' ' ' VAL . 14.1 tp -60.53 -44.41 96.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.44 110.728 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -71.58 -27.87 63.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.457 . . . . 0.44 110.029 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.07 -28.1 66.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.76 -0.654 . . . . 0.44 110.482 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.458 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.22 6.99 27.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.44 112.314 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.502 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -130.7 -44.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.44 109.873 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 64.73 -35.66 0.1 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.058 0.783 . . . . 0.44 115.058 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.64 -174.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.929 0.364 . . . . 0.44 110.817 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.55 88.69 13.82 Favored Pre-proline 0 N--CA 1.445 -0.717 0 CA-C-N 116.093 -0.503 . . . . 0.44 110.993 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.9 Cg_endo -110.68 143.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 123.312 2.675 . . . . 0.44 113.474 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 31.8 mt-30 -74.6 80.06 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.558 -2.015 . . . . 0.44 105.558 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.637 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.18 133.15 54.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.145 -1.388 . . . . 0.44 111.128 -175.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -179.77 -137.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.44 110.352 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.34 159.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.963 0.505 . . . . 0.44 111.984 179.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 tt -122.26 110.68 16.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.674 . . . . 0.44 110.418 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.68 -52.07 10.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 0.44 110.373 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 mt-10 -171.33 131.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.815 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.88 131.91 54.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.596 -0.275 . . . . 0.44 110.526 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 1.8 pp -114.45 158.67 21.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.957 0.408 . . . . 0.44 111.261 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -140.1 109.81 6.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.002 -0.545 . . . . 0.44 110.242 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -136.03 153.19 51.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.823 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -120.95 127.11 51.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.141 0.496 . . . . 0.44 111.353 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -91.68 163.89 26.3 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.44 110.417 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -38.27 81.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.602 2.868 . . . . 0.44 112.886 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.59 21.24 3.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.44 111.061 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.31 93.83 2.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.44 110.239 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -74.91 99.97 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.44 111.152 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tt -102.55 111.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.259 -0.428 . . . . 0.44 110.734 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.79 133.22 44.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.44 110.468 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 114.48 18.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.44 111.468 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.506 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.6 OUTLIER -110.82 125.55 53.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.872 -0.418 . . . . 0.44 109.872 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.4 m-85 -111.02 118.2 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.44 111.392 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.416 ' CE2' HG12 ' A' ' 50' ' ' VAL . 65.3 m95 -96.47 148.87 22.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.44 111.025 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.3 tm? -99.83 103.05 14.64 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.327 0.584 . . . . 0.44 111.34 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.637 HG11 ' HA ' ' A' ' 64' ' ' HIS . 11.2 t -80.65 145.87 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.266 -0.879 . . . . 0.44 111.665 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -113.29 -25.39 8.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.675 0.991 . . . . 0.44 113.675 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 6.9 ttm180 -162.42 163.23 27.82 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.364 -0.534 . . . . 0.44 111.586 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.667 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -157.21 123.8 4.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.44 111.527 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.89 139.99 47.22 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.013 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.09 -121.7 26.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.763 -0.732 . . . . 0.44 112.534 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 60' ' ' ILE . 24.7 mt-10 -132.05 142.64 45.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.431 0.158 . . . . 0.44 110.775 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.444 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.15 128.8 11.66 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.719 2.279 . . . . 0.44 111.183 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.564 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.6 p-90 -126.83 -61.03 1.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.381 0.512 . . . . 0.44 112.381 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.21 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.919 -0.658 . . . . 0.44 112.936 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt 177.99 35.15 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.703 0.287 . . . . 0.44 111.279 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -57.19 -37.79 72.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.88 0.371 . . . . 0.44 110.587 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.47 71.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.85 -0.691 . . . . 0.44 113.153 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 2.6 pm0 -140.16 93.29 9.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.44 111.28 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.61 138.82 5.29 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.056 2.504 . . . . 0.44 112.85 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -134.31 177.29 19.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.827 -0.702 . . . . 0.44 112.98 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -141.28 157.13 45.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.248 -0.278 . . . . 0.44 110.248 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.483 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -79.76 106.15 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.735 -0.386 . . . . 0.44 110.472 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.0 ptp -120.55 163.07 18.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.861 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.9 p -77.58 114.88 16.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.487 -0.324 . . . . 0.44 110.695 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.21 -18.91 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.44 111.176 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -55.26 -20.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.367 -0.379 . . . . 0.44 111.464 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.18 35.05 4.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.68 -0.771 . . . . 0.44 112.812 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.304 -0.258 . . . . 0.44 110.304 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.26 131.73 53.77 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.493 0.553 . . . . 0.44 112.493 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -15.51 61.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.613 -0.721 . . . . 0.44 110.414 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -49.05 13.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.283 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.9 -40.08 87.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.332 -0.395 . . . . 0.44 111.599 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.63 174.16 6.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.404 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.445 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 61.5 Cg_endo -73.86 127.91 11.94 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.061 1.84 . . . . 0.44 111.509 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.97 -14.86 29.98 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.644 2.229 . . . . 0.44 113.122 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.98 -9.95 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.291 0.478 . . . . 0.44 112.291 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.431 ' OD1' ' CE1' ' A' ' 84' ' ' PHE . 0.4 OUTLIER -129.73 38.21 3.86 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.774 0.287 . . . . 0.44 111.774 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.9 -47.36 15.35 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.822 -0.172 . . . . 0.44 111.068 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.6 Cg_exo -56.0 -35.28 94.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.336 2.024 . . . . 0.44 112.083 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 71' ' ' LEU . 3.8 t -77.46 -51.38 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.44 111.082 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.48 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -69.79 -29.92 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.44 110.806 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.89 -27.53 43.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.387 -0.37 . . . . 0.44 110.905 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -53.34 12.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.44 111.184 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 tp -78.46 -29.54 46.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.133 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -57.77 -42.6 84.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.014 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -71.49 -5.55 33.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.666 . . . . 0.44 109.937 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.003 -0.544 . . . . 0.44 111.253 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.832 0.349 . . . . 0.44 110.712 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.33 38.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.44 110.949 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 pp -146.05 123.23 11.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.842 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -102.94 150.27 23.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.213 0.53 . . . . 0.44 111.258 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 81' ' ' THR . 8.5 mt -136.56 130.49 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.546 -0.752 . . . . 0.44 110.205 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.97 124.57 42.29 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.82 -0.437 . . . . 0.44 109.82 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -132.01 162.53 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.212 0.53 . . . . 0.44 111.658 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.44 121.51 1.22 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.362 -0.836 . . . . 0.44 111.915 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.83 109.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.32 -0.622 . . . . 0.44 109.32 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -71.07 125.48 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 120.976 0.417 . . . . 0.44 111.416 -178.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -92.21 133.13 36.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.89 -0.595 . . . . 0.44 110.956 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 29.6 p-10 -96.45 -172.13 2.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.86 0.838 . . . . 0.44 112.433 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.37 -0.88 16.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.171 -1.377 . . . . 0.44 113.071 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 20.6 t-20 -129.39 40.68 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.44 111.844 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 52.22 21.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.035 0.383 . . . . 0.44 112.035 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -115.72 160.01 20.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.639 -0.504 . . . . 0.44 109.639 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -122.75 149.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.145 0.498 . . . . 0.44 111.922 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.49 101.65 14.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.549 -0.75 . . . . 0.44 110.041 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.457 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -108.08 137.67 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.302 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.825 0.345 . . . . 0.44 110.943 -179.806 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 111.592 0.219 . . . . 0.44 111.592 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -114.52 26.24 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.44 111.535 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' N ' ' HA ' ' A' ' 115' ' ' PHE . 4.8 tt -46.08 110.36 0.26 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.96 -0.563 . . . . 0.44 111.009 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -142.15 175.28 9.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.026 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.53 168.92 9.09 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.639 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.6 Cg_endo -46.66 169.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.693 2.929 . . . . 0.44 112.146 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.29 59.6 0.72 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.342 -0.933 . . . . 0.44 113.155 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.52 122.53 3.11 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 114.113 -1.044 . . . . 0.44 111.697 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.28 -7.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.28 0.632 . . . . 0.44 111.213 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -40.73 -57.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.389 0.614 . . . . 0.44 111.285 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -21.72 -80.43 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.337 -1.301 . . . . 0.44 112.252 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.5 mmt 41.83 -94.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.531 -0.304 . . . . 0.44 111.588 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.77 19.49 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.6 -0.809 . . . . 0.44 113.424 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -82.97 -165.71 1.14 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.529 0.205 . . . . 0.44 110.81 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.544 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.51 156.57 36.19 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.069 -0.345 . . . . 0.44 110.069 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.5 -24.64 0.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.772 2.315 . . . . 0.44 112.362 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -89.98 -59.97 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.042 0.386 . . . . 0.44 112.042 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -80.89 -4.56 55.29 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.258 0.466 . . . . 0.44 112.258 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.512 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -63.68 -57.08 11.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.593 0.235 . . . . 0.44 111.089 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.67 -41.77 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.631 -0.259 . . . . 0.44 111.354 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -50.36 -35.36 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.596 -0.274 . . . . 0.44 111.342 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -52.15 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.504 -0.316 . . . . 0.44 111.49 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.1 -20.09 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.44 111.032 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 13.9 tp -58.18 -41.57 84.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.44 110.475 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -26.96 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.44 110.421 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.1 tm-20 -72.12 -25.27 61.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.44 111.4 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -108.59 7.02 26.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.268 0.47 . . . . 0.44 112.268 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.554 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 10.6 t -133.28 -43.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.191 0.52 . . . . 0.44 109.974 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 52.88 8.63 0.63 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.442 -0.799 . . . . 0.44 115.028 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.489 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.6 -174.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.026 0.913 . . . . 0.44 110.149 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 p -114.58 87.34 14.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 116.221 -0.445 . . . . 0.44 109.839 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.649 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.0 Cg_endo -115.5 145.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 123.664 2.909 . . . . 0.44 114.066 -177.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.385 -2.08 . . . . 0.44 105.385 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.613 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.64 133.33 54.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.409 -1.268 . . . . 0.44 111.329 -175.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.04 -139.23 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.44 110.02 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 56.29 153.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.288 0.566 . . . . 0.44 112.102 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.4 tt -116.78 111.21 19.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.607 -0.724 . . . . 0.44 110.386 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CD1' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.58 -54.14 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.44 110.195 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.0 mt-10 -171.28 131.7 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.574 . . . . 0.44 110.438 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 126.6 39.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.692 0.282 . . . . 0.44 110.807 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -113.84 136.67 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 0.44 110.901 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -121.67 109.94 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.706 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -131.05 152.2 50.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.528 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -121.13 139.58 53.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.129 0.49 . . . . 0.44 111.381 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -103.23 162.67 19.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.557 -0.747 . . . . 0.44 110.133 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.1 Cg_endo -49.76 81.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.155 2.57 . . . . 0.44 112.344 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t70 89.28 10.2 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.45 -0.795 . . . . 0.44 111.595 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -137.34 93.94 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.3 . . . . 0.44 110.89 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -80.18 93.86 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.97 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.4 tt -96.76 111.87 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.327 -0.397 . . . . 0.44 111.241 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -106.82 132.54 52.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.44 110.512 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.405 HD13 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.39 114.58 18.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 0.44 111.422 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.454 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 2.1 m0 -109.34 125.53 52.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.259 -0.428 . . . . 0.44 110.226 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.8 m-85 -111.41 114.56 27.78 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.919 0.39 . . . . 0.44 110.932 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.447 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 61.3 m95 -94.73 148.83 21.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.878 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 14.6 tp -98.41 102.89 14.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.339 0.59 . . . . 0.44 111.755 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 64' ' ' HIS . 14.0 t -80.69 145.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.249 -0.887 . . . . 0.44 111.205 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -112.57 -26.96 8.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.101 1.149 . . . . 0.44 114.101 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 3.9 mtt-85 -161.83 164.08 28.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.673 0.67 . . . . 0.44 111.428 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.649 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -157.67 123.59 4.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.44 111.551 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 152.95 32.51 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.21 -0.45 . . . . 0.44 110.899 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.1 -125.05 38.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 0.44 112.36 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -135.0 148.1 65.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.6 0.238 . . . . 0.44 110.956 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.48 128.8 10.58 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.933 2.422 . . . . 0.44 111.163 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 66.8 p-90 -138.45 -58.56 0.63 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.075 -0.65 . . . . 0.44 112.749 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 41.38 -93.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.123 -0.56 . . . . 0.44 113.295 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER 175.12 32.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.28 . . . . 0.44 111.144 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -68.05 -33.37 74.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.947 0.403 . . . . 0.44 110.256 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.97 -0.633 . . . . 0.44 113.05 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -140.35 91.65 9.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 0.44 111.64 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.73 127.58 8.14 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.077 2.518 . . . . 0.44 112.602 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.3 177.05 19.47 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.574 -0.822 . . . . 0.44 112.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.7 155.28 39.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.432 -0.21 . . . . 0.44 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.14 107.14 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.44 110.459 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.431 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -119.55 163.06 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.771 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.07 122.66 33.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.44 111.161 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.411 ' CD1' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -79.97 -18.97 49.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.451 . . . . 0.44 111.121 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -53.0 -21.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.862 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.69 45.42 1.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.405 -0.902 . . . . 0.44 113.038 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.409 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . 11.6 tp -62.94 150.28 42.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.722 0.261 . . . . 0.44 110.378 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -117.46 131.8 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.455 0.539 . . . . 0.44 112.455 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.2 -15.29 61.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.452 -0.795 . . . . 0.44 110.648 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -48.93 14.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.367 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -39.02 87.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.45 -0.341 . . . . 0.44 110.945 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -81.11 171.43 12.26 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.324 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 57.2 Cg_endo -71.15 127.57 13.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.18 1.92 . . . . 0.44 111.875 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.64 -14.86 45.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.581 2.187 . . . . 0.44 112.84 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.84 -9.5 57.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.44 111.981 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.42 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -124.01 34.33 5.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.44 111.714 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.57 -39.01 5.57 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.451 -0.34 . . . . 0.44 111.876 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.7 Cg_exo -53.07 -40.74 75.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.064 1.843 . . . . 0.44 112.699 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.47 -51.23 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.317 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.465 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -67.3 -30.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.44 111.303 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -57.28 -28.46 63.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.44 110.691 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -51.86 13.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.44 111.365 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.428 HD21 ' CD1' ' A' ' 68' ' ' PHE . 2.1 tp -78.12 -39.51 41.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.44 111.483 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -53.54 -42.56 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.44 111.282 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -72.06 -3.64 24.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.921 -0.582 . . . . 0.44 110.133 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-N 116.166 -0.47 . . . . 0.44 111.011 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 tptt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.811 0.339 . . . . 0.44 111.062 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.08 125.56 51.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.756 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.24 139.05 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.44 111.065 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.7 mt-30 -102.46 155.41 18.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.44 111.805 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.2 mt -146.26 126.67 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.43 -0.805 . . . . 0.44 110.32 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.49 124.16 41.69 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.881 -0.328 . . . . 0.44 110.185 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -118.65 162.5 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.246 0.546 . . . . 0.44 111.875 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.34 117.19 1.19 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.264 -0.88 . . . . 0.44 111.934 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.476 HG22 HG22 ' A' ' 18' ' ' ILE . 4.7 mp -70.58 100.51 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.481 -0.563 . . . . 0.44 109.481 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.659 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -71.21 125.9 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 112.537 0.569 . . . . 0.44 112.537 -177.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -98.0 119.96 37.55 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.251 -0.886 . . . . 0.44 111.085 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.582 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.54 -172.93 0.84 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.019 0.438 . . . . 0.44 110.567 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 21.9 tt0 -81.28 12.83 3.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.879 0.696 . . . . 0.44 112.879 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -133.92 34.9 3.34 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.439 0.533 . . . . 0.44 112.439 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 5.32 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.878 0.371 . . . . 0.44 111.503 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -100.95 161.76 13.37 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.321 -0.992 . . . . 0.44 108.321 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CG1' ' HG2' ' A' ' 12' ' ' ARG . 6.7 mt -117.92 141.29 37.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.255 0.55 . . . . 0.44 111.665 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.488 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.02 92.77 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.335 -0.848 . . . . 0.44 110.254 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.513 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -107.97 162.07 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.206 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 110.189 -0.3 . . . . 0.44 110.189 179.375 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.53 0.205 . . . . 0.44 111.542 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -114.17 26.45 10.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.44 111.359 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 5.3 tt -40.34 117.07 0.75 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.682 -0.69 . . . . 0.44 111.222 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.3 -172.42 3.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.919 0.39 . . . . 0.44 111.504 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.513 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.37 163.08 28.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.44 111.879 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.2 Cg_endo -47.48 169.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.887 3.058 . . . . 0.44 112.314 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.05 59.32 0.73 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.449 -0.882 . . . . 0.44 113.349 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -132.13 109.04 0.82 Allowed Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.155 -1.022 . . . . 0.44 111.448 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.95 2.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.452 0.701 . . . . 0.44 111.176 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.599 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.43 -27.95 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.633 0.73 . . . . 0.44 110.571 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.571 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.551 -1.204 . . . . 0.44 111.333 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.3 mmt 32.36 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.458 0.474 . . . . 0.44 111.883 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.21 32.99 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.912 -0.661 . . . . 0.44 112.398 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.72 -177.01 5.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.857 0.361 . . . . 0.44 111.263 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.523 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.03 154.89 37.1 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.44 110.43 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.96 -24.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.867 2.378 . . . . 0.44 112.596 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -102.43 -42.21 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.518 -0.31 . . . . 0.44 111.595 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -80.22 -10.35 59.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.811 0.3 . . . . 0.44 111.811 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.6 -52.24 65.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.749 0.309 . . . . 0.44 111.201 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.501 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.3 m -78.09 -46.6 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.44 110.972 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.501 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 41.7 t -52.61 -37.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.44 111.191 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -78.5 -52.17 8.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.423 . . . . 0.44 111.677 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.28 -25.98 67.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.44 111.129 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.491 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 2.0 mp -54.05 -44.58 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.44 110.597 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -30.78 69.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.351 -0.611 . . . . 0.44 109.351 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 -31.07 52.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.44 111.393 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.567 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.76 7.0 26.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.144 0.794 . . . . 0.44 113.144 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.485 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 4.7 t -133.32 -44.64 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.44 110.681 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 51.65 18.04 3.64 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.652 0.621 . . . . 0.44 114.652 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -127.63 -170.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.871 0.836 . . . . 0.44 110.839 179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -115.28 87.09 15.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.44 109.91 179.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 10.6 Cg_endo -117.35 145.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.511 2.807 . . . . 0.44 115.177 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 89' ' ' ARG . 93.7 mt-30 -74.95 79.22 2.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.451 -2.426 . . . . 0.44 104.451 174.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.536 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.78 123.3 42.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.436 -1.256 . . . . 0.44 110.888 -175.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -176.68 -138.78 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.44 111.011 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m 53.19 169.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.245 0.545 . . . . 0.44 112.153 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.9 tt -128.87 109.56 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.44 110.374 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.59 -46.87 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.44 109.971 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 tt0 -171.67 155.56 4.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.754 -0.657 . . . . 0.44 110.338 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.83 132.1 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.578 -0.283 . . . . 0.44 110.599 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.18 158.8 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.44 110.88 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -140.04 128.31 22.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.44 110.947 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.42 ' CE1' HG12 ' A' ' 80' ' ' ILE . 6.5 p90 -141.0 147.62 38.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.269 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -121.08 132.26 54.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.256 0.551 . . . . 0.44 111.553 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -82.11 163.79 51.33 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.337 -0.847 . . . . 0.44 110.107 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.4 Cg_endo -49.64 82.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.185 2.59 . . . . 0.44 112.459 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 94.37 16.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.371 -0.831 . . . . 0.44 111.524 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt180 -137.45 150.16 47.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.462 -0.336 . . . . 0.44 110.741 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -121.57 116.31 24.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.44 110.942 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.42 HG12 ' CE1' ' A' ' 73' ' ' TYR . 1.8 tt -122.34 121.22 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.323 -0.398 . . . . 0.44 110.788 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.07 134.62 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.845 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 mt -125.64 114.26 18.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.44 111.368 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -109.21 122.49 47.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.44 110.37 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -104.25 121.17 42.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.44 110.972 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.6 m95 -108.15 148.89 29.25 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.07 -0.514 . . . . 0.44 111.544 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 46.3 tp -93.34 103.12 15.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.505 0.669 . . . . 0.44 111.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.659 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 17.4 t -88.71 145.59 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.145 -0.934 . . . . 0.44 111.654 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -102.2 -55.4 2.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.124 1.527 . . . . 0.44 115.124 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -163.4 165.85 23.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.931 0.787 . . . . 0.44 112.854 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 48.7 p90 -128.53 140.1 51.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.787 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.45 ' HB3' HG21 ' A' ' 61' ' ' THR . 0.9 OUTLIER -93.07 85.48 5.1 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 120.903 0.382 . . . . 0.44 110.411 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.57 -119.19 2.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.918 -0.658 . . . . 0.44 112.289 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 10.0 tt0 -135.12 131.12 19.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.434 0.159 . . . . 0.44 110.74 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.493 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 5.7 Cg_exo -77.07 128.87 10.15 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.895 2.397 . . . . 0.44 111.606 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 50.9 p-90 -142.19 -58.47 0.46 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.475 -0.49 . . . . 0.44 111.936 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 42.81 -96.13 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.686 -0.688 . . . . 0.44 113.017 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.08 39.34 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.761 0.315 . . . . 0.44 110.737 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.57 -47.64 83.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.343 -0.389 . . . . 0.44 111.03 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.74 -62.67 0.55 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.308 -0.948 . . . . 0.44 113.253 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -109.93 93.89 16.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 0.44 111.828 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.82 125.92 5.49 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.017 2.478 . . . . 0.44 112.643 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.72 177.47 17.48 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.922 -0.656 . . . . 0.44 113.004 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -120.54 157.25 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.6 0.238 . . . . 0.44 110.631 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -61.04 106.9 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.44 110.399 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.1 ptp -120.2 163.19 18.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.44 111.241 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -83.94 131.93 34.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.336 . . . . 0.44 110.952 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.437 ' HG ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.15 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.2 -13.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.44 111.936 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.71 38.95 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.474 -0.869 . . . . 0.44 113.109 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.403 ' HB2' HD11 ' A' ' 107' ' ' LEU . 9.0 tp -70.55 140.54 51.8 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.39 -0.226 . . . . 0.44 110.39 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.16 134.8 54.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.351 0.5 . . . . 0.44 112.351 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.4 61.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.714 -0.675 . . . . 0.44 110.883 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -49.12 13.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.384 -0.371 . . . . 0.44 111.559 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -38.79 83.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.46 -0.336 . . . . 0.44 111.442 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.568 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.48 174.08 6.62 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.402 -0.363 . . . . 0.44 110.408 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.46 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 65.2 Cg_endo -74.15 127.85 11.67 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.258 1.972 . . . . 0.44 111.515 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.0 -14.82 29.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.658 2.239 . . . . 0.44 113.181 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.09 -9.79 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.398 0.518 . . . . 0.44 112.398 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.1 38.23 3.81 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.713 0.292 . . . . 0.44 111.692 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.6 tt0 -71.17 -45.09 14.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.723 -0.217 . . . . 0.44 111.456 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -54.88 -37.36 92.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.119 1.879 . . . . 0.44 112.271 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.45 -51.45 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.564 . . . . 0.44 111.143 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.515 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -68.59 -29.84 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.824 -0.626 . . . . 0.44 110.923 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -28.69 53.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.975 0.417 . . . . 0.44 110.672 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.74 -49.19 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.579 . . . . 0.44 111.065 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 68' ' ' PHE . 9.7 tp -78.11 -27.51 48.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.44 111.272 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -58.86 -42.6 89.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.104 0.478 . . . . 0.44 110.914 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -74.51 -2.96 28.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.666 -0.697 . . . . 0.44 109.902 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-N 116.065 -0.516 . . . . 0.44 111.162 179.626 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.879 0.371 . . . . 0.44 110.889 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.02 136.33 33.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.44 110.776 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.18 138.56 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.44 110.822 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 27.7 mt-30 -102.84 155.22 18.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.207 0.527 . . . . 0.44 111.312 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' THR . 39.7 mm -146.5 139.29 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.621 -0.718 . . . . 0.44 110.641 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.66 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.58 150.28 46.11 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.44 109.639 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG22 ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -145.45 148.86 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.906 0.384 . . . . 0.44 110.935 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.57 107.37 0.33 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.435 -0.888 . . . . 0.44 112.886 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.636 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.41 103.87 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.081 -0.711 . . . . 0.44 109.081 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.567 HG12 ' CE3' ' A' ' 90' ' ' TRP . 1.2 tt -70.62 111.61 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.44 111.755 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -87.52 138.08 31.78 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.696 -0.684 . . . . 0.44 112.376 -179.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.743 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.3 p30 -90.52 -173.3 3.72 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.981 -1.008 . . . . 0.44 111.336 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 13.5 tp10 -78.24 0.91 23.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.119 -0.946 . . . . 0.44 112.326 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -122.38 40.33 3.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.286 0.476 . . . . 0.44 112.286 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.97 21.35 2.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 0.44 111.576 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 22.1 mt-10 -113.85 161.94 16.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.47 -0.567 . . . . 0.44 109.47 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -119.25 135.79 58.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.92 0.391 . . . . 0.44 111.729 -178.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.475 ' CD2' ' CG2' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -88.79 102.44 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.44 110.367 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.54 162.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.44 110.144 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 6.6 p . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 120.757 0.313 . . . . 0.44 110.608 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.522 0.201 . . . . 0.44 111.416 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.36 10.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.44 111.398 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' PHE . 5.2 tt -45.23 93.55 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.832 -0.622 . . . . 0.44 111.119 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.33 -179.97 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.16 0.505 . . . . 0.44 111.566 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.473 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -119.68 168.17 10.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 0.44 111.174 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.1 Cg_endo -46.95 168.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.276 2.65 . . . . 0.44 111.75 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.68 59.02 0.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.042 -1.075 . . . . 0.44 113.243 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -146.13 101.57 0.24 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.439 -0.88 . . . . 0.44 112.25 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.631 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 128.01 -9.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.374 0.67 . . . . 0.44 110.723 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.518 HG12 ' N ' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -43.31 -74.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.44 111.458 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.518 ' N ' HG12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -8.22 -82.16 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.818 -1.083 . . . . 0.44 112.565 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 44.35 -93.36 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.44 111.505 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.58 17.21 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.526 -0.845 . . . . 0.44 113.485 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.89 -163.45 0.59 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.596 0.236 . . . . 0.44 110.807 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.542 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.73 155.82 38.3 Favored Pre-proline 0 N--CA 1.456 -0.162 0 N-CA-C 110.159 -0.312 . . . . 0.44 110.159 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.82 -24.7 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.685 2.256 . . . . 0.44 112.442 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.33 -54.98 3.33 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.964 0.357 . . . . 0.44 111.964 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.49 -4.98 55.89 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.983 0.364 . . . . 0.44 111.983 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.4 -57.04 9.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.623 0.249 . . . . 0.44 110.974 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -78.37 -39.91 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.535 -0.302 . . . . 0.44 111.362 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.7 t -50.68 -35.81 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.44 110.854 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -49.47 13.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.44 110.422 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -64.41 -21.09 66.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 0.44 110.482 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.467 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.6 tp -57.02 -44.67 83.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 0.44 110.956 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -30.48 67.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.55 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.2 -26.27 64.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.442 . . . . 0.44 110.565 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.31 7.25 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.44 112.114 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.449 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -133.45 -44.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.161 0.505 . . . . 0.44 110.013 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.4 -40.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.44 114.519 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.497 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -86.59 -173.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.44 110.651 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -110.65 88.62 8.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.835 -0.62 . . . . 0.44 109.826 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 2.9 Cg_endo -111.12 152.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.706 0 C-N-CA 122.966 2.444 . . . . 0.44 114.555 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.469 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 42.8 mt-30 -74.66 80.06 2.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.839 -1.911 . . . . 0.44 105.839 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.576 ' HA ' HG13 ' A' ' 87' ' ' VAL . 1.2 t-160 -127.32 127.3 44.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.678 -1.146 . . . . 0.44 111.319 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.13 -136.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.941 -0.572 . . . . 0.44 110.634 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 54.03 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.196 0.522 . . . . 0.44 112.358 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 7.2 tt -125.14 110.34 13.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.44 110.74 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.98 -39.76 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.44 110.603 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -171.52 164.34 6.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.778 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 112.14 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.448 -0.342 . . . . 0.44 110.839 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.426 ' CD2' ' CD1' ' A' ' 82' ' ' LEU . 15.3 tp -99.53 128.0 45.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.35 . . . . 0.44 110.682 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -131.21 110.56 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.44 110.895 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.431 ' CZ ' HG22 ' A' ' 80' ' ' ILE . 2.5 p90 -139.41 150.23 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.44 110.415 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.09 124.79 45.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.232 0.539 . . . . 0.44 111.613 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.65 163.3 69.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.44 110.233 179.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.1 Cg_endo -50.82 83.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.966 2.444 . . . . 0.44 112.144 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.3 m-20 94.29 16.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.26 -0.882 . . . . 0.44 111.342 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 148.7 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.454 -0.339 . . . . 0.44 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -120.76 97.35 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.44 110.97 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.431 HG22 ' CZ ' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -102.97 111.89 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.44 110.743 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' ILE . 54.0 m -114.96 126.8 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.44 110.955 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -126.46 115.5 19.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.7 0.286 . . . . 0.44 111.228 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -94.6 122.87 37.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.186 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.0 m-85 -99.68 109.78 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.44 110.777 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 61.5 m95 -95.72 148.53 22.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.433 -0.348 . . . . 0.44 110.933 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.6 tp -102.1 102.92 13.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.298 0.57 . . . . 0.44 112.034 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 12.8 t -80.52 145.56 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.354 -0.839 . . . . 0.44 110.649 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.83 -43.11 3.66 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.792 1.404 . . . . 0.44 114.792 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.05 166.25 23.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.786 0.721 . . . . 0.44 112.377 -178.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.743 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 28.0 p90 -137.56 148.78 46.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.507 . . . . 0.44 111.745 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.01 96.3 8.06 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.159 -0.473 . . . . 0.44 111.047 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 -138.49 14.84 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.62 -0.8 . . . . 0.44 112.779 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.4 tt0 -106.07 122.63 41.68 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.615 -0.143 . . . . 0.44 110.615 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.529 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 2.9 Cg_exo -76.3 129.02 10.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.898 2.399 . . . . 0.44 112.192 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.543 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 3.6 p-90 -126.2 -77.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.15 -0.62 . . . . 0.44 111.741 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.683 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 67.33 -66.96 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.479 -0.867 . . . . 0.44 112.856 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 96.28 69.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.039 0.535 . . . . 0.44 110.811 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -83.36 -35.7 24.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.527 . . . . 0.44 110.772 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.86 -52.13 0.16 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.586 -0.816 . . . . 0.44 113.001 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -140.05 117.97 8.41 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.48 . . . . 0.44 111.621 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -43.72 144.87 2.09 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.923 2.415 . . . . 0.44 112.654 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.3 19.23 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.798 -0.715 . . . . 0.44 112.637 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -125.89 157.33 37.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.532 0.206 . . . . 0.44 110.603 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.476 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.0 m0 -60.89 105.81 0.51 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.998 -0.371 . . . . 0.44 109.998 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.3 ptm -120.76 154.21 35.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.44 111.542 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 124.64 25.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.44 111.027 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -80.06 -18.89 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.44 111.547 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.14 -18.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.44 111.94 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.48 41.47 1.72 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.401 -0.904 . . . . 0.44 113.179 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.408 HD21 ' N ' ' A' ' 111' ' ' ASN . 3.1 tt -62.88 148.05 48.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.98 -0.378 . . . . 0.44 109.98 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -123.22 131.22 53.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.814 0.672 . . . . 0.44 112.814 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.541 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -15.12 61.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.264 -0.88 . . . . 0.44 110.493 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.5 -49.28 13.67 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.283 -0.417 . . . . 0.44 111.579 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -38.34 85.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.737 0.303 . . . . 0.44 111.092 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.97 173.6 7.46 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.39 -0.368 . . . . 0.44 110.293 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.9 Cg_endo -74.3 128.02 11.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.24 1.96 . . . . 0.44 111.678 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.97 -14.84 35.21 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.682 2.255 . . . . 0.44 113.175 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.78 -9.8 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.168 0.432 . . . . 0.44 112.168 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.76 37.72 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.44 111.332 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.08 -43.5 3.65 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 112.438 0.533 . . . . 0.44 112.438 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.8 Cg_exo -45.2 -40.84 16.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.21 1.94 . . . . 0.44 113.166 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.51 -51.27 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.44 111.209 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.5 mm -65.83 -33.69 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.625 . . . . 0.44 111.467 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.92 -28.43 50.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.883 0.373 . . . . 0.44 110.845 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.26 -53.15 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.44 111.682 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 tp -78.52 -36.88 44.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.559 -0.292 . . . . 0.44 111.75 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -53.76 -42.71 68.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.9 0.381 . . . . 0.44 111.126 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -7.65 25.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.44 109.808 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.407 HD11 ' N ' ' A' ' 129' ' ' LEU . 8.2 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-N 115.982 -0.554 . . . . 0.44 111.042 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.7 tttt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.861 0.362 . . . . 0.44 111.027 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 133.3 38.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.44 110.736 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 pp -146.04 139.54 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.44 111.14 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 36.9 mt-30 -102.85 154.08 19.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.234 0.54 . . . . 0.44 111.881 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 40.0 mm -146.54 118.8 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.408 -0.815 . . . . 0.44 109.909 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -125.21 150.28 47.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.912 -0.315 . . . . 0.44 110.388 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -145.22 162.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.128 0.49 . . . . 0.44 111.472 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.79 114.81 1.18 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.628 -0.715 . . . . 0.44 112.203 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.581 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.5 mt -70.87 98.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.926 -0.768 . . . . 0.44 108.926 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.627 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.95 122.46 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.406 0.622 . . . . 0.44 112.276 -177.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.715 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -86.27 127.36 34.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.097 -0.956 . . . . 0.44 110.708 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 2.8 t-20 -73.24 -171.92 1.03 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 122.092 0.949 . . . . 0.44 112.692 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.69 -13.63 15.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.627 -1.624 . . . . 0.44 113.271 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -132.34 -82.93 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.44 111.799 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -149.82 14.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.44 111.71 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' HG3' ' CB ' ' A' ' 13' ' ' ASN . 1.8 pt-20 -100.72 160.39 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.014 -0.736 . . . . 0.44 109.014 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.459 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 6.1 mt -135.97 138.6 47.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.216 0.531 . . . . 0.44 111.911 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.427 ' N ' HG22 ' A' ' 18' ' ' ILE . 44.9 t80 -76.88 94.12 3.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.379 -0.828 . . . . 0.44 110.127 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.495 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.21 139.16 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.44 110.419 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.403 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 6.3 p . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.44 110.756 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.698 0.285 . . . . 0.44 111.002 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.9 ttpp -110.6 26.06 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.082 0.401 . . . . 0.44 112.082 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.402 ' N ' ' HA ' ' A' ' 115' ' ' PHE . 17.2 tp -66.4 69.25 0.06 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.864 -0.607 . . . . 0.44 110.629 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -106.92 -168.64 1.43 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.44 111.68 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.67 168.67 9.69 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.44 112.468 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 79.9 Cg_endo -80.11 169.3 17.81 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.459 3.44 . . . . 0.44 114.087 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 104.17 -1.63 43.91 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 115.409 0.923 . . . . 0.44 115.409 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.14 161.66 29.04 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.565 0.682 . . . . 0.44 112.649 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.6 5.5 0.37 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.879 0.471 . . . . 0.44 111.792 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.643 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.5 pt -54.96 -25.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.588 0.708 . . . . 0.44 110.331 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -40.57 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.529 -1.214 . . . . 0.44 111.391 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.1 mtp 32.12 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.502 0.501 . . . . 0.44 111.961 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.99 32.46 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.872 -0.68 . . . . 0.44 112.572 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.72 -172.07 3.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.911 0.386 . . . . 0.44 111.074 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.528 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.79 155.27 36.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.144 -0.48 . . . . 0.44 110.328 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.95 -24.96 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.884 2.39 . . . . 0.44 112.596 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -101.65 -44.24 5.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.44 111.538 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -80.2 -6.1 57.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.825 0.305 . . . . 0.44 111.825 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -62.28 -56.15 21.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.44 110.838 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 3.4 m -78.2 -45.3 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.49 . . . . 0.44 111.303 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.486 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 43.7 t -56.17 -39.27 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.44 111.501 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -78.36 -51.87 9.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.44 111.744 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 0.6 OUTLIER -68.98 -23.2 64.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.456 -0.338 . . . . 0.44 110.869 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -50.47 -44.28 55.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.739 -0.467 . . . . 0.44 109.739 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -33.92 65.43 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.074 -0.713 . . . . 0.44 109.074 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.72 -25.26 49.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.222 -0.899 . . . . 0.44 111.53 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.486 ' OE1' ' HA2' ' A' ' 37' ' ' GLY . 9.0 mp0 -108.43 5.09 25.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.568 0.581 . . . . 0.44 112.568 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.466 ' CG1' HG13 ' A' ' 60' ' ' ILE . 8.6 t -134.82 -44.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.44 110.225 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.672 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 60.82 1.63 2.04 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.245 -0.889 . . . . 0.44 114.318 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -119.05 -172.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.695 0.748 . . . . 0.44 110.141 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 p -113.38 87.89 12.1 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 116.243 -0.435 . . . . 0.44 110.618 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.562 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.0 Cg_endo -112.68 144.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.563 2.842 . . . . 0.44 113.9 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.448 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 4.8 pt20 -74.75 79.95 2.07 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.414 -2.069 . . . . 0.44 105.414 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.625 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.04 129.65 53.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.252 -1.34 . . . . 0.44 111.795 -175.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.606 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -176.66 -142.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.782 -0.645 . . . . 0.44 110.291 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 57.28 154.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.231 0.539 . . . . 0.44 112.21 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.0 tt -117.83 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.665 -0.698 . . . . 0.44 110.5 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.49 -54.05 7.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.44 109.94 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.4 tt0 -171.58 145.81 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.826 -0.625 . . . . 0.44 110.193 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.79 117.99 14.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.321 . . . . 0.44 110.654 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.58 147.05 25.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.44 111.093 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.22 112.07 11.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.63 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -137.75 128.95 27.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.44 110.641 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.75 118.62 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.052 0.453 . . . . 0.44 111.422 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.96 162.72 66.66 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.703 . . . . 0.44 110.387 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 2.2 Cg_endo -44.96 81.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.438 2.759 . . . . 0.44 112.595 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 36.6 t0 104.08 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.286 -0.87 . . . . 0.44 111.103 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.87 150.26 20.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.545 -0.298 . . . . 0.44 110.872 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -121.75 93.82 4.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.44 110.679 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.17 135.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.985 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.3 118.91 22.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.44 110.513 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.521 ' HG ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -115.08 114.34 25.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.44 111.255 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 7' ' ' ALA . 12.0 m0 -109.85 129.73 55.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.092 -0.504 . . . . 0.44 110.851 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 9.0 m-30 -115.79 112.12 21.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.999 0.428 . . . . 0.44 110.798 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 43.6 m95 -94.9 149.32 21.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.888 -0.597 . . . . 0.44 111.461 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 65' ' ' PHE . 23.3 tp -97.71 102.8 14.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.54 0.686 . . . . 0.44 111.558 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 t -85.44 146.22 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 114.983 -1.008 . . . . 0.44 111.693 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.44 -39.4 6.14 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.67 1.359 . . . . 0.44 114.67 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.85 165.43 25.27 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.96 0.8 . . . . 0.44 111.835 -178.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 3.3 p90 -147.6 128.49 14.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.229 -0.441 . . . . 0.44 111.714 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -77.35 113.19 14.88 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.23 -0.441 . . . . 0.44 110.835 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.54 -122.14 6.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.748 -0.739 . . . . 0.44 112.456 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.5 mt-10 -135.06 137.52 27.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.418 0.151 . . . . 0.44 110.825 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.31 128.84 10.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.781 2.321 . . . . 0.44 111.395 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.672 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.8 p-90 -128.68 -59.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.461 -0.496 . . . . 0.44 111.901 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.02 -98.82 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.849 -0.691 . . . . 0.44 112.99 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 177.61 37.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.716 0.293 . . . . 0.44 111.171 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -52.04 -41.92 62.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.85 0.357 . . . . 0.44 110.639 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.82 -5.35 42.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.705 -0.759 . . . . 0.44 113.324 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.403 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 12.6 mp0 -140.1 97.71 7.76 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.44 111.457 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -43.49 145.09 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.073 2.516 . . . . 0.44 112.802 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.11 19.42 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.768 -0.73 . . . . 0.44 112.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -141.81 157.16 45.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.321 -0.251 . . . . 0.44 110.321 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -65.57 105.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.44 110.486 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.4 ptm -120.71 163.39 18.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.954 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.0 p -86.33 114.74 23.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.44 110.713 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.413 ' HG ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.96 -18.85 60.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.44 111.202 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.3 p -54.22 -18.82 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.407 -0.36 . . . . 0.44 111.935 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.2 49.8 0.83 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.366 -0.921 . . . . 0.44 113.071 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.71 150.36 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.635 0.255 . . . . 0.44 110.427 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.04 131.65 55.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.427 0.529 . . . . 0.44 112.427 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.38 61.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.656 -0.702 . . . . 0.44 110.367 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -46.66 17.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.237 -0.438 . . . . 0.44 111.232 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -71.9 -22.53 61.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.115 -0.493 . . . . 0.44 112.105 -179.073 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -97.35 174.53 3.17 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.624 -0.262 . . . . 0.44 110.7 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 70.4 Cg_endo -75.3 136.02 19.26 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.277 1.985 . . . . 0.44 111.601 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.59 -14.36 35.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.901 2.401 . . . . 0.44 113.191 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -12.24 22.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.589 0.588 . . . . 0.44 112.589 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.521 ' ND2' ' HG ' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -130.87 37.96 3.74 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.805 0.298 . . . . 0.44 111.805 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -76.06 -48.1 3.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.738 -0.21 . . . . 0.44 111.009 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.4 Cg_exo -53.68 -38.29 84.47 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.371 2.047 . . . . 0.44 112.158 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.19 -51.05 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.771 . . . . 0.44 110.666 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.472 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -66.09 -29.98 48.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.44 110.926 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.13 -30.99 60.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.44 110.526 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -74.81 -52.0 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.44 111.429 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tp -78.19 -19.73 53.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.44 111.641 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.6 ttpp -80.38 -42.59 22.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.087 0.47 . . . . 0.44 110.554 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.62 -8.8 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 0.44 109.907 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.761 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.802 0.334 . . . . 0.44 110.898 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.44 121.97 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.44 110.901 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.408 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.9 pp -124.45 120.42 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.821 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -103.3 150.88 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.221 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.408 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 3.3 mp -141.92 134.38 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.44 110.48 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.692 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.96 158.03 34.63 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 109.359 -0.608 . . . . 0.44 109.359 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 35' ' ' PHE . 1.9 m -145.59 162.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.245 -0.582 . . . . 0.44 111.933 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.56 104.74 0.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.594 -0.812 . . . . 0.44 112.608 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.656 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.7 109.19 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.421 -0.955 . . . . 0.44 108.421 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.478 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.82 124.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.378 0.608 . . . . 0.44 112.323 -177.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.92 124.18 30.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.175 -0.92 . . . . 0.44 111.418 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.575 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 19.8 t-20 -69.56 177.26 3.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.843 -1.072 . . . . 0.44 112.015 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.543 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tp10 -56.05 -18.65 10.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.218 -1.355 . . . . 0.44 112.6 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -121.19 -82.38 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.738 0.304 . . . . 0.44 111.519 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.97 15.56 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.44 111.711 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 13' ' ' ASN . 2.1 mp0 -100.83 160.51 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.483 -0.562 . . . . 0.44 109.483 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.706 HG13 ' HA ' ' A' ' 12' ' ' ARG . 3.8 mp -134.0 139.84 47.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.437 . . . . 0.44 111.167 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.488 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -93.67 113.84 26.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.792 -0.64 . . . . 0.44 110.898 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -123.16 159.11 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.44 109.557 179.315 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.9 p . . . . . 0 C--N 1.326 -0.414 0 N-CA-C 110.058 -0.349 . . . . 0.44 110.058 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.511 0.196 . . . . 0.44 111.425 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.46 26.3 10.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.747 0.308 . . . . 0.44 111.667 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.4 tt -52.78 86.41 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.703 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -122.09 179.8 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.239 0.542 . . . . 0.44 111.778 -179.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 166.59 14.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.486 -0.779 . . . . 0.44 111.736 -179.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 7.6 Cg_endo -47.64 168.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.609 2.873 . . . . 0.44 111.461 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.24 59.78 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.75 -1.214 . . . . 0.44 114.209 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.42 103.14 0.49 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 114.765 -0.718 . . . . 0.44 112.069 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 125.56 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.395 0.678 . . . . 0.44 111.525 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -42.82 -46.16 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.494 0.664 . . . . 0.44 111.005 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.94 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.391 -1.277 . . . . 0.44 112.263 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 34.73 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.893 0.331 . . . . 0.44 111.893 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.88 24.25 0.08 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.548 -0.834 . . . . 0.44 113.203 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.41 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -90.04 -159.26 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.431 0.157 . . . . 0.44 110.747 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.507 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -100.72 152.74 37.92 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.912 -0.403 . . . . 0.44 109.912 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.507 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.64 -24.58 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.622 2.214 . . . . 0.44 112.192 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.94 -49.66 4.46 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.125 0.417 . . . . 0.44 112.125 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -80.54 -8.82 59.72 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.414 0.524 . . . . 0.44 112.414 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 40' ' ' ILE . . . -66.98 -57.33 7.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.082 -0.247 . . . . 0.44 111.375 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.3 p -78.92 -35.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.627 -0.26 . . . . 0.44 111.459 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 70.0 t -50.3 -35.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.44 110.333 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -34.82 47.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.501 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -76.95 -22.22 53.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.44 110.84 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.47 ' CG ' ' CE1' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -55.42 -44.39 76.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.998 0.428 . . . . 0.44 110.547 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.02 74.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.015 -0.539 . . . . 0.44 110.149 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -27.61 52.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.44 111.459 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -108.22 5.47 25.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.261 0.467 . . . . 0.44 112.261 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.494 ' CG1' HG13 ' A' ' 60' ' ' ILE . 17.0 t -134.5 -44.35 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.179 0.514 . . . . 0.44 110.369 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.631 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.22 18.04 12.53 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.44 114.744 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -128.38 -168.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 117.674 0.737 . . . . 0.44 110.676 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.28 86.73 18.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.44 109.923 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 16.8 Cg_endo -117.18 139.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 123.819 3.013 . . . . 0.44 114.532 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 31.7 mt-30 -74.84 79.32 2.11 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.315 -2.476 . . . . 0.44 104.315 174.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.583 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -114.22 126.72 55.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.077 -1.42 . . . . 0.44 111.142 -175.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -174.52 -150.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.692 -0.686 . . . . 0.44 110.846 -179.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.77 -177.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.44 111.903 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.769 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.6 pp -144.85 129.94 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.749 -0.659 . . . . 0.44 111.11 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -46.2 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.44 109.983 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.624 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.32 131.36 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.44 110.142 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -113.82 132.14 55.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.799 0.333 . . . . 0.44 111.006 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 tp -112.24 137.68 50.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.44 110.653 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.42 109.91 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.44 110.675 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -140.51 149.14 42.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.44 110.562 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.19 140.05 52.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.254 0.549 . . . . 0.44 111.429 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -87.7 163.12 39.71 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.821 . . . . 0.44 110.435 179.449 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -52.52 82.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.004 2.469 . . . . 0.44 112.137 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 11.9 t0 97.08 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.407 -0.815 . . . . 0.44 111.187 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 75' ' ' PHE . 7.3 ttp-105 -137.34 150.34 47.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.44 110.627 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -123.79 96.96 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.44 110.871 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 ' O ' HG21 ' A' ' 80' ' ' ILE . 2.8 tt -100.73 111.88 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.44 110.984 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.76 131.73 45.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.408 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.78 114.27 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.44 111.043 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.466 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 2.3 m0 -112.89 122.8 48.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.267 -0.424 . . . . 0.44 110.179 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -106.4 116.89 32.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.44 110.291 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.769 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.4 m95 -94.51 148.35 22.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.295 -0.411 . . . . 0.44 111.635 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.5 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.3 tp -102.87 102.9 13.03 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.319 0.58 . . . . 0.44 111.288 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.656 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 28.9 t -83.93 145.44 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 115.441 -0.8 . . . . 0.44 111.132 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.546 ' C ' ' HG2' ' A' ' 89' ' ' ARG . 8.1 pt-20 -115.8 -17.49 11.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.323 1.601 . . . . 0.44 115.323 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -161.89 165.62 27.41 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.878 1.217 . . . . 0.44 112.185 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -157.54 130.03 7.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.991 -0.549 . . . . 0.44 110.977 178.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.68 161.25 13.73 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.926 0.393 . . . . 0.44 111.197 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.12 -128.41 28.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.937 -0.649 . . . . 0.44 112.657 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.3 tt0 -127.12 127.88 24.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.371 -0.233 . . . . 0.44 110.371 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 90' ' ' TRP . 4.2 Cg_exo -76.9 128.56 10.1 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.561 2.174 . . . . 0.44 112.69 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.631 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 7.8 p-90 -133.79 -62.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.44 110.116 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 -67.45 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.44 112.789 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' TRP . 1.6 mmtt 81.45 43.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.966 0.412 . . . . 0.44 110.662 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -29.31 64.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.44 110.806 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.72 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.556 -0.83 . . . . 0.44 112.794 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -140.05 105.08 6.72 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 0.44 111.566 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -43.78 144.48 2.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.858 2.372 . . . . 0.44 112.388 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 169.64 22.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.62 -0.8 . . . . 0.44 112.93 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.21 157.31 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.342 -0.244 . . . . 0.44 110.342 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.74 106.05 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.44 110.581 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.1 ptm -120.56 163.25 18.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.44 110.797 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.6 t -72.87 114.86 11.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.438 -0.346 . . . . 0.44 110.668 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 11.8 tp -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.314 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.56 -13.33 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.468 -0.333 . . . . 0.44 111.506 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.94 34.76 5.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.6 -0.81 . . . . 0.44 112.871 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.7 tp -62.54 131.53 49.41 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.93 -0.396 . . . . 0.44 109.93 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 132.29 54.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.785 0.661 . . . . 0.44 112.785 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.42 61.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.416 -0.811 . . . . 0.44 110.285 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.78 -49.19 13.42 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.382 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -67.4 -38.34 84.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.393 -0.367 . . . . 0.44 111.674 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.89 174.06 6.7 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.494 -0.321 . . . . 0.44 110.281 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.4 Cg_endo -73.79 127.84 11.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.052 1.835 . . . . 0.44 111.355 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.53 -14.72 26.96 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.634 2.223 . . . . 0.44 113.289 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.75 -9.82 31.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.508 0.558 . . . . 0.44 112.508 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.67 42.3 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.869 0.322 . . . . 0.44 111.869 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 tt0 -73.22 -38.77 4.6 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.117 0.414 . . . . 0.44 112.117 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 73.3 Cg_exo -51.17 -41.41 57.94 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.1 1.866 . . . . 0.44 113.033 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.26 -51.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.405 . . . . 0.44 111.273 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.512 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.6 mm -65.97 -29.85 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.44 111.022 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.47 -29.85 62.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.44 110.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -80.09 -46.56 16.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.44 111.427 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 7.6 tp -78.14 -26.42 47.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.44 111.257 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -58.4 -42.57 87.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.141 0.496 . . . . 0.44 110.648 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 1.5 tpp180 -71.12 -5.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.44 109.875 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.968 -0.56 . . . . 0.44 111.225 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.852 0.358 . . . . 0.44 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.01 132.59 49.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.44 110.938 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.94 129.72 22.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.44 110.891 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -102.74 148.89 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.44 111.169 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 81' ' ' THR . 24.0 mm -135.54 134.13 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.594 -0.73 . . . . 0.44 110.805 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.684 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.94 125.19 43.54 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.719 -0.474 . . . . 0.44 109.719 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -131.63 155.7 41.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.251 0.548 . . . . 0.44 111.813 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.62 137.42 7.5 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.142 -0.935 . . . . 0.44 111.339 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.488 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.73 94.72 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.088 -0.245 . . . . 0.44 110.384 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.732 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -71.68 118.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.194 0.521 . . . . 0.44 111.351 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.332 -0.849 . . . . 0.44 110.262 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.623 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 7.4 p-10 -110.17 -173.52 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.484 0.92 . . . . 0.44 113.484 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -45.99 -28.5 1.17 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.075 -1.42 . . . . 0.44 113.432 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -92.58 26.74 2.54 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.958 -0.565 . . . . 0.44 111.578 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.91 25.89 0.34 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.211 0.529 . . . . 0.44 110.51 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 17.2 pt-20 -114.22 160.16 19.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.473 -0.785 . . . . 0.44 109.212 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.732 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -112.15 135.96 49.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.347 0.594 . . . . 0.44 112.441 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 10.9 t80 -91.02 103.27 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.306 -0.861 . . . . 0.44 109.933 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.458 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.58 147.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.926 0.394 . . . . 0.44 110.863 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.434 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 4.8 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.44 109.938 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 111.68 0.252 . . . . 0.44 111.68 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 mttt -114.36 26.01 10.6 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.962 0.41 . . . . 0.44 111.387 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -55.73 86.2 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.651 -0.704 . . . . 0.44 110.599 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.9 tt0 -106.89 -170.96 1.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.14 0.495 . . . . 0.44 111.741 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.86 166.04 16.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.691 -0.686 . . . . 0.44 111.44 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 61.1 Cg_endo -71.07 168.86 22.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.548 2.832 . . . . 0.44 111.708 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.43 59.36 0.72 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.326 -0.94 . . . . 0.44 113.601 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.44 120.02 3.4 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 114.118 -1.041 . . . . 0.44 111.527 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 119.05 -10.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.417 0.687 . . . . 0.44 110.727 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -37.78 -63.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.33 0.586 . . . . 0.44 111.358 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -15.41 -81.25 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.32 -1.309 . . . . 0.44 112.375 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.69 -93.27 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.457 -0.338 . . . . 0.44 111.696 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.6 22.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.505 -0.855 . . . . 0.44 113.447 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.6 -159.22 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.521 0.2 . . . . 0.44 110.884 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.538 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.44 155.61 37.68 Favored Pre-proline 0 N--CA 1.457 -0.082 0 N-CA-C 110.311 -0.255 . . . . 0.44 110.311 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -44.07 -24.83 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.781 2.321 . . . . 0.44 112.428 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.0 -49.6 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.44 111.8 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -80.42 -4.58 54.21 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.773 0.286 . . . . 0.44 111.773 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.539 ' HB3' HG13 ' A' ' 40' ' ' ILE . . . -64.61 -57.45 9.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.596 0.236 . . . . 0.44 111.214 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.468 ' HB ' HD11 ' A' ' 40' ' ' ILE . 1.2 p -78.79 -40.86 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.944 -0.303 . . . . 0.44 111.494 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.2 -35.22 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.814 0.34 . . . . 0.44 111.137 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -52.16 9.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.212 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.51 -19.91 65.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.44 110.87 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 7.9 tp -56.61 -44.44 81.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.44 110.459 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -26.78 68.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.44 109.836 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.2 tm-20 -75.36 -26.77 58.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.709 -0.678 . . . . 0.44 111.396 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.498 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.97 6.82 25.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.628 0.603 . . . . 0.44 112.628 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.487 ' CG1' HG13 ' A' ' 60' ' ' ILE . 8.2 t -131.46 -43.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.062 0.458 . . . . 0.44 110.395 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 57.46 7.34 2.9 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.751 -0.659 . . . . 0.44 114.679 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.487 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.9 -166.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.928 0.864 . . . . 0.44 110.512 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.454 HG22 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -113.16 87.89 11.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.44 110.888 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 11.7 Cg_endo -113.51 133.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.792 2.995 . . . . 0.44 113.852 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 7.9 pt20 -74.75 79.22 2.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.008 -2.219 . . . . 0.44 105.008 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.587 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -112.16 130.02 56.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.554 -1.657 . . . . 0.44 110.539 -175.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -178.17 -142.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.098 -0.501 . . . . 0.44 111.053 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t 52.75 171.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.22 0.533 . . . . 0.44 112.16 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 tt -131.31 105.65 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.53 -0.759 . . . . 0.44 110.404 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.64 -40.97 47.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.982 0.42 . . . . 0.44 110.121 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.8 tt0 -171.27 159.88 5.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.44 110.43 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -143.25 132.16 22.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.818 0.342 . . . . 0.44 110.965 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.39 128.95 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.649 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -129.35 110.84 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.44 110.76 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -138.49 104.48 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.44 110.545 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 15.8 pt-20 -88.5 126.62 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.044 0.449 . . . . 0.44 111.526 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -70.08 163.55 60.4 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.44 109.934 179.138 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -38.75 -28.51 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.499 2.799 . . . . 0.44 113.103 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -32.61 0.58 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.44 111.426 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 26.8 ttm180 -94.18 97.95 10.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.337 . . . . 0.44 111.61 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 9.4 m170 -78.97 100.21 7.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.44 110.809 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -104.59 130.89 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.44 111.053 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -121.44 132.01 54.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.44 110.465 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 mt -126.24 114.5 18.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.44 111.474 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -107.65 122.59 47.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.132 -0.485 . . . . 0.44 110.589 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.459 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 4.4 m-30 -100.64 109.56 21.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.355 -0.384 . . . . 0.44 110.429 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 21.8 m95 -96.31 148.6 22.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.54 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.519 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.9 tm? -90.83 103.03 15.79 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.315 0.579 . . . . 0.44 111.35 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 18.9 t -90.5 145.3 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.529 -0.76 . . . . 0.44 111.032 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.424 ' HB2' ' HG3' ' A' ' 63' ' ' GLN . 1.7 mm-40 -113.85 -25.39 8.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.733 1.753 . . . . 0.44 115.733 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.536 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -163.5 165.86 23.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.105 1.32 . . . . 0.44 112.809 -178.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.623 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -157.12 124.5 5.28 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.772 -0.649 . . . . 0.44 110.623 178.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.454 ' CB ' HG22 ' A' ' 61' ' ' THR . 0.7 OUTLIER -80.06 117.99 21.38 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.801 0.334 . . . . 0.44 111.126 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.25 -123.34 6.97 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.44 112.445 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.8 mt-10 -129.46 137.78 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 122.952 -0.146 . . . . 0.44 110.63 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.503 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -76.67 128.94 10.52 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.778 2.319 . . . . 0.44 110.969 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 51.1 p-90 -140.26 -58.99 0.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.776 0.658 . . . . 0.44 112.776 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 48.55 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.653 -0.784 . . . . 0.44 112.578 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -179.37 32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.628 0.252 . . . . 0.44 111.219 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -24.93 67.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.44 110.57 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.06 73.18 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.076 -0.583 . . . . 0.44 113.429 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.434 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 23.4 mt-30 -140.36 100.64 6.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.44 111.418 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 129.59 7.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.883 2.389 . . . . 0.44 112.385 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.429 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.09 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 0.44 113.14 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -153.27 157.13 39.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.245 -0.28 . . . . 0.44 110.245 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -71.59 105.69 3.75 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.604 -0.438 . . . . 0.44 109.824 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.45 ' C ' ' HB2' ' A' ' 17' ' ' GLU . 28.0 ptm -120.58 147.55 45.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.036 -0.529 . . . . 0.44 111.063 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 t -67.85 124.99 24.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.44 110.846 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -71.92 -20.76 61.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.44 111.225 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.13 -19.47 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.405 -0.362 . . . . 0.44 111.521 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.82 36.89 3.73 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.545 -0.836 . . . . 0.44 112.872 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 tp -62.74 129.11 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.932 -0.395 . . . . 0.44 109.932 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.99 134.79 54.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.769 0.655 . . . . 0.44 112.769 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.584 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -15.37 61.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.402 -0.817 . . . . 0.44 110.674 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -78.89 -49.25 13.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.44 111.772 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -30.31 68.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.377 -0.374 . . . . 0.44 111.652 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.584 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -88.45 173.97 5.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.537 -0.301 . . . . 0.44 110.621 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 72.3 Cg_endo -76.86 130.16 11.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.433 2.089 . . . . 0.44 111.596 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.58 -14.44 13.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.938 2.425 . . . . 0.44 113.728 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.71 -10.24 11.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.806 0.669 . . . . 0.44 112.806 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.24 45.67 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.742 0.306 . . . . 0.44 111.465 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.52 -54.41 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.769 0.285 . . . . 0.44 111.769 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.01 -33.09 7.24 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.396 2.064 . . . . 0.44 112.416 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 25.8 t -77.57 -51.03 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.44 110.502 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 115' ' ' PHE . 16.6 mm -65.59 -29.77 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.44 110.85 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.4 56.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.44 110.626 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -47.44 14.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.44 111.449 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.517 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 11.1 tp -78.18 -19.43 53.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.44 111.517 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 123' ' ' ILE . 3.8 ttpm? -71.14 -42.6 68.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.44 110.643 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -68.24 -9.46 47.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.583 -0.735 . . . . 0.44 110.004 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.125 0 CA-C-N 116.288 -0.414 . . . . 0.44 110.623 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mttm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.44 110.881 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 145.94 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.44 110.819 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.404 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 2.8 pp -146.02 124.35 12.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.95 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 15.2 mt-30 -102.49 155.72 18.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.44 111.727 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 3.7 mp -146.16 132.29 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.469 -0.787 . . . . 0.44 110.503 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.597 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.4 124.74 43.0 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.619 -0.511 . . . . 0.44 109.619 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -126.79 162.12 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.44 112.214 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.31 116.27 0.86 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.44 111.908 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.442 ' CG2' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.47 96.02 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.146 -0.316 . . . . 0.44 110.146 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.584 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 2.4 pt -79.35 111.68 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.164 0.507 . . . . 0.44 112.171 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.794 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.1 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.588 -0.733 . . . . 0.44 109.937 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.633 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.5 p-10 -125.34 -173.83 2.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.2 0.815 . . . . 0.44 113.2 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -22.21 12.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.326 -1.307 . . . . 0.44 113.534 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -98.08 30.77 2.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.575 -0.284 . . . . 0.44 111.336 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.41 28.92 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.316 0.579 . . . . 0.44 110.264 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.7 mt-10 -117.71 160.34 21.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.285 -0.87 . . . . 0.44 109.882 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -114.62 136.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.045 0.45 . . . . 0.44 111.596 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 44.5 t80 -87.88 93.68 9.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.862 -0.608 . . . . 0.44 110.619 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.602 HG12 HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -114.68 162.2 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.44 110.698 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.368 -0.378 . . . . 0.44 110.113 179.135 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.611 0.243 . . . . 0.44 111.204 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.49 26.47 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.526 -0.306 . . . . 0.44 111.602 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.5 tt -56.03 80.4 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 0.44 110.691 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -106.84 -168.31 1.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.945 0.402 . . . . 0.44 111.346 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.58 157.39 51.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.44 111.614 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 21.4 Cg_endo -60.06 167.37 7.45 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.216 2.61 . . . . 0.44 111.183 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.1 58.83 0.78 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 119.823 -1.179 . . . . 0.44 113.782 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -122.8 130.69 7.96 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.674 -0.763 . . . . 0.44 111.803 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 102.11 4.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.137 0.575 . . . . 0.44 111.695 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -54.95 -25.91 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.43 0.633 . . . . 0.44 110.547 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.28 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.833 -1.076 . . . . 0.44 110.965 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.1 mmm 35.49 -85.52 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.422 0.451 . . . . 0.44 111.807 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.42 30.63 0.15 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.89 -0.671 . . . . 0.44 112.385 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.5 mp0 -91.86 -178.27 4.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.872 0.368 . . . . 0.44 111.234 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.539 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.01 155.9 36.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.44 110.27 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.96 -24.78 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.847 2.365 . . . . 0.44 112.715 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -95.11 -49.38 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.18 0.437 . . . . 0.44 112.18 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -80.21 -23.25 41.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.954 0.353 . . . . 0.44 111.954 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.49 -48.43 77.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.44 110.952 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.1 -47.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.243 -0.435 . . . . 0.44 110.756 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 45.1 t -58.54 -35.73 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.44 111.036 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -74.89 -52.07 12.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.874 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -68.98 -26.47 65.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.44 110.79 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 50' ' ' VAL . 6.1 tp -51.94 -44.07 63.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.38 -0.373 . . . . 0.44 110.644 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.47 -31.19 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.158 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.1 -23.84 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.44 110.234 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.602 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 9.1 mm-40 -108.11 6.57 27.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.44 111.543 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -134.13 -45.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.167 0.508 . . . . 0.44 110.338 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.57 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 63.32 -27.32 0.08 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.934 1.133 . . . . 0.44 115.934 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.629 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -93.94 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 117.771 0.786 . . . . 0.44 111.466 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.5 p -105.81 89.57 3.66 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.641 -0.709 . . . . 0.44 110.039 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 84.1 Cg_endo -109.57 137.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.438 2.759 . . . . 0.44 115.367 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 89' ' ' ARG . 70.9 mt-30 -75.55 79.46 2.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.522 -2.399 . . . . 0.44 104.522 174.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.64 ' CE1' ' N ' ' A' ' 89' ' ' ARG . 1.8 m-70 -138.17 127.4 24.44 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.104 -0.953 . . . . 0.44 113.55 -173.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' CB ' ' A' ' 66' ' ' SER . 6.2 t80 173.5 173.72 0.14 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.774 -0.648 . . . . 0.44 111.028 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 5.4 t 106.14 154.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.736 0.814 . . . . 0.44 110.614 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 9.1 tt -106.75 146.88 30.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.324 -0.398 . . . . 0.44 111.466 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -117.13 -44.74 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.44 110.709 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.23 153.96 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.666 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -138.0 132.06 31.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.785 0.326 . . . . 0.44 111.003 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -118.01 124.39 48.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.44 110.737 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.82 109.88 17.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.44 110.538 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -134.42 153.22 52.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.44 110.648 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -114.89 140.13 49.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.291 0.567 . . . . 0.44 111.42 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -107.21 163.75 16.28 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.176 -0.92 . . . . 0.44 110.269 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 64.0 Cg_exo -39.26 81.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.457 2.772 . . . . 0.44 112.744 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.02 20.53 4.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.762 -0.654 . . . . 0.44 110.872 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -137.32 93.88 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.44 110.357 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -74.79 101.13 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.44 110.986 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -100.15 114.73 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.191 -0.458 . . . . 0.44 110.979 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 128.2 54.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.44 110.76 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.407 ' CD1' ' OD1' ' A' ' 119' ' ' ASN . 24.8 mt -126.07 114.64 18.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.511 -0.313 . . . . 0.44 111.277 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -105.05 122.54 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.44 110.845 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 4.4 m-30 -99.41 109.86 22.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.038 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.419 ' CZ2' HG13 ' A' ' 50' ' ' VAL . 21.2 m95 -99.69 148.16 24.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.033 0.444 . . . . 0.44 111.955 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.8 tp -91.34 122.2 33.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.44 110.137 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -124.06 145.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.44 110.921 -178.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 12' ' ' ARG . 10.7 tt0 -89.22 -69.78 0.69 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.691 1.737 . . . . 0.44 115.691 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.51 166.08 25.3 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.19 0.519 . . . . 0.44 112.227 -177.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.633 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 47.8 p90 -115.78 163.01 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.68 . . . . 0.44 111.254 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.67 72.27 0.95 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.72 0.295 . . . . 0.44 110.911 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 135.97 -115.97 1.41 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.701 -0.762 . . . . 0.44 112.637 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -134.18 118.77 14.14 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.587 -0.153 . . . . 0.44 110.587 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.549 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -75.74 128.97 11.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.836 2.357 . . . . 0.44 111.881 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.57 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 2.2 p-90 -121.86 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.453 -0.499 . . . . 0.44 111.705 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.602 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 60.55 -68.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.52 -0.763 . . . . 0.44 112.868 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 40.7 tttm 96.95 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.212 0.605 . . . . 0.44 110.969 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -31.31 21.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.625 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.3 -15.52 2.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.44 112.99 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -140.06 101.36 7.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.954 0.407 . . . . 0.44 111.373 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.55 146.22 1.4 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.062 2.508 . . . . 0.44 112.623 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.428 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.24 177.37 19.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.44 112.888 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.427 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 13.8 tt0 -153.12 157.34 40.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.33 -0.248 . . . . 0.44 110.33 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.72 106.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.655 -0.498 . . . . 0.44 109.655 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.13 156.53 30.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.122 -0.49 . . . . 0.44 111.262 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -67.12 114.54 5.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.44 110.87 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.455 ' HB2' HG23 ' A' ' 18' ' ' ILE . 3.0 tm? -78.4 -21.34 49.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.44 111.187 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.41 -12.53 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.44 111.547 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.15 40.87 2.02 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.585 -0.817 . . . . 0.44 112.891 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.7 tp -62.64 134.13 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.943 -0.391 . . . . 0.44 109.943 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 137.73 54.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.641 0.608 . . . . 0.44 112.641 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.29 -15.73 61.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.44 110.577 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.97 -49.25 13.06 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.44 111.58 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.22 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.319 -0.401 . . . . 0.44 111.47 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.94 173.91 6.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 0.44 110.684 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.454 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.9 Cg_endo -77.17 137.09 16.79 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.372 2.048 . . . . 0.44 111.916 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 20.1 Cg_endo -60.05 -14.09 26.58 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.901 2.401 . . . . 0.44 113.258 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -9.81 10.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.944 0.72 . . . . 0.44 112.944 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.414 ' ND2' HG21 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -138.91 47.52 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.424 0.528 . . . . 0.44 112.424 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -70.36 -58.1 5.16 Favored Pre-proline 0 CA--C 1.531 0.231 0 O-C-N 122.214 -0.304 . . . . 0.44 111.389 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.436 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -44.73 -31.02 4.64 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.501 2.134 . . . . 0.44 112.522 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 71.7 t -77.33 -50.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.59 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.515 HG13 ' CE2' ' A' ' 115' ' ' PHE . 26.8 mm -65.43 -31.54 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.006 -0.543 . . . . 0.44 110.58 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.83 36.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.44 110.902 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -51.61 8.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.44 111.696 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 tp -78.09 -30.1 49.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.44 111.496 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -56.71 -42.53 79.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.992 0.425 . . . . 0.44 110.869 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -67.47 -8.85 36.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.44 109.762 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.902 179.815 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.866 0.365 . . . . 0.44 110.973 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -104.91 144.62 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.806 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.6 pp -138.08 127.03 24.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 0.44 111.194 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -102.44 157.56 16.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.332 0.587 . . . . 0.44 111.869 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' THR . 73.1 mt -146.23 130.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.119 -0.946 . . . . 0.44 109.834 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.6 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.13 125.07 43.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.678 -0.49 . . . . 0.44 109.678 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -129.25 162.6 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.427 0.632 . . . . 0.44 111.925 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.11 113.55 0.64 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.041 -0.982 . . . . 0.44 111.428 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.75 99.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.654 -0.498 . . . . 0.44 109.654 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.558 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.26 119.57 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.275 0.56 . . . . 0.44 111.987 -178.476 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.63 141.79 28.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.905 . . . . 0.44 110.883 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -100.12 -173.17 2.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.474 -0.785 . . . . 0.44 112.001 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -73.75 -10.1 59.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.979 -1.01 . . . . 0.44 113.267 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.455 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 23.1 t-20 -111.89 30.91 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.952 0.352 . . . . 0.44 111.952 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.63 11.39 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.467 -0.333 . . . . 0.44 111.545 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HB2' HD22 ' A' ' 13' ' ' ASN . 0.0 OUTLIER -101.99 161.34 13.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.44 108.944 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -116.0 131.71 67.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 0.44 111.75 -178.396 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.419 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 7.0 t80 -82.92 107.63 15.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.758 -0.656 . . . . 0.44 110.524 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -123.47 162.16 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.841 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.44 110.244 179.329 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.593 0.235 . . . . 0.44 111.386 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.53 25.95 10.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.928 0.394 . . . . 0.44 111.749 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' N ' ' HA ' ' A' ' 115' ' ' PHE . 3.3 tt -65.7 78.45 0.07 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.92 -0.582 . . . . 0.44 110.009 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.95 -171.9 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 0.44 111.403 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.466 ' CE1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.86 156.48 54.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.44 111.766 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 8.9 Cg_endo -49.27 168.0 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.637 2.891 . . . . 0.44 111.831 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.34 59.21 0.76 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.859 -1.162 . . . . 0.44 114.033 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.701 ' C ' ' HG2' ' A' ' 39' ' ' LYS . . . -118.56 159.94 14.16 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.615 -0.793 . . . . 0.44 111.993 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.701 ' HG2' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 49.12 23.13 0.71 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.44 111.561 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.689 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER -61.81 -30.96 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.773 -1.195 . . . . 0.44 107.773 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.689 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.19 -80.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.968 -1.924 . . . . 0.44 111.028 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.9 mmt 41.32 -84.03 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.381 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.29 33.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.947 -0.644 . . . . 0.44 112.682 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.497 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 mp0 -93.56 -174.33 3.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.7 0.286 . . . . 0.44 111.266 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.525 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.92 153.98 38.98 Favored Pre-proline 0 N--CA 1.457 -0.124 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.378 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.69 -24.66 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.958 2.439 . . . . 0.44 112.532 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.1 -48.71 5.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.523 0.564 . . . . 0.44 112.523 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -80.42 -26.09 38.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.147 0.425 . . . . 0.44 112.147 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -55.48 -47.38 76.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 0.44 111.285 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.467 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.33 -51.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.295 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -52.82 -36.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.44 110.512 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -78.24 -43.31 28.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.203 0.525 . . . . 0.44 109.925 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' HG2' ' CG2' ' A' ' 40' ' ' ILE . 10.8 tp10 -64.42 -27.37 68.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.493 -0.776 . . . . 0.44 110.289 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.413 HD22 ' CD2' ' A' ' 64' ' ' HIS . 2.9 tp -56.57 -44.61 81.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.44 111.156 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -63.28 -35.41 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.322 0.582 . . . . 0.44 109.431 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tm-20 -77.75 -26.13 49.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.188 -0.915 . . . . 0.44 111.477 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 63.8 mm-40 -108.99 5.39 24.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.679 0.622 . . . . 0.44 112.679 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.457 ' CG1' HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.84 -44.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.316 0.579 . . . . 0.44 110.205 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.84 3.14 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.329 -0.85 . . . . 0.44 114.618 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -120.48 -173.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 117.907 0.853 . . . . 0.44 110.269 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 p -113.28 87.99 11.99 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.136 -0.484 . . . . 0.44 110.183 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.567 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.9 Cg_endo -113.23 145.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.612 2.875 . . . . 0.44 113.922 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.437 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 17.8 mt-30 -74.97 79.68 2.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 105.555 -2.017 . . . . 0.44 105.555 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.56 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.35 134.21 55.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.259 -1.337 . . . . 0.44 110.825 -176.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -179.3 -139.94 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.812 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 1.1 m 52.18 174.3 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.171 0.51 . . . . 0.44 112.111 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.1 tt -139.6 117.87 12.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.44 110.844 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.78 -55.61 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.44 110.221 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.1 mt-10 -171.13 131.38 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.44 110.441 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 132.08 46.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.579 -0.282 . . . . 0.44 110.651 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.56 161.95 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.44 110.993 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -125.69 124.1 40.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.44 110.851 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -120.88 152.71 38.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.464 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -120.76 120.9 36.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.151 0.5 . . . . 0.44 111.346 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -72.27 163.06 70.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.5 -0.773 . . . . 0.44 110.42 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.41 83.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.112 2.541 . . . . 0.44 112.316 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 16.8 m-20 95.29 15.2 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.44 111.57 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 8.2 tpp85 -137.44 150.14 47.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.44 110.7 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.7 105.6 10.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.44 110.82 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -111.36 154.31 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.38 . . . . 0.44 111.233 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -127.25 131.18 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.647 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.522 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 11.2 tp -126.32 114.56 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.582 -0.281 . . . . 0.44 111.289 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.552 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -110.26 135.64 50.69 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.718 0.294 . . . . 0.44 110.394 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -120.01 118.03 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.474 -0.33 . . . . 0.44 111.331 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.616 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.4 m95 -100.52 148.62 24.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.371 -0.377 . . . . 0.44 111.009 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.0 tp -96.6 102.89 14.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.46 0.648 . . . . 0.44 111.746 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 16.4 t -85.99 145.81 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 115.243 -0.89 . . . . 0.44 111.377 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.0 -39.77 5.65 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.484 1.29 . . . . 0.44 114.484 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.8 ptp180 -163.24 165.67 24.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.837 0.744 . . . . 0.44 112.097 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.567 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 4.6 p90 -144.72 130.4 19.06 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.209 -0.45 . . . . 0.44 111.505 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.69 105.95 11.36 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.804 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.76 -122.82 7.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 0.44 112.446 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -134.97 137.07 26.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.401 0.143 . . . . 0.44 110.838 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.45 128.75 10.57 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.755 2.303 . . . . 0.44 111.502 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.68 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.2 p-90 -130.47 -57.2 1.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.529 -0.468 . . . . 0.44 111.959 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.521 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 45.15 -94.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.799 -0.715 . . . . 0.44 112.991 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.4 mmtp 170.62 39.33 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.835 0.35 . . . . 0.44 111.189 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -42.69 99.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.488 -0.324 . . . . 0.44 110.696 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.47 6.67 50.19 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.652 -0.785 . . . . 0.44 113.642 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -140.2 99.12 7.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 117.31 0.555 . . . . 0.44 111.515 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -43.62 140.95 4.07 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.989 2.46 . . . . 0.44 112.668 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.17 177.05 19.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.668 -0.777 . . . . 0.44 112.768 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -147.96 157.18 43.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.44 110.432 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.538 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.2 m0 -61.86 105.92 0.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.44 110.114 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.2 ttm -120.55 159.81 24.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.12 -0.491 . . . . 0.44 111.277 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.2 p -83.93 123.85 30.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.44 110.746 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.429 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -80.01 -19.06 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.274 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 p -55.35 -19.82 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.445 -0.343 . . . . 0.44 111.727 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.18 45.8 1.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.433 -0.889 . . . . 0.44 113.076 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 111' ' ' ASN . 7.6 tt -62.95 150.54 41.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.595 0.236 . . . . 0.44 110.388 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.415 ' N ' HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -121.85 120.85 35.73 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.873 0.694 . . . . 0.44 112.873 -178.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.719 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.71 61.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.769 -0.651 . . . . 0.44 109.834 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.93 -46.25 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.413 -0.358 . . . . 0.44 111.562 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.56 -13.56 58.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.906 0.335 . . . . 0.44 111.906 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.719 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.61 175.71 3.86 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.61 -0.268 . . . . 0.44 110.59 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 68.6 Cg_endo -76.12 143.08 25.26 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.736 1.624 . . . . 0.44 110.949 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.05 -14.27 36.49 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.483 2.122 . . . . 0.44 113.213 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.62 -9.37 58.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.732 1.012 . . . . 0.44 113.732 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' O ' ' A' ' 116' ' ' PRO . 31.4 p-10 -124.48 32.74 5.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.521 0.934 . . . . 0.44 113.521 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.51 -55.19 1.68 Allowed Pre-proline 0 N--CA 1.467 0.389 0 C-N-CA 120.995 -0.282 . . . . 0.44 111.456 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.95 -37.13 11.95 Favored 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.509 2.139 . . . . 0.44 112.889 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.477 ' CG2' ' CE1' ' A' ' 84' ' ' PHE . 2.4 t -77.6 -51.18 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.832 -0.622 . . . . 0.44 110.891 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.422 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.8 mm -68.3 -29.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.518 -0.765 . . . . 0.44 111.264 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.84 57.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.412 . . . . 0.44 110.418 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -48.27 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.44 111.317 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 6.4 tp -78.21 -30.09 48.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.359 . . . . 0.44 111.534 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -56.57 -42.87 79.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.088 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -2.89 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.44 110.055 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-N 116.051 -0.522 . . . . 0.44 111.254 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttp . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.849 0.357 . . . . 0.44 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.19 129.57 36.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.44 110.931 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.48 122.02 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.44 110.717 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.415 HD12 " O3'" ' A' ' 131' ' ' 8OG . 3.8 pp -109.65 125.08 52.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.44 110.957 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 42.6 mt-30 -102.52 150.43 23.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.317 0.58 . . . . 0.44 111.54 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.1 mt -141.21 131.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.188 -0.914 . . . . 0.44 110.046 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.622 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.01 124.8 43.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.687 -0.486 . . . . 0.44 109.687 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -128.52 156.96 41.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.322 0.582 . . . . 0.44 111.85 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -148.6 118.16 0.94 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.074 -0.967 . . . . 0.44 111.262 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.613 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.11 108.96 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.446 -0.576 . . . . 0.44 109.446 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.82 128.28 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.44 111.386 -178.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -91.75 126.22 36.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.44 111.074 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.486 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 9.6 t-20 -87.6 -172.31 3.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.983 0.897 . . . . 0.44 112.346 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -77.9 -3.0 39.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.926 -1.488 . . . . 0.44 111.878 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -133.46 49.06 2.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.371 . . . . 0.44 111.203 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.85 28.88 0.39 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.099 -0.5 . . . . 0.44 111.451 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -118.17 149.53 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.042 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -120.4 146.65 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.44 111.599 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.434 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -95.85 116.58 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.725 . . . . 0.44 110.525 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.62 162.15 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.202 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.408 ' CB ' ' OE1' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -99.98 122.52 43.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 0.44 110.74 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 23' ' ' ARG . 54.0 ttm-85 -106.43 159.75 15.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.722 -0.473 . . . . 0.44 109.722 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 47.6 mmt-85 -69.48 60.67 0.14 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.118 0.485 . . . . 0.44 110.012 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . 48.94 -87.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.437 -0.802 . . . . 0.44 111.703 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -167.92 86.95 0.23 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.884 0.373 . . . . 0.44 111.245 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.02 -171.92 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.44 111.132 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.38 24.91 12.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.44 111.219 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.04 39.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.44 110.814 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 62.53 83.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.777 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.86 -8.82 47.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.515 . . . . 0.44 111.809 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.4 23.12 3.55 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.587 0.217 . . . . 0.44 111.587 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -114.47 26.01 10.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.079 0.466 . . . . 0.44 111.512 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.97 94.58 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.44 110.507 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -111.69 -166.46 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.44 111.652 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.82 163.04 29.94 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.747 -0.661 . . . . 0.44 111.426 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 35.5 Cg_endo -63.48 168.17 11.86 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.525 2.816 . . . . 0.44 112.003 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.32 58.83 0.77 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.122 -1.037 . . . . 0.44 113.927 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -120.95 138.57 12.74 Favored Glycine 0 C--N 1.313 -0.701 0 CA-C-N 114.756 -0.722 . . . . 0.44 111.974 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.622 ' NZ ' ' H2 ' ' A' 5014 ' ' HOH . 2.7 ttpm? 92.45 6.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.981 0.513 . . . . 0.44 112.047 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.588 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -55.82 -27.14 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.49 0.662 . . . . 0.44 110.533 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.2 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.728 -1.124 . . . . 0.44 111.039 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.9 mmm 37.92 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.438 0.461 . . . . 0.44 111.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.76 32.71 0.12 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.8 -0.714 . . . . 0.44 112.418 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt-10 -89.68 -175.02 4.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.782 0.325 . . . . 0.44 111.244 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.536 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.45 155.18 36.67 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.323 -0.399 . . . . 0.44 110.387 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.9 Cg_endo -44.62 -24.91 1.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.819 2.346 . . . . 0.44 112.593 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -104.09 -41.66 5.77 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.003 0.371 . . . . 0.44 112.003 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.4 mm-40 -79.04 -19.21 51.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.628 0.233 . . . . 0.44 111.628 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.481 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -58.41 -47.73 82.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.654 0.264 . . . . 0.44 111.303 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -78.11 -45.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.44 110.883 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.496 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 41.8 t -53.95 -36.94 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.44 111.65 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.38 -52.02 9.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 0.44 110.92 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.79 -22.93 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.23 -0.441 . . . . 0.44 110.811 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 6.2 tp -54.46 -44.81 72.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.812 0.339 . . . . 0.44 110.736 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.76 -28.38 68.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.311 -0.625 . . . . 0.44 109.311 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.27 -25.34 51.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.368 -0.833 . . . . 0.44 111.179 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 6.9 mm-40 -108.52 0.95 21.17 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.127 0.417 . . . . 0.44 112.127 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.526 ' CG1' HG13 ' A' ' 60' ' ' ILE . 2.1 t -134.79 -44.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.44 109.786 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -33.91 0.29 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.44 113.906 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.3 OUTLIER -77.69 -175.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.88 0.371 . . . . 0.44 111.084 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.23 89.02 13.52 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.904 -0.589 . . . . 0.44 110.209 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.623 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.8 Cg_endo -109.55 145.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.308 2.672 . . . . 0.44 114.104 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -74.74 79.93 2.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.621 -1.992 . . . . 0.44 105.621 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.32 136.93 54.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.377 -1.283 . . . . 0.44 111.252 -175.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.5 t80 179.16 -144.71 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.404 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 57.02 157.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.336 0.589 . . . . 0.44 112.536 178.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.0 tt -121.33 108.69 14.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.164 -0.926 . . . . 0.44 109.923 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -41.95 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.44 110.518 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.6 tt0 -171.25 160.28 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.44 110.721 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.3 131.41 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.556 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tp -122.73 137.13 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.44 110.853 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -125.82 109.8 12.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.44 110.444 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.4 153.1 47.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.497 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.22 132.7 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.44 111.482 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.538 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.9 162.95 21.24 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.44 110.012 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_endo -46.31 80.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.194 2.596 . . . . 0.44 112.58 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t0 85.7 11.85 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.442 -0.799 . . . . 0.44 111.786 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.35 97.25 3.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.661 0.267 . . . . 0.44 111.148 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.0 OUTLIER -74.9 106.56 6.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.484 -0.325 . . . . 0.44 110.951 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 tt -102.11 116.43 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.051 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.32 132.49 49.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.724 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.14 114.61 18.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.47 -0.332 . . . . 0.44 111.064 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.509 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -106.47 123.84 48.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.473 -0.331 . . . . 0.44 110.23 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 2.0 m-85 -105.93 109.9 22.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.879 0.371 . . . . 0.44 110.832 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.4 m95 -97.27 149.36 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.117 -0.492 . . . . 0.44 111.444 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.4 tp -99.89 102.84 14.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.253 0.549 . . . . 0.44 111.914 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 12.2 t -84.12 146.16 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.344 -0.844 . . . . 0.44 111.124 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.55 -26.47 8.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.528 1.307 . . . . 0.44 114.528 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 5.4 ttp180 -162.78 159.8 24.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.885 0.766 . . . . 0.44 111.73 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.623 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -152.18 125.89 8.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.204 -0.453 . . . . 0.44 111.329 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -74.37 146.04 43.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.958 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.47 -119.24 14.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.822 -0.704 . . . . 0.44 112.558 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -135.07 145.77 55.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.571 0.224 . . . . 0.44 110.792 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.7 Cg_exo -76.44 128.84 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.847 2.364 . . . . 0.44 111.241 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 42.2 p-90 -130.42 -64.25 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.342 -0.543 . . . . 0.44 112.43 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . 49.13 -107.68 0.32 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.559 -0.829 . . . . 0.44 112.477 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 164.45 67.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.917 0.389 . . . . 0.44 110.389 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' OE1' ' CB ' ' A' ' 21' ' ' THR . 2.3 pt-20 -86.36 -37.4 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.44 110.767 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.07 -6.67 10.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.556 -0.83 . . . . 0.44 113.507 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -140.06 97.03 7.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.134 0.467 . . . . 0.44 111.483 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -43.79 145.64 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.44 112.586 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.34 177.11 19.43 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.546 -0.835 . . . . 0.44 112.964 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.82 157.43 45.41 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.289 -0.263 . . . . 0.44 110.289 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -70.3 106.65 3.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.44 110.307 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -120.06 163.62 17.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 0.44 110.977 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 93.3 p -89.01 127.97 35.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 18' ' ' ILE . 5.1 tp -78.48 -18.9 54.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.44 111.184 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.93 -24.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.348 -0.387 . . . . 0.44 111.38 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.72 39.64 2.37 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.602 -0.809 . . . . 0.44 112.95 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.71 140.03 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.944 -0.391 . . . . 0.44 109.944 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.1 134.5 54.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.092 0.775 . . . . 0.44 113.092 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.37 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.26 -0.882 . . . . 0.44 110.278 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.0 -49.15 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.158 -0.474 . . . . 0.44 111.556 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -36.28 81.91 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.519 -0.31 . . . . 0.44 111.239 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.7 172.66 8.99 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.387 -0.37 . . . . 0.44 110.273 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 60.5 Cg_endo -72.77 127.76 12.64 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.139 1.893 . . . . 0.44 111.526 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.27 -14.75 31.01 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.701 2.267 . . . . 0.44 113.28 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.74 -9.73 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.436 0.532 . . . . 0.44 112.436 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -130.62 42.37 3.26 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.759 0.314 . . . . 0.44 111.725 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.424 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.43 -49.74 5.01 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 111.728 0.27 . . . . 0.44 111.728 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.4 Cg_exo -44.94 -33.95 8.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.461 2.107 . . . . 0.44 112.591 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.35 -48.72 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.44 110.427 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.539 HG13 ' CE2' ' A' ' 115' ' ' PHE . 8.7 mm -66.33 -31.93 55.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.817 -0.628 . . . . 0.44 110.719 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.66 -26.87 36.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.932 0.396 . . . . 0.44 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -53.17 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.44 111.864 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.409 ' CD2' HG21 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.24 -29.66 48.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.694 0.283 . . . . 0.44 111.47 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -55.17 -42.52 73.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.17 0.509 . . . . 0.44 110.74 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -65.13 -11.65 42.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.44 109.585 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.231 0.1 0 CA-C-N 115.86 -0.609 . . . . 0.44 111.055 179.749 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.695 " H3'" ' OP2' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5013 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5014 ' ' HOH . . . . . 0.622 ' H2 ' ' NZ ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.776 0.322 . . . . 0.44 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.05 102.91 11.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.957 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 145.5 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.427 HD12 " O3'" ' A' ' 131' ' ' 8OG . 3.5 pp -146.01 128.33 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.44 110.99 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -106.95 153.3 22.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.301 0.572 . . . . 0.44 112.029 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 81' ' ' THR . 5.3 mp -146.44 131.37 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.148 -0.933 . . . . 0.44 109.836 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.28 124.75 43.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.184 -0.302 . . . . 0.44 110.184 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -121.25 162.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.44 111.904 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.25 113.31 0.58 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.126 -0.943 . . . . 0.44 111.559 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.91 105.8 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.225 -0.657 . . . . 0.44 109.225 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -70.97 122.17 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.44 111.28 -178.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -93.17 127.72 38.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.167 -0.469 . . . . 0.44 110.342 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 2.5 t-20 -75.33 -172.09 1.65 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 122.219 1.009 . . . . 0.44 113.107 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.04 -17.81 41.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.446 -1.706 . . . . 0.44 112.859 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -120.33 -82.39 0.65 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.724 0.297 . . . . 0.44 111.559 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -158.8 16.05 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.44 111.677 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' HG2' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -100.91 155.14 18.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.716 -0.476 . . . . 0.44 109.716 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -124.34 144.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.327 0.584 . . . . 0.44 111.957 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.416 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 59.6 t80 -83.65 90.17 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.217 -0.901 . . . . 0.44 110.584 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.464 HG12 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -104.44 162.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.44 110.298 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 100' ' ' GLN . 5.5 p -89.86 116.05 27.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.372 -0.376 . . . . 0.44 110.402 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -119.75 119.48 33.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.889 0.376 . . . . 0.44 110.999 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 52.6 -102.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.44 110.769 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 172.55 -64.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.842 0.354 . . . . 0.44 110.935 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -166.6 -55.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.44 111.09 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -164.92 92.3 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.862 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.9 -169.81 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.44 111.035 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -99.88 53.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.821 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.3 mtt -132.83 38.11 3.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.44 110.888 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.49 -19.03 61.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.352 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.03 31.24 2.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.396 -0.366 . . . . 0.44 111.008 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.41 26.22 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.388 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 16.2 tp -69.18 63.88 0.14 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.807 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -106.85 -177.65 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.44 111.192 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.53 162.9 30.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.44 111.648 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.94 167.99 7.96 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.538 2.826 . . . . 0.44 111.857 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.28 59.07 0.77 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.365 -0.922 . . . . 0.44 113.255 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.76 121.43 3.43 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.355 -0.922 . . . . 0.44 111.978 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' HD2' ' H1 ' ' A' 5026 ' ' HOH . 0.0 OUTLIER 112.45 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.306 0.642 . . . . 0.44 111.866 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.603 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -53.81 -27.98 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.541 0.686 . . . . 0.44 110.683 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.58 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.72 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.44 111.147 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 mmt 34.96 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.362 0.414 . . . . 0.44 111.755 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.77 30.16 0.16 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.96 -0.638 . . . . 0.44 112.452 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.9 mp0 -93.59 -176.6 4.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.733 0.301 . . . . 0.44 111.127 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.563 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.84 158.94 33.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.44 110.202 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.76 -24.66 0.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.839 2.359 . . . . 0.44 112.525 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -89.86 -60.58 1.9 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.205 0.446 . . . . 0.44 112.205 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -4.84 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.589 0.589 . . . . 0.44 112.589 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -63.14 -55.29 26.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.44 111.103 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -78.25 -45.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.44 110.904 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.473 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 58.0 t -55.52 -36.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.121 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.37 -49.1 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 0.44 111.225 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -68.31 -22.6 64.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.44 111.212 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.455 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -56.52 -45.04 81.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 0.44 110.659 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -27.12 68.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.16 -0.681 . . . . 0.44 109.16 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.43 -30.63 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.307 -0.861 . . . . 0.44 111.279 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -109.08 5.78 24.37 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.832 0.678 . . . . 0.44 112.832 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 60' ' ' ILE . 2.6 t -134.02 -44.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.26 0.552 . . . . 0.44 110.24 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.57 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.55 7.02 1.25 Allowed Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.424 -0.807 . . . . 0.44 114.563 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.506 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -115.39 -172.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 117.902 0.851 . . . . 0.44 110.033 179.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 p -114.45 87.59 14.21 Favored Pre-proline 0 N--CA 1.438 -1.074 0 CA-C-N 116.326 -0.397 . . . . 0.44 110.537 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.627 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.4 Cg_endo -113.95 142.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.631 2.887 . . . . 0.44 113.598 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 8.8 mt-30 -74.87 79.94 2.12 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.202 -2.147 . . . . 0.44 105.202 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.598 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.15 129.12 53.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.809 -1.541 . . . . 0.44 111.407 -175.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -176.44 -141.69 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.44 110.07 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.73 159.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.334 0.588 . . . . 0.44 112.053 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.4 tt -122.18 113.0 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.345 -0.843 . . . . 0.44 110.318 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.44 -48.32 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.093 0.473 . . . . 0.44 110.017 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.39 166.31 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.637 -0.71 . . . . 0.44 110.216 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.34 132.02 22.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.809 0.338 . . . . 0.44 110.977 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 18.2 tp -113.78 120.77 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.44 110.64 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.68 109.93 16.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.44 110.664 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.86 146.46 37.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.717 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.14 120.13 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.072 0.463 . . . . 0.44 111.278 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -69.95 163.18 63.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.625 -0.716 . . . . 0.44 110.505 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -51.76 83.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.024 2.483 . . . . 0.44 112.058 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 26.2 m-20 95.59 15.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.259 -0.882 . . . . 0.44 111.323 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -137.38 150.17 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.44 110.526 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 5.5 t-160 -124.9 94.1 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.44 110.9 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -99.0 118.21 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.44 110.76 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.95 127.12 55.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.846 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 mt -126.28 114.71 18.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.506 -0.315 . . . . 0.44 111.074 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.544 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -106.32 123.02 47.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.405 -0.361 . . . . 0.44 110.553 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -99.72 116.07 30.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.82 0.343 . . . . 0.44 110.893 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.3 m95 -100.59 149.18 24.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.463 . . . . 0.44 111.257 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tm? -103.04 103.14 13.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.365 0.602 . . . . 0.44 112.04 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 64' ' ' HIS . 22.2 t -81.01 145.87 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.108 -0.951 . . . . 0.44 111.095 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 1.9 pm0 -119.63 -14.53 9.07 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.204 1.187 . . . . 0.44 114.204 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 11.3 tpp85 -162.9 154.91 18.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.611 0.641 . . . . 0.44 111.523 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.627 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -157.55 120.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.44 111.539 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.65 144.28 37.53 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.608 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 -124.57 36.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.644 -0.789 . . . . 0.44 112.201 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 45.4 mt-10 -135.11 143.08 44.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.519 0.199 . . . . 0.44 110.992 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.6 Cg_exo -75.92 128.77 11.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.747 2.298 . . . . 0.44 111.041 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.57 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 62.9 p-90 -129.72 -59.85 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.326 -0.549 . . . . 0.44 112.471 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 43.73 -96.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.921 -0.657 . . . . 0.44 112.795 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 175.65 35.98 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.677 0.275 . . . . 0.44 110.999 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -55.09 -38.22 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.361 . . . . 0.44 110.685 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.1 58.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.794 -0.717 . . . . 0.44 113.43 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.415 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 50.6 tt0 -140.13 97.02 7.9 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.087 0.443 . . . . 0.44 111.384 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.56 143.03 2.8 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.078 2.519 . . . . 0.44 112.828 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.27 19.31 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.833 -0.698 . . . . 0.44 112.851 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -142.89 157.38 44.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.326 -0.249 . . . . 0.44 110.326 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.64 105.84 5.92 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.679 -0.408 . . . . 0.44 110.24 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.4 ptm -120.75 163.15 18.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.44 110.857 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.04 114.83 17.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.44 110.543 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.3 tp -70.34 -18.86 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 0.44 111.342 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -53.42 -19.25 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 0.44 111.486 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.67 49.73 0.91 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.878 -0.677 . . . . 0.44 111.971 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.18 150.3 39.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.44 110.665 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -106.86 104.14 13.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.719 0.637 . . . . 0.44 112.719 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.524 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.81 61.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.938 -0.573 . . . . 0.44 110.077 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.29 -43.42 23.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.022 -0.535 . . . . 0.44 110.982 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -1.87 31.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.923 -0.58 . . . . 0.44 112.201 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.543 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -117.53 170.55 6.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.268 -0.271 . . . . 0.44 110.268 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.1 Cg_endo -54.4 127.88 27.78 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.099 1.866 . . . . 0.44 112.427 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.94 -20.41 45.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.612 2.208 . . . . 0.44 112.452 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.77 51.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.418 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.481 ' HB3' ' CE2' ' A' ' 115' ' ' PHE . 1.5 m-20 -114.71 -2.36 13.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.44 111.399 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -47.84 -48.29 61.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.717 -0.219 . . . . 0.44 111.519 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.9 Cg_exo -44.95 -34.88 9.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.27 1.98 . . . . 0.44 112.28 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.29 -51.14 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.805 -0.634 . . . . 0.44 110.618 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 115' ' ' PHE . 41.8 mm -64.89 -33.5 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.44 110.996 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.83 -27.04 39.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.44 111.073 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.19 -52.47 8.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.44 111.632 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -78.19 -30.14 48.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.44 111.509 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.473 ' HB2' HG23 ' A' ' 123' ' ' ILE . 42.2 tttm -56.69 -42.8 79.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.44 111.017 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -66.67 -10.09 42.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.767 -0.651 . . . . 0.44 109.721 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.231 0.113 0 CA-C-N 115.925 -0.58 . . . . 0.44 111.004 179.693 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.427 " O3'" HD12 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5025 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5026 ' ' HOH . . . . . 0.629 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.863 0.363 . . . . 0.44 111.267 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.02 111.18 22.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.44 110.949 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 132.52 43.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.44 110.86 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.441 ' CD1' " O3'" ' A' ' 131' ' ' 8OG . 3.4 pp -128.29 123.2 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.44 110.958 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.0 mt-30 -102.46 152.13 21.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.486 0.66 . . . . 0.44 112.0 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.1 pt -146.56 134.72 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.965 -1.016 . . . . 0.44 109.836 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.59 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.4 124.29 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.797 -0.361 . . . . 0.44 110.087 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.44 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -120.51 160.44 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.249 0.547 . . . . 0.44 111.661 -179.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.53 115.29 0.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.283 -0.872 . . . . 0.44 111.645 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.78 109.33 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.078 -0.712 . . . . 0.44 109.078 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.78 120.23 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.44 111.048 -178.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.34 118.25 23.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.345 -0.843 . . . . 0.44 111.696 -179.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' CA ' ' CZ3' ' A' ' 90' ' ' TRP . 20.3 t30 -76.09 -172.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 114.834 -1.076 . . . . 0.44 111.873 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.57 3.89 30.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.241 -1.345 . . . . 0.44 112.315 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -139.22 51.28 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.44 111.524 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.09 22.83 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.659 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -117.38 153.29 33.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.734 -0.839 . . . . 0.44 108.734 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 19' ' ' PHE . 1.4 mp -117.0 143.4 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.26 0.552 . . . . 0.44 111.963 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.476 ' N ' HG22 ' A' ' 18' ' ' ILE . 44.7 t80 -87.98 92.84 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.44 110.12 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.417 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.62 159.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.44 110.774 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 13.1 p -73.56 124.52 26.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.44 110.526 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -130.56 125.29 33.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.44 111.088 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.22 -105.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.041 -0.527 . . . . 0.44 111.017 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 169.17 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.7 0.285 . . . . 0.44 111.128 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 76.58 26.58 0.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.353 -0.385 . . . . 0.44 110.968 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -179.48 36.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.842 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -179.76 -165.9 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.44 111.027 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -119.79 88.81 3.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.869 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt -149.85 37.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.44 110.875 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.01 67.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.44 111.379 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.84 15.61 14.35 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.406 -0.361 . . . . 0.44 111.35 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.34 26.24 10.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.733 0.301 . . . . 0.44 111.593 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 22.2 tp -59.63 76.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.903 -0.59 . . . . 0.44 110.735 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -106.86 -172.65 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.44 111.679 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.6 160.56 41.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.731 -0.668 . . . . 0.44 111.901 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.402 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 36.7 Cg_endo -64.2 168.41 12.59 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.594 2.863 . . . . 0.44 111.657 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 59.5 0.74 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.037 -1.077 . . . . 0.44 114.082 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -126.92 117.39 2.73 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.655 -0.772 . . . . 0.44 112.039 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 121.62 4.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.395 0.678 . . . . 0.44 111.678 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.59 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -58.7 -26.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.444 0.64 . . . . 0.44 110.753 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.99 -83.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 0.44 111.332 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 33.45 -85.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.465 0.478 . . . . 0.44 111.889 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.46 34.05 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.848 -0.691 . . . . 0.44 112.516 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -88.18 -173.94 4.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.797 0.332 . . . . 0.44 111.231 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.52 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.2 154.6 37.61 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.435 . . . . 0.44 110.396 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.11 -26.21 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.89 2.393 . . . . 0.44 112.458 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.19 -39.35 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.44 111.779 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -80.23 -12.61 59.61 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.873 0.323 . . . . 0.44 111.873 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.2 -52.95 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.44 111.196 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -78.15 -43.84 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.293 -0.412 . . . . 0.44 111.161 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 48.7 t -53.66 -39.42 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.44 111.528 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.35 -52.02 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.563 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -67.19 -22.26 65.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.295 -0.411 . . . . 0.44 111.32 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.451 ' CD2' ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -54.33 -44.44 72.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.44 110.205 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -33.88 71.92 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.136 -0.69 . . . . 0.44 109.136 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.68 -25.79 49.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.268 -0.878 . . . . 0.44 111.358 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HG2' ' H2 ' ' A' 5037 ' ' HOH . 2.1 mp0 -108.69 6.1 25.45 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.49 0.552 . . . . 0.44 112.49 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.498 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 15.3 t -134.14 -44.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.166 0.507 . . . . 0.44 110.26 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.572 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.27 3.55 1.42 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.387 -0.824 . . . . 0.44 114.705 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.539 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -117.88 -173.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 117.999 0.9 . . . . 0.44 110.431 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.5 p -114.21 87.59 13.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 116.061 -0.518 . . . . 0.44 110.245 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.592 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -115.25 145.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.578 2.852 . . . . 0.44 114.217 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.84 79.94 2.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.205 -2.146 . . . . 0.44 105.205 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.608 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.6 131.67 54.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.22 -1.354 . . . . 0.44 112.018 -175.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -178.92 -140.97 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.611 -0.722 . . . . 0.44 110.251 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 58.26 158.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.248 0.547 . . . . 0.44 112.116 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -120.97 110.69 16.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.362 -0.836 . . . . 0.44 110.296 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.59 -46.3 26.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.44 110.182 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.53 157.49 4.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.44 110.269 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 115.34 8.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.44 110.836 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -109.19 136.55 48.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.44 110.594 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -130.44 115.54 16.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.44 110.775 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -135.47 147.66 48.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.44 110.633 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 4.8 pt-20 -120.07 127.06 52.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.105 0.479 . . . . 0.44 111.284 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.06 163.51 59.65 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.553 -0.749 . . . . 0.44 110.439 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.1 Cg_endo -53.8 82.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.992 2.461 . . . . 0.44 112.404 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER 101.57 11.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.959 0.904 . . . . 0.44 111.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.29 150.01 47.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.44 110.773 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.42 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 4.6 m170 -124.0 101.53 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.44 110.891 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.64 128.31 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.44 111.081 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.75 118.94 28.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.486 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -126.15 115.17 19.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.44 111.439 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.565 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -106.81 122.87 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.44 110.509 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.439 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 7.3 m-30 -98.61 119.03 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.837 0.351 . . . . 0.44 111.095 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 21.4 m95 -101.25 149.2 24.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.161 -0.472 . . . . 0.44 111.069 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.529 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.2 tm? -102.49 102.91 13.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.441 0.639 . . . . 0.44 112.053 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.655 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 17.0 t -80.19 146.0 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 115.091 -0.959 . . . . 0.44 111.027 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.71 -23.24 9.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.625 1.343 . . . . 0.44 114.625 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.25 160.05 26.4 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.873 0.761 . . . . 0.44 111.606 -178.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.592 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -156.92 124.3 5.31 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.152 -0.477 . . . . 0.44 111.381 179.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -82.78 127.6 33.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.274 -0.421 . . . . 0.44 110.7 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.52 -125.18 6.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 0.44 112.324 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 69.4 mt-10 -135.08 138.43 29.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.44 110.928 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.11 128.74 10.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.76 2.307 . . . . 0.44 111.132 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.572 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.3 p-90 -135.5 -57.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.454 -0.498 . . . . 0.44 112.268 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 46.77 -94.29 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.927 -0.654 . . . . 0.44 112.868 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -178.87 34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.687 0.28 . . . . 0.44 111.156 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.29 -34.9 78.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.889 0.376 . . . . 0.44 110.412 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.26 68.57 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.909 -0.662 . . . . 0.44 113.342 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -140.28 95.95 8.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.44 111.325 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.6 133.44 7.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.989 2.459 . . . . 0.44 112.789 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.33 177.44 19.18 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.824 -0.703 . . . . 0.44 112.762 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -147.55 157.05 43.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.258 -0.275 . . . . 0.44 110.258 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.68 106.29 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.66 -0.416 . . . . 0.44 110.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 22.0 ptm -120.38 150.96 39.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.44 110.755 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.1 p -70.59 114.65 8.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.44 110.408 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.438 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -65.16 -21.54 66.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.44 111.213 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.89 -17.79 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 0.44 111.509 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.42 35.04 4.95 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.663 -0.78 . . . . 0.44 112.816 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 tp -62.5 125.7 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.027 -0.36 . . . . 0.44 110.027 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 139.5 54.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.49 0.552 . . . . 0.44 112.49 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -15.76 61.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.44 110.395 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.94 -48.56 14.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.24 -0.436 . . . . 0.44 111.456 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -40.38 88.13 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.626 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.99 174.17 6.53 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.571 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.1 Cg_endo -76.18 130.26 11.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.263 1.975 . . . . 0.44 111.457 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.76 -14.5 17.87 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.886 2.391 . . . . 0.44 113.556 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -10.57 13.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.729 0.64 . . . . 0.44 112.729 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -134.99 45.43 2.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.765 0.317 . . . . 0.44 111.553 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.09 -49.38 7.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.877 0.325 . . . . 0.44 111.877 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.2 Cg_exo -44.89 -36.74 11.33 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.455 2.103 . . . . 0.44 112.871 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.439 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 20.3 t -77.46 -51.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.431 . . . . 0.44 110.984 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' CE2' ' A' ' 115' ' ' PHE . 10.7 mm -65.36 -32.1 56.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.44 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.8 -27.9 45.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.997 0.427 . . . . 0.44 110.725 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -48.49 13.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.509 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.04 -28.87 49.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.44 111.476 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -55.5 -42.64 74.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.821 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -69.96 -7.72 42.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.44 109.804 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.986 -0.552 . . . . 0.44 111.216 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.705 " H4'" ' OP3' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 5037 ' ' HOH . . . . . 0.561 ' H2 ' ' HG2' ' A' ' 57' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 5038 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.776 0.322 . . . . 0.44 111.199 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -99.76 103.08 14.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.44 110.905 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -113.98 145.16 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.44 110.679 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.0 pp -146.09 122.15 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.44 111.02 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -102.37 154.0 19.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.336 0.588 . . . . 0.44 111.869 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 81' ' ' THR . 3.4 mp -146.12 130.93 11.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.05 -0.977 . . . . 0.44 109.74 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.39 124.29 42.02 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.472 -0.566 . . . . 0.44 109.472 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -114.63 162.17 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.421 0.629 . . . . 0.44 111.913 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.54 106.01 0.43 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.086 -0.961 . . . . 0.44 111.985 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 2.8 mp -70.29 100.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.001 -0.74 . . . . 0.44 109.001 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -71.14 126.51 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.197 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -96.42 140.61 30.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.691 -0.686 . . . . 0.44 110.504 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.554 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -107.88 -172.39 2.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.89 0.853 . . . . 0.44 112.666 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.26 -18.26 63.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.948 -1.478 . . . . 0.44 112.259 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.15 39.12 2.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.885 0.374 . . . . 0.44 110.891 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.17 28.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.556 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -106.6 145.42 31.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.44 110.328 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -106.7 127.19 62.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 0.44 111.872 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' N ' HD11 ' A' ' 18' ' ' ILE . 51.0 t80 -78.09 87.49 4.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.599 -0.728 . . . . 0.44 109.753 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.494 HG12 HG13 ' A' ' 18' ' ' ILE . 1.2 pt -112.79 162.29 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.249 -0.432 . . . . 0.44 110.735 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.2 p -82.48 114.23 20.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.099 -0.334 . . . . 0.44 110.099 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HA ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.76 103.75 4.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.44 111.109 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 45.61 29.2 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.098 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.63 35.2 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.44 111.258 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -176.57 -69.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.44 111.162 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.15 147.54 47.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.44 111.077 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.39 -37.06 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.44 111.03 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -95.86 -45.23 7.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.44 110.825 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.06 43.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.44 110.816 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.89 -8.65 56.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.44 111.619 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -89.66 24.72 2.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.57 0.224 . . . . 0.44 111.565 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.28 26.16 10.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.89 0.376 . . . . 0.44 111.3 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 6.6 tt -39.58 93.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.655 -0.702 . . . . 0.44 111.307 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.1 tt0 -120.62 -168.88 1.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.44 111.164 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.75 158.16 50.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.44 111.713 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 18.0 Cg_endo -58.17 167.83 4.23 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.513 2.809 . . . . 0.44 111.496 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.56 59.24 0.75 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.143 -1.027 . . . . 0.44 113.692 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.626 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -125.15 120.7 4.02 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 114.447 -0.876 . . . . 0.44 112.026 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.696 ' HD2' ' H2 ' ' A' 5050 ' ' HOH . 0.0 OUTLIER 114.55 5.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.329 0.652 . . . . 0.44 111.751 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.599 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.8 -26.03 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.486 0.66 . . . . 0.44 110.733 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -42.31 -82.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.79 -1.096 . . . . 0.44 111.185 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 33.67 -86.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.507 0.504 . . . . 0.44 111.86 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.24 31.87 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.44 112.503 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.99 -175.64 4.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.809 0.338 . . . . 0.44 111.16 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.579 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.04 159.58 28.84 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.463 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 7.0 Cg_endo -47.79 -24.44 4.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.628 2.218 . . . . 0.44 112.468 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.8 -47.45 5.57 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.213 0.449 . . . . 0.44 112.213 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -80.13 -25.57 39.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.813 0.301 . . . . 0.44 111.813 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -55.63 -47.54 76.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.809 0.337 . . . . 0.44 110.988 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 2.8 m -78.14 -45.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.44 111.194 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 53.7 t -62.58 -35.79 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.868 -0.605 . . . . 0.44 111.449 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -41.68 33.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.421 -0.354 . . . . 0.44 111.458 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -78.13 -26.23 47.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.637 -0.256 . . . . 0.44 111.318 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.465 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -57.57 -45.11 85.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.799 0.333 . . . . 0.44 110.572 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -26.85 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.311 0.577 . . . . 0.44 109.489 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.11 -26.76 53.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.328 -0.851 . . . . 0.44 111.117 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -108.32 5.16 25.29 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.33 0.492 . . . . 0.44 112.33 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' CG1' HG13 ' A' ' 60' ' ' ILE . 1.3 t -134.78 -44.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.282 0.563 . . . . 0.44 109.603 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 59.78 0.48 1.0 Allowed Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.166 -0.925 . . . . 0.44 114.412 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -105.51 -173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.605 0.702 . . . . 0.44 110.375 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -114.55 88.04 15.28 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.44 110.374 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HG2' ' HB3' ' A' ' 64' ' ' HIS . 98.3 Cg_endo -112.11 152.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.927 3.084 . . . . 0.44 113.478 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 35.5 mt-30 -74.76 78.67 2.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 103.433 -2.802 . . . . 0.44 103.433 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.566 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -111.19 120.25 41.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.555 -1.657 . . . . 0.44 112.089 -174.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -178.55 -148.19 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.44 110.666 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.99 161.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.163 0.506 . . . . 0.44 112.006 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -125.31 116.98 22.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.475 -0.784 . . . . 0.44 110.377 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -76.54 -56.55 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.44 109.924 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mt-10 -172.05 131.66 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.44 110.171 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.38 132.01 56.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.44 110.987 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.78 134.67 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.44 110.5 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.4 109.87 15.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.44 110.772 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -126.24 153.05 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.44 110.522 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.09 133.91 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.52 . . . . 0.44 111.412 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -96.6 162.92 21.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.483 -0.78 . . . . 0.44 110.146 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.442 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 5.7 Cg_endo -47.6 80.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.166 2.577 . . . . 0.44 112.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' PHE . 5.0 t0 86.45 12.73 0.15 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.485 -0.779 . . . . 0.44 111.641 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.41 94.82 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.733 0.302 . . . . 0.44 111.112 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -74.84 109.31 8.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.751 0.31 . . . . 0.44 110.844 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -106.99 111.97 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.44 111.029 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.55 125.71 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.44 110.655 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.45 114.88 18.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.69 0.281 . . . . 0.44 111.467 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.551 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -108.54 122.76 47.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.416 -0.356 . . . . 0.44 110.378 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 9.8 m-30 -101.67 121.0 41.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.44 111.086 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.5 m95 -101.64 149.23 24.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.103 -0.499 . . . . 0.44 111.448 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 65' ' ' PHE . 26.1 tp -100.18 103.44 14.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.613 0.597 . . . . 0.44 112.613 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 10.3 t -86.29 145.29 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.793 -0.639 . . . . 0.44 110.408 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.03 -32.83 9.51 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.372 1.249 . . . . 0.44 114.372 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.26 165.5 26.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.49 0.586 . . . . 0.44 111.59 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.554 ' CZ2' ' ND2' ' A' ' 13' ' ' ASN . 1.2 p90 -152.04 128.71 10.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.325 -0.398 . . . . 0.44 111.554 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -77.0 135.18 38.67 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.077 -0.51 . . . . 0.44 110.883 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.85 -125.84 20.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.661 -0.781 . . . . 0.44 112.431 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -132.92 143.22 47.68 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.527 0.203 . . . . 0.44 110.864 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.27 128.86 10.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.83 2.353 . . . . 0.44 111.408 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.582 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -125.36 -61.26 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.446 -0.502 . . . . 0.44 112.179 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.26 -103.64 0.04 OUTLIER Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.819 -0.705 . . . . 0.44 113.04 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 173.27 38.39 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.556 0.217 . . . . 0.44 111.093 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.48 -41.73 73.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.744 0.307 . . . . 0.44 110.793 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 110.79 -19.63 25.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.685 -0.769 . . . . 0.44 113.143 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.54 99.14 30.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.036 0.446 . . . . 0.44 111.477 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.62 146.43 1.39 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.172 2.581 . . . . 0.44 112.663 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.12 177.39 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.82 -0.705 . . . . 0.44 112.758 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -143.21 157.17 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.452 -0.203 . . . . 0.44 110.452 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.488 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -74.08 106.39 5.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.892 0.377 . . . . 0.44 110.211 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.1 ptm -120.42 163.0 18.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.937 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.95 114.89 23.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.44 110.814 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -64.32 -18.96 65.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.257 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.0 p -54.44 -20.46 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.379 -0.373 . . . . 0.44 111.682 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.74 42.57 1.43 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.369 -0.92 . . . . 0.44 113.222 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.0 tt -62.94 150.29 42.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.806 0.303 . . . . 0.44 110.204 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.88 131.16 53.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.657 0.614 . . . . 0.44 112.657 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -14.84 61.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.449 -0.796 . . . . 0.44 110.538 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -49.22 13.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.408 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -38.82 86.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.887 0.375 . . . . 0.44 111.07 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.81 174.4 6.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.434 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 71.6 Cg_endo -75.21 127.76 10.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.176 1.917 . . . . 0.44 111.489 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.71 -15.0 39.31 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.667 2.245 . . . . 0.44 113.049 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.52 -9.76 57.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.982 0.364 . . . . 0.44 111.982 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.443 ' ND2' ' CE2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -122.64 28.67 7.22 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.44 111.755 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -70.64 -39.72 9.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.868 0.321 . . . . 0.44 111.868 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -53.5 -42.19 67.57 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.988 1.792 . . . . 0.44 112.308 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.43 -51.36 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.526 . . . . 0.44 110.849 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.42 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.31 -29.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.682 -0.69 . . . . 0.44 110.961 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -34.3 64.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.44 110.432 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.17 -49.63 66.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 0.44 110.91 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.416 HD21 ' CE1' ' A' ' 68' ' ' PHE . 9.2 tp -78.19 -28.63 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.44 111.271 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -57.08 -42.67 81.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.44 110.998 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -72.72 -5.09 35.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 0.44 109.983 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-N 116.018 -0.537 . . . . 0.44 111.059 179.682 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.423 " O3'" ' CG1' ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5049 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5050 ' ' HOH . . . . . 0.696 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.793 0.33 . . . . 0.44 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.03 104.03 12.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.44 110.905 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 136.26 54.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.836 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.41 128.49 20.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.44 110.969 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -102.45 154.16 19.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.331 0.586 . . . . 0.44 111.777 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.2 mm -146.31 129.39 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.253 -0.885 . . . . 0.44 109.892 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.67 124.5 42.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 110.104 -0.332 . . . . 0.44 110.104 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.534 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.13 161.95 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.445 0.64 . . . . 0.44 111.972 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.04 121.43 1.19 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.968 -1.015 . . . . 0.44 111.642 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -73.77 108.85 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.618 -0.512 . . . . 0.44 109.618 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.482 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.26 127.79 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 0.44 111.709 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.09 131.67 43.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.364 -0.835 . . . . 0.44 111.123 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.752 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p-10 -87.8 -173.04 4.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.357 0.599 . . . . 0.44 111.909 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 22.1 tt0 -73.54 6.29 3.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.057 -0.974 . . . . 0.44 113.391 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 21.5 t-20 -130.33 45.06 2.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.048 -0.407 . . . . 0.44 112.052 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.9 p30 46.92 25.48 0.47 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.918 0.39 . . . . 0.44 111.369 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.53 161.61 18.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.197 -0.668 . . . . 0.44 109.197 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.471 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -116.3 144.37 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.058 0.456 . . . . 0.44 111.88 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.464 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.98 102.66 14.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.797 -0.638 . . . . 0.44 111.09 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.01 162.14 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.44 110.334 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . 10.1 t -84.65 139.61 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.328 . . . . 0.44 110.928 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -125.91 101.93 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.44 110.824 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 62.21 -104.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.905 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -175.86 -167.78 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.816 0.341 . . . . 0.44 111.066 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.37 -65.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.152 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.9 -51.64 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.44 110.965 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.43 147.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.44 111.096 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.31 -75.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.89 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -143.17 87.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.44 110.941 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.06 -21.23 61.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.44 111.371 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t-20 -94.28 16.08 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.319 . . . . 0.44 111.448 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.33 26.35 10.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.056 0.391 . . . . 0.44 112.056 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -52.55 84.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.991 -0.549 . . . . 0.44 110.766 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -123.15 176.5 6.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.44 111.177 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.81 166.43 14.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 0.44 112.075 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.4 Cg_endo -47.44 168.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.924 3.083 . . . . 0.44 112.628 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.64 59.46 0.75 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.534 -0.841 . . . . 0.44 113.099 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.68 112.09 1.15 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 114.262 -0.969 . . . . 0.44 112.045 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HD2' ' H1 ' ' A' 5061 ' ' HOH . 0.0 OUTLIER 116.02 6.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.4 0.68 . . . . 0.44 111.853 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.602 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -55.06 -27.59 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.595 0.712 . . . . 0.44 110.271 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.9 -80.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.486 -1.234 . . . . 0.44 111.206 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.3 mmm 38.64 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.355 0.41 . . . . 0.44 111.662 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.68 33.79 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.44 112.67 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.487 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -96.94 -170.26 2.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.65 0.262 . . . . 0.44 111.019 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.581 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.9 159.04 30.68 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 116.567 -0.288 . . . . 0.44 110.287 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.581 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.91 -24.66 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.777 2.318 . . . . 0.44 112.5 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.91 -58.1 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.302 0.482 . . . . 0.44 112.302 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 8.0 pt20 -80.66 -4.88 55.9 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.497 0.554 . . . . 0.44 112.497 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -63.16 -57.27 11.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.44 111.013 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.427 HG12 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -78.78 -42.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.44 111.77 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.65 -35.65 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.551 -0.295 . . . . 0.44 111.203 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -78.21 -52.12 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.778 -0.369 . . . . 0.44 110.685 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -62.17 -20.09 63.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.44 110.625 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 2.1 tp -57.46 -44.67 85.0 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.575 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.93 -27.6 68.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.631 . . . . 0.44 109.914 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.19 -30.4 54.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.44 111.282 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.49 6.4 26.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.44 112.388 -178.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.572 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 43.4 t -133.43 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.811 -0.44 . . . . 0.44 109.811 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.78 -40.17 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.594 -0.73 . . . . 0.44 114.006 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.519 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.53 -177.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.06 0.457 . . . . 0.44 111.112 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.71 88.72 14.29 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 115.616 -0.72 . . . . 0.44 109.998 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.0 Cg_endo -111.55 146.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.404 2.736 . . . . 0.44 114.211 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.1 mt-30 -74.85 79.73 2.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.416 -2.068 . . . . 0.44 105.416 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.566 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.21 128.45 52.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.228 -1.351 . . . . 0.44 111.058 -176.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.11 -139.53 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.961 -0.563 . . . . 0.44 110.622 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.45 158.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.12 0.486 . . . . 0.44 111.85 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.6 tt -121.07 109.89 15.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.44 110.577 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.447 ' CE1' HG11 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -76.75 -43.39 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.977 0.418 . . . . 0.44 110.139 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt-10 -171.3 166.02 7.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.44 110.516 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.17 132.12 22.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.386 -0.37 . . . . 0.44 110.942 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 tp -117.4 124.55 49.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -122.28 110.16 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.649 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -140.67 153.16 45.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.686 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.25 140.22 48.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.296 0.569 . . . . 0.44 111.284 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.33 163.85 16.64 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.177 -0.919 . . . . 0.44 110.534 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 53.8 Cg_exo -41.58 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.458 2.772 . . . . 0.44 112.534 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.3 t0 73.56 20.67 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.44 110.597 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -137.31 93.87 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.44 110.317 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.54 98.61 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.44 110.94 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.62 111.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.44 110.885 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.98 133.83 43.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.1 mt -126.22 114.36 18.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.44 111.489 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.51 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.14 122.7 48.23 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.686 -0.487 . . . . 0.44 109.686 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.6 125.2 50.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.44 111.21 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 67.5 m95 -107.57 148.56 29.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.127 -0.488 . . . . 0.44 111.149 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.2 tp -98.97 103.01 14.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.326 0.584 . . . . 0.44 111.261 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.566 HG13 ' HA ' ' A' ' 64' ' ' HIS . 13.3 t -81.84 145.61 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.231 -0.895 . . . . 0.44 111.845 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.63 -35.34 6.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.602 1.334 . . . . 0.44 114.602 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.56 165.66 25.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.843 0.747 . . . . 0.44 112.014 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.752 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.5 p90 -151.02 130.76 13.16 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.63 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.6 139.67 40.73 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.2 -0.454 . . . . 0.44 110.815 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.43 -121.84 23.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.666 -0.778 . . . . 0.44 112.442 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -131.94 145.59 58.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.558 0.218 . . . . 0.44 110.835 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.63 128.71 10.4 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.841 2.361 . . . . 0.44 111.363 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.6 p-90 -133.34 -60.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.397 -0.521 . . . . 0.44 112.133 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.572 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.05 -100.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.921 -0.657 . . . . 0.44 113.001 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.56 32.85 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.61 0.243 . . . . 0.44 111.248 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.433 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.3 pt-20 -64.79 -27.04 68.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.35 . . . . 0.44 110.688 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.14 31.6 81.28 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.926 -0.654 . . . . 0.44 112.729 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.423 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 5.9 mm-40 -140.42 91.96 9.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.045 0.45 . . . . 0.44 111.253 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -43.6 126.51 5.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.025 2.483 . . . . 0.44 112.854 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 177.2 19.35 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.676 -0.773 . . . . 0.44 112.762 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.34 157.16 42.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.429 -0.211 . . . . 0.44 110.429 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.458 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -68.83 106.28 2.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.44 110.047 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.9 ptm -120.39 147.41 45.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.079 -0.51 . . . . 0.44 111.042 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.0 p -70.76 115.08 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.44 111.072 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -18.65 61.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.984 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.414 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 12.1 p -59.02 -9.94 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.31 -0.405 . . . . 0.44 111.783 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.13 50.36 0.89 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.834 -0.698 . . . . 0.44 112.164 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -62.11 142.27 57.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.44 110.404 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' N ' HD11 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -119.2 114.77 22.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.295 0.479 . . . . 0.44 112.295 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.27 61.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 0.44 110.242 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.94 -49.11 13.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.276 -0.42 . . . . 0.44 111.273 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -68.44 -33.43 74.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.768 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.06 174.03 6.63 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.434 -0.348 . . . . 0.44 110.406 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 64.4 Cg_endo -74.23 127.78 11.54 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.134 1.889 . . . . 0.44 111.387 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.86 -14.85 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.742 2.295 . . . . 0.44 113.285 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.4 -9.82 37.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.376 0.509 . . . . 0.44 112.376 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.16 37.82 3.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.833 0.308 . . . . 0.44 111.833 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -72.19 -43.99 10.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.53 0.196 . . . . 0.44 111.53 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -54.78 -38.96 91.76 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.106 1.871 . . . . 0.44 112.169 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.447 HG11 ' CE1' ' A' ' 68' ' ' PHE . 2.2 t -77.45 -51.31 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.793 -0.64 . . . . 0.44 111.01 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.518 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.36 -29.85 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.617 -0.719 . . . . 0.44 110.974 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.72 -31.06 57.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.393 . . . . 0.44 110.443 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -69.62 -52.43 25.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.44 110.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 2.7 tp -78.21 -19.53 53.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.44 111.585 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 123' ' ' ILE . 18.1 ttpp -72.41 -42.62 64.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.44 110.892 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -76.02 -3.65 36.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.44 110.131 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.38 -0.373 . . . . 0.44 110.849 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5061 ' ' HOH . . . . . 0.671 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 5062 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.813 0.34 . . . . 0.44 111.185 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.56 104.25 13.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.44 110.919 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 132.76 56.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.44 110.864 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -138.38 128.06 25.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.913 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -102.48 154.19 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.275 0.559 . . . . 0.44 111.792 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.9 mm -146.33 129.04 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.303 -0.862 . . . . 0.44 109.923 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.67 124.54 42.41 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 110.12 -0.326 . . . . 0.44 110.12 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.43 162.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.339 0.59 . . . . 0.44 111.893 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.95 120.85 1.12 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.44 111.688 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.479 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.76 108.94 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.536 -0.542 . . . . 0.44 109.536 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.48 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.32 127.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.44 111.796 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.03 132.37 42.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.349 -0.841 . . . . 0.44 111.081 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.752 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.7 p-10 -88.95 -173.01 3.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.368 0.604 . . . . 0.44 111.931 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 23.1 tt0 -73.29 5.8 3.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.005 -0.998 . . . . 0.44 113.391 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 19.7 t-20 -129.92 44.93 2.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.673 -0.411 . . . . 0.44 111.982 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.7 p30 46.76 25.61 0.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.427 . . . . 0.44 111.396 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.42 161.62 18.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.227 -0.657 . . . . 0.44 109.227 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.47 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -116.55 144.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.032 0.444 . . . . 0.44 111.828 -178.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.48 102.18 13.96 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.715 -0.675 . . . . 0.44 111.099 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.14 162.08 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.44 110.362 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.42 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . 11.0 t -85.71 137.58 32.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.44 110.981 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -123.94 101.46 7.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.806 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 63.17 -103.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.44 110.806 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -176.27 -168.6 0.26 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.854 0.359 . . . . 0.44 111.109 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.52 -64.07 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.44 111.129 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -105.89 -51.49 2.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.44 110.953 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.78 147.79 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.44 111.126 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.05 -74.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.44 110.892 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -143.11 87.06 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.53 -20.82 61.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.44 111.376 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.8 t-20 -94.99 16.24 16.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.507 -0.315 . . . . 0.44 111.412 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -114.41 26.32 10.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.009 0.374 . . . . 0.44 112.009 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -52.66 84.71 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.925 -0.58 . . . . 0.44 110.752 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -124.03 176.72 6.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.44 111.108 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.76 166.25 15.37 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.062 0.458 . . . . 0.44 112.014 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.5 Cg_endo -47.62 168.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.85 3.033 . . . . 0.44 112.527 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.54 59.47 0.75 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.485 -0.864 . . . . 0.44 113.112 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.84 110.33 0.95 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.252 -0.974 . . . . 0.44 112.039 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.683 ' HD2' ' H1 ' ' A' 5073 ' ' HOH . 0.0 OUTLIER 118.14 4.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.344 0.658 . . . . 0.44 111.734 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.602 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.65 -27.91 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.561 0.696 . . . . 0.44 110.343 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.54 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.521 -1.218 . . . . 0.44 111.26 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 78.4 mmm 39.13 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.304 0.377 . . . . 0.44 111.586 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.67 33.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.649 -0.786 . . . . 0.44 112.702 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.488 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -96.92 -170.15 1.99 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.555 0.217 . . . . 0.44 111.055 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.58 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.55 158.97 30.85 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 110.272 -0.27 . . . . 0.44 110.272 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.88 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.902 2.402 . . . . 0.44 112.496 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.66 -58.29 2.4 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.259 0.466 . . . . 0.44 112.259 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -80.72 -4.78 55.68 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.462 0.541 . . . . 0.44 112.462 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.488 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -62.85 -57.24 11.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.792 0.329 . . . . 0.44 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 85' ' ' TRP . 1.4 p -78.76 -42.75 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.165 -0.47 . . . . 0.44 111.783 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -50.66 -35.55 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.525 -0.307 . . . . 0.44 111.225 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -52.15 9.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.379 . . . . 0.44 110.926 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.0 mm-40 -63.34 -19.84 64.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.693 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 2.7 tp -56.76 -44.68 82.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.071 0.462 . . . . 0.44 110.541 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.73 -27.02 68.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.778 -0.647 . . . . 0.44 109.899 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.2 tm-20 -77.2 -30.63 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.44 111.23 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.44 6.69 26.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.414 0.524 . . . . 0.44 112.414 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.574 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 43.8 t -133.48 -44.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.754 -0.461 . . . . 0.44 109.754 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -40.1 0.25 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.7 -0.682 . . . . 0.44 113.951 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.519 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.46 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.014 0.435 . . . . 0.44 111.095 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.55 88.7 13.85 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.659 -0.701 . . . . 0.44 109.996 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.606 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.8 Cg_endo -111.48 146.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 123.394 2.729 . . . . 0.44 114.219 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.414 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.8 mt-30 -74.74 79.64 2.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.45 -2.056 . . . . 0.44 105.45 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.567 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.94 128.64 52.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.234 -1.348 . . . . 0.44 111.006 -176.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.04 -139.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.44 110.587 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.83 157.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.099 0.476 . . . . 0.44 111.86 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.3 tt -119.71 109.44 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.814 -0.63 . . . . 0.44 110.614 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.448 ' HD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -76.79 -43.54 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.44 110.151 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 2.7 mt-10 -171.24 165.66 7.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.44 110.624 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 132.11 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.386 -0.37 . . . . 0.44 110.882 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 tp -116.89 123.75 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.736 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -121.5 109.99 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.44 110.638 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -140.89 153.25 45.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.44 110.706 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -114.22 140.2 48.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.273 0.558 . . . . 0.44 111.307 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.75 163.84 16.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.257 -0.883 . . . . 0.44 110.475 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 54.1 Cg_exo -41.36 81.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.338 2.692 . . . . 0.44 112.554 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.6 t0 73.62 20.48 3.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.44 110.607 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -137.23 93.92 2.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.44 110.36 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.6 98.82 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.44 110.942 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.64 111.87 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.064 -0.517 . . . . 0.44 110.887 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.52 133.76 44.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.475 . . . . 0.44 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.1 mt -126.16 114.39 18.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.44 111.453 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.506 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.08 122.66 48.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.786 -0.45 . . . . 0.44 109.786 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.46 125.73 51.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.348 . . . . 0.44 111.269 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 67.6 m95 -107.86 148.5 29.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.115 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.7 tp -98.74 102.81 14.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.297 0.57 . . . . 0.44 111.332 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 64' ' ' HIS . 13.9 t -81.5 145.65 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.44 111.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -109.53 -35.17 6.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.584 1.327 . . . . 0.44 114.584 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.44 165.64 26.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.845 0.748 . . . . 0.44 112.017 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.752 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.4 p90 -151.47 130.54 12.63 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 0.44 111.572 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -76.35 140.87 41.62 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.827 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.16 -121.94 25.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.665 -0.779 . . . . 0.44 112.468 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -131.84 145.81 59.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.536 0.208 . . . . 0.44 110.779 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.484 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.72 128.76 10.36 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.836 2.357 . . . . 0.44 111.362 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.554 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.8 p-90 -133.51 -60.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.355 -0.538 . . . . 0.44 112.124 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.84 -99.66 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.904 -0.665 . . . . 0.44 113.02 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.46 33.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.554 0.216 . . . . 0.44 111.278 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.437 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.8 pt-20 -65.57 -26.81 68.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 0.44 110.608 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.54 32.04 82.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.926 -0.654 . . . . 0.44 112.836 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.42 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 6.5 mm-40 -140.38 92.2 9.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.44 111.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -43.57 126.37 5.38 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.091 2.527 . . . . 0.44 112.817 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.27 177.17 19.37 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.749 -0.738 . . . . 0.44 112.853 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.92 157.14 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.459 -0.2 . . . . 0.44 110.459 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -69.01 106.23 2.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.887 0.375 . . . . 0.44 110.031 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.6 ptm -120.47 148.12 44.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.036 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 77.4 p -70.89 114.97 9.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.436 -0.347 . . . . 0.44 111.058 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -18.7 60.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.032 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 11.9 p -59.3 -9.63 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.36 -0.382 . . . . 0.44 111.836 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.45 49.62 0.92 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.44 112.276 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -62.22 142.11 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.674 0.273 . . . . 0.44 110.42 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' N ' HD11 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -120.04 115.87 24.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.367 0.506 . . . . 0.44 112.367 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.16 61.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.821 -0.627 . . . . 0.44 110.211 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -49.03 13.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.228 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -68.39 -33.51 74.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.297 -0.41 . . . . 0.44 111.76 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.14 174.02 6.64 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.448 -0.342 . . . . 0.44 110.394 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.5 Cg_endo -73.95 127.81 11.78 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.107 1.871 . . . . 0.44 111.363 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.02 -14.83 30.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.738 2.292 . . . . 0.44 113.266 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -9.75 39.58 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.392 0.516 . . . . 0.44 112.392 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -130.07 37.82 3.86 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.827 0.306 . . . . 0.44 111.827 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.84 -43.87 11.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 111.528 0.195 . . . . 0.44 111.528 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.2 Cg_exo -54.76 -38.92 91.62 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.134 1.889 . . . . 0.44 112.244 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 68' ' ' PHE . 2.3 t -77.55 -51.31 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.44 111.036 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.521 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.41 -29.87 47.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.7 . . . . 0.44 111.027 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.66 -30.95 56.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.987 0.422 . . . . 0.44 110.409 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -69.8 -52.52 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.821 -0.627 . . . . 0.44 110.868 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 2.9 tp -78.16 -19.52 53.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.44 111.568 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.23 -42.74 65.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.114 0.483 . . . . 0.44 110.882 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -75.58 -3.92 37.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.44 110.176 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.821 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5073 ' ' HOH . . . . . 0.683 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 5074 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.882 0.372 . . . . 0.44 111.163 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -86.91 136.15 33.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.44 110.888 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 121.94 19.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.44 110.833 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' CD1' " O3'" ' A' ' 131' ' ' 8OG . 2.6 pp -112.51 125.99 54.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.761 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 10.8 mt-30 -102.95 160.05 14.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.09 0.472 . . . . 0.44 111.482 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.433 HD11 " H4'" ' A' ' 131' ' ' 8OG . 39.8 mt -144.8 135.2 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.44 110.461 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.618 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.39 150.11 45.95 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.735 -0.468 . . . . 0.44 109.735 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -144.99 149.95 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.938 0.399 . . . . 0.44 111.143 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.6 111.35 0.5 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.614 -0.803 . . . . 0.44 112.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.528 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -81.13 109.62 15.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.849 -0.797 . . . . 0.44 108.849 178.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.449 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -71.03 119.38 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.228 0.537 . . . . 0.44 111.82 -178.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 1.4 mmt85 -83.22 124.31 30.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.518 -0.765 . . . . 0.44 111.756 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.507 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -78.05 -172.92 2.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.22 -0.9 . . . . 0.44 110.528 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 3.0 tt0 -85.74 16.46 3.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.871 -0.604 . . . . 0.44 112.553 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -142.63 50.59 1.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.785 -0.366 . . . . 0.44 111.919 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.0 25.6 0.5 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.142 0.496 . . . . 0.44 111.217 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' ' HA ' ' A' ' 106' ' ' SER . 39.4 mt-10 -120.54 161.47 21.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.754 -0.832 . . . . 0.44 108.754 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 HG21 ' N ' ' A' ' 19' ' ' PHE . 13.0 mt -122.26 139.25 49.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.211 0.529 . . . . 0.44 111.356 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -86.19 94.36 9.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.406 -0.816 . . . . 0.44 110.869 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -114.48 148.59 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.44 109.688 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 1.8 t -70.72 111.91 6.54 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.809 -0.356 . . . . 0.44 110.433 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.06 110.85 18.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.44 111.516 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 49.43 26.15 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.44 111.489 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . 48.96 -165.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 0.44 111.279 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.22 -29.77 31.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.44 111.014 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 p30 -104.84 -176.14 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.44 110.818 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.89 56.25 3.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.44 111.131 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.36 114.94 20.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.44 110.875 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.7 mmt 60.27 79.89 0.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.44 110.81 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.87 -11.19 59.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.44 111.619 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -96.67 29.46 2.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.349 . . . . 0.44 111.08 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -114.11 26.3 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.44 111.112 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 21.5 tp -64.04 70.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.44 110.89 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -118.37 178.08 4.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.009 0.433 . . . . 0.44 111.508 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.03 162.36 33.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.886 -0.597 . . . . 0.44 112.187 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 8.0 Cg_endo -48.02 169.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.941 3.094 . . . . 0.44 111.482 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.48 59.97 0.71 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 119.742 -1.218 . . . . 0.44 113.664 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -144.42 107.64 0.45 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 114.222 -0.989 . . . . 0.44 111.67 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.689 ' HB2' ' H1 ' ' A' 5085 ' ' HOH . 0.0 OUTLIER 123.96 -10.79 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.516 0.726 . . . . 0.44 110.513 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.533 ' O ' ' C ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -43.75 -78.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.044 0.449 . . . . 0.44 110.961 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 5.38 -80.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.862 -1.063 . . . . 0.44 112.344 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttm 37.29 -133.43 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.416 -0.356 . . . . 0.44 111.378 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.32 14.81 5.6 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.576 -0.821 . . . . 0.44 113.033 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -71.09 -164.56 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.44 110.805 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.523 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.62 154.41 37.49 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 110.146 -0.316 . . . . 0.44 110.146 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.29 -24.82 1.07 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.696 2.264 . . . . 0.44 112.321 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.28 -47.97 4.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.99 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.37 -7.15 58.97 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.884 0.328 . . . . 0.44 111.884 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 40' ' ' ILE . . . -65.53 -55.62 16.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.565 0.221 . . . . 0.44 111.216 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.27 -40.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.007 -0.277 . . . . 0.44 111.06 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -50.58 -35.4 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.44 110.432 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -42.76 31.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.457 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -67.26 -26.12 66.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.44 110.251 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.468 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.1 tp -52.55 -44.35 65.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.993 -0.549 . . . . 0.44 110.452 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.54 -33.08 74.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.44 110.1 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -77.36 -25.57 51.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.732 -0.667 . . . . 0.44 111.149 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.18 5.19 25.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.895 0.332 . . . . 0.44 111.895 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.499 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 18.4 t -135.22 -44.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.319 0.581 . . . . 0.44 110.309 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.605 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.48 4.62 1.39 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.234 -0.894 . . . . 0.44 114.604 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.556 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -122.07 -173.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 117.897 0.848 . . . . 0.44 110.831 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.9 p -113.72 87.48 12.24 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-N 115.843 -0.617 . . . . 0.44 109.545 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.629 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.1 Cg_endo -115.27 149.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.643 2.895 . . . . 0.44 114.22 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.02 79.82 2.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.366 -2.087 . . . . 0.44 105.366 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.573 ' CD2' ' CG2' ' A' ' 87' ' ' VAL . 1.3 t-160 -123.5 130.5 52.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.553 -1.203 . . . . 0.44 111.244 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.55 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -177.86 -139.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.872 -0.604 . . . . 0.44 110.794 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.79 175.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.44 111.847 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.726 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -143.11 123.96 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.813 -0.631 . . . . 0.44 110.926 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.55 -44.61 34.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.498 . . . . 0.44 109.796 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.45 164.83 6.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.465 -0.789 . . . . 0.44 110.036 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 127.69 17.49 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.995 -0.282 . . . . 0.44 110.914 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.7 tp -106.63 121.09 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.44 110.503 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -122.22 112.01 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.44 110.92 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -141.04 148.06 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.44 110.45 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -121.08 139.97 52.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.44 111.457 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -105.04 162.76 18.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.485 -0.78 . . . . 0.44 110.285 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 7.6 Cg_endo -49.72 82.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.099 2.533 . . . . 0.44 112.25 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.2 m-20 87.74 11.35 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.361 -0.836 . . . . 0.44 111.595 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.28 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 0.44 110.866 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -80.34 107.15 12.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 0.44 111.094 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 tt -100.42 111.74 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.601 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.71 135.11 42.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.44 110.924 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.401 ' CD2' ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -126.26 114.44 18.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.429 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.454 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -116.15 122.79 46.12 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.322 -0.251 . . . . 0.44 110.322 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.7 m-85 -113.6 113.44 25.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.877 0.37 . . . . 0.44 110.273 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.726 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 44.0 m95 -94.77 148.59 22.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.011 -0.541 . . . . 0.44 111.452 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 65' ' ' PHE . 50.4 tp -104.8 102.73 12.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.391 0.615 . . . . 0.44 111.251 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.573 ' CG2' ' CD2' ' A' ' 64' ' ' HIS . 12.6 t -80.88 145.8 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 115.162 -0.926 . . . . 0.44 111.291 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.77 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.674 1.361 . . . . 0.44 114.674 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -161.78 165.52 27.82 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.868 0.758 . . . . 0.44 112.065 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.629 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 2.1 p90 -149.84 131.49 14.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.058 -0.519 . . . . 0.44 111.489 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.53 136.38 33.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.401 -0.363 . . . . 0.44 110.921 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -140.82 19.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.44 112.526 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.0 tt0 -115.1 129.82 24.75 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.383 0.135 . . . . 0.44 110.731 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.556 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.55 128.78 10.51 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.649 2.233 . . . . 0.44 111.721 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.605 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.1 p-90 -135.3 -57.74 0.8 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.458 -0.497 . . . . 0.44 111.866 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.502 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 43.51 -104.07 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.762 -0.732 . . . . 0.44 113.137 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 166.57 40.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.798 0.332 . . . . 0.44 110.885 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.484 ' HA ' ' H2 ' ' A' 5086 ' ' HOH . 0.0 OUTLIER -65.99 -41.26 91.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.44 110.981 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.97 -104.03 0.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.532 -0.842 . . . . 0.44 112.932 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.402 ' HB3' ' CB ' ' A' ' 24' ' ' ALA . 19.7 mt-30 -92.95 120.61 66.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.44 111.59 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -43.62 146.14 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.066 2.511 . . . . 0.44 112.682 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.31 19.23 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.85 -0.69 . . . . 0.44 112.808 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.5 157.23 29.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.621 0.248 . . . . 0.44 110.735 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.447 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.1 m0 -60.39 106.87 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.44 110.426 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -120.19 156.73 30.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.325 -0.398 . . . . 0.44 111.043 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 5.0 t -81.1 116.86 21.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.865 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 6.3 tp -72.66 -18.7 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.347 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.6 t -49.67 -21.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.72 0.295 . . . . 0.44 111.452 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.23 50.51 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.958 -0.639 . . . . 0.44 111.886 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tt -62.12 150.31 38.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.44 110.686 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -104.11 101.22 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.457 0.54 . . . . 0.44 112.457 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -16.89 61.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.27 0.557 . . . . 0.44 110.083 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.51 -48.81 13.24 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.053 -0.522 . . . . 0.44 111.073 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -35.64 80.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.911 -0.586 . . . . 0.44 112.008 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.523 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.6 169.19 21.87 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.545 -0.298 . . . . 0.44 110.415 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.4 Cg_endo -54.63 131.8 47.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.55 2.167 . . . . 0.44 112.93 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.504 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.17 -14.07 37.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.072 2.515 . . . . 0.44 112.627 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.04 58.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.971 0.36 . . . . 0.44 111.971 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 82' ' ' LEU . 1.7 m-20 -121.38 25.89 9.18 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.915 0.709 . . . . 0.44 112.915 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.02 -38.84 3.94 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 112.124 0.416 . . . . 0.44 112.124 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.9 Cg_exo -44.82 -41.9 15.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.181 1.921 . . . . 0.44 113.204 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.463 HG22 ' CE1' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -77.42 -51.34 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 0.44 111.071 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.523 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.1 mm -65.37 -29.93 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.44 111.222 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.64 -32.23 63.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.13 0.49 . . . . 0.44 110.35 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -71.06 -48.58 51.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.44 111.212 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.456 ' CB ' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -78.24 -30.8 48.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.44 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -54.9 -42.64 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.974 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -67.16 -10.1 46.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.653 . . . . 0.44 109.8 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.968 -0.56 . . . . 0.44 111.069 179.771 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.463 " O3'" ' CD1' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5085 ' ' HOH . . . . . 0.689 ' H1 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 5086 ' ' HOH . . . . . 0.484 ' H2 ' ' HA ' ' A' ' 98' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.832 0.348 . . . . 0.44 111.192 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.99 103.05 11.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.863 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.79 131.88 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.801 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.406 HD22 " O3'" ' A' ' 131' ' ' 8OG . 3.5 pp -125.57 123.02 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.048 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.4 153.75 19.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.339 0.59 . . . . 0.44 111.658 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' THR . 89.3 mt -146.36 131.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.44 110.107 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.6 124.46 42.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.28 -0.267 . . . . 0.44 110.28 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.467 HG23 ' CD1' ' A' ' 35' ' ' PHE . 1.5 m -117.13 162.68 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.45 . . . . 0.44 111.697 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.46 115.0 0.83 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.811 -0.709 . . . . 0.44 112.606 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.593 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.5 mp -70.61 95.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.938 -0.764 . . . . 0.44 108.938 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.625 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -71.0 111.82 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.387 0.613 . . . . 0.44 112.47 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -85.51 136.26 33.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.231 -0.895 . . . . 0.44 111.046 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.629 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 23.5 p30 -105.94 -172.89 2.17 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.766 0.793 . . . . 0.44 112.687 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -68.21 -4.4 13.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.44 113.693 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 56.2 t30 -124.19 42.51 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.638 -0.425 . . . . 0.44 112.087 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 46.22 27.05 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.44 111.613 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HG3' ' OD1' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -123.29 160.85 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.444 -0.576 . . . . 0.44 109.444 178.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -118.85 146.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.378 0.608 . . . . 0.44 112.295 -178.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t80 -90.04 95.79 10.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.44 109.86 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.513 HG12 HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -108.34 162.19 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.284 -0.416 . . . . 0.44 110.052 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p -81.13 111.87 17.97 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.063 -0.347 . . . . 0.44 110.063 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -124.14 134.67 53.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.44 111.383 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 48.56 27.31 1.42 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.44 111.404 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.09 -86.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.335 -0.393 . . . . 0.44 111.201 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.49 -47.2 0.25 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.505 -0.316 . . . . 0.44 111.07 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -150.18 -50.45 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.016 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.9 120.39 16.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.44 111.182 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.06 -76.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.44 110.804 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.11 118.5 4.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.722 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.37 -25.24 31.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.44 111.485 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.68 19.23 10.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.44 111.374 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.5 26.18 10.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.717 0.294 . . . . 0.44 111.65 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.0 tt -54.15 83.71 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.986 -0.552 . . . . 0.44 110.757 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.78 -179.08 3.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.84 0.353 . . . . 0.44 111.412 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 160.98 40.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.962 -0.563 . . . . 0.44 111.648 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 29.0 Cg_endo -61.5 168.09 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.484 2.789 . . . . 0.44 111.528 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.45 59.34 0.75 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 119.806 -1.188 . . . . 0.44 113.98 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.94 121.02 3.43 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.777 -0.711 . . . . 0.44 112.05 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.709 ' CD ' ' H1 ' ' A' 5098 ' ' HOH . 0.0 OUTLIER 115.02 6.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.382 0.673 . . . . 0.44 111.817 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.596 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -58.24 -25.92 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.582 0.706 . . . . 0.44 110.573 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -45.1 -85.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.738 -1.119 . . . . 0.44 111.24 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 38.29 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.312 0.383 . . . . 0.44 111.615 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.57 32.68 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 0.44 112.541 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.7 mp0 -91.6 -176.46 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.86 0.362 . . . . 0.44 111.222 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.543 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.64 156.17 35.62 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.314 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.99 -24.77 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.797 2.331 . . . . 0.44 112.715 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.32 -48.27 5.39 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.019 0.378 . . . . 0.44 112.019 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -80.27 -14.01 58.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.944 0.35 . . . . 0.44 111.944 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.93 -52.97 62.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.44 111.073 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.1 m -77.93 -44.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.936 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.496 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 46.6 t -57.77 -35.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 0.44 111.127 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -52.09 9.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 40' ' ' ILE . 2.1 mm-40 -65.42 -24.21 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.839 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.481 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -52.2 -44.27 64.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.88 0.371 . . . . 0.44 110.345 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -36.6 78.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.144 -0.688 . . . . 0.44 109.144 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.86 -25.03 48.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.243 -0.89 . . . . 0.44 111.493 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 76.4 mm-40 -108.44 5.94 25.79 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.478 0.547 . . . . 0.44 112.478 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.458 ' CG1' HG13 ' A' ' 60' ' ' ILE . 14.5 t -134.37 -44.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.44 110.543 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.504 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 60.59 5.29 4.88 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.623 -0.717 . . . . 0.44 114.353 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -122.5 -166.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 117.859 0.829 . . . . 0.44 110.852 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.419 HG22 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -112.57 88.08 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.44 110.73 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 16.4 Cg_endo -113.57 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.49 2.793 . . . . 0.44 114.462 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 27.8 mt-30 -74.65 79.39 2.01 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.508 -2.404 . . . . 0.44 104.508 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -113.04 132.9 55.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.12 -1.4 . . . . 0.44 110.684 -175.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -177.12 -143.1 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.025 -0.534 . . . . 0.44 110.829 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m 52.14 171.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.44 112.245 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.8 tt -134.24 114.48 13.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.445 -0.798 . . . . 0.44 110.452 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CD2' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.49 -56.04 4.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.44 109.811 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -171.51 131.84 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 0.44 110.241 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -114.59 132.08 56.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.812 0.339 . . . . 0.44 110.893 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HB2' HG21 ' A' ' 122' ' ' VAL . 7.5 tp -107.34 141.44 38.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.44 110.804 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -131.32 109.72 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.44 110.683 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 80' ' ' ILE . 1.8 p90 -141.02 138.25 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.44 110.296 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 8.3 pt-20 -107.41 140.11 40.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.262 0.553 . . . . 0.44 111.718 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -101.34 163.05 18.65 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.324 -0.853 . . . . 0.44 110.053 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 4.2 Cg_endo -46.6 81.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.196 2.598 . . . . 0.44 112.532 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.3 m-20 85.61 11.87 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.418 -0.81 . . . . 0.44 111.689 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -137.42 94.89 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.44 111.03 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 12.6 t-160 -74.84 97.92 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.44 110.997 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.43 HG22 ' CE2' ' A' ' 73' ' ' TYR . 3.0 tt -94.47 111.93 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.44 110.9 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.03 129.43 54.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.44 110.84 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.45 114.75 18.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.44 111.425 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -110.29 122.88 48.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.463 -0.335 . . . . 0.44 110.464 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 11.7 m-30 -103.22 113.08 26.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.839 0.352 . . . . 0.44 110.778 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.9 m95 -95.07 148.86 21.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.162 -0.472 . . . . 0.44 111.548 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.2 tm? -90.9 102.87 15.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.225 0.536 . . . . 0.44 111.551 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.593 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 20.9 t -89.53 144.87 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 115.529 -0.759 . . . . 0.44 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.52 ' C ' ' HG2' ' A' ' 89' ' ' ARG . 4.7 pm0 -121.28 -13.5 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.46 1.652 . . . . 0.44 115.46 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -160.94 160.05 30.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.044 1.293 . . . . 0.44 112.357 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -158.0 122.17 4.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.764 -0.653 . . . . 0.44 110.73 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.419 ' CB ' HG22 ' A' ' 61' ' ' THR . 1.5 mm-40 -83.33 117.98 23.37 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.882 0.372 . . . . 0.44 111.096 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.3 -125.61 8.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.44 112.531 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.13 136.12 28.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.577 -0.156 . . . . 0.44 110.577 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.99 128.91 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.766 2.311 . . . . 0.44 111.285 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 50.8 p-90 -140.95 -58.09 0.5 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.429 -0.509 . . . . 0.44 112.129 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 47.87 -93.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.679 -0.772 . . . . 0.44 112.501 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -171.93 33.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.761 0.315 . . . . 0.44 110.787 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -62.0 -47.09 86.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.585 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.46 -24.4 32.36 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.735 -0.745 . . . . 0.44 113.277 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -112.27 95.67 31.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.44 111.574 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.5 146.14 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.173 2.582 . . . . 0.44 112.767 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.71 18.95 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.835 -0.698 . . . . 0.44 112.76 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.43 154.39 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.289 -0.263 . . . . 0.44 110.289 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.518 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -66.83 105.62 1.64 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.663 -0.415 . . . . 0.44 110.073 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.419 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 1.1 ptm -121.06 153.38 37.48 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.108 -0.496 . . . . 0.44 111.378 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 5.4 p -74.21 114.96 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 0.44 111.146 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.405 ' HB2' HG23 ' A' ' 18' ' ' ILE . 1.9 tm? -60.78 -24.45 65.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.914 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.49 -19.78 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.44 111.617 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.96 35.15 4.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.555 -0.831 . . . . 0.44 113.025 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.8 tp -62.83 130.23 43.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.44 110.012 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.12 136.07 54.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.684 0.624 . . . . 0.44 112.684 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.38 -15.43 61.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.425 -0.807 . . . . 0.44 110.657 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -78.85 -49.1 13.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.299 -0.409 . . . . 0.44 111.624 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -35.26 77.96 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.488 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -82.82 174.02 6.67 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.473 -0.33 . . . . 0.44 110.636 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 68.4 Cg_endo -74.75 127.99 11.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.256 1.971 . . . . 0.44 111.488 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.13 -14.74 25.03 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.774 2.316 . . . . 0.44 113.35 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.99 -9.9 25.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.382 0.512 . . . . 0.44 112.382 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.86 41.0 3.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.78 0.324 . . . . 0.44 111.439 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.29 -46.3 7.85 Favored Pre-proline 0 N--CA 1.464 0.241 0 N-CA-C 112.205 0.446 . . . . 0.44 112.205 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.1 Cg_exo -47.83 -40.27 31.98 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.218 1.945 . . . . 0.44 112.816 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 71' ' ' LEU . 2.3 t -77.52 -51.42 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.504 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.4 mm -65.45 -29.96 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.44 110.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.27 -31.61 63.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.987 0.423 . . . . 0.44 110.627 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -50.06 36.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.44 111.11 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.17 -26.39 47.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.297 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.25 -42.67 86.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.44 110.814 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.04 -8.6 46.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.44 109.779 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-N 115.952 -0.567 . . . . 0.44 111.004 179.696 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.406 " O3'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5097 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5098 ' ' HOH . . . . . 0.709 ' H1 ' ' CD ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.773 0.321 . . . . 0.44 111.228 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 113.86 26.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.44 110.983 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 121.92 13.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.4 pp -100.36 121.02 40.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.751 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -102.61 151.32 22.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.44 111.153 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.422 ' N ' ' O ' ' A' ' 81' ' ' THR . 2.8 mp -140.06 139.0 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.503 -0.771 . . . . 0.44 110.486 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.716 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.78 140.8 52.6 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.469 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -144.49 149.78 17.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.427 -0.509 . . . . 0.44 111.167 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.67 125.52 1.88 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.712 -0.756 . . . . 0.44 112.402 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.8 109.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.284 -0.636 . . . . 0.44 109.284 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -71.16 121.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.157 0.503 . . . . 0.44 111.318 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.632 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -85.94 120.06 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.732 . . . . 0.44 111.129 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 27.5 p-10 -74.62 -171.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.313 -0.858 . . . . 0.44 111.914 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 8.3 tp10 -86.81 19.0 3.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.467 -1.242 . . . . 0.44 112.067 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -144.5 27.73 1.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.746 0.308 . . . . 0.44 111.663 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.61 3.86 4.72 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.754 0.279 . . . . 0.44 111.754 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 1.5 mm-40 -100.76 159.89 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.134 -0.691 . . . . 0.44 109.134 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 19' ' ' PHE . 7.0 mt -125.28 141.78 44.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.44 111.496 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.442 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -90.38 113.47 25.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.44 110.793 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.01 162.05 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.44 110.398 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 t -88.98 111.8 22.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.44 110.315 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HD2' ' CD1' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -102.89 83.96 2.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.44 111.312 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 50.95 23.54 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.44 111.536 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' CB ' ' HB3' ' A' ' 100' ' ' GLN . . . 47.59 27.73 1.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.715 0.293 . . . . 0.44 111.402 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.85 39.92 29.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.44 111.128 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -134.56 -173.77 3.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.44 110.954 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.87 -161.67 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.44 111.172 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.48 -79.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.446 -0.343 . . . . 0.44 110.889 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -96.49 73.21 2.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 0.44 110.693 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.3 -25.38 27.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.44 111.544 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.68 28.95 3.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.387 -0.37 . . . . 0.44 111.295 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -114.29 26.05 10.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.012 0.434 . . . . 0.44 111.515 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.404 ' CD1' ' HD2' ' A' ' 22' ' ' ARG . 1.1 tt -59.02 87.73 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.77 -0.65 . . . . 0.44 110.316 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -169.42 2.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.44 111.526 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.478 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.95 165.44 17.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.44 111.792 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.6 Cg_endo -47.83 168.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.788 2.992 . . . . 0.44 111.844 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.716 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.15 59.84 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.91 -1.138 . . . . 0.44 114.249 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.92 109.44 0.66 Allowed Glycine 0 C--N 1.312 -0.761 0 CA-C-N 114.473 -0.864 . . . . 0.44 111.697 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.704 ' CD ' ' H2 ' ' A' 5110 ' ' HOH . 0.0 OUTLIER 122.32 -8.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.463 0.705 . . . . 0.44 110.853 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.521 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.2 -65.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.256 0.55 . . . . 0.44 111.41 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -13.6 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.473 -1.24 . . . . 0.44 112.472 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 43.0 -94.0 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.421 -0.354 . . . . 0.44 111.598 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.23 18.11 0.09 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.479 -0.867 . . . . 0.44 113.579 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -79.55 -163.0 0.46 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.842 -0.211 . . . . 0.44 110.801 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.535 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.86 154.76 38.39 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.097 -0.334 . . . . 0.44 110.097 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.8 -24.86 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.702 2.268 . . . . 0.44 112.399 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.65 -52.22 4.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.358 -0.383 . . . . 0.44 112.015 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -80.51 -4.93 55.76 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.867 0.321 . . . . 0.44 111.867 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' CB ' HD11 ' A' ' 40' ' ' ILE . . . -66.19 -57.01 8.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.711 -0.222 . . . . 0.44 111.101 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.32 -40.65 25.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.44 111.264 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.7 t -50.46 -35.48 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.44 110.935 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -52.12 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 0.44 111.118 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.89 -25.59 67.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.44 110.65 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.408 ' CD2' ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -54.61 -44.43 73.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.192 -0.458 . . . . 0.44 110.576 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -27.41 67.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.44 109.734 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -77.14 -25.58 52.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.682 -0.69 . . . . 0.44 111.233 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -108.42 5.74 25.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.431 0.53 . . . . 0.44 112.431 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.549 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 16.4 t -134.53 -44.55 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.263 0.554 . . . . 0.44 110.286 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.622 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 56.79 3.41 0.7 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.393 -0.821 . . . . 0.44 114.577 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -119.75 -173.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.926 0.863 . . . . 0.44 110.392 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -113.96 87.5 12.87 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 116.093 -0.503 . . . . 0.44 109.901 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.595 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.9 Cg_endo -115.11 149.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.761 2.974 . . . . 0.44 113.924 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 83.2 mt-30 -74.81 79.62 2.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.546 -2.02 . . . . 0.44 105.546 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.519 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.57 127.57 49.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.505 -1.225 . . . . 0.44 111.061 -176.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.79 -136.98 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.776 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 56.6 163.26 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.219 0.533 . . . . 0.44 112.116 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.5 tt -126.19 113.18 16.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.44 110.289 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.65 -53.24 8.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.44 110.293 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.697 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.41 131.68 0.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.418 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 132.07 53.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.728 0.299 . . . . 0.44 111.023 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.424 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -106.54 159.34 16.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.289 -0.414 . . . . 0.44 110.922 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -140.08 109.92 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.485 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -133.33 153.01 51.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.44 110.679 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -121.24 140.05 52.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.197 0.522 . . . . 0.44 111.425 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -103.41 162.86 18.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.486 -0.779 . . . . 0.44 110.156 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.1 Cg_endo -45.8 80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.334 2.689 . . . . 0.44 112.815 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.5 t0 85.45 9.95 0.31 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.479 -0.782 . . . . 0.44 111.947 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 3.9 ttp-105 -137.39 101.39 4.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.44 111.087 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -74.89 115.84 14.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.44 110.829 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 1.1 tt -107.14 112.04 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.44 110.955 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.88 129.92 53.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.44 111.004 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.3 mt -126.37 114.43 18.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.58 -0.282 . . . . 0.44 111.146 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -111.95 122.43 47.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.367 -0.379 . . . . 0.44 111.044 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.697 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.4 m-30 -104.5 115.06 29.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.134 -0.485 . . . . 0.44 110.491 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 36.6 m95 -94.72 148.72 21.99 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.344 -0.389 . . . . 0.44 111.058 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.2 tm? -101.08 102.68 13.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.452 0.644 . . . . 0.44 111.361 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 t -82.11 145.77 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 115.105 -0.952 . . . . 0.44 111.658 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.97 -45.87 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.896 1.443 . . . . 0.44 114.896 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.8 ptm85 -163.13 165.93 24.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.839 0.745 . . . . 0.44 112.383 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.595 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 8.4 p90 -139.59 136.19 34.13 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.125 -0.488 . . . . 0.44 111.68 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.35 108.72 19.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.199 -0.455 . . . . 0.44 110.814 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.35 -121.47 6.86 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.74 -0.743 . . . . 0.44 112.427 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.5 tt0 -135.08 135.06 22.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.467 0.175 . . . . 0.44 110.917 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.56 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.47 128.73 10.54 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.796 2.331 . . . . 0.44 111.58 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.622 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.4 p-90 -133.47 -58.18 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.298 -0.561 . . . . 0.44 112.09 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.572 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 37.89 -92.39 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.026 -0.607 . . . . 0.44 113.257 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 95' ' ' TRP . 5.2 tmtm? 179.88 -69.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.812 0.339 . . . . 0.44 110.747 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 42.21 26.06 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.009 -0.541 . . . . 0.44 111.605 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.21 -65.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.013 -0.613 . . . . 0.44 113.545 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 98' ' ' GLU . 28.5 mt-30 -108.02 99.23 29.81 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.402 0.519 . . . . 0.44 112.402 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.47 146.55 3.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.139 2.559 . . . . 0.44 112.469 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.04 21.4 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.515 -0.85 . . . . 0.44 113.189 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.84 157.62 25.31 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.448 -0.205 . . . . 0.44 110.448 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.83 106.36 3.11 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.949 0.404 . . . . 0.44 110.609 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.401 ' CE ' ' NE ' ' A' ' 22' ' ' ARG . 2.6 mtp -120.87 164.11 17.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.962 -0.563 . . . . 0.44 111.384 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -70.75 116.96 11.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.44 110.339 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -18.71 50.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.44 111.62 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.12 -14.25 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.906 0.336 . . . . 0.44 111.906 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.79 35.24 4.7 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.536 -0.84 . . . . 0.44 113.153 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.74 135.91 57.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.079 -0.341 . . . . 0.44 110.079 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.09 131.48 53.71 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.676 0.621 . . . . 0.44 112.676 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.63 -15.3 61.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.298 -0.864 . . . . 0.44 110.975 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.71 -49.14 13.62 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.421 -0.354 . . . . 0.44 111.809 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -36.46 77.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.42 -0.354 . . . . 0.44 111.775 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.541 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -78.77 173.98 6.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.597 -0.274 . . . . 0.44 110.731 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.4 Cg_endo -76.46 137.17 18.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.358 2.039 . . . . 0.44 112.089 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 27.6 Cg_endo -62.01 -14.29 36.44 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.842 2.361 . . . . 0.44 113.202 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.3 -9.7 19.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 0.44 112.621 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.432 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -135.9 44.12 2.5 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.443 0.534 . . . . 0.44 112.443 -178.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.2 OUTLIER -76.05 -50.77 2.98 Favored Pre-proline 0 N--CA 1.463 0.186 0 N-CA-C 111.833 0.308 . . . . 0.44 111.833 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.461 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 79.6 Cg_exo -44.74 -38.02 12.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.447 2.098 . . . . 0.44 112.792 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.426 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.5 t -77.25 -49.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.611 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.541 HG13 ' CE2' ' A' ' 115' ' ' PHE . 11.3 mm -64.75 -29.97 48.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.44 110.747 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.05 -29.75 63.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.44 110.653 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.28 -48.52 15.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.44 111.629 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -78.19 -30.25 48.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.34 . . . . 0.44 111.425 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 123' ' ' ILE . 12.0 ttpt -55.58 -42.47 74.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.44 110.817 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -68.42 -7.47 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.636 . . . . 0.44 109.639 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 C--O 1.233 0.199 0 CA-C-N 116.012 -0.54 . . . . 0.44 111.073 179.743 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.404 " O3'" HD11 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5109 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5110 ' ' HOH . . . . . 0.704 ' H2 ' ' CD ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.855 0.36 . . . . 0.44 111.194 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.09 131.75 54.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.44 110.872 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -126.93 141.89 51.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.825 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.61 117.59 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.44 111.08 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.6 mt-30 -102.29 151.74 21.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.569 . . . . 0.44 111.841 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.441 ' CD1' " O3'" ' A' ' 131' ' ' 8OG . 4.3 mt -142.68 128.28 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.44 109.869 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.54 124.68 42.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.081 -0.34 . . . . 0.44 110.081 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.503 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.7 m -115.39 162.18 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.283 0.563 . . . . 0.44 111.924 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.42 102.08 0.23 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.335 -0.848 . . . . 0.44 111.957 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.91 110.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.094 -0.335 . . . . 0.44 110.094 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.561 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.55 115.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.44 111.066 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 3.7 mmt85 -82.14 133.7 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.969 -0.382 . . . . 0.44 109.969 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.452 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 10.3 p-10 -84.17 -172.01 3.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.44 113.062 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -56.61 -16.06 5.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.721 -1.581 . . . . 0.44 113.275 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -127.71 -83.0 0.6 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.839 0.311 . . . . 0.44 111.839 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.16 17.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.44 111.687 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HB2' ' ND2' ' A' ' 13' ' ' ASN . 19.8 mt-10 -100.89 160.11 14.64 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.765 -0.457 . . . . 0.44 109.765 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -135.08 145.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.44 111.997 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 14.0 t80 -84.48 89.63 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.44 110.79 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.478 HG12 HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -113.29 162.17 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.44 110.038 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 t -80.25 130.27 35.09 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.979 -0.378 . . . . 0.44 109.979 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 1.1 ptm180 -146.48 128.39 15.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.893 0.377 . . . . 0.44 111.167 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 mpp_? 45.83 28.53 0.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.103 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.99 32.8 2.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.44 111.175 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -158.49 53.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.989 -0.551 . . . . 0.44 111.015 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -57.1 158.14 5.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.068 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 59.76 30.67 20.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.44 111.073 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -155.53 -55.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.896 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.02 108.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.44 110.998 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.03 -18.95 29.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.325 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.51 31.29 2.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.405 -0.361 . . . . 0.44 110.879 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.03 26.37 10.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.44 111.507 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.8 tt -57.74 77.37 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.44 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -108.58 -170.65 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.091 0.472 . . . . 0.44 111.636 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.9 154.13 55.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.746 -0.661 . . . . 0.44 111.395 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.457 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 11.1 Cg_endo -53.84 167.47 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.233 2.622 . . . . 0.44 111.677 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 59.25 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.896 -1.145 . . . . 0.44 114.137 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.06 117.04 2.48 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 114.84 -0.68 . . . . 0.44 112.059 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 3.5 tttt 115.76 4.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.322 0.649 . . . . 0.44 111.513 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -53.98 -27.61 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.569 0.699 . . . . 0.44 110.665 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.22 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.581 -1.191 . . . . 0.44 111.161 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mmt 33.38 -85.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.558 0.537 . . . . 0.44 111.878 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.31 31.11 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.927 -0.654 . . . . 0.44 112.553 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.0 mp0 -91.61 -175.07 4.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.74 0.305 . . . . 0.44 111.168 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.563 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -111.92 159.0 35.14 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.313 -0.403 . . . . 0.44 110.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.95 -24.65 0.88 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.904 2.403 . . . . 0.44 112.696 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -58.08 2.61 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.61 0.596 . . . . 0.44 112.61 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -80.4 -20.07 44.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.44 112.39 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.3 -49.76 73.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.833 0.349 . . . . 0.44 111.148 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.505 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 2.6 m -76.03 -46.86 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.44 110.912 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.505 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 42.3 t -60.46 -35.85 65.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.44 111.087 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -70.91 -49.14 49.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.312 -0.404 . . . . 0.44 111.022 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -71.33 -27.97 63.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.44 111.028 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.446 ' CD2' ' ND1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -55.06 -44.08 74.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.44 110.55 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -61.44 -35.09 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 0.44 109.816 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.53 -33.54 54.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.44 111.339 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 20.5 mm-40 -100.05 4.83 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.15 0.426 . . . . 0.44 112.15 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.542 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 3.3 t -135.48 -43.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.115 0.483 . . . . 0.44 110.245 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.64 9.39 6.61 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.747 -0.661 . . . . 0.44 114.504 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.833 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 13.5 tt -115.88 162.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 117.46 0.63 . . . . 0.44 110.289 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.462 ' N ' HG12 ' A' ' 60' ' ' ILE . 1.5 p -98.82 88.44 0.72 Allowed Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 109.017 -0.735 . . . . 0.44 109.017 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.833 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 58.4 Cg_endo -113.31 156.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 124.236 3.291 . . . . 0.44 114.096 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -75.85 78.38 2.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 102.47 -3.159 . . . . 0.44 102.47 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -111.94 120.7 42.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.656 -1.611 . . . . 0.44 112.786 -173.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.535 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -177.95 -153.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.608 -0.724 . . . . 0.44 110.629 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m 59.56 154.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.44 111.874 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -118.39 120.02 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.44 110.437 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.71 -44.12 34.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.44 110.064 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 tt0 -171.44 162.81 6.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.44 110.187 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 132.16 22.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.3 . . . . 0.44 111.092 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' HB2' HG23 ' A' ' 122' ' ' VAL . 34.5 tp -113.77 122.32 46.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.44 110.822 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -116.86 109.85 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.44 110.723 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.19 143.41 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.44 110.497 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.13 124.52 44.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.44 111.547 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -85.24 163.23 46.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.44 110.089 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -51.56 81.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.921 2.414 . . . . 0.44 112.225 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 90.54 11.61 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.377 -0.829 . . . . 0.44 111.53 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -137.29 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.772 0.32 . . . . 0.44 111.007 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.46 106.96 10.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.44 111.101 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.09 112.63 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.44 110.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.93 128.76 54.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.44 110.665 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.4 ' CD2' ' CG2' ' A' ' 6' ' ' ILE . 9.4 mt -126.34 114.64 18.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.297 . . . . 0.44 111.472 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.536 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -108.84 122.86 48.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.352 . . . . 0.44 110.107 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 12.1 m-30 -103.43 112.04 24.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 0.44 110.888 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.739 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 34.9 m95 -95.12 149.23 21.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.44 111.437 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 65' ' ' PHE . 5.3 tp -106.3 103.18 12.59 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.684 0.624 . . . . 0.44 112.684 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 11.3 t -82.63 145.45 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.44 110.326 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -102.84 -35.23 8.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.358 1.244 . . . . 0.44 114.358 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.3 165.42 26.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.53 0.604 . . . . 0.44 112.0 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 9.2 p90 -138.93 157.96 45.08 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.103 -0.499 . . . . 0.44 111.289 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.469 ' N ' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -104.78 101.29 10.9 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.239 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.67 -115.02 5.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.596 -0.812 . . . . 0.44 112.065 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.5 tt0 -135.25 122.83 15.17 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.504 0.192 . . . . 0.44 111.432 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.0 Cg_exo -74.17 128.82 12.5 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.624 2.216 . . . . 0.44 110.794 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.539 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 20.8 p-90 -123.5 -60.85 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.44 111.833 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 57.2 -117.79 10.69 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.774 -0.727 . . . . 0.44 113.261 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.54 37.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.44 111.06 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -53.82 -24.52 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.44 111.012 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.42 -15.03 39.07 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.689 -0.767 . . . . 0.44 113.315 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.06 105.38 6.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.44 111.392 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.56 143.77 2.44 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.006 2.471 . . . . 0.44 112.727 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.31 19.29 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.774 -0.727 . . . . 0.44 112.971 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.15 157.17 44.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.257 -0.275 . . . . 0.44 110.257 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.27 106.52 0.54 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.872 0.368 . . . . 0.44 110.177 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.53 139.57 52.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.44 111.027 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.8 p -59.66 114.77 2.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.352 . . . . 0.44 110.825 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.72 -24.49 65.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.095 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.73 -18.23 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.44 111.575 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.73 35.89 4.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.631 -0.795 . . . . 0.44 112.789 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.412 ' CG ' HD12 ' A' ' 123' ' ' ILE . 12.3 tp -62.8 135.52 57.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.44 110.304 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.22 133.41 54.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.554 0.575 . . . . 0.44 112.554 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.53 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.35 61.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.503 -0.772 . . . . 0.44 110.779 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.85 -49.29 13.16 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.345 -0.389 . . . . 0.44 111.742 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -30.6 69.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.441 -0.345 . . . . 0.44 111.386 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -88.67 174.43 5.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.341 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 50.5 Cg_endo -69.61 127.97 15.49 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.968 1.779 . . . . 0.44 111.649 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.71 -14.81 45.06 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.228 . . . . 0.44 113.097 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.32 -9.79 44.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.144 0.424 . . . . 0.44 112.144 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.417 ' O ' HG21 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -124.21 27.22 7.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.475 0.179 . . . . 0.44 111.432 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.467 ' HA ' ' CG2' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -58.05 -49.07 95.71 Favored Pre-proline 0 N--CA 1.463 0.195 0 N-CA-C 112.278 0.473 . . . . 0.44 112.278 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 87.0 Cg_exo -46.86 -35.92 18.91 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.437 2.091 . . . . 0.44 113.176 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG13 ' CD2' ' A' ' 84' ' ' PHE . 21.3 t -77.54 -51.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.44 111.627 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.514 ' CG2' ' CZ ' ' A' ' 115' ' ' PHE . 2.5 tp -68.07 -30.6 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.44 110.788 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.99 -26.99 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.877 0.37 . . . . 0.44 110.672 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -49.07 12.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.002 -0.545 . . . . 0.44 111.446 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -29.53 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.489 -0.323 . . . . 0.44 111.432 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -56.04 -42.49 76.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.44 110.86 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.27 -3.9 29.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.44 109.892 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.935 -0.575 . . . . 0.44 111.194 179.702 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.441 " O3'" ' CD1' ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 5121 ' ' HOH . . . . . 0.448 ' H1 ' ' HZ1' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 5122 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tpp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.807 0.337 . . . . 0.44 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 102.9 12.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.44 111.034 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.38 143.41 53.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.798 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.47 ' CD1' " O3'" ' A' ' 131' ' ' 8OG . 3.6 pp -145.71 129.32 17.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.376 . . . . 0.44 111.074 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.423 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.4 mt-30 -102.57 153.62 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.442 0.639 . . . . 0.44 112.342 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -146.48 132.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.079 -0.964 . . . . 0.44 109.671 178.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.26 124.97 43.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.087 -0.245 . . . . 0.44 110.469 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -117.86 162.55 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.406 0.622 . . . . 0.44 112.101 -179.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.08 114.29 0.63 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.126 -0.943 . . . . 0.44 111.851 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.25 107.27 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.717 -0.475 . . . . 0.44 109.717 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.2 mt -71.42 123.29 25.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.446 . . . . 0.44 111.676 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.61 119.97 25.39 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.647 -0.706 . . . . 0.44 111.829 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.552 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.8 t-20 -77.72 -172.32 2.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.172 -0.922 . . . . 0.44 111.766 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 59.6 tt0 -82.45 -2.99 54.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.511 -1.222 . . . . 0.44 112.583 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -131.95 40.61 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.868 -0.333 . . . . 0.44 111.802 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.6 9.29 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.517 -0.31 . . . . 0.44 111.506 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 16.6 pt-20 -100.86 149.67 23.62 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.949 -0.76 . . . . 0.44 108.949 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.4 mp -115.11 141.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.238 0.542 . . . . 0.44 111.718 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 26.7 t80 -80.65 99.9 8.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.399 -0.819 . . . . 0.44 110.758 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.13 162.12 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.44 110.446 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 p -82.23 112.01 18.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.448 -0.342 . . . . 0.44 110.551 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.93 114.71 29.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.44 111.37 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 25' ' ' ALA . 4.7 mtm180 56.55 20.83 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.44 111.557 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.94 -86.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.688 0.28 . . . . 0.44 111.407 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -177.67 37.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.44 111.1 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -164.9 -177.08 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.44 110.881 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.54 56.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.44 111.152 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -156.4 26.99 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.44 111.05 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.41 ' HE2' ' O6 ' ' A' ' 131' ' ' 8OG . 1.0 OUTLIER -177.35 38.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.44 110.692 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.65 -22.02 65.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.44 111.473 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.84 21.48 7.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.455 -0.338 . . . . 0.44 111.274 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.37 10.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.39 . . . . 0.44 111.423 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.5 tt -50.85 89.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.44 110.95 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE1' ' N2 ' ' A' ' 131' ' ' 8OG . 0.6 OUTLIER -119.94 -177.18 3.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.379 . . . . 0.44 111.234 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CE1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.74 160.76 41.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 0.44 111.734 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.29 168.43 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.813 3.008 . . . . 0.44 112.068 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.71 59.24 0.75 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.132 -1.032 . . . . 0.44 114.129 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.77 116.57 1.91 Allowed Glycine 0 C--N 1.315 -0.622 0 CA-C-N 114.71 -0.745 . . . . 0.44 112.097 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 119.13 4.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.517 0.727 . . . . 0.44 111.783 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -57.2 -26.06 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.515 0.674 . . . . 0.44 110.71 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.16 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.678 -1.146 . . . . 0.44 111.32 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 mtm 31.59 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.455 0.472 . . . . 0.44 112.072 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -167.66 28.98 0.17 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.806 -0.712 . . . . 0.44 112.664 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.2 mp0 -92.43 -175.0 3.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.313 . . . . 0.44 111.101 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.537 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.71 154.94 38.94 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.303 -0.408 . . . . 0.44 110.226 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.92 -24.74 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.79 2.327 . . . . 0.44 112.601 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -50.84 5.04 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.21 0.448 . . . . 0.44 112.21 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.2 -22.03 42.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.44 111.84 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.415 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.58 -48.26 77.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.44 111.112 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.02 -46.82 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.44 110.829 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.506 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 44.6 t -56.28 -35.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.921 -0.581 . . . . 0.44 110.958 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -76.96 -50.19 13.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.44 110.728 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -23.71 66.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.44 110.746 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' CD2' ' CE1' ' A' ' 64' ' ' HIS . 4.2 tp -52.88 -44.48 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.44 110.54 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -33.05 74.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.581 . . . . 0.44 109.827 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 -24.85 50.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.44 111.197 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 4.0 mm-40 -108.66 5.5 24.94 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.048 0.388 . . . . 0.44 112.048 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.459 ' CG1' HG13 ' A' ' 60' ' ' ILE . 38.8 t -134.74 -44.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.388 0.613 . . . . 0.44 109.944 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.46 4.16 1.22 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.119 -0.946 . . . . 0.44 115.038 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -117.55 -172.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.157 0.979 . . . . 0.44 110.46 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.82 87.94 10.9 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 116.079 -0.509 . . . . 0.44 109.896 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.634 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.5 Cg_endo -114.34 144.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.579 2.852 . . . . 0.44 114.24 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 30.6 mt-30 -75.02 80.04 2.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.44 105.619 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.645 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -119.78 126.05 50.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.071 -1.422 . . . . 0.44 110.947 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 177.37 173.25 0.51 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.44 111.349 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 92.12 148.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.806 -0.633 . . . . 0.44 110.855 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -97.71 137.13 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.44 111.158 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -103.07 -47.71 4.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.44 110.299 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -171.43 157.81 5.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.44 110.566 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.4 127.93 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.445 -0.343 . . . . 0.44 110.977 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.25 124.47 38.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.44 110.497 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -116.91 118.11 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.44 110.755 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -137.37 136.37 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.44 110.685 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.13 120.38 42.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.498 . . . . 0.44 111.338 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.92 162.85 65.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.54 -0.755 . . . . 0.44 110.519 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.8 Cg_endo -41.74 82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.655 2.903 . . . . 0.44 112.587 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' PHE . 2.9 t70 98.43 -27.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.182 -0.917 . . . . 0.44 111.19 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 75' ' ' PHE . 6.1 ttp180 -90.45 150.11 21.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.44 110.824 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -120.32 101.65 7.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.934 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.465 ' CG1' " O3'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -102.85 124.95 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.093 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.98 118.58 32.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.44 110.117 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.8 OUTLIER -126.14 114.99 19.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.085 0.469 . . . . 0.44 111.898 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -104.74 122.7 46.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.843 -0.617 . . . . 0.44 110.405 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.427 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.2 m-30 -95.38 109.63 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.44 110.486 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.451 ' CD2' HG21 ' A' ' 50' ' ' VAL . 28.6 m95 -96.78 148.63 22.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.109 0.481 . . . . 0.44 111.853 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.5 tm? -95.15 138.56 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.44 111.713 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 64' ' ' HIS . 21.2 t -123.74 146.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.33 -0.85 . . . . 0.44 110.031 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.08 -22.04 9.15 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.732 1.382 . . . . 0.44 114.732 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.558 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 3.9 tpp85 -162.48 160.51 26.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 119.018 0.826 . . . . 0.44 111.661 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.634 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -157.06 125.42 5.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.063 -0.517 . . . . 0.44 111.178 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.62 149.37 34.77 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 116.291 -0.413 . . . . 0.44 111.03 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.46 -127.13 44.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.44 112.598 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.0 mt-10 -129.57 141.91 43.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.431 0.157 . . . . 0.44 110.689 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.549 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.1 Cg_exo -76.6 128.59 10.35 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.766 2.311 . . . . 0.44 111.607 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.675 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.2 p-90 -125.87 -58.72 1.38 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.443 -0.503 . . . . 0.44 111.63 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 97' ' ' LYS . . . 49.86 -76.26 0.0 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.901 -0.666 . . . . 0.44 112.806 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 95' ' ' TRP . 3.8 tptt 115.91 60.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.993 0.917 . . . . 0.44 110.488 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -33.32 35.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.71 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.17 -1.68 9.75 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.57 -0.824 . . . . 0.44 113.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -140.25 94.59 8.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 117.088 0.444 . . . . 0.44 111.45 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -43.61 145.64 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.063 2.509 . . . . 0.44 112.672 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.29 177.42 19.19 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.721 -0.752 . . . . 0.44 112.992 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.36 157.19 43.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.135 -0.32 . . . . 0.44 110.135 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.13 106.45 1.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.44 110.082 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 3.3 mtp -120.01 159.57 24.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.0 -0.546 . . . . 0.44 110.611 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.0 p -78.47 114.34 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.44 110.809 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.5 -19.54 45.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.44 111.052 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.6 t -56.66 -18.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.622 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.63 50.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.541 -0.838 . . . . 0.44 112.792 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 111' ' ' ASN . 6.4 tt -62.6 150.2 41.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.198 -0.297 . . . . 0.44 110.198 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.432 ' N ' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -117.02 132.27 56.74 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.57 0.582 . . . . 0.44 112.57 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.17 61.9 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.293 -0.867 . . . . 0.44 110.448 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.6 -49.24 13.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.44 111.556 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.53 -0.305 . . . . 0.44 111.182 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.92 172.38 10.05 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.44 110.301 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.2 Cg_endo -75.76 128.15 10.69 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.327 2.018 . . . . 0.44 111.523 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.31 -14.69 16.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.777 2.318 . . . . 0.44 113.474 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.93 -11.47 18.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 0.44 112.515 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -132.67 43.71 2.95 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.776 0.322 . . . . 0.44 111.533 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.8 tt0 -76.07 -47.11 3.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.874 0.324 . . . . 0.44 111.874 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.7 Cg_exo -45.83 -39.14 18.7 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.031 . . . . 0.44 112.837 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.423 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.6 t -77.27 -48.52 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.44 110.594 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.566 HG13 ' CE2' ' A' ' 115' ' ' PHE . 5.5 mm -65.18 -29.96 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.731 -0.668 . . . . 0.44 110.982 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.928 0.394 . . . . 0.44 110.485 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -46.24 16.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.902 -0.59 . . . . 0.44 111.47 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 129' ' ' LEU . 3.2 tm? -78.17 -28.71 48.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.44 111.266 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -63.85 -42.28 97.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.44 110.416 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -64.07 -9.66 17.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.528 -0.76 . . . . 0.44 110.04 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 126' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.344 -0.389 . . . . 0.44 111.088 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.743 ' OP3' " O4'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 5133 ' ' HOH . . . . . 0.402 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 5134 ' ' HOH . . . . . 0.554 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.8 0.333 . . . . 0.44 111.201 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -106.04 103.03 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.44 110.846 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -89.04 135.45 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.44 110.928 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.1 127.05 14.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.44 111.046 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.69 154.99 18.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.216 0.532 . . . . 0.44 111.418 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.1 mm -146.2 127.43 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.417 -0.81 . . . . 0.44 110.006 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.38 124.59 42.68 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 120.995 -0.282 . . . . 0.44 110.288 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -129.8 162.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.178 0.513 . . . . 0.44 111.375 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 123.69 1.54 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.546 -0.752 . . . . 0.44 112.095 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.527 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.79 110.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.325 -0.621 . . . . 0.44 109.325 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -71.61 125.93 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 0.44 110.963 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -93.0 126.83 38.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.231 -0.441 . . . . 0.44 111.346 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.473 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 5.9 t30 -89.5 -172.02 3.43 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.899 0.857 . . . . 0.44 112.088 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.79 -2.14 34.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.006 -1.452 . . . . 0.44 112.103 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -136.01 50.2 2.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 0.44 111.283 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 p30 45.38 26.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.44 111.44 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.404 ' HG3' ' CB ' ' A' ' 13' ' ' ASN . 11.5 pt-20 -112.36 150.29 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.44 109.258 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -121.99 144.76 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.447 0.642 . . . . 0.44 112.292 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CE1' ' CA ' ' A' ' 102' ' ' GLY . 36.3 t80 -82.5 91.5 6.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.44 110.127 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.9 162.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.497 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 100' ' ' GLN . 7.1 p -113.34 111.98 22.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.44 111.067 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.5 83.58 7.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.44 110.476 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 28.4 tpt180 45.74 43.8 10.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.44 111.557 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 100' ' ' GLN . . . 66.35 12.36 8.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.533 -0.303 . . . . 0.44 111.807 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.93 20.96 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.577 0.227 . . . . 0.44 111.49 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.55 93.46 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.568 -0.287 . . . . 0.44 110.833 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' A' ' 28' ' ' HIS . . . -162.45 -80.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.44 111.258 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m80 -176.76 -73.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.44 110.866 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.92 82.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.44 110.927 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -8.93 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.44 111.594 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.55 20.3 4.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.635 -0.257 . . . . 0.44 111.406 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.32 26.06 10.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.44 111.505 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.0 tp -52.12 92.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.44 110.857 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.54 -176.43 3.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.886 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.56 168.24 10.53 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.44 111.615 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.7 Cg_endo -47.5 168.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.602 2.868 . . . . 0.44 112.249 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.42 59.22 0.76 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.502 -0.856 . . . . 0.44 112.666 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.58 112.02 1.27 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.23 -0.985 . . . . 0.44 112.384 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER 113.97 5.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.168 0.587 . . . . 0.44 112.096 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.22 -29.47 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.742 0.782 . . . . 0.44 110.148 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -41.98 -79.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.305 -1.316 . . . . 0.44 111.25 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.4 mmt 41.35 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.376 -0.375 . . . . 0.44 111.539 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.27 33.22 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.754 -0.736 . . . . 0.44 112.762 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.24 -169.19 1.93 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.673 0.273 . . . . 0.44 111.019 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.548 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.96 156.24 36.17 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.44 110.301 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.3 Cg_endo -44.01 -24.8 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.766 2.31 . . . . 0.44 112.465 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -99.59 -48.34 4.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.443 -0.344 . . . . 0.44 111.912 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.32 -7.56 59.11 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.949 0.352 . . . . 0.44 111.949 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.477 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -63.68 -56.98 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 0.44 110.864 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 54' ' ' LEU . 1.4 p -78.3 -40.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.44 111.716 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.2 t -50.67 -37.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.896 -0.322 . . . . 0.44 110.995 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.87 -52.38 8.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.4 . . . . 0.44 111.306 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 9.3 tm-20 -66.35 -19.92 65.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.364 -0.38 . . . . 0.44 110.694 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 50' ' ' VAL . 14.1 tp -60.53 -44.41 96.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.44 110.728 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -71.58 -27.87 63.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.457 . . . . 0.44 110.029 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.07 -28.1 66.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.76 -0.654 . . . . 0.44 110.482 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.458 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.22 6.99 27.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.44 112.314 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.502 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -130.7 -44.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.44 109.873 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 64.73 -35.66 0.1 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.058 0.783 . . . . 0.44 115.058 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.64 -174.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.929 0.364 . . . . 0.44 110.817 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.55 88.69 13.82 Favored Pre-proline 0 N--CA 1.445 -0.717 0 CA-C-N 116.093 -0.503 . . . . 0.44 110.993 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.667 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.9 Cg_endo -110.68 143.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 123.312 2.675 . . . . 0.44 113.474 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 31.8 mt-30 -74.6 80.06 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.558 -2.015 . . . . 0.44 105.558 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.637 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.18 133.15 54.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.145 -1.388 . . . . 0.44 111.128 -175.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -179.77 -137.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.44 110.352 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.34 159.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.963 0.505 . . . . 0.44 111.984 179.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 tt -122.26 110.68 16.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.674 . . . . 0.44 110.418 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.68 -52.07 10.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 0.44 110.373 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.3 mt-10 -171.33 131.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.815 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.88 131.91 54.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.596 -0.275 . . . . 0.44 110.526 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 1.8 pp -114.45 158.67 21.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.957 0.408 . . . . 0.44 111.261 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -140.1 109.81 6.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.002 -0.545 . . . . 0.44 110.242 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -136.03 153.19 51.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.823 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -120.95 127.11 51.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.141 0.496 . . . . 0.44 111.353 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -91.68 163.89 26.3 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.44 110.417 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -38.27 81.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.602 2.868 . . . . 0.44 112.886 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.59 21.24 3.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.44 111.061 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.31 93.83 2.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.44 110.239 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -74.91 99.97 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.44 111.152 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tt -102.55 111.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.259 -0.428 . . . . 0.44 110.734 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.79 133.22 44.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.44 110.468 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 114.48 18.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.44 111.468 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.506 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.6 OUTLIER -110.82 125.55 53.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.872 -0.418 . . . . 0.44 109.872 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.4 m-85 -111.02 118.2 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.44 111.392 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.416 ' CE2' HG12 ' A' ' 50' ' ' VAL . 65.3 m95 -96.47 148.87 22.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.44 111.025 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.512 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.3 tm? -99.83 103.05 14.64 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.327 0.584 . . . . 0.44 111.34 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.637 HG11 ' HA ' ' A' ' 64' ' ' HIS . 11.2 t -80.65 145.87 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.266 -0.879 . . . . 0.44 111.665 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -113.29 -25.39 8.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.675 0.991 . . . . 0.44 113.675 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 6.9 ttm180 -162.42 163.23 27.82 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.364 -0.534 . . . . 0.44 111.586 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.667 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -157.21 123.8 4.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.44 111.527 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.89 139.99 47.22 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.013 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.09 -121.7 26.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.763 -0.732 . . . . 0.44 112.534 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 60' ' ' ILE . 24.7 mt-10 -132.05 142.64 45.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.431 0.158 . . . . 0.44 110.775 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.444 ' HA ' ' CG1' ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.15 128.8 11.66 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.719 2.279 . . . . 0.44 111.183 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.564 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.6 p-90 -126.83 -61.03 1.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.381 0.512 . . . . 0.44 112.381 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.21 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.919 -0.658 . . . . 0.44 112.936 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt 177.99 35.15 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.703 0.287 . . . . 0.44 111.279 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -57.19 -37.79 72.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.88 0.371 . . . . 0.44 110.587 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.47 71.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.85 -0.691 . . . . 0.44 113.153 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 2.6 pm0 -140.16 93.29 9.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.44 111.28 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.61 138.82 5.29 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.056 2.504 . . . . 0.44 112.85 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -134.31 177.29 19.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.827 -0.702 . . . . 0.44 112.98 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -141.28 157.13 45.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.248 -0.278 . . . . 0.44 110.248 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.483 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -79.76 106.15 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.735 -0.386 . . . . 0.44 110.472 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.0 ptp -120.55 163.07 18.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.861 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.9 p -77.58 114.88 16.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.487 -0.324 . . . . 0.44 110.695 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.21 -18.91 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.44 111.176 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -55.26 -20.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.367 -0.379 . . . . 0.44 111.464 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.18 35.05 4.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.68 -0.771 . . . . 0.44 112.812 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.304 -0.258 . . . . 0.44 110.304 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.26 131.73 53.77 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.493 0.553 . . . . 0.44 112.493 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -15.51 61.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.613 -0.721 . . . . 0.44 110.414 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -49.05 13.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.232 -0.44 . . . . 0.44 111.283 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.9 -40.08 87.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.332 -0.395 . . . . 0.44 111.599 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.63 174.16 6.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.404 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 61.5 Cg_endo -73.86 127.91 11.94 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.061 1.84 . . . . 0.44 111.509 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.97 -14.86 29.98 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.644 2.229 . . . . 0.44 113.122 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.98 -9.95 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.291 0.478 . . . . 0.44 112.291 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.431 ' OD1' ' CE1' ' A' ' 84' ' ' PHE . 0.4 OUTLIER -129.73 38.21 3.86 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.774 0.287 . . . . 0.44 111.774 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.9 -47.36 15.35 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.822 -0.172 . . . . 0.44 111.068 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.6 Cg_exo -56.0 -35.28 94.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.336 2.024 . . . . 0.44 112.083 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 71' ' ' LEU . 3.8 t -77.46 -51.38 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.44 111.082 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.48 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -69.79 -29.92 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.44 110.806 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.89 -27.53 43.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.387 -0.37 . . . . 0.44 110.905 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -53.34 12.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.44 111.184 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 tp -78.46 -29.54 46.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.133 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -57.77 -42.6 84.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.014 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -71.49 -5.55 33.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.666 . . . . 0.44 109.937 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.003 -0.544 . . . . 0.44 111.253 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.618 ' P ' " H3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5145 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5146 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.838 0.352 . . . . 0.44 111.16 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.32 125.71 47.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.44 110.712 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.33 38.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.44 110.949 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 pp -146.05 123.23 11.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.842 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -102.94 150.27 23.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.213 0.53 . . . . 0.44 111.258 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 81' ' ' THR . 8.5 mt -136.56 130.49 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.546 -0.752 . . . . 0.44 110.205 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.97 124.57 42.29 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.82 -0.437 . . . . 0.44 109.82 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -132.01 162.53 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.212 0.53 . . . . 0.44 111.658 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.44 121.51 1.22 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.362 -0.836 . . . . 0.44 111.915 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.83 109.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.32 -0.622 . . . . 0.44 109.32 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -71.07 125.48 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 120.976 0.417 . . . . 0.44 111.416 -178.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -92.21 133.13 36.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.89 -0.595 . . . . 0.44 110.956 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.602 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 29.6 p-10 -96.45 -172.13 2.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.86 0.838 . . . . 0.44 112.433 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.37 -0.88 16.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.171 -1.377 . . . . 0.44 113.071 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 20.6 t-20 -129.39 40.68 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.44 111.844 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 52.22 21.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.035 0.383 . . . . 0.44 112.035 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -115.72 160.01 20.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.639 -0.504 . . . . 0.44 109.639 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -122.75 149.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.145 0.498 . . . . 0.44 111.922 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.49 101.65 14.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.549 -0.75 . . . . 0.44 110.041 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.457 ' CG2' ' CD1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -108.08 137.67 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.302 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 p -93.07 142.76 26.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.825 0.345 . . . . 0.44 110.943 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 2.9 ttt180 -106.82 83.65 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.551 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? 41.06 60.25 2.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.058 -0.519 . . . . 0.44 111.294 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 64.34 37.2 8.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.44 111.035 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.31 65.81 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.44 111.049 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 43.16 81.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.999 -0.546 . . . . 0.44 111.51 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.45 -33.4 6.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.44 111.146 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -161.07 -47.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.889 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mtt -118.62 85.86 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.44 110.898 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.53 -9.05 52.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.44 111.73 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.61 11.31 13.1 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.592 0.219 . . . . 0.44 111.592 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -114.52 26.24 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.44 111.535 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 4.8 tt -46.08 110.36 0.26 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.96 -0.563 . . . . 0.44 111.009 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -142.15 175.28 9.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.026 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.53 168.92 9.09 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.639 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.6 Cg_endo -46.66 169.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.693 2.929 . . . . 0.44 112.146 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.29 59.6 0.72 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.342 -0.933 . . . . 0.44 113.155 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.52 122.53 3.11 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 114.113 -1.044 . . . . 0.44 111.697 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.28 -7.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.28 0.632 . . . . 0.44 111.213 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -40.73 -57.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.389 0.614 . . . . 0.44 111.285 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -21.72 -80.43 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.337 -1.301 . . . . 0.44 112.252 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.5 mmt 41.83 -94.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.531 -0.304 . . . . 0.44 111.588 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.77 19.49 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.6 -0.809 . . . . 0.44 113.424 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -82.97 -165.71 1.14 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.529 0.205 . . . . 0.44 110.81 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.544 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.51 156.57 36.19 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.069 -0.345 . . . . 0.44 110.069 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.5 -24.64 0.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.772 2.315 . . . . 0.44 112.362 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -89.98 -59.97 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.042 0.386 . . . . 0.44 112.042 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -80.89 -4.56 55.29 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.258 0.466 . . . . 0.44 112.258 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.512 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -63.68 -57.08 11.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.593 0.235 . . . . 0.44 111.089 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.67 -41.77 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.631 -0.259 . . . . 0.44 111.354 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -50.36 -35.36 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.596 -0.274 . . . . 0.44 111.342 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -52.15 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.504 -0.316 . . . . 0.44 111.49 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.1 -20.09 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.44 111.032 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 13.9 tp -58.18 -41.57 84.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.44 110.475 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -26.96 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.44 110.421 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.1 tm-20 -72.12 -25.27 61.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.44 111.4 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -108.59 7.02 26.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.268 0.47 . . . . 0.44 112.268 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.554 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 10.6 t -133.28 -43.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.191 0.52 . . . . 0.44 109.974 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 52.88 8.63 0.63 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.442 -0.799 . . . . 0.44 115.028 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.489 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.6 -174.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.026 0.913 . . . . 0.44 110.149 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 p -114.58 87.34 14.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 116.221 -0.445 . . . . 0.44 109.839 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.649 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.0 Cg_endo -115.5 145.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 123.664 2.909 . . . . 0.44 114.066 -177.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.385 -2.08 . . . . 0.44 105.385 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.613 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.64 133.33 54.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.409 -1.268 . . . . 0.44 111.329 -175.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.04 -139.23 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.44 110.02 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 56.29 153.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.288 0.566 . . . . 0.44 112.102 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.4 tt -116.78 111.21 19.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.607 -0.724 . . . . 0.44 110.386 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CD1' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.58 -54.14 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.44 110.195 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.0 mt-10 -171.28 131.7 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.574 . . . . 0.44 110.438 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 126.6 39.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.692 0.282 . . . . 0.44 110.807 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -113.84 136.67 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 0.44 110.901 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -121.67 109.94 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.706 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -131.05 152.2 50.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.528 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -121.13 139.58 53.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.129 0.49 . . . . 0.44 111.381 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -103.23 162.67 19.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.557 -0.747 . . . . 0.44 110.133 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.1 Cg_endo -49.76 81.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.155 2.57 . . . . 0.44 112.344 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t70 89.28 10.2 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.45 -0.795 . . . . 0.44 111.595 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -137.34 93.94 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.3 . . . . 0.44 110.89 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -80.18 93.86 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.97 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.4 tt -96.76 111.87 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.327 -0.397 . . . . 0.44 111.241 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -106.82 132.54 52.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.44 110.512 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.405 HD13 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.39 114.58 18.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 0.44 111.422 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.454 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 2.1 m0 -109.34 125.53 52.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.259 -0.428 . . . . 0.44 110.226 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.8 m-85 -111.41 114.56 27.78 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.919 0.39 . . . . 0.44 110.932 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.447 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 61.3 m95 -94.73 148.83 21.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.878 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 14.6 tp -98.41 102.89 14.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.339 0.59 . . . . 0.44 111.755 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 64' ' ' HIS . 14.0 t -80.69 145.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.249 -0.887 . . . . 0.44 111.205 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -112.57 -26.96 8.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.101 1.149 . . . . 0.44 114.101 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 3.9 mtt-85 -161.83 164.08 28.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.673 0.67 . . . . 0.44 111.428 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.649 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -157.67 123.59 4.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.44 111.551 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 152.95 32.51 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.21 -0.45 . . . . 0.44 110.899 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.1 -125.05 38.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 0.44 112.36 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -135.0 148.1 65.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.6 0.238 . . . . 0.44 110.956 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.48 128.8 10.58 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.933 2.422 . . . . 0.44 111.163 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 66.8 p-90 -138.45 -58.56 0.63 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.075 -0.65 . . . . 0.44 112.749 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 41.38 -93.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.123 -0.56 . . . . 0.44 113.295 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER 175.12 32.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.28 . . . . 0.44 111.144 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -68.05 -33.37 74.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.947 0.403 . . . . 0.44 110.256 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.97 -0.633 . . . . 0.44 113.05 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -140.35 91.65 9.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 0.44 111.64 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.73 127.58 8.14 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.077 2.518 . . . . 0.44 112.602 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.3 177.05 19.47 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.574 -0.822 . . . . 0.44 112.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.7 155.28 39.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.432 -0.21 . . . . 0.44 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.14 107.14 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.44 110.459 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.431 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -119.55 163.06 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.771 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.07 122.66 33.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.44 111.161 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.411 ' CD1' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -79.97 -18.97 49.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.451 . . . . 0.44 111.121 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -53.0 -21.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.862 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.69 45.42 1.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.405 -0.902 . . . . 0.44 113.038 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.409 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . 11.6 tp -62.94 150.28 42.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.722 0.261 . . . . 0.44 110.378 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -117.46 131.8 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.455 0.539 . . . . 0.44 112.455 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.605 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.2 -15.29 61.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.452 -0.795 . . . . 0.44 110.648 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -48.93 14.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.296 -0.411 . . . . 0.44 111.367 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -39.02 87.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.45 -0.341 . . . . 0.44 110.945 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.605 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -81.11 171.43 12.26 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.324 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 57.2 Cg_endo -71.15 127.57 13.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.18 1.92 . . . . 0.44 111.875 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.64 -14.86 45.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.581 2.187 . . . . 0.44 112.84 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.84 -9.5 57.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.44 111.981 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -124.01 34.33 5.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.44 111.714 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.57 -39.01 5.57 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.451 -0.34 . . . . 0.44 111.876 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.7 Cg_exo -53.07 -40.74 75.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.064 1.843 . . . . 0.44 112.699 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.47 -51.23 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.317 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.465 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -67.3 -30.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.44 111.303 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -57.28 -28.46 63.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.44 110.691 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -51.86 13.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.44 111.365 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.428 HD21 ' CD1' ' A' ' 68' ' ' PHE . 2.1 tp -78.12 -39.51 41.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.44 111.483 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -53.54 -42.56 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.44 111.282 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -72.06 -3.64 24.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.921 -0.582 . . . . 0.44 110.133 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-N 116.166 -0.47 . . . . 0.44 111.011 179.831 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.613 " C3'" ' OP1' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5157 ' ' HOH . . . . . 0.517 ' H2 ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 5158 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.844 0.354 . . . . 0.44 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -109.95 102.88 11.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.062 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.08 125.56 51.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.756 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.24 139.05 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.44 111.065 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.7 mt-30 -102.46 155.41 18.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.44 111.805 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.2 mt -146.26 126.67 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.43 -0.805 . . . . 0.44 110.32 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.49 124.16 41.69 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.881 -0.328 . . . . 0.44 110.185 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -118.65 162.5 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.246 0.546 . . . . 0.44 111.875 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.34 117.19 1.19 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.264 -0.88 . . . . 0.44 111.934 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.476 HG22 HG22 ' A' ' 18' ' ' ILE . 4.7 mp -70.58 100.51 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.481 -0.563 . . . . 0.44 109.481 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.659 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -71.21 125.9 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 112.537 0.569 . . . . 0.44 112.537 -177.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -98.0 119.96 37.55 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.251 -0.886 . . . . 0.44 111.085 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.582 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.54 -172.93 0.84 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.019 0.438 . . . . 0.44 110.567 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 21.9 tt0 -81.28 12.83 3.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.879 0.696 . . . . 0.44 112.879 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -133.92 34.9 3.34 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.439 0.533 . . . . 0.44 112.439 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 5.32 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.878 0.371 . . . . 0.44 111.503 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.488 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -100.95 161.76 13.37 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.321 -0.992 . . . . 0.44 108.321 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' CG1' ' HG2' ' A' ' 12' ' ' ARG . 6.7 mt -117.92 141.29 37.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.255 0.55 . . . . 0.44 111.665 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.488 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -93.02 92.77 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.335 -0.848 . . . . 0.44 110.254 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.513 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -107.97 162.07 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.206 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 p -87.36 119.11 27.29 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.189 -0.3 . . . . 0.44 110.189 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.429 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.68 119.81 16.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.44 111.21 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 46.39 28.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.44 110.99 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.45 29.43 3.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.476 . . . . 0.44 111.278 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.73 -22.98 12.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.22 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 64.24 81.11 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.309 -0.405 . . . . 0.44 110.821 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 60.87 63.07 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.44 111.07 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.4 -76.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.907 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.93 79.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.798 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.16 -25.67 23.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.44 111.48 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -91.24 14.06 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.523 -0.308 . . . . 0.44 111.542 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' HD3' ' N2 ' ' A' ' 131' ' ' 8OG . 1.4 mtpp -114.17 26.45 10.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.44 111.359 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' A' ' 22' ' ' ARG . 5.3 tt -40.34 117.07 0.75 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.682 -0.69 . . . . 0.44 111.222 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.3 -172.42 3.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.919 0.39 . . . . 0.44 111.504 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.513 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.37 163.08 28.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.44 111.879 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.2 Cg_endo -47.48 169.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.887 3.058 . . . . 0.44 112.314 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.05 59.32 0.73 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.449 -0.882 . . . . 0.44 113.349 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -132.13 109.04 0.82 Allowed Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.155 -1.022 . . . . 0.44 111.448 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.673 ' HD2' ' H2 ' ' A' 5170 ' ' HOH . 0.0 OUTLIER 123.95 2.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.452 0.701 . . . . 0.44 111.176 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.599 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.43 -27.95 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.633 0.73 . . . . 0.44 110.571 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.571 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.551 -1.204 . . . . 0.44 111.333 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.3 mmt 32.36 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.458 0.474 . . . . 0.44 111.883 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.21 32.99 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.912 -0.661 . . . . 0.44 112.398 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.72 -177.01 5.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.857 0.361 . . . . 0.44 111.263 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.523 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.03 154.89 37.1 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.44 110.43 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.96 -24.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.867 2.378 . . . . 0.44 112.596 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -102.43 -42.21 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.518 -0.31 . . . . 0.44 111.595 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -80.22 -10.35 59.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.811 0.3 . . . . 0.44 111.811 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.6 -52.24 65.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.749 0.309 . . . . 0.44 111.201 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.501 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.3 m -78.09 -46.6 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.44 110.972 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.501 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 41.7 t -52.61 -37.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.44 111.191 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -78.5 -52.17 8.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.423 . . . . 0.44 111.677 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.28 -25.98 67.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.44 111.129 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.491 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 2.0 mp -54.05 -44.58 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.44 110.597 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -30.78 69.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.351 -0.611 . . . . 0.44 109.351 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 -31.07 52.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.44 111.393 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.567 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.76 7.0 26.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.144 0.794 . . . . 0.44 113.144 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.485 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 4.7 t -133.32 -44.64 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.44 110.681 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.553 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 51.65 18.04 3.64 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.652 0.621 . . . . 0.44 114.652 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -127.63 -170.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.871 0.836 . . . . 0.44 110.839 179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -115.28 87.09 15.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.44 109.91 179.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 10.6 Cg_endo -117.35 145.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.511 2.807 . . . . 0.44 115.177 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 89' ' ' ARG . 93.7 mt-30 -74.95 79.22 2.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.451 -2.426 . . . . 0.44 104.451 174.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.78 123.3 42.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.436 -1.256 . . . . 0.44 110.888 -175.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -176.68 -138.78 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.44 111.011 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m 53.19 169.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.245 0.545 . . . . 0.44 112.153 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.9 tt -128.87 109.56 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.44 110.374 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.59 -46.87 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.44 109.971 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 tt0 -171.67 155.56 4.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.754 -0.657 . . . . 0.44 110.338 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.83 132.1 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.578 -0.283 . . . . 0.44 110.599 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.18 158.8 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.44 110.88 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -140.04 128.31 22.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.44 110.947 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.42 ' CE1' HG12 ' A' ' 80' ' ' ILE . 6.5 p90 -141.0 147.62 38.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.269 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -121.08 132.26 54.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.256 0.551 . . . . 0.44 111.553 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -82.11 163.79 51.33 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.337 -0.847 . . . . 0.44 110.107 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.4 Cg_endo -49.64 82.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.185 2.59 . . . . 0.44 112.459 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 94.37 16.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.371 -0.831 . . . . 0.44 111.524 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt180 -137.45 150.16 47.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.462 -0.336 . . . . 0.44 110.741 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -121.57 116.31 24.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.44 110.942 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.42 HG12 ' CE1' ' A' ' 73' ' ' TYR . 1.8 tt -122.34 121.22 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.323 -0.398 . . . . 0.44 110.788 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.07 134.62 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.845 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 mt -125.64 114.26 18.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.44 111.368 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -109.21 122.49 47.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.44 110.37 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -104.25 121.17 42.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.44 110.972 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.6 m95 -108.15 148.89 29.25 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.07 -0.514 . . . . 0.44 111.544 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 46.3 tp -93.34 103.12 15.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.505 0.669 . . . . 0.44 111.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.659 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 17.4 t -88.71 145.59 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.145 -0.934 . . . . 0.44 111.654 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -102.2 -55.4 2.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.124 1.527 . . . . 0.44 115.124 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -163.4 165.85 23.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.931 0.787 . . . . 0.44 112.854 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 48.7 p90 -128.53 140.1 51.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.787 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.45 ' HB3' HG21 ' A' ' 61' ' ' THR . 0.9 OUTLIER -93.07 85.48 5.1 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 120.903 0.382 . . . . 0.44 110.411 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.57 -119.19 2.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.918 -0.658 . . . . 0.44 112.289 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 10.0 tt0 -135.12 131.12 19.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.434 0.159 . . . . 0.44 110.74 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.493 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 5.7 Cg_exo -77.07 128.87 10.15 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.895 2.397 . . . . 0.44 111.606 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.553 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 50.9 p-90 -142.19 -58.47 0.46 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.475 -0.49 . . . . 0.44 111.936 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 42.81 -96.13 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.686 -0.688 . . . . 0.44 113.017 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.08 39.34 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.761 0.315 . . . . 0.44 110.737 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.57 -47.64 83.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.343 -0.389 . . . . 0.44 111.03 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.74 -62.67 0.55 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.308 -0.948 . . . . 0.44 113.253 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -109.93 93.89 16.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 0.44 111.828 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.82 125.92 5.49 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.017 2.478 . . . . 0.44 112.643 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.72 177.47 17.48 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.922 -0.656 . . . . 0.44 113.004 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -120.54 157.25 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.6 0.238 . . . . 0.44 110.631 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -61.04 106.9 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.44 110.399 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.1 ptp -120.2 163.19 18.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.44 111.241 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -83.94 131.93 34.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.336 . . . . 0.44 110.952 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.437 ' HG ' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.15 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.2 -13.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.44 111.936 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.71 38.95 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.474 -0.869 . . . . 0.44 113.109 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.403 ' HB2' HD11 ' A' ' 107' ' ' LEU . 9.0 tp -70.55 140.54 51.8 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.39 -0.226 . . . . 0.44 110.39 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.16 134.8 54.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.351 0.5 . . . . 0.44 112.351 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.4 61.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.714 -0.675 . . . . 0.44 110.883 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -49.12 13.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.384 -0.371 . . . . 0.44 111.559 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -38.79 83.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.46 -0.336 . . . . 0.44 111.442 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.568 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.48 174.08 6.62 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.402 -0.363 . . . . 0.44 110.408 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 65.2 Cg_endo -74.15 127.85 11.67 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.258 1.972 . . . . 0.44 111.515 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.0 -14.82 29.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.658 2.239 . . . . 0.44 113.181 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.09 -9.79 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.398 0.518 . . . . 0.44 112.398 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.1 38.23 3.81 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.713 0.292 . . . . 0.44 111.692 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.6 tt0 -71.17 -45.09 14.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.723 -0.217 . . . . 0.44 111.456 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -54.88 -37.36 92.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.119 1.879 . . . . 0.44 112.271 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.45 -51.45 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.564 . . . . 0.44 111.143 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.515 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -68.59 -29.84 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.824 -0.626 . . . . 0.44 110.923 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -28.69 53.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.975 0.417 . . . . 0.44 110.672 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.74 -49.19 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.579 . . . . 0.44 111.065 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 68' ' ' PHE . 9.7 tp -78.11 -27.51 48.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.44 111.272 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -58.86 -42.6 89.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.104 0.478 . . . . 0.44 110.914 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -74.51 -2.96 28.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.666 -0.697 . . . . 0.44 109.902 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-N 116.065 -0.516 . . . . 0.44 111.162 179.626 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.505 ' N2 ' ' HD3' ' A' ' 32' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 5169 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 5170 ' ' HOH . . . . . 0.673 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mtm . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.823 0.344 . . . . 0.44 111.233 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 135.77 35.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 0.44 110.889 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.02 136.33 33.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.44 110.776 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.444 ' CD2' " O3'" ' A' ' 131' ' ' 8OG . 1.2 pp -138.18 138.56 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.44 110.822 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 27.7 mt-30 -102.84 155.22 18.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.207 0.527 . . . . 0.44 111.312 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' THR . 39.7 mm -146.5 139.29 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.621 -0.718 . . . . 0.44 110.641 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.66 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.58 150.28 46.11 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.44 109.639 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG22 ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -145.45 148.86 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.906 0.384 . . . . 0.44 110.935 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.57 107.37 0.33 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.435 -0.888 . . . . 0.44 112.886 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.636 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.41 103.87 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.081 -0.711 . . . . 0.44 109.081 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.567 HG12 ' CE3' ' A' ' 90' ' ' TRP . 1.2 tt -70.62 111.61 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.44 111.755 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -87.52 138.08 31.78 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.696 -0.684 . . . . 0.44 112.376 -179.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.743 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.3 p30 -90.52 -173.3 3.72 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.981 -1.008 . . . . 0.44 111.336 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 13.5 tp10 -78.24 0.91 23.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.119 -0.946 . . . . 0.44 112.326 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -122.38 40.33 3.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.286 0.476 . . . . 0.44 112.286 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.97 21.35 2.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 0.44 111.576 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 22.1 mt-10 -113.85 161.94 16.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.47 -0.567 . . . . 0.44 109.47 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -119.25 135.79 58.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.92 0.391 . . . . 0.44 111.729 -178.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.475 ' CD2' ' CG2' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -88.79 102.44 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.44 110.367 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.54 162.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.44 110.144 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 6.6 p -86.35 111.86 20.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.757 0.313 . . . . 0.44 110.608 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 7.7 ptt180 -127.4 131.64 50.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.001 0.429 . . . . 0.44 110.656 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.06 -107.5 0.2 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.166 -0.47 . . . . 0.44 110.817 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 169.75 -76.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.44 110.978 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -167.24 -51.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.014 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -93.93 -48.67 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.832 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -169.05 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.052 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 m80 51.79 -176.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.369 . . . . 0.44 111.09 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.79 89.47 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.44 110.899 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.97 -8.97 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.44 111.569 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 3.01 53.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.626 -0.261 . . . . 0.44 111.416 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.36 10.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.44 111.398 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' PHE . 5.2 tt -45.23 93.55 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.832 -0.622 . . . . 0.44 111.119 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.33 -179.97 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.16 0.505 . . . . 0.44 111.566 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.473 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -119.68 168.17 10.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 0.44 111.174 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.1 Cg_endo -46.95 168.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.276 2.65 . . . . 0.44 111.75 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.68 59.02 0.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.042 -1.075 . . . . 0.44 113.243 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -146.13 101.57 0.24 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.439 -0.88 . . . . 0.44 112.25 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.712 ' HB2' ' H1 ' ' A' 5182 ' ' HOH . 0.1 OUTLIER 128.01 -9.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.374 0.67 . . . . 0.44 110.723 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.518 HG12 ' N ' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -43.31 -74.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.44 111.458 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' N ' HG12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -8.22 -82.16 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.818 -1.083 . . . . 0.44 112.565 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 44.35 -93.36 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.44 111.505 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.58 17.21 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.526 -0.845 . . . . 0.44 113.485 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.89 -163.45 0.59 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.596 0.236 . . . . 0.44 110.807 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.542 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.73 155.82 38.3 Favored Pre-proline 0 N--CA 1.456 -0.162 0 N-CA-C 110.159 -0.312 . . . . 0.44 110.159 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.82 -24.7 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.685 2.256 . . . . 0.44 112.442 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.33 -54.98 3.33 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.964 0.357 . . . . 0.44 111.964 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.49 -4.98 55.89 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.983 0.364 . . . . 0.44 111.983 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.4 -57.04 9.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.623 0.249 . . . . 0.44 110.974 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -78.37 -39.91 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.535 -0.302 . . . . 0.44 111.362 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.7 t -50.68 -35.81 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.44 110.854 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -49.47 13.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.44 110.422 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -64.41 -21.09 66.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 0.44 110.482 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.467 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.6 tp -57.02 -44.67 83.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 0.44 110.956 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -30.48 67.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.55 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.2 -26.27 64.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.442 . . . . 0.44 110.565 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.31 7.25 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.44 112.114 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.449 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -133.45 -44.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.161 0.505 . . . . 0.44 110.013 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.4 -40.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.44 114.519 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.497 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -86.59 -173.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.44 110.651 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -110.65 88.62 8.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.835 -0.62 . . . . 0.44 109.826 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 2.9 Cg_endo -111.12 152.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.706 0 C-N-CA 122.966 2.444 . . . . 0.44 114.555 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.469 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 42.8 mt-30 -74.66 80.06 2.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.839 -1.911 . . . . 0.44 105.839 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.576 ' HA ' HG13 ' A' ' 87' ' ' VAL . 1.2 t-160 -127.32 127.3 44.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.678 -1.146 . . . . 0.44 111.319 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.13 -136.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.941 -0.572 . . . . 0.44 110.634 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 54.03 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.196 0.522 . . . . 0.44 112.358 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 7.2 tt -125.14 110.34 13.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.44 110.74 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.98 -39.76 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.44 110.603 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -171.52 164.34 6.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.778 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 112.14 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.448 -0.342 . . . . 0.44 110.839 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.426 ' CD2' ' CD1' ' A' ' 82' ' ' LEU . 15.3 tp -99.53 128.0 45.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.35 . . . . 0.44 110.682 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -131.21 110.56 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.44 110.895 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.431 ' CZ ' HG22 ' A' ' 80' ' ' ILE . 2.5 p90 -139.41 150.23 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.44 110.415 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.09 124.79 45.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.232 0.539 . . . . 0.44 111.613 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.65 163.3 69.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.44 110.233 179.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.1 Cg_endo -50.82 83.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.966 2.444 . . . . 0.44 112.144 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.3 m-20 94.29 16.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.26 -0.882 . . . . 0.44 111.342 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 148.7 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.454 -0.339 . . . . 0.44 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -120.76 97.35 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.44 110.97 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.431 HG22 ' CZ ' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -102.97 111.89 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.44 110.743 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' ILE . 54.0 m -114.96 126.8 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.44 110.955 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -126.46 115.5 19.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.7 0.286 . . . . 0.44 111.228 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -94.6 122.87 37.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.362 -0.381 . . . . 0.44 111.186 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.0 m-85 -99.68 109.78 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.44 110.777 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 61.5 m95 -95.72 148.53 22.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.433 -0.348 . . . . 0.44 110.933 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.6 tp -102.1 102.92 13.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.298 0.57 . . . . 0.44 112.034 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 12.8 t -80.52 145.56 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.354 -0.839 . . . . 0.44 110.649 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.83 -43.11 3.66 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.792 1.404 . . . . 0.44 114.792 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.05 166.25 23.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.786 0.721 . . . . 0.44 112.377 -178.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.743 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 28.0 p90 -137.56 148.78 46.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.507 . . . . 0.44 111.745 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.01 96.3 8.06 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.159 -0.473 . . . . 0.44 111.047 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 -138.49 14.84 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.62 -0.8 . . . . 0.44 112.779 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.4 tt0 -106.07 122.63 41.68 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.615 -0.143 . . . . 0.44 110.615 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.529 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 2.9 Cg_exo -76.3 129.02 10.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.898 2.399 . . . . 0.44 112.192 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.543 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 3.6 p-90 -126.2 -77.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.15 -0.62 . . . . 0.44 111.741 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.683 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 67.33 -66.96 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.479 -0.867 . . . . 0.44 112.856 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 96.28 69.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.039 0.535 . . . . 0.44 110.811 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.699 ' HA ' ' H2 ' ' A' 5182 ' ' HOH . 1.1 pp20? -83.36 -35.7 24.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.527 . . . . 0.44 110.772 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.86 -52.13 0.16 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.586 -0.816 . . . . 0.44 113.001 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -140.05 117.97 8.41 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.48 . . . . 0.44 111.621 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -43.72 144.87 2.09 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.923 2.415 . . . . 0.44 112.654 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.3 19.23 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.798 -0.715 . . . . 0.44 112.637 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -125.89 157.33 37.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.532 0.206 . . . . 0.44 110.603 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.476 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.0 m0 -60.89 105.81 0.51 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.998 -0.371 . . . . 0.44 109.998 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.3 ptm -120.76 154.21 35.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.44 111.542 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.36 124.64 25.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.44 111.027 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -80.06 -18.89 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.44 111.547 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.0 p -54.14 -18.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.44 111.94 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.48 41.47 1.72 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.401 -0.904 . . . . 0.44 113.179 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.408 HD21 ' N ' ' A' ' 111' ' ' ASN . 3.1 tt -62.88 148.05 48.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.98 -0.378 . . . . 0.44 109.98 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -123.22 131.22 53.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.814 0.672 . . . . 0.44 112.814 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.541 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -15.12 61.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.264 -0.88 . . . . 0.44 110.493 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.5 -49.28 13.67 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.283 -0.417 . . . . 0.44 111.579 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -38.34 85.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.737 0.303 . . . . 0.44 111.092 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.97 173.6 7.46 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.39 -0.368 . . . . 0.44 110.293 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.9 Cg_endo -74.3 128.02 11.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.24 1.96 . . . . 0.44 111.678 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.97 -14.84 35.21 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.682 2.255 . . . . 0.44 113.175 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.78 -9.8 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.168 0.432 . . . . 0.44 112.168 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.76 37.72 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.44 111.332 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.08 -43.5 3.65 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 112.438 0.533 . . . . 0.44 112.438 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.8 Cg_exo -45.2 -40.84 16.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.21 1.94 . . . . 0.44 113.166 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.51 -51.27 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.44 111.209 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.5 mm -65.83 -33.69 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.625 . . . . 0.44 111.467 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.92 -28.43 50.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.883 0.373 . . . . 0.44 110.845 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.26 -53.15 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.44 111.682 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 tp -78.52 -36.88 44.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.559 -0.292 . . . . 0.44 111.75 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -53.76 -42.71 68.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.9 0.381 . . . . 0.44 111.126 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -7.65 25.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.44 109.808 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.407 HD11 ' N ' ' A' ' 129' ' ' LEU . 8.2 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-N 115.982 -0.554 . . . . 0.44 111.042 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.444 " O3'" ' CD2' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5181 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5182 ' ' HOH . . . . . 0.712 ' H1 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttm . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.806 0.336 . . . . 0.44 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -110.05 102.98 11.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.44 111.027 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 133.3 38.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.44 110.736 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.417 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.0 pp -146.04 139.54 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.44 111.14 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 36.9 mt-30 -102.85 154.08 19.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.234 0.54 . . . . 0.44 111.881 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 40.0 mm -146.54 118.8 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.408 -0.815 . . . . 0.44 109.909 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -125.21 150.28 47.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.912 -0.315 . . . . 0.44 110.388 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -145.22 162.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.128 0.49 . . . . 0.44 111.472 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.79 114.81 1.18 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.628 -0.715 . . . . 0.44 112.203 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.581 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.5 mt -70.87 98.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.926 -0.768 . . . . 0.44 108.926 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.627 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.95 122.46 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.406 0.622 . . . . 0.44 112.276 -177.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.715 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -86.27 127.36 34.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.097 -0.956 . . . . 0.44 110.708 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 2.8 t-20 -73.24 -171.92 1.03 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 122.092 0.949 . . . . 0.44 112.692 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.69 -13.63 15.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.627 -1.624 . . . . 0.44 113.271 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -132.34 -82.93 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.44 111.799 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -149.82 14.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.44 111.71 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' HG3' ' CB ' ' A' ' 13' ' ' ASN . 1.8 pt-20 -100.72 160.39 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.014 -0.736 . . . . 0.44 109.014 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.459 ' CG2' ' O ' ' A' ' 11' ' ' ILE . 6.1 mt -135.97 138.6 47.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.216 0.531 . . . . 0.44 111.911 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' N ' HG22 ' A' ' 18' ' ' ILE . 44.9 t80 -76.88 94.12 3.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.379 -0.828 . . . . 0.44 110.127 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.495 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.21 139.16 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.44 110.419 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.403 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 6.3 p -70.95 123.8 22.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.44 110.756 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.1 133.9 51.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.44 110.734 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 1.4 ptt-85 40.45 -104.64 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.087 -0.506 . . . . 0.44 111.315 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 23' ' ' ARG . . . 166.5 -24.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.26 . . . . 0.44 111.223 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 24' ' ' ALA . . . 79.93 35.17 0.15 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.901 0.381 . . . . 0.44 110.833 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -177.18 37.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.44 110.7 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.05 -167.19 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.083 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.71 -20.2 12.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.44 111.33 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.2 mtt -64.25 79.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.464 -0.334 . . . . 0.44 111.183 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.11 -9.1 56.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.528 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -96.21 31.42 2.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.446 -0.343 . . . . 0.44 111.002 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.9 ttpp -110.6 26.06 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.082 0.401 . . . . 0.44 112.082 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.402 ' N ' ' HA ' ' A' ' 115' ' ' PHE . 17.2 tp -66.4 69.25 0.06 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.864 -0.607 . . . . 0.44 110.629 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -106.92 -168.64 1.43 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.44 111.68 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.67 168.67 9.69 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.44 112.468 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 79.9 Cg_endo -80.11 169.3 17.81 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.459 3.44 . . . . 0.44 114.087 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 104.17 -1.63 43.91 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 115.409 0.923 . . . . 0.44 115.409 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.14 161.66 29.04 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.565 0.682 . . . . 0.44 112.649 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.717 ' CD ' ' H1 ' ' A' 5194 ' ' HOH . 0.0 OUTLIER 86.6 5.5 0.37 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.879 0.471 . . . . 0.44 111.792 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.643 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.5 pt -54.96 -25.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.588 0.708 . . . . 0.44 110.331 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -40.57 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.529 -1.214 . . . . 0.44 111.391 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.1 mtp 32.12 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.502 0.501 . . . . 0.44 111.961 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.99 32.46 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.872 -0.68 . . . . 0.44 112.572 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.72 -172.07 3.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.911 0.386 . . . . 0.44 111.074 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.528 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.79 155.27 36.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.144 -0.48 . . . . 0.44 110.328 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.95 -24.96 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.884 2.39 . . . . 0.44 112.596 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -101.65 -44.24 5.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.44 111.538 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -80.2 -6.1 57.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.825 0.305 . . . . 0.44 111.825 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -62.28 -56.15 21.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.44 110.838 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 3.4 m -78.2 -45.3 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.49 . . . . 0.44 111.303 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.486 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 43.7 t -56.17 -39.27 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.44 111.501 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -78.36 -51.87 9.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.44 111.744 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 0.6 OUTLIER -68.98 -23.2 64.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.456 -0.338 . . . . 0.44 110.869 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -50.47 -44.28 55.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.739 -0.467 . . . . 0.44 109.739 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -33.92 65.43 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.074 -0.713 . . . . 0.44 109.074 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.72 -25.26 49.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.222 -0.899 . . . . 0.44 111.53 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.715 ' CG ' ' H2 ' ' A' 5193 ' ' HOH . 9.0 mp0 -108.43 5.09 25.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.568 0.581 . . . . 0.44 112.568 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.466 ' CG1' HG13 ' A' ' 60' ' ' ILE . 8.6 t -134.82 -44.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.44 110.225 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.672 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 60.82 1.63 2.04 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.245 -0.889 . . . . 0.44 114.318 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -119.05 -172.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.695 0.748 . . . . 0.44 110.141 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 p -113.38 87.89 12.1 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 116.243 -0.435 . . . . 0.44 110.618 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.562 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.0 Cg_endo -112.68 144.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.563 2.842 . . . . 0.44 113.9 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.448 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 4.8 pt20 -74.75 79.95 2.07 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.414 -2.069 . . . . 0.44 105.414 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.625 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.04 129.65 53.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.252 -1.34 . . . . 0.44 111.795 -175.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.606 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -176.66 -142.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.782 -0.645 . . . . 0.44 110.291 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 57.28 154.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.231 0.539 . . . . 0.44 112.21 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 3.0 tt -117.83 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.665 -0.698 . . . . 0.44 110.5 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.49 -54.05 7.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.44 109.94 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.4 tt0 -171.58 145.81 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.826 -0.625 . . . . 0.44 110.193 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.79 117.99 14.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.321 . . . . 0.44 110.654 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.58 147.05 25.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.44 111.093 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.22 112.07 11.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.63 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -137.75 128.95 27.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.44 110.641 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.75 118.62 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.052 0.453 . . . . 0.44 111.422 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.96 162.72 66.66 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.703 . . . . 0.44 110.387 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 2.2 Cg_endo -44.96 81.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.438 2.759 . . . . 0.44 112.595 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 36.6 t0 104.08 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.286 -0.87 . . . . 0.44 111.103 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.87 150.26 20.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.545 -0.298 . . . . 0.44 110.872 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -121.75 93.82 4.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.44 110.679 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.431 ' CG1' " O3'" ' A' ' 131' ' ' 8OG . 0.1 OUTLIER -93.17 135.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.985 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.3 118.91 22.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.44 110.513 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' HG ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -115.08 114.34 25.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.44 111.255 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 7' ' ' ALA . 12.0 m0 -109.85 129.73 55.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.092 -0.504 . . . . 0.44 110.851 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 9.0 m-30 -115.79 112.12 21.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.999 0.428 . . . . 0.44 110.798 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 43.6 m95 -94.9 149.32 21.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.888 -0.597 . . . . 0.44 111.461 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 65' ' ' PHE . 23.3 tp -97.71 102.8 14.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.54 0.686 . . . . 0.44 111.558 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 t -85.44 146.22 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 114.983 -1.008 . . . . 0.44 111.693 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.44 -39.4 6.14 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.67 1.359 . . . . 0.44 114.67 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.85 165.43 25.27 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.96 0.8 . . . . 0.44 111.835 -178.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.562 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 3.3 p90 -147.6 128.49 14.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.229 -0.441 . . . . 0.44 111.714 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -77.35 113.19 14.88 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.23 -0.441 . . . . 0.44 110.835 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.54 -122.14 6.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.748 -0.739 . . . . 0.44 112.456 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.5 mt-10 -135.06 137.52 27.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.418 0.151 . . . . 0.44 110.825 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.31 128.84 10.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.781 2.321 . . . . 0.44 111.395 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.672 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.8 p-90 -128.68 -59.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.461 -0.496 . . . . 0.44 111.901 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.02 -98.82 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.849 -0.691 . . . . 0.44 112.99 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 177.61 37.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.716 0.293 . . . . 0.44 111.171 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -52.04 -41.92 62.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.85 0.357 . . . . 0.44 110.639 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.82 -5.35 42.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.705 -0.759 . . . . 0.44 113.324 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.403 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 12.6 mp0 -140.1 97.71 7.76 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.44 111.457 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -43.49 145.09 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.073 2.516 . . . . 0.44 112.802 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.11 19.42 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.768 -0.73 . . . . 0.44 112.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -141.81 157.16 45.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.321 -0.251 . . . . 0.44 110.321 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -65.57 105.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.44 110.486 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.4 ptm -120.71 163.39 18.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.954 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.0 p -86.33 114.74 23.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.44 110.713 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.413 ' HG ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.96 -18.85 60.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.44 111.202 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.3 p -54.22 -18.82 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.407 -0.36 . . . . 0.44 111.935 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.2 49.8 0.83 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.366 -0.921 . . . . 0.44 113.071 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.71 150.36 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.635 0.255 . . . . 0.44 110.427 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.04 131.65 55.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.427 0.529 . . . . 0.44 112.427 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.38 61.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.656 -0.702 . . . . 0.44 110.367 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -46.66 17.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.237 -0.438 . . . . 0.44 111.232 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -71.9 -22.53 61.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.115 -0.493 . . . . 0.44 112.105 -179.073 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -97.35 174.53 3.17 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.624 -0.262 . . . . 0.44 110.7 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 70.4 Cg_endo -75.3 136.02 19.26 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.277 1.985 . . . . 0.44 111.601 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.59 -14.36 35.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.901 2.401 . . . . 0.44 113.191 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -12.24 22.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.589 0.588 . . . . 0.44 112.589 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.521 ' ND2' ' HG ' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -130.87 37.96 3.74 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.805 0.298 . . . . 0.44 111.805 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -76.06 -48.1 3.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.738 -0.21 . . . . 0.44 111.009 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.4 Cg_exo -53.68 -38.29 84.47 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.371 2.047 . . . . 0.44 112.158 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.19 -51.05 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.771 . . . . 0.44 110.666 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.472 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -66.09 -29.98 48.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.44 110.926 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.13 -30.99 60.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.44 110.526 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -74.81 -52.0 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.44 111.429 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tp -78.19 -19.73 53.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.44 111.641 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.6 ttpp -80.38 -42.59 22.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.087 0.47 . . . . 0.44 110.554 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.62 -8.8 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 0.44 109.907 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.761 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.431 " O3'" ' CG1' ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 5193 ' ' HOH . . . . . 0.715 ' H2 ' ' CG ' ' A' ' 57' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 5194 ' ' HOH . . . . . 0.717 ' H1 ' ' CD ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.752 0.311 . . . . 0.44 111.188 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -101.0 103.0 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.44 110.898 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.44 121.97 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.44 110.901 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.408 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.9 pp -124.45 120.42 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.821 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -103.3 150.88 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.221 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 3.3 mp -141.92 134.38 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.44 110.48 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.692 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.96 158.03 34.63 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 109.359 -0.608 . . . . 0.44 109.359 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 35' ' ' PHE . 1.9 m -145.59 162.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.245 -0.582 . . . . 0.44 111.933 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.56 104.74 0.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.594 -0.812 . . . . 0.44 112.608 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.656 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.7 109.19 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.421 -0.955 . . . . 0.44 108.421 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.478 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.82 124.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.378 0.608 . . . . 0.44 112.323 -177.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.92 124.18 30.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.175 -0.92 . . . . 0.44 111.418 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.575 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 19.8 t-20 -69.56 177.26 3.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.843 -1.072 . . . . 0.44 112.015 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.543 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tp10 -56.05 -18.65 10.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.218 -1.355 . . . . 0.44 112.6 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -121.19 -82.38 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.738 0.304 . . . . 0.44 111.519 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.97 15.56 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.44 111.711 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 13' ' ' ASN . 2.1 mp0 -100.83 160.51 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.483 -0.562 . . . . 0.44 109.483 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.706 HG13 ' HA ' ' A' ' 12' ' ' ARG . 3.8 mp -134.0 139.84 47.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.437 . . . . 0.44 111.167 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.488 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -93.67 113.84 26.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.792 -0.64 . . . . 0.44 110.898 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -123.16 159.11 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.44 109.557 179.315 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.9 p -70.77 111.62 6.35 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.058 -0.349 . . . . 0.44 110.058 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -124.47 110.6 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.41 . . . . 0.44 111.173 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 52.92 23.91 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.44 111.275 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 49.79 -174.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.876 0.37 . . . . 0.44 111.212 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.03 -29.56 43.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.44 110.95 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -170.6 35.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.44 110.785 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.23 -166.81 1.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.44 111.125 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.04 38.57 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.44 110.947 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.0 mtt -122.54 75.29 1.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.44 110.756 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.4 -26.18 24.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.44 111.38 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.8 11.03 21.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.44 111.425 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.46 26.3 10.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.747 0.308 . . . . 0.44 111.667 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.4 tt -52.78 86.41 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.703 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -122.09 179.8 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.239 0.542 . . . . 0.44 111.778 -179.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 166.59 14.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.486 -0.779 . . . . 0.44 111.736 -179.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 7.6 Cg_endo -47.64 168.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.609 2.873 . . . . 0.44 111.461 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.24 59.78 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.75 -1.214 . . . . 0.44 114.209 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.42 103.14 0.49 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 114.765 -0.718 . . . . 0.44 112.069 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 125.56 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.395 0.678 . . . . 0.44 111.525 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -42.82 -46.16 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.494 0.664 . . . . 0.44 111.005 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.94 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.391 -1.277 . . . . 0.44 112.263 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 34.73 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.893 0.331 . . . . 0.44 111.893 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.88 24.25 0.08 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.548 -0.834 . . . . 0.44 113.203 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.41 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -90.04 -159.26 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.431 0.157 . . . . 0.44 110.747 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.507 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -100.72 152.74 37.92 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.912 -0.403 . . . . 0.44 109.912 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.507 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.64 -24.58 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.622 2.214 . . . . 0.44 112.192 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' O ' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.94 -49.66 4.46 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.125 0.417 . . . . 0.44 112.125 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -80.54 -8.82 59.72 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.414 0.524 . . . . 0.44 112.414 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 40' ' ' ILE . . . -66.98 -57.33 7.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.082 -0.247 . . . . 0.44 111.375 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.493 ' N ' HD12 ' A' ' 40' ' ' ILE . 2.3 p -78.92 -35.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.627 -0.26 . . . . 0.44 111.459 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 47' ' ' GLU . 70.0 t -50.3 -35.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.44 110.333 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -34.82 47.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.501 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -76.95 -22.22 53.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.44 110.84 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.47 ' CG ' ' CE1' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -55.42 -44.39 76.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.998 0.428 . . . . 0.44 110.547 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.02 74.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.015 -0.539 . . . . 0.44 110.149 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -27.61 52.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.44 111.459 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -108.22 5.47 25.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.261 0.467 . . . . 0.44 112.261 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.494 ' CG1' HG13 ' A' ' 60' ' ' ILE . 17.0 t -134.5 -44.35 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.179 0.514 . . . . 0.44 110.369 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.631 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.22 18.04 12.53 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.44 114.744 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -128.38 -168.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 117.674 0.737 . . . . 0.44 110.676 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.28 86.73 18.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.44 109.923 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 16.8 Cg_endo -117.18 139.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 123.819 3.013 . . . . 0.44 114.532 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 31.7 mt-30 -74.84 79.32 2.11 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.315 -2.476 . . . . 0.44 104.315 174.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.583 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -114.22 126.72 55.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.077 -1.42 . . . . 0.44 111.142 -175.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -174.52 -150.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.692 -0.686 . . . . 0.44 110.846 -179.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.77 -177.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.44 111.903 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.769 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.6 pp -144.85 129.94 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.749 -0.659 . . . . 0.44 111.11 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -46.2 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.44 109.983 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.624 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.32 131.36 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.44 110.142 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -113.82 132.14 55.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.799 0.333 . . . . 0.44 111.006 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 tp -112.24 137.68 50.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.44 110.653 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.42 109.91 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.44 110.675 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -140.51 149.14 42.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.44 110.562 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.19 140.05 52.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.254 0.549 . . . . 0.44 111.429 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -87.7 163.12 39.71 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.821 . . . . 0.44 110.435 179.449 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -52.52 82.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.004 2.469 . . . . 0.44 112.137 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 11.9 t0 97.08 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.407 -0.815 . . . . 0.44 111.187 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 75' ' ' PHE . 7.3 ttp-105 -137.34 150.34 47.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.44 110.627 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -123.79 96.96 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.44 110.871 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 ' O ' HG21 ' A' ' 80' ' ' ILE . 2.8 tt -100.73 111.88 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.44 110.984 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.76 131.73 45.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.408 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.78 114.27 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.44 111.043 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.466 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 2.3 m0 -112.89 122.8 48.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.267 -0.424 . . . . 0.44 110.179 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -106.4 116.89 32.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.44 110.291 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.769 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.4 m95 -94.51 148.35 22.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.295 -0.411 . . . . 0.44 111.635 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.5 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.3 tp -102.87 102.9 13.03 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.319 0.58 . . . . 0.44 111.288 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.656 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 28.9 t -83.93 145.44 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 115.441 -0.8 . . . . 0.44 111.132 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.546 ' C ' ' HG2' ' A' ' 89' ' ' ARG . 8.1 pt-20 -115.8 -17.49 11.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.323 1.601 . . . . 0.44 115.323 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -161.89 165.62 27.41 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.878 1.217 . . . . 0.44 112.185 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -157.54 130.03 7.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.991 -0.549 . . . . 0.44 110.977 178.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.68 161.25 13.73 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.926 0.393 . . . . 0.44 111.197 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.12 -128.41 28.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.937 -0.649 . . . . 0.44 112.657 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.3 tt0 -127.12 127.88 24.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.371 -0.233 . . . . 0.44 110.371 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 90' ' ' TRP . 4.2 Cg_exo -76.9 128.56 10.1 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.561 2.174 . . . . 0.44 112.69 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.631 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 7.8 p-90 -133.79 -62.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.44 110.116 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 -67.45 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.44 112.789 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' TRP . 1.6 mmtt 81.45 43.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.966 0.412 . . . . 0.44 110.662 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -29.31 64.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.44 110.806 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.72 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.556 -0.83 . . . . 0.44 112.794 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -140.05 105.08 6.72 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 0.44 111.566 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -43.78 144.48 2.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.858 2.372 . . . . 0.44 112.388 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 169.64 22.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.62 -0.8 . . . . 0.44 112.93 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.21 157.31 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.342 -0.244 . . . . 0.44 110.342 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.74 106.05 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.44 110.581 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.1 ptm -120.56 163.25 18.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.44 110.797 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.6 t -72.87 114.86 11.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.438 -0.346 . . . . 0.44 110.668 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 11.8 tp -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.44 111.314 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.56 -13.33 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.468 -0.333 . . . . 0.44 111.506 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.94 34.76 5.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.6 -0.81 . . . . 0.44 112.871 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.7 tp -62.54 131.53 49.41 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.93 -0.396 . . . . 0.44 109.93 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 132.29 54.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.785 0.661 . . . . 0.44 112.785 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.561 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.42 61.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.416 -0.811 . . . . 0.44 110.285 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.78 -49.19 13.42 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.382 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -67.4 -38.34 84.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.393 -0.367 . . . . 0.44 111.674 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.89 174.06 6.7 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.494 -0.321 . . . . 0.44 110.281 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.4 Cg_endo -73.79 127.84 11.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.052 1.835 . . . . 0.44 111.355 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.53 -14.72 26.96 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.634 2.223 . . . . 0.44 113.289 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.75 -9.82 31.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.508 0.558 . . . . 0.44 112.508 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.67 42.3 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.869 0.322 . . . . 0.44 111.869 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 tt0 -73.22 -38.77 4.6 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.117 0.414 . . . . 0.44 112.117 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 73.3 Cg_exo -51.17 -41.41 57.94 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.1 1.866 . . . . 0.44 113.033 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.26 -51.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.405 . . . . 0.44 111.273 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.512 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.6 mm -65.97 -29.85 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.44 111.022 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.47 -29.85 62.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.44 110.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -80.09 -46.56 16.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.44 111.427 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 7.6 tp -78.14 -26.42 47.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.44 111.257 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -58.4 -42.57 87.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.141 0.496 . . . . 0.44 110.648 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 1.5 tpp180 -71.12 -5.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.44 109.875 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.968 -0.56 . . . . 0.44 111.225 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.582 ' OP2' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5205 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5206 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.88 0.371 . . . . 0.44 111.153 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.59 127.22 41.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.896 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.01 132.59 49.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.44 110.938 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.94 129.72 22.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.44 110.891 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -102.74 148.89 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.44 111.169 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.411 HD12 ' OP2' ' A' ' 131' ' ' 8OG . 24.0 mm -135.54 134.13 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.594 -0.73 . . . . 0.44 110.805 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.684 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.94 125.19 43.54 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.719 -0.474 . . . . 0.44 109.719 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -131.63 155.7 41.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.251 0.548 . . . . 0.44 111.813 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.62 137.42 7.5 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.142 -0.935 . . . . 0.44 111.339 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.488 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -85.73 94.72 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.088 -0.245 . . . . 0.44 110.384 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.732 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -71.68 118.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.194 0.521 . . . . 0.44 111.351 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.332 -0.849 . . . . 0.44 110.262 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.623 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 7.4 p-10 -110.17 -173.52 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.484 0.92 . . . . 0.44 113.484 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -45.99 -28.5 1.17 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.075 -1.42 . . . . 0.44 113.432 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -92.58 26.74 2.54 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.958 -0.565 . . . . 0.44 111.578 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.91 25.89 0.34 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.211 0.529 . . . . 0.44 110.51 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 17.2 pt-20 -114.22 160.16 19.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.473 -0.785 . . . . 0.44 109.212 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.732 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -112.15 135.96 49.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.347 0.594 . . . . 0.44 112.441 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 10.9 t80 -91.02 103.27 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.306 -0.861 . . . . 0.44 109.933 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.458 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.58 147.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.926 0.394 . . . . 0.44 110.863 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.434 ' HB ' ' CB ' ' A' ' 100' ' ' GLN . 4.8 p -88.72 111.62 22.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.44 109.938 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.434 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 24.6 ptt-85 -113.92 172.19 7.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.44 111.096 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -74.8 57.25 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.054 -0.521 . . . . 0.44 110.3 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 49.2 -168.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.332 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.91 44.39 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.44 110.974 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -153.19 -44.13 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.44 111.057 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.62 173.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.389 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.86 30.67 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.44 110.962 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.6 mtt -140.84 38.39 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.44 110.772 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.71 -8.74 15.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.44 112.033 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 16.91 3.16 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.68 0.252 . . . . 0.44 111.68 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 mttt -114.36 26.01 10.6 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.962 0.41 . . . . 0.44 111.387 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -55.73 86.2 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.651 -0.704 . . . . 0.44 110.599 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.9 tt0 -106.89 -170.96 1.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.14 0.495 . . . . 0.44 111.741 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.86 166.04 16.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.691 -0.686 . . . . 0.44 111.44 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 61.1 Cg_endo -71.07 168.86 22.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.548 2.832 . . . . 0.44 111.708 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.43 59.36 0.72 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.326 -0.94 . . . . 0.44 113.601 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.44 120.02 3.4 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 114.118 -1.041 . . . . 0.44 111.527 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.668 ' HD2' ' H2 ' ' A' 5218 ' ' HOH . 0.0 OUTLIER 119.05 -10.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.417 0.687 . . . . 0.44 110.727 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -37.78 -63.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.33 0.586 . . . . 0.44 111.358 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -15.41 -81.25 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.32 -1.309 . . . . 0.44 112.375 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.69 -93.27 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.457 -0.338 . . . . 0.44 111.696 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.6 22.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.505 -0.855 . . . . 0.44 113.447 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.6 -159.22 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.521 0.2 . . . . 0.44 110.884 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.538 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.44 155.61 37.68 Favored Pre-proline 0 N--CA 1.457 -0.082 0 N-CA-C 110.311 -0.255 . . . . 0.44 110.311 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.0 Cg_endo -44.07 -24.83 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.781 2.321 . . . . 0.44 112.428 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.0 -49.6 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.44 111.8 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -80.42 -4.58 54.21 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.773 0.286 . . . . 0.44 111.773 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.539 ' HB3' HG13 ' A' ' 40' ' ' ILE . . . -64.61 -57.45 9.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.596 0.236 . . . . 0.44 111.214 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.468 ' HB ' HD11 ' A' ' 40' ' ' ILE . 1.2 p -78.79 -40.86 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.944 -0.303 . . . . 0.44 111.494 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.2 -35.22 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.814 0.34 . . . . 0.44 111.137 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -52.16 9.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.212 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -67.51 -19.91 65.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.44 110.87 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 7.9 tp -56.61 -44.44 81.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.44 110.459 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -26.78 68.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.44 109.836 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.2 tm-20 -75.36 -26.77 58.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.709 -0.678 . . . . 0.44 111.396 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.498 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.97 6.82 25.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.628 0.603 . . . . 0.44 112.628 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.487 ' CG1' HG13 ' A' ' 60' ' ' ILE . 8.2 t -131.46 -43.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.062 0.458 . . . . 0.44 110.395 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 57.46 7.34 2.9 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.751 -0.659 . . . . 0.44 114.679 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.487 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.9 -166.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.928 0.864 . . . . 0.44 110.512 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.454 HG22 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -113.16 87.89 11.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.44 110.888 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 11.7 Cg_endo -113.51 133.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.792 2.995 . . . . 0.44 113.852 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 7.9 pt20 -74.75 79.22 2.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.008 -2.219 . . . . 0.44 105.008 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.587 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -112.16 130.02 56.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.554 -1.657 . . . . 0.44 110.539 -175.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -178.17 -142.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.098 -0.501 . . . . 0.44 111.053 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t 52.75 171.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.22 0.533 . . . . 0.44 112.16 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.2 tt -131.31 105.65 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.53 -0.759 . . . . 0.44 110.404 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.64 -40.97 47.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.982 0.42 . . . . 0.44 110.121 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.8 tt0 -171.27 159.88 5.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.44 110.43 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -143.25 132.16 22.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.818 0.342 . . . . 0.44 110.965 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.39 128.95 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.649 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -129.35 110.84 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.44 110.76 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -138.49 104.48 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.44 110.545 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 15.8 pt-20 -88.5 126.62 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.044 0.449 . . . . 0.44 111.526 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -70.08 163.55 60.4 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.44 109.934 179.138 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -38.75 -28.51 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.499 2.799 . . . . 0.44 113.103 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -32.61 0.58 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.44 111.426 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 26.8 ttm180 -94.18 97.95 10.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.337 . . . . 0.44 111.61 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 79' ' ' HIS . 9.4 m170 -78.97 100.21 7.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.44 110.809 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -104.59 130.89 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.44 111.053 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -121.44 132.01 54.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.44 110.465 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 mt -126.24 114.5 18.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.44 111.474 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -107.65 122.59 47.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.132 -0.485 . . . . 0.44 110.589 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.459 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 4.4 m-30 -100.64 109.56 21.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.355 -0.384 . . . . 0.44 110.429 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 21.8 m95 -96.31 148.6 22.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.54 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.519 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.9 tm? -90.83 103.03 15.79 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.315 0.579 . . . . 0.44 111.35 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 18.9 t -90.5 145.3 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.529 -0.76 . . . . 0.44 111.032 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.424 ' HB2' ' HG3' ' A' ' 63' ' ' GLN . 1.7 mm-40 -113.85 -25.39 8.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.733 1.753 . . . . 0.44 115.733 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.536 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -163.5 165.86 23.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.105 1.32 . . . . 0.44 112.809 -178.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.623 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.6 OUTLIER -157.12 124.5 5.28 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.772 -0.649 . . . . 0.44 110.623 178.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.454 ' CB ' HG22 ' A' ' 61' ' ' THR . 0.7 OUTLIER -80.06 117.99 21.38 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.801 0.334 . . . . 0.44 111.126 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.25 -123.34 6.97 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.44 112.445 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.8 mt-10 -129.46 137.78 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 122.952 -0.146 . . . . 0.44 110.63 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.503 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -76.67 128.94 10.52 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.778 2.319 . . . . 0.44 110.969 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 51.1 p-90 -140.26 -58.99 0.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.776 0.658 . . . . 0.44 112.776 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 48.55 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.653 -0.784 . . . . 0.44 112.578 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -179.37 32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.628 0.252 . . . . 0.44 111.219 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -24.93 67.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.44 110.57 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.06 73.18 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.076 -0.583 . . . . 0.44 113.429 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.434 ' CB ' ' HB ' ' A' ' 21' ' ' THR . 23.4 mt-30 -140.36 100.64 6.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.44 111.418 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 129.59 7.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.883 2.389 . . . . 0.44 112.385 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.429 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.09 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 0.44 113.14 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -153.27 157.13 39.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.245 -0.28 . . . . 0.44 110.245 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -71.59 105.69 3.75 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.604 -0.438 . . . . 0.44 109.824 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.45 ' C ' ' HB2' ' A' ' 17' ' ' GLU . 28.0 ptm -120.58 147.55 45.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.036 -0.529 . . . . 0.44 111.063 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 t -67.85 124.99 24.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.44 110.846 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -71.92 -20.76 61.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.44 111.225 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.13 -19.47 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.405 -0.362 . . . . 0.44 111.521 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.82 36.89 3.73 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.545 -0.836 . . . . 0.44 112.872 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 tp -62.74 129.11 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.932 -0.395 . . . . 0.44 109.932 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.99 134.79 54.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.769 0.655 . . . . 0.44 112.769 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.584 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -15.37 61.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.402 -0.817 . . . . 0.44 110.674 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -78.89 -49.25 13.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.44 111.772 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -30.31 68.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.377 -0.374 . . . . 0.44 111.652 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.584 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -88.45 173.97 5.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.537 -0.301 . . . . 0.44 110.621 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 72.3 Cg_endo -76.86 130.16 11.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.433 2.089 . . . . 0.44 111.596 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.58 -14.44 13.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.938 2.425 . . . . 0.44 113.728 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.71 -10.24 11.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.806 0.669 . . . . 0.44 112.806 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.24 45.67 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.742 0.306 . . . . 0.44 111.465 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.52 -54.41 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.769 0.285 . . . . 0.44 111.769 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.01 -33.09 7.24 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.396 2.064 . . . . 0.44 112.416 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 25.8 t -77.57 -51.03 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.44 110.502 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 115' ' ' PHE . 16.6 mm -65.59 -29.77 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.44 110.85 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.4 56.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.44 110.626 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -47.44 14.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.44 111.449 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.517 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 11.1 tp -78.18 -19.43 53.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.44 111.517 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 123' ' ' ILE . 3.8 ttpm? -71.14 -42.6 68.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.44 110.643 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -68.24 -9.46 47.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.583 -0.735 . . . . 0.44 110.004 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.125 0 CA-C-N 116.288 -0.414 . . . . 0.44 110.623 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.573 ' P ' " H3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5217 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5218 ' ' HOH . . . . . 0.668 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.828 0.346 . . . . 0.44 111.124 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -93.83 135.47 35.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.881 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 145.94 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.44 110.819 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.422 ' CD2' " O3'" ' A' ' 131' ' ' 8OG . 2.8 pp -146.02 124.35 12.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.95 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 15.2 mt-30 -102.49 155.72 18.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.44 111.727 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 3.7 mp -146.16 132.29 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.469 -0.787 . . . . 0.44 110.503 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.597 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.4 124.74 43.0 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.619 -0.511 . . . . 0.44 109.619 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -126.79 162.12 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.44 112.214 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.31 116.27 0.86 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.44 111.908 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.442 ' CG2' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.47 96.02 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.146 -0.316 . . . . 0.44 110.146 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.584 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 2.4 pt -79.35 111.68 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.164 0.507 . . . . 0.44 112.171 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.794 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.1 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.588 -0.733 . . . . 0.44 109.937 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.633 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.5 p-10 -125.34 -173.83 2.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.2 0.815 . . . . 0.44 113.2 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -22.21 12.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.326 -1.307 . . . . 0.44 113.534 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -98.08 30.77 2.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.575 -0.284 . . . . 0.44 111.336 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.41 28.92 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.316 0.579 . . . . 0.44 110.264 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.7 mt-10 -117.71 160.34 21.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.285 -0.87 . . . . 0.44 109.882 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -114.62 136.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.045 0.45 . . . . 0.44 111.596 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 44.5 t80 -87.88 93.68 9.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.862 -0.608 . . . . 0.44 110.619 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.602 HG12 HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -114.68 162.2 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.44 110.698 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.9 p -71.72 129.65 39.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.368 -0.378 . . . . 0.44 110.113 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.93 128.45 42.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.775 0.321 . . . . 0.44 110.817 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 54.6 -112.38 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.404 . . . . 0.44 110.162 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 172.98 176.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 0.44 110.977 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.77 -30.89 10.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.44 110.988 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -111.08 -43.63 3.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.44 110.844 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.22 -176.01 3.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.44 111.028 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -84.09 -80.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.44 110.916 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.21 38.32 27.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.018 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.96 97.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.44 111.318 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.88 20.84 9.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.204 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.49 26.47 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.526 -0.306 . . . . 0.44 111.602 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.5 tt -56.03 80.4 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 0.44 110.691 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -106.84 -168.31 1.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.945 0.402 . . . . 0.44 111.346 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.58 157.39 51.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.44 111.614 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 21.4 Cg_endo -60.06 167.37 7.45 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.216 2.61 . . . . 0.44 111.183 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.1 58.83 0.78 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 119.823 -1.179 . . . . 0.44 113.782 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -122.8 130.69 7.96 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.674 -0.763 . . . . 0.44 111.803 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 102.11 4.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.137 0.575 . . . . 0.44 111.695 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -54.95 -25.91 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.43 0.633 . . . . 0.44 110.547 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.28 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.833 -1.076 . . . . 0.44 110.965 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.1 mmm 35.49 -85.52 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.422 0.451 . . . . 0.44 111.807 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.42 30.63 0.15 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.89 -0.671 . . . . 0.44 112.385 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.5 mp0 -91.86 -178.27 4.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.872 0.368 . . . . 0.44 111.234 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.539 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.01 155.9 36.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.44 110.27 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.96 -24.78 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.847 2.365 . . . . 0.44 112.715 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -95.11 -49.38 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.18 0.437 . . . . 0.44 112.18 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -80.21 -23.25 41.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.954 0.353 . . . . 0.44 111.954 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.42 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.49 -48.43 77.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.44 110.952 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.1 -47.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.243 -0.435 . . . . 0.44 110.756 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 45.1 t -58.54 -35.73 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.44 111.036 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -74.89 -52.07 12.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.874 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -68.98 -26.47 65.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.44 110.79 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 50' ' ' VAL . 6.1 tp -51.94 -44.07 63.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.38 -0.373 . . . . 0.44 110.644 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.47 -31.19 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.158 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.1 -23.84 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.44 110.234 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.602 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 9.1 mm-40 -108.11 6.57 27.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.44 111.543 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -134.13 -45.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.167 0.508 . . . . 0.44 110.338 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.57 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 63.32 -27.32 0.08 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.934 1.133 . . . . 0.44 115.934 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.629 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -93.94 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 117.771 0.786 . . . . 0.44 111.466 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.5 p -105.81 89.57 3.66 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.641 -0.709 . . . . 0.44 110.039 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 84.1 Cg_endo -109.57 137.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.438 2.759 . . . . 0.44 115.367 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 89' ' ' ARG . 70.9 mt-30 -75.55 79.46 2.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.522 -2.399 . . . . 0.44 104.522 174.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.64 ' CE1' ' N ' ' A' ' 89' ' ' ARG . 1.8 m-70 -138.17 127.4 24.44 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.104 -0.953 . . . . 0.44 113.55 -173.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' CB ' ' A' ' 66' ' ' SER . 6.2 t80 173.5 173.72 0.14 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.774 -0.648 . . . . 0.44 111.028 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 5.4 t 106.14 154.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.736 0.814 . . . . 0.44 110.614 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 9.1 tt -106.75 146.88 30.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.324 -0.398 . . . . 0.44 111.466 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -117.13 -44.74 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.44 110.709 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.23 153.96 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.666 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -138.0 132.06 31.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.785 0.326 . . . . 0.44 111.003 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -118.01 124.39 48.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.44 110.737 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.82 109.88 17.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.44 110.538 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -134.42 153.22 52.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.44 110.648 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -114.89 140.13 49.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.291 0.567 . . . . 0.44 111.42 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -107.21 163.75 16.28 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.176 -0.92 . . . . 0.44 110.269 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 64.0 Cg_exo -39.26 81.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.457 2.772 . . . . 0.44 112.744 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.02 20.53 4.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.762 -0.654 . . . . 0.44 110.872 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -137.32 93.88 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.44 110.357 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -74.79 101.13 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.44 110.986 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -100.15 114.73 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.191 -0.458 . . . . 0.44 110.979 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 128.2 54.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.44 110.76 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.407 ' CD1' ' OD1' ' A' ' 119' ' ' ASN . 24.8 mt -126.07 114.64 18.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.511 -0.313 . . . . 0.44 111.277 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -105.05 122.54 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.44 110.845 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 4.4 m-30 -99.41 109.86 22.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.038 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.419 ' CZ2' HG13 ' A' ' 50' ' ' VAL . 21.2 m95 -99.69 148.16 24.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.033 0.444 . . . . 0.44 111.955 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.8 tp -91.34 122.2 33.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.44 110.137 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -124.06 145.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.44 110.921 -178.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 12' ' ' ARG . 10.7 tt0 -89.22 -69.78 0.69 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.691 1.737 . . . . 0.44 115.691 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.51 166.08 25.3 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.19 0.519 . . . . 0.44 112.227 -177.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.633 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 47.8 p90 -115.78 163.01 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.68 . . . . 0.44 111.254 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.67 72.27 0.95 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.72 0.295 . . . . 0.44 110.911 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 135.97 -115.97 1.41 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.701 -0.762 . . . . 0.44 112.637 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -134.18 118.77 14.14 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.587 -0.153 . . . . 0.44 110.587 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.549 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -75.74 128.97 11.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.836 2.357 . . . . 0.44 111.881 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.57 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 2.2 p-90 -121.86 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.453 -0.499 . . . . 0.44 111.705 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.602 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 60.55 -68.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.52 -0.763 . . . . 0.44 112.868 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 40.7 tttm 96.95 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.212 0.605 . . . . 0.44 110.969 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -31.31 21.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.625 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.3 -15.52 2.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.44 112.99 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -140.06 101.36 7.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.954 0.407 . . . . 0.44 111.373 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.55 146.22 1.4 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.062 2.508 . . . . 0.44 112.623 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.428 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.24 177.37 19.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.44 112.888 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.427 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 13.8 tt0 -153.12 157.34 40.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.33 -0.248 . . . . 0.44 110.33 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.72 106.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.655 -0.498 . . . . 0.44 109.655 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.13 156.53 30.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.122 -0.49 . . . . 0.44 111.262 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -67.12 114.54 5.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.44 110.87 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.455 ' HB2' HG23 ' A' ' 18' ' ' ILE . 3.0 tm? -78.4 -21.34 49.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.44 111.187 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.41 -12.53 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.44 111.547 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.15 40.87 2.02 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.585 -0.817 . . . . 0.44 112.891 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.7 tp -62.64 134.13 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.943 -0.391 . . . . 0.44 109.943 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 137.73 54.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.641 0.608 . . . . 0.44 112.641 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.544 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.29 -15.73 61.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.44 110.577 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.97 -49.25 13.06 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.44 111.58 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.22 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.319 -0.401 . . . . 0.44 111.47 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.94 173.91 6.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 0.44 110.684 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.454 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.9 Cg_endo -77.17 137.09 16.79 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.372 2.048 . . . . 0.44 111.916 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 20.1 Cg_endo -60.05 -14.09 26.58 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.901 2.401 . . . . 0.44 113.258 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -9.81 10.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.944 0.72 . . . . 0.44 112.944 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.414 ' ND2' HG21 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -138.91 47.52 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.424 0.528 . . . . 0.44 112.424 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -70.36 -58.1 5.16 Favored Pre-proline 0 CA--C 1.531 0.231 0 O-C-N 122.214 -0.304 . . . . 0.44 111.389 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.436 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -44.73 -31.02 4.64 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.501 2.134 . . . . 0.44 112.522 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 71.7 t -77.33 -50.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.59 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.515 HG13 ' CE2' ' A' ' 115' ' ' PHE . 26.8 mm -65.43 -31.54 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.006 -0.543 . . . . 0.44 110.58 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.83 36.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.44 110.902 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -51.61 8.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.44 111.696 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 tp -78.09 -30.1 49.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.44 111.496 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -56.71 -42.53 79.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.992 0.425 . . . . 0.44 110.869 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -67.47 -8.85 36.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.44 109.762 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.902 179.815 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.422 " O3'" ' CD2' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5229 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5230 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.833 0.349 . . . . 0.44 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.75 102.91 12.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.44 110.973 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -104.91 144.62 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.44 110.806 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.6 pp -138.08 127.03 24.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 0.44 111.194 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -102.44 157.56 16.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.332 0.587 . . . . 0.44 111.869 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' THR . 73.1 mt -146.23 130.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.119 -0.946 . . . . 0.44 109.834 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.6 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.13 125.07 43.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.678 -0.49 . . . . 0.44 109.678 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.466 HG22 ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -129.25 162.6 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.427 0.632 . . . . 0.44 111.925 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.11 113.55 0.64 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.041 -0.982 . . . . 0.44 111.428 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.75 99.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.654 -0.498 . . . . 0.44 109.654 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.558 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.26 119.57 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.275 0.56 . . . . 0.44 111.987 -178.476 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.63 141.79 28.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.905 . . . . 0.44 110.883 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -100.12 -173.17 2.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.474 -0.785 . . . . 0.44 112.001 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -73.75 -10.1 59.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.979 -1.01 . . . . 0.44 113.267 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.455 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 23.1 t-20 -111.89 30.91 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.952 0.352 . . . . 0.44 111.952 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.63 11.39 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.467 -0.333 . . . . 0.44 111.545 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HB2' HD22 ' A' ' 13' ' ' ASN . 0.0 OUTLIER -101.99 161.34 13.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.44 108.944 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -116.0 131.71 67.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 0.44 111.75 -178.396 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.419 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 7.0 t80 -82.92 107.63 15.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.758 -0.656 . . . . 0.44 110.524 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -123.47 162.16 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.841 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 p -79.18 111.74 15.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.44 110.244 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' CG ' ' HG ' ' A' ' 33' ' ' LEU . 2.7 tmm_? -119.19 169.78 9.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.916 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -60.85 -14.64 23.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.508 . . . . 0.44 111.204 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 23' ' ' ARG . . . 80.86 -76.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.33 -0.396 . . . . 0.44 111.458 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.427 ' N ' ' HD3' ' A' ' 23' ' ' ARG . . . -164.3 -79.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.806 0.336 . . . . 0.44 111.265 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.27 34.73 3.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.44 110.989 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.28 151.16 26.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.44 111.11 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -178.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.44 110.824 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mtt 59.92 72.36 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.44 110.838 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.05 -27.5 23.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.44 111.406 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.29 22.16 7.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.386 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.53 25.95 10.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.928 0.394 . . . . 0.44 111.749 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' N ' ' HA ' ' A' ' 115' ' ' PHE . 3.3 tt -65.7 78.45 0.07 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.92 -0.582 . . . . 0.44 110.009 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.95 -171.9 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 0.44 111.403 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.466 ' CE1' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.86 156.48 54.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.44 111.766 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.449 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 8.9 Cg_endo -49.27 168.0 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.637 2.891 . . . . 0.44 111.831 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.34 59.21 0.76 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.859 -1.162 . . . . 0.44 114.033 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.701 ' C ' ' HG2' ' A' ' 39' ' ' LYS . . . -118.56 159.94 14.16 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.615 -0.793 . . . . 0.44 111.993 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.701 ' HG2' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 49.12 23.13 0.71 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.44 111.561 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.689 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER -61.81 -30.96 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.773 -1.195 . . . . 0.44 107.773 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.689 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.19 -80.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.968 -1.924 . . . . 0.44 111.028 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.9 mmt 41.32 -84.03 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.381 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.29 33.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.947 -0.644 . . . . 0.44 112.682 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 mp0 -93.56 -174.33 3.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.7 0.286 . . . . 0.44 111.266 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.525 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.92 153.98 38.98 Favored Pre-proline 0 N--CA 1.457 -0.124 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.378 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.69 -24.66 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.958 2.439 . . . . 0.44 112.532 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.1 -48.71 5.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.523 0.564 . . . . 0.44 112.523 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -80.42 -26.09 38.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.147 0.425 . . . . 0.44 112.147 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -55.48 -47.38 76.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 0.44 111.285 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.467 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.33 -51.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.295 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -52.82 -36.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.44 110.512 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -78.24 -43.31 28.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.203 0.525 . . . . 0.44 109.925 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' HG2' ' CG2' ' A' ' 40' ' ' ILE . 10.8 tp10 -64.42 -27.37 68.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.493 -0.776 . . . . 0.44 110.289 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.413 HD22 ' CD2' ' A' ' 64' ' ' HIS . 2.9 tp -56.57 -44.61 81.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.44 111.156 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -63.28 -35.41 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.322 0.582 . . . . 0.44 109.431 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tm-20 -77.75 -26.13 49.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.188 -0.915 . . . . 0.44 111.477 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 63.8 mm-40 -108.99 5.39 24.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.679 0.622 . . . . 0.44 112.679 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.457 ' CG1' HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.84 -44.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.316 0.579 . . . . 0.44 110.205 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.84 3.14 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.329 -0.85 . . . . 0.44 114.618 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -120.48 -173.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 117.907 0.853 . . . . 0.44 110.269 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 p -113.28 87.99 11.99 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.136 -0.484 . . . . 0.44 110.183 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.567 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.9 Cg_endo -113.23 145.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.612 2.875 . . . . 0.44 113.922 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 17.8 mt-30 -74.97 79.68 2.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 105.555 -2.017 . . . . 0.44 105.555 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.56 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.35 134.21 55.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.259 -1.337 . . . . 0.44 110.825 -176.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -179.3 -139.94 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.812 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 1.1 m 52.18 174.3 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.171 0.51 . . . . 0.44 112.111 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.1 tt -139.6 117.87 12.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.44 110.844 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.78 -55.61 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.44 110.221 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.1 mt-10 -171.13 131.38 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.44 110.441 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 132.08 46.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.579 -0.282 . . . . 0.44 110.651 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.56 161.95 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.44 110.993 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -125.69 124.1 40.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.44 110.851 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -120.88 152.71 38.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.44 110.464 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -120.76 120.9 36.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.151 0.5 . . . . 0.44 111.346 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -72.27 163.06 70.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.5 -0.773 . . . . 0.44 110.42 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.41 83.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.112 2.541 . . . . 0.44 112.316 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 16.8 m-20 95.29 15.2 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.44 111.57 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 8.2 tpp85 -137.44 150.14 47.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.44 110.7 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.7 105.6 10.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.44 110.82 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -111.36 154.31 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.38 . . . . 0.44 111.233 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -127.25 131.18 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.647 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.522 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 11.2 tp -126.32 114.56 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.582 -0.281 . . . . 0.44 111.289 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.552 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -110.26 135.64 50.69 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.718 0.294 . . . . 0.44 110.394 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -120.01 118.03 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.474 -0.33 . . . . 0.44 111.331 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.616 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.4 m95 -100.52 148.62 24.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.371 -0.377 . . . . 0.44 111.009 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.0 tp -96.6 102.89 14.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.46 0.648 . . . . 0.44 111.746 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 16.4 t -85.99 145.81 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 115.243 -0.89 . . . . 0.44 111.377 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.0 -39.77 5.65 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.484 1.29 . . . . 0.44 114.484 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.8 ptp180 -163.24 165.67 24.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.837 0.744 . . . . 0.44 112.097 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.567 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 4.6 p90 -144.72 130.4 19.06 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.209 -0.45 . . . . 0.44 111.505 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.69 105.95 11.36 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.804 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.76 -122.82 7.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 0.44 112.446 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -134.97 137.07 26.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.401 0.143 . . . . 0.44 110.838 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.45 128.75 10.57 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.755 2.303 . . . . 0.44 111.502 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.68 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.2 p-90 -130.47 -57.2 1.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.529 -0.468 . . . . 0.44 111.959 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.521 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 45.15 -94.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.799 -0.715 . . . . 0.44 112.991 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.4 mmtp 170.62 39.33 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.835 0.35 . . . . 0.44 111.189 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -42.69 99.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.488 -0.324 . . . . 0.44 110.696 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.47 6.67 50.19 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.652 -0.785 . . . . 0.44 113.642 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -140.2 99.12 7.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 117.31 0.555 . . . . 0.44 111.515 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -43.62 140.95 4.07 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.989 2.46 . . . . 0.44 112.668 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.17 177.05 19.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.668 -0.777 . . . . 0.44 112.768 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -147.96 157.18 43.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.44 110.432 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.538 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.2 m0 -61.86 105.92 0.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.44 110.114 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.2 ttm -120.55 159.81 24.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.12 -0.491 . . . . 0.44 111.277 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.2 p -83.93 123.85 30.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.44 110.746 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -80.01 -19.06 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.274 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 p -55.35 -19.82 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.445 -0.343 . . . . 0.44 111.727 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.18 45.8 1.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.433 -0.889 . . . . 0.44 113.076 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 111' ' ' ASN . 7.6 tt -62.95 150.54 41.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.595 0.236 . . . . 0.44 110.388 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.415 ' N ' HD21 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -121.85 120.85 35.73 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.873 0.694 . . . . 0.44 112.873 -178.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.719 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.71 61.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.769 -0.651 . . . . 0.44 109.834 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.93 -46.25 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.413 -0.358 . . . . 0.44 111.562 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.56 -13.56 58.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.906 0.335 . . . . 0.44 111.906 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.719 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.61 175.71 3.86 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.61 -0.268 . . . . 0.44 110.59 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 68.6 Cg_endo -76.12 143.08 25.26 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.736 1.624 . . . . 0.44 110.949 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HG2' ' N1 ' ' A' ' 131' ' ' 8OG . 25.5 Cg_endo -62.05 -14.27 36.49 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.483 2.122 . . . . 0.44 113.213 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.62 -9.37 58.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.732 1.012 . . . . 0.44 113.732 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' O ' ' A' ' 116' ' ' PRO . 31.4 p-10 -124.48 32.74 5.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.521 0.934 . . . . 0.44 113.521 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.51 -55.19 1.68 Allowed Pre-proline 0 N--CA 1.467 0.389 0 C-N-CA 120.995 -0.282 . . . . 0.44 111.456 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.95 -37.13 11.95 Favored 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.509 2.139 . . . . 0.44 112.889 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.477 ' CG2' ' CE1' ' A' ' 84' ' ' PHE . 2.4 t -77.6 -51.18 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.832 -0.622 . . . . 0.44 110.891 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.422 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.8 mm -68.3 -29.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.518 -0.765 . . . . 0.44 111.264 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.84 57.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.412 . . . . 0.44 110.418 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -48.27 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.44 111.317 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 6.4 tp -78.21 -30.09 48.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.359 . . . . 0.44 111.534 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -56.57 -42.87 79.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.088 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -2.89 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.44 110.055 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-N 116.051 -0.522 . . . . 0.44 111.254 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.423 ' N1 ' ' HG2' ' A' ' 117' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5241 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5242 ' ' HOH . . . . . 0.475 ' H2 ' ' HG3' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.91 0.386 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.48 122.02 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.717 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.624 HD11 HD12 ' A' ' 80' ' ' ILE . 3.8 pp -109.65 125.08 52.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.487 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.6 mt-30 -102.52 150.43 23.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.317 0.58 . . . . 0.0 111.54 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.612 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.1 mt -141.21 131.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.046 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.051 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.01 124.8 43.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -128.52 156.96 41.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.322 0.582 . . . . 0.0 111.85 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -148.6 118.16 0.94 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.262 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.621 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.11 108.96 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.725 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -70.82 128.28 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.386 -178.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -91.75 126.22 36.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 9.6 t-20 -87.6 -172.31 3.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.983 0.897 . . . . 0.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -77.9 -3.0 39.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.878 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -133.46 49.06 2.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.203 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.85 28.88 0.39 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.451 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 6.7 pt-20 -118.17 149.53 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.042 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.793 HG21 HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -120.4 146.65 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 111.599 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -95.85 116.58 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.525 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.62 162.15 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.202 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.74 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -114.47 26.01 10.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.079 0.466 . . . . 0.0 111.512 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -53.97 94.58 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.507 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -111.69 -166.46 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 111.652 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.82 163.04 29.94 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.426 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 35.5 Cg_endo -63.48 168.17 11.86 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.525 2.816 . . . . 0.0 112.003 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.32 58.83 0.77 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.927 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -120.95 138.57 12.74 Favored Glycine 0 C--N 1.313 -0.701 0 CA-C-N 114.756 -0.722 . . . . 0.0 111.974 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 2.7 ttpm? 92.45 6.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.981 0.513 . . . . 0.0 112.047 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.051 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -55.82 -27.14 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.49 0.662 . . . . 0.0 110.533 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.2 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.039 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.9 mmm 37.92 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.438 0.461 . . . . 0.0 111.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.76 32.71 0.12 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt-10 -89.68 -175.02 4.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.782 0.325 . . . . 0.0 111.244 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.896 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.45 155.18 36.67 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.896 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.9 Cg_endo -44.62 -24.91 1.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.819 2.346 . . . . 0.0 112.593 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.2 mt-10 -104.09 -41.66 5.77 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.4 mm-40 -79.04 -19.21 51.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.007 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.41 -47.73 82.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.654 0.264 . . . . 0.0 111.303 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.838 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.11 -45.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.883 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.8 t -53.95 -36.94 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.65 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.38 -52.02 9.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 1.4 mm-40 -64.79 -22.93 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.826 ' O ' HG23 ' A' ' 58' ' ' VAL . 6.2 tp -54.46 -44.81 72.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.812 0.339 . . . . 0.0 110.736 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.76 -28.38 68.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.27 -25.34 51.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.179 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 6.9 mm-40 -108.52 0.95 21.17 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.988 HG12 HG13 ' A' ' 60' ' ' ILE . 2.1 t -134.79 -44.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 109.786 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -33.91 0.29 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.906 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.988 HG13 HG12 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -77.69 -175.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.88 0.371 . . . . 0.0 111.084 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.23 89.02 13.52 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.209 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.643 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.8 Cg_endo -109.55 145.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.308 2.672 . . . . 0.0 114.104 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 70.6 mt-30 -74.74 79.93 2.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.82 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.32 136.93 54.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.252 -175.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.5 t80 179.16 -144.71 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 57.02 157.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.336 0.589 . . . . 0.0 112.536 178.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.0 tt -121.33 108.69 14.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.923 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -41.95 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.518 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.6 tt0 -171.25 160.28 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.3 131.41 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.556 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.643 ' HB2' HG22 ' A' ' 122' ' ' VAL . 5.6 tp -122.73 137.13 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -125.82 109.8 12.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.4 153.1 47.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.22 132.7 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 111.482 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.9 162.95 21.24 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.012 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_endo -46.31 80.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.194 2.596 . . . . 0.0 112.58 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t0 85.7 11.85 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.786 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.441 ' CG ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -137.35 97.25 3.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.661 0.267 . . . . 0.0 111.148 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.0 OUTLIER -74.9 106.56 6.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.951 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.624 HD12 HD11 ' A' ' 4' ' ' LEU . 1.4 tt -102.11 116.43 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.051 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.32 132.49 49.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -126.14 114.61 18.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.064 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -106.47 123.84 48.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.23 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 2.0 m-85 -105.93 109.9 22.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.675 ' NE1' HG11 ' A' ' 50' ' ' VAL . 19.4 m95 -97.27 149.36 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.444 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.4 tp -99.89 102.84 14.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.253 0.549 . . . . 0.0 111.914 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.82 HG13 ' CB ' ' A' ' 64' ' ' HIS . 12.2 t -84.12 146.16 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.124 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.55 -26.47 8.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 5.4 ttp180 -162.78 159.8 24.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.885 0.766 . . . . 0.0 111.73 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.725 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -152.18 125.89 8.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.329 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -74.37 146.04 43.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.958 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.47 -119.24 14.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.558 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 tt0 -135.07 145.77 55.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.571 0.224 . . . . 0.0 110.792 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 3.7 Cg_exo -76.44 128.84 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.847 2.364 . . . . 0.0 111.241 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.578 ' NE1' HG23 ' A' ' 60' ' ' ILE . 42.2 p-90 -130.42 -64.25 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.43 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . 49.13 -107.68 0.32 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.477 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 164.45 67.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.389 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' OE1' ' CB ' ' A' ' 21' ' ' THR . 2.3 pt-20 -86.36 -37.4 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.07 -6.67 10.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.507 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HB2' ' HG1' ' A' ' 21' ' ' THR . 1.2 mp0 -140.06 97.03 7.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.134 0.467 . . . . 0.0 111.483 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -43.79 145.64 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 112.586 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.34 177.11 19.43 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.964 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.82 157.43 45.41 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -70.3 106.65 3.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.307 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -120.06 163.62 17.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 93.3 p -89.01 127.97 35.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 18' ' ' ILE . 5.1 tp -78.48 -18.9 54.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.6 t -48.93 -24.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.38 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.72 39.64 2.37 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.95 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.769 HD13 HD21 ' A' ' 126' ' ' LEU . 4.1 tt -62.71 140.03 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.756 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -123.1 134.5 54.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.615 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.37 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.278 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.0 -49.15 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -36.28 81.91 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.239 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.7 172.66 8.99 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.273 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.48 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 60.5 Cg_endo -72.77 127.76 12.64 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.139 1.893 . . . . 0.0 111.526 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.27 -14.75 31.01 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.701 2.267 . . . . 0.0 113.28 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.74 -9.73 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -130.62 42.37 3.26 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.725 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.424 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.43 -49.74 5.01 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.4 Cg_exo -44.94 -33.95 8.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.461 2.107 . . . . 0.0 112.591 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' ' 71' ' ' LEU . 14.0 t -77.35 -48.72 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.427 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.704 HG22 ' HB2' ' A' ' 127' ' ' LYS . 8.7 mm -66.33 -31.93 55.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.719 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.66 -26.87 36.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.932 0.396 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -53.17 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.864 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.24 -29.66 48.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.694 0.283 . . . . 0.0 111.47 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.843 ' N ' HD23 ' A' ' 126' ' ' LEU . 24.7 ttpp -55.17 -42.52 73.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.17 0.509 . . . . 0.0 110.74 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -65.13 -11.65 42.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.585 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.2 mp . . . . . 0 C--O 1.231 0.1 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.055 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.8 0.333 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 145.5 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.744 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.5 pp -146.01 128.33 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 13.9 mt-30 -106.95 153.3 22.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 112.029 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.744 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.3 mp -146.44 131.37 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.836 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.058 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.28 124.75 43.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -121.25 162.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 111.904 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 113.31 0.58 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.559 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.891 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.91 105.8 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.716 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -70.97 122.17 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.28 -178.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -93.17 127.72 38.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.342 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 2.5 t-20 -75.33 -172.09 1.65 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 122.219 1.009 . . . . 0.0 113.107 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.04 -17.81 41.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.859 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -120.33 -82.39 0.65 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.724 0.297 . . . . 0.0 111.559 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -158.8 16.05 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.677 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HG2' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -100.91 155.14 18.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.891 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -124.34 144.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.327 0.584 . . . . 0.0 111.957 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.412 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 59.6 t80 -83.65 90.17 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.584 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.885 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -104.44 162.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.298 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.435 HG22 ' OE1' ' A' ' 98' ' ' GLU . 5.5 p . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.845 0.355 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.41 26.22 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.388 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 16.2 tp -69.18 63.88 0.14 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.807 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -177.65 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.53 162.9 30.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.648 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 28.3 Cg_endo -60.94 167.99 7.96 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.538 2.826 . . . . 0.0 111.857 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.28 59.07 0.77 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.255 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.76 121.43 3.43 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.978 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.45 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.306 0.642 . . . . 0.0 111.866 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.058 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -53.81 -27.98 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.541 0.686 . . . . 0.0 110.683 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.599 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.72 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.427 ' HE3' ' HD3' ' A' ' 39' ' ' LYS . 2.4 mmt 34.96 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.362 0.414 . . . . 0.0 111.755 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.77 30.16 0.16 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.452 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.9 mp0 -93.59 -176.6 4.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.733 0.301 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.946 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.84 158.94 33.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.202 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.946 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.76 -24.66 0.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.839 2.359 . . . . 0.0 112.525 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -89.86 -60.58 1.9 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -4.84 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.904 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -63.14 -55.29 26.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 111.103 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -78.25 -45.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.904 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.473 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 58.0 t -55.52 -36.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.37 -49.1 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 40' ' ' ILE . 22.0 tp10 -68.31 -22.6 64.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.212 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -56.52 -45.04 81.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 0.0 110.659 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -27.12 68.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.43 -30.63 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.279 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -109.08 5.78 24.37 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.015 HG12 HG13 ' A' ' 60' ' ' ILE . 2.6 t -134.02 -44.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.26 0.552 . . . . 0.0 110.24 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.586 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.55 7.02 1.25 Allowed Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 114.563 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.015 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -115.39 -172.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 117.902 0.851 . . . . 0.0 110.033 179.082 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 p -114.45 87.59 14.21 Favored Pre-proline 0 N--CA 1.438 -1.074 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.537 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.647 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.4 Cg_endo -113.95 142.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.631 2.887 . . . . 0.0 113.598 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 8.8 mt-30 -74.87 79.94 2.12 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.042 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.15 129.12 53.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.407 -175.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -176.44 -141.69 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.07 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.73 159.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.334 0.588 . . . . 0.0 112.053 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' A' ' 70' ' ' LYS . 5.4 tt -122.18 113.0 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.318 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.44 -48.32 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.093 0.473 . . . . 0.0 110.017 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.39 166.31 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.216 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.34 132.02 22.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.809 0.338 . . . . 0.0 110.977 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.696 ' HB2' HG22 ' A' ' 122' ' ' VAL . 18.2 tp -113.78 120.77 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.64 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.68 109.93 16.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.86 146.46 37.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.717 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.14 120.13 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.072 0.463 . . . . 0.0 111.278 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -69.95 163.18 63.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.505 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -51.76 83.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.024 2.483 . . . . 0.0 112.058 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 26.2 m-20 95.59 15.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.323 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD3' HD21 ' A' ' 4' ' ' LEU . 9.8 ttm180 -137.38 150.17 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.526 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.9 94.1 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.9 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -99.0 118.21 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.95 127.12 55.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.604 HD13 ' CG ' ' A' ' 119' ' ' ASN . 5.4 mt -126.28 114.71 18.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.074 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.544 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -106.32 123.02 47.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.553 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 m-30 -99.72 116.07 30.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.664 ' CE2' HG11 ' A' ' 50' ' ' VAL . 24.3 m95 -100.59 149.18 24.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.257 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tm? -103.04 103.14 13.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.365 0.602 . . . . 0.0 112.04 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.042 HG22 ' ND1' ' A' ' 64' ' ' HIS . 22.2 t -81.01 145.87 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.095 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 1.9 pm0 -119.63 -14.53 9.07 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.601 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 11.3 tpp85 -162.9 154.91 18.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.611 0.641 . . . . 0.0 111.523 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.716 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.55 120.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.539 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.65 144.28 37.53 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 -124.57 36.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.201 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 45.4 mt-10 -135.11 143.08 44.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.519 0.199 . . . . 0.0 110.992 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.548 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.6 Cg_exo -75.92 128.77 11.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.041 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 62.9 p-90 -129.72 -59.85 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.471 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 43.73 -96.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.795 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 175.65 35.98 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.677 0.275 . . . . 0.0 110.999 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 21' ' ' THR . 9.0 pt-20 -55.09 -38.22 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.685 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.1 58.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.43 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -140.13 97.02 7.9 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.087 0.443 . . . . 0.0 111.384 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.56 143.03 2.8 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.078 2.519 . . . . 0.0 112.828 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.27 19.31 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.851 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -142.89 157.38 44.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.326 -0.249 . . . . 0.0 110.326 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.64 105.84 5.92 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.4 ptm -120.75 163.15 18.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.857 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.647 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -78.04 114.83 17.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 110.543 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.862 HD11 HD12 ' A' ' 110' ' ' LEU . 11.3 tp -70.34 -18.86 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.342 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.737 ' CG2' HD21 ' A' ' 129' ' ' LEU . 11.0 p -53.42 -19.25 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.486 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.67 49.73 0.91 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.971 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.862 HD12 HD11 ' A' ' 107' ' ' LEU . 9.2 tt -62.18 150.3 39.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.665 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.425 ' N ' HD23 ' A' ' 110' ' ' LEU . 4.3 t-20 -106.86 104.14 13.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.535 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.81 61.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.077 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.29 -43.42 23.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.982 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -1.87 31.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.201 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.571 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -117.53 170.55 6.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.1 Cg_endo -54.4 127.88 27.78 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.099 1.866 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.94 -20.41 45.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.612 2.208 . . . . 0.0 112.452 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.77 51.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.604 ' CG ' HD13 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -114.71 -2.36 13.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.399 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -47.84 -48.29 61.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.519 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.9 Cg_exo -44.95 -34.88 9.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.27 1.98 . . . . 0.0 112.28 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.29 -51.14 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.618 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.588 HG22 ' HB2' ' A' ' 127' ' ' LYS . 41.8 mm -64.89 -33.5 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.996 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . . . -54.83 -27.04 39.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 111.073 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.19 -52.47 8.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.632 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 126' ' ' LEU . 1.3 tm? -78.19 -30.14 48.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.509 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 123' ' ' ILE . 42.2 tttm -56.69 -42.8 79.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 111.017 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -66.67 -10.09 42.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.721 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.737 HD21 ' CG2' ' A' ' 108' ' ' VAL . 8.0 mp . . . . . 0 C--O 1.231 0.113 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.004 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 132.52 43.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' A' ' 80' ' ' ILE . 3.4 pp -128.29 123.2 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.55 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.0 mt-30 -102.46 152.13 21.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.486 0.66 . . . . 0.0 112.0 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.1 pt -146.56 134.72 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.836 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.4 124.29 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -120.51 160.44 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.249 0.547 . . . . 0.0 111.661 -179.313 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.53 115.29 0.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.645 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.967 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.78 109.33 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -70.78 120.23 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.048 -178.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.711 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.34 118.25 23.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.696 -179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.457 ' CA ' ' CZ3' ' A' ' 90' ' ' TRP . 20.3 t30 -76.09 -172.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.873 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.57 3.89 30.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.315 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -139.22 51.28 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.524 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.09 22.83 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.659 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.763 ' C ' HD12 ' A' ' 18' ' ' ILE . 17.6 mt-10 -117.38 153.29 33.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.967 HG21 HG22 ' A' ' 10' ' ' ILE . 1.4 mp -117.0 143.4 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.963 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 44.7 t80 -87.98 92.84 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.12 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.52 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.62 159.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.741 ' O ' HD12 ' A' ' 33' ' ' LEU . 13.1 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.526 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.638 0.256 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.34 26.24 10.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.733 0.301 . . . . 0.0 111.593 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 21' ' ' THR . 22.2 tp -59.63 76.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.735 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -106.86 -172.65 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 111.679 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.733 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.6 160.56 41.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.901 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.642 ' HG3' HD11 ' A' ' 11' ' ' ILE . 36.7 Cg_endo -64.2 168.41 12.59 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.594 2.863 . . . . 0.0 111.657 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 59.5 0.74 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.037 -1.077 . . . . 0.0 114.082 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -126.92 117.39 2.73 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.655 -0.772 . . . . 0.0 112.039 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 121.62 4.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.395 0.678 . . . . 0.0 111.678 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.034 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -58.7 -26.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.444 0.64 . . . . 0.0 110.753 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.99 -83.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.332 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 33.45 -85.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.465 0.478 . . . . 0.0 111.889 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.46 34.05 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.516 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.462 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -88.18 -173.94 4.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.797 0.332 . . . . 0.0 111.231 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.889 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.2 154.6 37.61 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.396 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.889 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.11 -26.21 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.89 2.393 . . . . 0.0 112.458 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -104.19 -39.35 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.779 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -80.23 -12.61 59.61 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.924 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.2 -52.95 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 111.196 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.15 -43.84 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -53.66 -39.42 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.528 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.35 -52.02 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -67.19 -22.26 65.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.686 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -54.33 -44.44 72.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.205 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -33.88 71.92 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.68 -25.79 49.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.358 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.422 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.1 mp0 -108.69 6.1 25.45 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 60' ' ' ILE . 15.3 t -134.14 -44.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.166 0.507 . . . . 0.0 110.26 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.27 3.55 1.42 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.705 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.963 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.88 -173.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 117.999 0.9 . . . . 0.0 110.431 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.5 p -114.21 87.59 13.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.607 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -115.25 145.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.578 2.852 . . . . 0.0 114.217 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.84 79.94 2.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.997 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.6 131.67 54.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.018 -175.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -178.92 -140.97 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 58.26 158.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.248 0.547 . . . . 0.0 112.116 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -120.97 110.69 16.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.296 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.59 -46.3 26.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.182 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.53 157.49 4.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.269 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 115.34 8.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.836 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.575 ' CB ' HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -109.19 136.55 48.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.594 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -130.44 115.54 16.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -135.47 147.66 48.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.633 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 4.8 pt-20 -120.07 127.06 52.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.105 0.479 . . . . 0.0 111.284 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.06 163.51 59.65 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.1 Cg_endo -53.8 82.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.992 2.461 . . . . 0.0 112.404 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER 101.57 11.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.959 0.904 . . . . 0.0 111.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.29 150.01 47.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.773 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 4.6 m170 -124.0 101.53 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.534 ' CG1' HD11 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -100.64 128.31 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.75 118.94 28.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.665 ' CD1' HG21 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -126.15 115.17 19.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.439 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.565 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -106.81 122.87 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.509 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CD2' HG11 ' A' ' 122' ' ' VAL . 7.3 m-30 -98.61 119.03 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.095 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.697 ' NE1' HG11 ' A' ' 50' ' ' VAL . 21.4 m95 -101.25 149.2 24.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.538 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.2 tm? -102.49 102.91 13.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.441 0.639 . . . . 0.0 112.053 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' ND1' ' A' ' 64' ' ' HIS . 17.0 t -80.19 146.0 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.027 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.71 -23.24 9.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.25 160.05 26.4 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.873 0.761 . . . . 0.0 111.606 -178.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.668 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -156.92 124.3 5.31 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.381 179.169 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -82.78 127.6 33.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.52 -125.18 6.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.324 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 69.4 mt-10 -135.08 138.43 29.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.625 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.11 128.74 10.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.76 2.307 . . . . 0.0 111.132 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.582 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.3 p-90 -135.5 -57.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.268 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 46.77 -94.29 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.868 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -178.87 34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.687 0.28 . . . . 0.0 111.156 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.29 -34.9 78.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.889 0.376 . . . . 0.0 110.412 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.26 68.57 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.342 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -140.28 95.95 8.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.6 133.44 7.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.989 2.459 . . . . 0.0 112.789 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.33 177.44 19.18 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.762 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -147.55 157.05 43.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.68 106.29 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 22.0 ptm -120.38 150.96 39.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.1 p -70.59 114.65 8.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.752 ' HB2' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -65.16 -21.54 66.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.89 -17.79 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.509 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.42 35.04 4.95 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.816 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 107' ' ' LEU . 12.6 tp -62.5 125.7 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 139.5 54.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -15.76 61.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.395 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.94 -48.56 14.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.472 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -40.38 88.13 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.626 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.99 174.17 6.53 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.1 Cg_endo -76.18 130.26 11.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.263 1.975 . . . . 0.0 111.457 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.76 -14.5 17.87 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.886 2.391 . . . . 0.0 113.556 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -10.57 13.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.527 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.7 m-20 -134.99 45.43 2.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.765 0.317 . . . . 0.0 111.553 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.09 -49.38 7.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.2 Cg_exo -44.89 -36.74 11.33 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.455 2.103 . . . . 0.0 112.871 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.742 HG11 ' CD2' ' A' ' 84' ' ' PHE . 20.3 t -77.46 -51.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.984 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.586 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 10.7 mm -65.36 -32.1 56.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.8 -27.9 45.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.997 0.427 . . . . 0.0 110.725 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -48.49 13.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.509 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.0 tm? -78.04 -28.87 49.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.476 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.468 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.0 ttpp -55.5 -42.64 74.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -69.96 -7.72 42.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.804 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.216 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 tptt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.837 0.351 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -113.98 145.16 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.679 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.09 122.15 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -102.37 154.0 19.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.336 0.588 . . . . 0.0 111.869 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.4 mp -146.12 130.93 11.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.74 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.39 124.29 42.02 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -114.63 162.17 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.421 0.629 . . . . 0.0 111.913 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.54 106.01 0.43 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.985 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.831 HG23 ' CG1' ' A' ' 18' ' ' ILE . 2.8 mp -70.29 100.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.694 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.14 126.51 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -96.42 140.61 30.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.504 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.493 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 14.8 t30 -107.88 -172.39 2.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.89 0.853 . . . . 0.0 112.666 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.26 -18.26 63.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.259 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.15 39.12 2.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.885 0.374 . . . . 0.0 110.891 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.17 28.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.556 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -106.6 145.42 31.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.328 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.831 ' CG1' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -106.7 127.19 62.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 0.0 111.872 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.73 ' N ' HD12 ' A' ' 18' ' ' ILE . 51.0 t80 -78.09 87.49 4.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.753 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.702 HD11 ' SD ' ' A' ' 105' ' ' MET . 1.2 pt -112.79 162.29 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 100' ' ' GLN . 14.2 p . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t30 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.57 0.224 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.28 26.16 10.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.89 0.376 . . . . 0.0 111.3 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 33' ' ' LEU . 6.6 tt -39.58 93.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.307 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.1 tt0 -120.62 -168.88 1.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.164 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.75 158.16 50.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.531 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 18.0 Cg_endo -58.17 167.83 4.23 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.513 2.809 . . . . 0.0 111.496 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.56 59.24 0.75 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.692 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.626 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -125.15 120.7 4.02 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 114.447 -0.876 . . . . 0.0 112.026 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.55 5.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.329 0.652 . . . . 0.0 111.751 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.8 -26.03 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.486 0.66 . . . . 0.0 110.733 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.543 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.31 -82.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.185 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 33.67 -86.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.507 0.504 . . . . 0.0 111.86 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.24 31.87 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.503 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.99 -175.64 4.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.809 0.338 . . . . 0.0 111.16 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.921 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.04 159.58 28.84 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.463 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.921 ' HD2' HG22 ' A' ' 45' ' ' THR . 7.0 Cg_endo -47.79 -24.44 4.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.468 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -97.8 -47.45 5.57 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 4.8 mm-40 -80.13 -25.57 39.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.939 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -55.63 -47.54 76.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.809 0.337 . . . . 0.0 110.988 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.839 HG12 ' HB1' ' A' ' 7' ' ' ALA . 2.8 m -78.14 -45.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.7 t -62.58 -35.79 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.449 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -78.31 -41.68 33.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.458 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.641 ' CB ' HG22 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -78.13 -26.23 47.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.318 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.961 HD23 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -57.57 -45.11 85.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.572 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -26.85 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.311 0.577 . . . . 0.0 109.489 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.11 -26.76 53.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.117 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -108.32 5.16 25.29 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 54' ' ' LEU . 1.3 t -134.78 -44.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.282 0.563 . . . . 0.0 109.603 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.6 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 59.78 0.48 1.0 Allowed Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.412 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.881 ' CG1' HG12 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -105.51 -173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.605 0.702 . . . . 0.0 110.375 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -114.55 88.04 15.28 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.374 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.574 ' HG2' ' HB3' ' A' ' 64' ' ' HIS . 98.3 Cg_endo -112.11 152.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.927 3.084 . . . . 0.0 113.478 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.423 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 35.5 mt-30 -74.76 78.67 2.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.961 ' CD2' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -111.19 120.25 41.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.555 -1.657 . . . . 0.0 112.089 -174.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -178.55 -148.19 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.99 161.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.163 0.506 . . . . 0.0 112.006 179.039 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -125.31 116.98 22.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -76.54 -56.55 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 109.924 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mt-10 -172.05 131.66 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.171 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -117.38 132.01 56.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.603 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -117.78 134.67 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.4 109.87 15.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -126.24 153.05 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.522 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.09 133.91 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.52 . . . . 0.0 111.412 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -96.6 162.92 21.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.146 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 5.7 Cg_endo -47.6 80.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.166 2.577 . . . . 0.0 112.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' PHE . 5.0 t0 86.45 12.73 0.15 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.641 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.41 94.82 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.733 0.302 . . . . 0.0 111.112 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -74.84 109.31 8.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.751 0.31 . . . . 0.0 110.844 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -106.99 111.97 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.029 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.55 125.71 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 71' ' ' LEU . 1.1 pp -126.45 114.88 18.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.69 0.281 . . . . 0.0 111.467 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -108.54 122.76 47.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 9.8 m-30 -101.67 121.0 41.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 111.086 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.758 ' NE1' HG11 ' A' ' 50' ' ' VAL . 19.5 m95 -101.64 149.23 24.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 65' ' ' PHE . 26.1 tp -100.18 103.44 14.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.914 HG13 ' HA ' ' A' ' 64' ' ' HIS . 10.3 t -86.29 145.29 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.03 -32.83 9.51 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.26 165.5 26.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.49 0.586 . . . . 0.0 111.59 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.694 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -152.04 128.71 10.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.554 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -77.0 135.18 38.67 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.85 -125.84 20.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.431 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.4 tt0 -132.92 143.22 47.68 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.527 0.203 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.668 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.7 Cg_exo -76.27 128.86 10.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.83 2.353 . . . . 0.0 111.408 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.6 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -125.36 -61.26 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.179 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.26 -103.64 0.04 OUTLIER Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.04 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.27 38.39 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.556 0.217 . . . . 0.0 111.093 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.48 -41.73 73.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 110.79 -19.63 25.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.143 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.604 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -126.54 99.14 30.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.036 0.446 . . . . 0.0 111.477 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.62 146.43 1.39 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.172 2.581 . . . . 0.0 112.663 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.12 177.39 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.758 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -143.21 157.17 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -74.08 106.39 5.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.702 ' SD ' HD11 ' A' ' 20' ' ' ILE . 4.1 ptm -120.42 163.0 18.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.95 114.89 23.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.814 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -64.32 -18.96 65.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.713 ' O ' HD21 ' A' ' 129' ' ' LEU . 12.0 p -54.44 -20.46 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.682 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.74 42.57 1.43 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.222 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.583 HD12 HD21 ' A' ' 107' ' ' LEU . 8.0 tt -62.94 150.29 42.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.806 0.303 . . . . 0.0 110.204 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -122.88 131.16 53.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -14.84 61.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -49.22 13.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.18 -38.82 86.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.887 0.375 . . . . 0.0 111.07 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.81 174.4 6.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 71.6 Cg_endo -75.21 127.76 10.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.176 1.917 . . . . 0.0 111.489 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.71 -15.0 39.31 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.667 2.245 . . . . 0.0 113.049 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.52 -9.76 57.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.583 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -122.64 28.67 7.22 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -70.64 -39.72 9.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -53.5 -42.19 67.57 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.988 1.792 . . . . 0.0 112.308 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -77.43 -51.36 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.423 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.31 -29.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.961 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -34.3 64.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 110.432 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.17 -49.63 66.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.91 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' A' ' 68' ' ' PHE . 9.2 tp -78.19 -28.63 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.618 ' O ' HD12 ' A' ' 129' ' ' LEU . 17.2 tttt -57.08 -42.67 81.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.998 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -72.72 -5.09 35.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.983 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 108' ' ' VAL . 3.7 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.847 0.355 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 136.26 54.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.41 128.49 20.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.48 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.2 mt-30 -102.45 154.16 19.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.331 0.586 . . . . 0.0 111.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.434 ' HB ' HD23 ' A' ' 82' ' ' LEU . 38.2 mm -146.31 129.39 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.892 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.5 42.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.578 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.13 161.95 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.445 0.64 . . . . 0.0 111.972 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.04 121.43 1.19 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.642 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.486 ' HB ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -73.77 108.85 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.719 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.26 127.79 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 0.0 111.709 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.09 131.67 43.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.123 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.771 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p-10 -87.8 -173.04 4.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.357 0.599 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 22.1 tt0 -73.54 6.29 3.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.391 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 21.5 t-20 -130.33 45.06 2.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.048 -0.407 . . . . 0.0 112.052 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 46.92 25.48 0.47 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.918 0.39 . . . . 0.0 111.369 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.509 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.53 161.61 18.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.661 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.3 144.37 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.058 0.456 . . . . 0.0 111.88 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.98 102.66 14.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.423 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.01 162.14 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.334 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.937 HG22 ' O ' ' A' ' 34' ' ' GLU . 10.1 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t-20 . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.33 26.35 10.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 114' ' ' ASP . 2.2 tt -52.55 84.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.766 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.937 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -123.15 176.5 6.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.177 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.81 166.43 14.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 0.0 112.075 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.4 Cg_endo -47.44 168.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.924 3.083 . . . . 0.0 112.628 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.64 59.46 0.75 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.099 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.68 112.09 1.15 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 114.262 -0.969 . . . . 0.0 112.045 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.02 6.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.4 0.68 . . . . 0.0 111.853 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.013 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -55.06 -27.59 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.271 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.9 -80.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.206 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.3 mmm 38.64 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.355 0.41 . . . . 0.0 111.662 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.68 33.79 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.67 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.492 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -96.94 -170.26 2.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.65 0.262 . . . . 0.0 111.019 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.924 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.9 159.04 30.68 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.287 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.924 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.91 -24.66 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.777 2.318 . . . . 0.0 112.5 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -92.91 -58.1 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 8.0 pt20 -80.66 -4.88 55.9 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.795 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -63.16 -57.27 11.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 111.013 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.617 HG22 HD13 ' A' ' 54' ' ' LEU . 1.4 p -78.78 -42.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.77 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.3 t -50.65 -35.65 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.203 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -78.21 -52.12 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.685 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -62.17 -20.09 63.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.625 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.9 HD11 ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -57.46 -44.67 85.0 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.93 -27.6 68.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.914 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.19 -30.4 54.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.282 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.49 6.4 26.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.912 HG12 HG13 ' A' ' 60' ' ' ILE . 43.4 t -133.43 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.78 -40.17 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.006 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.912 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.53 -177.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.06 0.457 . . . . 0.0 111.112 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.71 88.72 14.29 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.738 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.0 Cg_endo -111.55 146.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.404 2.736 . . . . 0.0 114.211 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.1 mt-30 -74.85 79.73 2.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.951 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.21 128.45 52.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.058 -176.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.11 -139.53 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.622 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.45 158.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.12 0.486 . . . . 0.0 111.85 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.594 HD21 ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -121.07 109.89 15.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.577 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.75 -43.39 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.977 0.418 . . . . 0.0 110.139 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt-10 -171.3 166.02 7.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.516 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.17 132.12 22.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 tp -117.4 124.55 49.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -122.28 110.16 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.649 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -140.67 153.16 45.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.686 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.25 140.22 48.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.296 0.569 . . . . 0.0 111.284 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.33 163.85 16.64 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.534 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 53.8 Cg_exo -41.58 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.534 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.3 t0 73.56 20.67 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.597 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttt180 -137.31 93.87 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.317 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.54 98.61 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 110.94 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.62 111.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.98 133.83 43.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.771 HD13 HD21 ' A' ' 119' ' ' ASN . 32.1 mt -126.22 114.36 18.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.489 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.14 122.7 48.23 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.6 125.2 50.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.53 ' CE2' HG11 ' A' ' 50' ' ' VAL . 67.5 m95 -107.57 148.56 29.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.2 tp -98.97 103.01 14.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.326 0.584 . . . . 0.0 111.261 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.951 HG22 ' ND1' ' A' ' 64' ' ' HIS . 13.3 t -81.84 145.61 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.845 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.63 -35.34 6.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.56 165.66 25.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.843 0.747 . . . . 0.0 112.014 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.771 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.5 p90 -151.02 130.76 13.16 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.6 139.67 40.73 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.43 -121.84 23.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.8 mt-10 -131.94 145.59 58.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.558 0.218 . . . . 0.0 110.835 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.63 128.71 10.4 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.841 2.361 . . . . 0.0 111.363 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.564 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.6 p-90 -133.34 -60.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.133 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.05 -100.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.001 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.56 32.85 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.3 pt-20 -64.79 -27.04 68.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.35 . . . . 0.0 110.688 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.14 31.6 81.28 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.729 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 5.9 mm-40 -140.42 91.96 9.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.045 0.45 . . . . 0.0 111.253 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -43.6 126.51 5.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.025 2.483 . . . . 0.0 112.854 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 177.2 19.35 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.762 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.34 157.16 42.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -68.83 106.28 2.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.047 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.9 ptm -120.39 147.41 45.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.697 ' HB2' HG12 ' A' ' 108' ' ' VAL . 77.0 p -70.76 115.08 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.661 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -62.03 -18.65 61.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.909 ' HA ' HD21 ' A' ' 129' ' ' LEU . 12.1 p -59.02 -9.94 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.783 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.13 50.36 0.89 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.164 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.75 HD13 ' N ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -62.11 142.27 57.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 110.404 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.75 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -119.2 114.77 22.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.27 61.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.242 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.94 -49.11 13.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.741 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -68.44 -33.43 74.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.768 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.06 174.03 6.63 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.406 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 64.4 Cg_endo -74.23 127.78 11.54 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.134 1.889 . . . . 0.0 111.387 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.86 -14.85 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.742 2.295 . . . . 0.0 113.285 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.4 -9.82 37.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.771 HD21 HD13 ' A' ' 82' ' ' LEU . 1.3 m-20 -130.16 37.82 3.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -72.19 -43.99 10.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -54.78 -38.96 91.76 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.106 1.871 . . . . 0.0 112.169 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 69' ' ' GLU . 2.2 t -77.45 -51.31 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.01 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.522 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.36 -29.85 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.72 -31.06 57.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.393 . . . . 0.0 110.443 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -69.62 -52.43 25.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.705 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.7 tp -78.21 -19.53 53.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.585 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.41 -42.62 64.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.892 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -76.02 -3.65 36.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.131 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.841 0.353 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 132.76 56.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -138.38 128.06 25.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.3 mt-30 -102.48 154.19 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.275 0.559 . . . . 0.0 111.792 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.519 ' HB ' HD23 ' A' ' 82' ' ' LEU . 37.9 mm -146.33 129.04 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.923 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.54 42.41 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.43 162.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.339 0.59 . . . . 0.0 111.893 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.95 120.85 1.12 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.688 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.76 108.94 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.726 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.32 127.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.796 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.03 132.37 42.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.081 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.768 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.7 p-10 -88.95 -173.01 3.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 111.931 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 23.1 tt0 -73.29 5.8 3.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.391 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 19.7 t-20 -129.92 44.93 2.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.982 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.7 p30 46.76 25.61 0.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.427 . . . . 0.0 111.396 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.42 161.62 18.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.666 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.55 144.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.032 0.444 . . . . 0.0 111.828 -178.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.48 102.18 13.96 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.099 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.14 162.08 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.362 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.933 HG22 ' O ' ' A' ' 34' ' ' GLU . 11.0 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.981 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.8 t-20 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.551 0.215 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -114.41 26.32 10.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.744 HD12 ' HB3' ' A' ' 114' ' ' ASP . 2.2 tt -52.66 84.71 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.752 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.933 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -124.03 176.72 6.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.76 166.25 15.37 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.062 0.458 . . . . 0.0 112.014 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.5 Cg_endo -47.62 168.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.85 3.033 . . . . 0.0 112.527 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.54 59.47 0.75 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.112 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.84 110.33 0.95 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.252 -0.974 . . . . 0.0 112.039 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.627 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 118.14 4.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.344 0.658 . . . . 0.0 111.734 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.013 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.65 -27.91 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.561 0.696 . . . . 0.0 110.343 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.54 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.26 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 78.4 mmm 39.13 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.304 0.377 . . . . 0.0 111.586 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.67 33.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.702 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.494 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -96.92 -170.15 1.99 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.555 0.217 . . . . 0.0 111.055 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.915 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.55 158.97 30.85 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.915 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.88 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.902 2.402 . . . . 0.0 112.496 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -92.66 -58.29 2.4 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -80.72 -4.78 55.68 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.785 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.85 -57.24 11.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.792 0.329 . . . . 0.0 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.629 HG22 HD13 ' A' ' 54' ' ' LEU . 1.4 p -78.76 -42.75 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.783 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.2 t -50.66 -35.55 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.225 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -52.15 9.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.926 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.0 mm-40 -63.34 -19.84 64.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.693 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.923 HD11 ' HE2' ' A' ' 64' ' ' HIS . 2.7 tp -56.76 -44.68 82.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.071 0.462 . . . . 0.0 110.541 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.73 -27.02 68.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.899 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.2 tm-20 -77.2 -30.63 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.23 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.448 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.44 6.69 26.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.914 HG12 HG13 ' A' ' 60' ' ' ILE . 43.8 t -133.48 -44.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -40.1 0.25 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.951 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.914 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.46 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.014 0.435 . . . . 0.0 111.095 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.55 88.7 13.85 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.996 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.742 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.8 Cg_endo -111.48 146.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 123.394 2.729 . . . . 0.0 114.219 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.8 mt-30 -74.74 79.64 2.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.956 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.94 128.64 52.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.006 -176.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.04 -139.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.587 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.83 157.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.099 0.476 . . . . 0.0 111.86 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.558 HD21 ' HD3' ' A' ' 70' ' ' LYS . 5.3 tt -119.71 109.44 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.79 -43.54 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.151 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 2.7 mt-10 -171.24 165.66 7.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.624 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.15 132.11 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 tp -116.89 123.75 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -121.5 109.99 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.638 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -140.89 153.25 45.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -114.22 140.2 48.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.273 0.558 . . . . 0.0 111.307 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.75 163.84 16.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.475 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 54.1 Cg_exo -41.36 81.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.338 2.692 . . . . 0.0 112.554 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.6 t0 73.62 20.48 3.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.607 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 7.5 ttt180 -137.23 93.92 2.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.6 98.82 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 110.942 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.64 111.87 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.52 133.76 44.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.787 HD13 HD21 ' A' ' 119' ' ' ASN . 35.1 mt -126.16 114.39 18.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.453 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.08 122.66 48.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.46 125.73 51.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.348 . . . . 0.0 111.269 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.551 ' HE1' ' HB1' ' A' ' 7' ' ' ALA . 67.6 m95 -107.86 148.5 29.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.7 tp -98.74 102.81 14.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 111.332 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.956 HG22 ' ND1' ' A' ' 64' ' ' HIS . 13.9 t -81.5 145.65 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -109.53 -35.17 6.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.44 165.64 26.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.845 0.748 . . . . 0.0 112.017 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.768 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.4 p90 -151.47 130.54 12.63 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.572 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -76.35 140.87 41.62 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.16 -121.94 25.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.468 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.7 mt-10 -131.84 145.81 59.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.536 0.208 . . . . 0.0 110.779 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.72 128.76 10.36 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.836 2.357 . . . . 0.0 111.362 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.8 p-90 -133.51 -60.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.124 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.84 -99.66 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.02 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.46 33.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.554 0.216 . . . . 0.0 111.278 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.8 pt-20 -65.57 -26.81 68.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 0.0 110.608 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.54 32.04 82.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.836 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 6.5 mm-40 -140.38 92.2 9.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 111.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -43.57 126.37 5.38 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.091 2.527 . . . . 0.0 112.817 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.27 177.17 19.37 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.853 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.92 157.14 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -69.01 106.23 2.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.887 0.375 . . . . 0.0 110.031 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 9.6 ptm -120.47 148.12 44.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.036 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.686 ' HB2' HG12 ' A' ' 108' ' ' VAL . 77.4 p -70.89 114.97 9.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.058 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.666 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -61.41 -18.7 60.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.909 ' HA ' HD21 ' A' ' 129' ' ' LEU . 11.9 p -59.3 -9.63 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.836 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.45 49.62 0.92 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.276 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -62.22 142.11 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 110.42 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.734 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -120.04 115.87 24.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.16 61.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.211 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -49.03 13.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.744 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -68.39 -33.51 74.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.76 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.14 174.02 6.64 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.394 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.47 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.5 Cg_endo -73.95 127.81 11.78 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.107 1.871 . . . . 0.0 111.363 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.02 -14.83 30.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.738 2.292 . . . . 0.0 113.266 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -9.75 39.58 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.787 HD21 HD13 ' A' ' 82' ' ' LEU . 1.3 m-20 -130.07 37.82 3.86 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.84 -43.87 11.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.2 Cg_exo -54.76 -38.92 91.62 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.134 1.889 . . . . 0.0 112.244 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.434 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 2.3 t -77.55 -51.31 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.036 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.526 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.41 -29.87 47.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.027 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.66 -30.95 56.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.987 0.422 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -69.8 -52.52 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.868 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.695 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.9 tp -78.16 -19.52 53.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.23 -42.74 65.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.114 0.483 . . . . 0.0 110.882 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -75.58 -3.92 37.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.176 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttp . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 121.94 19.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.51 125.99 54.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.761 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 10.8 mt-30 -102.95 160.05 14.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.09 0.472 . . . . 0.0 111.482 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.615 HD12 ' CD1' ' A' ' 82' ' ' LEU . 39.8 mt -144.8 135.2 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.461 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.006 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.39 150.11 45.95 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -144.99 149.95 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.938 0.399 . . . . 0.0 111.143 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.6 111.35 0.5 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.09 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -81.13 109.62 15.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.743 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -71.03 119.38 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.228 0.537 . . . . 0.0 111.82 -178.151 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 1.4 mmt85 -83.22 124.31 30.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.756 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -78.05 -172.92 2.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.528 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 tt0 -85.74 16.46 3.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.553 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -142.63 50.59 1.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.919 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.0 25.6 0.5 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.142 0.496 . . . . 0.0 111.217 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 105' ' ' MET . 39.4 mt-10 -120.54 161.47 21.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.09 HG21 HG22 ' A' ' 10' ' ' ILE . 13.0 mt -122.26 139.25 49.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.211 0.529 . . . . 0.0 111.356 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.9 OUTLIER -86.19 94.36 9.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.869 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -114.48 148.59 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.688 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.8 t . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.433 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.832 0.349 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -114.11 26.3 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.112 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 21.5 tp -64.04 70.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -118.37 178.08 4.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.03 162.36 33.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.187 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 8.0 Cg_endo -48.02 169.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.941 3.094 . . . . 0.0 111.482 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.48 59.97 0.71 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.664 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -144.42 107.64 0.45 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 114.222 -0.989 . . . . 0.0 111.67 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.96 -10.79 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.516 0.726 . . . . 0.0 110.513 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.006 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.75 -78.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.044 0.449 . . . . 0.0 110.961 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.625 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 5.38 -80.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.344 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttm 37.29 -133.43 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.378 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.32 14.81 5.6 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.033 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -71.09 -164.56 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 110.805 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.872 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.62 154.41 37.49 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.872 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.29 -24.82 1.07 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -100.28 -47.97 4.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.99 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.37 -7.15 58.97 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -65.53 -55.62 16.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.565 0.221 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.743 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.27 -40.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.06 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.58 -35.4 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.432 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -42.76 31.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.457 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -67.26 -26.12 66.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.251 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.621 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.1 tp -52.55 -44.35 65.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.54 -33.08 74.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.1 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -77.36 -25.57 51.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.149 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 4.2 mm-40 -108.18 5.19 25.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 18.4 t -135.22 -44.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.319 0.581 . . . . 0.0 110.309 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.62 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.48 4.62 1.39 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.604 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.07 -173.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 117.897 0.848 . . . . 0.0 110.831 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.9 p -113.72 87.48 12.24 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.545 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.754 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.1 Cg_endo -115.27 149.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.643 2.895 . . . . 0.0 114.22 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.02 79.82 2.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.85 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.5 130.5 52.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.244 -175.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.55 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -177.86 -139.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.794 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.79 175.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.847 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.763 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -143.11 123.96 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.926 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.55 -44.61 34.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.498 . . . . 0.0 109.796 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.45 164.83 6.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.036 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 127.69 17.49 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 121' ' ' PRO . 48.7 tp -106.63 121.09 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.503 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -122.22 112.01 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -141.04 148.06 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.45 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -121.08 139.97 52.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.457 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -105.04 162.76 18.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.285 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.477 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 7.6 Cg_endo -49.72 82.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.099 2.533 . . . . 0.0 112.25 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.2 m-20 87.74 11.35 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.595 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -137.28 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 0.0 110.866 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -80.34 107.15 12.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 tt -100.42 111.74 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.71 135.11 42.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.924 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.823 HD21 ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -126.26 114.44 18.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.774 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -116.15 122.79 46.12 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.769 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 1.7 m-85 -113.6 113.44 25.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.877 0.37 . . . . 0.0 110.273 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.763 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 44.0 m95 -94.77 148.59 22.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 65' ' ' PHE . 50.4 tp -104.8 102.73 12.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.391 0.615 . . . . 0.0 111.251 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.85 HG22 ' ND1' ' A' ' 64' ' ' HIS . 12.6 t -80.88 145.8 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.291 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.77 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -161.78 165.52 27.82 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.868 0.758 . . . . 0.0 112.065 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.743 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.1 p90 -149.84 131.49 14.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.489 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.53 136.38 33.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -140.82 19.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.526 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.0 tt0 -115.1 129.82 24.75 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.383 0.135 . . . . 0.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.55 128.78 10.51 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.649 2.233 . . . . 0.0 111.721 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.62 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.1 p-90 -135.3 -57.74 0.8 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.866 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.51 -104.07 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.137 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 166.57 40.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -41.26 91.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.981 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.97 -104.03 0.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.932 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -92.95 120.61 66.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -43.62 146.14 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.066 2.511 . . . . 0.0 112.682 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.31 19.23 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.808 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.5 157.23 29.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 110.735 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.1 m0 -60.39 106.87 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 110.426 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -120.19 156.73 30.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.476 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 5.0 t -81.1 116.86 21.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.843 HD22 ' CD1' ' A' ' 18' ' ' ILE . 6.3 tp -72.66 -18.7 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 108' ' ' VAL . 21.6 t -49.67 -21.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.72 0.295 . . . . 0.0 111.452 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.23 50.51 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.886 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 107' ' ' LEU . 8.6 tt -62.12 150.31 38.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -104.11 101.22 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -16.89 61.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.27 0.557 . . . . 0.0 110.083 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.51 -48.81 13.24 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.073 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -35.64 80.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.008 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.6 169.19 21.87 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.415 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.4 Cg_endo -54.63 131.8 47.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.55 2.167 . . . . 0.0 112.93 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.504 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.17 -14.07 37.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.072 2.515 . . . . 0.0 112.627 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.04 58.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.823 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.7 m-20 -121.38 25.89 9.18 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.02 -38.84 3.94 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.9 Cg_exo -44.82 -41.9 15.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.181 1.921 . . . . 0.0 113.204 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.769 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -77.42 -51.34 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.071 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.1 mm -65.37 -29.93 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.222 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.23 63.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.13 0.49 . . . . 0.0 110.35 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -71.06 -48.58 51.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.835 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.24 -30.8 48.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.835 ' N ' HD23 ' A' ' 126' ' ' LEU . 35.2 tttp -54.9 -42.64 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -67.16 -10.1 46.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.8 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.7 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.069 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.79 131.88 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.801 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.5 pp -125.57 123.02 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.593 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.4 153.75 19.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.339 0.59 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.506 ' CG2' HD23 ' A' ' 82' ' ' LEU . 89.3 mt -146.36 131.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.107 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.043 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.6 124.46 42.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.5 m -117.13 162.68 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.45 . . . . 0.0 111.697 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -144.46 115.0 0.83 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.606 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.757 HG22 HG13 ' A' ' 18' ' ' ILE . 1.5 mp -70.61 95.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.698 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.0 111.82 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.47 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -85.51 136.26 33.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.046 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.652 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 23.5 p30 -105.94 -172.89 2.17 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.766 0.793 . . . . 0.0 112.687 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -68.21 -4.4 13.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.693 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 8.6 t-20 -124.19 42.51 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.087 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 46.22 27.05 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.613 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB3' ' HA ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.867 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.85 146.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.378 0.608 . . . . 0.0 112.295 -178.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.557 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t80 -90.04 95.79 10.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.86 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.867 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -108.34 162.19 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.356 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.665 0.269 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.5 26.18 10.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.717 0.294 . . . . 0.0 111.65 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.0 tt -54.15 83.71 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.757 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.78 -179.08 3.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.84 0.353 . . . . 0.0 111.412 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.534 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 160.98 40.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.648 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 29.0 Cg_endo -61.5 168.09 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.484 2.789 . . . . 0.0 111.528 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.45 59.34 0.75 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.98 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.94 121.02 3.43 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.777 -0.711 . . . . 0.0 112.05 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 115.02 6.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.382 0.673 . . . . 0.0 111.817 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.046 HD12 ' HB1' ' A' ' 49' ' ' ALA . 1.1 pt -58.24 -25.92 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.582 0.706 . . . . 0.0 110.573 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HB3' ' H ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -45.1 -85.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.24 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 38.29 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.312 0.383 . . . . 0.0 111.615 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.57 32.68 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.541 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.7 mp0 -91.6 -176.46 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.86 0.362 . . . . 0.0 111.222 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.916 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.64 156.17 35.62 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.916 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.99 -24.77 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.797 2.331 . . . . 0.0 112.715 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.32 -48.27 5.39 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -80.27 -14.01 58.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.046 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.93 -52.97 62.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 111.073 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.821 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.1 m -77.93 -44.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.6 t -57.77 -35.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.127 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -52.09 9.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.496 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.1 mm-40 -65.42 -24.21 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.936 HD21 ' CE1' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -52.2 -44.27 64.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.88 0.371 . . . . 0.0 110.345 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -36.6 78.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.86 -25.03 48.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.493 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 76.4 mm-40 -108.44 5.94 25.79 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.964 HG12 HG13 ' A' ' 60' ' ' ILE . 14.5 t -134.37 -44.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 110.543 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 60.59 5.29 4.88 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.623 -0.717 . . . . 0.0 114.353 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.964 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.5 -166.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 117.859 0.829 . . . . 0.0 110.852 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.601 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -112.57 88.08 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.813 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.4 Cg_endo -113.57 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.49 2.793 . . . . 0.0 114.462 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 27.8 mt-30 -74.65 79.39 2.01 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.936 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -113.04 132.9 55.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.684 -175.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -177.12 -143.1 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.829 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 2.1 m 52.14 171.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 112.245 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 67' ' ' LEU . 4.8 tt -134.24 114.48 13.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.452 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.565 ' HE1' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.49 -56.04 4.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.811 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -171.51 131.84 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.241 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -114.59 132.08 56.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HB2' HG22 ' A' ' 122' ' ' VAL . 7.5 tp -107.34 141.44 38.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -131.32 109.72 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.683 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -141.02 138.25 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.296 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 8.3 pt-20 -107.41 140.11 40.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.262 0.553 . . . . 0.0 111.718 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -101.34 163.05 18.65 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.053 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 4.2 Cg_endo -46.6 81.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.196 2.598 . . . . 0.0 112.532 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.3 m-20 85.61 11.87 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.689 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HG2' HD23 ' A' ' 4' ' ' LEU . 3.6 ttt180 -137.42 94.89 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 12.6 t-160 -74.84 97.92 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 tt -94.47 111.93 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.03 129.43 54.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.822 HD13 ' OD1' ' A' ' 119' ' ' ASN . 11.4 mt -126.45 114.75 18.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.425 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.521 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -110.29 122.88 48.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.464 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 11.7 m-30 -103.22 113.08 26.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.735 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.9 m95 -95.07 148.86 21.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.548 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.2 tm? -90.9 102.87 15.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.225 0.536 . . . . 0.0 111.551 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.9 t -89.53 144.87 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 4.7 pm0 -121.28 -13.5 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -160.94 160.05 30.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.044 1.293 . . . . 0.0 112.357 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.653 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -158.0 122.17 4.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.73 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.601 ' CB ' HG23 ' A' ' 61' ' ' THR . 1.5 mm-40 -83.33 117.98 23.37 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.882 0.372 . . . . 0.0 111.096 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.3 -125.61 8.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.531 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.13 136.12 28.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.577 -0.156 . . . . 0.0 110.577 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.676 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.99 128.91 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.766 2.311 . . . . 0.0 111.285 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 50.8 p-90 -140.95 -58.09 0.5 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.129 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 47.87 -93.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.501 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -171.93 33.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.787 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 26.0 pt-20 -62.0 -47.09 86.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 99.46 -24.4 32.36 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.277 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -112.27 95.67 31.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.574 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.5 146.14 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.173 2.582 . . . . 0.0 112.767 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.71 18.95 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.76 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.43 154.39 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.52 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -66.83 105.62 1.64 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.073 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.718 ' SD ' HD11 ' A' ' 20' ' ' ILE . 1.1 ptm -121.06 153.38 37.48 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.378 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 5.4 p -74.21 114.96 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.146 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.9 tm? -60.78 -24.45 65.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.685 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.5 t -55.49 -19.78 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.96 35.15 4.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.025 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 110' ' ' LEU . 10.8 tp -62.83 130.23 43.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.12 136.07 54.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.38 -15.43 61.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.657 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -78.85 -49.1 13.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.624 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -35.26 77.96 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.488 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -82.82 174.02 6.67 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.636 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 68.4 Cg_endo -74.75 127.99 11.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.256 1.971 . . . . 0.0 111.488 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.13 -14.74 25.03 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.774 2.316 . . . . 0.0 113.35 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.99 -9.9 25.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.822 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -131.86 41.0 3.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 111.439 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.29 -46.3 7.85 Favored Pre-proline 0 N--CA 1.464 0.241 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.1 Cg_exo -47.83 -40.27 31.98 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.218 1.945 . . . . 0.0 112.816 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.3 t -77.52 -51.42 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.4 mm -65.45 -29.96 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.27 -31.61 63.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.987 0.423 . . . . 0.0 110.627 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -50.06 36.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.802 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -78.17 -26.39 47.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.297 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.25 -42.67 86.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 110.814 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.04 -8.6 46.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.779 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.004 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.758 0.313 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 121.92 13.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 78' ' ' ARG . 3.4 pp -100.36 121.02 40.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.751 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -102.61 151.32 22.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.723 HD11 ' CD1' ' A' ' 4' ' ' LEU . 2.8 mp -140.06 139.0 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.486 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.964 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.78 140.8 52.6 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.525 HG11 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -144.49 149.78 17.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.67 125.52 1.88 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.402 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.994 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -83.8 109.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.734 HG23 HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -71.16 121.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.157 0.503 . . . . 0.0 111.318 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -85.94 120.06 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.129 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.511 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 27.5 p-10 -74.62 -171.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.914 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 8.3 tp10 -86.81 19.0 3.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.067 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -144.5 27.73 1.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.663 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.61 3.86 4.72 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 1.5 mm-40 -100.76 159.89 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.994 HG21 HG22 ' A' ' 10' ' ' ILE . 7.0 mt -125.28 141.78 44.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 111.496 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -90.38 113.47 25.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.793 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.01 162.05 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.315 179.266 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.67 0.271 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -114.29 26.05 10.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.012 0.434 . . . . 0.0 111.515 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.02 87.73 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -169.42 2.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.526 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.765 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.95 165.44 17.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.792 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.6 Cg_endo -47.83 168.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.788 2.992 . . . . 0.0 111.844 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.737 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.15 59.84 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.249 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.92 109.44 0.66 Allowed Glycine 0 C--N 1.312 -0.761 0 CA-C-N 114.473 -0.864 . . . . 0.0 111.697 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 122.32 -8.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.463 0.705 . . . . 0.0 110.853 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.964 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.2 -65.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.256 0.55 . . . . 0.0 111.41 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -13.6 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.472 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 43.0 -94.0 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.598 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.23 18.11 0.09 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.579 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -79.55 -163.0 0.46 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.842 -0.211 . . . . 0.0 110.801 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.865 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.86 154.76 38.39 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.865 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.8 -24.86 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.702 2.268 . . . . 0.0 112.399 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.711 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.65 -52.22 4.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.015 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -80.51 -4.93 55.76 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -66.19 -57.01 8.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.101 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.738 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.32 -40.65 25.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 111.264 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.7 t -50.46 -35.48 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.935 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -52.12 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.89 -25.59 67.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.65 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.682 HD13 ' CG2' ' A' ' 50' ' ' VAL . 2.1 tp -54.61 -44.43 73.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.576 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -27.41 67.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.734 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -77.14 -25.58 52.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.233 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 1.8 mp0 -108.42 5.74 25.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.918 HG12 HG13 ' A' ' 60' ' ' ILE . 16.4 t -134.53 -44.55 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 110.286 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.636 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 56.79 3.41 0.7 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.577 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.918 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.75 -173.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.926 0.863 . . . . 0.0 110.392 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -113.96 87.5 12.87 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.901 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.755 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.9 Cg_endo -115.11 149.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.761 2.974 . . . . 0.0 113.924 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 83.2 mt-30 -74.81 79.62 2.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.907 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.57 127.57 49.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.061 -176.148 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.79 -136.98 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.776 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 56.6 163.26 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.219 0.533 . . . . 0.0 112.116 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.5 tt -126.19 113.18 16.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.289 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.863 ' CE1' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.65 -53.24 8.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.293 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.714 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.41 131.68 0.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -125.11 132.07 53.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.728 0.299 . . . . 0.0 111.023 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.879 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -106.54 159.34 16.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.666 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.0 tt0 -140.08 109.92 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.485 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -133.33 153.01 51.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.24 140.05 52.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 111.425 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -103.41 162.86 18.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.156 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.1 Cg_endo -45.8 80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.334 2.689 . . . . 0.0 112.815 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.5 t0 85.45 9.95 0.31 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.947 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.822 ' HG2' HD23 ' A' ' 4' ' ' LEU . 3.9 ttp-105 -137.39 101.39 4.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 111.087 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.0 m-70 -74.89 115.84 14.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.829 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 4' ' ' LEU . 1.1 tt -107.14 112.04 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.955 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.88 129.92 53.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.754 HD13 ' OD1' ' A' ' 119' ' ' ASN . 26.3 mt -126.37 114.43 18.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.146 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -111.95 122.43 47.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.044 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.714 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.4 m-30 -104.5 115.06 29.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.491 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.738 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 36.6 m95 -94.72 148.72 21.99 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.058 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.2 tm? -101.08 102.68 13.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.452 0.644 . . . . 0.0 111.361 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.907 HG22 ' CE1' ' A' ' 64' ' ' HIS . 11.5 t -82.11 145.77 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.658 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.97 -45.87 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.8 ptm85 -163.13 165.93 24.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.839 0.745 . . . . 0.0 112.383 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HE3' HG22 ' A' ' 11' ' ' ILE . 8.4 p90 -139.59 136.19 34.13 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.68 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.35 108.72 19.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.35 -121.47 6.86 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.427 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.5 tt0 -135.08 135.06 22.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.467 0.175 . . . . 0.0 110.917 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.555 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.47 128.73 10.54 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.796 2.331 . . . . 0.0 111.58 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.636 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.4 p-90 -133.47 -58.18 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.09 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.572 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 37.89 -92.39 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.257 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 95' ' ' TRP . 5.2 tmtm? 179.88 -69.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.812 0.339 . . . . 0.0 110.747 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 42.21 26.06 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.605 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.21 -65.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.545 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 98' ' ' GLU . 28.5 mt-30 -108.02 99.23 29.81 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.47 146.55 3.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.139 2.559 . . . . 0.0 112.469 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.04 21.4 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.189 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.84 157.62 25.31 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.83 106.36 3.11 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.609 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.6 mtp -120.87 164.11 17.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -70.75 116.96 11.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.339 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.548 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.83 -18.71 50.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.62 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.491 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.2 t -57.12 -14.25 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.79 35.24 4.7 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.153 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 107' ' ' LEU . 11.5 tp -62.74 135.91 57.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.09 131.48 53.71 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.63 -15.3 61.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.975 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.71 -49.14 13.62 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.809 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -36.46 77.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.775 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.565 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -78.77 173.98 6.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.731 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.4 Cg_endo -76.46 137.17 18.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.358 2.039 . . . . 0.0 112.089 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 27.6 Cg_endo -62.01 -14.29 36.44 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.842 2.361 . . . . 0.0 113.202 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.3 -9.7 19.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.754 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -135.9 44.12 2.5 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.2 OUTLIER -76.05 -50.77 2.98 Favored Pre-proline 0 N--CA 1.463 0.186 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.486 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 79.6 Cg_exo -44.74 -38.02 12.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.447 2.098 . . . . 0.0 112.792 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.879 ' CG2' HD23 ' A' ' 71' ' ' LEU . 2.5 t -77.25 -49.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.611 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.565 HG13 ' CE2' ' A' ' 115' ' ' PHE . 11.3 mm -64.75 -29.97 48.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.747 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.05 -29.75 63.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 110.653 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.28 -48.52 15.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.629 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.863 HD23 ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -78.19 -30.25 48.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.34 . . . . 0.0 111.425 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HB2' HG22 ' A' ' 123' ' ' ILE . 12.0 ttpt -55.58 -42.47 74.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.817 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -68.42 -7.47 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.639 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 108' ' ' VAL . 24.7 mt . . . . . 0 C--O 1.233 0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.073 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -126.93 141.89 51.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.4 pp -145.61 117.59 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.547 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.6 mt-30 -102.29 151.74 21.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.841 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.492 ' CG2' HD23 ' A' ' 82' ' ' LEU . 4.3 mt -142.68 128.28 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.869 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.099 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.54 124.68 42.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.536 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.7 m -115.39 162.18 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.283 0.563 . . . . 0.0 111.924 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.42 102.08 0.23 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.957 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.94 HG22 HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.91 110.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.606 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.55 115.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.066 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 3.7 mmt85 -82.14 133.7 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.452 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 10.3 p-10 -84.17 -172.01 3.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 113.062 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -56.61 -16.06 5.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.721 -1.581 . . . . 0.0 113.275 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -127.71 -83.0 0.6 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.16 17.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 111.687 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HB2' ' ND2' ' A' ' 13' ' ' ASN . 19.8 mt-10 -100.89 160.11 14.64 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.94 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -135.08 145.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 111.997 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 14.0 t80 -84.48 89.63 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.79 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.895 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -113.29 162.17 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.038 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.3 t . . . . . 0 C--N 1.327 -0.391 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.791 0.329 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.03 26.37 10.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.507 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.555 HD21 ' HE2' ' A' ' 105' ' ' MET . 3.8 tt -57.74 77.37 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -108.58 -170.65 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.091 0.472 . . . . 0.0 111.636 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.9 154.13 55.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 11.1 Cg_endo -53.84 167.47 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.233 2.622 . . . . 0.0 111.677 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 59.25 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.137 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.06 117.04 2.48 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 114.84 -0.68 . . . . 0.0 112.059 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 3.5 tttt 115.76 4.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.322 0.649 . . . . 0.0 111.513 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.099 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -53.98 -27.61 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.569 0.699 . . . . 0.0 110.665 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.588 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.22 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mmt 33.38 -85.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.558 0.537 . . . . 0.0 111.878 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.31 31.11 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.553 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.459 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.0 mp0 -91.61 -175.07 4.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -111.92 159.0 35.14 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.95 -24.65 0.88 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.904 2.403 . . . . 0.0 112.696 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -90.68 -58.08 2.61 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.167 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -80.4 -20.07 44.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.924 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.3 -49.76 73.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.833 0.349 . . . . 0.0 111.148 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.928 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.6 m -76.03 -46.86 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 47' ' ' GLU . 42.3 t -60.46 -35.85 65.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.087 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -70.91 -49.14 49.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.022 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.7 ' CB ' HG22 ' A' ' 40' ' ' ILE . 7.0 tp10 -71.33 -27.97 63.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.934 HD23 ' ND1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -55.06 -44.08 74.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.55 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -61.44 -35.09 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 0.0 109.816 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.53 -33.54 54.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.339 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 20.5 mm-40 -100.05 4.83 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.026 HG12 HG22 ' A' ' 60' ' ' ILE . 3.3 t -135.48 -43.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.115 0.483 . . . . 0.0 110.245 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.64 9.39 6.61 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.747 -0.661 . . . . 0.0 114.504 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.026 HG22 HG12 ' A' ' 58' ' ' VAL . 13.5 tt -115.88 162.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 117.46 0.63 . . . . 0.0 110.289 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.491 ' N ' HG12 ' A' ' 60' ' ' ILE . 1.5 p -98.82 88.44 0.72 Allowed Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.839 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 58.4 Cg_endo -113.31 156.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 124.236 3.291 . . . . 0.0 114.096 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -75.85 78.38 2.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.934 ' ND1' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -111.94 120.7 42.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.786 -173.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.535 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -177.95 -153.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.629 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m 59.56 154.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -118.39 120.02 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.437 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.71 -44.12 34.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.064 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 tt0 -171.44 162.81 6.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.187 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.576 ' HD2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.53 132.16 22.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.449 ' HB2' HG22 ' A' ' 122' ' ' VAL . 34.5 tp -113.77 122.32 46.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.822 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -116.86 109.85 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.723 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.19 143.41 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.497 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.13 124.52 44.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 111.547 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -85.24 163.23 46.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.089 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -51.56 81.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.921 2.414 . . . . 0.0 112.225 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 90.54 11.61 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.53 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -137.29 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.772 0.32 . . . . 0.0 111.007 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -78.46 106.96 10.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.101 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.09 112.63 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.93 128.76 54.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.665 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.818 HD13 ' OD1' ' A' ' 119' ' ' ASN . 9.4 mt -126.34 114.64 18.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.297 . . . . 0.0 111.472 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -108.84 122.86 48.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.107 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.782 ' CD2' HG11 ' A' ' 122' ' ' VAL . 12.1 m-30 -103.43 112.04 24.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.928 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.9 m95 -95.12 149.23 21.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.437 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 65' ' ' PHE . 5.3 tp -106.3 103.18 12.59 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.862 HG13 ' HA ' ' A' ' 64' ' ' HIS . 11.3 t -82.63 145.45 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.326 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -102.84 -35.23 8.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.3 165.42 26.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.53 0.604 . . . . 0.0 112.0 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.716 ' HB2' HD13 ' A' ' 60' ' ' ILE . 9.2 p90 -138.93 157.96 45.08 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.289 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.764 ' C ' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -104.78 101.29 10.9 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.239 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.67 -115.02 5.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.065 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.5 tt0 -135.25 122.83 15.17 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.504 0.192 . . . . 0.0 111.432 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.0 Cg_exo -74.17 128.82 12.5 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.624 2.216 . . . . 0.0 110.794 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.547 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 20.8 p-90 -123.5 -60.85 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.833 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 57.2 -117.79 10.69 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.261 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.54 37.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.06 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -53.82 -24.52 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.42 -15.03 39.07 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.315 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.06 105.38 6.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 111.392 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.56 143.77 2.44 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.006 2.471 . . . . 0.0 112.727 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.31 19.29 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.971 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.15 157.17 44.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.27 106.52 0.54 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.872 0.368 . . . . 0.0 110.177 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.555 ' HE2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.53 139.57 52.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.027 179.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.574 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.8 p -59.66 114.77 2.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.352 . . . . 0.0 110.825 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.1 tm? -67.72 -24.49 65.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.574 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.5 p -57.73 -18.23 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.73 35.89 4.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.789 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 123' ' ' ILE . 12.3 tp -62.8 135.52 57.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.22 133.41 54.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.35 61.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.779 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.85 -49.29 13.16 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.742 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -30.6 69.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.386 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.731 ' CZ ' HG21 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -88.67 174.43 5.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.341 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 50.5 Cg_endo -69.61 127.97 15.49 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.968 1.779 . . . . 0.0 111.649 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.71 -14.81 45.06 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.228 . . . . 0.0 113.097 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.32 -9.79 44.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.818 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -124.21 27.22 7.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.475 0.179 . . . . 0.0 111.432 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' HA ' ' CG2' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -58.05 -49.07 95.71 Favored Pre-proline 0 N--CA 1.463 0.195 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 87.0 Cg_exo -46.86 -35.92 18.91 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.437 2.091 . . . . 0.0 113.176 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 84' ' ' PHE . 21.3 t -77.54 -51.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.627 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 110' ' ' LEU . 2.5 tp -68.07 -30.6 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.788 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.99 -26.99 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.877 0.37 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -49.07 12.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.446 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -78.16 -29.53 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -56.04 -42.49 76.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.27 -3.9 29.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.892 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.2 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.194 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.808 0.337 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.38 143.41 53.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.6 pp -145.71 129.32 17.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.074 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.54 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.4 mt-30 -102.57 153.62 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.442 0.639 . . . . 0.0 112.342 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -146.48 132.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.671 178.347 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.26 124.97 43.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.469 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.579 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -117.86 162.55 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.406 0.622 . . . . 0.0 112.101 -179.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.08 114.29 0.63 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.851 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.087 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.25 107.27 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.42 123.29 25.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.446 . . . . 0.0 111.676 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.674 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -83.61 119.97 25.39 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.829 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.552 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.8 t-20 -77.72 -172.32 2.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.766 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 59.6 tt0 -82.45 -2.99 54.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.583 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -131.95 40.61 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.802 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.6 9.29 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.506 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.726 ' C ' HD12 ' A' ' 18' ' ' ILE . 16.6 pt-20 -100.86 149.67 23.62 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.087 HG21 HG22 ' A' ' 10' ' ' ILE . 1.4 mp -115.11 141.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.238 0.542 . . . . 0.0 111.718 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 26.7 t80 -80.65 99.9 8.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.758 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.13 162.12 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.446 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.564 HG21 ' OE2' ' A' ' 98' ' ' GLU . 3.6 p . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.551 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.587 0.232 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.37 10.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.39 . . . . 0.0 111.423 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.5 tt -50.85 89.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -119.94 -177.18 3.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.379 . . . . 0.0 111.234 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.765 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.74 160.76 41.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.734 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.29 168.43 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.813 3.008 . . . . 0.0 112.068 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.71 59.24 0.75 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.132 -1.032 . . . . 0.0 114.129 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.77 116.57 1.91 Allowed Glycine 0 C--N 1.315 -0.622 0 CA-C-N 114.71 -0.745 . . . . 0.0 112.097 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 119.13 4.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.517 0.727 . . . . 0.0 111.783 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.042 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -57.2 -26.06 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.515 0.674 . . . . 0.0 110.71 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.16 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.32 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 mtm 31.59 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.455 0.472 . . . . 0.0 112.072 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -167.66 28.98 0.17 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.664 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.2 mp0 -92.43 -175.0 3.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.313 . . . . 0.0 111.101 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.864 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.71 154.94 38.94 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.864 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.92 -24.74 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.79 2.327 . . . . 0.0 112.601 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.719 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -94.44 -50.84 5.04 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.2 -22.03 42.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.899 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.58 -48.26 77.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.813 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.02 -46.82 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -56.28 -35.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.958 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -76.96 -50.19 13.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.617 ' CB ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -65.63 -23.71 66.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.834 HD21 ' CE1' ' A' ' 64' ' ' HIS . 4.2 tp -52.88 -44.48 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -33.05 74.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.827 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 -24.85 50.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.197 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 4.0 mm-40 -108.66 5.5 24.94 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.915 HG12 HG13 ' A' ' 60' ' ' ILE . 38.8 t -134.74 -44.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.388 0.613 . . . . 0.0 109.944 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.692 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.46 4.16 1.22 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.119 -0.946 . . . . 0.0 115.038 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.915 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.55 -172.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.157 0.979 . . . . 0.0 110.46 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.82 87.94 10.9 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.664 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.5 Cg_endo -114.34 144.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.579 2.852 . . . . 0.0 114.24 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 30.6 mt-30 -75.02 80.04 2.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.834 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.78 126.05 50.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.947 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 177.37 173.25 0.51 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 92.12 148.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.855 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -97.71 137.13 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.07 -47.71 4.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.299 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -171.43 157.81 5.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.566 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.4 127.93 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.977 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.805 HD23 HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -127.25 124.47 38.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.497 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -116.91 118.11 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.755 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -137.37 136.37 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.685 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.13 120.38 42.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.498 . . . . 0.0 111.338 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.92 162.85 65.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.519 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.8 Cg_endo -41.74 82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.655 2.903 . . . . 0.0 112.587 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' PHE . 2.9 t70 98.43 -27.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.19 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 75' ' ' PHE . 6.1 ttp180 -90.45 150.11 21.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.824 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -120.32 101.65 7.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.85 124.95 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.474 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -117.98 118.58 32.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.117 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.805 HD11 HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -126.14 114.99 19.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.085 0.469 . . . . 0.0 111.898 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.474 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.6 m0 -104.74 122.7 46.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.405 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.2 m-30 -95.38 109.63 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.727 ' NE1' HG11 ' A' ' 50' ' ' VAL . 28.6 m95 -96.78 148.63 22.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.109 0.481 . . . . 0.0 111.853 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.5 tm? -95.15 138.56 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.713 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.789 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.2 t -123.74 146.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.031 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.08 -22.04 9.15 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 3.9 tpp85 -162.48 160.51 26.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 119.018 0.826 . . . . 0.0 111.661 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.723 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.06 125.42 5.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.178 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.62 149.37 34.77 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.03 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.46 -127.13 44.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.598 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.0 mt-10 -129.57 141.91 43.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.431 0.157 . . . . 0.0 110.689 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.604 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.1 Cg_exo -76.6 128.59 10.35 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.766 2.311 . . . . 0.0 111.607 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.692 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.2 p-90 -125.87 -58.72 1.38 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.63 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 97' ' ' LYS . . . 49.86 -76.26 0.0 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.806 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 95' ' ' TRP . 3.8 tptt 115.91 60.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.993 0.917 . . . . 0.0 110.488 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.564 ' OE2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -80.62 -33.32 35.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.71 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.17 -1.68 9.75 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -140.25 94.59 8.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 117.088 0.444 . . . . 0.0 111.45 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -43.61 145.64 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.672 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.29 177.42 19.19 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.992 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.36 157.19 43.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.13 106.45 1.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.082 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 3.3 mtp -120.01 159.57 24.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.611 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.0 p -78.47 114.34 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.673 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -80.5 -19.54 45.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.052 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG13 HD21 ' A' ' 129' ' ' LEU . 33.6 t -56.66 -18.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.622 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.63 50.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.792 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.766 HD22 HD12 ' A' ' 123' ' ' ILE . 6.4 tt -62.6 150.2 41.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.465 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -117.02 132.27 56.74 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.17 61.9 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.6 -49.24 13.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.556 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.182 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.588 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.92 172.38 10.05 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.301 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.2 Cg_endo -75.76 128.15 10.69 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.327 2.018 . . . . 0.0 111.523 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.31 -14.69 16.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.777 2.318 . . . . 0.0 113.474 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.93 -11.47 18.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.713 HD21 HD22 ' A' ' 82' ' ' LEU . 1.4 m-20 -132.67 43.71 2.95 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.8 tt0 -76.07 -47.11 3.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.7 Cg_exo -45.83 -39.14 18.7 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.031 . . . . 0.0 112.837 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -77.27 -48.52 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.594 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.766 HD12 HD22 ' A' ' 110' ' ' LEU . 5.5 mm -65.18 -29.96 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.928 0.394 . . . . 0.0 110.485 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -46.24 16.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.47 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.2 tm? -78.17 -28.71 48.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 111.266 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 123' ' ' ILE . 10.4 ttpt -63.85 -42.28 97.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.416 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -64.07 -9.66 17.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.04 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.427 HD21 HG13 ' A' ' 108' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 tttm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.805 0.336 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -89.04 135.45 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.1 127.05 14.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.472 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.69 154.99 18.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.216 0.532 . . . . 0.0 111.418 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 5' ' ' GLN . 39.1 mm -146.2 127.43 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.006 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.059 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.38 124.59 42.68 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.288 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.668 HG11 ' OE2' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -129.8 162.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.178 0.513 . . . . 0.0 111.375 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 123.69 1.54 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.095 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.783 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -70.79 110.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.701 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.61 125.93 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.963 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -93.0 126.83 38.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.346 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.469 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 5.9 t30 -89.5 -172.02 3.43 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.899 0.857 . . . . 0.0 112.088 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.79 -2.14 34.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.103 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -136.01 50.2 2.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 0.0 111.283 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 p30 45.38 26.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.44 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HG3' ' CB ' ' A' ' 13' ' ' ASN . 11.5 pt-20 -112.36 150.29 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.85 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.99 144.76 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.447 0.642 . . . . 0.0 112.292 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CE1' ' CA ' ' A' ' 102' ' ' GLY . 36.3 t80 -82.5 91.5 6.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.127 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.85 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -98.9 162.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.497 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 100' ' ' GLN . 7.1 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.489 0.185 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.32 26.06 10.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.505 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 114' ' ' ASP . 17.0 tp -52.12 92.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.668 ' OE2' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -128.54 -176.43 3.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.783 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.56 168.24 10.53 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.615 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.7 Cg_endo -47.5 168.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.602 2.868 . . . . 0.0 112.249 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.42 59.22 0.76 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.666 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.58 112.02 1.27 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.23 -0.985 . . . . 0.0 112.384 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER 113.97 5.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.168 0.587 . . . . 0.0 112.096 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.059 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.22 -29.47 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.742 0.782 . . . . 0.0 110.148 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.98 -79.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.25 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.4 mmt 41.35 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.539 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.27 33.22 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.762 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.24 -169.19 1.93 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.673 0.273 . . . . 0.0 111.019 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.96 156.24 36.17 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.301 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -44.01 -24.8 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.766 2.31 . . . . 0.0 112.465 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.9 mp0 -99.59 -48.34 4.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.912 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.32 -7.56 59.11 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.824 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -63.68 -56.98 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 0.0 110.864 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.779 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 1.4 p -78.3 -40.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.716 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 59.2 t -50.67 -37.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.995 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.87 -52.38 8.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.306 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HB3' HG22 ' A' ' 40' ' ' ILE . 9.3 tm-20 -66.35 -19.92 65.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.694 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.78 HD11 ' CE1' ' A' ' 64' ' ' HIS . 14.1 tp -60.53 -44.41 96.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.728 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HA ' HG12 ' A' ' 58' ' ' VAL . 1.3 tm0? -71.58 -27.87 63.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.457 . . . . 0.0 110.029 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.07 -28.1 66.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.482 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.471 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.22 6.99 27.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.314 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.908 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -130.7 -44.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 64.73 -35.66 0.1 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.058 0.783 . . . . 0.0 115.058 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.908 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.64 -174.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.929 0.364 . . . . 0.0 110.817 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.55 88.69 13.82 Favored Pre-proline 0 N--CA 1.445 -0.717 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.689 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.9 Cg_endo -110.68 143.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 123.312 2.675 . . . . 0.0 113.474 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 31.8 mt-30 -74.6 80.06 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.821 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.18 133.15 54.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.128 -175.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -179.77 -137.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.352 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.34 159.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.963 0.505 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.4 tt -122.26 110.68 16.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.68 -52.07 10.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.373 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.605 ' HB3' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -171.33 131.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -121.88 131.91 54.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.526 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.979 HD23 HG21 ' A' ' 122' ' ' VAL . 1.8 pp -114.45 158.67 21.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.957 0.408 . . . . 0.0 111.261 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.455 ' N ' HD12 ' A' ' 71' ' ' LEU . 9.0 tt0 -140.1 109.81 6.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.242 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -136.03 153.19 51.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -120.95 127.11 51.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.141 0.496 . . . . 0.0 111.353 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -91.68 163.89 26.3 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.417 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 50.5 Cg_exo -38.27 81.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.602 2.868 . . . . 0.0 112.886 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.59 21.24 3.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.061 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.31 93.83 2.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.239 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -74.91 99.97 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.152 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tt -102.55 111.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.79 133.22 44.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.468 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.618 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.13 114.48 18.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 111.468 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -110.82 125.55 53.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.618 ' CE1' HD12 ' A' ' 82' ' ' LEU . 2.4 m-85 -111.02 118.2 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.392 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.779 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 65.3 m95 -96.47 148.87 22.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.025 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.3 tm? -99.83 103.05 14.64 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.327 0.584 . . . . 0.0 111.34 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.821 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.2 t -80.65 145.87 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.665 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -113.29 -25.39 8.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 6.9 ttm180 -162.42 163.23 27.82 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.586 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.701 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -157.21 123.8 4.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.527 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.89 139.99 47.22 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.09 -121.7 26.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 60' ' ' ILE . 24.7 mt-10 -132.05 142.64 45.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.431 0.158 . . . . 0.0 110.775 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.541 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.15 128.8 11.66 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.719 2.279 . . . . 0.0 111.183 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.607 ' HE1' HG23 ' A' ' 60' ' ' ILE . 50.6 p-90 -126.83 -61.03 1.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.21 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.936 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt 177.99 35.15 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 7.9 pt-20 -57.19 -37.79 72.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.88 0.371 . . . . 0.0 110.587 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.47 71.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.153 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 2.6 pm0 -140.16 93.29 9.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.28 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.61 138.82 5.29 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.056 2.504 . . . . 0.0 112.85 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -134.31 177.29 19.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.98 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -141.28 157.13 45.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -79.76 106.15 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.472 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.462 ' HG3' HD11 ' A' ' 20' ' ' ILE . 3.0 ptp -120.55 163.07 18.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.768 ' HB2' HG12 ' A' ' 108' ' ' VAL . 8.9 p -77.58 114.88 16.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.695 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.0 tm? -63.21 -18.91 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.768 HG12 ' HB2' ' A' ' 106' ' ' SER . 13.0 p -55.26 -20.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.464 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.18 35.05 4.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.812 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.71 HD22 HD21 ' A' ' 107' ' ' LEU . 10.7 tp -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.26 131.73 53.77 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -15.51 61.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.414 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -49.05 13.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -66.9 -40.08 87.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.599 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.63 174.16 6.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.445 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 61.5 Cg_endo -73.86 127.91 11.94 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.061 1.84 . . . . 0.0 111.509 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.97 -14.86 29.98 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.644 2.229 . . . . 0.0 113.122 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.98 -9.95 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.661 ' ND2' HD21 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -129.73 38.21 3.86 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.9 -47.36 15.35 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.068 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.6 Cg_exo -56.0 -35.28 94.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.336 2.024 . . . . 0.0 112.083 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.979 HG21 HD23 ' A' ' 71' ' ' LEU . 3.8 t -77.46 -51.38 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.082 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -69.79 -29.92 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.806 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.89 -27.53 43.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.905 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -53.34 12.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 68' ' ' PHE . 1.7 tp -78.46 -29.54 46.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.3 tttm -57.77 -42.6 84.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.014 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.519 ' C ' HD12 ' A' ' 129' ' ' LEU . 6.1 ttp180 -71.49 -5.55 33.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.937 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.731 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.253 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.832 0.349 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.33 38.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.719 HD21 ' HD3' ' A' ' 78' ' ' ARG . 3.0 pp -146.05 123.23 11.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -102.94 150.27 23.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.213 0.53 . . . . 0.0 111.258 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.596 ' HB ' HD22 ' A' ' 82' ' ' LEU . 8.5 mt -136.56 130.49 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.205 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.852 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.97 124.57 42.29 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.505 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -132.01 162.53 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.212 0.53 . . . . 0.0 111.658 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.44 121.51 1.22 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.915 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.912 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -70.83 109.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.696 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.07 125.48 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 120.976 0.417 . . . . 0.0 111.416 -178.767 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -92.21 133.13 36.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.956 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.629 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 29.6 p-10 -96.45 -172.13 2.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.86 0.838 . . . . 0.0 112.433 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.37 -0.88 16.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.071 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 20.6 t-20 -129.39 40.68 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 111.844 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 52.22 21.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -115.72 160.01 20.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.912 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -122.75 149.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.145 0.498 . . . . 0.0 111.922 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.49 101.65 14.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.041 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.908 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.08 137.67 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.302 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.2 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.825 0.345 . . . . 0.0 110.943 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -114.52 26.24 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.535 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 ' HB ' ' A' ' 20' ' ' ILE . 4.8 tt -46.08 110.36 0.26 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -142.15 175.28 9.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.785 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.53 168.92 9.09 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.639 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.6 Cg_endo -46.66 169.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.693 2.929 . . . . 0.0 112.146 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.29 59.6 0.72 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.155 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.52 122.53 3.11 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 114.113 -1.044 . . . . 0.0 111.697 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.28 -7.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.28 0.632 . . . . 0.0 111.213 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.852 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -40.73 -57.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.389 0.614 . . . . 0.0 111.285 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -21.72 -80.43 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.252 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.5 mmt 41.83 -94.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.588 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.77 19.49 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.424 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -82.97 -165.71 1.14 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.529 0.205 . . . . 0.0 110.81 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.885 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.51 156.57 36.19 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.885 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.5 -24.64 0.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.772 2.315 . . . . 0.0 112.362 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.3 mm-40 -89.98 -59.97 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -80.89 -4.56 55.29 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -63.68 -57.08 11.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.593 0.235 . . . . 0.0 111.089 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.697 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.67 -41.77 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.354 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.5 t -50.36 -35.36 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.342 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -52.15 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.49 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 10.2 mm-40 -70.1 -20.09 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.896 HD11 ' CE1' ' A' ' 64' ' ' HIS . 13.9 tp -58.18 -41.57 84.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -26.96 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.1 tm-20 -72.12 -25.27 61.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.4 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -108.59 7.02 26.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.985 HG12 HG13 ' A' ' 60' ' ' ILE . 10.6 t -133.28 -43.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.191 0.52 . . . . 0.0 109.974 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 52.88 8.63 0.63 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.442 -0.799 . . . . 0.0 115.028 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.985 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.6 -174.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.026 0.913 . . . . 0.0 110.149 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 p -114.58 87.34 14.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.67 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.0 Cg_endo -115.5 145.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 123.664 2.909 . . . . 0.0 114.066 -177.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.896 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -122.64 133.33 54.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.329 -175.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.04 -139.23 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.02 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 56.29 153.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.617 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.4 tt -116.78 111.21 19.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.386 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.56 ' CZ ' HG12 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -76.58 -54.14 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.195 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.0 mt-10 -171.28 131.7 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.438 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.617 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.27 126.6 39.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.692 0.282 . . . . 0.0 110.807 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 122' ' ' VAL . 1.2 pt? -113.84 136.67 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' HG21 ' A' ' 81' ' ' THR . 5.0 tt0 -121.67 109.94 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -131.05 152.2 50.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.5 pt-20 -121.13 139.58 53.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 111.381 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -103.23 162.67 19.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.133 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.1 Cg_endo -49.76 81.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.155 2.57 . . . . 0.0 112.344 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t70 89.28 10.2 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.595 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.719 ' HD3' HD21 ' A' ' 4' ' ' LEU . 3.2 tmm_? -137.34 93.94 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.3 . . . . 0.0 110.89 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 17.2 m80 -80.18 93.86 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.97 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 80' ' ' ILE . 15.4 tt -96.76 111.87 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -106.82 132.54 52.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.39 114.58 18.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 0.0 111.422 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.1 m0 -109.34 125.53 52.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.226 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.646 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.8 m-85 -111.41 114.56 27.78 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.932 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.542 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 61.3 m95 -94.73 148.83 21.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 14.6 tp -98.41 102.89 14.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 111.755 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.809 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.0 t -80.69 145.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.205 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 8.7 pt-20 -112.57 -26.96 8.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 3.9 mtt-85 -161.83 164.08 28.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.673 0.67 . . . . 0.0 111.428 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.696 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.67 123.59 4.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 152.95 32.51 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.1 -125.05 38.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.36 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -135.0 148.1 65.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.6 0.238 . . . . 0.0 110.956 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.636 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.48 128.8 10.58 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.933 2.422 . . . . 0.0 111.163 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 66.8 p-90 -138.45 -58.56 0.63 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.749 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 41.38 -93.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.295 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER 175.12 32.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.28 . . . . 0.0 111.144 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' OE1' HG21 ' A' ' 21' ' ' THR . 4.1 pt-20 -68.05 -33.37 74.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.947 0.403 . . . . 0.0 110.256 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.05 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -140.35 91.65 9.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 0.0 111.64 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.73 127.58 8.14 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.077 2.518 . . . . 0.0 112.602 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.3 177.05 19.47 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.7 155.28 39.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.14 107.14 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 110.459 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -119.55 163.06 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.771 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.07 122.66 33.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.098 HD21 HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -79.97 -18.97 49.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.625 HG23 HD21 ' A' ' 129' ' ' LEU . 12.5 p -53.0 -21.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.69 45.42 1.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.038 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.098 HD22 HD21 ' A' ' 107' ' ' LEU . 11.6 tp -62.94 150.28 42.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.722 0.261 . . . . 0.0 110.378 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -117.46 131.8 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.2 -15.29 61.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.648 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -48.93 14.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.367 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.98 -39.02 87.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.945 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -81.11 171.43 12.26 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.324 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 57.2 Cg_endo -71.15 127.57 13.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.18 1.92 . . . . 0.0 111.875 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.64 -14.86 45.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.581 2.187 . . . . 0.0 112.84 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.84 -9.5 57.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.42 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -124.01 34.33 5.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.714 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.57 -39.01 5.57 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.876 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.7 Cg_exo -53.07 -40.74 75.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.064 1.843 . . . . 0.0 112.699 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.72 HG21 HD22 ' A' ' 71' ' ' LEU . 2.3 t -77.47 -51.23 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.317 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.7 OUTLIER -67.3 -30.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.303 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.28 -28.46 63.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -51.86 13.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.365 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.1 tp -78.12 -39.51 41.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.483 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.522 ' HB2' HG22 ' A' ' 123' ' ' ILE . 5.2 tttm -53.54 -42.56 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.282 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -72.06 -3.64 24.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.133 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 108' ' ' VAL . 5.6 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.011 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 tptt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.811 0.339 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.08 125.56 51.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.756 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.1 pp -125.24 139.05 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.583 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.7 mt-30 -102.46 155.41 18.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.805 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 30.2 mt -146.26 126.67 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.32 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.996 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.49 124.16 41.69 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.185 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -118.65 162.5 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.34 117.19 1.19 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.934 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.911 ' CG2' HG21 ' A' ' 18' ' ' ILE . 4.7 mp -70.58 100.51 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.788 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -71.21 125.9 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -98.0 119.96 37.55 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.085 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.593 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.54 -172.93 0.84 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.019 0.438 . . . . 0.0 110.567 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 21.9 tt0 -81.28 12.83 3.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -133.92 34.9 3.34 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 5.32 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -100.95 161.76 13.37 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.911 HG21 ' CG2' ' A' ' 10' ' ' ILE . 6.7 mt -117.92 141.29 37.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.255 0.55 . . . . 0.0 111.665 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -93.02 92.77 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.254 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.853 HG13 HG22 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.97 162.07 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.206 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.429 HG21 ' OE1' ' A' ' 98' ' ' GLU . 5.0 p . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.53 0.205 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -114.17 26.45 10.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 111.359 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.3 tt -40.34 117.07 0.75 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.222 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.728 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -158.3 -172.42 3.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.504 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.37 163.08 28.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.879 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.52 ' HG3' HD11 ' A' ' 11' ' ' ILE . 6.2 Cg_endo -47.48 169.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.887 3.058 . . . . 0.0 112.314 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.05 59.32 0.73 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.449 -0.882 . . . . 0.0 113.349 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -132.13 109.04 0.82 Allowed Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.155 -1.022 . . . . 0.0 111.448 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.95 2.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.452 0.701 . . . . 0.0 111.176 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.996 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.43 -27.95 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.633 0.73 . . . . 0.0 110.571 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.591 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.333 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.3 mmt 32.36 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.458 0.474 . . . . 0.0 111.883 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.21 32.99 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.398 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.72 -177.01 5.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.857 0.361 . . . . 0.0 111.263 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.887 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.03 154.89 37.1 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.96 -24.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.867 2.378 . . . . 0.0 112.596 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.8 mt-10 -102.43 -42.21 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.595 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -80.22 -10.35 59.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.951 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.6 -52.24 65.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.749 0.309 . . . . 0.0 111.201 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.747 ' O ' HD13 ' A' ' 54' ' ' LEU . 1.3 m -78.09 -46.6 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.7 t -52.61 -37.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -78.5 -52.17 8.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.677 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 40' ' ' ILE . 2.5 mm-40 -65.28 -25.98 67.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 50' ' ' VAL . 2.0 mp -54.05 -44.58 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.597 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -30.78 69.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 -31.07 52.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.393 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.585 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.76 7.0 26.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.969 HG12 HG13 ' A' ' 60' ' ' ILE . 4.7 t -133.32 -44.64 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 51.65 18.04 3.64 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.969 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.63 -170.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.871 0.836 . . . . 0.0 110.839 179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.819 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -115.28 87.09 15.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.91 179.18 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG3' HG11 ' A' ' 58' ' ' VAL . 10.6 Cg_endo -117.35 145.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.511 2.807 . . . . 0.0 115.177 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 89' ' ' ARG . 93.7 mt-30 -74.95 79.22 2.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 174.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.943 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.78 123.3 42.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.888 -175.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -176.68 -138.78 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.011 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m 53.19 169.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.245 0.545 . . . . 0.0 112.153 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.9 tt -128.87 109.56 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.374 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.778 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.59 -46.87 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 109.971 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 tt0 -171.67 155.56 4.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.83 132.1 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.599 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.635 HD22 ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.18 158.8 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.448 ' N ' HD22 ' A' ' 71' ' ' LEU . 7.5 tt0 -140.04 128.31 22.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.5 p90 -141.0 147.62 38.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -121.08 132.26 54.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.256 0.551 . . . . 0.0 111.553 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -82.11 163.79 51.33 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.107 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.4 Cg_endo -49.64 82.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.185 2.59 . . . . 0.0 112.459 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 94.37 16.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.524 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt180 -137.45 150.16 47.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -121.57 116.31 24.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.942 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 73' ' ' TYR . 1.8 tt -122.34 121.22 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.788 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.07 134.62 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 71' ' ' LEU . 6.6 mt -125.64 114.26 18.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -109.21 122.49 47.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.37 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -104.25 121.17 42.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.628 ' CE2' HG11 ' A' ' 50' ' ' VAL . 20.6 m95 -108.15 148.89 29.25 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.544 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 46.3 tp -93.34 103.12 15.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.505 0.669 . . . . 0.0 111.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.943 HG22 ' ND1' ' A' ' 64' ' ' HIS . 17.4 t -88.71 145.59 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.654 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -102.2 -55.4 2.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -163.4 165.85 23.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.931 0.787 . . . . 0.0 112.854 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.65 ' CE3' HG22 ' A' ' 11' ' ' ILE . 48.7 p90 -128.53 140.1 51.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.787 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.819 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.9 OUTLIER -93.07 85.48 5.1 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 120.903 0.382 . . . . 0.0 110.411 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.57 -119.19 2.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.289 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 10.0 tt0 -135.12 131.12 19.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.434 0.159 . . . . 0.0 110.74 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 5.7 Cg_exo -77.07 128.87 10.15 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.895 2.397 . . . . 0.0 111.606 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.569 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 50.9 p-90 -142.19 -58.47 0.46 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.936 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 42.81 -96.13 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.017 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.08 39.34 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.761 0.315 . . . . 0.0 110.737 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -58.57 -47.64 83.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.03 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.74 -62.67 0.55 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.253 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -109.93 93.89 16.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 111.828 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.82 125.92 5.49 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.017 2.478 . . . . 0.0 112.643 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.72 177.47 17.48 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.004 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -120.54 157.25 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.6 0.238 . . . . 0.0 110.631 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.401 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.1 m0 -61.04 106.9 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.399 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.608 ' HG3' HD12 ' A' ' 20' ' ' ILE . 8.1 ptp -120.2 163.19 18.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.241 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.661 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -83.94 131.93 34.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.952 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.15 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.3 p -61.2 -13.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.936 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.71 38.95 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.109 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 107' ' ' LEU . 9.0 tp -70.55 140.54 51.8 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.16 134.8 54.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.4 61.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.883 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -49.12 13.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.559 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.74 -38.79 83.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.48 174.08 6.62 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.408 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.46 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 65.2 Cg_endo -74.15 127.85 11.67 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.258 1.972 . . . . 0.0 111.515 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.0 -14.82 29.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.658 2.239 . . . . 0.0 113.181 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.09 -9.79 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.1 38.23 3.81 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.713 0.292 . . . . 0.0 111.692 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.6 tt0 -71.17 -45.09 14.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -54.88 -37.36 92.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.119 1.879 . . . . 0.0 112.271 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.45 -51.45 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.143 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.525 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -68.59 -29.84 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.923 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -28.69 53.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.975 0.417 . . . . 0.0 110.672 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.74 -49.19 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.065 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.778 HD22 ' CE2' ' A' ' 68' ' ' PHE . 9.7 tp -78.11 -27.51 48.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.272 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -58.86 -42.6 89.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -74.51 -2.96 28.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.902 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 108' ' ' VAL . 3.3 mt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.162 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.02 136.33 33.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 80' ' ' ILE . 1.2 pp -138.18 138.56 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.43 ' O ' HD13 ' A' ' 6' ' ' ILE . 27.7 mt-30 -102.84 155.22 18.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.207 0.527 . . . . 0.0 111.312 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' THR . 39.7 mm -146.5 139.29 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.641 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.942 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.58 150.28 46.11 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.564 HG11 ' CE1' ' A' ' 84' ' ' PHE . 0.4 OUTLIER -145.45 148.86 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.906 0.384 . . . . 0.0 110.935 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.57 107.37 0.33 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.886 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.676 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.41 103.87 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.802 HG21 ' CD2' ' A' ' 19' ' ' PHE . 1.2 tt -70.62 111.61 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.755 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.606 ' HG2' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -87.52 138.08 31.78 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.376 -179.046 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.76 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.3 p30 -90.52 -173.3 3.72 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.336 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 13.5 tp10 -78.24 0.91 23.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.326 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -122.38 40.33 3.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.97 21.35 2.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 111.576 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 22.1 mt-10 -113.85 161.94 16.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.676 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.25 135.79 58.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.92 0.391 . . . . 0.0 111.729 -178.377 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.802 ' CD2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -88.79 102.44 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.367 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.54 162.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.855 HG21 ' CD ' ' A' ' 98' ' ' GLU . 6.6 p . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 120.757 0.313 . . . . 0.0 110.608 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.522 0.201 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.36 10.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.2 tt -45.23 93.55 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.3 OUTLIER -126.33 -179.97 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 111.566 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.68 168.17 10.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.174 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.1 Cg_endo -46.95 168.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.276 2.65 . . . . 0.0 111.75 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.68 59.02 0.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.243 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -146.13 101.57 0.24 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.439 -0.88 . . . . 0.0 112.25 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.631 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 128.01 -9.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.374 0.67 . . . . 0.0 110.723 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.942 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -43.31 -74.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.618 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -8.22 -82.16 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.565 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 44.35 -93.36 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.505 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.58 17.21 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.485 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.89 -163.45 0.59 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.596 0.236 . . . . 0.0 110.807 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.909 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.73 155.82 38.3 Favored Pre-proline 0 N--CA 1.456 -0.162 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.909 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.82 -24.7 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.685 2.256 . . . . 0.0 112.442 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.719 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.7 mm-40 -94.33 -54.98 3.33 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.49 -4.98 55.89 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.4 -57.04 9.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.623 0.249 . . . . 0.0 110.974 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.726 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -78.37 -39.91 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.362 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 47' ' ' GLU . 56.7 t -50.68 -35.81 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -49.47 13.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 110.422 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 44.1 tp10 -64.41 -21.09 66.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.482 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.829 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.6 tp -57.02 -44.67 83.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -30.48 67.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.55 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.2 -26.27 64.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.442 . . . . 0.0 110.565 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.714 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.31 7.25 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.114 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.45 -44.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.161 0.505 . . . . 0.0 110.013 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.4 -40.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 114.519 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.782 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.59 -173.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.651 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -110.65 88.62 8.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.826 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 2.9 Cg_endo -111.12 152.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.706 0 C-N-CA 122.966 2.444 . . . . 0.0 114.555 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.494 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 42.8 mt-30 -74.66 80.06 2.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.833 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.32 127.3 44.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.319 -176.076 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.13 -136.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.634 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 54.03 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.196 0.522 . . . . 0.0 112.358 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.608 ' O ' HD23 ' A' ' 67' ' ' LEU . 7.2 tt -125.14 110.34 13.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.74 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.98 -39.76 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.603 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -171.52 164.34 6.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.778 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 112.14 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.933 HD23 ' CD1' ' A' ' 82' ' ' LEU . 15.3 tp -99.53 128.0 45.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.35 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -131.21 110.56 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.607 ' HE1' HD11 ' A' ' 82' ' ' LEU . 2.5 p90 -139.41 150.23 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.415 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.09 124.79 45.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.232 0.539 . . . . 0.0 111.613 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.65 163.3 69.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.233 179.113 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.1 Cg_endo -50.82 83.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.966 2.444 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.3 m-20 94.29 16.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.342 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 148.7 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -120.76 97.35 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.446 HD12 HD11 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -102.97 111.89 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.743 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' ILE . 54.0 m -114.96 126.8 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.933 ' CD1' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.46 115.5 19.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.228 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.544 ' O ' HG13 ' A' ' 8' ' ' VAL . 12.5 m0 -94.6 122.87 37.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CE1' HG11 ' A' ' 8' ' ' VAL . 3.0 m-85 -99.68 109.78 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 61.5 m95 -95.72 148.53 22.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.6 tp -102.1 102.92 13.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.298 0.57 . . . . 0.0 112.034 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.833 HG22 ' ND1' ' A' ' 64' ' ' HIS . 12.8 t -80.52 145.56 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.649 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.83 -43.11 3.66 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.05 166.25 23.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.786 0.721 . . . . 0.0 112.377 -178.177 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.76 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 28.0 p90 -137.56 148.78 46.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.745 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.01 96.3 8.06 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 -138.49 14.84 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.779 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.4 tt0 -106.07 122.63 41.68 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 2.9 Cg_exo -76.3 129.02 10.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.898 2.399 . . . . 0.0 112.192 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.742 ' HE1' HG23 ' A' ' 60' ' ' ILE . 3.6 p-90 -126.2 -77.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.741 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.714 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 67.33 -66.96 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.856 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 96.28 69.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.039 0.535 . . . . 0.0 110.811 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.855 ' CD ' HG21 ' A' ' 21' ' ' THR . 1.1 pp20? -83.36 -35.7 24.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.86 -52.13 0.16 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.001 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -140.05 117.97 8.41 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.48 . . . . 0.0 111.621 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -43.72 144.87 2.09 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.923 2.415 . . . . 0.0 112.654 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.3 19.23 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.637 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -125.89 157.33 37.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.532 0.206 . . . . 0.0 110.603 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.486 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.0 m0 -60.89 105.81 0.51 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.3 ptm -120.76 154.21 35.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.542 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.5 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -72.36 124.64 25.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.027 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -80.06 -18.89 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.547 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.0 p -54.14 -18.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.48 41.47 1.72 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.024 HD12 HD21 ' A' ' 107' ' ' LEU . 3.1 tt -62.88 148.05 48.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.569 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -123.22 131.22 53.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -15.12 61.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.493 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.5 -49.28 13.67 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.12 -38.34 85.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.092 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.97 173.6 7.46 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.293 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.9 Cg_endo -74.3 128.02 11.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.24 1.96 . . . . 0.0 111.678 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.97 -14.84 35.21 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.682 2.255 . . . . 0.0 113.175 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.78 -9.8 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.453 HD22 HD22 ' A' ' 82' ' ' LEU . 1.8 m-20 -128.76 37.72 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.332 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.08 -43.5 3.65 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.8 Cg_exo -45.2 -40.84 16.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.21 1.94 . . . . 0.0 113.166 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.0 t -77.51 -51.27 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.209 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.5 mm -65.83 -33.69 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.467 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.92 -28.43 50.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.883 0.373 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.26 -53.15 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.682 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 129' ' ' LEU . 5.2 tp -78.52 -36.88 44.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.75 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.635 ' HB2' HG22 ' A' ' 123' ' ' ILE . 17.2 ttpt -53.76 -42.71 68.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.9 0.381 . . . . 0.0 111.126 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -7.65 25.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.808 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 126' ' ' LEU . 8.2 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.042 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.7 tttt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.861 0.362 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 133.3 38.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.656 HD11 HG13 ' A' ' 80' ' ' ILE . 3.0 pp -146.04 139.54 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 36.9 mt-30 -102.85 154.08 19.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.234 0.54 . . . . 0.0 111.881 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 40.0 mm -146.54 118.8 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.909 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.961 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.21 150.28 47.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.388 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -145.22 162.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.128 0.49 . . . . 0.0 111.472 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -136.79 114.81 1.18 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.203 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.955 HG22 HG21 ' A' ' 18' ' ' ILE . 1.5 mt -70.87 98.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.904 HG23 HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.95 122.46 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.406 0.622 . . . . 0.0 112.276 -177.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -86.27 127.36 34.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.708 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 2.8 t-20 -73.24 -171.92 1.03 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 122.092 0.949 . . . . 0.0 112.692 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.69 -13.63 15.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.627 -1.624 . . . . 0.0 113.271 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -132.34 -82.93 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.799 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -149.82 14.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.71 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 1.8 pt-20 -100.72 160.39 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.955 HG21 HG22 ' A' ' 10' ' ' ILE . 6.1 mt -135.97 138.6 47.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 111.911 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -76.88 94.12 3.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.127 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.21 139.16 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.419 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.435 HG22 ' CD ' ' A' ' 98' ' ' GLU . 6.3 p . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.698 0.285 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.9 ttpp -110.6 26.06 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.408 ' N ' ' HA ' ' A' ' 115' ' ' PHE . 17.2 tp -66.4 69.25 0.06 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.629 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -106.92 -168.64 1.43 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 111.68 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.729 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.67 168.67 9.69 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.468 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 79.9 Cg_endo -80.11 169.3 17.81 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.459 3.44 . . . . 0.0 114.087 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 104.17 -1.63 43.91 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.14 161.66 29.04 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.565 0.682 . . . . 0.0 112.649 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.6 5.5 0.37 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.879 0.471 . . . . 0.0 111.792 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.961 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.5 pt -54.96 -25.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.588 0.708 . . . . 0.0 110.331 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.57 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.391 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.1 mtp 32.12 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.502 0.501 . . . . 0.0 111.961 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.99 32.46 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.572 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.72 -172.07 3.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.883 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.79 155.27 36.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.328 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.883 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.95 -24.96 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 112.596 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.7 mt-10 -101.65 -44.24 5.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.538 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -80.2 -6.1 57.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.925 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.28 -56.15 21.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.908 HG11 ' NE1' ' A' ' 85' ' ' TRP . 3.4 m -78.2 -45.3 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.303 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 47' ' ' GLU . 43.7 t -56.17 -39.27 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.501 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -78.36 -51.87 9.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.744 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 0.6 OUTLIER -68.98 -23.2 64.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.738 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -50.47 -44.28 55.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -33.92 65.43 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.72 -25.26 49.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.53 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.505 ' OE1' ' HA2' ' A' ' 37' ' ' GLY . 9.0 mp0 -108.43 5.09 25.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.979 HG12 HG13 ' A' ' 60' ' ' ILE . 8.6 t -134.82 -44.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.225 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.69 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 60.82 1.63 2.04 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.245 -0.889 . . . . 0.0 114.318 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.979 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.05 -172.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.695 0.748 . . . . 0.0 110.141 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 p -113.38 87.89 12.1 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.618 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.0 Cg_endo -112.68 144.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.563 2.842 . . . . 0.0 113.9 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 4.8 pt20 -74.75 79.95 2.07 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.933 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.04 129.65 53.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.795 -175.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.606 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -176.66 -142.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.291 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 57.28 154.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.231 0.539 . . . . 0.0 112.21 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.543 HD11 ' HG2' ' A' ' 70' ' ' LYS . 3.0 tt -117.83 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.5 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.622 ' HE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.49 -54.05 7.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 109.94 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.4 tt0 -171.58 145.81 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -136.79 117.99 14.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.321 . . . . 0.0 110.654 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.574 ' CD2' HG21 ' A' ' 122' ' ' VAL . 1.1 pp -98.58 147.05 25.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.22 112.07 11.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -137.75 128.95 27.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.75 118.62 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.052 0.453 . . . . 0.0 111.422 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.96 162.72 66.66 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.387 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 2.2 Cg_endo -44.96 81.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.438 2.759 . . . . 0.0 112.595 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 36.6 t0 104.08 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.87 150.26 20.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.872 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -121.75 93.82 4.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.679 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.656 HG13 HD11 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -93.17 135.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.3 118.91 22.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.513 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.534 ' HG ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -115.08 114.34 25.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.255 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.85 129.73 55.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 8' ' ' VAL . 9.0 m-30 -115.79 112.12 21.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.999 0.428 . . . . 0.0 110.798 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.908 ' NE1' HG11 ' A' ' 50' ' ' VAL . 43.6 m95 -94.9 149.32 21.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.461 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 65' ' ' PHE . 23.3 tp -97.71 102.8 14.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.54 0.686 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.933 HG22 ' ND1' ' A' ' 64' ' ' HIS . 11.5 t -85.44 146.22 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.693 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.44 -39.4 6.14 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.85 165.43 25.27 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.96 0.8 . . . . 0.0 111.835 -178.659 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.672 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.3 p90 -147.6 128.49 14.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.714 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -77.35 113.19 14.88 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.54 -122.14 6.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.456 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.5 mt-10 -135.06 137.52 27.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.418 0.151 . . . . 0.0 110.825 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.564 ' CA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.31 128.84 10.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.781 2.321 . . . . 0.0 111.395 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.69 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.8 p-90 -128.68 -59.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.901 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.02 -98.82 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.99 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 177.61 37.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.716 0.293 . . . . 0.0 111.171 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' CD ' HG22 ' A' ' 21' ' ' THR . 8.9 pt-20 -52.04 -41.92 62.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.82 -5.35 42.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.324 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -140.1 97.71 7.76 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 111.457 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -43.49 145.09 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.073 2.516 . . . . 0.0 112.802 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.11 19.42 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -141.81 157.16 45.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -65.57 105.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.486 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.4 ptm -120.71 163.39 18.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.954 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.548 ' HB2' HG12 ' A' ' 108' ' ' VAL . 28.0 p -86.33 114.74 23.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.817 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.96 -18.85 60.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.3 p -54.22 -18.82 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.935 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.2 49.8 0.83 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.071 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 123' ' ' ILE . 8.3 tt -62.71 150.36 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.635 0.255 . . . . 0.0 110.427 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.04 131.65 55.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.38 61.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.367 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -46.66 17.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.232 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -71.9 -22.53 61.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.105 -179.073 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -97.35 174.53 3.17 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.7 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 70.4 Cg_endo -75.3 136.02 19.26 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.277 1.985 . . . . 0.0 111.601 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.59 -14.36 35.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.901 2.401 . . . . 0.0 113.191 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -12.24 22.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.534 ' ND2' ' HG ' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -130.87 37.96 3.74 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -76.06 -48.1 3.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.009 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.4 Cg_exo -53.68 -38.29 84.47 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.371 2.047 . . . . 0.0 112.158 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 71' ' ' LEU . 1.6 t -77.19 -51.05 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.666 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.48 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -66.09 -29.98 48.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.13 -30.99 60.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.526 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -74.81 -52.0 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.429 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.622 HD13 ' HE2' ' A' ' 68' ' ' PHE . 2.3 tp -78.19 -19.73 53.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.641 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HB2' HG22 ' A' ' 123' ' ' ILE . 6.6 ttpp -80.38 -42.59 22.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.554 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.62 -8.8 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.907 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.557 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.44 121.97 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.655 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.9 pp -124.45 120.42 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -103.3 150.88 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.655 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.3 mp -141.92 134.38 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.48 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.708 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.96 158.03 34.63 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -145.59 162.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.933 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.56 104.74 0.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.608 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.069 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.7 109.19 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.703 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -70.82 124.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.378 0.608 . . . . 0.0 112.323 -177.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.726 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.92 124.18 30.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.418 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.567 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 19.8 t-20 -69.56 177.26 3.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.015 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tp10 -56.05 -18.65 10.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.6 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -121.19 -82.38 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.738 0.304 . . . . 0.0 111.519 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.97 15.56 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.711 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.537 ' C ' HD12 ' A' ' 18' ' ' ILE . 2.1 mp0 -100.83 160.51 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.069 HG21 HG22 ' A' ' 10' ' ' ILE . 3.8 mp -134.0 139.84 47.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.437 . . . . 0.0 111.167 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.512 ' HE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -93.67 113.84 26.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.898 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.545 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -123.16 159.11 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.557 179.315 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.9 p . . . . . 0 C--N 1.326 -0.414 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.511 0.196 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.46 26.3 10.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.747 0.308 . . . . 0.0 111.667 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 114' ' ' ASP . 1.4 tt -52.78 86.41 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.703 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -122.09 179.8 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.778 -179.282 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 166.59 14.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.736 -179.36 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 7.6 Cg_endo -47.64 168.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.609 2.873 . . . . 0.0 111.461 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.24 59.78 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.75 -1.214 . . . . 0.0 114.209 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.42 103.14 0.49 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 114.765 -0.718 . . . . 0.0 112.069 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 125.56 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.395 0.678 . . . . 0.0 111.525 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.668 HG21 ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -42.82 -46.16 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.494 0.664 . . . . 0.0 111.005 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.94 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.263 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 34.73 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.88 24.25 0.08 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -90.04 -159.26 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.431 0.157 . . . . 0.0 110.747 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -100.72 152.74 37.92 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.64 -24.58 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.622 2.214 . . . . 0.0 112.192 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.94 -49.66 4.46 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -80.54 -8.82 59.72 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.651 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -66.98 -57.33 7.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.375 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.557 HG22 ' CD1' ' A' ' 54' ' ' LEU . 2.3 p -78.92 -35.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.459 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 47' ' ' GLU . 70.0 t -50.3 -35.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.333 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -34.82 47.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.501 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -76.95 -22.22 53.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.826 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -55.42 -44.39 76.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.02 74.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.149 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -27.61 52.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.459 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.9 mt-10 -108.22 5.47 25.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.986 HG12 HG13 ' A' ' 60' ' ' ILE . 17.0 t -134.5 -44.35 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.179 0.514 . . . . 0.0 110.369 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.653 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.22 18.04 12.53 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 114.744 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.986 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -128.38 -168.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 117.674 0.737 . . . . 0.0 110.676 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.685 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -116.28 86.73 18.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.923 179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.8 Cg_endo -117.18 139.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 123.819 3.013 . . . . 0.0 114.532 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 31.7 mt-30 -74.84 79.32 2.11 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 174.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.866 ' HB2' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -114.22 126.72 55.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.142 -175.5 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -174.52 -150.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.846 -179.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.77 -177.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.903 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.6 pp -144.85 129.94 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.11 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -46.2 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.983 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.32 131.36 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.142 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.636 ' HE2' HD13 ' A' ' 67' ' ' LEU . 1.1 ptpm? -113.82 132.14 55.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.799 0.333 . . . . 0.0 111.006 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 122' ' ' VAL . 9.7 tp -112.24 137.68 50.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.653 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.42 109.91 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.675 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -140.51 149.14 42.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.19 140.05 52.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.254 0.549 . . . . 0.0 111.429 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -87.7 163.12 39.71 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.435 179.449 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -52.52 82.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.004 2.469 . . . . 0.0 112.137 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 11.9 t0 97.08 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.187 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 75' ' ' PHE . 7.3 ttp-105 -137.34 150.34 47.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -123.79 96.96 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.871 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 4' ' ' LEU . 2.8 tt -100.73 111.88 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 110.984 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.76 131.73 45.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.408 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -125.78 114.27 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.3 m0 -112.89 122.8 48.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.632 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -106.4 116.89 32.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 110.291 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.4 m95 -94.51 148.35 22.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.635 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.5 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.3 tp -102.87 102.9 13.03 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.319 0.58 . . . . 0.0 111.288 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.866 HG13 ' HB2' ' A' ' 64' ' ' HIS . 28.9 t -83.93 145.44 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.132 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.55 ' C ' ' HG2' ' A' ' 89' ' ' ARG . 8.1 pt-20 -115.8 -17.49 11.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -161.89 165.62 27.41 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.878 1.217 . . . . 0.0 112.185 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.703 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -157.54 130.03 7.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.977 178.511 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.685 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -99.68 161.25 13.73 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.12 -128.41 28.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.657 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.3 tt0 -127.12 127.88 24.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HA ' HG12 ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.9 128.56 10.1 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.561 2.174 . . . . 0.0 112.69 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.653 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 7.8 p-90 -133.79 -62.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.0 110.116 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 -67.45 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.789 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' TRP . 1.6 mmtt 81.45 43.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.966 0.412 . . . . 0.0 110.662 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -71.42 -29.31 64.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.806 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.72 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.794 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.428 ' O ' HG22 ' A' ' 21' ' ' THR . 3.9 mp0 -140.05 105.08 6.72 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -43.78 144.48 2.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.858 2.372 . . . . 0.0 112.388 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 169.64 22.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.93 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.21 157.31 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.74 106.05 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.581 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.1 ptm -120.56 163.25 18.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.797 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.6 t -72.87 114.86 11.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.668 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 18' ' ' ILE . 11.8 tp -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.314 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.56 -13.33 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.506 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.94 34.76 5.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.871 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 123' ' ' ILE . 11.7 tp -62.54 131.53 49.41 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 132.29 54.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.42 61.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.285 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.78 -49.19 13.42 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.382 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.613 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -67.4 -38.34 84.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.674 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.89 174.06 6.7 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.4 Cg_endo -73.79 127.84 11.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.052 1.835 . . . . 0.0 111.355 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.53 -14.72 26.96 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.634 2.223 . . . . 0.0 113.289 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.75 -9.82 31.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.67 42.3 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 tt0 -73.22 -38.77 4.6 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 73.3 Cg_exo -51.17 -41.41 57.94 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.1 1.866 . . . . 0.0 113.033 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.26 -51.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.405 . . . . 0.0 111.273 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.53 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.6 mm -65.97 -29.85 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.47 -29.85 62.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -80.09 -46.56 16.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 68' ' ' PHE . 7.6 tp -78.14 -26.42 47.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 111.257 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -58.4 -42.57 87.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.141 0.496 . . . . 0.0 110.648 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 1.5 tpp180 -71.12 -5.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.875 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.225 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.01 132.59 49.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.94 129.72 22.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.853 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 mt-30 -102.74 148.89 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.169 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.853 HD13 ' O ' ' A' ' 5' ' ' GLN . 24.0 mm -135.54 134.13 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.94 125.19 43.54 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -131.63 155.7 41.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.251 0.548 . . . . 0.0 111.813 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.62 137.42 7.5 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.339 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.721 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -85.73 94.72 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.384 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.979 HG23 HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -71.68 118.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.194 0.521 . . . . 0.0 111.351 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.262 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.621 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 7.4 p-10 -110.17 -173.52 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -45.99 -28.5 1.17 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.075 -1.42 . . . . 0.0 113.432 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -92.58 26.74 2.54 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.578 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.91 25.89 0.34 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.211 0.529 . . . . 0.0 110.51 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 17.2 pt-20 -114.22 160.16 19.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.212 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.75 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -112.15 135.96 49.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.347 0.594 . . . . 0.0 112.441 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 10.9 t80 -91.02 103.27 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.933 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.458 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.58 147.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.926 0.394 . . . . 0.0 110.863 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 98' ' ' GLU . 4.8 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.938 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 mttt -114.36 26.01 10.6 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.962 0.41 . . . . 0.0 111.387 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -55.73 86.2 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.9 tt0 -106.89 -170.96 1.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.14 0.495 . . . . 0.0 111.741 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.668 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.86 166.04 16.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.44 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 61.1 Cg_endo -71.07 168.86 22.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.548 2.832 . . . . 0.0 111.708 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.43 59.36 0.72 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.601 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.44 120.02 3.4 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 114.118 -1.041 . . . . 0.0 111.527 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 119.05 -10.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.417 0.687 . . . . 0.0 110.727 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.915 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -37.78 -63.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.33 0.586 . . . . 0.0 111.358 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' N ' HG12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -15.41 -81.25 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.375 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.69 -93.27 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.696 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.6 22.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.447 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.6 -159.22 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.521 0.2 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.901 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.44 155.61 37.68 Favored Pre-proline 0 N--CA 1.457 -0.082 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.901 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -44.07 -24.83 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.781 2.321 . . . . 0.0 112.428 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.681 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.0 mm-40 -100.0 -49.6 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.8 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -80.42 -4.58 54.21 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -64.61 -57.45 9.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.596 0.236 . . . . 0.0 111.214 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.51 ' N ' HD12 ' A' ' 40' ' ' ILE . 1.2 p -78.79 -40.86 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.494 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.6 t -50.2 -35.22 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -52.16 9.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.212 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -67.51 -19.91 65.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.798 HD11 ' CE1' ' A' ' 64' ' ' HIS . 7.9 tp -56.61 -44.44 81.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 110.459 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -26.78 68.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.836 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.2 tm-20 -75.36 -26.77 58.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.396 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.97 6.82 25.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.978 HG12 HG13 ' A' ' 60' ' ' ILE . 8.2 t -131.46 -43.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.062 0.458 . . . . 0.0 110.395 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 57.46 7.34 2.9 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.751 -0.659 . . . . 0.0 114.679 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.978 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.9 -166.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.928 0.864 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.643 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -113.16 87.89 11.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.888 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.684 ' HG3' HG11 ' A' ' 58' ' ' VAL . 11.7 Cg_endo -113.51 133.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.852 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 7.9 pt20 -74.75 79.22 2.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.836 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -112.16 130.02 56.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.539 -175.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -178.17 -142.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.053 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t 52.75 171.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 112.16 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 67' ' ' LEU . 4.2 tt -131.31 105.65 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.404 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.64 -40.97 47.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.982 0.42 . . . . 0.0 110.121 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.8 tt0 -171.27 159.88 5.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.43 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -143.25 132.16 22.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.818 0.342 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' A' ' 122' ' ' VAL . 5.5 tp -122.39 128.95 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.649 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.739 ' CD ' HG23 ' A' ' 81' ' ' THR . 1.1 tp10 -129.35 110.84 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.712 ' HE1' HD12 ' A' ' 82' ' ' LEU . 3.4 p90 -138.49 104.48 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.545 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 15.8 pt-20 -88.5 126.62 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.044 0.449 . . . . 0.0 111.526 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -70.08 163.55 60.4 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.934 179.138 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -38.75 -28.51 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.499 2.799 . . . . 0.0 113.103 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -32.61 0.58 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.426 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 26.8 ttm180 -94.18 97.95 10.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.337 . . . . 0.0 111.61 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.1 m-70 -78.97 100.21 7.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -104.59 130.89 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.739 HG23 ' CD ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -121.44 132.01 54.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.465 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.061 HD13 ' ND2' ' A' ' 119' ' ' ASN . 22.2 mt -126.24 114.5 18.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.474 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -107.65 122.59 47.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.589 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.726 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -100.64 109.56 21.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.429 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.484 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 21.8 m95 -96.31 148.6 22.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.54 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.567 HD12 ' OE2' ' A' ' 88' ' ' GLU . 1.9 tm? -90.83 103.03 15.79 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.315 0.579 . . . . 0.0 111.35 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.979 HG11 HG23 ' A' ' 11' ' ' ILE . 18.9 t -90.5 145.3 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.567 ' OE2' HD12 ' A' ' 86' ' ' LEU . 1.7 mm-40 -113.85 -25.39 8.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.537 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -163.5 165.86 23.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.105 1.32 . . . . 0.0 112.809 -178.767 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.684 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -157.12 124.5 5.28 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.623 178.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.643 ' CB ' HG23 ' A' ' 61' ' ' THR . 0.7 OUTLIER -80.06 117.99 21.38 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.801 0.334 . . . . 0.0 111.126 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.25 -123.34 6.97 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.445 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.8 mt-10 -129.46 137.78 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 122.952 -0.146 . . . . 0.0 110.63 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.608 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.8 Cg_exo -76.67 128.94 10.52 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.778 2.319 . . . . 0.0 110.969 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 51.1 p-90 -140.26 -58.99 0.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 48.55 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.578 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -179.37 32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.628 0.252 . . . . 0.0 111.219 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -63.96 -24.93 67.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.57 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.06 73.18 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.429 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.446 ' O ' ' HB ' ' A' ' 21' ' ' THR . 23.4 mt-30 -140.36 100.64 6.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 129.59 7.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.883 2.389 . . . . 0.0 112.385 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.429 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.09 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.14 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -153.27 157.13 39.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -71.59 105.69 3.75 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.824 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.464 ' C ' ' HB2' ' A' ' 17' ' ' GLU . 28.0 ptm -120.58 147.55 45.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.063 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.428 ' OG ' HG12 ' A' ' 108' ' ' VAL . 1.3 t -67.85 124.99 24.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.846 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.817 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.4 tm? -71.92 -20.76 61.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.225 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' A' ' 129' ' ' LEU . 11.7 p -55.13 -19.47 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.521 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.82 36.89 3.73 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.872 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 107' ' ' LEU . 10.6 tp -62.74 129.11 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.99 134.79 54.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.601 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -15.37 61.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.674 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -78.89 -49.25 13.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.772 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -30.31 68.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.652 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -88.45 173.97 5.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.621 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 72.3 Cg_endo -76.86 130.16 11.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.433 2.089 . . . . 0.0 111.596 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.58 -14.44 13.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.938 2.425 . . . . 0.0 113.728 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.71 -10.24 11.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 1.061 ' ND2' HD13 ' A' ' 82' ' ' LEU . 1.2 m-20 -136.24 45.67 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.742 0.306 . . . . 0.0 111.465 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.52 -54.41 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.01 -33.09 7.24 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.396 2.064 . . . . 0.0 112.416 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.726 HG11 ' CD2' ' A' ' 84' ' ' PHE . 25.8 t -77.57 -51.03 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.668 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 16.6 mm -65.59 -29.77 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.4 56.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 110.626 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -47.44 14.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.449 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.769 ' O ' HD22 ' A' ' 129' ' ' LEU . 11.1 tp -78.18 -19.43 53.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.517 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 123' ' ' ILE . 3.8 ttpm? -71.14 -42.6 68.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 110.643 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -68.24 -9.46 47.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.004 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.125 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.623 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mttm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 145.94 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.645 ' CD1' HD11 ' A' ' 6' ' ' ILE . 2.8 pp -146.02 124.35 12.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.95 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.2 mt-30 -102.49 155.72 18.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.727 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.7 mp -146.16 132.29 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.503 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.065 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.4 124.74 43.0 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -126.79 162.12 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.0 112.214 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.31 116.27 0.86 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.908 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.724 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.47 96.02 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.764 HG22 ' CG ' ' A' ' 64' ' ' HIS . 2.4 pt -79.35 111.68 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.164 0.507 . . . . 0.0 112.171 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.796 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.1 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.937 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.635 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.5 p-10 -125.34 -173.83 2.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -22.21 12.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.326 -1.307 . . . . 0.0 113.534 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -98.08 30.77 2.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.336 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.41 28.92 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.316 0.579 . . . . 0.0 110.264 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.7 mt-10 -117.71 160.34 21.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.957 HG21 HD23 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -114.62 136.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.045 0.45 . . . . 0.0 111.596 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.916 ' N ' HD13 ' A' ' 18' ' ' ILE . 44.5 t80 -87.88 93.68 9.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.619 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -114.68 162.2 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.621 HG21 ' CD ' ' A' ' 98' ' ' GLU . 27.9 p . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.611 0.243 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.49 26.47 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.602 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.651 HD21 HD12 ' A' ' 20' ' ' ILE . 2.5 tt -56.03 80.4 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -106.84 -168.31 1.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.945 0.402 . . . . 0.0 111.346 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.724 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.58 157.39 51.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.614 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.519 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 21.4 Cg_endo -60.06 167.37 7.45 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.216 2.61 . . . . 0.0 111.183 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.1 58.83 0.78 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.782 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -122.8 130.69 7.96 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.674 -0.763 . . . . 0.0 111.803 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 102.11 4.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.137 0.575 . . . . 0.0 111.695 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.065 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -54.95 -25.91 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.43 0.633 . . . . 0.0 110.547 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.28 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.965 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.1 mmm 35.49 -85.52 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.422 0.451 . . . . 0.0 111.807 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.42 30.63 0.15 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.385 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.5 mp0 -91.86 -178.27 4.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.01 155.9 36.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.27 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.96 -24.78 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.847 2.365 . . . . 0.0 112.715 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.692 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.3 mt-10 -95.11 -49.38 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -80.21 -23.25 41.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.021 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.49 -48.43 77.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.952 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.818 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.1 -47.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.756 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.1 t -58.54 -35.73 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.036 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -74.89 -52.07 12.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.619 ' CB ' HG22 ' A' ' 40' ' ' ILE . 5.5 tp10 -68.98 -26.47 65.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 6.1 tp -51.94 -44.07 63.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.47 -31.19 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.158 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.1 -23.84 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.234 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.62 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 9.1 mm-40 -108.11 6.57 27.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.543 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.918 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -134.13 -45.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 110.338 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 63.32 -27.32 0.08 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.934 1.133 . . . . 0.0 115.934 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.918 HD12 HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -93.94 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 117.771 0.786 . . . . 0.0 111.466 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.5 p -105.81 89.57 3.66 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.039 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 84.1 Cg_endo -109.57 137.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.438 2.759 . . . . 0.0 115.367 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 89' ' ' ARG . 70.9 mt-30 -75.55 79.46 2.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 174.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.771 ' HE2' ' HE3' ' A' ' 90' ' ' TRP . 1.8 m-70 -138.17 127.4 24.44 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.55 -173.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CE1' HG22 ' A' ' 51' ' ' VAL . 6.2 t80 173.5 173.72 0.14 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.028 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 5.4 t 106.14 154.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.736 0.814 . . . . 0.0 110.614 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.536 HD11 ' HE3' ' A' ' 70' ' ' LYS . 9.1 tt -106.75 146.88 30.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.675 ' HE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -117.13 -44.74 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.709 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.23 153.96 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.666 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE3' HD11 ' A' ' 67' ' ' LEU . 2.5 ptpp? -138.0 132.06 31.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 5.4 tp -118.01 124.39 48.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.737 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.82 109.88 17.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.538 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -134.42 153.22 52.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.648 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -114.89 140.13 49.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.291 0.567 . . . . 0.0 111.42 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -107.21 163.75 16.28 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.269 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 64.0 Cg_exo -39.26 81.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.457 2.772 . . . . 0.0 112.744 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.02 20.53 4.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.431 ' NH1' HD23 ' A' ' 4' ' ' LEU . 2.8 tpt85 -137.32 93.88 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -74.79 101.13 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -100.15 114.73 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.979 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 128.2 54.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.76 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.86 HD13 ' OD1' ' A' ' 119' ' ' ASN . 24.8 mt -126.07 114.64 18.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.277 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.2 m0 -105.05 122.54 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.701 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -99.41 109.86 22.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.038 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.788 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.2 m95 -99.69 148.16 24.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.033 0.444 . . . . 0.0 111.955 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.8 tp -91.34 122.2 33.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.137 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.639 HG12 ' CA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -124.06 145.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.921 -178.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 12' ' ' ARG . 10.7 tt0 -89.22 -69.78 0.69 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.51 166.08 25.3 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.19 0.519 . . . . 0.0 112.227 -177.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.771 ' HE3' ' HE2' ' A' ' 64' ' ' HIS . 47.8 p90 -115.78 163.01 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.254 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.67 72.27 0.95 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.72 0.295 . . . . 0.0 110.911 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 135.97 -115.97 1.41 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.637 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -134.18 118.77 14.14 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.554 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -75.74 128.97 11.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.836 2.357 . . . . 0.0 111.881 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.804 ' HE1' HG23 ' A' ' 60' ' ' ILE . 2.2 p-90 -121.86 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.705 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.62 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 60.55 -68.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.868 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 40.7 tttm 96.95 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.212 0.605 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.621 ' CD ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.16 -31.31 21.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.625 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.3 -15.52 2.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.99 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -140.06 101.36 7.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.954 0.407 . . . . 0.0 111.373 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.55 146.22 1.4 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.062 2.508 . . . . 0.0 112.623 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.428 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.24 177.37 19.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.888 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 13.8 tt0 -153.12 157.34 40.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.403 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.72 106.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.13 156.53 30.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.262 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.435 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -67.12 114.54 5.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.957 HD23 HG21 ' A' ' 18' ' ' ILE . 3.0 tm? -78.4 -21.34 49.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.487 HG22 HD21 ' A' ' 129' ' ' LEU . 10.9 p -63.41 -12.53 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.547 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.15 40.87 2.02 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.891 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 110' ' ' LEU . 11.7 tp -62.64 134.13 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 137.73 54.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.29 -15.73 61.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.577 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.97 -49.25 13.06 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.58 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.22 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.47 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.563 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.94 173.91 6.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.454 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.9 Cg_endo -77.17 137.09 16.79 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.372 2.048 . . . . 0.0 111.916 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 20.1 Cg_endo -60.05 -14.09 26.58 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.901 2.401 . . . . 0.0 113.258 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -9.81 10.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.86 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -138.91 47.52 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -70.36 -58.1 5.16 Favored Pre-proline 0 CA--C 1.531 0.231 0 O-C-N 122.214 -0.304 . . . . 0.0 111.389 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.46 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -44.73 -31.02 4.64 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.501 2.134 . . . . 0.0 112.522 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 84' ' ' PHE . 71.7 t -77.33 -50.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.59 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' A' ' 127' ' ' LYS . 26.8 mm -65.43 -31.54 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.83 36.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 110.902 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -51.61 8.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.696 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.675 HD13 ' HE2' ' A' ' 68' ' ' PHE . 11.8 tp -78.09 -30.1 49.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.496 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.668 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.8 ttpt -56.71 -42.53 79.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -67.47 -8.85 36.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.762 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.487 HD21 HG22 ' A' ' 108' ' ' VAL . 10.7 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.866 0.365 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -104.91 144.62 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.6 pp -138.08 127.03 24.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.439 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.2 mt-30 -102.44 157.56 16.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.332 0.587 . . . . 0.0 111.869 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.507 ' HB ' HD12 ' A' ' 82' ' ' LEU . 73.1 mt -146.23 130.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.694 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.13 125.07 43.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -129.25 162.6 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.427 0.632 . . . . 0.0 111.925 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -148.11 113.55 0.64 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.428 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.766 HD12 ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -70.75 99.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.732 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.26 119.57 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.275 0.56 . . . . 0.0 111.987 -178.476 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.63 141.79 28.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.883 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -100.12 -173.17 2.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.001 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -73.75 -10.1 59.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.267 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.456 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 23.1 t-20 -111.89 30.91 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.63 11.39 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.545 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' HB2' HD21 ' A' ' 13' ' ' ASN . 0.0 OUTLIER -101.99 161.34 13.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.63 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -116.0 131.71 67.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 0.0 111.75 -178.396 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 7.0 t80 -82.92 107.63 15.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.524 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.486 HG13 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -123.47 162.16 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 100' ' ' GLN . 4.3 p . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.593 0.235 . . . . 0.0 111.386 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.53 25.95 10.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.928 0.394 . . . . 0.0 111.749 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.44 HD23 ' C ' ' A' ' 33' ' ' LEU . 3.3 tt -65.7 78.45 0.07 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.009 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.95 -171.9 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.766 ' CD2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.86 156.48 54.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.766 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.493 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 8.9 Cg_endo -49.27 168.0 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.637 2.891 . . . . 0.0 111.831 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.34 59.21 0.76 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.033 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.711 ' C ' ' HG2' ' A' ' 39' ' ' LYS . . . -118.56 159.94 14.16 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.615 -0.793 . . . . 0.0 111.993 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.711 ' HG2' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 49.12 23.13 0.71 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 111.561 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.049 HD12 ' HB1' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -61.81 -30.96 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.704 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.19 -80.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.028 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.9 mmt 41.32 -84.03 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.381 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.29 33.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.682 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 mp0 -93.56 -174.33 3.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.7 0.286 . . . . 0.0 111.266 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.867 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.92 153.98 38.98 Favored Pre-proline 0 N--CA 1.457 -0.124 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.378 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.867 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.69 -24.66 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.958 2.439 . . . . 0.0 112.532 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.7 mt-10 -98.1 -48.71 5.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -80.42 -26.09 38.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.049 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -55.48 -47.38 76.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.33 -51.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.295 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.1 t -52.82 -36.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.512 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -78.24 -43.31 28.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.203 0.525 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.59 ' HG2' HG22 ' A' ' 40' ' ' ILE . 10.8 tp10 -64.42 -27.37 68.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.289 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.83 HD11 ' CE1' ' A' ' 64' ' ' HIS . 2.9 tp -56.57 -44.61 81.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -63.28 -35.41 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.431 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tm-20 -77.75 -26.13 49.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.477 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 36' ' ' PRO . 63.8 mm-40 -108.99 5.39 24.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.931 HG12 HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.84 -44.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.696 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.84 3.14 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.618 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.931 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.48 -173.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 117.907 0.853 . . . . 0.0 110.269 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 p -113.28 87.99 11.99 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.183 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.761 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.9 Cg_endo -113.23 145.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.612 2.875 . . . . 0.0 113.922 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.44 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 17.8 mt-30 -74.97 79.68 2.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.832 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.35 134.21 55.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.825 -176.253 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -179.3 -139.94 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 1.1 m 52.18 174.3 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.171 0.51 . . . . 0.0 112.111 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD11 ' CD ' ' A' ' 70' ' ' LYS . 6.1 tt -139.6 117.87 12.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.844 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.758 ' CE1' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.78 -55.61 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.221 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.614 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.1 mt-10 -171.13 131.38 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.441 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.762 ' CD ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.36 132.08 46.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.651 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.758 HD21 HG22 ' A' ' 122' ' ' VAL . 3.1 pp -140.56 161.95 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.666 ' HB2' HG23 ' A' ' 81' ' ' THR . 14.5 tt0 -125.69 124.1 40.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -120.88 152.71 38.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -120.76 120.9 36.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.151 0.5 . . . . 0.0 111.346 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -72.27 163.06 70.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.42 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.41 83.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.112 2.541 . . . . 0.0 112.316 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 16.8 m-20 95.29 15.2 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 8.2 tpp85 -137.44 150.14 47.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.7 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.7 105.6 10.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -111.36 154.31 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -127.25 131.18 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.647 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.536 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 11.2 tp -126.32 114.56 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.289 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.568 ' CH2' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -110.26 135.64 50.69 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.955 ' CD1' HG11 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -120.01 118.03 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.331 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.4 m95 -100.52 148.62 24.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.0 tp -96.6 102.89 14.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.46 0.648 . . . . 0.0 111.746 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.832 HG13 ' CB ' ' A' ' 64' ' ' HIS . 16.4 t -85.99 145.81 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.377 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.0 -39.77 5.65 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.8 ptp180 -163.24 165.67 24.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.837 0.744 . . . . 0.0 112.097 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.732 ' HE3' HG22 ' A' ' 11' ' ' ILE . 4.6 p90 -144.72 130.4 19.06 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.505 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.69 105.95 11.36 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.76 -122.82 7.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.446 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -134.97 137.07 26.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.401 0.143 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.594 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.45 128.75 10.57 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.755 2.303 . . . . 0.0 111.502 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.696 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.2 p-90 -130.47 -57.2 1.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.959 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.521 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 45.15 -94.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.991 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.4 mmtp 170.62 39.33 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 111.189 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -42.69 99.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.696 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.47 6.67 50.19 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.642 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 8.7 mp0 -140.2 99.12 7.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 117.31 0.555 . . . . 0.0 111.515 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -43.62 140.95 4.07 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.989 2.46 . . . . 0.0 112.668 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.17 177.05 19.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.768 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -147.96 157.18 43.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.545 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.2 m0 -61.86 105.92 0.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.114 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.2 ttm -120.55 159.81 24.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.277 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.547 ' HB2' HG12 ' A' ' 108' ' ' VAL . 5.2 p -83.93 123.85 30.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.746 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -80.01 -19.06 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.274 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.4 p -55.35 -19.82 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.18 45.8 1.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.076 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.608 HD12 ' CD2' ' A' ' 107' ' ' LEU . 7.6 tt -62.95 150.54 41.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.595 0.236 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -121.85 120.85 35.73 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.719 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.71 61.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.834 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.93 -46.25 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.562 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.56 -13.56 58.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.719 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.61 175.71 3.86 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.59 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 68.6 Cg_endo -76.12 143.08 25.26 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.736 1.624 . . . . 0.0 110.949 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.05 -14.27 36.49 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.483 2.122 . . . . 0.0 113.213 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.62 -9.37 58.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' O ' ' A' ' 116' ' ' PRO . 31.4 p-10 -124.48 32.74 5.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.522 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.51 -55.19 1.68 Allowed Pre-proline 0 N--CA 1.467 0.389 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.456 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.95 -37.13 11.95 Favored 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.509 2.139 . . . . 0.0 112.889 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.955 HG11 ' CD1' ' A' ' 84' ' ' PHE . 2.4 t -77.6 -51.18 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.891 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.528 HD12 ' CD2' ' A' ' 110' ' ' LEU . 1.8 mm -68.3 -29.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.264 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.84 57.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.412 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -48.27 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.317 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.758 HD13 ' CE1' ' A' ' 68' ' ' PHE . 6.4 tp -78.21 -30.09 48.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.534 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -56.57 -42.87 79.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -75.59 -2.89 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttp . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.849 0.357 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.19 129.57 36.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.48 122.02 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.717 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.861 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.8 pp -109.65 125.08 52.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.487 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.6 mt-30 -102.52 150.43 23.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.317 0.58 . . . . 0.0 111.54 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.612 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.1 mt -141.21 131.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.046 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.051 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.01 124.8 43.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -128.52 156.96 41.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.322 0.582 . . . . 0.0 111.85 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -148.6 118.16 0.94 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.262 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.621 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.11 108.96 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.725 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -70.82 128.28 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.386 -178.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -91.75 126.22 36.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 9.6 t-20 -87.6 -172.31 3.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.983 0.897 . . . . 0.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -77.9 -3.0 39.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.878 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -133.46 49.06 2.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.203 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.85 28.88 0.39 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.451 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 6.7 pt-20 -118.17 149.53 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.042 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.793 HG21 HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -120.4 146.65 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 111.599 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -95.85 116.58 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.525 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.62 162.15 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.202 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -99.98 122.52 43.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.74 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' NH1' HD12 ' A' ' 33' ' ' LEU . 54.0 ttm-85 -106.43 159.75 15.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 47.6 mmt-85 -69.48 60.67 0.14 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.118 0.485 . . . . 0.0 110.012 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . 48.94 -87.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.703 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -167.92 86.95 0.23 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.884 0.373 . . . . 0.0 111.245 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.02 -171.92 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.38 24.91 12.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.219 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.04 39.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.814 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.401 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER 62.53 83.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.777 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.86 -8.82 47.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.809 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.4 23.12 3.55 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -114.47 26.01 10.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.079 0.466 . . . . 0.0 111.512 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.571 HD12 ' NH1' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -53.97 94.58 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.507 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -111.69 -166.46 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 111.652 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.82 163.04 29.94 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.426 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 35.5 Cg_endo -63.48 168.17 11.86 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.525 2.816 . . . . 0.0 112.003 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.32 58.83 0.77 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.927 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -120.95 138.57 12.74 Favored Glycine 0 C--N 1.313 -0.701 0 CA-C-N 114.756 -0.722 . . . . 0.0 111.974 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 2.7 ttpm? 92.45 6.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.981 0.513 . . . . 0.0 112.047 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.051 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -55.82 -27.14 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.49 0.662 . . . . 0.0 110.533 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.2 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.039 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.9 mmm 37.92 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.438 0.461 . . . . 0.0 111.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.76 32.71 0.12 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt-10 -89.68 -175.02 4.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.782 0.325 . . . . 0.0 111.244 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.896 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.45 155.18 36.67 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.896 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.9 Cg_endo -44.62 -24.91 1.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.819 2.346 . . . . 0.0 112.593 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.2 mt-10 -104.09 -41.66 5.77 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.4 mm-40 -79.04 -19.21 51.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.007 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.41 -47.73 82.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.654 0.264 . . . . 0.0 111.303 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.838 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.11 -45.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.883 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.8 t -53.95 -36.94 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.65 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.38 -52.02 9.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 1.4 mm-40 -64.79 -22.93 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.826 ' O ' HG23 ' A' ' 58' ' ' VAL . 6.2 tp -54.46 -44.81 72.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.812 0.339 . . . . 0.0 110.736 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.76 -28.38 68.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.27 -25.34 51.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.179 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 6.9 mm-40 -108.52 0.95 21.17 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.988 HG12 HG13 ' A' ' 60' ' ' ILE . 2.1 t -134.79 -44.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 109.786 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -33.91 0.29 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.906 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.988 HG13 HG12 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -77.69 -175.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.88 0.371 . . . . 0.0 111.084 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.23 89.02 13.52 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.209 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.643 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.8 Cg_endo -109.55 145.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.308 2.672 . . . . 0.0 114.104 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 70.6 mt-30 -74.74 79.93 2.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.82 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.32 136.93 54.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.252 -175.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.5 t80 179.16 -144.71 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 57.02 157.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.336 0.589 . . . . 0.0 112.536 178.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.0 tt -121.33 108.69 14.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.923 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -41.95 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.518 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.6 tt0 -171.25 160.28 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.3 131.41 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.556 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.643 ' HB2' HG22 ' A' ' 122' ' ' VAL . 5.6 tp -122.73 137.13 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -125.82 109.8 12.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.4 153.1 47.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.22 132.7 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 111.482 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.538 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.9 162.95 21.24 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.012 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_endo -46.31 80.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.194 2.596 . . . . 0.0 112.58 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t0 85.7 11.85 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.786 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.441 ' CG ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -137.35 97.25 3.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.661 0.267 . . . . 0.0 111.148 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.0 OUTLIER -74.9 106.56 6.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.951 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.624 HD12 HD11 ' A' ' 4' ' ' LEU . 1.4 tt -102.11 116.43 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.051 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.32 132.49 49.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -126.14 114.61 18.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.064 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -106.47 123.84 48.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.23 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 2.0 m-85 -105.93 109.9 22.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.675 ' NE1' HG11 ' A' ' 50' ' ' VAL . 19.4 m95 -97.27 149.36 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.444 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.4 tp -99.89 102.84 14.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.253 0.549 . . . . 0.0 111.914 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.82 HG13 ' CB ' ' A' ' 64' ' ' HIS . 12.2 t -84.12 146.16 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.124 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.55 -26.47 8.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 5.4 ttp180 -162.78 159.8 24.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.885 0.766 . . . . 0.0 111.73 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.725 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -152.18 125.89 8.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.329 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -74.37 146.04 43.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.958 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.47 -119.24 14.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.558 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 tt0 -135.07 145.77 55.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.571 0.224 . . . . 0.0 110.792 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 3.7 Cg_exo -76.44 128.84 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.847 2.364 . . . . 0.0 111.241 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.578 ' NE1' HG23 ' A' ' 60' ' ' ILE . 42.2 p-90 -130.42 -64.25 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.43 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . 49.13 -107.68 0.32 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.477 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 164.45 67.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.389 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' OE1' ' CB ' ' A' ' 21' ' ' THR . 2.3 pt-20 -86.36 -37.4 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.07 -6.67 10.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.507 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HB2' ' HG1' ' A' ' 21' ' ' THR . 1.2 mp0 -140.06 97.03 7.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.134 0.467 . . . . 0.0 111.483 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -43.79 145.64 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 112.586 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.34 177.11 19.43 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.964 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.82 157.43 45.41 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -70.3 106.65 3.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.307 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -120.06 163.62 17.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 93.3 p -89.01 127.97 35.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 18' ' ' ILE . 5.1 tp -78.48 -18.9 54.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.6 t -48.93 -24.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.38 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.72 39.64 2.37 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.95 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.769 HD13 HD21 ' A' ' 126' ' ' LEU . 4.1 tt -62.71 140.03 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.756 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -123.1 134.5 54.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.615 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.37 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.278 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.0 -49.15 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -36.28 81.91 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.239 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.7 172.66 8.99 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.273 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 60.5 Cg_endo -72.77 127.76 12.64 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.139 1.893 . . . . 0.0 111.526 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.27 -14.75 31.01 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.701 2.267 . . . . 0.0 113.28 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.74 -9.73 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -130.62 42.37 3.26 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.725 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.424 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.43 -49.74 5.01 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.4 Cg_exo -44.94 -33.95 8.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.461 2.107 . . . . 0.0 112.591 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' ' 71' ' ' LEU . 14.0 t -77.35 -48.72 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.427 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.704 HG22 ' HB2' ' A' ' 127' ' ' LYS . 8.7 mm -66.33 -31.93 55.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.719 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.66 -26.87 36.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.932 0.396 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -53.17 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.864 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.24 -29.66 48.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.694 0.283 . . . . 0.0 111.47 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.843 ' N ' HD23 ' A' ' 126' ' ' LEU . 24.7 ttpp -55.17 -42.52 73.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.17 0.509 . . . . 0.0 110.74 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -65.13 -11.65 42.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.585 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.2 mp . . . . . 0 C--O 1.231 0.1 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.055 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.861 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.776 0.322 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.05 102.91 11.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 145.5 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.744 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.5 pp -146.01 128.33 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 13.9 mt-30 -106.95 153.3 22.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 112.029 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.744 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.3 mp -146.44 131.37 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.836 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.058 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.28 124.75 43.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -121.25 162.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 111.904 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 113.31 0.58 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.559 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.891 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.91 105.8 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.716 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -70.97 122.17 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.28 -178.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -93.17 127.72 38.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.342 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 2.5 t-20 -75.33 -172.09 1.65 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 122.219 1.009 . . . . 0.0 113.107 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.04 -17.81 41.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.859 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -120.33 -82.39 0.65 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.724 0.297 . . . . 0.0 111.559 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -158.8 16.05 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.677 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HG2' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -100.91 155.14 18.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.891 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -124.34 144.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.327 0.584 . . . . 0.0 111.957 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.412 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 59.6 t80 -83.65 90.17 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.584 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.885 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -104.44 162.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.298 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.435 HG22 ' OE1' ' A' ' 98' ' ' GLU . 5.5 p -89.86 116.05 27.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.582 ' CG ' HD13 ' A' ' 33' ' ' LEU . 9.1 ttp180 -119.75 119.48 33.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.889 0.376 . . . . 0.0 110.999 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 11.9 ttm-85 52.6 -102.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.769 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 172.55 -64.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.842 0.354 . . . . 0.0 110.935 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -166.6 -55.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.09 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -164.92 92.3 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.9 -169.81 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.035 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -99.88 53.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.3 mtt -132.83 38.11 3.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.49 -19.03 61.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.352 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.03 31.24 2.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.008 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.41 26.22 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.388 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.582 HD13 ' CG ' ' A' ' 22' ' ' ARG . 16.2 tp -69.18 63.88 0.14 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.807 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -177.65 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.53 162.9 30.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.648 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 28.3 Cg_endo -60.94 167.99 7.96 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.538 2.826 . . . . 0.0 111.857 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.28 59.07 0.77 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.255 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.76 121.43 3.43 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.978 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.45 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.306 0.642 . . . . 0.0 111.866 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.058 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -53.81 -27.98 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.541 0.686 . . . . 0.0 110.683 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.599 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.72 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.427 ' HE3' ' HD3' ' A' ' 39' ' ' LYS . 2.4 mmt 34.96 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.362 0.414 . . . . 0.0 111.755 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.77 30.16 0.16 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.452 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.9 mp0 -93.59 -176.6 4.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.733 0.301 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.946 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.84 158.94 33.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.202 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.946 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.76 -24.66 0.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.839 2.359 . . . . 0.0 112.525 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -89.86 -60.58 1.9 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -4.84 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.904 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -63.14 -55.29 26.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 111.103 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -78.25 -45.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.904 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.473 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 58.0 t -55.52 -36.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.37 -49.1 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 40' ' ' ILE . 22.0 tp10 -68.31 -22.6 64.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.212 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -56.52 -45.04 81.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 0.0 110.659 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -27.12 68.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.43 -30.63 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.279 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -109.08 5.78 24.37 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.015 HG12 HG13 ' A' ' 60' ' ' ILE . 2.6 t -134.02 -44.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.26 0.552 . . . . 0.0 110.24 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.586 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.55 7.02 1.25 Allowed Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 114.563 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.015 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -115.39 -172.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 117.902 0.851 . . . . 0.0 110.033 179.082 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 p -114.45 87.59 14.21 Favored Pre-proline 0 N--CA 1.438 -1.074 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.537 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.647 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.4 Cg_endo -113.95 142.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.631 2.887 . . . . 0.0 113.598 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 8.8 mt-30 -74.87 79.94 2.12 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.042 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.15 129.12 53.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.407 -175.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -176.44 -141.69 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.07 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.73 159.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.334 0.588 . . . . 0.0 112.053 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' A' ' 70' ' ' LYS . 5.4 tt -122.18 113.0 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.318 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.44 -48.32 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.093 0.473 . . . . 0.0 110.017 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.39 166.31 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.216 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.34 132.02 22.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.809 0.338 . . . . 0.0 110.977 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.696 ' HB2' HG22 ' A' ' 122' ' ' VAL . 18.2 tp -113.78 120.77 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.64 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.68 109.93 16.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.86 146.46 37.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.717 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -121.14 120.13 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.072 0.463 . . . . 0.0 111.278 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -69.95 163.18 63.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.505 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -51.76 83.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.024 2.483 . . . . 0.0 112.058 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 26.2 m-20 95.59 15.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.323 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD3' HD21 ' A' ' 4' ' ' LEU . 9.8 ttm180 -137.38 150.17 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.526 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.9 94.1 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.9 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -99.0 118.21 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.95 127.12 55.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.604 HD13 ' CG ' ' A' ' 119' ' ' ASN . 5.4 mt -126.28 114.71 18.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.074 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.544 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -106.32 123.02 47.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.553 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 m-30 -99.72 116.07 30.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.664 ' CE2' HG11 ' A' ' 50' ' ' VAL . 24.3 m95 -100.59 149.18 24.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.257 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tm? -103.04 103.14 13.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.365 0.602 . . . . 0.0 112.04 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.042 HG22 ' ND1' ' A' ' 64' ' ' HIS . 22.2 t -81.01 145.87 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.095 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 1.9 pm0 -119.63 -14.53 9.07 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.601 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 11.3 tpp85 -162.9 154.91 18.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.611 0.641 . . . . 0.0 111.523 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.716 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.55 120.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.539 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.65 144.28 37.53 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 -124.57 36.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.201 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 45.4 mt-10 -135.11 143.08 44.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.519 0.199 . . . . 0.0 110.992 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.548 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.6 Cg_exo -75.92 128.77 11.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.041 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 62.9 p-90 -129.72 -59.85 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.471 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 43.73 -96.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.795 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 175.65 35.98 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.677 0.275 . . . . 0.0 110.999 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 21' ' ' THR . 9.0 pt-20 -55.09 -38.22 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.685 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.1 58.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.43 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -140.13 97.02 7.9 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.087 0.443 . . . . 0.0 111.384 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.56 143.03 2.8 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.078 2.519 . . . . 0.0 112.828 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.27 19.31 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.851 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -142.89 157.38 44.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.326 -0.249 . . . . 0.0 110.326 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.64 105.84 5.92 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.4 ptm -120.75 163.15 18.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.857 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.647 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -78.04 114.83 17.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 110.543 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.862 HD11 HD12 ' A' ' 110' ' ' LEU . 11.3 tp -70.34 -18.86 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.342 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.737 ' CG2' HD21 ' A' ' 129' ' ' LEU . 11.0 p -53.42 -19.25 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.486 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.67 49.73 0.91 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.971 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.862 HD12 HD11 ' A' ' 107' ' ' LEU . 9.2 tt -62.18 150.3 39.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.665 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' N ' HD23 ' A' ' 110' ' ' LEU . 4.3 t-20 -106.86 104.14 13.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.535 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.81 61.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.077 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.29 -43.42 23.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.982 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -1.87 31.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.201 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.571 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -117.53 170.55 6.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.1 Cg_endo -54.4 127.88 27.78 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.099 1.866 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.94 -20.41 45.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.612 2.208 . . . . 0.0 112.452 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.77 51.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.604 ' CG ' HD13 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -114.71 -2.36 13.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.399 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -47.84 -48.29 61.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.519 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.9 Cg_exo -44.95 -34.88 9.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.27 1.98 . . . . 0.0 112.28 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.29 -51.14 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.618 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.588 HG22 ' HB2' ' A' ' 127' ' ' LYS . 41.8 mm -64.89 -33.5 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.996 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . . . -54.83 -27.04 39.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 111.073 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.19 -52.47 8.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.632 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 126' ' ' LEU . 1.3 tm? -78.19 -30.14 48.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.509 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 123' ' ' ILE . 42.2 tttm -56.69 -42.8 79.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 111.017 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -66.67 -10.09 42.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.721 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.737 HD21 ' CG2' ' A' ' 108' ' ' VAL . 8.0 mp . . . . . 0 C--O 1.231 0.113 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.004 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.497 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.863 0.363 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.02 111.18 22.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 132.52 43.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.585 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.4 pp -128.29 123.2 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.55 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.0 mt-30 -102.46 152.13 21.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.486 0.66 . . . . 0.0 112.0 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.1 pt -146.56 134.72 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.836 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.4 124.29 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -120.51 160.44 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.249 0.547 . . . . 0.0 111.661 -179.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.53 115.29 0.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.645 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.967 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.78 109.33 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -70.78 120.23 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.048 -178.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.711 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.34 118.25 23.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.696 -179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' CA ' ' CZ3' ' A' ' 90' ' ' TRP . 20.3 t30 -76.09 -172.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.873 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.57 3.89 30.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.315 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -139.22 51.28 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.524 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.09 22.83 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.659 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.763 ' C ' HD12 ' A' ' 18' ' ' ILE . 17.6 mt-10 -117.38 153.29 33.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.967 HG21 HG22 ' A' ' 10' ' ' ILE . 1.4 mp -117.0 143.4 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.963 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 44.7 t80 -87.98 92.84 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.12 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.52 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.62 159.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.741 ' O ' HD12 ' A' ' 33' ' ' LEU . 13.1 p -73.56 124.52 26.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.526 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 33' ' ' LEU . 11.6 ttp180 -130.56 125.29 33.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.088 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 54.22 -105.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.017 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 169.17 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.7 0.285 . . . . 0.0 111.128 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 76.58 26.58 0.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.968 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -179.48 36.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -179.76 -165.9 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.027 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -119.79 88.81 3.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt -149.85 37.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -64.55 -24.01 67.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.379 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.84 15.61 14.35 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.35 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.34 26.24 10.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.733 0.301 . . . . 0.0 111.593 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 21' ' ' THR . 22.2 tp -59.63 76.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.735 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -106.86 -172.65 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 111.679 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.733 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.6 160.56 41.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.901 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.642 ' HG3' HD11 ' A' ' 11' ' ' ILE . 36.7 Cg_endo -64.2 168.41 12.59 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.594 2.863 . . . . 0.0 111.657 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 59.5 0.74 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.037 -1.077 . . . . 0.0 114.082 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -126.92 117.39 2.73 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.655 -0.772 . . . . 0.0 112.039 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 121.62 4.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.395 0.678 . . . . 0.0 111.678 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.034 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -58.7 -26.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.444 0.64 . . . . 0.0 110.753 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.99 -83.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.332 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 33.45 -85.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.465 0.478 . . . . 0.0 111.889 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.46 34.05 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.516 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.462 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -88.18 -173.94 4.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.797 0.332 . . . . 0.0 111.231 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.889 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.2 154.6 37.61 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.396 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.889 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.11 -26.21 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.89 2.393 . . . . 0.0 112.458 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -104.19 -39.35 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.779 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -80.23 -12.61 59.61 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.924 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.2 -52.95 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 111.196 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.15 -43.84 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -53.66 -39.42 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.528 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.35 -52.02 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -67.19 -22.26 65.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.686 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -54.33 -44.44 72.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.205 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -33.88 71.92 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.68 -25.79 49.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.358 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.422 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.1 mp0 -108.69 6.1 25.45 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 60' ' ' ILE . 15.3 t -134.14 -44.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.166 0.507 . . . . 0.0 110.26 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.27 3.55 1.42 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.705 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.963 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.88 -173.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 117.999 0.9 . . . . 0.0 110.431 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.5 p -114.21 87.59 13.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.607 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -115.25 145.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.578 2.852 . . . . 0.0 114.217 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.84 79.94 2.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.997 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.6 131.67 54.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.018 -175.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -178.92 -140.97 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 58.26 158.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.248 0.547 . . . . 0.0 112.116 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -120.97 110.69 16.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.296 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.59 -46.3 26.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.182 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.53 157.49 4.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.269 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 115.34 8.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.836 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.575 ' CB ' HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -109.19 136.55 48.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.594 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -130.44 115.54 16.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -135.47 147.66 48.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.633 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 4.8 pt-20 -120.07 127.06 52.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.105 0.479 . . . . 0.0 111.284 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.06 163.51 59.65 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.1 Cg_endo -53.8 82.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.992 2.461 . . . . 0.0 112.404 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER 101.57 11.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.959 0.904 . . . . 0.0 111.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.29 150.01 47.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.773 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 4.6 m170 -124.0 101.53 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.534 ' CG1' HD11 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -100.64 128.31 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.75 118.94 28.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.665 ' CD1' HG21 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -126.15 115.17 19.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.439 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.565 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -106.81 122.87 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.509 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CD2' HG11 ' A' ' 122' ' ' VAL . 7.3 m-30 -98.61 119.03 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.095 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.697 ' NE1' HG11 ' A' ' 50' ' ' VAL . 21.4 m95 -101.25 149.2 24.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.538 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.2 tm? -102.49 102.91 13.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.441 0.639 . . . . 0.0 112.053 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' ND1' ' A' ' 64' ' ' HIS . 17.0 t -80.19 146.0 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.027 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.71 -23.24 9.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.25 160.05 26.4 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.873 0.761 . . . . 0.0 111.606 -178.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.668 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -156.92 124.3 5.31 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.381 179.169 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -82.78 127.6 33.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.52 -125.18 6.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.324 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 69.4 mt-10 -135.08 138.43 29.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.625 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.11 128.74 10.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.76 2.307 . . . . 0.0 111.132 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.582 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.3 p-90 -135.5 -57.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.268 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 46.77 -94.29 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.868 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -178.87 34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.687 0.28 . . . . 0.0 111.156 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.29 -34.9 78.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.889 0.376 . . . . 0.0 110.412 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.26 68.57 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.342 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -140.28 95.95 8.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.6 133.44 7.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.989 2.459 . . . . 0.0 112.789 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.33 177.44 19.18 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.762 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -147.55 157.05 43.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.68 106.29 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 22.0 ptm -120.38 150.96 39.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.1 p -70.59 114.65 8.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.752 ' HB2' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -65.16 -21.54 66.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.89 -17.79 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.509 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.42 35.04 4.95 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.816 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 107' ' ' LEU . 12.6 tp -62.5 125.7 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 139.5 54.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -15.76 61.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.395 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.94 -48.56 14.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.472 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -40.38 88.13 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.626 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.99 174.17 6.53 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.1 Cg_endo -76.18 130.26 11.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.263 1.975 . . . . 0.0 111.457 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.76 -14.5 17.87 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.886 2.391 . . . . 0.0 113.556 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -10.57 13.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.527 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.7 m-20 -134.99 45.43 2.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.765 0.317 . . . . 0.0 111.553 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.09 -49.38 7.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.2 Cg_exo -44.89 -36.74 11.33 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.455 2.103 . . . . 0.0 112.871 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.742 HG11 ' CD2' ' A' ' 84' ' ' PHE . 20.3 t -77.46 -51.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.984 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.586 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 10.7 mm -65.36 -32.1 56.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.8 -27.9 45.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.997 0.427 . . . . 0.0 110.725 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -48.49 13.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.509 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.0 tm? -78.04 -28.87 49.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.476 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.468 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.0 ttpp -55.5 -42.64 74.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -69.96 -7.72 42.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.804 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.216 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.699 ' OP3' " H4'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.776 0.322 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -99.76 103.08 14.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -113.98 145.16 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.679 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.09 122.15 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -102.37 154.0 19.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.336 0.588 . . . . 0.0 111.869 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.4 mp -146.12 130.93 11.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.74 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.39 124.29 42.02 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -114.63 162.17 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.421 0.629 . . . . 0.0 111.913 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.54 106.01 0.43 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.985 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.831 HG23 ' CG1' ' A' ' 18' ' ' ILE . 2.8 mp -70.29 100.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.694 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.14 126.51 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -96.42 140.61 30.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.504 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.493 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 14.8 t30 -107.88 -172.39 2.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.89 0.853 . . . . 0.0 112.666 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.26 -18.26 63.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.259 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.15 39.12 2.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.885 0.374 . . . . 0.0 110.891 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.17 28.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.556 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -106.6 145.42 31.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.328 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.831 ' CG1' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -106.7 127.19 62.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 0.0 111.872 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.73 ' N ' HD12 ' A' ' 18' ' ' ILE . 51.0 t80 -78.09 87.49 4.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.753 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.702 HD11 ' SD ' ' A' ' 105' ' ' MET . 1.2 pt -112.79 162.29 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 100' ' ' GLN . 14.2 p -82.48 114.23 20.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HA ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.76 103.75 4.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 111.109 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.896 ' CG ' ' HB1' ' A' ' 30' ' ' ALA . 6.6 mtp180 45.61 29.2 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 101' ' ' PRO . . . -106.63 35.2 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.258 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.831 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . . . -176.57 -69.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.15 147.54 47.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.077 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.39 -37.06 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.03 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -95.86 -45.23 7.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.06 43.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.816 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.896 ' HB1' ' CG ' ' A' ' 23' ' ' ARG . . . -72.89 -8.65 56.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.619 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -89.66 24.72 2.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.57 0.224 . . . . 0.0 111.565 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.28 26.16 10.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.89 0.376 . . . . 0.0 111.3 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 33' ' ' LEU . 6.6 tt -39.58 93.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.307 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.1 tt0 -120.62 -168.88 1.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.164 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.75 158.16 50.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.531 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 18.0 Cg_endo -58.17 167.83 4.23 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.513 2.809 . . . . 0.0 111.496 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.56 59.24 0.75 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.692 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.626 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -125.15 120.7 4.02 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 114.447 -0.876 . . . . 0.0 112.026 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.55 5.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.329 0.652 . . . . 0.0 111.751 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.8 -26.03 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.486 0.66 . . . . 0.0 110.733 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.543 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.31 -82.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.185 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 33.67 -86.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.507 0.504 . . . . 0.0 111.86 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.24 31.87 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.503 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.99 -175.64 4.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.809 0.338 . . . . 0.0 111.16 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.921 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.04 159.58 28.84 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.463 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.921 ' HD2' HG22 ' A' ' 45' ' ' THR . 7.0 Cg_endo -47.79 -24.44 4.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.468 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -97.8 -47.45 5.57 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 4.8 mm-40 -80.13 -25.57 39.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.939 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -55.63 -47.54 76.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.809 0.337 . . . . 0.0 110.988 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.839 HG12 ' HB1' ' A' ' 7' ' ' ALA . 2.8 m -78.14 -45.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.7 t -62.58 -35.79 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.449 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -78.31 -41.68 33.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.458 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.641 ' CB ' HG22 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -78.13 -26.23 47.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.318 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.961 HD23 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -57.57 -45.11 85.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.572 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -26.85 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.311 0.577 . . . . 0.0 109.489 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.11 -26.76 53.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.117 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -108.32 5.16 25.29 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 54' ' ' LEU . 1.3 t -134.78 -44.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.282 0.563 . . . . 0.0 109.603 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.6 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 59.78 0.48 1.0 Allowed Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.412 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.881 ' CG1' HG12 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -105.51 -173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.605 0.702 . . . . 0.0 110.375 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -114.55 88.04 15.28 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.374 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.574 ' HG2' ' HB3' ' A' ' 64' ' ' HIS . 98.3 Cg_endo -112.11 152.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.927 3.084 . . . . 0.0 113.478 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.423 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 35.5 mt-30 -74.76 78.67 2.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.961 ' CD2' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -111.19 120.25 41.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.555 -1.657 . . . . 0.0 112.089 -174.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -178.55 -148.19 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.99 161.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.163 0.506 . . . . 0.0 112.006 179.039 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -125.31 116.98 22.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -76.54 -56.55 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 109.924 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mt-10 -172.05 131.66 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.171 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -117.38 132.01 56.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.603 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -117.78 134.67 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.4 109.87 15.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -126.24 153.05 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.522 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -121.09 133.91 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.52 . . . . 0.0 111.412 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -96.6 162.92 21.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.146 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 5.7 Cg_endo -47.6 80.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.166 2.577 . . . . 0.0 112.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' PHE . 5.0 t0 86.45 12.73 0.15 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.641 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.41 94.82 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.733 0.302 . . . . 0.0 111.112 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -74.84 109.31 8.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.751 0.31 . . . . 0.0 110.844 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -106.99 111.97 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.029 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.55 125.71 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 71' ' ' LEU . 1.1 pp -126.45 114.88 18.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.69 0.281 . . . . 0.0 111.467 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -108.54 122.76 47.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 9.8 m-30 -101.67 121.0 41.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 111.086 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.758 ' NE1' HG11 ' A' ' 50' ' ' VAL . 19.5 m95 -101.64 149.23 24.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 65' ' ' PHE . 26.1 tp -100.18 103.44 14.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.914 HG13 ' HA ' ' A' ' 64' ' ' HIS . 10.3 t -86.29 145.29 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.03 -32.83 9.51 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.26 165.5 26.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.49 0.586 . . . . 0.0 111.59 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.694 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -152.04 128.71 10.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.554 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -77.0 135.18 38.67 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.85 -125.84 20.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.431 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.4 tt0 -132.92 143.22 47.68 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.527 0.203 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.668 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.7 Cg_exo -76.27 128.86 10.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.83 2.353 . . . . 0.0 111.408 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.6 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -125.36 -61.26 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.179 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.26 -103.64 0.04 OUTLIER Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.04 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.27 38.39 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.556 0.217 . . . . 0.0 111.093 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.48 -41.73 73.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 110.79 -19.63 25.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.143 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.604 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -126.54 99.14 30.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.036 0.446 . . . . 0.0 111.477 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.831 ' HD2' ' HB2' ' A' ' 25' ' ' ALA . 57.8 Cg_exo -43.62 146.43 1.39 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.172 2.581 . . . . 0.0 112.663 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.12 177.39 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.758 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -143.21 157.17 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -74.08 106.39 5.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.702 ' SD ' HD11 ' A' ' 20' ' ' ILE . 4.1 ptm -120.42 163.0 18.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.95 114.89 23.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.814 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -64.32 -18.96 65.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.713 ' O ' HD21 ' A' ' 129' ' ' LEU . 12.0 p -54.44 -20.46 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.682 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.74 42.57 1.43 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.222 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.583 HD12 HD21 ' A' ' 107' ' ' LEU . 8.0 tt -62.94 150.29 42.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.806 0.303 . . . . 0.0 110.204 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -122.88 131.16 53.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -14.84 61.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -49.22 13.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.18 -38.82 86.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.887 0.375 . . . . 0.0 111.07 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.81 174.4 6.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 71.6 Cg_endo -75.21 127.76 10.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.176 1.917 . . . . 0.0 111.489 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.71 -15.0 39.31 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.667 2.245 . . . . 0.0 113.049 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.52 -9.76 57.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.583 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -122.64 28.67 7.22 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -70.64 -39.72 9.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -53.5 -42.19 67.57 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.988 1.792 . . . . 0.0 112.308 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -77.43 -51.36 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.423 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.31 -29.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.961 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -34.3 64.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 110.432 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.17 -49.63 66.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.91 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' A' ' 68' ' ' PHE . 9.2 tp -78.19 -28.63 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.618 ' O ' HD12 ' A' ' 129' ' ' LEU . 17.2 tttt -57.08 -42.67 81.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.998 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -72.72 -5.09 35.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.983 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 108' ' ' VAL . 3.7 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.423 " O3'" ' CG1' ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.793 0.33 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.03 104.03 12.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 136.26 54.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.41 128.49 20.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.2 mt-30 -102.45 154.16 19.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.331 0.586 . . . . 0.0 111.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.434 ' HB ' HD23 ' A' ' 82' ' ' LEU . 38.2 mm -146.31 129.39 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.892 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.5 42.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.578 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.13 161.95 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.445 0.64 . . . . 0.0 111.972 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.04 121.43 1.19 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.642 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' HB ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -73.77 108.85 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.719 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.26 127.79 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 0.0 111.709 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.09 131.67 43.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.123 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.771 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p-10 -87.8 -173.04 4.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.357 0.599 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 22.1 tt0 -73.54 6.29 3.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.391 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 21.5 t-20 -130.33 45.06 2.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.048 -0.407 . . . . 0.0 112.052 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 46.92 25.48 0.47 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.918 0.39 . . . . 0.0 111.369 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.509 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.53 161.61 18.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.661 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.3 144.37 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.058 0.456 . . . . 0.0 111.88 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.98 102.66 14.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.01 162.14 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.334 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.937 HG22 ' O ' ' A' ' 34' ' ' GLU . 10.1 t -84.65 139.61 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -125.91 101.93 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 30' ' ' ALA . 8.1 ttm-85 62.21 -104.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -175.86 -167.78 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.816 0.341 . . . . 0.0 111.066 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.37 -65.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.9 -51.64 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.965 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.43 147.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.096 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.31 -75.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -143.17 87.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HB2' ' HG3' ' A' ' 23' ' ' ARG . . . -72.06 -21.23 61.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.371 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t-20 -94.28 16.08 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.448 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.33 26.35 10.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 114' ' ' ASP . 2.2 tt -52.55 84.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.766 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.937 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -123.15 176.5 6.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.177 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.81 166.43 14.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 0.0 112.075 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.4 Cg_endo -47.44 168.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.924 3.083 . . . . 0.0 112.628 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.64 59.46 0.75 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.099 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.68 112.09 1.15 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 114.262 -0.969 . . . . 0.0 112.045 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.02 6.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.4 0.68 . . . . 0.0 111.853 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.013 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -55.06 -27.59 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.271 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.9 -80.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.206 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.3 mmm 38.64 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.355 0.41 . . . . 0.0 111.662 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.68 33.79 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.67 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.492 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -96.94 -170.26 2.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.65 0.262 . . . . 0.0 111.019 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.924 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.9 159.04 30.68 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.287 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.924 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.91 -24.66 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.777 2.318 . . . . 0.0 112.5 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -92.91 -58.1 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 8.0 pt20 -80.66 -4.88 55.9 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.795 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -63.16 -57.27 11.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 111.013 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.617 HG22 HD13 ' A' ' 54' ' ' LEU . 1.4 p -78.78 -42.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.77 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.3 t -50.65 -35.65 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.203 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -78.21 -52.12 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.685 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -62.17 -20.09 63.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.625 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.9 HD11 ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -57.46 -44.67 85.0 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.93 -27.6 68.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.914 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.19 -30.4 54.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.282 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.49 6.4 26.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.912 HG12 HG13 ' A' ' 60' ' ' ILE . 43.4 t -133.43 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.78 -40.17 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.006 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.912 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.53 -177.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.06 0.457 . . . . 0.0 111.112 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.71 88.72 14.29 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.738 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.0 Cg_endo -111.55 146.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.404 2.736 . . . . 0.0 114.211 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.1 mt-30 -74.85 79.73 2.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.951 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.21 128.45 52.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.058 -176.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.11 -139.53 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.622 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.45 158.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.12 0.486 . . . . 0.0 111.85 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.594 HD21 ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -121.07 109.89 15.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.577 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.75 -43.39 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.977 0.418 . . . . 0.0 110.139 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt-10 -171.3 166.02 7.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.516 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.17 132.12 22.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 tp -117.4 124.55 49.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -122.28 110.16 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.649 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -140.67 153.16 45.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.686 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.25 140.22 48.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.296 0.569 . . . . 0.0 111.284 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.33 163.85 16.64 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.534 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 53.8 Cg_exo -41.58 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.534 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.3 t0 73.56 20.67 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.597 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttt180 -137.31 93.87 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.317 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.54 98.61 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 110.94 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.62 111.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.98 133.83 43.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.771 HD13 HD21 ' A' ' 119' ' ' ASN . 32.1 mt -126.22 114.36 18.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.489 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.14 122.7 48.23 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.6 125.2 50.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.53 ' CE2' HG11 ' A' ' 50' ' ' VAL . 67.5 m95 -107.57 148.56 29.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.2 tp -98.97 103.01 14.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.326 0.584 . . . . 0.0 111.261 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.951 HG22 ' ND1' ' A' ' 64' ' ' HIS . 13.3 t -81.84 145.61 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.845 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.63 -35.34 6.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.56 165.66 25.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.843 0.747 . . . . 0.0 112.014 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.771 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.5 p90 -151.02 130.76 13.16 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.6 139.67 40.73 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.43 -121.84 23.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.8 mt-10 -131.94 145.59 58.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.558 0.218 . . . . 0.0 110.835 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.63 128.71 10.4 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.841 2.361 . . . . 0.0 111.363 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.564 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.6 p-90 -133.34 -60.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.133 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.05 -100.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.001 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.56 32.85 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.3 pt-20 -64.79 -27.04 68.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.35 . . . . 0.0 110.688 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.14 31.6 81.28 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.729 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 5.9 mm-40 -140.42 91.96 9.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.045 0.45 . . . . 0.0 111.253 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -43.6 126.51 5.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.025 2.483 . . . . 0.0 112.854 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 177.2 19.35 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.762 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.34 157.16 42.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -68.83 106.28 2.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.047 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.9 ptm -120.39 147.41 45.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.697 ' HB2' HG12 ' A' ' 108' ' ' VAL . 77.0 p -70.76 115.08 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.661 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -62.03 -18.65 61.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.909 ' HA ' HD21 ' A' ' 129' ' ' LEU . 12.1 p -59.02 -9.94 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.783 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.13 50.36 0.89 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.164 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.75 HD13 ' N ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -62.11 142.27 57.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 110.404 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.75 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -119.2 114.77 22.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.27 61.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.242 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.94 -49.11 13.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.741 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -68.44 -33.43 74.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.768 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.06 174.03 6.63 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.406 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 64.4 Cg_endo -74.23 127.78 11.54 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.134 1.889 . . . . 0.0 111.387 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.86 -14.85 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.742 2.295 . . . . 0.0 113.285 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.4 -9.82 37.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.771 HD21 HD13 ' A' ' 82' ' ' LEU . 1.3 m-20 -130.16 37.82 3.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -72.19 -43.99 10.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -54.78 -38.96 91.76 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.106 1.871 . . . . 0.0 112.169 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 69' ' ' GLU . 2.2 t -77.45 -51.31 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.01 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.522 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.36 -29.85 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.72 -31.06 57.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.393 . . . . 0.0 110.443 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -69.62 -52.43 25.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.705 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.7 tp -78.21 -19.53 53.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.585 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.41 -42.62 64.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.892 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -76.02 -3.65 36.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.131 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.813 0.34 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.56 104.25 13.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 132.76 56.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -138.38 128.06 25.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.3 mt-30 -102.48 154.19 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.275 0.559 . . . . 0.0 111.792 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.519 ' HB ' HD23 ' A' ' 82' ' ' LEU . 37.9 mm -146.33 129.04 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.923 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.54 42.41 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.43 162.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.339 0.59 . . . . 0.0 111.893 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.95 120.85 1.12 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.688 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.76 108.94 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.726 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.32 127.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.796 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.03 132.37 42.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.081 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.768 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.7 p-10 -88.95 -173.01 3.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 111.931 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 23.1 tt0 -73.29 5.8 3.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.391 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 19.7 t-20 -129.92 44.93 2.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.982 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.7 p30 46.76 25.61 0.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.427 . . . . 0.0 111.396 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.42 161.62 18.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.666 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.55 144.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.032 0.444 . . . . 0.0 111.828 -178.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.48 102.18 13.96 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.099 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.14 162.08 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.362 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.933 HG22 ' O ' ' A' ' 34' ' ' GLU . 11.0 t -85.71 137.58 32.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.981 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -123.94 101.46 7.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.806 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 63.17 -103.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.806 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -176.27 -168.6 0.26 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.854 0.359 . . . . 0.0 111.109 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.52 -64.07 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -105.89 -51.49 2.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.78 147.79 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.05 -74.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -143.11 87.06 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.53 -20.82 61.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.376 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.8 t-20 -94.99 16.24 16.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.412 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -114.41 26.32 10.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.744 HD12 ' HB3' ' A' ' 114' ' ' ASP . 2.2 tt -52.66 84.71 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.752 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.933 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -124.03 176.72 6.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.76 166.25 15.37 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.062 0.458 . . . . 0.0 112.014 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.5 Cg_endo -47.62 168.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.85 3.033 . . . . 0.0 112.527 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.54 59.47 0.75 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.112 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.84 110.33 0.95 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.252 -0.974 . . . . 0.0 112.039 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.627 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 118.14 4.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.344 0.658 . . . . 0.0 111.734 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.013 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.65 -27.91 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.561 0.696 . . . . 0.0 110.343 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.54 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.26 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 78.4 mmm 39.13 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.304 0.377 . . . . 0.0 111.586 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.67 33.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.702 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -96.92 -170.15 1.99 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.555 0.217 . . . . 0.0 111.055 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.915 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.55 158.97 30.85 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.915 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.88 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.902 2.402 . . . . 0.0 112.496 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -92.66 -58.29 2.4 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -80.72 -4.78 55.68 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.785 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.85 -57.24 11.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.792 0.329 . . . . 0.0 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.629 HG22 HD13 ' A' ' 54' ' ' LEU . 1.4 p -78.76 -42.75 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.783 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.2 t -50.66 -35.55 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.225 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -52.15 9.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.926 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.0 mm-40 -63.34 -19.84 64.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.693 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.923 HD11 ' HE2' ' A' ' 64' ' ' HIS . 2.7 tp -56.76 -44.68 82.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.071 0.462 . . . . 0.0 110.541 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.73 -27.02 68.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.899 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.2 tm-20 -77.2 -30.63 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.23 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.44 6.69 26.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.914 HG12 HG13 ' A' ' 60' ' ' ILE . 43.8 t -133.48 -44.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -40.1 0.25 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.951 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.914 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.46 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.014 0.435 . . . . 0.0 111.095 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.55 88.7 13.85 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.996 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.742 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.8 Cg_endo -111.48 146.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 123.394 2.729 . . . . 0.0 114.219 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.8 mt-30 -74.74 79.64 2.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.956 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.94 128.64 52.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.006 -176.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.04 -139.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.587 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.83 157.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.099 0.476 . . . . 0.0 111.86 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.558 HD21 ' HD3' ' A' ' 70' ' ' LYS . 5.3 tt -119.71 109.44 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.79 -43.54 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.151 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 2.7 mt-10 -171.24 165.66 7.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.624 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.15 132.11 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 tp -116.89 123.75 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -121.5 109.99 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.638 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -140.89 153.25 45.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -114.22 140.2 48.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.273 0.558 . . . . 0.0 111.307 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.75 163.84 16.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.475 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 54.1 Cg_exo -41.36 81.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.338 2.692 . . . . 0.0 112.554 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.6 t0 73.62 20.48 3.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.607 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 7.5 ttt180 -137.23 93.92 2.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.6 98.82 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 110.942 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.64 111.87 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.52 133.76 44.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.787 HD13 HD21 ' A' ' 119' ' ' ASN . 35.1 mt -126.16 114.39 18.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.453 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.08 122.66 48.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.46 125.73 51.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.348 . . . . 0.0 111.269 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.551 ' HE1' ' HB1' ' A' ' 7' ' ' ALA . 67.6 m95 -107.86 148.5 29.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.7 tp -98.74 102.81 14.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 111.332 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.956 HG22 ' ND1' ' A' ' 64' ' ' HIS . 13.9 t -81.5 145.65 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -109.53 -35.17 6.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.44 165.64 26.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.845 0.748 . . . . 0.0 112.017 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.768 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.4 p90 -151.47 130.54 12.63 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.572 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -76.35 140.87 41.62 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.16 -121.94 25.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.468 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.7 mt-10 -131.84 145.81 59.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.536 0.208 . . . . 0.0 110.779 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.72 128.76 10.36 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.836 2.357 . . . . 0.0 111.362 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.8 p-90 -133.51 -60.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.124 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.84 -99.66 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.02 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.46 33.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.554 0.216 . . . . 0.0 111.278 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.8 pt-20 -65.57 -26.81 68.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 0.0 110.608 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.54 32.04 82.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.836 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 6.5 mm-40 -140.38 92.2 9.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 111.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -43.57 126.37 5.38 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.091 2.527 . . . . 0.0 112.817 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.27 177.17 19.37 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.853 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.92 157.14 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -69.01 106.23 2.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.887 0.375 . . . . 0.0 110.031 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 9.6 ptm -120.47 148.12 44.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.036 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.686 ' HB2' HG12 ' A' ' 108' ' ' VAL . 77.4 p -70.89 114.97 9.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.058 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.666 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -61.41 -18.7 60.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.909 ' HA ' HD21 ' A' ' 129' ' ' LEU . 11.9 p -59.3 -9.63 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.836 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.45 49.62 0.92 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.276 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -62.22 142.11 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 110.42 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.734 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -120.04 115.87 24.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.16 61.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.211 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -49.03 13.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.744 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -68.39 -33.51 74.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.76 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.14 174.02 6.64 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.394 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.5 Cg_endo -73.95 127.81 11.78 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.107 1.871 . . . . 0.0 111.363 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.02 -14.83 30.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.738 2.292 . . . . 0.0 113.266 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -9.75 39.58 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.787 HD21 HD13 ' A' ' 82' ' ' LEU . 1.3 m-20 -130.07 37.82 3.86 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.84 -43.87 11.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.2 Cg_exo -54.76 -38.92 91.62 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.134 1.889 . . . . 0.0 112.244 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 2.3 t -77.55 -51.31 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.036 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.526 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.41 -29.87 47.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.027 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.66 -30.95 56.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.987 0.422 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -69.8 -52.52 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.868 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.695 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.9 tp -78.16 -19.52 53.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.23 -42.74 65.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.114 0.483 . . . . 0.0 110.882 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -75.58 -3.92 37.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.176 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.882 0.372 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -86.91 136.15 33.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 121.94 19.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.629 HD11 " O3'" ' A' ' 131' ' ' 8OG . 2.6 pp -112.51 125.99 54.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.761 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 10.8 mt-30 -102.95 160.05 14.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.09 0.472 . . . . 0.0 111.482 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.615 HD12 ' CD1' ' A' ' 82' ' ' LEU . 39.8 mt -144.8 135.2 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.461 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.006 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.39 150.11 45.95 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -144.99 149.95 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.938 0.399 . . . . 0.0 111.143 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.6 111.35 0.5 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.09 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -81.13 109.62 15.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.743 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -71.03 119.38 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.228 0.537 . . . . 0.0 111.82 -178.151 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 1.4 mmt85 -83.22 124.31 30.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.756 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -78.05 -172.92 2.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.528 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 tt0 -85.74 16.46 3.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.553 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -142.63 50.59 1.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.919 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.0 25.6 0.5 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.142 0.496 . . . . 0.0 111.217 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 105' ' ' MET . 39.4 mt-10 -120.54 161.47 21.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.09 HG21 HG22 ' A' ' 10' ' ' ILE . 13.0 mt -122.26 139.25 49.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.211 0.529 . . . . 0.0 111.356 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.9 OUTLIER -86.19 94.36 9.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.869 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -114.48 148.59 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.688 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.8 t -70.72 111.91 6.54 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.433 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.731 ' HD2' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -118.06 110.85 18.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.516 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 49.43 26.15 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.489 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 100' ' ' GLN . . . 48.96 -165.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 111.279 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.22 -29.77 31.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.014 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 p30 -104.84 -176.14 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.89 56.25 3.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.36 114.94 20.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.7 mmt 60.27 79.89 0.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.87 -11.19 59.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.619 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -96.67 29.46 2.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.349 . . . . 0.0 111.08 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -114.11 26.3 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.112 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.731 HD22 ' HD2' ' A' ' 22' ' ' ARG . 21.5 tp -64.04 70.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -118.37 178.08 4.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.03 162.36 33.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.187 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 8.0 Cg_endo -48.02 169.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.941 3.094 . . . . 0.0 111.482 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.48 59.97 0.71 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.664 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -144.42 107.64 0.45 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 114.222 -0.989 . . . . 0.0 111.67 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.96 -10.79 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.516 0.726 . . . . 0.0 110.513 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.006 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.75 -78.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.044 0.449 . . . . 0.0 110.961 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.625 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 5.38 -80.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.344 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttm 37.29 -133.43 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.378 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.32 14.81 5.6 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.033 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -71.09 -164.56 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 110.805 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.872 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.62 154.41 37.49 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.872 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.29 -24.82 1.07 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -100.28 -47.97 4.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.99 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.37 -7.15 58.97 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -65.53 -55.62 16.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.565 0.221 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.743 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.27 -40.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.06 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.58 -35.4 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.432 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -42.76 31.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.457 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -67.26 -26.12 66.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.251 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.621 ' O ' HG23 ' A' ' 58' ' ' VAL . 1.1 tp -52.55 -44.35 65.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.54 -33.08 74.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.1 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -77.36 -25.57 51.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.149 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 4.2 mm-40 -108.18 5.19 25.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 18.4 t -135.22 -44.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.319 0.581 . . . . 0.0 110.309 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.62 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.48 4.62 1.39 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.604 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.07 -173.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 117.897 0.848 . . . . 0.0 110.831 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.9 p -113.72 87.48 12.24 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.545 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.754 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.1 Cg_endo -115.27 149.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.643 2.895 . . . . 0.0 114.22 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.02 79.82 2.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.85 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.5 130.5 52.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.244 -175.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.55 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -177.86 -139.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.794 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.79 175.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.847 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.763 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -143.11 123.96 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.926 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.55 -44.61 34.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.498 . . . . 0.0 109.796 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.45 164.83 6.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.036 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 127.69 17.49 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 121' ' ' PRO . 48.7 tp -106.63 121.09 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.503 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -122.22 112.01 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -141.04 148.06 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.45 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -121.08 139.97 52.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.457 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -105.04 162.76 18.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.285 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.477 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 7.6 Cg_endo -49.72 82.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.099 2.533 . . . . 0.0 112.25 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.2 m-20 87.74 11.35 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.595 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -137.28 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 0.0 110.866 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -80.34 107.15 12.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.476 HD12 " O3'" ' A' ' 131' ' ' 8OG . 1.6 tt -100.42 111.74 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.71 135.11 42.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.924 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.823 HD21 ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -126.26 114.44 18.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.774 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -116.15 122.79 46.12 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.769 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 1.7 m-85 -113.6 113.44 25.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.877 0.37 . . . . 0.0 110.273 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.763 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 44.0 m95 -94.77 148.59 22.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 65' ' ' PHE . 50.4 tp -104.8 102.73 12.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.391 0.615 . . . . 0.0 111.251 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.85 HG22 ' ND1' ' A' ' 64' ' ' HIS . 12.6 t -80.88 145.8 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.291 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.77 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -161.78 165.52 27.82 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.868 0.758 . . . . 0.0 112.065 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.743 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.1 p90 -149.84 131.49 14.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.489 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.53 136.38 33.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -140.82 19.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.526 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.0 tt0 -115.1 129.82 24.75 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.383 0.135 . . . . 0.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.55 128.78 10.51 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.649 2.233 . . . . 0.0 111.721 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.62 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.1 p-90 -135.3 -57.74 0.8 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.866 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.51 -104.07 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.137 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 166.57 40.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -41.26 91.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.981 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.97 -104.03 0.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.932 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 19.7 mt-30 -92.95 120.61 66.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -43.62 146.14 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.066 2.511 . . . . 0.0 112.682 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.31 19.23 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.808 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.5 157.23 29.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 110.735 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.1 m0 -60.39 106.87 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 110.426 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -120.19 156.73 30.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.476 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 5.0 t -81.1 116.86 21.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.843 HD22 ' CD1' ' A' ' 18' ' ' ILE . 6.3 tp -72.66 -18.7 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 108' ' ' VAL . 21.6 t -49.67 -21.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.72 0.295 . . . . 0.0 111.452 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.23 50.51 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.886 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 107' ' ' LEU . 8.6 tt -62.12 150.31 38.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -104.11 101.22 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -16.89 61.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.27 0.557 . . . . 0.0 110.083 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.51 -48.81 13.24 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.073 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -35.64 80.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.008 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.6 169.19 21.87 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.415 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.4 Cg_endo -54.63 131.8 47.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.55 2.167 . . . . 0.0 112.93 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.504 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.17 -14.07 37.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.072 2.515 . . . . 0.0 112.627 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.04 58.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.823 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.7 m-20 -121.38 25.89 9.18 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.02 -38.84 3.94 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.9 Cg_exo -44.82 -41.9 15.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.181 1.921 . . . . 0.0 113.204 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.769 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -77.42 -51.34 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.071 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.1 mm -65.37 -29.93 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.222 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.23 63.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.13 0.49 . . . . 0.0 110.35 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -71.06 -48.58 51.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.835 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.24 -30.8 48.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.835 ' N ' HD23 ' A' ' 126' ' ' LEU . 35.2 tttp -54.9 -42.64 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -67.16 -10.1 46.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.8 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.7 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.069 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.629 " O3'" HD11 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.832 0.348 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.99 103.05 11.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.79 131.88 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.801 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.5 pp -125.57 123.02 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.593 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.4 153.75 19.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.339 0.59 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.732 HD11 " H4'" ' A' ' 131' ' ' 8OG . 89.3 mt -146.36 131.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.107 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.043 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.6 124.46 42.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.5 m -117.13 162.68 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.45 . . . . 0.0 111.697 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -144.46 115.0 0.83 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.606 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.757 HG22 HG13 ' A' ' 18' ' ' ILE . 1.5 mp -70.61 95.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.698 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.0 111.82 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.47 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -85.51 136.26 33.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.046 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.652 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 23.5 p30 -105.94 -172.89 2.17 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.766 0.793 . . . . 0.0 112.687 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -68.21 -4.4 13.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.693 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 8.6 t-20 -124.19 42.51 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.087 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 46.22 27.05 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.613 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB3' ' HA ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.867 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.85 146.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.378 0.608 . . . . 0.0 112.295 -178.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.557 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t80 -90.04 95.79 10.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.86 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.867 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -108.34 162.19 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p -81.13 111.87 17.97 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.407 ' HG2' ' CG ' ' A' ' 23' ' ' ARG . 13.9 ttm180 -124.14 134.67 53.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 111.383 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' NH1' ' HB1' ' A' ' 30' ' ' ALA . 2.4 mtt-85 48.56 27.31 1.42 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.404 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.09 -86.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.578 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . . . -144.49 -47.2 0.25 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.07 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -150.18 -50.45 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.016 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.9 120.39 16.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.182 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.06 -76.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.804 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.11 118.5 4.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.722 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' HB1' ' NH1' ' A' ' 23' ' ' ARG . . . -83.37 -25.24 31.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.485 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.68 19.23 10.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.374 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.5 26.18 10.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.717 0.294 . . . . 0.0 111.65 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.0 tt -54.15 83.71 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.757 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.78 -179.08 3.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.84 0.353 . . . . 0.0 111.412 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.534 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 160.98 40.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.648 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 29.0 Cg_endo -61.5 168.09 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.484 2.789 . . . . 0.0 111.528 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.45 59.34 0.75 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.98 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.94 121.02 3.43 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.777 -0.711 . . . . 0.0 112.05 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 115.02 6.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.382 0.673 . . . . 0.0 111.817 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.046 HD12 ' HB1' ' A' ' 49' ' ' ALA . 1.1 pt -58.24 -25.92 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.582 0.706 . . . . 0.0 110.573 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HB3' ' H ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -45.1 -85.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.24 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 38.29 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.312 0.383 . . . . 0.0 111.615 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.57 32.68 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.541 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.7 mp0 -91.6 -176.46 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.86 0.362 . . . . 0.0 111.222 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.916 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.64 156.17 35.62 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.916 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.99 -24.77 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.797 2.331 . . . . 0.0 112.715 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.32 -48.27 5.39 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -80.27 -14.01 58.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.046 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.93 -52.97 62.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 111.073 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.821 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.1 m -77.93 -44.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.6 t -57.77 -35.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.127 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -52.09 9.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.496 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.1 mm-40 -65.42 -24.21 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.936 HD21 ' CE1' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -52.2 -44.27 64.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.88 0.371 . . . . 0.0 110.345 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -36.6 78.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.86 -25.03 48.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.493 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 76.4 mm-40 -108.44 5.94 25.79 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.964 HG12 HG13 ' A' ' 60' ' ' ILE . 14.5 t -134.37 -44.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 110.543 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 60.59 5.29 4.88 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.623 -0.717 . . . . 0.0 114.353 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.964 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.5 -166.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 117.859 0.829 . . . . 0.0 110.852 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.601 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -112.57 88.08 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.813 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.4 Cg_endo -113.57 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.49 2.793 . . . . 0.0 114.462 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 27.8 mt-30 -74.65 79.39 2.01 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.936 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -113.04 132.9 55.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.684 -175.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -177.12 -143.1 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.829 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 2.1 m 52.14 171.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 112.245 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 67' ' ' LEU . 4.8 tt -134.24 114.48 13.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.452 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.565 ' HE1' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.49 -56.04 4.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.811 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -171.51 131.84 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.241 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -114.59 132.08 56.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HB2' HG22 ' A' ' 122' ' ' VAL . 7.5 tp -107.34 141.44 38.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -131.32 109.72 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.683 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -141.02 138.25 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.296 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 8.3 pt-20 -107.41 140.11 40.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.262 0.553 . . . . 0.0 111.718 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -101.34 163.05 18.65 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.053 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 4.2 Cg_endo -46.6 81.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.196 2.598 . . . . 0.0 112.532 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.3 m-20 85.61 11.87 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.689 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HG2' HD23 ' A' ' 4' ' ' LEU . 3.6 ttt180 -137.42 94.89 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 12.6 t-160 -74.84 97.92 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 tt -94.47 111.93 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.03 129.43 54.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.822 HD13 ' OD1' ' A' ' 119' ' ' ASN . 11.4 mt -126.45 114.75 18.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.425 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.521 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -110.29 122.88 48.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.464 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 11.7 m-30 -103.22 113.08 26.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.735 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.9 m95 -95.07 148.86 21.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.548 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.2 tm? -90.9 102.87 15.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.225 0.536 . . . . 0.0 111.551 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.9 t -89.53 144.87 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 4.7 pm0 -121.28 -13.5 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -160.94 160.05 30.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.044 1.293 . . . . 0.0 112.357 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.653 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -158.0 122.17 4.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.73 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.601 ' CB ' HG23 ' A' ' 61' ' ' THR . 1.5 mm-40 -83.33 117.98 23.37 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.882 0.372 . . . . 0.0 111.096 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.3 -125.61 8.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.531 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.13 136.12 28.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.577 -0.156 . . . . 0.0 110.577 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.676 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.99 128.91 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.766 2.311 . . . . 0.0 111.285 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 50.8 p-90 -140.95 -58.09 0.5 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.129 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 47.87 -93.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.501 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -171.93 33.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.787 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 26.0 pt-20 -62.0 -47.09 86.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 99.46 -24.4 32.36 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.277 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -112.27 95.67 31.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.574 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 55.5 Cg_exo -43.5 146.14 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.173 2.582 . . . . 0.0 112.767 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.71 18.95 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.76 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.43 154.39 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.52 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -66.83 105.62 1.64 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.073 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.718 ' SD ' HD11 ' A' ' 20' ' ' ILE . 1.1 ptm -121.06 153.38 37.48 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.378 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 5.4 p -74.21 114.96 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.146 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.9 tm? -60.78 -24.45 65.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.685 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.5 t -55.49 -19.78 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.96 35.15 4.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.025 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 110' ' ' LEU . 10.8 tp -62.83 130.23 43.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.12 136.07 54.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.38 -15.43 61.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.657 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -78.85 -49.1 13.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.624 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -35.26 77.96 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.488 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -82.82 174.02 6.67 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.636 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 68.4 Cg_endo -74.75 127.99 11.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.256 1.971 . . . . 0.0 111.488 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.13 -14.74 25.03 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.774 2.316 . . . . 0.0 113.35 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.99 -9.9 25.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.822 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -131.86 41.0 3.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 111.439 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.29 -46.3 7.85 Favored Pre-proline 0 N--CA 1.464 0.241 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.1 Cg_exo -47.83 -40.27 31.98 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.218 1.945 . . . . 0.0 112.816 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.3 t -77.52 -51.42 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.4 mm -65.45 -29.96 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.27 -31.61 63.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.987 0.423 . . . . 0.0 110.627 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -50.06 36.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.802 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -78.17 -26.39 47.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.297 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.25 -42.67 86.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 110.814 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.04 -8.6 46.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.779 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.004 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.732 " H4'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.773 0.321 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 113.86 26.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 121.92 13.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 78' ' ' ARG . 3.4 pp -100.36 121.02 40.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.751 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -102.61 151.32 22.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.723 HD11 ' CD1' ' A' ' 4' ' ' LEU . 2.8 mp -140.06 139.0 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.486 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.964 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.78 140.8 52.6 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.525 HG11 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -144.49 149.78 17.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.67 125.52 1.88 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.402 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.994 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -83.8 109.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.734 HG23 HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -71.16 121.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.157 0.503 . . . . 0.0 111.318 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -85.94 120.06 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.129 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.511 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 27.5 p-10 -74.62 -171.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.914 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 8.3 tp10 -86.81 19.0 3.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.067 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -144.5 27.73 1.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.663 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.61 3.86 4.72 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 1.5 mm-40 -100.76 159.89 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.994 HG21 HG22 ' A' ' 10' ' ' ILE . 7.0 mt -125.28 141.78 44.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 111.496 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -90.38 113.47 25.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.793 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.01 162.05 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 t -88.98 111.8 22.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.315 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HD2' HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -102.89 83.96 2.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.312 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' CG ' ' HA ' ' A' ' 30' ' ' ALA . 6.1 mtm180 50.95 23.54 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.536 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.832 ' HB2' ' HB3' ' A' ' 100' ' ' GLN . . . 47.59 27.73 1.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.715 0.293 . . . . 0.0 111.402 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.85 39.92 29.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.128 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 24' ' ' ALA . 3.1 p30 -134.56 -173.77 3.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.954 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.87 -161.67 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.48 -79.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -96.49 73.21 2.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.693 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . . . -85.3 -25.38 27.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.544 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.68 28.95 3.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.295 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -114.29 26.05 10.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.012 0.434 . . . . 0.0 111.515 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.612 HD11 ' HD2' ' A' ' 22' ' ' ARG . 1.1 tt -59.02 87.73 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -169.42 2.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.526 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.765 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.95 165.44 17.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.792 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.6 Cg_endo -47.83 168.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.788 2.992 . . . . 0.0 111.844 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.737 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.15 59.84 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.249 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.92 109.44 0.66 Allowed Glycine 0 C--N 1.312 -0.761 0 CA-C-N 114.473 -0.864 . . . . 0.0 111.697 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 122.32 -8.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.463 0.705 . . . . 0.0 110.853 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.964 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.2 -65.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.256 0.55 . . . . 0.0 111.41 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -13.6 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.472 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 43.0 -94.0 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.598 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.23 18.11 0.09 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.579 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -79.55 -163.0 0.46 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.842 -0.211 . . . . 0.0 110.801 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.865 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.86 154.76 38.39 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.865 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.8 -24.86 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.702 2.268 . . . . 0.0 112.399 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.711 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.65 -52.22 4.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.015 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -80.51 -4.93 55.76 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -66.19 -57.01 8.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.101 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.738 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.32 -40.65 25.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 111.264 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.7 t -50.46 -35.48 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.935 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -52.12 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.89 -25.59 67.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.65 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.682 HD13 ' CG2' ' A' ' 50' ' ' VAL . 2.1 tp -54.61 -44.43 73.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.576 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -27.41 67.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.734 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -77.14 -25.58 52.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.233 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 1.8 mp0 -108.42 5.74 25.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.918 HG12 HG13 ' A' ' 60' ' ' ILE . 16.4 t -134.53 -44.55 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 110.286 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.636 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 56.79 3.41 0.7 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.577 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.918 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.75 -173.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.926 0.863 . . . . 0.0 110.392 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -113.96 87.5 12.87 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.901 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.755 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.9 Cg_endo -115.11 149.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.761 2.974 . . . . 0.0 113.924 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 83.2 mt-30 -74.81 79.62 2.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.907 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.57 127.57 49.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.061 -176.148 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.79 -136.98 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.776 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 56.6 163.26 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.219 0.533 . . . . 0.0 112.116 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.5 tt -126.19 113.18 16.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.289 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.863 ' CE1' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.65 -53.24 8.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.293 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.714 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.41 131.68 0.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -125.11 132.07 53.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.728 0.299 . . . . 0.0 111.023 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.879 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -106.54 159.34 16.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.666 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.0 tt0 -140.08 109.92 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.485 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -133.33 153.01 51.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.24 140.05 52.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 111.425 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -103.41 162.86 18.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.156 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.1 Cg_endo -45.8 80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.334 2.689 . . . . 0.0 112.815 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.5 t0 85.45 9.95 0.31 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.947 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.822 ' HG2' HD23 ' A' ' 4' ' ' LEU . 3.9 ttp-105 -137.39 101.39 4.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 111.087 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.0 m-70 -74.89 115.84 14.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.829 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 4' ' ' LEU . 1.1 tt -107.14 112.04 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.955 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.88 129.92 53.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.754 HD13 ' OD1' ' A' ' 119' ' ' ASN . 26.3 mt -126.37 114.43 18.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.146 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -111.95 122.43 47.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.044 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.714 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.4 m-30 -104.5 115.06 29.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.491 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.738 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 36.6 m95 -94.72 148.72 21.99 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.058 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.2 tm? -101.08 102.68 13.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.452 0.644 . . . . 0.0 111.361 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.907 HG22 ' CE1' ' A' ' 64' ' ' HIS . 11.5 t -82.11 145.77 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.658 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.97 -45.87 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.8 ptm85 -163.13 165.93 24.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.839 0.745 . . . . 0.0 112.383 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HE3' HG22 ' A' ' 11' ' ' ILE . 8.4 p90 -139.59 136.19 34.13 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.68 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.35 108.72 19.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.35 -121.47 6.86 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.427 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.5 tt0 -135.08 135.06 22.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.467 0.175 . . . . 0.0 110.917 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.555 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.47 128.73 10.54 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.796 2.331 . . . . 0.0 111.58 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.636 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.4 p-90 -133.47 -58.18 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.09 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.572 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 37.89 -92.39 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.257 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 95' ' ' TRP . 5.2 tmtm? 179.88 -69.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.812 0.339 . . . . 0.0 110.747 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 42.21 26.06 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.605 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.21 -65.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.545 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.832 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 28.5 mt-30 -108.02 99.23 29.81 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.47 146.55 3.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.139 2.559 . . . . 0.0 112.469 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.04 21.4 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.189 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.84 157.62 25.31 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.83 106.36 3.11 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.609 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.401 ' CE ' ' NE ' ' A' ' 22' ' ' ARG . 2.6 mtp -120.87 164.11 17.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -70.75 116.96 11.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.339 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.548 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.83 -18.71 50.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.62 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.491 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.2 t -57.12 -14.25 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.79 35.24 4.7 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.153 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 107' ' ' LEU . 11.5 tp -62.74 135.91 57.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.09 131.48 53.71 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.63 -15.3 61.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.975 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.71 -49.14 13.62 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.809 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -36.46 77.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.775 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.565 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -78.77 173.98 6.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.731 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.4 Cg_endo -76.46 137.17 18.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.358 2.039 . . . . 0.0 112.089 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 27.6 Cg_endo -62.01 -14.29 36.44 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.842 2.361 . . . . 0.0 113.202 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.3 -9.7 19.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.754 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -135.9 44.12 2.5 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.2 OUTLIER -76.05 -50.77 2.98 Favored Pre-proline 0 N--CA 1.463 0.186 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 79.6 Cg_exo -44.74 -38.02 12.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.447 2.098 . . . . 0.0 112.792 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.879 ' CG2' HD23 ' A' ' 71' ' ' LEU . 2.5 t -77.25 -49.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.611 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.565 HG13 ' CE2' ' A' ' 115' ' ' PHE . 11.3 mm -64.75 -29.97 48.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.747 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.05 -29.75 63.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 110.653 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.28 -48.52 15.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.629 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.863 HD23 ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -78.19 -30.25 48.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.34 . . . . 0.0 111.425 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HB2' HG22 ' A' ' 123' ' ' ILE . 12.0 ttpt -55.58 -42.47 74.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.817 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -68.42 -7.47 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.639 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 108' ' ' VAL . 24.7 mt . . . . . 0 C--O 1.233 0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.073 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.713 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.855 0.36 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.09 131.75 54.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -126.93 141.89 51.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.4 pp -145.61 117.59 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.547 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.6 mt-30 -102.29 151.74 21.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.841 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.65 HD11 " O3'" ' A' ' 131' ' ' 8OG . 4.3 mt -142.68 128.28 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.869 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.099 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.54 124.68 42.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.536 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.7 m -115.39 162.18 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.283 0.563 . . . . 0.0 111.924 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.42 102.08 0.23 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.957 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.94 HG22 HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.91 110.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.606 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.55 115.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.066 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 3.7 mmt85 -82.14 133.7 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.452 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 10.3 p-10 -84.17 -172.01 3.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 113.062 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -56.61 -16.06 5.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.721 -1.581 . . . . 0.0 113.275 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -127.71 -83.0 0.6 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.16 17.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 111.687 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HB2' ' ND2' ' A' ' 13' ' ' ASN . 19.8 mt-10 -100.89 160.11 14.64 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.94 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -135.08 145.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 111.997 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 14.0 t80 -84.48 89.63 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.79 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.895 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -113.29 162.17 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.038 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.3 t -80.25 130.27 35.09 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 1.1 ptm180 -146.48 128.39 15.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 111.167 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 mpp_? 45.83 28.53 0.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 100' ' ' GLN . . . -99.99 32.8 2.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.175 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . -158.49 53.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.015 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -57.1 158.14 5.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 59.76 30.67 20.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.073 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -155.53 -55.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.02 108.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.03 -18.95 29.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.325 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.51 31.29 2.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.879 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.03 26.37 10.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.507 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HE1' ' A' ' 105' ' ' MET . 3.8 tt -57.74 77.37 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -108.58 -170.65 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.091 0.472 . . . . 0.0 111.636 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.9 154.13 55.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 11.1 Cg_endo -53.84 167.47 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.233 2.622 . . . . 0.0 111.677 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 59.25 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.137 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.06 117.04 2.48 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 114.84 -0.68 . . . . 0.0 112.059 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 3.5 tttt 115.76 4.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.322 0.649 . . . . 0.0 111.513 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.099 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -53.98 -27.61 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.569 0.699 . . . . 0.0 110.665 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.588 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.22 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mmt 33.38 -85.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.558 0.537 . . . . 0.0 111.878 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.31 31.11 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.553 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.459 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.0 mp0 -91.61 -175.07 4.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -111.92 159.0 35.14 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.95 -24.65 0.88 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.904 2.403 . . . . 0.0 112.696 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -90.68 -58.08 2.61 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.167 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -80.4 -20.07 44.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.924 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.3 -49.76 73.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.833 0.349 . . . . 0.0 111.148 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.928 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.6 m -76.03 -46.86 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 47' ' ' GLU . 42.3 t -60.46 -35.85 65.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.087 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -70.91 -49.14 49.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.022 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.7 ' CB ' HG22 ' A' ' 40' ' ' ILE . 7.0 tp10 -71.33 -27.97 63.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.934 HD23 ' ND1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -55.06 -44.08 74.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.55 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -61.44 -35.09 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 0.0 109.816 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.53 -33.54 54.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.339 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 20.5 mm-40 -100.05 4.83 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.026 HG12 HG22 ' A' ' 60' ' ' ILE . 3.3 t -135.48 -43.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.115 0.483 . . . . 0.0 110.245 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.64 9.39 6.61 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.747 -0.661 . . . . 0.0 114.504 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.026 HG22 HG12 ' A' ' 58' ' ' VAL . 13.5 tt -115.88 162.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 117.46 0.63 . . . . 0.0 110.289 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.491 ' N ' HG12 ' A' ' 60' ' ' ILE . 1.5 p -98.82 88.44 0.72 Allowed Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.839 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 58.4 Cg_endo -113.31 156.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 124.236 3.291 . . . . 0.0 114.096 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -75.85 78.38 2.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.934 ' ND1' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -111.94 120.7 42.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.786 -173.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.535 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -177.95 -153.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.629 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m 59.56 154.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -118.39 120.02 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.437 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.71 -44.12 34.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.064 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 tt0 -171.44 162.81 6.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.187 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.576 ' HD2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.53 132.16 22.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.449 ' HB2' HG22 ' A' ' 122' ' ' VAL . 34.5 tp -113.77 122.32 46.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.822 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -116.86 109.85 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.723 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.19 143.41 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.497 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.13 124.52 44.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 111.547 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -85.24 163.23 46.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.089 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -51.56 81.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.921 2.414 . . . . 0.0 112.225 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 90.54 11.61 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.53 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -137.29 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.772 0.32 . . . . 0.0 111.007 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -78.46 106.96 10.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.101 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.09 112.63 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.93 128.76 54.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.665 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.818 HD13 ' OD1' ' A' ' 119' ' ' ASN . 9.4 mt -126.34 114.64 18.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.297 . . . . 0.0 111.472 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -108.84 122.86 48.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.107 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.782 ' CD2' HG11 ' A' ' 122' ' ' VAL . 12.1 m-30 -103.43 112.04 24.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.928 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.9 m95 -95.12 149.23 21.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.437 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 65' ' ' PHE . 5.3 tp -106.3 103.18 12.59 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.862 HG13 ' HA ' ' A' ' 64' ' ' HIS . 11.3 t -82.63 145.45 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.326 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -102.84 -35.23 8.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.3 165.42 26.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.53 0.604 . . . . 0.0 112.0 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.716 ' HB2' HD13 ' A' ' 60' ' ' ILE . 9.2 p90 -138.93 157.96 45.08 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.289 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.764 ' C ' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -104.78 101.29 10.9 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.239 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.67 -115.02 5.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.065 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.5 tt0 -135.25 122.83 15.17 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.504 0.192 . . . . 0.0 111.432 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.0 Cg_exo -74.17 128.82 12.5 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.624 2.216 . . . . 0.0 110.794 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.547 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 20.8 p-90 -123.5 -60.85 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.833 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 57.2 -117.79 10.69 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.261 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.54 37.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.06 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -53.82 -24.52 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.42 -15.03 39.07 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.315 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.779 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -140.06 105.38 6.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 111.392 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.56 143.77 2.44 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.006 2.471 . . . . 0.0 112.727 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.31 19.29 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.971 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.15 157.17 44.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.27 106.52 0.54 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.872 0.368 . . . . 0.0 110.177 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.553 ' HE1' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.53 139.57 52.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.027 179.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.574 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.8 p -59.66 114.77 2.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.352 . . . . 0.0 110.825 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.1 tm? -67.72 -24.49 65.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.574 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.5 p -57.73 -18.23 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.73 35.89 4.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.789 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 123' ' ' ILE . 12.3 tp -62.8 135.52 57.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.22 133.41 54.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.35 61.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.779 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.85 -49.29 13.16 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.742 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -30.6 69.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.386 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.731 ' CZ ' HG21 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -88.67 174.43 5.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.341 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 50.5 Cg_endo -69.61 127.97 15.49 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.968 1.779 . . . . 0.0 111.649 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.71 -14.81 45.06 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.228 . . . . 0.0 113.097 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.32 -9.79 44.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.818 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -124.21 27.22 7.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.475 0.179 . . . . 0.0 111.432 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' HA ' ' CG2' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -58.05 -49.07 95.71 Favored Pre-proline 0 N--CA 1.463 0.195 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 87.0 Cg_exo -46.86 -35.92 18.91 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.437 2.091 . . . . 0.0 113.176 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 84' ' ' PHE . 21.3 t -77.54 -51.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.627 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 110' ' ' LEU . 2.5 tp -68.07 -30.6 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.788 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.99 -26.99 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.877 0.37 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -49.07 12.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.446 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -78.16 -29.53 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -56.04 -42.49 76.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.27 -3.9 29.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.892 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.2 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.194 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.65 " O3'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tpp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.807 0.337 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 102.9 12.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.38 143.41 53.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.939 HD11 " O3'" ' A' ' 131' ' ' 8OG . 3.6 pp -145.71 129.32 17.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.074 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.54 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.4 mt-30 -102.57 153.62 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.442 0.639 . . . . 0.0 112.342 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -146.48 132.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.671 178.347 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.26 124.97 43.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.469 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.579 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -117.86 162.55 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.406 0.622 . . . . 0.0 112.101 -179.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.08 114.29 0.63 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.851 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.087 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.25 107.27 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.42 123.29 25.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.446 . . . . 0.0 111.676 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.674 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -83.61 119.97 25.39 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.829 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.552 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.8 t-20 -77.72 -172.32 2.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.766 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 59.6 tt0 -82.45 -2.99 54.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.583 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -131.95 40.61 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.802 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.6 9.29 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.506 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.726 ' C ' HD12 ' A' ' 18' ' ' ILE . 16.6 pt-20 -100.86 149.67 23.62 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.087 HG21 HG22 ' A' ' 10' ' ' ILE . 1.4 mp -115.11 141.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.238 0.542 . . . . 0.0 111.718 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 26.7 t80 -80.65 99.9 8.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.758 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.13 162.12 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.446 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.564 HG21 ' OE2' ' A' ' 98' ' ' GLU . 3.6 p -82.23 112.01 18.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.551 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.93 114.71 29.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.37 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HD3' ' HB1' ' A' ' 30' ' ' ALA . 4.7 mtm180 56.55 20.83 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.557 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.94 -86.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.688 0.28 . . . . 0.0 111.407 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . . . -177.67 37.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.1 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -164.9 -177.08 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.54 56.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -156.4 26.99 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.05 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -177.35 38.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.454 ' HB1' ' HD3' ' A' ' 23' ' ' ARG . . . -67.65 -22.02 65.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.473 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.84 21.48 7.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.274 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HG2' ' O6 ' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -114.34 26.37 10.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.39 . . . . 0.0 111.423 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.5 tt -50.85 89.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE1' ' N2 ' ' A' ' 131' ' ' 8OG . 0.6 OUTLIER -119.94 -177.18 3.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.379 . . . . 0.0 111.234 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.765 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.74 160.76 41.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.734 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.29 168.43 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.813 3.008 . . . . 0.0 112.068 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.71 59.24 0.75 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.132 -1.032 . . . . 0.0 114.129 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.77 116.57 1.91 Allowed Glycine 0 C--N 1.315 -0.622 0 CA-C-N 114.71 -0.745 . . . . 0.0 112.097 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 119.13 4.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.517 0.727 . . . . 0.0 111.783 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.042 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -57.2 -26.06 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.515 0.674 . . . . 0.0 110.71 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.16 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.32 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 mtm 31.59 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.455 0.472 . . . . 0.0 112.072 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -167.66 28.98 0.17 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.664 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.2 mp0 -92.43 -175.0 3.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.313 . . . . 0.0 111.101 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.864 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.71 154.94 38.94 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.864 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.92 -24.74 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.79 2.327 . . . . 0.0 112.601 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.719 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -94.44 -50.84 5.04 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.2 -22.03 42.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.899 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.58 -48.26 77.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.813 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.02 -46.82 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -56.28 -35.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.958 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -76.96 -50.19 13.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.617 ' CB ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -65.63 -23.71 66.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.834 HD21 ' CE1' ' A' ' 64' ' ' HIS . 4.2 tp -52.88 -44.48 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -33.05 74.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.827 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 -24.85 50.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.197 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 4.0 mm-40 -108.66 5.5 24.94 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.915 HG12 HG13 ' A' ' 60' ' ' ILE . 38.8 t -134.74 -44.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.388 0.613 . . . . 0.0 109.944 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.692 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.46 4.16 1.22 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.119 -0.946 . . . . 0.0 115.038 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.915 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.55 -172.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.157 0.979 . . . . 0.0 110.46 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.82 87.94 10.9 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.664 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.5 Cg_endo -114.34 144.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.579 2.852 . . . . 0.0 114.24 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 30.6 mt-30 -75.02 80.04 2.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.834 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.78 126.05 50.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.947 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 177.37 173.25 0.51 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 92.12 148.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.855 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -97.71 137.13 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.07 -47.71 4.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.299 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -171.43 157.81 5.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.566 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.4 127.93 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.977 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.805 HD23 HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -127.25 124.47 38.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.497 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -116.91 118.11 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.755 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -137.37 136.37 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.685 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.13 120.38 42.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.498 . . . . 0.0 111.338 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.92 162.85 65.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.519 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.8 Cg_endo -41.74 82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.655 2.903 . . . . 0.0 112.587 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' PHE . 2.9 t70 98.43 -27.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.19 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 75' ' ' PHE . 6.1 ttp180 -90.45 150.11 21.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.824 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -120.32 101.65 7.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.62 HD11 " O3'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -102.85 124.95 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.474 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -117.98 118.58 32.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.117 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.805 HD11 HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -126.14 114.99 19.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.085 0.469 . . . . 0.0 111.898 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.474 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.6 m0 -104.74 122.7 46.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.405 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.2 m-30 -95.38 109.63 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.727 ' NE1' HG11 ' A' ' 50' ' ' VAL . 28.6 m95 -96.78 148.63 22.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.109 0.481 . . . . 0.0 111.853 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.5 tm? -95.15 138.56 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.713 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.789 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.2 t -123.74 146.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.031 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.08 -22.04 9.15 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 3.9 tpp85 -162.48 160.51 26.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 119.018 0.826 . . . . 0.0 111.661 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.723 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.06 125.42 5.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.178 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.62 149.37 34.77 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.03 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.46 -127.13 44.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.598 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.0 mt-10 -129.57 141.91 43.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.431 0.157 . . . . 0.0 110.689 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.604 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.1 Cg_exo -76.6 128.59 10.35 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.766 2.311 . . . . 0.0 111.607 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.692 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.2 p-90 -125.87 -58.72 1.38 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.63 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 97' ' ' LYS . . . 49.86 -76.26 0.0 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.806 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 95' ' ' TRP . 3.8 tptt 115.91 60.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.993 0.917 . . . . 0.0 110.488 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' OE2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -80.62 -33.32 35.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.71 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.17 -1.68 9.75 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -140.25 94.59 8.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 117.088 0.444 . . . . 0.0 111.45 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 57.6 Cg_exo -43.61 145.64 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.672 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.29 177.42 19.19 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.992 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.36 157.19 43.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.13 106.45 1.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.082 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 3.3 mtp -120.01 159.57 24.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.611 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.0 p -78.47 114.34 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.673 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -80.5 -19.54 45.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.052 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG13 HD21 ' A' ' 129' ' ' LEU . 33.6 t -56.66 -18.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.622 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.63 50.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.792 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.766 HD22 HD12 ' A' ' 123' ' ' ILE . 6.4 tt -62.6 150.2 41.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.465 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -117.02 132.27 56.74 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.17 61.9 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.6 -49.24 13.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.556 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.182 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.588 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.92 172.38 10.05 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.301 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.2 Cg_endo -75.76 128.15 10.69 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.327 2.018 . . . . 0.0 111.523 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.31 -14.69 16.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.777 2.318 . . . . 0.0 113.474 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.93 -11.47 18.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.713 HD21 HD22 ' A' ' 82' ' ' LEU . 1.4 m-20 -132.67 43.71 2.95 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.8 tt0 -76.07 -47.11 3.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.7 Cg_exo -45.83 -39.14 18.7 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.031 . . . . 0.0 112.837 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -77.27 -48.52 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.594 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.766 HD12 HD22 ' A' ' 110' ' ' LEU . 5.5 mm -65.18 -29.96 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.928 0.394 . . . . 0.0 110.485 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -46.24 16.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.47 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.2 tm? -78.17 -28.71 48.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 111.266 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 123' ' ' ILE . 10.4 ttpt -63.85 -42.28 97.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.416 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -64.07 -9.66 17.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.04 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.427 HD21 HG13 ' A' ' 108' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.939 " O3'" HD11 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.8 0.333 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -106.04 103.03 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.846 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -89.04 135.45 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.1 127.05 14.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.472 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.69 154.99 18.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.216 0.532 . . . . 0.0 111.418 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.468 HD11 " O3'" ' A' ' 131' ' ' 8OG . 39.1 mm -146.2 127.43 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.006 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.059 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.38 124.59 42.68 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.288 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.668 HG11 ' OE2' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -129.8 162.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.178 0.513 . . . . 0.0 111.375 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 123.69 1.54 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.095 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.783 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -70.79 110.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.701 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.61 125.93 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.963 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -93.0 126.83 38.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.346 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.469 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 5.9 t30 -89.5 -172.02 3.43 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.899 0.857 . . . . 0.0 112.088 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.79 -2.14 34.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.103 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -136.01 50.2 2.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 0.0 111.283 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 p30 45.38 26.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.44 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HG3' ' CB ' ' A' ' 13' ' ' ASN . 11.5 pt-20 -112.36 150.29 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.85 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.99 144.76 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.447 0.642 . . . . 0.0 112.292 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CE1' ' CA ' ' A' ' 102' ' ' GLY . 36.3 t80 -82.5 91.5 6.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.127 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.85 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -98.9 162.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.497 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 100' ' ' GLN . 7.1 p -113.34 111.98 22.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.067 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HA ' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -87.5 83.58 7.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.476 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.734 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 28.4 tpt180 45.74 43.8 10.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.557 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 66.35 12.36 8.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.807 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.93 20.96 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.577 0.227 . . . . 0.0 111.49 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.55 93.46 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.833 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.734 ' HB3' ' HG3' ' A' ' 23' ' ' ARG . . . -162.45 -80.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.258 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m80 -176.76 -73.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.92 82.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -8.93 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.594 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.55 20.3 4.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.406 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.32 26.06 10.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.505 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 22' ' ' ARG . 17.0 tp -52.12 92.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.668 ' OE2' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -128.54 -176.43 3.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.783 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.56 168.24 10.53 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.615 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.7 Cg_endo -47.5 168.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.602 2.868 . . . . 0.0 112.249 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.42 59.22 0.76 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.666 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.58 112.02 1.27 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.23 -0.985 . . . . 0.0 112.384 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER 113.97 5.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.168 0.587 . . . . 0.0 112.096 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.059 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.22 -29.47 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.742 0.782 . . . . 0.0 110.148 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.98 -79.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.25 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.4 mmt 41.35 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.539 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.27 33.22 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.762 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.24 -169.19 1.93 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.673 0.273 . . . . 0.0 111.019 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.96 156.24 36.17 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.301 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -44.01 -24.8 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.766 2.31 . . . . 0.0 112.465 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.9 mp0 -99.59 -48.34 4.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.912 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.32 -7.56 59.11 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.824 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -63.68 -56.98 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 0.0 110.864 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.779 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 1.4 p -78.3 -40.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.716 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 59.2 t -50.67 -37.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.995 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.87 -52.38 8.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.306 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HB3' HG22 ' A' ' 40' ' ' ILE . 9.3 tm-20 -66.35 -19.92 65.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.694 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.78 HD11 ' CE1' ' A' ' 64' ' ' HIS . 14.1 tp -60.53 -44.41 96.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.728 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HA ' HG12 ' A' ' 58' ' ' VAL . 1.3 tm0? -71.58 -27.87 63.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.457 . . . . 0.0 110.029 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.07 -28.1 66.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.482 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.22 6.99 27.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.314 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.908 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -130.7 -44.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 64.73 -35.66 0.1 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.058 0.783 . . . . 0.0 115.058 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.908 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.64 -174.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.929 0.364 . . . . 0.0 110.817 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.55 88.69 13.82 Favored Pre-proline 0 N--CA 1.445 -0.717 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.689 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.9 Cg_endo -110.68 143.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 123.312 2.675 . . . . 0.0 113.474 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 31.8 mt-30 -74.6 80.06 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.821 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.18 133.15 54.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.128 -175.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -179.77 -137.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.352 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.34 159.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.963 0.505 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.4 tt -122.26 110.68 16.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.68 -52.07 10.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.373 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.605 ' HB3' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -171.33 131.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -121.88 131.91 54.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.526 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.979 HD23 HG21 ' A' ' 122' ' ' VAL . 1.8 pp -114.45 158.67 21.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.957 0.408 . . . . 0.0 111.261 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.455 ' N ' HD12 ' A' ' 71' ' ' LEU . 9.0 tt0 -140.1 109.81 6.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.242 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -136.03 153.19 51.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -120.95 127.11 51.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.141 0.496 . . . . 0.0 111.353 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -91.68 163.89 26.3 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.417 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 50.5 Cg_exo -38.27 81.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.602 2.868 . . . . 0.0 112.886 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.59 21.24 3.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.061 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.31 93.83 2.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.239 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -74.91 99.97 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.152 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tt -102.55 111.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.79 133.22 44.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.468 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.618 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.13 114.48 18.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 111.468 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -110.82 125.55 53.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.618 ' CE1' HD12 ' A' ' 82' ' ' LEU . 2.4 m-85 -111.02 118.2 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.392 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.779 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 65.3 m95 -96.47 148.87 22.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.025 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.3 tm? -99.83 103.05 14.64 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.327 0.584 . . . . 0.0 111.34 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.821 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.2 t -80.65 145.87 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.665 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -113.29 -25.39 8.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 6.9 ttm180 -162.42 163.23 27.82 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.586 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.701 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -157.21 123.8 4.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.527 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.89 139.99 47.22 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.09 -121.7 26.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 60' ' ' ILE . 24.7 mt-10 -132.05 142.64 45.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.431 0.158 . . . . 0.0 110.775 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.541 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.15 128.8 11.66 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.719 2.279 . . . . 0.0 111.183 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.607 ' HE1' HG23 ' A' ' 60' ' ' ILE . 50.6 p-90 -126.83 -61.03 1.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.21 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.936 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt 177.99 35.15 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 7.9 pt-20 -57.19 -37.79 72.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.88 0.371 . . . . 0.0 110.587 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.47 71.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.153 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 2.6 pm0 -140.16 93.29 9.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.28 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.61 138.82 5.29 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.056 2.504 . . . . 0.0 112.85 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -134.31 177.29 19.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.98 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -141.28 157.13 45.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -79.76 106.15 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.472 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.462 ' HG3' HD11 ' A' ' 20' ' ' ILE . 3.0 ptp -120.55 163.07 18.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.768 ' HB2' HG12 ' A' ' 108' ' ' VAL . 8.9 p -77.58 114.88 16.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.695 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.0 tm? -63.21 -18.91 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.768 HG12 ' HB2' ' A' ' 106' ' ' SER . 13.0 p -55.26 -20.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.464 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.18 35.05 4.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.812 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.71 HD22 HD21 ' A' ' 107' ' ' LEU . 10.7 tp -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.26 131.73 53.77 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -15.51 61.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.414 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -49.05 13.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -66.9 -40.08 87.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.599 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.63 174.16 6.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 61.5 Cg_endo -73.86 127.91 11.94 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.061 1.84 . . . . 0.0 111.509 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.97 -14.86 29.98 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.644 2.229 . . . . 0.0 113.122 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.98 -9.95 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.661 ' ND2' HD21 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -129.73 38.21 3.86 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.9 -47.36 15.35 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.068 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.6 Cg_exo -56.0 -35.28 94.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.336 2.024 . . . . 0.0 112.083 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.979 HG21 HD23 ' A' ' 71' ' ' LEU . 3.8 t -77.46 -51.38 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.082 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -69.79 -29.92 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.806 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.89 -27.53 43.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.905 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -53.34 12.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 68' ' ' PHE . 1.7 tp -78.46 -29.54 46.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.3 tttm -57.77 -42.6 84.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.014 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.519 ' C ' HD12 ' A' ' 129' ' ' LEU . 6.1 ttp180 -71.49 -5.55 33.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.937 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.731 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.253 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.629 " H3'" ' OP3' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.838 0.352 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.32 125.71 47.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.712 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.33 38.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.719 HD21 ' HD3' ' A' ' 78' ' ' ARG . 3.0 pp -146.05 123.23 11.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -102.94 150.27 23.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.213 0.53 . . . . 0.0 111.258 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.596 ' HB ' HD22 ' A' ' 82' ' ' LEU . 8.5 mt -136.56 130.49 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.205 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.852 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.97 124.57 42.29 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.505 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -132.01 162.53 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.212 0.53 . . . . 0.0 111.658 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.44 121.51 1.22 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.915 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.912 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -70.83 109.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.696 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.07 125.48 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 120.976 0.417 . . . . 0.0 111.416 -178.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -92.21 133.13 36.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.956 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.629 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 29.6 p-10 -96.45 -172.13 2.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.86 0.838 . . . . 0.0 112.433 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.37 -0.88 16.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.071 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 20.6 t-20 -129.39 40.68 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 111.844 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 52.22 21.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -115.72 160.01 20.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.912 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -122.75 149.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.145 0.498 . . . . 0.0 111.922 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.49 101.65 14.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.041 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.908 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.08 137.67 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.302 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.2 p -93.07 142.76 26.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.825 0.345 . . . . 0.0 110.943 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 2.9 ttt180 -106.82 83.65 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? 41.06 60.25 2.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.294 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 64.34 37.2 8.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.31 65.81 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.049 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 43.16 81.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.51 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.45 -33.4 6.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -161.07 -47.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mtt -118.62 85.86 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.53 -9.05 52.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.73 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.61 11.31 13.1 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -114.52 26.24 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.535 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 ' HB ' ' A' ' 20' ' ' ILE . 4.8 tt -46.08 110.36 0.26 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -142.15 175.28 9.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.785 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.53 168.92 9.09 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.639 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.6 Cg_endo -46.66 169.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.693 2.929 . . . . 0.0 112.146 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.29 59.6 0.72 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.155 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.52 122.53 3.11 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 114.113 -1.044 . . . . 0.0 111.697 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.28 -7.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.28 0.632 . . . . 0.0 111.213 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.852 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -40.73 -57.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.389 0.614 . . . . 0.0 111.285 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -21.72 -80.43 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.252 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.5 mmt 41.83 -94.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.588 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.77 19.49 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.424 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -82.97 -165.71 1.14 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.529 0.205 . . . . 0.0 110.81 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.885 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.51 156.57 36.19 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.885 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.5 -24.64 0.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.772 2.315 . . . . 0.0 112.362 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.3 mm-40 -89.98 -59.97 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -80.89 -4.56 55.29 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -63.68 -57.08 11.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.593 0.235 . . . . 0.0 111.089 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.697 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.67 -41.77 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.354 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.5 t -50.36 -35.36 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.342 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -52.15 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.49 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 10.2 mm-40 -70.1 -20.09 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.896 HD11 ' CE1' ' A' ' 64' ' ' HIS . 13.9 tp -58.18 -41.57 84.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -26.96 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.1 tm-20 -72.12 -25.27 61.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.4 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -108.59 7.02 26.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.985 HG12 HG13 ' A' ' 60' ' ' ILE . 10.6 t -133.28 -43.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.191 0.52 . . . . 0.0 109.974 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 52.88 8.63 0.63 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.442 -0.799 . . . . 0.0 115.028 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.985 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.6 -174.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.026 0.913 . . . . 0.0 110.149 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 p -114.58 87.34 14.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.67 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.0 Cg_endo -115.5 145.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 123.664 2.909 . . . . 0.0 114.066 -177.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.896 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -122.64 133.33 54.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.329 -175.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.04 -139.23 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.02 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 56.29 153.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.617 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.4 tt -116.78 111.21 19.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.386 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.56 ' CZ ' HG12 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -76.58 -54.14 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.195 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.0 mt-10 -171.28 131.7 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.438 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.617 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.27 126.6 39.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.692 0.282 . . . . 0.0 110.807 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 122' ' ' VAL . 1.2 pt? -113.84 136.67 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' HG21 ' A' ' 81' ' ' THR . 5.0 tt0 -121.67 109.94 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -131.05 152.2 50.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.5 pt-20 -121.13 139.58 53.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 111.381 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -103.23 162.67 19.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.133 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.1 Cg_endo -49.76 81.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.155 2.57 . . . . 0.0 112.344 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t70 89.28 10.2 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.595 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.719 ' HD3' HD21 ' A' ' 4' ' ' LEU . 3.2 tmm_? -137.34 93.94 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.3 . . . . 0.0 110.89 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 17.2 m80 -80.18 93.86 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.97 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 80' ' ' ILE . 15.4 tt -96.76 111.87 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -106.82 132.54 52.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.39 114.58 18.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 0.0 111.422 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.1 m0 -109.34 125.53 52.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.226 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.646 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.8 m-85 -111.41 114.56 27.78 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.932 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.542 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 61.3 m95 -94.73 148.83 21.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 14.6 tp -98.41 102.89 14.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 111.755 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.809 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.0 t -80.69 145.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.205 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 8.7 pt-20 -112.57 -26.96 8.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 3.9 mtt-85 -161.83 164.08 28.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.673 0.67 . . . . 0.0 111.428 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.696 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.67 123.59 4.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 152.95 32.51 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.1 -125.05 38.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.36 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -135.0 148.1 65.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.6 0.238 . . . . 0.0 110.956 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.636 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.48 128.8 10.58 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.933 2.422 . . . . 0.0 111.163 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 66.8 p-90 -138.45 -58.56 0.63 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.749 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 41.38 -93.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.295 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER 175.12 32.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.28 . . . . 0.0 111.144 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' OE1' HG21 ' A' ' 21' ' ' THR . 4.1 pt-20 -68.05 -33.37 74.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.947 0.403 . . . . 0.0 110.256 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.05 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -140.35 91.65 9.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 0.0 111.64 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.73 127.58 8.14 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.077 2.518 . . . . 0.0 112.602 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.3 177.05 19.47 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.7 155.28 39.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.14 107.14 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 110.459 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -119.55 163.06 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.771 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.07 122.66 33.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.098 HD21 HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -79.97 -18.97 49.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.625 HG23 HD21 ' A' ' 129' ' ' LEU . 12.5 p -53.0 -21.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.69 45.42 1.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.038 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.098 HD22 HD21 ' A' ' 107' ' ' LEU . 11.6 tp -62.94 150.28 42.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.722 0.261 . . . . 0.0 110.378 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -117.46 131.8 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.2 -15.29 61.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.648 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -48.93 14.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.367 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.98 -39.02 87.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.945 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -81.11 171.43 12.26 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.324 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 57.2 Cg_endo -71.15 127.57 13.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.18 1.92 . . . . 0.0 111.875 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.64 -14.86 45.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.581 2.187 . . . . 0.0 112.84 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.84 -9.5 57.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -124.01 34.33 5.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.714 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.57 -39.01 5.57 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.876 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.7 Cg_exo -53.07 -40.74 75.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.064 1.843 . . . . 0.0 112.699 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.72 HG21 HD22 ' A' ' 71' ' ' LEU . 2.3 t -77.47 -51.23 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.317 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.7 OUTLIER -67.3 -30.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.303 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.28 -28.46 63.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -51.86 13.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.365 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.1 tp -78.12 -39.51 41.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.483 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.522 ' HB2' HG22 ' A' ' 123' ' ' ILE . 5.2 tttm -53.54 -42.56 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.282 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -72.06 -3.64 24.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.133 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 108' ' ' VAL . 5.6 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.011 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.613 ' OP1' " C3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.844 0.354 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -109.95 102.88 11.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.08 125.56 51.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.756 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.1 pp -125.24 139.05 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.583 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.7 mt-30 -102.46 155.41 18.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.805 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.699 HD11 " O3'" ' A' ' 131' ' ' 8OG . 30.2 mt -146.26 126.67 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.32 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.996 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.49 124.16 41.69 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.185 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -118.65 162.5 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.34 117.19 1.19 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.934 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.911 ' CG2' HG21 ' A' ' 18' ' ' ILE . 4.7 mp -70.58 100.51 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.788 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -71.21 125.9 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -98.0 119.96 37.55 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.085 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.593 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.54 -172.93 0.84 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.019 0.438 . . . . 0.0 110.567 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 21.9 tt0 -81.28 12.83 3.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -133.92 34.9 3.34 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 5.32 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -100.95 161.76 13.37 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.911 HG21 ' CG2' ' A' ' 10' ' ' ILE . 6.7 mt -117.92 141.29 37.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.255 0.55 . . . . 0.0 111.665 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -93.02 92.77 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.254 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.853 HG13 HG22 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.97 162.07 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.206 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.429 HG21 ' OE1' ' A' ' 98' ' ' GLU . 5.0 p -87.36 119.11 27.29 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.68 119.81 16.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 111.21 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.824 ' HG3' ' HB1' ' A' ' 30' ' ' ALA . 0.9 OUTLIER 46.39 28.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.99 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 100' ' ' GLN . . . -98.45 29.43 3.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.278 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.73 -22.98 12.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.22 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 64.24 81.11 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 60.87 63.07 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.4 -76.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.93 79.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.824 ' HB1' ' HG3' ' A' ' 23' ' ' ARG . . . -87.16 -25.67 23.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.48 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -91.24 14.06 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.542 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HD3' ' N2 ' ' A' ' 131' ' ' 8OG . 1.4 mtpp -114.17 26.45 10.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 111.359 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.3 tt -40.34 117.07 0.75 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.222 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.728 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -158.3 -172.42 3.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.504 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.37 163.08 28.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.879 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.52 ' HG3' HD11 ' A' ' 11' ' ' ILE . 6.2 Cg_endo -47.48 169.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.887 3.058 . . . . 0.0 112.314 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.05 59.32 0.73 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.449 -0.882 . . . . 0.0 113.349 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -132.13 109.04 0.82 Allowed Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.155 -1.022 . . . . 0.0 111.448 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.95 2.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.452 0.701 . . . . 0.0 111.176 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.996 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.43 -27.95 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.633 0.73 . . . . 0.0 110.571 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.591 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.333 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.3 mmt 32.36 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.458 0.474 . . . . 0.0 111.883 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.21 32.99 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.398 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.72 -177.01 5.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.857 0.361 . . . . 0.0 111.263 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.887 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.03 154.89 37.1 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.96 -24.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.867 2.378 . . . . 0.0 112.596 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.8 mt-10 -102.43 -42.21 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.595 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -80.22 -10.35 59.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.951 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.6 -52.24 65.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.749 0.309 . . . . 0.0 111.201 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.747 ' O ' HD13 ' A' ' 54' ' ' LEU . 1.3 m -78.09 -46.6 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.7 t -52.61 -37.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -78.5 -52.17 8.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.677 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 40' ' ' ILE . 2.5 mm-40 -65.28 -25.98 67.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 50' ' ' VAL . 2.0 mp -54.05 -44.58 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.597 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -30.78 69.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 -31.07 52.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.393 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.585 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.76 7.0 26.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.969 HG12 HG13 ' A' ' 60' ' ' ILE . 4.7 t -133.32 -44.64 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 51.65 18.04 3.64 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.969 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.63 -170.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.871 0.836 . . . . 0.0 110.839 179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.819 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -115.28 87.09 15.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.91 179.18 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG3' HG11 ' A' ' 58' ' ' VAL . 10.6 Cg_endo -117.35 145.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.511 2.807 . . . . 0.0 115.177 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 89' ' ' ARG . 93.7 mt-30 -74.95 79.22 2.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 174.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.943 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.78 123.3 42.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.888 -175.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -176.68 -138.78 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.011 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m 53.19 169.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.245 0.545 . . . . 0.0 112.153 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.9 tt -128.87 109.56 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.374 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.778 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.59 -46.87 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 109.971 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 tt0 -171.67 155.56 4.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.83 132.1 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.599 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.635 HD22 ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.18 158.8 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.448 ' N ' HD22 ' A' ' 71' ' ' LEU . 7.5 tt0 -140.04 128.31 22.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.5 p90 -141.0 147.62 38.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -121.08 132.26 54.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.256 0.551 . . . . 0.0 111.553 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -82.11 163.79 51.33 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.107 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.4 Cg_endo -49.64 82.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.185 2.59 . . . . 0.0 112.459 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 94.37 16.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.524 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt180 -137.45 150.16 47.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -121.57 116.31 24.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.942 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 73' ' ' TYR . 1.8 tt -122.34 121.22 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.788 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.07 134.62 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 71' ' ' LEU . 6.6 mt -125.64 114.26 18.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -109.21 122.49 47.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.37 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -104.25 121.17 42.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.628 ' CE2' HG11 ' A' ' 50' ' ' VAL . 20.6 m95 -108.15 148.89 29.25 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.544 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 46.3 tp -93.34 103.12 15.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.505 0.669 . . . . 0.0 111.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.943 HG22 ' ND1' ' A' ' 64' ' ' HIS . 17.4 t -88.71 145.59 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.654 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -102.2 -55.4 2.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -163.4 165.85 23.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.931 0.787 . . . . 0.0 112.854 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.65 ' CE3' HG22 ' A' ' 11' ' ' ILE . 48.7 p90 -128.53 140.1 51.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.787 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.819 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.9 OUTLIER -93.07 85.48 5.1 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 120.903 0.382 . . . . 0.0 110.411 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.57 -119.19 2.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.289 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 10.0 tt0 -135.12 131.12 19.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.434 0.159 . . . . 0.0 110.74 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 5.7 Cg_exo -77.07 128.87 10.15 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.895 2.397 . . . . 0.0 111.606 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.569 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 50.9 p-90 -142.19 -58.47 0.46 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.936 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 42.81 -96.13 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.017 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.08 39.34 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.761 0.315 . . . . 0.0 110.737 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -58.57 -47.64 83.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.03 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.74 -62.67 0.55 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.253 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . 3.4 pm0 -109.93 93.89 16.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 111.828 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.518 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 61.9 Cg_exo -43.82 125.92 5.49 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.017 2.478 . . . . 0.0 112.643 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.72 177.47 17.48 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.004 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HE2' ' A' ' 105' ' ' MET . 70.9 tt0 -120.54 157.25 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.6 0.238 . . . . 0.0 110.631 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.401 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.1 m0 -61.04 106.9 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.399 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.608 ' HG3' HD12 ' A' ' 20' ' ' ILE . 8.1 ptp -120.2 163.19 18.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.241 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.661 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -83.94 131.93 34.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.952 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.15 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.3 p -61.2 -13.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.936 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.71 38.95 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.109 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 107' ' ' LEU . 9.0 tp -70.55 140.54 51.8 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.16 134.8 54.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.4 61.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.883 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -49.12 13.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.559 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.74 -38.79 83.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.48 174.08 6.62 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.408 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 65.2 Cg_endo -74.15 127.85 11.67 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.258 1.972 . . . . 0.0 111.515 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.0 -14.82 29.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.658 2.239 . . . . 0.0 113.181 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.09 -9.79 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.1 38.23 3.81 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.713 0.292 . . . . 0.0 111.692 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.6 tt0 -71.17 -45.09 14.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -54.88 -37.36 92.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.119 1.879 . . . . 0.0 112.271 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.45 -51.45 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.143 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.525 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -68.59 -29.84 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.923 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -28.69 53.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.975 0.417 . . . . 0.0 110.672 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.74 -49.19 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.065 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.778 HD22 ' CE2' ' A' ' 68' ' ' PHE . 9.7 tp -78.11 -27.51 48.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.272 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -58.86 -42.6 89.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -74.51 -2.96 28.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.902 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 108' ' ' VAL . 3.3 mt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.162 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.699 " O3'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mtm . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 135.77 35.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.02 136.33 33.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.74 HD22 " O3'" ' A' ' 131' ' ' 8OG . 1.2 pp -138.18 138.56 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.43 ' O ' HD13 ' A' ' 6' ' ' ILE . 27.7 mt-30 -102.84 155.22 18.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.207 0.527 . . . . 0.0 111.312 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.473 HD11 " O5'" ' A' ' 131' ' ' 8OG . 39.7 mm -146.5 139.29 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.641 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.942 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.58 150.28 46.11 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.564 HG11 ' CE1' ' A' ' 84' ' ' PHE . 0.4 OUTLIER -145.45 148.86 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.906 0.384 . . . . 0.0 110.935 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.57 107.37 0.33 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.886 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.676 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.41 103.87 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.802 HG21 ' CD2' ' A' ' 19' ' ' PHE . 1.2 tt -70.62 111.61 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.755 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.606 ' HG2' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -87.52 138.08 31.78 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.376 -179.046 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.76 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.3 p30 -90.52 -173.3 3.72 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.336 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 13.5 tp10 -78.24 0.91 23.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.326 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -122.38 40.33 3.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.97 21.35 2.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 111.576 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 22.1 mt-10 -113.85 161.94 16.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.676 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.25 135.79 58.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.92 0.391 . . . . 0.0 111.729 -178.377 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.802 ' CD2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -88.79 102.44 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.367 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.54 162.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.855 HG21 ' CD ' ' A' ' 98' ' ' GLU . 6.6 p -86.35 111.86 20.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.757 0.313 . . . . 0.0 110.608 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 7.7 ptt180 -127.4 131.64 50.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.001 0.429 . . . . 0.0 110.656 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 48.06 -107.5 0.2 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 169.75 -76.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.978 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -167.24 -51.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.014 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -93.93 -48.67 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -169.05 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.052 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 m80 51.79 -176.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.09 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.79 89.47 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.97 -8.97 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.569 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 3.01 53.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.416 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.36 10.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.2 tt -45.23 93.55 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.3 OUTLIER -126.33 -179.97 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 111.566 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.68 168.17 10.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.174 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.1 Cg_endo -46.95 168.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.276 2.65 . . . . 0.0 111.75 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.68 59.02 0.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.243 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -146.13 101.57 0.24 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.439 -0.88 . . . . 0.0 112.25 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.631 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 128.01 -9.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.374 0.67 . . . . 0.0 110.723 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.942 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -43.31 -74.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.618 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -8.22 -82.16 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.565 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 44.35 -93.36 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.505 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.58 17.21 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.485 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.89 -163.45 0.59 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.596 0.236 . . . . 0.0 110.807 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.909 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.73 155.82 38.3 Favored Pre-proline 0 N--CA 1.456 -0.162 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.909 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.82 -24.7 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.685 2.256 . . . . 0.0 112.442 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.719 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.7 mm-40 -94.33 -54.98 3.33 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.49 -4.98 55.89 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.4 -57.04 9.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.623 0.249 . . . . 0.0 110.974 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.726 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -78.37 -39.91 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.362 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 47' ' ' GLU . 56.7 t -50.68 -35.81 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -49.47 13.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 110.422 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 44.1 tp10 -64.41 -21.09 66.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.482 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.829 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.6 tp -57.02 -44.67 83.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -30.48 67.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.55 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.2 -26.27 64.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.442 . . . . 0.0 110.565 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.714 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.31 7.25 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.114 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.45 -44.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.161 0.505 . . . . 0.0 110.013 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.4 -40.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 114.519 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.782 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.59 -173.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.651 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -110.65 88.62 8.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.826 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 2.9 Cg_endo -111.12 152.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.706 0 C-N-CA 122.966 2.444 . . . . 0.0 114.555 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.494 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 42.8 mt-30 -74.66 80.06 2.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.833 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.32 127.3 44.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.319 -176.076 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.13 -136.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.634 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 54.03 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.196 0.522 . . . . 0.0 112.358 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.608 ' O ' HD23 ' A' ' 67' ' ' LEU . 7.2 tt -125.14 110.34 13.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.74 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.98 -39.76 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.603 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -171.52 164.34 6.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.778 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 112.14 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.933 HD23 ' CD1' ' A' ' 82' ' ' LEU . 15.3 tp -99.53 128.0 45.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.35 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -131.21 110.56 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.607 ' HE1' HD11 ' A' ' 82' ' ' LEU . 2.5 p90 -139.41 150.23 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.415 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.09 124.79 45.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.232 0.539 . . . . 0.0 111.613 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.65 163.3 69.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.233 179.113 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.1 Cg_endo -50.82 83.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.966 2.444 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.3 m-20 94.29 16.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.342 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 148.7 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -120.76 97.35 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.446 HD12 HD11 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -102.97 111.89 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.743 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' ILE . 54.0 m -114.96 126.8 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.933 ' CD1' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.46 115.5 19.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.228 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.544 ' O ' HG13 ' A' ' 8' ' ' VAL . 12.5 m0 -94.6 122.87 37.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CE1' HG11 ' A' ' 8' ' ' VAL . 3.0 m-85 -99.68 109.78 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 61.5 m95 -95.72 148.53 22.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.6 tp -102.1 102.92 13.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.298 0.57 . . . . 0.0 112.034 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.833 HG22 ' ND1' ' A' ' 64' ' ' HIS . 12.8 t -80.52 145.56 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.649 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.83 -43.11 3.66 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.05 166.25 23.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.786 0.721 . . . . 0.0 112.377 -178.177 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.76 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 28.0 p90 -137.56 148.78 46.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.745 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.01 96.3 8.06 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 -138.49 14.84 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.779 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.4 tt0 -106.07 122.63 41.68 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 2.9 Cg_exo -76.3 129.02 10.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.898 2.399 . . . . 0.0 112.192 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.742 ' HE1' HG23 ' A' ' 60' ' ' ILE . 3.6 p-90 -126.2 -77.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.741 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.714 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 67.33 -66.96 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.856 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 96.28 69.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.039 0.535 . . . . 0.0 110.811 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.855 ' CD ' HG21 ' A' ' 21' ' ' THR . 1.1 pp20? -83.36 -35.7 24.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.86 -52.13 0.16 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.001 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -140.05 117.97 8.41 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.48 . . . . 0.0 111.621 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -43.72 144.87 2.09 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.923 2.415 . . . . 0.0 112.654 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.3 19.23 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.637 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -125.89 157.33 37.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.532 0.206 . . . . 0.0 110.603 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.486 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.0 m0 -60.89 105.81 0.51 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.3 ptm -120.76 154.21 35.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.542 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.5 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -72.36 124.64 25.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.027 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -80.06 -18.89 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.547 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.0 p -54.14 -18.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.48 41.47 1.72 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.024 HD12 HD21 ' A' ' 107' ' ' LEU . 3.1 tt -62.88 148.05 48.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.569 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -123.22 131.22 53.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -15.12 61.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.493 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.5 -49.28 13.67 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.12 -38.34 85.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.092 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.97 173.6 7.46 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.293 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.9 Cg_endo -74.3 128.02 11.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.24 1.96 . . . . 0.0 111.678 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.97 -14.84 35.21 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.682 2.255 . . . . 0.0 113.175 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' H22' ' A' ' 131' ' ' 8OG . . . -66.78 -9.8 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.453 HD22 HD22 ' A' ' 82' ' ' LEU . 1.8 m-20 -128.76 37.72 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.332 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.08 -43.5 3.65 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.8 Cg_exo -45.2 -40.84 16.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.21 1.94 . . . . 0.0 113.166 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.0 t -77.51 -51.27 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.209 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.5 mm -65.83 -33.69 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.467 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.92 -28.43 50.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.883 0.373 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.26 -53.15 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.682 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 129' ' ' LEU . 5.2 tp -78.52 -36.88 44.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.75 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.635 ' HB2' HG22 ' A' ' 123' ' ' ILE . 17.2 ttpt -53.76 -42.71 68.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.9 0.381 . . . . 0.0 111.126 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -7.65 25.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.808 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 126' ' ' LEU . 8.2 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.042 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.74 " O3'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttm . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.806 0.336 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -110.05 102.98 11.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.027 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 133.3 38.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.656 HD11 HG13 ' A' ' 80' ' ' ILE . 3.0 pp -146.04 139.54 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 36.9 mt-30 -102.85 154.08 19.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.234 0.54 . . . . 0.0 111.881 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.626 HD11 " H4'" ' A' ' 131' ' ' 8OG . 40.0 mm -146.54 118.8 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.909 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.961 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.21 150.28 47.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.388 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -145.22 162.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.128 0.49 . . . . 0.0 111.472 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -136.79 114.81 1.18 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.203 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.955 HG22 HG21 ' A' ' 18' ' ' ILE . 1.5 mt -70.87 98.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.904 HG23 HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.95 122.46 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.406 0.622 . . . . 0.0 112.276 -177.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -86.27 127.36 34.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.708 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 2.8 t-20 -73.24 -171.92 1.03 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 122.092 0.949 . . . . 0.0 112.692 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.69 -13.63 15.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.627 -1.624 . . . . 0.0 113.271 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -132.34 -82.93 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.799 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -149.82 14.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.71 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 1.8 pt-20 -100.72 160.39 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.955 HG21 HG22 ' A' ' 10' ' ' ILE . 6.1 mt -135.97 138.6 47.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 111.911 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -76.88 94.12 3.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.127 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.21 139.16 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.419 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.435 HG22 ' CD ' ' A' ' 98' ' ' GLU . 6.3 p -70.95 123.8 22.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.84 ' HG3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -126.1 133.9 51.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.734 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.4 ptt-85 40.45 -104.64 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.315 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 166.5 -24.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.26 . . . . 0.0 111.223 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 79.93 35.17 0.15 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.901 0.381 . . . . 0.0 110.833 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -177.18 37.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.7 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.05 -167.19 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.083 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.71 -20.2 12.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.33 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.2 mtt -64.25 79.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.183 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.11 -9.1 56.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.528 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -96.21 31.42 2.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.002 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.9 ttpp -110.6 26.06 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.84 HD13 ' HG3' ' A' ' 22' ' ' ARG . 17.2 tp -66.4 69.25 0.06 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.629 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -106.92 -168.64 1.43 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 111.68 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.729 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.67 168.67 9.69 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.468 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 79.9 Cg_endo -80.11 169.3 17.81 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.459 3.44 . . . . 0.0 114.087 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 104.17 -1.63 43.91 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.14 161.66 29.04 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.565 0.682 . . . . 0.0 112.649 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.6 5.5 0.37 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.879 0.471 . . . . 0.0 111.792 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.961 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.5 pt -54.96 -25.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.588 0.708 . . . . 0.0 110.331 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.57 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.391 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.1 mtp 32.12 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.502 0.501 . . . . 0.0 111.961 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.99 32.46 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.572 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.72 -172.07 3.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.883 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.79 155.27 36.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.328 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.883 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.95 -24.96 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 112.596 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.7 mt-10 -101.65 -44.24 5.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.538 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -80.2 -6.1 57.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.925 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.28 -56.15 21.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.908 HG11 ' NE1' ' A' ' 85' ' ' TRP . 3.4 m -78.2 -45.3 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.303 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 47' ' ' GLU . 43.7 t -56.17 -39.27 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.501 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -78.36 -51.87 9.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.744 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 0.6 OUTLIER -68.98 -23.2 64.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.738 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -50.47 -44.28 55.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -33.92 65.43 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.72 -25.26 49.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.53 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.505 ' OE1' ' HA2' ' A' ' 37' ' ' GLY . 9.0 mp0 -108.43 5.09 25.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.979 HG12 HG13 ' A' ' 60' ' ' ILE . 8.6 t -134.82 -44.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.225 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.69 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 60.82 1.63 2.04 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.245 -0.889 . . . . 0.0 114.318 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.979 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.05 -172.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.695 0.748 . . . . 0.0 110.141 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 p -113.38 87.89 12.1 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.618 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.0 Cg_endo -112.68 144.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.563 2.842 . . . . 0.0 113.9 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 4.8 pt20 -74.75 79.95 2.07 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.933 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.04 129.65 53.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.795 -175.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.606 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -176.66 -142.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.291 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 57.28 154.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.231 0.539 . . . . 0.0 112.21 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.543 HD11 ' HG2' ' A' ' 70' ' ' LYS . 3.0 tt -117.83 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.5 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.622 ' HE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.49 -54.05 7.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 109.94 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.4 tt0 -171.58 145.81 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -136.79 117.99 14.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.321 . . . . 0.0 110.654 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.574 ' CD2' HG21 ' A' ' 122' ' ' VAL . 1.1 pp -98.58 147.05 25.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.22 112.07 11.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -137.75 128.95 27.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.75 118.62 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.052 0.453 . . . . 0.0 111.422 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.96 162.72 66.66 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.387 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 2.2 Cg_endo -44.96 81.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.438 2.759 . . . . 0.0 112.595 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 36.6 t0 104.08 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.87 150.26 20.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.872 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -121.75 93.82 4.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.679 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.656 HG13 HD11 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -93.17 135.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.3 118.91 22.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.513 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.534 ' HG ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -115.08 114.34 25.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.255 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.85 129.73 55.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 8' ' ' VAL . 9.0 m-30 -115.79 112.12 21.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.999 0.428 . . . . 0.0 110.798 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.908 ' NE1' HG11 ' A' ' 50' ' ' VAL . 43.6 m95 -94.9 149.32 21.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.461 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 65' ' ' PHE . 23.3 tp -97.71 102.8 14.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.54 0.686 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.933 HG22 ' ND1' ' A' ' 64' ' ' HIS . 11.5 t -85.44 146.22 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.693 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.44 -39.4 6.14 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.85 165.43 25.27 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.96 0.8 . . . . 0.0 111.835 -178.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.672 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.3 p90 -147.6 128.49 14.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.714 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -77.35 113.19 14.88 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.54 -122.14 6.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.456 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.5 mt-10 -135.06 137.52 27.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.418 0.151 . . . . 0.0 110.825 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.564 ' CA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.31 128.84 10.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.781 2.321 . . . . 0.0 111.395 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.69 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.8 p-90 -128.68 -59.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.901 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.02 -98.82 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.99 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 177.61 37.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.716 0.293 . . . . 0.0 111.171 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' CD ' HG22 ' A' ' 21' ' ' THR . 8.9 pt-20 -52.04 -41.92 62.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.82 -5.35 42.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.324 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -140.1 97.71 7.76 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 111.457 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -43.49 145.09 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.073 2.516 . . . . 0.0 112.802 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.11 19.42 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -141.81 157.16 45.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -65.57 105.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.486 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.4 ptm -120.71 163.39 18.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.954 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.548 ' HB2' HG12 ' A' ' 108' ' ' VAL . 28.0 p -86.33 114.74 23.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.817 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.96 -18.85 60.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.3 p -54.22 -18.82 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.935 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.2 49.8 0.83 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.071 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 123' ' ' ILE . 8.3 tt -62.71 150.36 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.635 0.255 . . . . 0.0 110.427 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.04 131.65 55.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.38 61.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.367 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -46.66 17.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.232 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -71.9 -22.53 61.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.105 -179.073 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -97.35 174.53 3.17 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.7 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 70.4 Cg_endo -75.3 136.02 19.26 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.277 1.985 . . . . 0.0 111.601 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.59 -14.36 35.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.901 2.401 . . . . 0.0 113.191 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -12.24 22.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.534 ' ND2' ' HG ' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -130.87 37.96 3.74 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -76.06 -48.1 3.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.009 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.4 Cg_exo -53.68 -38.29 84.47 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.371 2.047 . . . . 0.0 112.158 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 71' ' ' LEU . 1.6 t -77.19 -51.05 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.666 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.48 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -66.09 -29.98 48.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.13 -30.99 60.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.526 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -74.81 -52.0 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.429 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.622 HD13 ' HE2' ' A' ' 68' ' ' PHE . 2.3 tp -78.19 -19.73 53.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.641 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HB2' HG22 ' A' ' 123' ' ' ILE . 6.6 ttpp -80.38 -42.59 22.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.554 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.62 -8.8 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.907 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.557 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.626 " H4'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.752 0.311 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -101.0 103.0 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.44 121.97 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.79 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.9 pp -124.45 120.42 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -103.3 150.88 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.655 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.3 mp -141.92 134.38 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.48 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.708 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.96 158.03 34.63 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -145.59 162.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.933 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.56 104.74 0.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.608 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.069 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.7 109.19 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.703 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -70.82 124.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.378 0.608 . . . . 0.0 112.323 -177.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.726 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.92 124.18 30.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.418 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.567 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 19.8 t-20 -69.56 177.26 3.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.015 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tp10 -56.05 -18.65 10.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.6 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -121.19 -82.38 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.738 0.304 . . . . 0.0 111.519 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.97 15.56 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.711 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.537 ' C ' HD12 ' A' ' 18' ' ' ILE . 2.1 mp0 -100.83 160.51 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.069 HG21 HG22 ' A' ' 10' ' ' ILE . 3.8 mp -134.0 139.84 47.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.437 . . . . 0.0 111.167 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.512 ' HE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -93.67 113.84 26.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.898 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.545 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -123.16 159.11 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.557 179.315 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.9 p -70.77 111.62 6.35 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HG3' ' CD1' ' A' ' 33' ' ' LEU . 1.9 ttt180 -124.47 110.6 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.41 . . . . 0.0 111.173 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 52.92 23.91 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.275 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . . . 49.79 -174.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.876 0.37 . . . . 0.0 111.212 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.03 -29.56 43.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -170.6 35.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.785 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . . . -99.23 -166.81 1.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.04 38.57 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.0 mtt -122.54 75.29 1.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.756 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.4 -26.18 24.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.8 11.03 21.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.425 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.46 26.3 10.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.747 0.308 . . . . 0.0 111.667 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 114' ' ' ASP . 1.4 tt -52.78 86.41 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.703 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -122.09 179.8 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.778 -179.282 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 166.59 14.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.736 -179.36 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 7.6 Cg_endo -47.64 168.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.609 2.873 . . . . 0.0 111.461 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.24 59.78 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.75 -1.214 . . . . 0.0 114.209 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.42 103.14 0.49 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 114.765 -0.718 . . . . 0.0 112.069 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 125.56 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.395 0.678 . . . . 0.0 111.525 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.668 HG21 ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -42.82 -46.16 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.494 0.664 . . . . 0.0 111.005 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.94 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.263 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 34.73 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.88 24.25 0.08 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -90.04 -159.26 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.431 0.157 . . . . 0.0 110.747 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -100.72 152.74 37.92 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.64 -24.58 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.622 2.214 . . . . 0.0 112.192 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.94 -49.66 4.46 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -80.54 -8.82 59.72 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.651 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -66.98 -57.33 7.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.375 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.557 HG22 ' CD1' ' A' ' 54' ' ' LEU . 2.3 p -78.92 -35.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.459 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 47' ' ' GLU . 70.0 t -50.3 -35.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.333 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -34.82 47.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.501 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -76.95 -22.22 53.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.826 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -55.42 -44.39 76.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.02 74.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.149 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -27.61 52.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.459 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.9 mt-10 -108.22 5.47 25.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.986 HG12 HG13 ' A' ' 60' ' ' ILE . 17.0 t -134.5 -44.35 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.179 0.514 . . . . 0.0 110.369 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.653 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.22 18.04 12.53 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 114.744 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.986 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -128.38 -168.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 117.674 0.737 . . . . 0.0 110.676 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.685 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -116.28 86.73 18.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.923 179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.8 Cg_endo -117.18 139.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 123.819 3.013 . . . . 0.0 114.532 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 31.7 mt-30 -74.84 79.32 2.11 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 174.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.866 ' HB2' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -114.22 126.72 55.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.142 -175.5 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -174.52 -150.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.846 -179.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.77 -177.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.903 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.6 pp -144.85 129.94 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.11 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -46.2 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.983 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.32 131.36 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.142 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.636 ' HE2' HD13 ' A' ' 67' ' ' LEU . 1.1 ptpm? -113.82 132.14 55.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.799 0.333 . . . . 0.0 111.006 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 122' ' ' VAL . 9.7 tp -112.24 137.68 50.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.653 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.42 109.91 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.675 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -140.51 149.14 42.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.19 140.05 52.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.254 0.549 . . . . 0.0 111.429 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -87.7 163.12 39.71 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.435 179.449 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -52.52 82.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.004 2.469 . . . . 0.0 112.137 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 11.9 t0 97.08 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.187 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 75' ' ' PHE . 7.3 ttp-105 -137.34 150.34 47.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -123.79 96.96 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.871 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 4' ' ' LEU . 2.8 tt -100.73 111.88 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 110.984 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.76 131.73 45.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.408 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -125.78 114.27 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.3 m0 -112.89 122.8 48.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.632 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -106.4 116.89 32.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 110.291 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.4 m95 -94.51 148.35 22.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.635 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.5 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.3 tp -102.87 102.9 13.03 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.319 0.58 . . . . 0.0 111.288 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.866 HG13 ' HB2' ' A' ' 64' ' ' HIS . 28.9 t -83.93 145.44 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.132 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.55 ' C ' ' HG2' ' A' ' 89' ' ' ARG . 8.1 pt-20 -115.8 -17.49 11.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -161.89 165.62 27.41 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.878 1.217 . . . . 0.0 112.185 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.703 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -157.54 130.03 7.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.977 178.511 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.685 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -99.68 161.25 13.73 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.12 -128.41 28.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.657 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.3 tt0 -127.12 127.88 24.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HA ' HG12 ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.9 128.56 10.1 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.561 2.174 . . . . 0.0 112.69 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.653 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 7.8 p-90 -133.79 -62.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.0 110.116 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 -67.45 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.789 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' TRP . 1.6 mmtt 81.45 43.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.966 0.412 . . . . 0.0 110.662 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -71.42 -29.31 64.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.806 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.72 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.794 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.546 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 3.9 mp0 -140.05 105.08 6.72 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -43.78 144.48 2.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.858 2.372 . . . . 0.0 112.388 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 169.64 22.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.93 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.21 157.31 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.74 106.05 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.581 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.1 ptm -120.56 163.25 18.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.797 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.6 t -72.87 114.86 11.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.668 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 18' ' ' ILE . 11.8 tp -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.314 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.56 -13.33 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.506 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.94 34.76 5.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.871 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 123' ' ' ILE . 11.7 tp -62.54 131.53 49.41 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 132.29 54.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.42 61.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.285 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.78 -49.19 13.42 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.382 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.613 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -67.4 -38.34 84.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.674 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.89 174.06 6.7 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.4 Cg_endo -73.79 127.84 11.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.052 1.835 . . . . 0.0 111.355 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.53 -14.72 26.96 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.634 2.223 . . . . 0.0 113.289 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.75 -9.82 31.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.67 42.3 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 tt0 -73.22 -38.77 4.6 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 73.3 Cg_exo -51.17 -41.41 57.94 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.1 1.866 . . . . 0.0 113.033 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.26 -51.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.405 . . . . 0.0 111.273 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.53 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.6 mm -65.97 -29.85 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.47 -29.85 62.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -80.09 -46.56 16.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 68' ' ' PHE . 7.6 tp -78.14 -26.42 47.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 111.257 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -58.4 -42.57 87.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.141 0.496 . . . . 0.0 110.648 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 1.5 tpp180 -71.12 -5.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.875 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.225 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.79 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.88 0.371 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.59 127.22 41.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.01 132.59 49.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.548 HD13 HO3' ' A' ' 131' ' ' 8OG . 3.1 pp -140.94 129.72 22.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.853 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 mt-30 -102.74 148.89 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.169 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.853 HD13 ' O ' ' A' ' 5' ' ' GLN . 24.0 mm -135.54 134.13 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.94 125.19 43.54 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -131.63 155.7 41.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.251 0.548 . . . . 0.0 111.813 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.62 137.42 7.5 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.339 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.721 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -85.73 94.72 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.384 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.979 HG23 HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -71.68 118.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.194 0.521 . . . . 0.0 111.351 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.262 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.621 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 7.4 p-10 -110.17 -173.52 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -45.99 -28.5 1.17 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.075 -1.42 . . . . 0.0 113.432 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -92.58 26.74 2.54 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.578 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.91 25.89 0.34 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.211 0.529 . . . . 0.0 110.51 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 17.2 pt-20 -114.22 160.16 19.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.212 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.75 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -112.15 135.96 49.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.347 0.594 . . . . 0.0 112.441 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 10.9 t80 -91.02 103.27 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.933 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.458 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.58 147.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.926 0.394 . . . . 0.0 110.863 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 98' ' ' GLU . 4.8 p -88.72 111.62 22.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.938 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 24.6 ptt-85 -113.92 172.19 7.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 111.096 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' MET . 16.4 mmm180 -74.8 57.25 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.3 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 49.2 -168.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.332 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.91 44.39 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.974 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -153.19 -44.13 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.057 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.62 173.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.389 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.86 30.67 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.962 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 6.6 mtt -140.84 38.39 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.772 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.71 -8.74 15.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.033 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 16.91 3.16 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 mttt -114.36 26.01 10.6 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.962 0.41 . . . . 0.0 111.387 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -55.73 86.2 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.9 tt0 -106.89 -170.96 1.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.14 0.495 . . . . 0.0 111.741 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.668 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.86 166.04 16.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.44 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 61.1 Cg_endo -71.07 168.86 22.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.548 2.832 . . . . 0.0 111.708 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.43 59.36 0.72 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.601 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.44 120.02 3.4 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 114.118 -1.041 . . . . 0.0 111.527 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 119.05 -10.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.417 0.687 . . . . 0.0 110.727 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.915 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -37.78 -63.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.33 0.586 . . . . 0.0 111.358 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' N ' HG12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -15.41 -81.25 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.375 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.69 -93.27 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.696 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.6 22.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.447 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.6 -159.22 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.521 0.2 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.901 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.44 155.61 37.68 Favored Pre-proline 0 N--CA 1.457 -0.082 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.901 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -44.07 -24.83 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.781 2.321 . . . . 0.0 112.428 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.681 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.0 mm-40 -100.0 -49.6 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.8 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -80.42 -4.58 54.21 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -64.61 -57.45 9.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.596 0.236 . . . . 0.0 111.214 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.51 ' N ' HD12 ' A' ' 40' ' ' ILE . 1.2 p -78.79 -40.86 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.494 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.6 t -50.2 -35.22 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -52.16 9.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.212 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -67.51 -19.91 65.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.798 HD11 ' CE1' ' A' ' 64' ' ' HIS . 7.9 tp -56.61 -44.44 81.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 110.459 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -26.78 68.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.836 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.2 tm-20 -75.36 -26.77 58.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.396 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.97 6.82 25.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.978 HG12 HG13 ' A' ' 60' ' ' ILE . 8.2 t -131.46 -43.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.062 0.458 . . . . 0.0 110.395 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 57.46 7.34 2.9 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.751 -0.659 . . . . 0.0 114.679 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.978 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.9 -166.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.928 0.864 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.643 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -113.16 87.89 11.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.888 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.684 ' HG3' HG11 ' A' ' 58' ' ' VAL . 11.7 Cg_endo -113.51 133.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.852 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 7.9 pt20 -74.75 79.22 2.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.836 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -112.16 130.02 56.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.539 -175.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -178.17 -142.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.053 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t 52.75 171.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 112.16 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 67' ' ' LEU . 4.2 tt -131.31 105.65 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.404 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.64 -40.97 47.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.982 0.42 . . . . 0.0 110.121 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.8 tt0 -171.27 159.88 5.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.43 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -143.25 132.16 22.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.818 0.342 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' A' ' 122' ' ' VAL . 5.5 tp -122.39 128.95 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.649 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.739 ' CD ' HG23 ' A' ' 81' ' ' THR . 1.1 tp10 -129.35 110.84 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.712 ' HE1' HD12 ' A' ' 82' ' ' LEU . 3.4 p90 -138.49 104.48 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.545 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 15.8 pt-20 -88.5 126.62 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.044 0.449 . . . . 0.0 111.526 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -70.08 163.55 60.4 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.934 179.138 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -38.75 -28.51 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.499 2.799 . . . . 0.0 113.103 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -32.61 0.58 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.426 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 26.8 ttm180 -94.18 97.95 10.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.337 . . . . 0.0 111.61 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.1 m-70 -78.97 100.21 7.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -104.59 130.89 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.739 HG23 ' CD ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -121.44 132.01 54.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.465 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.061 HD13 ' ND2' ' A' ' 119' ' ' ASN . 22.2 mt -126.24 114.5 18.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.474 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -107.65 122.59 47.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.589 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.726 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -100.64 109.56 21.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.429 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.484 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 21.8 m95 -96.31 148.6 22.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.54 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.567 HD12 ' OE2' ' A' ' 88' ' ' GLU . 1.9 tm? -90.83 103.03 15.79 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.315 0.579 . . . . 0.0 111.35 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.979 HG11 HG23 ' A' ' 11' ' ' ILE . 18.9 t -90.5 145.3 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.567 ' OE2' HD12 ' A' ' 86' ' ' LEU . 1.7 mm-40 -113.85 -25.39 8.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.537 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -163.5 165.86 23.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.105 1.32 . . . . 0.0 112.809 -178.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.684 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -157.12 124.5 5.28 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.623 178.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.643 ' CB ' HG23 ' A' ' 61' ' ' THR . 0.7 OUTLIER -80.06 117.99 21.38 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.801 0.334 . . . . 0.0 111.126 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.25 -123.34 6.97 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.445 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.8 mt-10 -129.46 137.78 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 122.952 -0.146 . . . . 0.0 110.63 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.608 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.8 Cg_exo -76.67 128.94 10.52 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.778 2.319 . . . . 0.0 110.969 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 51.1 p-90 -140.26 -58.99 0.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 48.55 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.578 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -179.37 32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.628 0.252 . . . . 0.0 111.219 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -63.96 -24.93 67.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.57 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.06 73.18 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.429 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.446 ' O ' ' HB ' ' A' ' 21' ' ' THR . 23.4 mt-30 -140.36 100.64 6.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 129.59 7.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.883 2.389 . . . . 0.0 112.385 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.429 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.09 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.14 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -153.27 157.13 39.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -71.59 105.69 3.75 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.824 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.464 ' C ' ' HB2' ' A' ' 17' ' ' GLU . 28.0 ptm -120.58 147.55 45.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.063 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.428 ' OG ' HG12 ' A' ' 108' ' ' VAL . 1.3 t -67.85 124.99 24.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.846 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.817 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.4 tm? -71.92 -20.76 61.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.225 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' A' ' 129' ' ' LEU . 11.7 p -55.13 -19.47 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.521 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.82 36.89 3.73 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.872 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 107' ' ' LEU . 10.6 tp -62.74 129.11 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.99 134.79 54.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.601 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -15.37 61.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.674 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -78.89 -49.25 13.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.772 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -30.31 68.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.652 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -88.45 173.97 5.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.621 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 72.3 Cg_endo -76.86 130.16 11.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.433 2.089 . . . . 0.0 111.596 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.58 -14.44 13.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.938 2.425 . . . . 0.0 113.728 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.71 -10.24 11.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 1.061 ' ND2' HD13 ' A' ' 82' ' ' LEU . 1.2 m-20 -136.24 45.67 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.742 0.306 . . . . 0.0 111.465 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.52 -54.41 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.01 -33.09 7.24 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.396 2.064 . . . . 0.0 112.416 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.726 HG11 ' CD2' ' A' ' 84' ' ' PHE . 25.8 t -77.57 -51.03 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.668 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 16.6 mm -65.59 -29.77 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.4 56.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 110.626 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -47.44 14.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.449 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.769 ' O ' HD22 ' A' ' 129' ' ' LEU . 11.1 tp -78.18 -19.43 53.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.517 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 123' ' ' ILE . 3.8 ttpm? -71.14 -42.6 68.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 110.643 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -68.24 -9.46 47.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.004 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.125 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.623 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.604 ' P ' " H3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.828 0.346 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -93.83 135.47 35.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 145.94 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.645 ' CD1' HD11 ' A' ' 6' ' ' ILE . 2.8 pp -146.02 124.35 12.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.95 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.2 mt-30 -102.49 155.72 18.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.727 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.7 mp -146.16 132.29 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.503 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.065 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.4 124.74 43.0 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -126.79 162.12 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.0 112.214 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.31 116.27 0.86 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.908 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.724 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.47 96.02 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.764 HG22 ' CG ' ' A' ' 64' ' ' HIS . 2.4 pt -79.35 111.68 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.164 0.507 . . . . 0.0 112.171 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.796 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.1 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.937 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.635 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.5 p-10 -125.34 -173.83 2.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -22.21 12.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.326 -1.307 . . . . 0.0 113.534 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -98.08 30.77 2.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.336 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.41 28.92 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.316 0.579 . . . . 0.0 110.264 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.7 mt-10 -117.71 160.34 21.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.957 HG21 HD23 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -114.62 136.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.045 0.45 . . . . 0.0 111.596 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.916 ' N ' HD13 ' A' ' 18' ' ' ILE . 44.5 t80 -87.88 93.68 9.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.619 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -114.68 162.2 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.621 HG21 ' CD ' ' A' ' 98' ' ' GLU . 27.9 p -71.72 129.65 39.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.93 128.45 42.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.775 0.321 . . . . 0.0 110.817 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 15.4 mtm180 54.6 -112.38 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.162 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . 172.98 176.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 0.0 110.977 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . . . -103.77 -30.89 10.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.988 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -111.08 -43.63 3.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -101.22 -176.01 3.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.028 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -84.09 -80.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.559 ' SD ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 53.21 38.32 27.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.018 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.96 97.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.318 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.88 20.84 9.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.49 26.47 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.602 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.651 HD21 HD12 ' A' ' 20' ' ' ILE . 2.5 tt -56.03 80.4 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -106.84 -168.31 1.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.945 0.402 . . . . 0.0 111.346 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.724 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.58 157.39 51.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.614 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.519 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 21.4 Cg_endo -60.06 167.37 7.45 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.216 2.61 . . . . 0.0 111.183 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.1 58.83 0.78 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.782 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -122.8 130.69 7.96 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.674 -0.763 . . . . 0.0 111.803 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 102.11 4.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.137 0.575 . . . . 0.0 111.695 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.065 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -54.95 -25.91 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.43 0.633 . . . . 0.0 110.547 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.28 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.965 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.1 mmm 35.49 -85.52 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.422 0.451 . . . . 0.0 111.807 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.42 30.63 0.15 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.385 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.5 mp0 -91.86 -178.27 4.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.01 155.9 36.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.27 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.96 -24.78 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.847 2.365 . . . . 0.0 112.715 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.692 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.3 mt-10 -95.11 -49.38 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -80.21 -23.25 41.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.021 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.49 -48.43 77.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.952 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.818 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.1 -47.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.756 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.1 t -58.54 -35.73 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.036 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -74.89 -52.07 12.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.619 ' CB ' HG22 ' A' ' 40' ' ' ILE . 5.5 tp10 -68.98 -26.47 65.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 6.1 tp -51.94 -44.07 63.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.47 -31.19 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.158 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.1 -23.84 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.234 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.62 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 9.1 mm-40 -108.11 6.57 27.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.543 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.918 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -134.13 -45.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 110.338 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 63.32 -27.32 0.08 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.934 1.133 . . . . 0.0 115.934 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.918 HD12 HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -93.94 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 117.771 0.786 . . . . 0.0 111.466 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.5 p -105.81 89.57 3.66 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.039 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 84.1 Cg_endo -109.57 137.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.438 2.759 . . . . 0.0 115.367 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 89' ' ' ARG . 70.9 mt-30 -75.55 79.46 2.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 174.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.771 ' HE2' ' HE3' ' A' ' 90' ' ' TRP . 1.8 m-70 -138.17 127.4 24.44 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.55 -173.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CE1' HG22 ' A' ' 51' ' ' VAL . 6.2 t80 173.5 173.72 0.14 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.028 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 5.4 t 106.14 154.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.736 0.814 . . . . 0.0 110.614 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.536 HD11 ' HE3' ' A' ' 70' ' ' LYS . 9.1 tt -106.75 146.88 30.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.675 ' HE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -117.13 -44.74 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.709 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.23 153.96 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.666 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE3' HD11 ' A' ' 67' ' ' LEU . 2.5 ptpp? -138.0 132.06 31.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 5.4 tp -118.01 124.39 48.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.737 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.82 109.88 17.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.538 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -134.42 153.22 52.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.648 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -114.89 140.13 49.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.291 0.567 . . . . 0.0 111.42 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -107.21 163.75 16.28 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.269 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 64.0 Cg_exo -39.26 81.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.457 2.772 . . . . 0.0 112.744 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.02 20.53 4.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.431 ' NH1' HD23 ' A' ' 4' ' ' LEU . 2.8 tpt85 -137.32 93.88 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -74.79 101.13 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -100.15 114.73 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.979 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 128.2 54.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.76 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.86 HD13 ' OD1' ' A' ' 119' ' ' ASN . 24.8 mt -126.07 114.64 18.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.277 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.2 m0 -105.05 122.54 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.701 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -99.41 109.86 22.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.038 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.788 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.2 m95 -99.69 148.16 24.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.033 0.444 . . . . 0.0 111.955 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.8 tp -91.34 122.2 33.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.137 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.639 HG12 ' CA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -124.06 145.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.921 -178.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 12' ' ' ARG . 10.7 tt0 -89.22 -69.78 0.69 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.51 166.08 25.3 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.19 0.519 . . . . 0.0 112.227 -177.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.771 ' HE3' ' HE2' ' A' ' 64' ' ' HIS . 47.8 p90 -115.78 163.01 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.254 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.67 72.27 0.95 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.72 0.295 . . . . 0.0 110.911 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 135.97 -115.97 1.41 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.637 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -134.18 118.77 14.14 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.554 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -75.74 128.97 11.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.836 2.357 . . . . 0.0 111.881 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.804 ' HE1' HG23 ' A' ' 60' ' ' ILE . 2.2 p-90 -121.86 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.705 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.62 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 60.55 -68.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.868 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 40.7 tttm 96.95 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.212 0.605 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.621 ' CD ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.16 -31.31 21.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.625 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.3 -15.52 2.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.99 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -140.06 101.36 7.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.954 0.407 . . . . 0.0 111.373 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 54.3 Cg_exo -43.55 146.22 1.4 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.062 2.508 . . . . 0.0 112.623 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.428 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.24 177.37 19.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.888 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 13.8 tt0 -153.12 157.34 40.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.403 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.72 106.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.13 156.53 30.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.262 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.435 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -67.12 114.54 5.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.957 HD23 HG21 ' A' ' 18' ' ' ILE . 3.0 tm? -78.4 -21.34 49.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.487 HG22 HD21 ' A' ' 129' ' ' LEU . 10.9 p -63.41 -12.53 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.547 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.15 40.87 2.02 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.891 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 110' ' ' LEU . 11.7 tp -62.64 134.13 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 137.73 54.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.29 -15.73 61.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.577 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.97 -49.25 13.06 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.58 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.22 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.47 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.563 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.94 173.91 6.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.454 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.9 Cg_endo -77.17 137.09 16.79 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.372 2.048 . . . . 0.0 111.916 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 20.1 Cg_endo -60.05 -14.09 26.58 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.901 2.401 . . . . 0.0 113.258 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -9.81 10.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.86 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -138.91 47.52 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -70.36 -58.1 5.16 Favored Pre-proline 0 CA--C 1.531 0.231 0 O-C-N 122.214 -0.304 . . . . 0.0 111.389 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.46 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -44.73 -31.02 4.64 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.501 2.134 . . . . 0.0 112.522 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 84' ' ' PHE . 71.7 t -77.33 -50.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.59 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' A' ' 127' ' ' LYS . 26.8 mm -65.43 -31.54 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.83 36.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 110.902 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -51.61 8.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.696 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.675 HD13 ' HE2' ' A' ' 68' ' ' PHE . 11.8 tp -78.09 -30.1 49.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.496 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.668 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.8 ttpt -56.71 -42.53 79.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -67.47 -8.85 36.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.762 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.487 HD21 HG22 ' A' ' 108' ' ' VAL . 10.7 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.508 " O3'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.833 0.349 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.75 102.91 12.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.973 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -104.91 144.62 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.6 pp -138.08 127.03 24.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.439 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.2 mt-30 -102.44 157.56 16.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.332 0.587 . . . . 0.0 111.869 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.507 ' HB ' HD12 ' A' ' 82' ' ' LEU . 73.1 mt -146.23 130.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.694 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.13 125.07 43.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -129.25 162.6 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.427 0.632 . . . . 0.0 111.925 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -148.11 113.55 0.64 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.428 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.766 HD12 ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -70.75 99.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.732 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.26 119.57 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.275 0.56 . . . . 0.0 111.987 -178.476 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.63 141.79 28.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.883 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -100.12 -173.17 2.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.001 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -73.75 -10.1 59.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.267 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.456 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 23.1 t-20 -111.89 30.91 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.63 11.39 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.545 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' HB2' HD21 ' A' ' 13' ' ' ASN . 0.0 OUTLIER -101.99 161.34 13.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.63 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -116.0 131.71 67.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 0.0 111.75 -178.396 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 7.0 t80 -82.92 107.63 15.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.524 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.486 HG13 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -123.47 162.16 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 100' ' ' GLN . 4.3 p -79.18 111.74 15.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HG2' ' HG ' ' A' ' 33' ' ' LEU . 2.7 tmm_? -119.19 169.78 9.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.61 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -60.85 -14.64 23.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.204 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 80.86 -76.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.458 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' N ' ' HD3' ' A' ' 23' ' ' ARG . . . -164.3 -79.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.806 0.336 . . . . 0.0 111.265 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.27 34.73 3.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.989 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . -108.28 151.16 26.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.11 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -178.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.824 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mtt 59.92 72.36 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 23' ' ' ARG . . . -87.05 -27.5 23.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.406 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -95.29 22.16 7.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.386 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.53 25.95 10.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.928 0.394 . . . . 0.0 111.749 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.44 HD23 ' C ' ' A' ' 33' ' ' LEU . 3.3 tt -65.7 78.45 0.07 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.009 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.95 -171.9 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.766 ' CD2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.86 156.48 54.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.766 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.493 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 8.9 Cg_endo -49.27 168.0 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.637 2.891 . . . . 0.0 111.831 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.34 59.21 0.76 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.033 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.711 ' C ' ' HG2' ' A' ' 39' ' ' LYS . . . -118.56 159.94 14.16 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.615 -0.793 . . . . 0.0 111.993 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.711 ' HG2' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 49.12 23.13 0.71 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 111.561 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.049 HD12 ' HB1' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -61.81 -30.96 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.704 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.19 -80.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.028 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.9 mmt 41.32 -84.03 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.381 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.29 33.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.682 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 mp0 -93.56 -174.33 3.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.7 0.286 . . . . 0.0 111.266 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.867 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.92 153.98 38.98 Favored Pre-proline 0 N--CA 1.457 -0.124 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.378 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.867 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.69 -24.66 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.958 2.439 . . . . 0.0 112.532 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.7 mt-10 -98.1 -48.71 5.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -80.42 -26.09 38.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.049 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -55.48 -47.38 76.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.33 -51.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.295 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.1 t -52.82 -36.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.512 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -78.24 -43.31 28.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.203 0.525 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.59 ' HG2' HG22 ' A' ' 40' ' ' ILE . 10.8 tp10 -64.42 -27.37 68.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.289 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.83 HD11 ' CE1' ' A' ' 64' ' ' HIS . 2.9 tp -56.57 -44.61 81.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -63.28 -35.41 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.431 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tm-20 -77.75 -26.13 49.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.477 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 36' ' ' PRO . 63.8 mm-40 -108.99 5.39 24.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.931 HG12 HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.84 -44.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.696 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.84 3.14 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.618 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.931 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.48 -173.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 117.907 0.853 . . . . 0.0 110.269 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 p -113.28 87.99 11.99 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.183 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.761 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.9 Cg_endo -113.23 145.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.612 2.875 . . . . 0.0 113.922 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.44 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 17.8 mt-30 -74.97 79.68 2.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.832 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.35 134.21 55.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.825 -176.253 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -179.3 -139.94 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 1.1 m 52.18 174.3 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.171 0.51 . . . . 0.0 112.111 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD11 ' CD ' ' A' ' 70' ' ' LYS . 6.1 tt -139.6 117.87 12.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.844 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.758 ' CE1' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.78 -55.61 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.221 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.614 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.1 mt-10 -171.13 131.38 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.441 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.762 ' CD ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.36 132.08 46.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.651 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.758 HD21 HG22 ' A' ' 122' ' ' VAL . 3.1 pp -140.56 161.95 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.666 ' HB2' HG23 ' A' ' 81' ' ' THR . 14.5 tt0 -125.69 124.1 40.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -120.88 152.71 38.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -120.76 120.9 36.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.151 0.5 . . . . 0.0 111.346 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -72.27 163.06 70.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.42 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.41 83.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.112 2.541 . . . . 0.0 112.316 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 16.8 m-20 95.29 15.2 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 8.2 tpp85 -137.44 150.14 47.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.7 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.7 105.6 10.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -111.36 154.31 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -127.25 131.18 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.647 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.536 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 11.2 tp -126.32 114.56 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.289 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.568 ' CH2' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -110.26 135.64 50.69 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.955 ' CD1' HG11 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -120.01 118.03 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.331 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.4 m95 -100.52 148.62 24.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.0 tp -96.6 102.89 14.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.46 0.648 . . . . 0.0 111.746 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.832 HG13 ' CB ' ' A' ' 64' ' ' HIS . 16.4 t -85.99 145.81 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.377 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.0 -39.77 5.65 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.8 ptp180 -163.24 165.67 24.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.837 0.744 . . . . 0.0 112.097 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.732 ' HE3' HG22 ' A' ' 11' ' ' ILE . 4.6 p90 -144.72 130.4 19.06 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.505 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.69 105.95 11.36 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.76 -122.82 7.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.446 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -134.97 137.07 26.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.401 0.143 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.594 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.45 128.75 10.57 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.755 2.303 . . . . 0.0 111.502 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.696 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.2 p-90 -130.47 -57.2 1.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.959 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.521 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 45.15 -94.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.991 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.4 mmtp 170.62 39.33 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 111.189 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -42.69 99.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.696 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.47 6.67 50.19 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.642 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 8.7 mp0 -140.2 99.12 7.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 117.31 0.555 . . . . 0.0 111.515 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -43.62 140.95 4.07 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.989 2.46 . . . . 0.0 112.668 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.17 177.05 19.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.768 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -147.96 157.18 43.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.545 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.2 m0 -61.86 105.92 0.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.114 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.2 ttm -120.55 159.81 24.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.277 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.547 ' HB2' HG12 ' A' ' 108' ' ' VAL . 5.2 p -83.93 123.85 30.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.746 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -80.01 -19.06 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.274 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.4 p -55.35 -19.82 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.18 45.8 1.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.076 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.608 HD12 ' CD2' ' A' ' 107' ' ' LEU . 7.6 tt -62.95 150.54 41.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.595 0.236 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -121.85 120.85 35.73 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.719 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.71 61.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.834 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.93 -46.25 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.562 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.56 -13.56 58.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.719 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.61 175.71 3.86 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.59 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 68.6 Cg_endo -76.12 143.08 25.26 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.736 1.624 . . . . 0.0 110.949 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.449 ' HG2' ' N1 ' ' A' ' 131' ' ' 8OG . 25.5 Cg_endo -62.05 -14.27 36.49 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.483 2.122 . . . . 0.0 113.213 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.689 ' HB2' ' N3 ' ' A' ' 131' ' ' 8OG . . . -75.62 -9.37 58.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' O ' ' A' ' 116' ' ' PRO . 31.4 p-10 -124.48 32.74 5.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.522 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.51 -55.19 1.68 Allowed Pre-proline 0 N--CA 1.467 0.389 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.456 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.95 -37.13 11.95 Favored 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.509 2.139 . . . . 0.0 112.889 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.955 HG11 ' CD1' ' A' ' 84' ' ' PHE . 2.4 t -77.6 -51.18 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.891 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.528 HD12 ' CD2' ' A' ' 110' ' ' LEU . 1.8 mm -68.3 -29.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.264 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.84 57.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.412 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -48.27 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.317 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.758 HD13 ' CE1' ' A' ' 68' ' ' PHE . 6.4 tp -78.21 -30.09 48.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.534 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -56.57 -42.87 79.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -75.59 -2.89 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.689 ' N3 ' ' HB2' ' A' ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.91 0.386 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.48 122.02 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.717 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.624 HD11 HD12 ' A' ' 80' ' ' ILE . 3.8 pp -109.65 125.08 52.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.487 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.6 mt-30 -102.52 150.43 23.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.317 0.58 . . . . 0.0 111.54 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.612 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.1 mt -141.21 131.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.046 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.051 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.01 124.8 43.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -128.52 156.96 41.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.322 0.582 . . . . 0.0 111.85 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -148.6 118.16 0.94 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.262 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.621 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.11 108.96 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.725 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -70.82 128.28 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.386 -178.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -91.75 126.22 36.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 9.6 t-20 -87.6 -172.31 3.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.983 0.897 . . . . 0.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -77.9 -3.0 39.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.878 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -133.46 49.06 2.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.203 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.85 28.88 0.39 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.451 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 6.7 pt-20 -118.17 149.53 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.042 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.793 HG21 HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -120.4 146.65 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 111.599 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -95.85 116.58 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.525 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.62 162.15 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.202 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.74 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -114.47 26.01 10.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.079 0.466 . . . . 0.0 111.512 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.5 OUTLIER -53.97 94.58 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.507 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -111.69 -166.46 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 111.652 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.82 163.04 29.94 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.426 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 35.5 Cg_endo -63.48 168.17 11.86 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.525 2.816 . . . . 0.0 112.003 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.32 58.83 0.77 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.927 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -120.95 138.57 12.74 Favored Glycine 0 C--N 1.313 -0.701 0 CA-C-N 114.756 -0.722 . . . . 0.0 111.974 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 2.7 ttpm? 92.45 6.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.981 0.513 . . . . 0.0 112.047 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.051 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -55.82 -27.14 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.49 0.662 . . . . 0.0 110.533 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.2 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.039 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.9 mmm 37.92 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.438 0.461 . . . . 0.0 111.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.76 32.71 0.12 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt-10 -89.68 -175.02 4.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.782 0.325 . . . . 0.0 111.244 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.896 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.45 155.18 36.67 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.896 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.9 Cg_endo -44.62 -24.91 1.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.819 2.346 . . . . 0.0 112.593 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.2 mt-10 -104.09 -41.66 5.77 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.4 mm-40 -79.04 -19.21 51.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.007 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.41 -47.73 82.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.654 0.264 . . . . 0.0 111.303 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.838 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.11 -45.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.883 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.8 t -53.95 -36.94 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.65 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.38 -52.02 9.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 1.4 mm-40 -64.79 -22.93 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.981 HD11 ' CE1' ' A' ' 64' ' ' HIS . 6.2 tp -54.46 -44.81 72.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.812 0.339 . . . . 0.0 110.736 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.76 -28.38 68.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.27 -25.34 51.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.179 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 6.9 mm-40 -108.52 0.95 21.17 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.988 HG12 HG13 ' A' ' 60' ' ' ILE . 2.1 t -134.79 -44.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 109.786 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -33.91 0.29 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.906 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.988 HG13 HG12 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -77.69 -175.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.88 0.371 . . . . 0.0 111.084 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.23 89.02 13.52 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.209 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.643 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.8 Cg_endo -109.55 145.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.308 2.672 . . . . 0.0 114.104 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 70.6 mt-30 -74.74 79.93 2.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.981 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.32 136.93 54.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.252 -175.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.5 t80 179.16 -144.71 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 57.02 157.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.336 0.589 . . . . 0.0 112.536 178.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.0 tt -121.33 108.69 14.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.923 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -41.95 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.518 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.6 tt0 -171.25 160.28 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.3 131.41 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.556 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.643 ' HB2' HG22 ' A' ' 122' ' ' VAL . 5.6 tp -122.73 137.13 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -125.82 109.8 12.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.4 153.1 47.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.22 132.7 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 111.482 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.9 162.95 21.24 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.012 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_endo -46.31 80.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.194 2.596 . . . . 0.0 112.58 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t0 85.7 11.85 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.786 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.441 ' CG ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -137.35 97.25 3.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.661 0.267 . . . . 0.0 111.148 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.0 OUTLIER -74.9 106.56 6.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.951 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.624 HD12 HD11 ' A' ' 4' ' ' LEU . 1.4 tt -102.11 116.43 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.051 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.32 132.49 49.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -126.14 114.61 18.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.064 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -106.47 123.84 48.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.23 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 2.0 m-85 -105.93 109.9 22.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.675 ' NE1' HG11 ' A' ' 50' ' ' VAL . 19.4 m95 -97.27 149.36 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.444 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.4 tp -99.89 102.84 14.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.253 0.549 . . . . 0.0 111.914 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.82 HG13 ' CB ' ' A' ' 64' ' ' HIS . 12.2 t -84.12 146.16 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.124 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.55 -26.47 8.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 5.4 ttp180 -162.78 159.8 24.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.885 0.766 . . . . 0.0 111.73 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.725 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -152.18 125.89 8.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.329 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -74.37 146.04 43.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.958 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.47 -119.24 14.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.558 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 tt0 -135.07 145.77 55.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.571 0.224 . . . . 0.0 110.792 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 3.7 Cg_exo -76.44 128.84 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.847 2.364 . . . . 0.0 111.241 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.578 ' NE1' HG23 ' A' ' 60' ' ' ILE . 42.2 p-90 -130.42 -64.25 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.43 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . 49.13 -107.68 0.32 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.477 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 164.45 67.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.389 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.408 ' OE1' ' CB ' ' A' ' 21' ' ' THR . 2.3 pt-20 -86.36 -37.4 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.07 -6.67 10.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.507 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HB2' ' HG1' ' A' ' 21' ' ' THR . 1.2 mp0 -140.06 97.03 7.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.134 0.467 . . . . 0.0 111.483 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -43.79 145.64 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 112.586 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.34 177.11 19.43 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.964 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.82 157.43 45.41 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -70.3 106.65 3.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.307 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -120.06 163.62 17.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 93.3 p -89.01 127.97 35.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 18' ' ' ILE . 5.1 tp -78.48 -18.9 54.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.6 t -48.93 -24.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.38 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.72 39.64 2.37 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.95 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.769 HD13 HD21 ' A' ' 126' ' ' LEU . 4.1 tt -62.71 140.03 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.756 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -123.1 134.5 54.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.615 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.37 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.278 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.0 -49.15 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -36.28 81.91 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.239 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.7 172.66 8.99 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.273 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.48 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 60.5 Cg_endo -72.77 127.76 12.64 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.139 1.893 . . . . 0.0 111.526 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.27 -14.75 31.01 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.701 2.267 . . . . 0.0 113.28 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.74 -9.73 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -130.62 42.37 3.26 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.725 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.424 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.43 -49.74 5.01 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.4 Cg_exo -44.94 -33.95 8.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.461 2.107 . . . . 0.0 112.591 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' ' 71' ' ' LEU . 14.0 t -77.35 -48.72 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.427 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.704 HG22 ' HB2' ' A' ' 127' ' ' LYS . 8.7 mm -66.33 -31.93 55.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.719 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.66 -26.87 36.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.932 0.396 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -53.17 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.864 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.24 -29.66 48.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.694 0.283 . . . . 0.0 111.47 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.843 ' N ' HD23 ' A' ' 126' ' ' LEU . 24.7 ttpp -55.17 -42.52 73.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.17 0.509 . . . . 0.0 110.74 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -65.13 -11.65 42.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.585 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.2 mp . . . . . 0 C--O 1.231 0.1 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.055 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.8 0.333 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 145.5 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.744 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.5 pp -146.01 128.33 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 13.9 mt-30 -106.95 153.3 22.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 112.029 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.744 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.3 mp -146.44 131.37 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.836 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.058 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.28 124.75 43.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -121.25 162.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 111.904 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 113.31 0.58 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.559 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.891 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.91 105.8 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.716 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -70.97 122.17 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.28 -178.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -93.17 127.72 38.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.342 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 2.5 t-20 -75.33 -172.09 1.65 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 122.219 1.009 . . . . 0.0 113.107 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.04 -17.81 41.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.859 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -120.33 -82.39 0.65 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.724 0.297 . . . . 0.0 111.559 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -158.8 16.05 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.677 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HG2' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -100.91 155.14 18.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.891 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -124.34 144.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.327 0.584 . . . . 0.0 111.957 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.412 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 59.6 t80 -83.65 90.17 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.584 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.885 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -104.44 162.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.298 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.435 HG22 ' OE1' ' A' ' 98' ' ' GLU . 5.5 p . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.845 0.355 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.41 26.22 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.388 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 16.2 tp -69.18 63.88 0.14 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.807 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -177.65 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.53 162.9 30.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.648 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 28.3 Cg_endo -60.94 167.99 7.96 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.538 2.826 . . . . 0.0 111.857 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.28 59.07 0.77 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.255 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.76 121.43 3.43 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.978 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.45 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.306 0.642 . . . . 0.0 111.866 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.058 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -53.81 -27.98 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.541 0.686 . . . . 0.0 110.683 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.599 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.72 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.427 ' HE3' ' HD3' ' A' ' 39' ' ' LYS . 2.4 mmt 34.96 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.362 0.414 . . . . 0.0 111.755 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.77 30.16 0.16 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.452 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.9 mp0 -93.59 -176.6 4.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.733 0.301 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.946 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.84 158.94 33.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.202 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.946 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.76 -24.66 0.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.839 2.359 . . . . 0.0 112.525 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -89.86 -60.58 1.9 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -4.84 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.904 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -63.14 -55.29 26.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 111.103 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.739 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -78.25 -45.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.904 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.473 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 58.0 t -55.52 -36.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.37 -49.1 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 40' ' ' ILE . 22.0 tp10 -68.31 -22.6 64.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.212 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -56.52 -45.04 81.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 0.0 110.659 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -27.12 68.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.43 -30.63 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.279 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -109.08 5.78 24.37 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.015 HG12 HG13 ' A' ' 60' ' ' ILE . 2.6 t -134.02 -44.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.26 0.552 . . . . 0.0 110.24 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.586 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.55 7.02 1.25 Allowed Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 114.563 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.015 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -115.39 -172.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 117.902 0.851 . . . . 0.0 110.033 179.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 p -114.45 87.59 14.21 Favored Pre-proline 0 N--CA 1.438 -1.074 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.537 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.647 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.4 Cg_endo -113.95 142.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.631 2.887 . . . . 0.0 113.598 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 8.8 mt-30 -74.87 79.94 2.12 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.042 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.15 129.12 53.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.407 -175.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -176.44 -141.69 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.07 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.73 159.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.334 0.588 . . . . 0.0 112.053 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' A' ' 70' ' ' LYS . 5.4 tt -122.18 113.0 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.318 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.44 -48.32 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.093 0.473 . . . . 0.0 110.017 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.39 166.31 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.216 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.34 132.02 22.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.809 0.338 . . . . 0.0 110.977 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.696 ' HB2' HG22 ' A' ' 122' ' ' VAL . 18.2 tp -113.78 120.77 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.64 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.68 109.93 16.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.86 146.46 37.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.717 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.14 120.13 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.072 0.463 . . . . 0.0 111.278 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -69.95 163.18 63.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.505 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -51.76 83.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.024 2.483 . . . . 0.0 112.058 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 26.2 m-20 95.59 15.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.323 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD3' HD21 ' A' ' 4' ' ' LEU . 9.8 ttm180 -137.38 150.17 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.526 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 5.5 t-160 -124.9 94.1 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.9 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -99.0 118.21 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.95 127.12 55.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.741 HD13 ' ND2' ' A' ' 119' ' ' ASN . 5.4 mt -126.28 114.71 18.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.074 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.544 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -106.32 123.02 47.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.553 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 m-30 -99.72 116.07 30.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.664 ' CE2' HG11 ' A' ' 50' ' ' VAL . 24.3 m95 -100.59 149.18 24.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.257 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tm? -103.04 103.14 13.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.365 0.602 . . . . 0.0 112.04 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.042 HG22 ' ND1' ' A' ' 64' ' ' HIS . 22.2 t -81.01 145.87 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.095 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 1.9 pm0 -119.63 -14.53 9.07 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.601 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 11.3 tpp85 -162.9 154.91 18.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.611 0.641 . . . . 0.0 111.523 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.716 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.55 120.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.539 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.65 144.28 37.53 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 -124.57 36.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.201 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 45.4 mt-10 -135.11 143.08 44.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.519 0.199 . . . . 0.0 110.992 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.548 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.6 Cg_exo -75.92 128.77 11.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.041 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 62.9 p-90 -129.72 -59.85 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.471 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 43.73 -96.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.795 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 175.65 35.98 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.677 0.275 . . . . 0.0 110.999 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 21' ' ' THR . 9.0 pt-20 -55.09 -38.22 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.685 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.1 58.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.43 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -140.13 97.02 7.9 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.087 0.443 . . . . 0.0 111.384 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.56 143.03 2.8 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.078 2.519 . . . . 0.0 112.828 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.27 19.31 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.851 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -142.89 157.38 44.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.326 -0.249 . . . . 0.0 110.326 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.64 105.84 5.92 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.4 ptm -120.75 163.15 18.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.857 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.647 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -78.04 114.83 17.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 110.543 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.862 HD11 HD12 ' A' ' 110' ' ' LEU . 11.3 tp -70.34 -18.86 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.342 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.737 ' CG2' HD21 ' A' ' 129' ' ' LEU . 11.0 p -53.42 -19.25 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.486 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.67 49.73 0.91 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.971 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.862 HD12 HD11 ' A' ' 107' ' ' LEU . 9.2 tt -62.18 150.3 39.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.665 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.425 ' N ' HD23 ' A' ' 110' ' ' LEU . 4.3 t-20 -106.86 104.14 13.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.535 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.81 61.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.077 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.29 -43.42 23.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.982 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -1.87 31.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.201 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.571 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -117.53 170.55 6.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.1 Cg_endo -54.4 127.88 27.78 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.099 1.866 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.94 -20.41 45.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.612 2.208 . . . . 0.0 112.452 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.77 51.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.741 ' ND2' HD13 ' A' ' 82' ' ' LEU . 1.5 m-20 -114.71 -2.36 13.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.399 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -47.84 -48.29 61.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.519 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.9 Cg_exo -44.95 -34.88 9.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.27 1.98 . . . . 0.0 112.28 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.29 -51.14 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.618 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.588 HG22 ' HB2' ' A' ' 127' ' ' LYS . 41.8 mm -64.89 -33.5 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.996 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . . . -54.83 -27.04 39.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 111.073 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.19 -52.47 8.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.632 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 126' ' ' LEU . 1.3 tm? -78.19 -30.14 48.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.509 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 123' ' ' ILE . 42.2 tttm -56.69 -42.8 79.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 111.017 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -66.67 -10.09 42.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.721 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.737 HD21 ' CG2' ' A' ' 108' ' ' VAL . 8.0 mp . . . . . 0 C--O 1.231 0.113 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.004 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.786 0.327 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 132.52 43.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' A' ' 80' ' ' ILE . 3.4 pp -128.29 123.2 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.55 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.0 mt-30 -102.46 152.13 21.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.486 0.66 . . . . 0.0 112.0 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.1 pt -146.56 134.72 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.836 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.4 124.29 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -120.51 160.44 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.249 0.547 . . . . 0.0 111.661 -179.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.53 115.29 0.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.645 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.967 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.78 109.33 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -70.78 120.23 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.048 -178.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.711 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.34 118.25 23.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.696 -179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.457 ' CA ' ' CZ3' ' A' ' 90' ' ' TRP . 20.3 t30 -76.09 -172.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.873 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.57 3.89 30.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.315 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -139.22 51.28 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.524 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.09 22.83 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.659 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.763 ' C ' HD12 ' A' ' 18' ' ' ILE . 17.6 mt-10 -117.38 153.29 33.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.967 HG21 HG22 ' A' ' 10' ' ' ILE . 1.4 mp -117.0 143.4 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.963 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 44.7 t80 -87.98 92.84 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.12 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.52 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.62 159.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.741 ' O ' HD12 ' A' ' 33' ' ' LEU . 13.1 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.526 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.638 0.256 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.34 26.24 10.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.733 0.301 . . . . 0.0 111.593 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 21' ' ' THR . 22.2 tp -59.63 76.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.735 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -106.86 -172.65 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 111.679 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.733 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.6 160.56 41.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.901 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.642 ' HG3' HD11 ' A' ' 11' ' ' ILE . 36.7 Cg_endo -64.2 168.41 12.59 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.594 2.863 . . . . 0.0 111.657 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 59.5 0.74 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.037 -1.077 . . . . 0.0 114.082 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -126.92 117.39 2.73 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.655 -0.772 . . . . 0.0 112.039 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 121.62 4.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.395 0.678 . . . . 0.0 111.678 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.034 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -58.7 -26.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.444 0.64 . . . . 0.0 110.753 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.99 -83.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.332 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 33.45 -85.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.465 0.478 . . . . 0.0 111.889 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.46 34.05 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.516 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.462 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -88.18 -173.94 4.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.797 0.332 . . . . 0.0 111.231 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.889 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.2 154.6 37.61 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.396 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.889 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.11 -26.21 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.89 2.393 . . . . 0.0 112.458 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -104.19 -39.35 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.779 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -80.23 -12.61 59.61 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.924 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.2 -52.95 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 111.196 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.15 -43.84 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -53.66 -39.42 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.528 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.35 -52.02 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -67.19 -22.26 65.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.686 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -54.33 -44.44 72.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.205 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -33.88 71.92 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.68 -25.79 49.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.358 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.422 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.1 mp0 -108.69 6.1 25.45 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 60' ' ' ILE . 15.3 t -134.14 -44.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.166 0.507 . . . . 0.0 110.26 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.27 3.55 1.42 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.705 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.963 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.88 -173.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 117.999 0.9 . . . . 0.0 110.431 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.5 p -114.21 87.59 13.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.607 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -115.25 145.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.578 2.852 . . . . 0.0 114.217 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.84 79.94 2.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.997 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.6 131.67 54.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.018 -175.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -178.92 -140.97 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 58.26 158.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.248 0.547 . . . . 0.0 112.116 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -120.97 110.69 16.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.296 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.59 -46.3 26.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.182 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.53 157.49 4.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.269 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 115.34 8.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.836 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.575 ' CB ' HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -109.19 136.55 48.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.594 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -130.44 115.54 16.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -135.47 147.66 48.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.633 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 4.8 pt-20 -120.07 127.06 52.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.105 0.479 . . . . 0.0 111.284 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.06 163.51 59.65 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.1 Cg_endo -53.8 82.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.992 2.461 . . . . 0.0 112.404 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER 101.57 11.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.959 0.904 . . . . 0.0 111.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.29 150.01 47.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.773 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 4.6 m170 -124.0 101.53 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.534 ' CG1' HD11 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -100.64 128.31 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.75 118.94 28.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.665 ' CD1' HG21 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -126.15 115.17 19.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.439 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.565 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -106.81 122.87 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.509 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CD2' HG11 ' A' ' 122' ' ' VAL . 7.3 m-30 -98.61 119.03 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.095 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.697 ' NE1' HG11 ' A' ' 50' ' ' VAL . 21.4 m95 -101.25 149.2 24.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.538 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.2 tm? -102.49 102.91 13.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.441 0.639 . . . . 0.0 112.053 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' ND1' ' A' ' 64' ' ' HIS . 17.0 t -80.19 146.0 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.027 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.71 -23.24 9.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.25 160.05 26.4 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.873 0.761 . . . . 0.0 111.606 -178.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.668 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -156.92 124.3 5.31 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.381 179.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -82.78 127.6 33.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.52 -125.18 6.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.324 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 69.4 mt-10 -135.08 138.43 29.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.625 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.11 128.74 10.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.76 2.307 . . . . 0.0 111.132 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.582 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.3 p-90 -135.5 -57.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.268 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 46.77 -94.29 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.868 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -178.87 34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.687 0.28 . . . . 0.0 111.156 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.29 -34.9 78.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.889 0.376 . . . . 0.0 110.412 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.26 68.57 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.342 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -140.28 95.95 8.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.6 133.44 7.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.989 2.459 . . . . 0.0 112.789 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.33 177.44 19.18 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.762 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -147.55 157.05 43.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.68 106.29 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 22.0 ptm -120.38 150.96 39.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.1 p -70.59 114.65 8.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.752 ' HB2' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -65.16 -21.54 66.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.89 -17.79 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.509 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.42 35.04 4.95 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.816 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 107' ' ' LEU . 12.6 tp -62.5 125.7 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 139.5 54.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -15.76 61.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.395 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.94 -48.56 14.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.472 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -40.38 88.13 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.626 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.99 174.17 6.53 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.1 Cg_endo -76.18 130.26 11.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.263 1.975 . . . . 0.0 111.457 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.76 -14.5 17.87 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.886 2.391 . . . . 0.0 113.556 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -10.57 13.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.527 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.7 m-20 -134.99 45.43 2.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.765 0.317 . . . . 0.0 111.553 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.09 -49.38 7.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.2 Cg_exo -44.89 -36.74 11.33 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.455 2.103 . . . . 0.0 112.871 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.742 HG11 ' CD2' ' A' ' 84' ' ' PHE . 20.3 t -77.46 -51.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.984 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.586 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 10.7 mm -65.36 -32.1 56.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.8 -27.9 45.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.997 0.427 . . . . 0.0 110.725 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -48.49 13.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.509 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.0 tm? -78.04 -28.87 49.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.476 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.468 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.0 ttpp -55.5 -42.64 74.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -69.96 -7.72 42.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.804 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.216 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 tptt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.837 0.351 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -113.98 145.16 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.679 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.09 122.15 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -102.37 154.0 19.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.336 0.588 . . . . 0.0 111.869 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.4 mp -146.12 130.93 11.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.74 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.39 124.29 42.02 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -114.63 162.17 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.421 0.629 . . . . 0.0 111.913 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.54 106.01 0.43 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.985 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.831 HG23 ' CG1' ' A' ' 18' ' ' ILE . 2.8 mp -70.29 100.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.694 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.14 126.51 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -96.42 140.61 30.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.504 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.554 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -107.88 -172.39 2.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.89 0.853 . . . . 0.0 112.666 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.26 -18.26 63.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.259 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.15 39.12 2.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.885 0.374 . . . . 0.0 110.891 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.17 28.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.556 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -106.6 145.42 31.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.328 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.831 ' CG1' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -106.7 127.19 62.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 0.0 111.872 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.73 ' N ' HD12 ' A' ' 18' ' ' ILE . 51.0 t80 -78.09 87.49 4.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.753 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.702 HD11 ' SD ' ' A' ' 105' ' ' MET . 1.2 pt -112.79 162.29 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 100' ' ' GLN . 14.2 p . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t30 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.57 0.224 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.28 26.16 10.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.89 0.376 . . . . 0.0 111.3 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 33' ' ' LEU . 6.6 tt -39.58 93.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.307 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.1 tt0 -120.62 -168.88 1.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.164 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.75 158.16 50.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.531 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 18.0 Cg_endo -58.17 167.83 4.23 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.513 2.809 . . . . 0.0 111.496 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.56 59.24 0.75 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.692 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.626 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -125.15 120.7 4.02 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 114.447 -0.876 . . . . 0.0 112.026 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.55 5.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.329 0.652 . . . . 0.0 111.751 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.8 -26.03 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.486 0.66 . . . . 0.0 110.733 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.543 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.31 -82.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.185 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 33.67 -86.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.507 0.504 . . . . 0.0 111.86 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.24 31.87 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.503 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.99 -175.64 4.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.809 0.338 . . . . 0.0 111.16 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.921 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.04 159.58 28.84 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.463 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.921 ' HD2' HG22 ' A' ' 45' ' ' THR . 7.0 Cg_endo -47.79 -24.44 4.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.468 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -97.8 -47.45 5.57 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 4.8 mm-40 -80.13 -25.57 39.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.939 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -55.63 -47.54 76.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.809 0.337 . . . . 0.0 110.988 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.839 HG12 ' HB1' ' A' ' 7' ' ' ALA . 2.8 m -78.14 -45.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.7 t -62.58 -35.79 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.449 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -78.31 -41.68 33.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.458 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.641 ' CB ' HG22 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -78.13 -26.23 47.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.318 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.961 HD23 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -57.57 -45.11 85.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.572 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -26.85 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.311 0.577 . . . . 0.0 109.489 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.11 -26.76 53.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.117 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -108.32 5.16 25.29 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 54' ' ' LEU . 1.3 t -134.78 -44.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.282 0.563 . . . . 0.0 109.603 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.6 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 59.78 0.48 1.0 Allowed Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.412 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.881 ' CG1' HG12 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -105.51 -173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.605 0.702 . . . . 0.0 110.375 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -114.55 88.04 15.28 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.374 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.574 ' HG2' ' HB3' ' A' ' 64' ' ' HIS . 98.3 Cg_endo -112.11 152.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.927 3.084 . . . . 0.0 113.478 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.423 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 35.5 mt-30 -74.76 78.67 2.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.961 ' CD2' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -111.19 120.25 41.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.555 -1.657 . . . . 0.0 112.089 -174.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -178.55 -148.19 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.99 161.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.163 0.506 . . . . 0.0 112.006 179.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -125.31 116.98 22.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -76.54 -56.55 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 109.924 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mt-10 -172.05 131.66 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.171 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -117.38 132.01 56.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.603 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -117.78 134.67 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.4 109.87 15.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -126.24 153.05 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.522 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.09 133.91 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.52 . . . . 0.0 111.412 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -96.6 162.92 21.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.146 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 5.7 Cg_endo -47.6 80.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.166 2.577 . . . . 0.0 112.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' PHE . 5.0 t0 86.45 12.73 0.15 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.641 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.41 94.82 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.733 0.302 . . . . 0.0 111.112 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.426 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -74.84 109.31 8.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.751 0.31 . . . . 0.0 110.844 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -106.99 111.97 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.029 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.55 125.71 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 71' ' ' LEU . 1.1 pp -126.45 114.88 18.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.69 0.281 . . . . 0.0 111.467 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -108.54 122.76 47.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 9.8 m-30 -101.67 121.0 41.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 111.086 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.758 ' NE1' HG11 ' A' ' 50' ' ' VAL . 19.5 m95 -101.64 149.23 24.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 65' ' ' PHE . 26.1 tp -100.18 103.44 14.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.914 HG13 ' HA ' ' A' ' 64' ' ' HIS . 10.3 t -86.29 145.29 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.03 -32.83 9.51 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.26 165.5 26.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.49 0.586 . . . . 0.0 111.59 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.694 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -152.04 128.71 10.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.554 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -77.0 135.18 38.67 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.85 -125.84 20.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.431 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.4 tt0 -132.92 143.22 47.68 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.527 0.203 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.668 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.7 Cg_exo -76.27 128.86 10.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.83 2.353 . . . . 0.0 111.408 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.6 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -125.36 -61.26 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.179 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.26 -103.64 0.04 OUTLIER Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.04 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.27 38.39 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.556 0.217 . . . . 0.0 111.093 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.48 -41.73 73.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 110.79 -19.63 25.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.143 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.604 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -126.54 99.14 30.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.036 0.446 . . . . 0.0 111.477 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.62 146.43 1.39 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.172 2.581 . . . . 0.0 112.663 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.12 177.39 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.758 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -143.21 157.17 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -74.08 106.39 5.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.702 ' SD ' HD11 ' A' ' 20' ' ' ILE . 4.1 ptm -120.42 163.0 18.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.95 114.89 23.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.814 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -64.32 -18.96 65.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.713 ' O ' HD21 ' A' ' 129' ' ' LEU . 12.0 p -54.44 -20.46 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.682 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.74 42.57 1.43 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.222 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.583 HD12 HD21 ' A' ' 107' ' ' LEU . 8.0 tt -62.94 150.29 42.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.806 0.303 . . . . 0.0 110.204 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -122.88 131.16 53.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -14.84 61.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -49.22 13.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.18 -38.82 86.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.887 0.375 . . . . 0.0 111.07 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.81 174.4 6.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 71.6 Cg_endo -75.21 127.76 10.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.176 1.917 . . . . 0.0 111.489 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.71 -15.0 39.31 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.667 2.245 . . . . 0.0 113.049 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.52 -9.76 57.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.583 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -122.64 28.67 7.22 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -70.64 -39.72 9.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -53.5 -42.19 67.57 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.988 1.792 . . . . 0.0 112.308 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -77.43 -51.36 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.423 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.31 -29.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.961 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -34.3 64.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 110.432 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.17 -49.63 66.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.91 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' A' ' 68' ' ' PHE . 9.2 tp -78.19 -28.63 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.618 ' O ' HD12 ' A' ' 129' ' ' LEU . 17.2 tttt -57.08 -42.67 81.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.998 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -72.72 -5.09 35.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.983 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 108' ' ' VAL . 3.7 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.847 0.355 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 136.26 54.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.41 128.49 20.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.48 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.2 mt-30 -102.45 154.16 19.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.331 0.586 . . . . 0.0 111.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.434 ' HB ' HD23 ' A' ' 82' ' ' LEU . 38.2 mm -146.31 129.39 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.892 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.5 42.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.578 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.13 161.95 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.445 0.64 . . . . 0.0 111.972 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.04 121.43 1.19 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.642 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.486 ' HB ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -73.77 108.85 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.719 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.26 127.79 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 0.0 111.709 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.09 131.67 43.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.123 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.771 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p-10 -87.8 -173.04 4.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.357 0.599 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 22.1 tt0 -73.54 6.29 3.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.391 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 21.5 t-20 -130.33 45.06 2.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.048 -0.407 . . . . 0.0 112.052 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.9 p30 46.92 25.48 0.47 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.918 0.39 . . . . 0.0 111.369 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.509 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.53 161.61 18.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.661 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.3 144.37 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.058 0.456 . . . . 0.0 111.88 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.98 102.66 14.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.423 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.01 162.14 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.334 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.937 HG22 ' O ' ' A' ' 34' ' ' GLU . 10.1 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t-20 . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.33 26.35 10.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 114' ' ' ASP . 2.2 tt -52.55 84.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.766 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.937 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -123.15 176.5 6.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.177 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.81 166.43 14.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 0.0 112.075 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.4 Cg_endo -47.44 168.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.924 3.083 . . . . 0.0 112.628 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.64 59.46 0.75 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.099 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.68 112.09 1.15 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 114.262 -0.969 . . . . 0.0 112.045 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.02 6.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.4 0.68 . . . . 0.0 111.853 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.013 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -55.06 -27.59 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.271 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.9 -80.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.206 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.3 mmm 38.64 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.355 0.41 . . . . 0.0 111.662 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.68 33.79 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.67 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.492 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -96.94 -170.26 2.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.65 0.262 . . . . 0.0 111.019 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.924 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.9 159.04 30.68 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.287 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.924 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.91 -24.66 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.777 2.318 . . . . 0.0 112.5 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -92.91 -58.1 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 8.0 pt20 -80.66 -4.88 55.9 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.795 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -63.16 -57.27 11.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 111.013 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.617 HG22 HD13 ' A' ' 54' ' ' LEU . 1.4 p -78.78 -42.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.77 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.3 t -50.65 -35.65 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.203 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -78.21 -52.12 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.685 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -62.17 -20.09 63.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.625 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.9 HD11 ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -57.46 -44.67 85.0 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.93 -27.6 68.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.914 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.19 -30.4 54.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.282 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.49 6.4 26.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.912 HG12 HG13 ' A' ' 60' ' ' ILE . 43.4 t -133.43 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.78 -40.17 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.006 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.912 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.53 -177.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.06 0.457 . . . . 0.0 111.112 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.71 88.72 14.29 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.738 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.0 Cg_endo -111.55 146.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.404 2.736 . . . . 0.0 114.211 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.1 mt-30 -74.85 79.73 2.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.951 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.21 128.45 52.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.058 -176.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.11 -139.53 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.622 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.45 158.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.12 0.486 . . . . 0.0 111.85 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.594 HD21 ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -121.07 109.89 15.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.577 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.75 -43.39 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.977 0.418 . . . . 0.0 110.139 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt-10 -171.3 166.02 7.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.516 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.17 132.12 22.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 tp -117.4 124.55 49.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -122.28 110.16 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.649 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -140.67 153.16 45.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.686 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.25 140.22 48.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.296 0.569 . . . . 0.0 111.284 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.33 163.85 16.64 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.534 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 53.8 Cg_exo -41.58 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.534 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.3 t0 73.56 20.67 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.597 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttt180 -137.31 93.87 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.317 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.54 98.61 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 110.94 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.62 111.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.98 133.83 43.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.771 HD13 HD21 ' A' ' 119' ' ' ASN . 32.1 mt -126.22 114.36 18.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.489 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.14 122.7 48.23 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.6 125.2 50.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.53 ' CE2' HG11 ' A' ' 50' ' ' VAL . 67.5 m95 -107.57 148.56 29.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.2 tp -98.97 103.01 14.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.326 0.584 . . . . 0.0 111.261 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.951 HG22 ' ND1' ' A' ' 64' ' ' HIS . 13.3 t -81.84 145.61 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.845 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.63 -35.34 6.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.56 165.66 25.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.843 0.747 . . . . 0.0 112.014 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.771 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.5 p90 -151.02 130.76 13.16 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.6 139.67 40.73 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.43 -121.84 23.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.8 mt-10 -131.94 145.59 58.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.558 0.218 . . . . 0.0 110.835 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.63 128.71 10.4 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.841 2.361 . . . . 0.0 111.363 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.564 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.6 p-90 -133.34 -60.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.133 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.05 -100.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.001 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.56 32.85 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.3 pt-20 -64.79 -27.04 68.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.35 . . . . 0.0 110.688 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.14 31.6 81.28 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.729 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 5.9 mm-40 -140.42 91.96 9.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.045 0.45 . . . . 0.0 111.253 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -43.6 126.51 5.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.025 2.483 . . . . 0.0 112.854 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 177.2 19.35 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.762 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.34 157.16 42.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -68.83 106.28 2.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.047 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.9 ptm -120.39 147.41 45.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.697 ' HB2' HG12 ' A' ' 108' ' ' VAL . 77.0 p -70.76 115.08 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.661 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -62.03 -18.65 61.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.909 ' HA ' HD21 ' A' ' 129' ' ' LEU . 12.1 p -59.02 -9.94 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.783 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.13 50.36 0.89 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.164 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.75 HD13 ' N ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -62.11 142.27 57.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 110.404 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.75 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -119.2 114.77 22.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.27 61.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.242 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.94 -49.11 13.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.741 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -68.44 -33.43 74.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.768 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.06 174.03 6.63 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.406 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 64.4 Cg_endo -74.23 127.78 11.54 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.134 1.889 . . . . 0.0 111.387 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.86 -14.85 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.742 2.295 . . . . 0.0 113.285 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.4 -9.82 37.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.771 HD21 HD13 ' A' ' 82' ' ' LEU . 1.3 m-20 -130.16 37.82 3.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -72.19 -43.99 10.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -54.78 -38.96 91.76 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.106 1.871 . . . . 0.0 112.169 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 69' ' ' GLU . 2.2 t -77.45 -51.31 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.01 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.522 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.36 -29.85 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.72 -31.06 57.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.393 . . . . 0.0 110.443 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -69.62 -52.43 25.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.705 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.7 tp -78.21 -19.53 53.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.585 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.41 -42.62 64.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.892 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -76.02 -3.65 36.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.131 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.841 0.353 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 132.76 56.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -138.38 128.06 25.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.3 mt-30 -102.48 154.19 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.275 0.559 . . . . 0.0 111.792 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.519 ' HB ' HD23 ' A' ' 82' ' ' LEU . 37.9 mm -146.33 129.04 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.923 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.54 42.41 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.43 162.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.339 0.59 . . . . 0.0 111.893 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.95 120.85 1.12 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.688 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.76 108.94 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.726 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.32 127.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.796 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.03 132.37 42.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.081 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.768 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.7 p-10 -88.95 -173.01 3.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 111.931 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 23.1 tt0 -73.29 5.8 3.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.391 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 19.7 t-20 -129.92 44.93 2.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.982 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.7 p30 46.76 25.61 0.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.427 . . . . 0.0 111.396 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.42 161.62 18.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.666 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.55 144.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.032 0.444 . . . . 0.0 111.828 -178.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.48 102.18 13.96 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.099 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.14 162.08 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.362 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.933 HG22 ' O ' ' A' ' 34' ' ' GLU . 11.0 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.981 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.8 t-20 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.551 0.215 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -114.41 26.32 10.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.744 HD12 ' HB3' ' A' ' 114' ' ' ASP . 2.2 tt -52.66 84.71 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.752 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.933 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -124.03 176.72 6.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.76 166.25 15.37 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.062 0.458 . . . . 0.0 112.014 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.5 Cg_endo -47.62 168.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.85 3.033 . . . . 0.0 112.527 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.54 59.47 0.75 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.112 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.84 110.33 0.95 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.252 -0.974 . . . . 0.0 112.039 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.627 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 118.14 4.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.344 0.658 . . . . 0.0 111.734 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.013 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.65 -27.91 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.561 0.696 . . . . 0.0 110.343 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.54 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.26 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 78.4 mmm 39.13 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.304 0.377 . . . . 0.0 111.586 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.67 33.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.702 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.494 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -96.92 -170.15 1.99 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.555 0.217 . . . . 0.0 111.055 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.915 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.55 158.97 30.85 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.915 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.88 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.902 2.402 . . . . 0.0 112.496 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -92.66 -58.29 2.4 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -80.72 -4.78 55.68 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.785 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.85 -57.24 11.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.792 0.329 . . . . 0.0 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.629 HG22 HD13 ' A' ' 54' ' ' LEU . 1.4 p -78.76 -42.75 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.783 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.2 t -50.66 -35.55 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.225 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -52.15 9.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.926 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.0 mm-40 -63.34 -19.84 64.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.693 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.923 HD11 ' HE2' ' A' ' 64' ' ' HIS . 2.7 tp -56.76 -44.68 82.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.071 0.462 . . . . 0.0 110.541 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.73 -27.02 68.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.899 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.2 tm-20 -77.2 -30.63 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.23 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.448 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.44 6.69 26.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.914 HG12 HG13 ' A' ' 60' ' ' ILE . 43.8 t -133.48 -44.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -40.1 0.25 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.951 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.914 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.46 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.014 0.435 . . . . 0.0 111.095 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.55 88.7 13.85 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.996 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.742 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.8 Cg_endo -111.48 146.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 123.394 2.729 . . . . 0.0 114.219 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.8 mt-30 -74.74 79.64 2.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.956 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.94 128.64 52.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.006 -176.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.04 -139.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.587 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.83 157.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.099 0.476 . . . . 0.0 111.86 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.558 HD21 ' HD3' ' A' ' 70' ' ' LYS . 5.3 tt -119.71 109.44 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.79 -43.54 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.151 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 2.7 mt-10 -171.24 165.66 7.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.624 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.15 132.11 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 tp -116.89 123.75 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -121.5 109.99 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.638 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -140.89 153.25 45.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -114.22 140.2 48.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.273 0.558 . . . . 0.0 111.307 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.75 163.84 16.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.475 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 54.1 Cg_exo -41.36 81.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.338 2.692 . . . . 0.0 112.554 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.6 t0 73.62 20.48 3.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.607 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 7.5 ttt180 -137.23 93.92 2.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.6 98.82 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 110.942 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.64 111.87 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.52 133.76 44.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.787 HD13 HD21 ' A' ' 119' ' ' ASN . 35.1 mt -126.16 114.39 18.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.453 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.08 122.66 48.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.46 125.73 51.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.348 . . . . 0.0 111.269 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.551 ' HE1' ' HB1' ' A' ' 7' ' ' ALA . 67.6 m95 -107.86 148.5 29.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.7 tp -98.74 102.81 14.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 111.332 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.956 HG22 ' ND1' ' A' ' 64' ' ' HIS . 13.9 t -81.5 145.65 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -109.53 -35.17 6.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.44 165.64 26.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.845 0.748 . . . . 0.0 112.017 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.768 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.4 p90 -151.47 130.54 12.63 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.572 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -76.35 140.87 41.62 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.16 -121.94 25.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.468 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.7 mt-10 -131.84 145.81 59.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.536 0.208 . . . . 0.0 110.779 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.72 128.76 10.36 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.836 2.357 . . . . 0.0 111.362 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.8 p-90 -133.51 -60.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.124 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.84 -99.66 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.02 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.46 33.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.554 0.216 . . . . 0.0 111.278 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.8 pt-20 -65.57 -26.81 68.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 0.0 110.608 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.54 32.04 82.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.836 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 6.5 mm-40 -140.38 92.2 9.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 111.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -43.57 126.37 5.38 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.091 2.527 . . . . 0.0 112.817 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.27 177.17 19.37 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.853 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.92 157.14 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -69.01 106.23 2.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.887 0.375 . . . . 0.0 110.031 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 9.6 ptm -120.47 148.12 44.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.036 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.686 ' HB2' HG12 ' A' ' 108' ' ' VAL . 77.4 p -70.89 114.97 9.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.058 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.666 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -61.41 -18.7 60.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.909 ' HA ' HD21 ' A' ' 129' ' ' LEU . 11.9 p -59.3 -9.63 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.836 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.45 49.62 0.92 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.276 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -62.22 142.11 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 110.42 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.734 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -120.04 115.87 24.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.16 61.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.211 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -49.03 13.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.744 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -68.39 -33.51 74.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.76 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.14 174.02 6.64 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.394 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.47 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.5 Cg_endo -73.95 127.81 11.78 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.107 1.871 . . . . 0.0 111.363 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.02 -14.83 30.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.738 2.292 . . . . 0.0 113.266 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -9.75 39.58 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.787 HD21 HD13 ' A' ' 82' ' ' LEU . 1.3 m-20 -130.07 37.82 3.86 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.84 -43.87 11.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.2 Cg_exo -54.76 -38.92 91.62 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.134 1.889 . . . . 0.0 112.244 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.434 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 2.3 t -77.55 -51.31 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.036 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.526 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.41 -29.87 47.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.027 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.66 -30.95 56.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.987 0.422 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -69.8 -52.52 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.868 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.695 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.9 tp -78.16 -19.52 53.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.23 -42.74 65.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.114 0.483 . . . . 0.0 110.882 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -75.58 -3.92 37.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.176 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttp . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 121.94 19.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.51 125.99 54.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.761 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 10.8 mt-30 -102.95 160.05 14.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.09 0.472 . . . . 0.0 111.482 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.615 HD12 ' CD1' ' A' ' 82' ' ' LEU . 39.8 mt -144.8 135.2 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.461 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.006 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.39 150.11 45.95 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -144.99 149.95 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.938 0.399 . . . . 0.0 111.143 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.6 111.35 0.5 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.09 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -81.13 109.62 15.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.743 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -71.03 119.38 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.228 0.537 . . . . 0.0 111.82 -178.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 1.4 mmt85 -83.22 124.31 30.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.756 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.54 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -78.05 -172.92 2.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.528 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 tt0 -85.74 16.46 3.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.553 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -142.63 50.59 1.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.919 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.0 25.6 0.5 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.142 0.496 . . . . 0.0 111.217 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 105' ' ' MET . 39.4 mt-10 -120.54 161.47 21.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.09 HG21 HG22 ' A' ' 10' ' ' ILE . 13.0 mt -122.26 139.25 49.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.211 0.529 . . . . 0.0 111.356 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.9 OUTLIER -86.19 94.36 9.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.869 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -114.48 148.59 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.688 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.8 t . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.433 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.832 0.349 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -114.11 26.3 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.112 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 21.5 tp -64.04 70.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -118.37 178.08 4.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.03 162.36 33.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.187 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 8.0 Cg_endo -48.02 169.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.941 3.094 . . . . 0.0 111.482 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.48 59.97 0.71 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.664 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -144.42 107.64 0.45 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 114.222 -0.989 . . . . 0.0 111.67 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.96 -10.79 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.516 0.726 . . . . 0.0 110.513 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.006 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.75 -78.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.044 0.449 . . . . 0.0 110.961 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.625 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 5.38 -80.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.344 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttm 37.29 -133.43 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.378 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.32 14.81 5.6 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.033 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -71.09 -164.56 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 110.805 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.872 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.62 154.41 37.49 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.872 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.29 -24.82 1.07 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -100.28 -47.97 4.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.99 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.37 -7.15 58.97 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -65.53 -55.62 16.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.565 0.221 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.743 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.27 -40.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.06 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.58 -35.4 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.432 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -42.76 31.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.457 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -67.26 -26.12 66.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.251 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.738 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.1 tp -52.55 -44.35 65.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.54 -33.08 74.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.1 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -77.36 -25.57 51.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.149 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 4.2 mm-40 -108.18 5.19 25.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 18.4 t -135.22 -44.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.319 0.581 . . . . 0.0 110.309 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.62 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.48 4.62 1.39 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.604 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.07 -173.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 117.897 0.848 . . . . 0.0 110.831 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.9 p -113.72 87.48 12.24 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.545 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.754 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.1 Cg_endo -115.27 149.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.643 2.895 . . . . 0.0 114.22 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.02 79.82 2.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.05 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.3 t-160 -123.5 130.5 52.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.244 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.55 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -177.86 -139.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.794 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.79 175.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.847 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.763 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -143.11 123.96 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.926 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.55 -44.61 34.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.498 . . . . 0.0 109.796 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.45 164.83 6.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.036 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 127.69 17.49 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 121' ' ' PRO . 48.7 tp -106.63 121.09 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.503 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -122.22 112.01 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -141.04 148.06 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.45 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -121.08 139.97 52.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.457 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -105.04 162.76 18.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.285 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.477 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 7.6 Cg_endo -49.72 82.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.099 2.533 . . . . 0.0 112.25 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.2 m-20 87.74 11.35 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.595 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -137.28 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 0.0 110.866 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -80.34 107.15 12.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 tt -100.42 111.74 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.71 135.11 42.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.924 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.823 HD21 ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -126.26 114.44 18.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.774 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -116.15 122.79 46.12 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.769 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 1.7 m-85 -113.6 113.44 25.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.877 0.37 . . . . 0.0 110.273 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.763 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 44.0 m95 -94.77 148.59 22.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 65' ' ' PHE . 50.4 tp -104.8 102.73 12.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.391 0.615 . . . . 0.0 111.251 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.05 HG22 ' CD2' ' A' ' 64' ' ' HIS . 12.6 t -80.88 145.8 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.291 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.77 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -161.78 165.52 27.82 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.868 0.758 . . . . 0.0 112.065 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.743 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.1 p90 -149.84 131.49 14.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.489 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.53 136.38 33.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -140.82 19.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.526 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.0 tt0 -115.1 129.82 24.75 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.383 0.135 . . . . 0.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.55 128.78 10.51 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.649 2.233 . . . . 0.0 111.721 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.62 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.1 p-90 -135.3 -57.74 0.8 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.866 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.51 -104.07 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.137 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 166.57 40.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -41.26 91.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.981 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.97 -104.03 0.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.932 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -92.95 120.61 66.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -43.62 146.14 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.066 2.511 . . . . 0.0 112.682 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.31 19.23 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.808 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.5 157.23 29.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 110.735 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.1 m0 -60.39 106.87 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 110.426 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -120.19 156.73 30.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.476 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 5.0 t -81.1 116.86 21.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.843 HD22 ' CD1' ' A' ' 18' ' ' ILE . 6.3 tp -72.66 -18.7 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 108' ' ' VAL . 21.6 t -49.67 -21.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.72 0.295 . . . . 0.0 111.452 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.23 50.51 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.886 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 107' ' ' LEU . 8.6 tt -62.12 150.31 38.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -104.11 101.22 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -16.89 61.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.27 0.557 . . . . 0.0 110.083 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.51 -48.81 13.24 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.073 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -35.64 80.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.008 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.6 169.19 21.87 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.415 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.4 Cg_endo -54.63 131.8 47.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.55 2.167 . . . . 0.0 112.93 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.504 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.17 -14.07 37.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.072 2.515 . . . . 0.0 112.627 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.04 58.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.823 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.7 m-20 -121.38 25.89 9.18 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.02 -38.84 3.94 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.9 Cg_exo -44.82 -41.9 15.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.181 1.921 . . . . 0.0 113.204 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.769 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -77.42 -51.34 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.071 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.1 mm -65.37 -29.93 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.222 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.23 63.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.13 0.49 . . . . 0.0 110.35 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -71.06 -48.58 51.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.835 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.24 -30.8 48.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.835 ' N ' HD23 ' A' ' 126' ' ' LEU . 35.2 tttp -54.9 -42.64 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -67.16 -10.1 46.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.8 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.7 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.069 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.791 0.329 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.79 131.88 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.801 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.5 pp -125.57 123.02 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.593 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.4 153.75 19.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.339 0.59 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.506 ' CG2' HD23 ' A' ' 82' ' ' LEU . 89.3 mt -146.36 131.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.107 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.043 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.6 124.46 42.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.5 m -117.13 162.68 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.45 . . . . 0.0 111.697 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -144.46 115.0 0.83 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.606 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.757 HG22 HG13 ' A' ' 18' ' ' ILE . 1.5 mp -70.61 95.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.698 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.0 111.82 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.47 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -85.51 136.26 33.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.046 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.652 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 23.5 p30 -105.94 -172.89 2.17 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.766 0.793 . . . . 0.0 112.687 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -68.21 -4.4 13.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.693 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 56.2 t30 -124.19 42.51 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.087 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 46.22 27.05 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.613 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB3' ' HA ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.867 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.85 146.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.378 0.608 . . . . 0.0 112.295 -178.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.557 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t80 -90.04 95.79 10.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.86 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.867 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -108.34 162.19 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.356 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.665 0.269 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.5 26.18 10.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.717 0.294 . . . . 0.0 111.65 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.0 tt -54.15 83.71 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.757 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.78 -179.08 3.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.84 0.353 . . . . 0.0 111.412 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.534 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 160.98 40.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.648 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 29.0 Cg_endo -61.5 168.09 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.484 2.789 . . . . 0.0 111.528 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.45 59.34 0.75 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.98 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.94 121.02 3.43 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.777 -0.711 . . . . 0.0 112.05 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 115.02 6.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.382 0.673 . . . . 0.0 111.817 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.046 HD12 ' HB1' ' A' ' 49' ' ' ALA . 1.1 pt -58.24 -25.92 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.582 0.706 . . . . 0.0 110.573 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HB3' ' H ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -45.1 -85.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.24 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 38.29 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.312 0.383 . . . . 0.0 111.615 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.57 32.68 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.541 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.7 mp0 -91.6 -176.46 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.86 0.362 . . . . 0.0 111.222 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.916 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.64 156.17 35.62 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.916 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.99 -24.77 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.797 2.331 . . . . 0.0 112.715 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.32 -48.27 5.39 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -80.27 -14.01 58.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.046 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.93 -52.97 62.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 111.073 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.821 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.1 m -77.93 -44.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.6 t -57.77 -35.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.127 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -52.09 9.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.496 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.1 mm-40 -65.42 -24.21 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.029 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -52.2 -44.27 64.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.88 0.371 . . . . 0.0 110.345 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -36.6 78.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.86 -25.03 48.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.493 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 76.4 mm-40 -108.44 5.94 25.79 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.964 HG12 HG13 ' A' ' 60' ' ' ILE . 14.5 t -134.37 -44.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 110.543 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 60.59 5.29 4.88 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.623 -0.717 . . . . 0.0 114.353 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.964 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.5 -166.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 117.859 0.829 . . . . 0.0 110.852 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.601 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -112.57 88.08 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.813 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.4 Cg_endo -113.57 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.49 2.793 . . . . 0.0 114.462 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 27.8 mt-30 -74.65 79.39 2.01 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.029 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -113.04 132.9 55.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.684 -175.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -177.12 -143.1 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.829 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 2.1 m 52.14 171.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 112.245 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 67' ' ' LEU . 4.8 tt -134.24 114.48 13.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.452 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.565 ' HE1' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.49 -56.04 4.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.811 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -171.51 131.84 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.241 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -114.59 132.08 56.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HB2' HG22 ' A' ' 122' ' ' VAL . 7.5 tp -107.34 141.44 38.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -131.32 109.72 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.683 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -141.02 138.25 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.296 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 8.3 pt-20 -107.41 140.11 40.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.262 0.553 . . . . 0.0 111.718 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -101.34 163.05 18.65 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.053 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 4.2 Cg_endo -46.6 81.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.196 2.598 . . . . 0.0 112.532 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.3 m-20 85.61 11.87 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.689 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HG2' HD23 ' A' ' 4' ' ' LEU . 3.6 ttt180 -137.42 94.89 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 12.6 t-160 -74.84 97.92 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 tt -94.47 111.93 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.03 129.43 54.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.822 HD13 ' OD1' ' A' ' 119' ' ' ASN . 11.4 mt -126.45 114.75 18.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.425 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.521 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -110.29 122.88 48.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.464 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 11.7 m-30 -103.22 113.08 26.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.735 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.9 m95 -95.07 148.86 21.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.548 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.2 tm? -90.9 102.87 15.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.225 0.536 . . . . 0.0 111.551 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.9 t -89.53 144.87 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 4.7 pm0 -121.28 -13.5 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -160.94 160.05 30.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.044 1.293 . . . . 0.0 112.357 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.653 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -158.0 122.17 4.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.73 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.601 ' CB ' HG23 ' A' ' 61' ' ' THR . 1.5 mm-40 -83.33 117.98 23.37 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.882 0.372 . . . . 0.0 111.096 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.3 -125.61 8.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.531 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.13 136.12 28.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.577 -0.156 . . . . 0.0 110.577 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.676 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.99 128.91 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.766 2.311 . . . . 0.0 111.285 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 50.8 p-90 -140.95 -58.09 0.5 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.129 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 47.87 -93.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.501 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -171.93 33.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.787 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 26.0 pt-20 -62.0 -47.09 86.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 99.46 -24.4 32.36 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.277 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -112.27 95.67 31.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.574 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.5 146.14 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.173 2.582 . . . . 0.0 112.767 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.71 18.95 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.76 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.43 154.39 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.52 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -66.83 105.62 1.64 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.073 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.718 ' SD ' HD11 ' A' ' 20' ' ' ILE . 1.1 ptm -121.06 153.38 37.48 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.378 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 5.4 p -74.21 114.96 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.146 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.9 tm? -60.78 -24.45 65.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.685 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.5 t -55.49 -19.78 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.96 35.15 4.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.025 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 110' ' ' LEU . 10.8 tp -62.83 130.23 43.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.12 136.07 54.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.38 -15.43 61.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.657 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -78.85 -49.1 13.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.624 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -35.26 77.96 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.488 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -82.82 174.02 6.67 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.636 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 68.4 Cg_endo -74.75 127.99 11.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.256 1.971 . . . . 0.0 111.488 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.13 -14.74 25.03 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.774 2.316 . . . . 0.0 113.35 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.99 -9.9 25.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.822 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -131.86 41.0 3.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 111.439 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.29 -46.3 7.85 Favored Pre-proline 0 N--CA 1.464 0.241 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.1 Cg_exo -47.83 -40.27 31.98 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.218 1.945 . . . . 0.0 112.816 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.3 t -77.52 -51.42 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.4 mm -65.45 -29.96 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.27 -31.61 63.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.987 0.423 . . . . 0.0 110.627 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -50.06 36.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.802 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -78.17 -26.39 47.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.297 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.25 -42.67 86.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 110.814 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.04 -8.6 46.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.779 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.004 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.758 0.313 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 121.92 13.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 78' ' ' ARG . 3.4 pp -100.36 121.02 40.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.751 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -102.61 151.32 22.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.723 HD11 ' CD1' ' A' ' 4' ' ' LEU . 2.8 mp -140.06 139.0 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.486 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.964 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.78 140.8 52.6 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.525 HG11 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -144.49 149.78 17.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.67 125.52 1.88 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.402 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.994 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -83.8 109.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.734 HG23 HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -71.16 121.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.157 0.503 . . . . 0.0 111.318 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -85.94 120.06 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.129 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.511 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 27.5 p-10 -74.62 -171.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.914 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 8.3 tp10 -86.81 19.0 3.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.067 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -144.5 27.73 1.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.663 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.61 3.86 4.72 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 1.5 mm-40 -100.76 159.89 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.994 HG21 HG22 ' A' ' 10' ' ' ILE . 7.0 mt -125.28 141.78 44.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 111.496 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -90.38 113.47 25.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.793 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.01 162.05 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.315 179.266 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.67 0.271 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -114.29 26.05 10.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.012 0.434 . . . . 0.0 111.515 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.02 87.73 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -169.42 2.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.526 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.765 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.95 165.44 17.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.792 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.6 Cg_endo -47.83 168.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.788 2.992 . . . . 0.0 111.844 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.737 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.15 59.84 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.249 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.92 109.44 0.66 Allowed Glycine 0 C--N 1.312 -0.761 0 CA-C-N 114.473 -0.864 . . . . 0.0 111.697 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 122.32 -8.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.463 0.705 . . . . 0.0 110.853 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.964 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.2 -65.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.256 0.55 . . . . 0.0 111.41 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -13.6 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.472 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 43.0 -94.0 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.598 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.23 18.11 0.09 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.579 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -79.55 -163.0 0.46 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.842 -0.211 . . . . 0.0 110.801 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.865 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.86 154.76 38.39 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.865 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.8 -24.86 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.702 2.268 . . . . 0.0 112.399 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.711 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.65 -52.22 4.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.015 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -80.51 -4.93 55.76 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -66.19 -57.01 8.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.101 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.738 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.32 -40.65 25.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 111.264 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.7 t -50.46 -35.48 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.935 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -52.12 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.89 -25.59 67.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.65 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.682 HD13 ' CG2' ' A' ' 50' ' ' VAL . 2.1 tp -54.61 -44.43 73.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.576 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -27.41 67.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.734 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -77.14 -25.58 52.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.233 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 1.8 mp0 -108.42 5.74 25.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.918 HG12 HG13 ' A' ' 60' ' ' ILE . 16.4 t -134.53 -44.55 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 110.286 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.636 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 56.79 3.41 0.7 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.577 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.918 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.75 -173.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.926 0.863 . . . . 0.0 110.392 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -113.96 87.5 12.87 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.901 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.755 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.9 Cg_endo -115.11 149.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.761 2.974 . . . . 0.0 113.924 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 83.2 mt-30 -74.81 79.62 2.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.907 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.57 127.57 49.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.061 -176.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.79 -136.98 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.776 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 56.6 163.26 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.219 0.533 . . . . 0.0 112.116 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.5 tt -126.19 113.18 16.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.289 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.863 ' CE1' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.65 -53.24 8.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.293 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.714 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.41 131.68 0.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -125.11 132.07 53.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.728 0.299 . . . . 0.0 111.023 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.879 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -106.54 159.34 16.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.666 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.0 tt0 -140.08 109.92 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.485 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -133.33 153.01 51.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.24 140.05 52.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 111.425 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -103.41 162.86 18.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.156 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.1 Cg_endo -45.8 80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.334 2.689 . . . . 0.0 112.815 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.5 t0 85.45 9.95 0.31 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.947 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.822 ' HG2' HD23 ' A' ' 4' ' ' LEU . 3.9 ttp-105 -137.39 101.39 4.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 111.087 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.0 m-70 -74.89 115.84 14.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.829 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 4' ' ' LEU . 1.1 tt -107.14 112.04 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.955 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.88 129.92 53.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.754 HD13 ' OD1' ' A' ' 119' ' ' ASN . 26.3 mt -126.37 114.43 18.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.146 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -111.95 122.43 47.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.044 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.714 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.4 m-30 -104.5 115.06 29.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.491 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.738 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 36.6 m95 -94.72 148.72 21.99 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.058 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.2 tm? -101.08 102.68 13.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.452 0.644 . . . . 0.0 111.361 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.907 HG22 ' CE1' ' A' ' 64' ' ' HIS . 11.5 t -82.11 145.77 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.658 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.97 -45.87 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.8 ptm85 -163.13 165.93 24.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.839 0.745 . . . . 0.0 112.383 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HE3' HG22 ' A' ' 11' ' ' ILE . 8.4 p90 -139.59 136.19 34.13 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.68 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.35 108.72 19.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.35 -121.47 6.86 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.427 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.5 tt0 -135.08 135.06 22.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.467 0.175 . . . . 0.0 110.917 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.555 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.47 128.73 10.54 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.796 2.331 . . . . 0.0 111.58 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.636 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.4 p-90 -133.47 -58.18 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.09 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.572 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 37.89 -92.39 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.257 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 95' ' ' TRP . 5.2 tmtm? 179.88 -69.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.812 0.339 . . . . 0.0 110.747 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 42.21 26.06 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.605 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.21 -65.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.545 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 98' ' ' GLU . 28.5 mt-30 -108.02 99.23 29.81 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.47 146.55 3.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.139 2.559 . . . . 0.0 112.469 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.04 21.4 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.189 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.84 157.62 25.31 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.83 106.36 3.11 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.609 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.6 mtp -120.87 164.11 17.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -70.75 116.96 11.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.339 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.548 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.83 -18.71 50.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.62 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.491 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.2 t -57.12 -14.25 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.79 35.24 4.7 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.153 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 107' ' ' LEU . 11.5 tp -62.74 135.91 57.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.09 131.48 53.71 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.63 -15.3 61.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.975 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.71 -49.14 13.62 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.809 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -36.46 77.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.775 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.565 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -78.77 173.98 6.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.731 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.4 Cg_endo -76.46 137.17 18.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.358 2.039 . . . . 0.0 112.089 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 27.6 Cg_endo -62.01 -14.29 36.44 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.842 2.361 . . . . 0.0 113.202 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.3 -9.7 19.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.754 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -135.9 44.12 2.5 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.2 OUTLIER -76.05 -50.77 2.98 Favored Pre-proline 0 N--CA 1.463 0.186 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.486 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 79.6 Cg_exo -44.74 -38.02 12.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.447 2.098 . . . . 0.0 112.792 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.879 ' CG2' HD23 ' A' ' 71' ' ' LEU . 2.5 t -77.25 -49.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.611 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.565 HG13 ' CE2' ' A' ' 115' ' ' PHE . 11.3 mm -64.75 -29.97 48.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.747 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.05 -29.75 63.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 110.653 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.28 -48.52 15.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.629 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.863 HD23 ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -78.19 -30.25 48.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.34 . . . . 0.0 111.425 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HB2' HG22 ' A' ' 123' ' ' ILE . 12.0 ttpt -55.58 -42.47 74.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.817 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -68.42 -7.47 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.639 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 108' ' ' VAL . 24.7 mt . . . . . 0 C--O 1.233 0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.073 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.833 0.349 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -126.93 141.89 51.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.4 pp -145.61 117.59 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.547 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.6 mt-30 -102.29 151.74 21.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.841 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.492 ' CG2' HD23 ' A' ' 82' ' ' LEU . 4.3 mt -142.68 128.28 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.869 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.099 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.54 124.68 42.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.536 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.7 m -115.39 162.18 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.283 0.563 . . . . 0.0 111.924 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.42 102.08 0.23 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.957 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.94 HG22 HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.91 110.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.606 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.55 115.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.066 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 3.7 mmt85 -82.14 133.7 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.452 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 10.3 p-10 -84.17 -172.01 3.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 113.062 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -56.61 -16.06 5.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.721 -1.581 . . . . 0.0 113.275 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -127.71 -83.0 0.6 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.16 17.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 111.687 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HB2' ' ND2' ' A' ' 13' ' ' ASN . 19.8 mt-10 -100.89 160.11 14.64 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.94 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -135.08 145.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 111.997 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 14.0 t80 -84.48 89.63 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.79 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.895 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -113.29 162.17 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.038 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.3 t . . . . . 0 C--N 1.327 -0.391 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.791 0.329 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.03 26.37 10.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.507 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.555 HD21 ' HE2' ' A' ' 105' ' ' MET . 3.8 tt -57.74 77.37 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -108.58 -170.65 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.091 0.472 . . . . 0.0 111.636 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.9 154.13 55.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 11.1 Cg_endo -53.84 167.47 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.233 2.622 . . . . 0.0 111.677 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 59.25 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.137 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.06 117.04 2.48 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 114.84 -0.68 . . . . 0.0 112.059 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 3.5 tttt 115.76 4.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.322 0.649 . . . . 0.0 111.513 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.099 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -53.98 -27.61 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.569 0.699 . . . . 0.0 110.665 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.588 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.22 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mmt 33.38 -85.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.558 0.537 . . . . 0.0 111.878 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.31 31.11 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.553 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.459 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.0 mp0 -91.61 -175.07 4.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -111.92 159.0 35.14 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.95 -24.65 0.88 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.904 2.403 . . . . 0.0 112.696 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -90.68 -58.08 2.61 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -80.4 -20.07 44.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.924 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.3 -49.76 73.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.833 0.349 . . . . 0.0 111.148 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.928 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.6 m -76.03 -46.86 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 47' ' ' GLU . 42.3 t -60.46 -35.85 65.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.087 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -70.91 -49.14 49.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.022 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.7 ' CB ' HG22 ' A' ' 40' ' ' ILE . 7.0 tp10 -71.33 -27.97 63.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.934 HD23 ' ND1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -55.06 -44.08 74.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.55 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -61.44 -35.09 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 0.0 109.816 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.53 -33.54 54.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.339 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 20.5 mm-40 -100.05 4.83 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.026 HG12 HG22 ' A' ' 60' ' ' ILE . 3.3 t -135.48 -43.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.115 0.483 . . . . 0.0 110.245 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.64 9.39 6.61 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.747 -0.661 . . . . 0.0 114.504 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.026 HG22 HG12 ' A' ' 58' ' ' VAL . 13.5 tt -115.88 162.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 117.46 0.63 . . . . 0.0 110.289 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.491 ' N ' HG12 ' A' ' 60' ' ' ILE . 1.5 p -98.82 88.44 0.72 Allowed Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.839 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 58.4 Cg_endo -113.31 156.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 124.236 3.291 . . . . 0.0 114.096 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -75.85 78.38 2.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.934 ' ND1' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -111.94 120.7 42.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.786 -173.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.535 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -177.95 -153.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.629 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m 59.56 154.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -118.39 120.02 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.437 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.71 -44.12 34.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.064 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 tt0 -171.44 162.81 6.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.187 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.576 ' HD2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.53 132.16 22.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.449 ' HB2' HG22 ' A' ' 122' ' ' VAL . 34.5 tp -113.77 122.32 46.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.822 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -116.86 109.85 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.723 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.19 143.41 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.497 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.13 124.52 44.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 111.547 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -85.24 163.23 46.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.089 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -51.56 81.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.921 2.414 . . . . 0.0 112.225 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 90.54 11.61 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.53 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -137.29 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.772 0.32 . . . . 0.0 111.007 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -78.46 106.96 10.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.101 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.09 112.63 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.93 128.76 54.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.665 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.818 HD13 ' OD1' ' A' ' 119' ' ' ASN . 9.4 mt -126.34 114.64 18.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.297 . . . . 0.0 111.472 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -108.84 122.86 48.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.107 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.782 ' CD2' HG11 ' A' ' 122' ' ' VAL . 12.1 m-30 -103.43 112.04 24.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.928 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.9 m95 -95.12 149.23 21.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.437 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 65' ' ' PHE . 5.3 tp -106.3 103.18 12.59 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.862 HG13 ' HA ' ' A' ' 64' ' ' HIS . 11.3 t -82.63 145.45 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.326 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -102.84 -35.23 8.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.3 165.42 26.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.53 0.604 . . . . 0.0 112.0 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.716 ' HB2' HD13 ' A' ' 60' ' ' ILE . 9.2 p90 -138.93 157.96 45.08 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.289 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.764 ' C ' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -104.78 101.29 10.9 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.239 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.67 -115.02 5.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.065 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.5 tt0 -135.25 122.83 15.17 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.504 0.192 . . . . 0.0 111.432 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.0 Cg_exo -74.17 128.82 12.5 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.624 2.216 . . . . 0.0 110.794 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.547 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 20.8 p-90 -123.5 -60.85 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.833 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 57.2 -117.79 10.69 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.261 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.54 37.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.06 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -53.82 -24.52 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.42 -15.03 39.07 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.315 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.06 105.38 6.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 111.392 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.56 143.77 2.44 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.006 2.471 . . . . 0.0 112.727 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.31 19.29 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.971 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.15 157.17 44.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.27 106.52 0.54 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.872 0.368 . . . . 0.0 110.177 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.555 ' HE2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.53 139.57 52.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.027 179.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.574 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.8 p -59.66 114.77 2.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.352 . . . . 0.0 110.825 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.1 tm? -67.72 -24.49 65.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.574 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.5 p -57.73 -18.23 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.73 35.89 4.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.789 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 123' ' ' ILE . 12.3 tp -62.8 135.52 57.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.22 133.41 54.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.35 61.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.779 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.85 -49.29 13.16 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.742 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -30.6 69.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.386 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.731 ' CZ ' HG21 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -88.67 174.43 5.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.341 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 50.5 Cg_endo -69.61 127.97 15.49 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.968 1.779 . . . . 0.0 111.649 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.71 -14.81 45.06 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.228 . . . . 0.0 113.097 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.32 -9.79 44.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.818 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -124.21 27.22 7.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.475 0.179 . . . . 0.0 111.432 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' HA ' ' CG2' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -58.05 -49.07 95.71 Favored Pre-proline 0 N--CA 1.463 0.195 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 87.0 Cg_exo -46.86 -35.92 18.91 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.437 2.091 . . . . 0.0 113.176 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 84' ' ' PHE . 21.3 t -77.54 -51.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.627 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 110' ' ' LEU . 2.5 tp -68.07 -30.6 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.788 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.99 -26.99 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.877 0.37 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -49.07 12.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.446 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -78.16 -29.53 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -56.04 -42.49 76.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.27 -3.9 29.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.892 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.2 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.194 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.808 0.337 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.38 143.41 53.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.6 pp -145.71 129.32 17.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.074 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.54 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.4 mt-30 -102.57 153.62 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.442 0.639 . . . . 0.0 112.342 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -146.48 132.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.671 178.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.26 124.97 43.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.469 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.579 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -117.86 162.55 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.406 0.622 . . . . 0.0 112.101 -179.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.08 114.29 0.63 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.851 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.087 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.25 107.27 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.42 123.29 25.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.446 . . . . 0.0 111.676 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.674 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -83.61 119.97 25.39 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.829 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.552 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.8 t-20 -77.72 -172.32 2.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.766 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 59.6 tt0 -82.45 -2.99 54.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.583 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -131.95 40.61 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.802 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.6 9.29 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.506 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.726 ' C ' HD12 ' A' ' 18' ' ' ILE . 16.6 pt-20 -100.86 149.67 23.62 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.087 HG21 HG22 ' A' ' 10' ' ' ILE . 1.4 mp -115.11 141.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.238 0.542 . . . . 0.0 111.718 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 26.7 t80 -80.65 99.9 8.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.758 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.13 162.12 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.446 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.564 HG21 ' OE2' ' A' ' 98' ' ' GLU . 3.6 p . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.551 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.587 0.232 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.37 10.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.39 . . . . 0.0 111.423 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.5 tt -50.85 89.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -119.94 -177.18 3.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.379 . . . . 0.0 111.234 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.765 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.74 160.76 41.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.734 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.29 168.43 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.813 3.008 . . . . 0.0 112.068 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.71 59.24 0.75 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.132 -1.032 . . . . 0.0 114.129 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.77 116.57 1.91 Allowed Glycine 0 C--N 1.315 -0.622 0 CA-C-N 114.71 -0.745 . . . . 0.0 112.097 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 119.13 4.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.517 0.727 . . . . 0.0 111.783 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.042 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -57.2 -26.06 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.515 0.674 . . . . 0.0 110.71 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.16 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.32 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 mtm 31.59 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.455 0.472 . . . . 0.0 112.072 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -167.66 28.98 0.17 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.664 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.2 mp0 -92.43 -175.0 3.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.313 . . . . 0.0 111.101 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.864 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.71 154.94 38.94 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.864 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.92 -24.74 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.79 2.327 . . . . 0.0 112.601 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.719 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -94.44 -50.84 5.04 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.2 -22.03 42.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.899 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.58 -48.26 77.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.813 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.02 -46.82 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -56.28 -35.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.958 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -76.96 -50.19 13.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.617 ' CB ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -65.63 -23.71 66.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.834 HD21 ' CE1' ' A' ' 64' ' ' HIS . 4.2 tp -52.88 -44.48 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -33.05 74.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.827 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 -24.85 50.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.197 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 4.0 mm-40 -108.66 5.5 24.94 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.915 HG12 HG13 ' A' ' 60' ' ' ILE . 38.8 t -134.74 -44.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.388 0.613 . . . . 0.0 109.944 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.692 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.46 4.16 1.22 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.119 -0.946 . . . . 0.0 115.038 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.915 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.55 -172.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.157 0.979 . . . . 0.0 110.46 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.82 87.94 10.9 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.664 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.5 Cg_endo -114.34 144.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.579 2.852 . . . . 0.0 114.24 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 30.6 mt-30 -75.02 80.04 2.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.834 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.78 126.05 50.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.947 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 177.37 173.25 0.51 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 92.12 148.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.855 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -97.71 137.13 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.07 -47.71 4.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.299 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -171.43 157.81 5.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.566 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.4 127.93 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.977 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.805 HD23 HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -127.25 124.47 38.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.497 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -116.91 118.11 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.755 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -137.37 136.37 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.685 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.13 120.38 42.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.498 . . . . 0.0 111.338 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.92 162.85 65.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.519 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.8 Cg_endo -41.74 82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.655 2.903 . . . . 0.0 112.587 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' PHE . 2.9 t70 98.43 -27.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.19 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 75' ' ' PHE . 6.1 ttp180 -90.45 150.11 21.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.824 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -120.32 101.65 7.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.85 124.95 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.474 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -117.98 118.58 32.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.117 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.805 HD11 HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -126.14 114.99 19.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.085 0.469 . . . . 0.0 111.898 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.474 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.6 m0 -104.74 122.7 46.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.405 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.2 m-30 -95.38 109.63 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.727 ' NE1' HG11 ' A' ' 50' ' ' VAL . 28.6 m95 -96.78 148.63 22.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.109 0.481 . . . . 0.0 111.853 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.5 tm? -95.15 138.56 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.713 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.789 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.2 t -123.74 146.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.031 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.08 -22.04 9.15 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 3.9 tpp85 -162.48 160.51 26.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 119.018 0.826 . . . . 0.0 111.661 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.723 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.06 125.42 5.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.178 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.62 149.37 34.77 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.03 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.46 -127.13 44.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.598 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.0 mt-10 -129.57 141.91 43.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.431 0.157 . . . . 0.0 110.689 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.604 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.1 Cg_exo -76.6 128.59 10.35 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.766 2.311 . . . . 0.0 111.607 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.692 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.2 p-90 -125.87 -58.72 1.38 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.63 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 97' ' ' LYS . . . 49.86 -76.26 0.0 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.806 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 95' ' ' TRP . 3.8 tptt 115.91 60.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.993 0.917 . . . . 0.0 110.488 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.564 ' OE2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -80.62 -33.32 35.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.71 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.17 -1.68 9.75 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -140.25 94.59 8.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 117.088 0.444 . . . . 0.0 111.45 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -43.61 145.64 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.672 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.29 177.42 19.19 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.992 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.36 157.19 43.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.13 106.45 1.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.082 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 3.3 mtp -120.01 159.57 24.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.611 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.0 p -78.47 114.34 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.673 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -80.5 -19.54 45.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.052 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG13 HD21 ' A' ' 129' ' ' LEU . 33.6 t -56.66 -18.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.622 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.63 50.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.792 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.766 HD22 HD12 ' A' ' 123' ' ' ILE . 6.4 tt -62.6 150.2 41.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.465 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -117.02 132.27 56.74 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.17 61.9 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.6 -49.24 13.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.556 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.182 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.588 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.92 172.38 10.05 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.301 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.2 Cg_endo -75.76 128.15 10.69 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.327 2.018 . . . . 0.0 111.523 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.31 -14.69 16.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.777 2.318 . . . . 0.0 113.474 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.93 -11.47 18.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.713 HD21 HD22 ' A' ' 82' ' ' LEU . 1.4 m-20 -132.67 43.71 2.95 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.8 tt0 -76.07 -47.11 3.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.7 Cg_exo -45.83 -39.14 18.7 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.031 . . . . 0.0 112.837 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -77.27 -48.52 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.594 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.766 HD12 HD22 ' A' ' 110' ' ' LEU . 5.5 mm -65.18 -29.96 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.928 0.394 . . . . 0.0 110.485 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -46.24 16.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.47 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.2 tm? -78.17 -28.71 48.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 111.266 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 123' ' ' ILE . 10.4 ttpt -63.85 -42.28 97.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.416 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -64.07 -9.66 17.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.04 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.427 HD21 HG13 ' A' ' 108' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 tttm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.805 0.336 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -89.04 135.45 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.1 127.05 14.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.472 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.69 154.99 18.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.216 0.532 . . . . 0.0 111.418 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 5' ' ' GLN . 39.1 mm -146.2 127.43 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.006 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.059 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.38 124.59 42.68 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.288 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.668 HG11 ' OE2' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -129.8 162.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.178 0.513 . . . . 0.0 111.375 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 123.69 1.54 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.095 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.783 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -70.79 110.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.701 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.61 125.93 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.963 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -93.0 126.83 38.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.346 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.469 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 5.9 t30 -89.5 -172.02 3.43 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.899 0.857 . . . . 0.0 112.088 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.79 -2.14 34.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.103 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -136.01 50.2 2.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 0.0 111.283 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 p30 45.38 26.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.44 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HG3' ' CB ' ' A' ' 13' ' ' ASN . 11.5 pt-20 -112.36 150.29 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.85 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.99 144.76 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.447 0.642 . . . . 0.0 112.292 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CE1' ' CA ' ' A' ' 102' ' ' GLY . 36.3 t80 -82.5 91.5 6.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.127 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.85 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -98.9 162.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.497 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 100' ' ' GLN . 7.1 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.489 0.185 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.32 26.06 10.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.505 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 114' ' ' ASP . 17.0 tp -52.12 92.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.668 ' OE2' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -128.54 -176.43 3.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.783 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.56 168.24 10.53 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.615 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.7 Cg_endo -47.5 168.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.602 2.868 . . . . 0.0 112.249 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.42 59.22 0.76 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.666 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.58 112.02 1.27 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.23 -0.985 . . . . 0.0 112.384 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER 113.97 5.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.168 0.587 . . . . 0.0 112.096 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.059 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.22 -29.47 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.742 0.782 . . . . 0.0 110.148 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.98 -79.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.25 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.4 mmt 41.35 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.539 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.27 33.22 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.762 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.24 -169.19 1.93 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.673 0.273 . . . . 0.0 111.019 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.96 156.24 36.17 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.301 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -44.01 -24.8 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.766 2.31 . . . . 0.0 112.465 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.9 mp0 -99.59 -48.34 4.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.912 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.32 -7.56 59.11 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.824 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -63.68 -56.98 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 0.0 110.864 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.779 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 1.4 p -78.3 -40.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.716 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 59.2 t -50.67 -37.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.995 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.87 -52.38 8.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.306 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HB3' HG22 ' A' ' 40' ' ' ILE . 9.3 tm-20 -66.35 -19.92 65.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.694 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.729 HD11 ' CE1' ' A' ' 64' ' ' HIS . 14.1 tp -60.53 -44.41 96.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.728 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HA ' HG12 ' A' ' 58' ' ' VAL . 1.3 tm0? -71.58 -27.87 63.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.457 . . . . 0.0 110.029 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.07 -28.1 66.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.482 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.471 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.22 6.99 27.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.314 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.908 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -130.7 -44.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 64.73 -35.66 0.1 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.058 0.783 . . . . 0.0 115.058 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.908 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.64 -174.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.929 0.364 . . . . 0.0 110.817 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.55 88.69 13.82 Favored Pre-proline 0 N--CA 1.445 -0.717 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.689 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.9 Cg_endo -110.68 143.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 123.312 2.675 . . . . 0.0 113.474 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 31.8 mt-30 -74.6 80.06 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.821 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.18 133.15 54.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.128 -175.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -179.77 -137.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.352 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.34 159.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.963 0.505 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.4 tt -122.26 110.68 16.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.68 -52.07 10.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.373 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.605 ' HB3' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -171.33 131.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -121.88 131.91 54.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.526 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.979 HD23 HG21 ' A' ' 122' ' ' VAL . 1.8 pp -114.45 158.67 21.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.957 0.408 . . . . 0.0 111.261 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.455 ' N ' HD12 ' A' ' 71' ' ' LEU . 9.0 tt0 -140.1 109.81 6.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.242 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -136.03 153.19 51.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -120.95 127.11 51.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.141 0.496 . . . . 0.0 111.353 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -91.68 163.89 26.3 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.417 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 50.5 Cg_exo -38.27 81.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.602 2.868 . . . . 0.0 112.886 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.59 21.24 3.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.061 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.31 93.83 2.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.239 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -74.91 99.97 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.152 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tt -102.55 111.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.79 133.22 44.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.468 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.618 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.13 114.48 18.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 111.468 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -110.82 125.55 53.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.618 ' CE1' HD12 ' A' ' 82' ' ' LEU . 2.4 m-85 -111.02 118.2 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.392 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.779 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 65.3 m95 -96.47 148.87 22.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.025 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.3 tm? -99.83 103.05 14.64 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.327 0.584 . . . . 0.0 111.34 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.821 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.2 t -80.65 145.87 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.665 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -113.29 -25.39 8.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 6.9 ttm180 -162.42 163.23 27.82 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.586 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.701 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -157.21 123.8 4.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.527 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.89 139.99 47.22 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.09 -121.7 26.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 60' ' ' ILE . 24.7 mt-10 -132.05 142.64 45.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.431 0.158 . . . . 0.0 110.775 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.541 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.15 128.8 11.66 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.719 2.279 . . . . 0.0 111.183 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.607 ' HE1' HG23 ' A' ' 60' ' ' ILE . 50.6 p-90 -126.83 -61.03 1.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.21 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.936 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt 177.99 35.15 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 7.9 pt-20 -57.19 -37.79 72.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.88 0.371 . . . . 0.0 110.587 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.47 71.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.153 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 2.6 pm0 -140.16 93.29 9.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.28 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.61 138.82 5.29 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.056 2.504 . . . . 0.0 112.85 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -134.31 177.29 19.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.98 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -141.28 157.13 45.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -79.76 106.15 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.472 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.462 ' HG3' HD11 ' A' ' 20' ' ' ILE . 3.0 ptp -120.55 163.07 18.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.768 ' HB2' HG12 ' A' ' 108' ' ' VAL . 8.9 p -77.58 114.88 16.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.695 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.0 tm? -63.21 -18.91 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.768 HG12 ' HB2' ' A' ' 106' ' ' SER . 13.0 p -55.26 -20.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.464 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.18 35.05 4.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.812 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.71 HD22 HD21 ' A' ' 107' ' ' LEU . 10.7 tp -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.26 131.73 53.77 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -15.51 61.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.414 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -49.05 13.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.467 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -66.9 -40.08 87.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.599 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.63 174.16 6.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.445 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 61.5 Cg_endo -73.86 127.91 11.94 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.061 1.84 . . . . 0.0 111.509 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.97 -14.86 29.98 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.644 2.229 . . . . 0.0 113.122 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.98 -9.95 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.661 ' ND2' HD21 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -129.73 38.21 3.86 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.9 -47.36 15.35 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.068 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.6 Cg_exo -56.0 -35.28 94.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.336 2.024 . . . . 0.0 112.083 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.979 HG21 HD23 ' A' ' 71' ' ' LEU . 3.8 t -77.46 -51.38 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.082 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -69.79 -29.92 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.806 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.89 -27.53 43.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.905 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -53.34 12.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 68' ' ' PHE . 1.7 tp -78.46 -29.54 46.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.3 tttm -57.77 -42.6 84.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.014 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.519 ' C ' HD12 ' A' ' 129' ' ' LEU . 6.1 ttp180 -71.49 -5.55 33.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.937 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.731 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.253 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.832 0.349 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.33 38.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.719 HD21 ' HD3' ' A' ' 78' ' ' ARG . 3.0 pp -146.05 123.23 11.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -102.94 150.27 23.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.213 0.53 . . . . 0.0 111.258 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.596 ' HB ' HD22 ' A' ' 82' ' ' LEU . 8.5 mt -136.56 130.49 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.205 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.852 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.97 124.57 42.29 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.505 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -132.01 162.53 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.212 0.53 . . . . 0.0 111.658 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.44 121.51 1.22 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.915 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.912 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -70.83 109.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.696 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.07 125.48 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 120.976 0.417 . . . . 0.0 111.416 -178.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -92.21 133.13 36.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.956 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.629 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 29.6 p-10 -96.45 -172.13 2.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.86 0.838 . . . . 0.0 112.433 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.37 -0.88 16.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.071 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 20.6 t-20 -129.39 40.68 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 111.844 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 52.22 21.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -115.72 160.01 20.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.912 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -122.75 149.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.145 0.498 . . . . 0.0 111.922 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.49 101.65 14.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.041 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.908 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.08 137.67 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.302 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.2 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.825 0.345 . . . . 0.0 110.943 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -114.52 26.24 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.535 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 ' HB ' ' A' ' 20' ' ' ILE . 4.8 tt -46.08 110.36 0.26 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -142.15 175.28 9.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.785 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.53 168.92 9.09 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.639 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.6 Cg_endo -46.66 169.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.693 2.929 . . . . 0.0 112.146 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.29 59.6 0.72 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.155 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.52 122.53 3.11 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 114.113 -1.044 . . . . 0.0 111.697 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.28 -7.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.28 0.632 . . . . 0.0 111.213 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.852 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -40.73 -57.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.389 0.614 . . . . 0.0 111.285 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -21.72 -80.43 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.252 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.5 mmt 41.83 -94.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.588 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.77 19.49 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.424 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -82.97 -165.71 1.14 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.529 0.205 . . . . 0.0 110.81 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.885 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.51 156.57 36.19 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.885 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.5 -24.64 0.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.772 2.315 . . . . 0.0 112.362 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.3 mm-40 -89.98 -59.97 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -80.89 -4.56 55.29 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -63.68 -57.08 11.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.593 0.235 . . . . 0.0 111.089 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.697 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.67 -41.77 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.354 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.5 t -50.36 -35.36 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.342 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -52.15 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.49 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 10.2 mm-40 -70.1 -20.09 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.825 HD11 ' CE1' ' A' ' 64' ' ' HIS . 13.9 tp -58.18 -41.57 84.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -26.96 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.1 tm-20 -72.12 -25.27 61.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.4 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -108.59 7.02 26.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.985 HG12 HG13 ' A' ' 60' ' ' ILE . 10.6 t -133.28 -43.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.191 0.52 . . . . 0.0 109.974 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 52.88 8.63 0.63 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.442 -0.799 . . . . 0.0 115.028 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.985 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.6 -174.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.026 0.913 . . . . 0.0 110.149 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 p -114.58 87.34 14.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.67 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.0 Cg_endo -115.5 145.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 123.664 2.909 . . . . 0.0 114.066 -177.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.825 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -122.64 133.33 54.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.329 -175.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.04 -139.23 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.02 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 56.29 153.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.617 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.4 tt -116.78 111.21 19.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.386 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.56 ' CZ ' HG12 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -76.58 -54.14 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.195 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.0 mt-10 -171.28 131.7 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.438 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.617 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.27 126.6 39.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.692 0.282 . . . . 0.0 110.807 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 122' ' ' VAL . 1.2 pt? -113.84 136.67 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' HG21 ' A' ' 81' ' ' THR . 5.0 tt0 -121.67 109.94 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -131.05 152.2 50.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.5 pt-20 -121.13 139.58 53.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 111.381 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -103.23 162.67 19.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.133 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.1 Cg_endo -49.76 81.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.155 2.57 . . . . 0.0 112.344 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t70 89.28 10.2 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.595 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.719 ' HD3' HD21 ' A' ' 4' ' ' LEU . 3.2 tmm_? -137.34 93.94 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.3 . . . . 0.0 110.89 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 17.2 m80 -80.18 93.86 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.97 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 80' ' ' ILE . 15.4 tt -96.76 111.87 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -106.82 132.54 52.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.39 114.58 18.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 0.0 111.422 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.1 m0 -109.34 125.53 52.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.226 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.646 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.8 m-85 -111.41 114.56 27.78 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.932 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.542 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 61.3 m95 -94.73 148.83 21.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 14.6 tp -98.41 102.89 14.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 111.755 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.809 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.0 t -80.69 145.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.205 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 8.7 pt-20 -112.57 -26.96 8.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 3.9 mtt-85 -161.83 164.08 28.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.673 0.67 . . . . 0.0 111.428 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.696 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.67 123.59 4.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 152.95 32.51 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.1 -125.05 38.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.36 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -135.0 148.1 65.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.6 0.238 . . . . 0.0 110.956 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.636 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.48 128.8 10.58 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.933 2.422 . . . . 0.0 111.163 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 66.8 p-90 -138.45 -58.56 0.63 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.749 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 41.38 -93.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.295 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER 175.12 32.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.28 . . . . 0.0 111.144 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' OE1' HG21 ' A' ' 21' ' ' THR . 4.1 pt-20 -68.05 -33.37 74.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.947 0.403 . . . . 0.0 110.256 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.05 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -140.35 91.65 9.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 0.0 111.64 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.73 127.58 8.14 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.077 2.518 . . . . 0.0 112.602 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.3 177.05 19.47 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.7 155.28 39.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.14 107.14 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 110.459 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -119.55 163.06 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.771 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.07 122.66 33.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.098 HD21 HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -79.97 -18.97 49.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.625 HG23 HD21 ' A' ' 129' ' ' LEU . 12.5 p -53.0 -21.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.69 45.42 1.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.038 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.098 HD22 HD21 ' A' ' 107' ' ' LEU . 11.6 tp -62.94 150.28 42.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.722 0.261 . . . . 0.0 110.378 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -117.46 131.8 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.2 -15.29 61.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.648 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -48.93 14.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.367 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.98 -39.02 87.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.945 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -81.11 171.43 12.26 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.324 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 57.2 Cg_endo -71.15 127.57 13.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.18 1.92 . . . . 0.0 111.875 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.64 -14.86 45.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.581 2.187 . . . . 0.0 112.84 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.84 -9.5 57.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.42 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -124.01 34.33 5.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.714 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.57 -39.01 5.57 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.876 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.7 Cg_exo -53.07 -40.74 75.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.064 1.843 . . . . 0.0 112.699 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.72 HG21 HD22 ' A' ' 71' ' ' LEU . 2.3 t -77.47 -51.23 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.317 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.7 OUTLIER -67.3 -30.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.303 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.28 -28.46 63.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -51.86 13.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.365 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.1 tp -78.12 -39.51 41.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.483 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.522 ' HB2' HG22 ' A' ' 123' ' ' ILE . 5.2 tttm -53.54 -42.56 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.282 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -72.06 -3.64 24.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.133 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 108' ' ' VAL . 5.6 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.011 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 tptt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.811 0.339 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.08 125.56 51.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.756 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.1 pp -125.24 139.05 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.583 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.7 mt-30 -102.46 155.41 18.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.805 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 30.2 mt -146.26 126.67 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.32 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.996 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.49 124.16 41.69 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.185 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -118.65 162.5 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.34 117.19 1.19 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.934 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.911 ' CG2' HG21 ' A' ' 18' ' ' ILE . 4.7 mp -70.58 100.51 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.788 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -71.21 125.9 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -98.0 119.96 37.55 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.085 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.593 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.54 -172.93 0.84 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.019 0.438 . . . . 0.0 110.567 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 21.9 tt0 -81.28 12.83 3.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -133.92 34.9 3.34 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 5.32 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -100.95 161.76 13.37 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.911 HG21 ' CG2' ' A' ' 10' ' ' ILE . 6.7 mt -117.92 141.29 37.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.255 0.55 . . . . 0.0 111.665 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -93.02 92.77 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.254 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.853 HG13 HG22 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.97 162.07 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.206 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.429 HG21 ' OE1' ' A' ' 98' ' ' GLU . 5.0 p . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.53 0.205 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -114.17 26.45 10.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 111.359 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.3 tt -40.34 117.07 0.75 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.222 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.728 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -158.3 -172.42 3.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.504 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.37 163.08 28.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.879 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.52 ' HG3' HD11 ' A' ' 11' ' ' ILE . 6.2 Cg_endo -47.48 169.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.887 3.058 . . . . 0.0 112.314 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.05 59.32 0.73 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.449 -0.882 . . . . 0.0 113.349 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -132.13 109.04 0.82 Allowed Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.155 -1.022 . . . . 0.0 111.448 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.95 2.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.452 0.701 . . . . 0.0 111.176 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.996 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.43 -27.95 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.633 0.73 . . . . 0.0 110.571 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.591 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.333 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.3 mmt 32.36 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.458 0.474 . . . . 0.0 111.883 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.21 32.99 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.398 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.72 -177.01 5.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.857 0.361 . . . . 0.0 111.263 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.887 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.03 154.89 37.1 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.96 -24.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.867 2.378 . . . . 0.0 112.596 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.8 mt-10 -102.43 -42.21 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.595 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -80.22 -10.35 59.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.951 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.6 -52.24 65.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.749 0.309 . . . . 0.0 111.201 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.747 ' O ' HD13 ' A' ' 54' ' ' LEU . 1.3 m -78.09 -46.6 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.7 t -52.61 -37.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -78.5 -52.17 8.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.677 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 40' ' ' ILE . 2.5 mm-40 -65.28 -25.98 67.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 50' ' ' VAL . 2.0 mp -54.05 -44.58 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.597 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -30.78 69.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 -31.07 52.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.393 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.585 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.76 7.0 26.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.969 HG12 HG13 ' A' ' 60' ' ' ILE . 4.7 t -133.32 -44.64 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 51.65 18.04 3.64 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.969 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.63 -170.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.871 0.836 . . . . 0.0 110.839 179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.819 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -115.28 87.09 15.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.91 179.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG3' HG11 ' A' ' 58' ' ' VAL . 10.6 Cg_endo -117.35 145.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.511 2.807 . . . . 0.0 115.177 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 89' ' ' ARG . 93.7 mt-30 -74.95 79.22 2.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 174.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.943 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.78 123.3 42.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.888 -175.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -176.68 -138.78 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.011 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m 53.19 169.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.245 0.545 . . . . 0.0 112.153 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.9 tt -128.87 109.56 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.374 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.778 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.59 -46.87 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 109.971 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 tt0 -171.67 155.56 4.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.83 132.1 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.599 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.635 HD22 ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.18 158.8 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.448 ' N ' HD22 ' A' ' 71' ' ' LEU . 7.5 tt0 -140.04 128.31 22.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.5 p90 -141.0 147.62 38.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -121.08 132.26 54.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.256 0.551 . . . . 0.0 111.553 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -82.11 163.79 51.33 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.107 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.4 Cg_endo -49.64 82.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.185 2.59 . . . . 0.0 112.459 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 94.37 16.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.524 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt180 -137.45 150.16 47.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -121.57 116.31 24.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.942 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 73' ' ' TYR . 1.8 tt -122.34 121.22 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.788 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.07 134.62 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 71' ' ' LEU . 6.6 mt -125.64 114.26 18.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -109.21 122.49 47.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.37 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -104.25 121.17 42.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.628 ' CE2' HG11 ' A' ' 50' ' ' VAL . 20.6 m95 -108.15 148.89 29.25 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.544 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 46.3 tp -93.34 103.12 15.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.505 0.669 . . . . 0.0 111.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.943 HG22 ' ND1' ' A' ' 64' ' ' HIS . 17.4 t -88.71 145.59 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.654 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -102.2 -55.4 2.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -163.4 165.85 23.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.931 0.787 . . . . 0.0 112.854 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.65 ' CE3' HG22 ' A' ' 11' ' ' ILE . 48.7 p90 -128.53 140.1 51.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.787 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.819 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.9 OUTLIER -93.07 85.48 5.1 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 120.903 0.382 . . . . 0.0 110.411 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.57 -119.19 2.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.289 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 10.0 tt0 -135.12 131.12 19.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.434 0.159 . . . . 0.0 110.74 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 5.7 Cg_exo -77.07 128.87 10.15 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.895 2.397 . . . . 0.0 111.606 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.569 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 50.9 p-90 -142.19 -58.47 0.46 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.936 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 42.81 -96.13 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.017 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.08 39.34 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.761 0.315 . . . . 0.0 110.737 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -58.57 -47.64 83.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.03 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.74 -62.67 0.55 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.253 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -109.93 93.89 16.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 111.828 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -43.82 125.92 5.49 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.017 2.478 . . . . 0.0 112.643 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.72 177.47 17.48 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.004 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -120.54 157.25 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.6 0.238 . . . . 0.0 110.631 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.401 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.1 m0 -61.04 106.9 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.399 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.608 ' HG3' HD12 ' A' ' 20' ' ' ILE . 8.1 ptp -120.2 163.19 18.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.241 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.661 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -83.94 131.93 34.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.952 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.15 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.3 p -61.2 -13.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.936 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.71 38.95 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.109 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 107' ' ' LEU . 9.0 tp -70.55 140.54 51.8 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.16 134.8 54.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.4 61.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.883 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -49.12 13.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.559 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.74 -38.79 83.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.48 174.08 6.62 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.408 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.46 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 65.2 Cg_endo -74.15 127.85 11.67 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.258 1.972 . . . . 0.0 111.515 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.0 -14.82 29.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.658 2.239 . . . . 0.0 113.181 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.09 -9.79 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.1 38.23 3.81 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.713 0.292 . . . . 0.0 111.692 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.6 tt0 -71.17 -45.09 14.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -54.88 -37.36 92.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.119 1.879 . . . . 0.0 112.271 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.45 -51.45 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.143 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.525 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -68.59 -29.84 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.923 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -28.69 53.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.975 0.417 . . . . 0.0 110.672 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.74 -49.19 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.065 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.778 HD22 ' CE2' ' A' ' 68' ' ' PHE . 9.7 tp -78.11 -27.51 48.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.272 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -58.86 -42.6 89.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -74.51 -2.96 28.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.902 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 108' ' ' VAL . 3.3 mt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.162 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.02 136.33 33.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 80' ' ' ILE . 1.2 pp -138.18 138.56 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.43 ' O ' HD13 ' A' ' 6' ' ' ILE . 27.7 mt-30 -102.84 155.22 18.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.207 0.527 . . . . 0.0 111.312 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' THR . 39.7 mm -146.5 139.29 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.641 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.942 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.58 150.28 46.11 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.564 HG11 ' CE1' ' A' ' 84' ' ' PHE . 0.4 OUTLIER -145.45 148.86 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.906 0.384 . . . . 0.0 110.935 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.57 107.37 0.33 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.886 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.676 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.41 103.87 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.802 HG21 ' CD2' ' A' ' 19' ' ' PHE . 1.2 tt -70.62 111.61 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.755 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.606 ' HG2' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -87.52 138.08 31.78 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.376 -179.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.76 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.3 p30 -90.52 -173.3 3.72 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.336 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 13.5 tp10 -78.24 0.91 23.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.326 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -122.38 40.33 3.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.97 21.35 2.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 111.576 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 22.1 mt-10 -113.85 161.94 16.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.676 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.25 135.79 58.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.92 0.391 . . . . 0.0 111.729 -178.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.802 ' CD2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -88.79 102.44 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.367 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.54 162.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.855 HG21 ' CD ' ' A' ' 98' ' ' GLU . 6.6 p . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 120.757 0.313 . . . . 0.0 110.608 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.522 0.201 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.36 10.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.2 tt -45.23 93.55 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.3 OUTLIER -126.33 -179.97 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 111.566 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.68 168.17 10.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.174 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.1 Cg_endo -46.95 168.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.276 2.65 . . . . 0.0 111.75 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.68 59.02 0.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.243 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -146.13 101.57 0.24 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.439 -0.88 . . . . 0.0 112.25 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.631 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 128.01 -9.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.374 0.67 . . . . 0.0 110.723 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.942 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -43.31 -74.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.618 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -8.22 -82.16 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.565 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 44.35 -93.36 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.505 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.58 17.21 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.485 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.89 -163.45 0.59 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.596 0.236 . . . . 0.0 110.807 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.909 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.73 155.82 38.3 Favored Pre-proline 0 N--CA 1.456 -0.162 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.909 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.82 -24.7 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.685 2.256 . . . . 0.0 112.442 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.719 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.7 mm-40 -94.33 -54.98 3.33 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.49 -4.98 55.89 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.4 -57.04 9.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.623 0.249 . . . . 0.0 110.974 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.726 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -78.37 -39.91 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.362 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 47' ' ' GLU . 56.7 t -50.68 -35.81 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -49.47 13.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 110.422 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 44.1 tp10 -64.41 -21.09 66.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.482 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.641 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.6 tp -57.02 -44.67 83.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -30.48 67.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.55 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.2 -26.27 64.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.442 . . . . 0.0 110.565 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.714 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.31 7.25 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.114 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.782 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.45 -44.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.161 0.505 . . . . 0.0 110.013 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.4 -40.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 114.519 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.782 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.59 -173.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.651 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -110.65 88.62 8.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.826 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 2.9 Cg_endo -111.12 152.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.706 0 C-N-CA 122.966 2.444 . . . . 0.0 114.555 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.494 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 42.8 mt-30 -74.66 80.06 2.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.033 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.2 t-160 -127.32 127.3 44.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.319 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.13 -136.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.634 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 54.03 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.196 0.522 . . . . 0.0 112.358 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.608 ' O ' HD23 ' A' ' 67' ' ' LEU . 7.2 tt -125.14 110.34 13.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.74 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.98 -39.76 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.603 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -171.52 164.34 6.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.778 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 112.14 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.933 HD23 ' CD1' ' A' ' 82' ' ' LEU . 15.3 tp -99.53 128.0 45.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.35 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -131.21 110.56 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.607 ' HE1' HD11 ' A' ' 82' ' ' LEU . 2.5 p90 -139.41 150.23 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.415 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.09 124.79 45.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.232 0.539 . . . . 0.0 111.613 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.65 163.3 69.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.233 179.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.1 Cg_endo -50.82 83.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.966 2.444 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.3 m-20 94.29 16.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.342 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 148.7 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -120.76 97.35 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.446 HD12 HD11 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -102.97 111.89 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.743 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' ILE . 54.0 m -114.96 126.8 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.933 ' CD1' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.46 115.5 19.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.228 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.544 ' O ' HG13 ' A' ' 8' ' ' VAL . 12.5 m0 -94.6 122.87 37.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CE1' HG11 ' A' ' 8' ' ' VAL . 3.0 m-85 -99.68 109.78 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 61.5 m95 -95.72 148.53 22.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.6 tp -102.1 102.92 13.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.298 0.57 . . . . 0.0 112.034 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.033 HG22 ' CD2' ' A' ' 64' ' ' HIS . 12.8 t -80.52 145.56 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.649 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.83 -43.11 3.66 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.05 166.25 23.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.786 0.721 . . . . 0.0 112.377 -178.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.76 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 28.0 p90 -137.56 148.78 46.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.745 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.01 96.3 8.06 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 -138.49 14.84 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.779 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.4 tt0 -106.07 122.63 41.68 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 2.9 Cg_exo -76.3 129.02 10.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.898 2.399 . . . . 0.0 112.192 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.742 ' HE1' HG23 ' A' ' 60' ' ' ILE . 3.6 p-90 -126.2 -77.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.741 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.714 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 67.33 -66.96 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.856 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 96.28 69.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.039 0.535 . . . . 0.0 110.811 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.855 ' CD ' HG21 ' A' ' 21' ' ' THR . 1.1 pp20? -83.36 -35.7 24.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.86 -52.13 0.16 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.001 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -140.05 117.97 8.41 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.48 . . . . 0.0 111.621 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -43.72 144.87 2.09 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.923 2.415 . . . . 0.0 112.654 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.3 19.23 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.637 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -125.89 157.33 37.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.532 0.206 . . . . 0.0 110.603 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.486 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.0 m0 -60.89 105.81 0.51 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.3 ptm -120.76 154.21 35.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.542 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.5 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -72.36 124.64 25.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.027 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -80.06 -18.89 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.547 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.0 p -54.14 -18.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.48 41.47 1.72 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.024 HD12 HD21 ' A' ' 107' ' ' LEU . 3.1 tt -62.88 148.05 48.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.569 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -123.22 131.22 53.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -15.12 61.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.493 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.5 -49.28 13.67 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.12 -38.34 85.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.092 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.97 173.6 7.46 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.293 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.9 Cg_endo -74.3 128.02 11.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.24 1.96 . . . . 0.0 111.678 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.97 -14.84 35.21 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.682 2.255 . . . . 0.0 113.175 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.78 -9.8 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.543 HD21 HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -128.76 37.72 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.332 -179.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.08 -43.5 3.65 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.8 Cg_exo -45.2 -40.84 16.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.21 1.94 . . . . 0.0 113.166 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.0 t -77.51 -51.27 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.209 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.5 mm -65.83 -33.69 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.467 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.92 -28.43 50.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.883 0.373 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.26 -53.15 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.682 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 129' ' ' LEU . 5.2 tp -78.52 -36.88 44.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.75 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.635 ' HB2' HG22 ' A' ' 123' ' ' ILE . 17.2 ttpt -53.76 -42.71 68.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.9 0.381 . . . . 0.0 111.126 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -7.65 25.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.808 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 126' ' ' LEU . 8.2 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.042 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.7 tttt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.861 0.362 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 133.3 38.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.656 HD11 HG13 ' A' ' 80' ' ' ILE . 3.0 pp -146.04 139.54 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 36.9 mt-30 -102.85 154.08 19.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.234 0.54 . . . . 0.0 111.881 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 40.0 mm -146.54 118.8 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.909 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.961 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.21 150.28 47.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.388 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -145.22 162.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.128 0.49 . . . . 0.0 111.472 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -136.79 114.81 1.18 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.203 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.955 HG22 HG21 ' A' ' 18' ' ' ILE . 1.5 mt -70.87 98.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.904 HG23 HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.95 122.46 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.406 0.622 . . . . 0.0 112.276 -177.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -86.27 127.36 34.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.708 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 2.8 t-20 -73.24 -171.92 1.03 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 122.092 0.949 . . . . 0.0 112.692 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.69 -13.63 15.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.627 -1.624 . . . . 0.0 113.271 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -132.34 -82.93 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.799 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -149.82 14.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.71 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 1.8 pt-20 -100.72 160.39 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.955 HG21 HG22 ' A' ' 10' ' ' ILE . 6.1 mt -135.97 138.6 47.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 111.911 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -76.88 94.12 3.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.127 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.21 139.16 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.419 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.435 HG22 ' CD ' ' A' ' 98' ' ' GLU . 6.3 p . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.698 0.285 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.9 ttpp -110.6 26.06 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.408 ' N ' ' HA ' ' A' ' 115' ' ' PHE . 17.2 tp -66.4 69.25 0.06 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.629 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -106.92 -168.64 1.43 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 111.68 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.729 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.67 168.67 9.69 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.468 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 79.9 Cg_endo -80.11 169.3 17.81 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.459 3.44 . . . . 0.0 114.087 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 104.17 -1.63 43.91 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.14 161.66 29.04 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.565 0.682 . . . . 0.0 112.649 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.6 5.5 0.37 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.879 0.471 . . . . 0.0 111.792 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.961 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.5 pt -54.96 -25.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.588 0.708 . . . . 0.0 110.331 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.57 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.391 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.1 mtp 32.12 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.502 0.501 . . . . 0.0 111.961 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.99 32.46 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.572 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.72 -172.07 3.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.883 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.79 155.27 36.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.328 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.883 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.95 -24.96 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 112.596 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.7 mt-10 -101.65 -44.24 5.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.538 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -80.2 -6.1 57.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.925 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.28 -56.15 21.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.908 HG11 ' NE1' ' A' ' 85' ' ' TRP . 3.4 m -78.2 -45.3 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.303 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 47' ' ' GLU . 43.7 t -56.17 -39.27 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.501 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -78.36 -51.87 9.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.744 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 0.6 OUTLIER -68.98 -23.2 64.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.738 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -50.47 -44.28 55.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -33.92 65.43 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.72 -25.26 49.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.53 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.505 ' OE1' ' HA2' ' A' ' 37' ' ' GLY . 9.0 mp0 -108.43 5.09 25.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.979 HG12 HG13 ' A' ' 60' ' ' ILE . 8.6 t -134.82 -44.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.225 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.69 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 60.82 1.63 2.04 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.245 -0.889 . . . . 0.0 114.318 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.979 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.05 -172.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.695 0.748 . . . . 0.0 110.141 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 p -113.38 87.89 12.1 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.618 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.0 Cg_endo -112.68 144.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.563 2.842 . . . . 0.0 113.9 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 4.8 pt20 -74.75 79.95 2.07 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.933 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.04 129.65 53.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.795 -175.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.606 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -176.66 -142.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.291 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 57.28 154.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.231 0.539 . . . . 0.0 112.21 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.543 HD11 ' HG2' ' A' ' 70' ' ' LYS . 3.0 tt -117.83 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.5 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.622 ' HE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.49 -54.05 7.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 109.94 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.4 tt0 -171.58 145.81 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -136.79 117.99 14.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.321 . . . . 0.0 110.654 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.574 ' CD2' HG21 ' A' ' 122' ' ' VAL . 1.1 pp -98.58 147.05 25.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.22 112.07 11.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -137.75 128.95 27.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.75 118.62 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.052 0.453 . . . . 0.0 111.422 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.96 162.72 66.66 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.387 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 2.2 Cg_endo -44.96 81.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.438 2.759 . . . . 0.0 112.595 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 36.6 t0 104.08 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.87 150.26 20.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.872 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -121.75 93.82 4.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.679 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.656 HG13 HD11 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -93.17 135.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.3 118.91 22.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.513 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.534 ' HG ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -115.08 114.34 25.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.255 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.85 129.73 55.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 8' ' ' VAL . 9.0 m-30 -115.79 112.12 21.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.999 0.428 . . . . 0.0 110.798 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.908 ' NE1' HG11 ' A' ' 50' ' ' VAL . 43.6 m95 -94.9 149.32 21.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.461 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 65' ' ' PHE . 23.3 tp -97.71 102.8 14.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.54 0.686 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.933 HG22 ' ND1' ' A' ' 64' ' ' HIS . 11.5 t -85.44 146.22 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.693 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.44 -39.4 6.14 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.85 165.43 25.27 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.96 0.8 . . . . 0.0 111.835 -178.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.672 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.3 p90 -147.6 128.49 14.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.714 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -77.35 113.19 14.88 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.54 -122.14 6.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.456 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.5 mt-10 -135.06 137.52 27.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.418 0.151 . . . . 0.0 110.825 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.564 ' CA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.31 128.84 10.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.781 2.321 . . . . 0.0 111.395 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.69 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.8 p-90 -128.68 -59.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.901 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.02 -98.82 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.99 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 177.61 37.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.716 0.293 . . . . 0.0 111.171 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.435 ' CD ' HG22 ' A' ' 21' ' ' THR . 8.9 pt-20 -52.04 -41.92 62.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.82 -5.35 42.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.324 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -140.1 97.71 7.76 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 111.457 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -43.49 145.09 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.073 2.516 . . . . 0.0 112.802 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.11 19.42 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -141.81 157.16 45.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -65.57 105.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.486 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.4 ptm -120.71 163.39 18.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.954 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.548 ' HB2' HG12 ' A' ' 108' ' ' VAL . 28.0 p -86.33 114.74 23.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.817 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.96 -18.85 60.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.3 p -54.22 -18.82 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.935 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.2 49.8 0.83 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.071 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 123' ' ' ILE . 8.3 tt -62.71 150.36 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.635 0.255 . . . . 0.0 110.427 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.04 131.65 55.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.38 61.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.367 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -46.66 17.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.232 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -71.9 -22.53 61.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.105 -179.073 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -97.35 174.53 3.17 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.7 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 70.4 Cg_endo -75.3 136.02 19.26 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.277 1.985 . . . . 0.0 111.601 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.59 -14.36 35.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.901 2.401 . . . . 0.0 113.191 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -12.24 22.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.534 ' ND2' ' HG ' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -130.87 37.96 3.74 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -76.06 -48.1 3.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.009 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.4 Cg_exo -53.68 -38.29 84.47 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.371 2.047 . . . . 0.0 112.158 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 71' ' ' LEU . 1.6 t -77.19 -51.05 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.666 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.48 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -66.09 -29.98 48.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.13 -30.99 60.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.526 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -74.81 -52.0 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.429 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.622 HD13 ' HE2' ' A' ' 68' ' ' PHE . 2.3 tp -78.19 -19.73 53.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.641 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HB2' HG22 ' A' ' 123' ' ' ILE . 6.6 ttpp -80.38 -42.59 22.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.554 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.62 -8.8 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.907 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.557 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.44 121.97 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.655 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.9 pp -124.45 120.42 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -103.3 150.88 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.655 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.3 mp -141.92 134.38 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.48 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.708 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.96 158.03 34.63 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -145.59 162.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.933 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.56 104.74 0.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.608 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.069 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.7 109.19 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.703 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -70.82 124.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.378 0.608 . . . . 0.0 112.323 -177.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.726 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.92 124.18 30.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.418 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.567 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 19.8 t-20 -69.56 177.26 3.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.015 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tp10 -56.05 -18.65 10.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.6 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -121.19 -82.38 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.738 0.304 . . . . 0.0 111.519 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.97 15.56 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.711 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.537 ' C ' HD12 ' A' ' 18' ' ' ILE . 2.1 mp0 -100.83 160.51 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.069 HG21 HG22 ' A' ' 10' ' ' ILE . 3.8 mp -134.0 139.84 47.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.437 . . . . 0.0 111.167 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.512 ' HE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -93.67 113.84 26.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.898 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.545 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -123.16 159.11 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.557 179.315 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.9 p . . . . . 0 C--N 1.326 -0.414 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.511 0.196 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.46 26.3 10.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.747 0.308 . . . . 0.0 111.667 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 114' ' ' ASP . 1.4 tt -52.78 86.41 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.703 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -122.09 179.8 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.778 -179.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 166.59 14.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.736 -179.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 7.6 Cg_endo -47.64 168.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.609 2.873 . . . . 0.0 111.461 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.24 59.78 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.75 -1.214 . . . . 0.0 114.209 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.42 103.14 0.49 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 114.765 -0.718 . . . . 0.0 112.069 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 125.56 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.395 0.678 . . . . 0.0 111.525 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.668 HG21 ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -42.82 -46.16 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.494 0.664 . . . . 0.0 111.005 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.94 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.263 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 34.73 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.88 24.25 0.08 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -90.04 -159.26 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.431 0.157 . . . . 0.0 110.747 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -100.72 152.74 37.92 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.64 -24.58 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.622 2.214 . . . . 0.0 112.192 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.94 -49.66 4.46 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -80.54 -8.82 59.72 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.651 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -66.98 -57.33 7.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.375 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.557 HG22 ' CD1' ' A' ' 54' ' ' LEU . 2.3 p -78.92 -35.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.459 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 47' ' ' GLU . 70.0 t -50.3 -35.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.333 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -34.82 47.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.501 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -76.95 -22.22 53.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.686 HD21 ' CG ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -55.42 -44.39 76.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.02 74.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.149 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -27.61 52.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.459 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.9 mt-10 -108.22 5.47 25.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.986 HG12 HG13 ' A' ' 60' ' ' ILE . 17.0 t -134.5 -44.35 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.179 0.514 . . . . 0.0 110.369 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.653 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.22 18.04 12.53 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 114.744 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.986 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -128.38 -168.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 117.674 0.737 . . . . 0.0 110.676 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.685 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -116.28 86.73 18.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.923 179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.8 Cg_endo -117.18 139.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 123.819 3.013 . . . . 0.0 114.532 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 31.7 mt-30 -74.84 79.32 2.11 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 174.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.028 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.0 OUTLIER -114.22 126.72 55.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.142 -175.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -174.52 -150.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.846 -179.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.77 -177.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.903 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.6 pp -144.85 129.94 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.11 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -46.2 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.983 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.32 131.36 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.142 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.636 ' HE2' HD13 ' A' ' 67' ' ' LEU . 1.1 ptpm? -113.82 132.14 55.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.799 0.333 . . . . 0.0 111.006 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 122' ' ' VAL . 9.7 tp -112.24 137.68 50.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.653 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.42 109.91 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.675 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -140.51 149.14 42.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.19 140.05 52.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.254 0.549 . . . . 0.0 111.429 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -87.7 163.12 39.71 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.435 179.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -52.52 82.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.004 2.469 . . . . 0.0 112.137 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 11.9 t0 97.08 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.187 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 75' ' ' PHE . 7.3 ttp-105 -137.34 150.34 47.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -123.79 96.96 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.871 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 4' ' ' LEU . 2.8 tt -100.73 111.88 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 110.984 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.76 131.73 45.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.408 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -125.78 114.27 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.3 m0 -112.89 122.8 48.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.632 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -106.4 116.89 32.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 110.291 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.4 m95 -94.51 148.35 22.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.635 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.5 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.3 tp -102.87 102.9 13.03 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.319 0.58 . . . . 0.0 111.288 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.028 HG22 ' CD2' ' A' ' 64' ' ' HIS . 28.9 t -83.93 145.44 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.132 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.55 ' C ' ' HG2' ' A' ' 89' ' ' ARG . 8.1 pt-20 -115.8 -17.49 11.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -161.89 165.62 27.41 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.878 1.217 . . . . 0.0 112.185 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.703 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -157.54 130.03 7.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.977 178.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.685 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -99.68 161.25 13.73 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.12 -128.41 28.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.657 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.3 tt0 -127.12 127.88 24.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HA ' HG12 ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.9 128.56 10.1 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.561 2.174 . . . . 0.0 112.69 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.653 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 7.8 p-90 -133.79 -62.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.0 110.116 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 -67.45 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.789 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' TRP . 1.6 mmtt 81.45 43.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.966 0.412 . . . . 0.0 110.662 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -71.42 -29.31 64.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.806 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.72 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.794 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.428 ' O ' HG22 ' A' ' 21' ' ' THR . 3.9 mp0 -140.05 105.08 6.72 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -43.78 144.48 2.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.858 2.372 . . . . 0.0 112.388 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 169.64 22.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.93 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.21 157.31 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.74 106.05 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.581 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.1 ptm -120.56 163.25 18.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.797 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.6 t -72.87 114.86 11.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.668 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 18' ' ' ILE . 11.8 tp -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.314 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.56 -13.33 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.506 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.94 34.76 5.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.871 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 123' ' ' ILE . 11.7 tp -62.54 131.53 49.41 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 132.29 54.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.42 61.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.285 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.78 -49.19 13.42 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.382 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.613 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -67.4 -38.34 84.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.674 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.89 174.06 6.7 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.4 Cg_endo -73.79 127.84 11.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.052 1.835 . . . . 0.0 111.355 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.53 -14.72 26.96 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.634 2.223 . . . . 0.0 113.289 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.75 -9.82 31.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.67 42.3 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 tt0 -73.22 -38.77 4.6 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 73.3 Cg_exo -51.17 -41.41 57.94 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.1 1.866 . . . . 0.0 113.033 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.26 -51.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.405 . . . . 0.0 111.273 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.53 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.6 mm -65.97 -29.85 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.47 -29.85 62.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -80.09 -46.56 16.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 68' ' ' PHE . 7.6 tp -78.14 -26.42 47.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 111.257 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -58.4 -42.57 87.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.141 0.496 . . . . 0.0 110.648 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 1.5 tpp180 -71.12 -5.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.875 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.225 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.852 0.358 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.01 132.59 49.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.94 129.72 22.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.853 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 mt-30 -102.74 148.89 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.169 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.853 HD13 ' O ' ' A' ' 5' ' ' GLN . 24.0 mm -135.54 134.13 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.94 125.19 43.54 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -131.63 155.7 41.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.251 0.548 . . . . 0.0 111.813 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.62 137.42 7.5 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.339 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.721 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -85.73 94.72 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.384 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.979 HG23 HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -71.68 118.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.194 0.521 . . . . 0.0 111.351 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.262 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.621 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 7.4 p-10 -110.17 -173.52 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -45.99 -28.5 1.17 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.075 -1.42 . . . . 0.0 113.432 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -92.58 26.74 2.54 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.578 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.91 25.89 0.34 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.211 0.529 . . . . 0.0 110.51 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 17.2 pt-20 -114.22 160.16 19.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.212 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.75 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -112.15 135.96 49.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.347 0.594 . . . . 0.0 112.441 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 10.9 t80 -91.02 103.27 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.933 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.458 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.58 147.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.926 0.394 . . . . 0.0 110.863 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 98' ' ' GLU . 4.8 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.938 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 mttt -114.36 26.01 10.6 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.962 0.41 . . . . 0.0 111.387 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -55.73 86.2 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.9 tt0 -106.89 -170.96 1.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.14 0.495 . . . . 0.0 111.741 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.668 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.86 166.04 16.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.44 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 61.1 Cg_endo -71.07 168.86 22.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.548 2.832 . . . . 0.0 111.708 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.43 59.36 0.72 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.601 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.44 120.02 3.4 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 114.118 -1.041 . . . . 0.0 111.527 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 119.05 -10.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.417 0.687 . . . . 0.0 110.727 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.915 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -37.78 -63.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.33 0.586 . . . . 0.0 111.358 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' N ' HG12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -15.41 -81.25 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.375 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.69 -93.27 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.696 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.6 22.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.447 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.6 -159.22 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.521 0.2 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.901 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.44 155.61 37.68 Favored Pre-proline 0 N--CA 1.457 -0.082 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.901 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -44.07 -24.83 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.781 2.321 . . . . 0.0 112.428 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.681 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.0 mm-40 -100.0 -49.6 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.8 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -80.42 -4.58 54.21 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -64.61 -57.45 9.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.596 0.236 . . . . 0.0 111.214 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.51 ' N ' HD12 ' A' ' 40' ' ' ILE . 1.2 p -78.79 -40.86 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.494 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.6 t -50.2 -35.22 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -52.16 9.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.212 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -67.51 -19.91 65.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.941 HD11 ' CE1' ' A' ' 64' ' ' HIS . 7.9 tp -56.61 -44.44 81.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 110.459 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -26.78 68.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.836 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.2 tm-20 -75.36 -26.77 58.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.396 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.97 6.82 25.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.978 HG12 HG13 ' A' ' 60' ' ' ILE . 8.2 t -131.46 -43.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.062 0.458 . . . . 0.0 110.395 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 57.46 7.34 2.9 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.751 -0.659 . . . . 0.0 114.679 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.978 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.9 -166.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.928 0.864 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.643 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -113.16 87.89 11.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.888 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.684 ' HG3' HG11 ' A' ' 58' ' ' VAL . 11.7 Cg_endo -113.51 133.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.852 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 7.9 pt20 -74.75 79.22 2.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.941 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -112.16 130.02 56.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.539 -175.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -178.17 -142.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.053 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t 52.75 171.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 112.16 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 67' ' ' LEU . 4.2 tt -131.31 105.65 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.404 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.64 -40.97 47.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.982 0.42 . . . . 0.0 110.121 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.8 tt0 -171.27 159.88 5.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.43 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -143.25 132.16 22.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.818 0.342 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' A' ' 122' ' ' VAL . 5.5 tp -122.39 128.95 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.649 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.739 ' CD ' HG23 ' A' ' 81' ' ' THR . 1.1 tp10 -129.35 110.84 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.712 ' HE1' HD12 ' A' ' 82' ' ' LEU . 3.4 p90 -138.49 104.48 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.545 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 15.8 pt-20 -88.5 126.62 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.044 0.449 . . . . 0.0 111.526 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -70.08 163.55 60.4 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.934 179.138 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -38.75 -28.51 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.499 2.799 . . . . 0.0 113.103 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -32.61 0.58 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.426 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 26.8 ttm180 -94.18 97.95 10.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.337 . . . . 0.0 111.61 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 9.4 m170 -78.97 100.21 7.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -104.59 130.89 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.739 HG23 ' CD ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -121.44 132.01 54.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.465 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.911 HD13 ' OD1' ' A' ' 119' ' ' ASN . 22.2 mt -126.24 114.5 18.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.474 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -107.65 122.59 47.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.589 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.726 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -100.64 109.56 21.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.429 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.484 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 21.8 m95 -96.31 148.6 22.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.54 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.567 HD12 ' OE2' ' A' ' 88' ' ' GLU . 1.9 tm? -90.83 103.03 15.79 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.315 0.579 . . . . 0.0 111.35 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.979 HG11 HG23 ' A' ' 11' ' ' ILE . 18.9 t -90.5 145.3 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.567 ' OE2' HD12 ' A' ' 86' ' ' LEU . 1.7 mm-40 -113.85 -25.39 8.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.537 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -163.5 165.86 23.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.105 1.32 . . . . 0.0 112.809 -178.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.684 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -157.12 124.5 5.28 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.623 178.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.643 ' CB ' HG23 ' A' ' 61' ' ' THR . 0.7 OUTLIER -80.06 117.99 21.38 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.801 0.334 . . . . 0.0 111.126 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.25 -123.34 6.97 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.445 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.8 mt-10 -129.46 137.78 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 122.952 -0.146 . . . . 0.0 110.63 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.608 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.8 Cg_exo -76.67 128.94 10.52 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.778 2.319 . . . . 0.0 110.969 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 51.1 p-90 -140.26 -58.99 0.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 48.55 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.578 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -179.37 32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.628 0.252 . . . . 0.0 111.219 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -63.96 -24.93 67.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.57 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.06 73.18 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.429 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.446 ' O ' ' HB ' ' A' ' 21' ' ' THR . 23.4 mt-30 -140.36 100.64 6.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 129.59 7.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.883 2.389 . . . . 0.0 112.385 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.429 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.09 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.14 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -153.27 157.13 39.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -71.59 105.69 3.75 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.824 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.464 ' C ' ' HB2' ' A' ' 17' ' ' GLU . 28.0 ptm -120.58 147.55 45.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.063 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.428 ' OG ' HG12 ' A' ' 108' ' ' VAL . 1.3 t -67.85 124.99 24.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.846 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.817 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.4 tm? -71.92 -20.76 61.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.225 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' A' ' 129' ' ' LEU . 11.7 p -55.13 -19.47 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.521 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.82 36.89 3.73 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.872 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 107' ' ' LEU . 10.6 tp -62.74 129.11 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.99 134.79 54.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.601 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -15.37 61.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.674 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -78.89 -49.25 13.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.772 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -30.31 68.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.652 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -88.45 173.97 5.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.621 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 72.3 Cg_endo -76.86 130.16 11.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.433 2.089 . . . . 0.0 111.596 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.58 -14.44 13.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.938 2.425 . . . . 0.0 113.728 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.71 -10.24 11.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.911 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -136.24 45.67 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.742 0.306 . . . . 0.0 111.465 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.52 -54.41 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.01 -33.09 7.24 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.396 2.064 . . . . 0.0 112.416 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.726 HG11 ' CD2' ' A' ' 84' ' ' PHE . 25.8 t -77.57 -51.03 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.668 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 16.6 mm -65.59 -29.77 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.4 56.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 110.626 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -47.44 14.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.449 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.769 ' O ' HD22 ' A' ' 129' ' ' LEU . 11.1 tp -78.18 -19.43 53.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.517 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 123' ' ' ILE . 3.8 ttpm? -71.14 -42.6 68.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 110.643 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -68.24 -9.46 47.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.004 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.125 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.623 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mttm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 145.94 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.645 ' CD1' HD11 ' A' ' 6' ' ' ILE . 2.8 pp -146.02 124.35 12.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.95 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.2 mt-30 -102.49 155.72 18.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.727 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.7 mp -146.16 132.29 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.503 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.065 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.4 124.74 43.0 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -126.79 162.12 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.0 112.214 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.31 116.27 0.86 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.908 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.724 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.47 96.02 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.764 HG22 ' CG ' ' A' ' 64' ' ' HIS . 2.4 pt -79.35 111.68 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.164 0.507 . . . . 0.0 112.171 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.796 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.1 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.937 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.635 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.5 p-10 -125.34 -173.83 2.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -22.21 12.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.326 -1.307 . . . . 0.0 113.534 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -98.08 30.77 2.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.336 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.41 28.92 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.316 0.579 . . . . 0.0 110.264 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.7 mt-10 -117.71 160.34 21.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.957 HG21 HD23 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -114.62 136.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.045 0.45 . . . . 0.0 111.596 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.916 ' N ' HD13 ' A' ' 18' ' ' ILE . 44.5 t80 -87.88 93.68 9.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.619 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -114.68 162.2 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.621 HG21 ' CD ' ' A' ' 98' ' ' GLU . 27.9 p . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.611 0.243 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.49 26.47 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.602 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.651 HD21 HD12 ' A' ' 20' ' ' ILE . 2.5 tt -56.03 80.4 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -106.84 -168.31 1.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.945 0.402 . . . . 0.0 111.346 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.724 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.58 157.39 51.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.614 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.519 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 21.4 Cg_endo -60.06 167.37 7.45 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.216 2.61 . . . . 0.0 111.183 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.1 58.83 0.78 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.782 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -122.8 130.69 7.96 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.674 -0.763 . . . . 0.0 111.803 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 102.11 4.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.137 0.575 . . . . 0.0 111.695 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.065 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -54.95 -25.91 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.43 0.633 . . . . 0.0 110.547 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.28 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.965 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.1 mmm 35.49 -85.52 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.422 0.451 . . . . 0.0 111.807 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.42 30.63 0.15 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.385 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.5 mp0 -91.86 -178.27 4.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.01 155.9 36.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.27 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.96 -24.78 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.847 2.365 . . . . 0.0 112.715 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.692 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.3 mt-10 -95.11 -49.38 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -80.21 -23.25 41.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.021 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.49 -48.43 77.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.952 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.818 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.1 -47.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.756 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.1 t -58.54 -35.73 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.036 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -74.89 -52.07 12.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.619 ' CB ' HG22 ' A' ' 40' ' ' ILE . 5.5 tp10 -68.98 -26.47 65.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 6.1 tp -51.94 -44.07 63.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.47 -31.19 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.158 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.1 -23.84 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.234 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.62 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 9.1 mm-40 -108.11 6.57 27.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.543 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.918 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -134.13 -45.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 110.338 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 63.32 -27.32 0.08 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.934 1.133 . . . . 0.0 115.934 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.918 HD12 HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -93.94 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 117.771 0.786 . . . . 0.0 111.466 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.5 p -105.81 89.57 3.66 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.039 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 84.1 Cg_endo -109.57 137.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.438 2.759 . . . . 0.0 115.367 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 89' ' ' ARG . 70.9 mt-30 -75.55 79.46 2.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 174.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.771 ' HE2' ' HE3' ' A' ' 90' ' ' TRP . 1.8 m-70 -138.17 127.4 24.44 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.55 -173.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CE1' HG22 ' A' ' 51' ' ' VAL . 6.2 t80 173.5 173.72 0.14 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.028 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 5.4 t 106.14 154.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.736 0.814 . . . . 0.0 110.614 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.536 HD11 ' HE3' ' A' ' 70' ' ' LYS . 9.1 tt -106.75 146.88 30.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.675 ' HE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -117.13 -44.74 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.709 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.23 153.96 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.666 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE3' HD11 ' A' ' 67' ' ' LEU . 2.5 ptpp? -138.0 132.06 31.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 5.4 tp -118.01 124.39 48.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.737 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.82 109.88 17.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.538 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -134.42 153.22 52.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.648 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -114.89 140.13 49.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.291 0.567 . . . . 0.0 111.42 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -107.21 163.75 16.28 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.269 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 64.0 Cg_exo -39.26 81.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.457 2.772 . . . . 0.0 112.744 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.02 20.53 4.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.431 ' NH1' HD23 ' A' ' 4' ' ' LEU . 2.8 tpt85 -137.32 93.88 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -74.79 101.13 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -100.15 114.73 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.979 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 128.2 54.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.76 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.86 HD13 ' OD1' ' A' ' 119' ' ' ASN . 24.8 mt -126.07 114.64 18.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.277 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.2 m0 -105.05 122.54 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.701 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -99.41 109.86 22.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.038 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.788 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.2 m95 -99.69 148.16 24.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.033 0.444 . . . . 0.0 111.955 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.8 tp -91.34 122.2 33.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.137 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.639 HG12 ' CA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -124.06 145.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.921 -178.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 12' ' ' ARG . 10.7 tt0 -89.22 -69.78 0.69 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.51 166.08 25.3 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.19 0.519 . . . . 0.0 112.227 -177.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.771 ' HE3' ' HE2' ' A' ' 64' ' ' HIS . 47.8 p90 -115.78 163.01 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.254 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.67 72.27 0.95 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.72 0.295 . . . . 0.0 110.911 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 135.97 -115.97 1.41 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.637 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -134.18 118.77 14.14 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.554 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -75.74 128.97 11.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.836 2.357 . . . . 0.0 111.881 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.804 ' HE1' HG23 ' A' ' 60' ' ' ILE . 2.2 p-90 -121.86 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.705 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.62 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 60.55 -68.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.868 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 40.7 tttm 96.95 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.212 0.605 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.621 ' CD ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.16 -31.31 21.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.625 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.3 -15.52 2.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.99 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -140.06 101.36 7.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.954 0.407 . . . . 0.0 111.373 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.55 146.22 1.4 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.062 2.508 . . . . 0.0 112.623 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.428 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.24 177.37 19.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.888 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 13.8 tt0 -153.12 157.34 40.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.403 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.72 106.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.13 156.53 30.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.262 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.435 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -67.12 114.54 5.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.957 HD23 HG21 ' A' ' 18' ' ' ILE . 3.0 tm? -78.4 -21.34 49.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.487 HG22 HD21 ' A' ' 129' ' ' LEU . 10.9 p -63.41 -12.53 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.547 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.15 40.87 2.02 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.891 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 110' ' ' LEU . 11.7 tp -62.64 134.13 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 137.73 54.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.29 -15.73 61.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.577 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.97 -49.25 13.06 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.58 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.22 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.47 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.563 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.94 173.91 6.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.454 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.9 Cg_endo -77.17 137.09 16.79 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.372 2.048 . . . . 0.0 111.916 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 20.1 Cg_endo -60.05 -14.09 26.58 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.901 2.401 . . . . 0.0 113.258 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -9.81 10.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.86 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -138.91 47.52 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -70.36 -58.1 5.16 Favored Pre-proline 0 CA--C 1.531 0.231 0 O-C-N 122.214 -0.304 . . . . 0.0 111.389 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.46 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -44.73 -31.02 4.64 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.501 2.134 . . . . 0.0 112.522 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 84' ' ' PHE . 71.7 t -77.33 -50.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.59 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' A' ' 127' ' ' LYS . 26.8 mm -65.43 -31.54 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.83 36.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 110.902 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -51.61 8.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.696 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.675 HD13 ' HE2' ' A' ' 68' ' ' PHE . 11.8 tp -78.09 -30.1 49.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.496 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.668 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.8 ttpt -56.71 -42.53 79.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -67.47 -8.85 36.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.762 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.487 HD21 HG22 ' A' ' 108' ' ' VAL . 10.7 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.866 0.365 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -104.91 144.62 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.6 pp -138.08 127.03 24.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.439 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.2 mt-30 -102.44 157.56 16.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.332 0.587 . . . . 0.0 111.869 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.507 ' HB ' HD12 ' A' ' 82' ' ' LEU . 73.1 mt -146.23 130.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.694 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.13 125.07 43.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -129.25 162.6 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.427 0.632 . . . . 0.0 111.925 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -148.11 113.55 0.64 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.428 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.766 HD12 ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -70.75 99.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.732 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.26 119.57 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.275 0.56 . . . . 0.0 111.987 -178.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.63 141.79 28.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.883 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -100.12 -173.17 2.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.001 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -73.75 -10.1 59.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.267 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.456 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 23.1 t-20 -111.89 30.91 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.63 11.39 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.545 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' HB2' HD21 ' A' ' 13' ' ' ASN . 0.0 OUTLIER -101.99 161.34 13.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.63 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -116.0 131.71 67.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 0.0 111.75 -178.396 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 7.0 t80 -82.92 107.63 15.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.524 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.486 HG13 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -123.47 162.16 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 100' ' ' GLN . 4.3 p . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.593 0.235 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.53 25.95 10.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.928 0.394 . . . . 0.0 111.749 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.44 HD23 ' C ' ' A' ' 33' ' ' LEU . 3.3 tt -65.7 78.45 0.07 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.009 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.95 -171.9 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.766 ' CD2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.86 156.48 54.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.766 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.493 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 8.9 Cg_endo -49.27 168.0 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.637 2.891 . . . . 0.0 111.831 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.34 59.21 0.76 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.033 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.711 ' C ' ' HG2' ' A' ' 39' ' ' LYS . . . -118.56 159.94 14.16 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.615 -0.793 . . . . 0.0 111.993 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.711 ' HG2' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 49.12 23.13 0.71 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 111.561 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.049 HD12 ' HB1' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -61.81 -30.96 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.704 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.19 -80.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.028 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.9 mmt 41.32 -84.03 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.381 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.29 33.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.682 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 mp0 -93.56 -174.33 3.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.7 0.286 . . . . 0.0 111.266 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.867 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.92 153.98 38.98 Favored Pre-proline 0 N--CA 1.457 -0.124 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.378 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.867 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.69 -24.66 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.958 2.439 . . . . 0.0 112.532 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.7 mt-10 -98.1 -48.71 5.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -80.42 -26.09 38.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.049 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -55.48 -47.38 76.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.33 -51.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.295 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.1 t -52.82 -36.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.512 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -78.24 -43.31 28.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.203 0.525 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.59 ' HG2' HG22 ' A' ' 40' ' ' ILE . 10.8 tp10 -64.42 -27.37 68.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.289 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 64' ' ' HIS . 2.9 tp -56.57 -44.61 81.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -63.28 -35.41 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.431 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tm-20 -77.75 -26.13 49.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.477 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 36' ' ' PRO . 63.8 mm-40 -108.99 5.39 24.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.931 HG12 HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.84 -44.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.696 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.84 3.14 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.618 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.931 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.48 -173.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 117.907 0.853 . . . . 0.0 110.269 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 p -113.28 87.99 11.99 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.183 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.761 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.9 Cg_endo -113.23 145.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.612 2.875 . . . . 0.0 113.922 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.44 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 17.8 mt-30 -74.97 79.68 2.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.925 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -120.35 134.21 55.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.825 -176.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -179.3 -139.94 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 1.1 m 52.18 174.3 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.171 0.51 . . . . 0.0 112.111 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD11 ' CD ' ' A' ' 70' ' ' LYS . 6.1 tt -139.6 117.87 12.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.844 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.758 ' CE1' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.78 -55.61 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.221 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.614 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.1 mt-10 -171.13 131.38 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.441 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.762 ' CD ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.36 132.08 46.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.651 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.758 HD21 HG22 ' A' ' 122' ' ' VAL . 3.1 pp -140.56 161.95 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.666 ' HB2' HG23 ' A' ' 81' ' ' THR . 14.5 tt0 -125.69 124.1 40.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -120.88 152.71 38.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -120.76 120.9 36.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.151 0.5 . . . . 0.0 111.346 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -72.27 163.06 70.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.42 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.41 83.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.112 2.541 . . . . 0.0 112.316 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 16.8 m-20 95.29 15.2 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 8.2 tpp85 -137.44 150.14 47.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.7 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.7 105.6 10.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -111.36 154.31 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -127.25 131.18 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.647 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.536 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 11.2 tp -126.32 114.56 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.289 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.568 ' CH2' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -110.26 135.64 50.69 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.955 ' CD1' HG11 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -120.01 118.03 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.331 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.4 m95 -100.52 148.62 24.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.0 tp -96.6 102.89 14.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.46 0.648 . . . . 0.0 111.746 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.832 HG13 ' CB ' ' A' ' 64' ' ' HIS . 16.4 t -85.99 145.81 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.377 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.0 -39.77 5.65 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.8 ptp180 -163.24 165.67 24.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.837 0.744 . . . . 0.0 112.097 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.732 ' HE3' HG22 ' A' ' 11' ' ' ILE . 4.6 p90 -144.72 130.4 19.06 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.505 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.69 105.95 11.36 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.76 -122.82 7.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.446 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -134.97 137.07 26.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.401 0.143 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.594 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.45 128.75 10.57 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.755 2.303 . . . . 0.0 111.502 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.696 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.2 p-90 -130.47 -57.2 1.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.959 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.521 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 45.15 -94.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.991 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.4 mmtp 170.62 39.33 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 111.189 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -42.69 99.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.696 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.47 6.67 50.19 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.642 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 8.7 mp0 -140.2 99.12 7.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 117.31 0.555 . . . . 0.0 111.515 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -43.62 140.95 4.07 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.989 2.46 . . . . 0.0 112.668 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.17 177.05 19.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.768 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -147.96 157.18 43.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.545 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.2 m0 -61.86 105.92 0.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.114 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.2 ttm -120.55 159.81 24.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.277 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.547 ' HB2' HG12 ' A' ' 108' ' ' VAL . 5.2 p -83.93 123.85 30.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.746 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -80.01 -19.06 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.274 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.4 p -55.35 -19.82 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.18 45.8 1.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.076 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.608 HD12 ' CD2' ' A' ' 107' ' ' LEU . 7.6 tt -62.95 150.54 41.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.595 0.236 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -121.85 120.85 35.73 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.719 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.71 61.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.834 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.93 -46.25 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.562 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.56 -13.56 58.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.719 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.61 175.71 3.86 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.59 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 68.6 Cg_endo -76.12 143.08 25.26 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.736 1.624 . . . . 0.0 110.949 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.05 -14.27 36.49 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.483 2.122 . . . . 0.0 113.213 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.62 -9.37 58.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' O ' ' A' ' 116' ' ' PRO . 31.4 p-10 -124.48 32.74 5.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.522 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.51 -55.19 1.68 Allowed Pre-proline 0 N--CA 1.467 0.389 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.456 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.95 -37.13 11.95 Favored 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.509 2.139 . . . . 0.0 112.889 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.955 HG11 ' CD1' ' A' ' 84' ' ' PHE . 2.4 t -77.6 -51.18 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.891 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.528 HD12 ' CD2' ' A' ' 110' ' ' LEU . 1.8 mm -68.3 -29.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.264 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.84 57.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.412 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -48.27 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.317 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.758 HD13 ' CE1' ' A' ' 68' ' ' PHE . 6.4 tp -78.21 -30.09 48.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.534 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -56.57 -42.87 79.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -75.59 -2.89 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttp . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.849 0.357 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.19 129.57 36.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.48 122.02 37.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.717 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.861 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.8 pp -109.65 125.08 52.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.487 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 42.6 mt-30 -102.52 150.43 23.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.317 0.58 . . . . 0.0 111.54 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.612 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.1 mt -141.21 131.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.046 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.051 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.01 124.8 43.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -128.52 156.96 41.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.322 0.582 . . . . 0.0 111.85 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -148.6 118.16 0.94 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.262 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.621 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.11 108.96 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.725 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -70.82 128.28 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.386 -178.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -91.75 126.22 36.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 9.6 t-20 -87.6 -172.31 3.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.983 0.897 . . . . 0.0 112.346 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -77.9 -3.0 39.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.878 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -133.46 49.06 2.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.203 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 44.85 28.88 0.39 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.451 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 6.7 pt-20 -118.17 149.53 40.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.042 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.793 HG21 HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -120.4 146.65 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 111.599 -179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -95.85 116.58 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.525 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.62 162.15 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.202 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -99.98 122.52 43.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.74 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' NH1' HD12 ' A' ' 33' ' ' LEU . 54.0 ttm-85 -106.43 159.75 15.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.452 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 47.6 mmt-85 -69.48 60.67 0.14 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.118 0.485 . . . . 0.0 110.012 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . 48.94 -87.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.703 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 23' ' ' ARG . . . -167.92 86.95 0.23 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.884 0.373 . . . . 0.0 111.245 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.02 -171.92 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.38 24.91 12.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.219 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 179.04 39.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.814 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.401 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 0.7 OUTLIER 62.53 83.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.777 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.86 -8.82 47.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.809 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.4 23.12 3.55 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -114.47 26.01 10.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.079 0.466 . . . . 0.0 111.512 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.571 HD12 ' NH1' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -53.97 94.58 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.507 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -111.69 -166.46 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.093 0.473 . . . . 0.0 111.652 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.82 163.04 29.94 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.426 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 35.5 Cg_endo -63.48 168.17 11.86 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.525 2.816 . . . . 0.0 112.003 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.32 58.83 0.77 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.927 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -120.95 138.57 12.74 Favored Glycine 0 C--N 1.313 -0.701 0 CA-C-N 114.756 -0.722 . . . . 0.0 111.974 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 2.7 ttpm? 92.45 6.11 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.981 0.513 . . . . 0.0 112.047 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.051 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -55.82 -27.14 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.49 0.662 . . . . 0.0 110.533 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.2 -84.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.039 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.9 mmm 37.92 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.438 0.461 . . . . 0.0 111.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.76 32.71 0.12 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.418 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mt-10 -89.68 -175.02 4.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.782 0.325 . . . . 0.0 111.244 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.896 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.45 155.18 36.67 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.387 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.896 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.9 Cg_endo -44.62 -24.91 1.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.819 2.346 . . . . 0.0 112.593 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.746 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.2 mt-10 -104.09 -41.66 5.77 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 3.4 mm-40 -79.04 -19.21 51.99 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.007 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.41 -47.73 82.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.654 0.264 . . . . 0.0 111.303 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.838 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.11 -45.95 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.883 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.8 t -53.95 -36.94 32.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.65 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -77.38 -52.02 9.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 1.4 mm-40 -64.79 -22.93 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.981 HD11 ' CE1' ' A' ' 64' ' ' HIS . 6.2 tp -54.46 -44.81 72.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.812 0.339 . . . . 0.0 110.736 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.76 -28.38 68.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.27 -25.34 51.34 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.179 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 6.9 mm-40 -108.52 0.95 21.17 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.988 HG12 HG13 ' A' ' 60' ' ' ILE . 2.1 t -134.79 -44.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 109.786 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.99 -33.91 0.29 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.906 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.988 HG13 HG12 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -77.69 -175.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.88 0.371 . . . . 0.0 111.084 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.23 89.02 13.52 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.209 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.643 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.8 Cg_endo -109.55 145.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.308 2.672 . . . . 0.0 114.104 -177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 70.6 mt-30 -74.74 79.93 2.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.981 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.32 136.93 54.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.252 -175.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.5 t80 179.16 -144.71 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.7 OUTLIER 57.02 157.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.336 0.589 . . . . 0.0 112.536 178.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.0 tt -121.33 108.69 14.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.923 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.45 -41.95 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.518 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.6 tt0 -171.25 160.28 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.3 131.41 21.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.556 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.643 ' HB2' HG22 ' A' ' 122' ' ' VAL . 5.6 tp -122.73 137.13 55.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -125.82 109.8 12.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.444 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.4 153.1 47.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.22 132.7 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 111.482 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.538 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -96.9 162.95 21.24 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.012 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.9 Cg_endo -46.31 80.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.194 2.596 . . . . 0.0 112.58 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t0 85.7 11.85 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.786 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.441 ' CG ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -137.35 97.25 3.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.661 0.267 . . . . 0.0 111.148 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.0 OUTLIER -74.9 106.56 6.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.951 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.624 HD12 HD11 ' A' ' 4' ' ' LEU . 1.4 tt -102.11 116.43 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.051 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.32 132.49 49.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.724 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -126.14 114.61 18.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.064 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -106.47 123.84 48.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.23 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 2.0 m-85 -105.93 109.9 22.0 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.832 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.675 ' NE1' HG11 ' A' ' 50' ' ' VAL . 19.4 m95 -97.27 149.36 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.444 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.4 tp -99.89 102.84 14.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.253 0.549 . . . . 0.0 111.914 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.82 HG13 ' CB ' ' A' ' 64' ' ' HIS . 12.2 t -84.12 146.16 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.124 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -113.55 -26.47 8.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 5.4 ttp180 -162.78 159.8 24.53 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 118.885 0.766 . . . . 0.0 111.73 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.725 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -152.18 125.89 8.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.329 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -74.37 146.04 43.32 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.958 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.47 -119.24 14.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.558 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.6 tt0 -135.07 145.77 55.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.571 0.224 . . . . 0.0 110.792 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 3.7 Cg_exo -76.44 128.84 10.64 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.847 2.364 . . . . 0.0 111.241 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.578 ' NE1' HG23 ' A' ' 60' ' ' ILE . 42.2 p-90 -130.42 -64.25 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.43 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . 49.13 -107.68 0.32 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.477 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 164.45 67.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.389 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.408 ' OE1' ' CB ' ' A' ' 21' ' ' THR . 2.3 pt-20 -86.36 -37.4 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.767 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 121.07 -6.67 10.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.507 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.427 ' HB2' ' HG1' ' A' ' 21' ' ' THR . 1.2 mp0 -140.06 97.03 7.97 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 117.134 0.467 . . . . 0.0 111.483 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -43.79 145.64 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.019 2.479 . . . . 0.0 112.586 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.34 177.11 19.43 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.964 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.82 157.43 45.41 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -70.3 106.65 3.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.307 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -120.06 163.62 17.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.977 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 93.3 p -89.01 127.97 35.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.793 HD22 HG21 ' A' ' 18' ' ' ILE . 5.1 tp -78.48 -18.9 54.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.184 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.6 t -48.93 -24.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.38 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.72 39.64 2.37 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.95 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.769 HD13 HD21 ' A' ' 126' ' ' LEU . 4.1 tt -62.71 140.03 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.756 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -123.1 134.5 54.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.615 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.33 -15.37 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.278 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.0 -49.15 13.17 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -36.28 81.91 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.239 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -82.7 172.66 8.99 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.273 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 60.5 Cg_endo -72.77 127.76 12.64 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.139 1.893 . . . . 0.0 111.526 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.27 -14.75 31.01 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.701 2.267 . . . . 0.0 113.28 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.74 -9.73 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -130.62 42.37 3.26 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.759 0.314 . . . . 0.0 111.725 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.424 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.43 -49.74 5.01 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.4 Cg_exo -44.94 -33.95 8.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.461 2.107 . . . . 0.0 112.591 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.643 HG22 ' HB2' ' A' ' 71' ' ' LEU . 14.0 t -77.35 -48.72 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.427 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.704 HG22 ' HB2' ' A' ' 127' ' ' LYS . 8.7 mm -66.33 -31.93 55.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.719 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.66 -26.87 36.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.932 0.396 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -53.17 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.864 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.24 -29.66 48.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.694 0.283 . . . . 0.0 111.47 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.843 ' N ' HD23 ' A' ' 126' ' ' LEU . 24.7 ttpp -55.17 -42.52 73.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.17 0.509 . . . . 0.0 110.74 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -65.13 -11.65 42.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.585 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.2 mp . . . . . 0 C--O 1.231 0.1 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.055 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.861 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.776 0.322 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.05 102.91 11.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 145.5 40.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.744 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.5 pp -146.01 128.33 15.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.99 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 13.9 mt-30 -106.95 153.3 22.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 112.029 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.744 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.3 mp -146.44 131.37 11.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.836 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.058 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.28 124.75 43.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -121.25 162.27 20.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.353 0.597 . . . . 0.0 111.904 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.25 113.31 0.58 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.559 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.891 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.91 105.8 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.716 HG22 ' CE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -70.97 122.17 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.28 -178.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -93.17 127.72 38.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.342 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 2.5 t-20 -75.33 -172.09 1.65 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 122.219 1.009 . . . . 0.0 113.107 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -60.04 -17.81 41.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.859 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -120.33 -82.39 0.65 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.724 0.297 . . . . 0.0 111.559 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -158.8 16.05 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.677 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HG2' ' CB ' ' A' ' 13' ' ' ASN . 0.8 OUTLIER -100.91 155.14 18.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.891 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -124.34 144.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.327 0.584 . . . . 0.0 111.957 -179.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.412 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 59.6 t80 -83.65 90.17 7.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.584 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.885 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -104.44 162.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.298 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.435 HG22 ' OE1' ' A' ' 98' ' ' GLU . 5.5 p -89.86 116.05 27.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.582 ' CG ' HD13 ' A' ' 33' ' ' LEU . 9.1 ttp180 -119.75 119.48 33.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.889 0.376 . . . . 0.0 110.999 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 11.9 ttm-85 52.6 -102.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.769 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 172.55 -64.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.842 0.354 . . . . 0.0 110.935 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -166.6 -55.91 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.09 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -164.92 92.3 0.58 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.9 -169.81 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.035 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -99.88 53.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.3 mtt -132.83 38.11 3.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.49 -19.03 61.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.352 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.03 31.24 2.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.008 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.41 26.22 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.388 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.582 HD13 ' CG ' ' A' ' 22' ' ' ARG . 16.2 tp -69.18 63.88 0.14 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.807 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -177.65 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.53 162.9 30.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.648 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 28.3 Cg_endo -60.94 167.99 7.96 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.538 2.826 . . . . 0.0 111.857 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.28 59.07 0.77 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.255 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.76 121.43 3.43 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 114.355 -0.922 . . . . 0.0 111.978 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 112.45 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.306 0.642 . . . . 0.0 111.866 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.058 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -53.81 -27.98 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.541 0.686 . . . . 0.0 110.683 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.599 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -45.72 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.147 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.427 ' HE3' ' HD3' ' A' ' 39' ' ' LYS . 2.4 mmt 34.96 -85.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.362 0.414 . . . . 0.0 111.755 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -168.77 30.16 0.16 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.452 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 4.9 mp0 -93.59 -176.6 4.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.733 0.301 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.946 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.84 158.94 33.52 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.202 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.946 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.2 Cg_endo -43.76 -24.66 0.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.839 2.359 . . . . 0.0 112.525 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -89.86 -60.58 1.9 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -4.84 55.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.904 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -63.14 -55.29 26.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.703 0.287 . . . . 0.0 111.103 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.739 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -78.25 -45.45 26.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.925 0.393 . . . . 0.0 110.904 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.473 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 58.0 t -55.52 -36.73 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.37 -49.1 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.225 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.436 ' HB3' HG22 ' A' ' 40' ' ' ILE . 22.0 tp10 -68.31 -22.6 64.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.212 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -56.52 -45.04 81.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 0.0 110.659 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -27.12 68.51 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.43 -30.63 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.279 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -109.08 5.78 24.37 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.015 HG12 HG13 ' A' ' 60' ' ' ILE . 2.6 t -134.02 -44.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.26 0.552 . . . . 0.0 110.24 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.586 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.55 7.02 1.25 Allowed Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 114.563 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.015 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -115.39 -172.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 117.902 0.851 . . . . 0.0 110.033 179.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 p -114.45 87.59 14.21 Favored Pre-proline 0 N--CA 1.438 -1.074 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.537 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.647 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.4 Cg_endo -113.95 142.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.631 2.887 . . . . 0.0 113.598 -177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 8.8 mt-30 -74.87 79.94 2.12 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.042 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.15 129.12 53.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.809 -1.541 . . . . 0.0 111.407 -175.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.533 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -176.44 -141.69 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.07 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.73 159.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.334 0.588 . . . . 0.0 112.053 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' A' ' 70' ' ' LYS . 5.4 tt -122.18 113.0 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.318 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.44 -48.32 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.093 0.473 . . . . 0.0 110.017 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.39 166.31 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.216 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.34 132.02 22.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.809 0.338 . . . . 0.0 110.977 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.696 ' HB2' HG22 ' A' ' 122' ' ' VAL . 18.2 tp -113.78 120.77 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.64 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -118.68 109.93 16.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.86 146.46 37.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.717 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.14 120.13 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.072 0.463 . . . . 0.0 111.278 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -69.95 163.18 63.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.505 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.9 Cg_endo -51.76 83.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.024 2.483 . . . . 0.0 112.058 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 26.2 m-20 95.59 15.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.323 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HD3' HD21 ' A' ' 4' ' ' LEU . 9.8 ttm180 -137.38 150.17 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.526 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 5.5 t-160 -124.9 94.1 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.791 0.329 . . . . 0.0 110.9 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.4 tt -99.0 118.21 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.95 127.12 55.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.741 HD13 ' ND2' ' A' ' 119' ' ' ASN . 5.4 mt -126.28 114.71 18.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.074 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.544 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -106.32 123.02 47.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.553 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 m-30 -99.72 116.07 30.96 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.664 ' CE2' HG11 ' A' ' 50' ' ' VAL . 24.3 m95 -100.59 149.18 24.0 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.257 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.8 tm? -103.04 103.14 13.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.365 0.602 . . . . 0.0 112.04 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.042 HG22 ' ND1' ' A' ' 64' ' ' HIS . 22.2 t -81.01 145.87 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.095 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 1.9 pm0 -119.63 -14.53 9.07 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.601 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 11.3 tpp85 -162.9 154.91 18.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.611 0.641 . . . . 0.0 111.523 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.716 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -157.55 120.46 3.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.539 178.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -77.65 144.28 37.53 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 59.79 -124.57 36.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.201 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 45.4 mt-10 -135.11 143.08 44.39 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.519 0.199 . . . . 0.0 110.992 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.548 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.6 Cg_exo -75.92 128.77 11.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.041 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 62.9 p-90 -129.72 -59.85 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.471 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 43.73 -96.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.795 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER 175.65 35.98 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.677 0.275 . . . . 0.0 110.999 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 21' ' ' THR . 9.0 pt-20 -55.09 -38.22 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.361 . . . . 0.0 110.685 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.1 58.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.43 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -140.13 97.02 7.9 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.087 0.443 . . . . 0.0 111.384 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -43.56 143.03 2.8 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.078 2.519 . . . . 0.0 112.828 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.31 177.27 19.31 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.851 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -142.89 157.38 44.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.326 -0.249 . . . . 0.0 110.326 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.402 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.64 105.84 5.92 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.4 ptm -120.75 163.15 18.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.857 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.647 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -78.04 114.83 17.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 110.543 179.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.862 HD11 HD12 ' A' ' 110' ' ' LEU . 11.3 tp -70.34 -18.86 63.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.342 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.737 ' CG2' HD21 ' A' ' 129' ' ' LEU . 11.0 p -53.42 -19.25 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.486 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.67 49.73 0.91 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.971 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.862 HD12 HD11 ' A' ' 107' ' ' LEU . 9.2 tt -62.18 150.3 39.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.728 0.299 . . . . 0.0 110.665 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' N ' HD23 ' A' ' 110' ' ' LEU . 4.3 t-20 -106.86 104.14 13.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.535 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.81 61.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.077 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.29 -43.42 23.7 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.982 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -1.87 31.83 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.201 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.571 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -117.53 170.55 6.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.1 Cg_endo -54.4 127.88 27.78 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.099 1.866 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.94 -20.41 45.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.612 2.208 . . . . 0.0 112.452 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.77 51.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.418 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.741 ' ND2' HD13 ' A' ' 82' ' ' LEU . 1.5 m-20 -114.71 -2.36 13.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.399 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -47.84 -48.29 61.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.519 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 89.9 Cg_exo -44.95 -34.88 9.39 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.27 1.98 . . . . 0.0 112.28 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.29 -51.14 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.618 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.588 HG22 ' HB2' ' A' ' 127' ' ' LYS . 41.8 mm -64.89 -33.5 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.996 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . . . -54.83 -27.04 39.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 111.073 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -78.19 -52.47 8.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.632 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 126' ' ' LEU . 1.3 tm? -78.19 -30.14 48.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.509 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.588 ' HB2' HG22 ' A' ' 123' ' ' ILE . 42.2 tttm -56.69 -42.8 79.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 111.017 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -66.67 -10.09 42.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.721 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.737 HD21 ' CG2' ' A' ' 108' ' ' VAL . 8.0 mp . . . . . 0 C--O 1.231 0.113 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.004 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.497 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 ptt? . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.863 0.363 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.02 111.18 22.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 132.52 43.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.585 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.4 pp -128.29 123.2 33.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.958 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.55 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 16.0 mt-30 -102.46 152.13 21.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.486 0.66 . . . . 0.0 112.0 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 4.1 pt -146.56 134.72 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.836 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.4 124.29 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -120.51 160.44 21.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.249 0.547 . . . . 0.0 111.661 -179.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.53 115.29 0.7 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.645 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.967 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.78 109.33 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -70.78 120.23 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.1 0.476 . . . . 0.0 111.048 -178.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.711 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.34 118.25 23.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.696 -179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' CA ' ' CZ3' ' A' ' 90' ' ' TRP . 20.3 t30 -76.09 -172.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.873 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.57 3.89 30.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.241 -1.345 . . . . 0.0 112.315 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -139.22 51.28 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 111.524 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 47.09 22.83 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.659 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.763 ' C ' HD12 ' A' ' 18' ' ' ILE . 17.6 mt-10 -117.38 153.29 33.29 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.967 HG21 HG22 ' A' ' 10' ' ' ILE . 1.4 mp -117.0 143.4 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.26 0.552 . . . . 0.0 111.963 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 44.7 t80 -87.98 92.84 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.12 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.52 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.62 159.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.741 ' O ' HD12 ' A' ' 33' ' ' LEU . 13.1 p -73.56 124.52 26.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.526 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 33' ' ' LEU . 11.6 ttp180 -130.56 125.29 33.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.088 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 54.22 -105.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.017 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 169.17 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.7 0.285 . . . . 0.0 111.128 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 76.58 26.58 0.85 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.968 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -179.48 36.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -179.76 -165.9 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.027 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -119.79 88.81 3.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt -149.85 37.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -64.55 -24.01 67.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.379 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.84 15.61 14.35 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.35 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.34 26.24 10.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.733 0.301 . . . . 0.0 111.593 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 21' ' ' THR . 22.2 tp -59.63 76.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.735 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -106.86 -172.65 2.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 111.679 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.733 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.6 160.56 41.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.901 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.642 ' HG3' HD11 ' A' ' 11' ' ' ILE . 36.7 Cg_endo -64.2 168.41 12.59 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.594 2.863 . . . . 0.0 111.657 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.65 59.5 0.74 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.037 -1.077 . . . . 0.0 114.082 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -126.92 117.39 2.73 Favored Glycine 0 C--N 1.313 -0.702 0 CA-C-N 114.655 -0.772 . . . . 0.0 112.039 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.629 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 121.62 4.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.395 0.678 . . . . 0.0 111.678 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.034 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -58.7 -26.0 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.444 0.64 . . . . 0.0 110.753 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.99 -83.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.332 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 33.45 -85.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.465 0.478 . . . . 0.0 111.889 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.46 34.05 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.516 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.462 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -88.18 -173.94 4.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.797 0.332 . . . . 0.0 111.231 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.889 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.2 154.6 37.61 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.396 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.889 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.11 -26.21 1.41 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.89 2.393 . . . . 0.0 112.458 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -104.19 -39.35 6.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.779 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -80.23 -12.61 59.61 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.924 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.2 -52.95 62.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.766 0.317 . . . . 0.0 111.196 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.15 -43.84 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.161 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -53.66 -39.42 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.528 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -78.35 -52.02 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.9 mm-40 -67.19 -22.26 65.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.32 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.686 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -54.33 -44.44 72.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.205 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -33.88 71.92 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -77.68 -25.79 49.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.358 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.422 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.1 mp0 -108.69 6.1 25.45 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.963 HG12 HG13 ' A' ' 60' ' ' ILE . 15.3 t -134.14 -44.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.166 0.507 . . . . 0.0 110.26 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.27 3.55 1.42 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.705 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.963 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.88 -173.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 117.999 0.9 . . . . 0.0 110.431 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.5 p -114.21 87.59 13.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.607 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -115.25 145.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.578 2.852 . . . . 0.0 114.217 -177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.84 79.94 2.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.997 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.6 131.67 54.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.018 -175.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -178.92 -140.97 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 58.26 158.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.248 0.547 . . . . 0.0 112.116 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -120.97 110.69 16.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.296 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.59 -46.3 26.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 0.0 110.182 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.53 157.49 4.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.269 179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 115.34 8.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.836 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.575 ' CB ' HG22 ' A' ' 122' ' ' VAL . 0.4 OUTLIER -109.19 136.55 48.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.0 110.594 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -130.44 115.54 16.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -135.47 147.66 48.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.633 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HB2' ' CD2' ' A' ' 79' ' ' HIS . 4.8 pt-20 -120.07 127.06 52.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.105 0.479 . . . . 0.0 111.284 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -79.06 163.51 59.65 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.1 Cg_endo -53.8 82.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.992 2.461 . . . . 0.0 112.404 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER 101.57 11.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.959 0.904 . . . . 0.0 111.373 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.29 150.01 47.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.773 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CD2' ' HB2' ' A' ' 74' ' ' GLU . 4.6 m170 -124.0 101.53 7.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.534 ' CG1' HD11 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -100.64 128.31 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.75 118.94 28.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.665 ' CD1' HG21 ' A' ' 122' ' ' VAL . 0.7 OUTLIER -126.15 115.17 19.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 111.439 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.565 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -106.81 122.87 47.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.509 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CD2' HG11 ' A' ' 122' ' ' VAL . 7.3 m-30 -98.61 119.03 36.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.095 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.697 ' NE1' HG11 ' A' ' 50' ' ' VAL . 21.4 m95 -101.25 149.2 24.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.069 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.538 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.2 tm? -102.49 102.91 13.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.441 0.639 . . . . 0.0 112.053 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' ND1' ' A' ' 64' ' ' HIS . 17.0 t -80.19 146.0 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.027 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -114.71 -23.24 9.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.25 160.05 26.4 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.873 0.761 . . . . 0.0 111.606 -178.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.668 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -156.92 124.3 5.31 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.381 179.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -82.78 127.6 33.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.7 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.52 -125.18 6.82 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.324 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 69.4 mt-10 -135.08 138.43 29.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.625 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.11 128.74 10.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.76 2.307 . . . . 0.0 111.132 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.582 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.3 p-90 -135.5 -57.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.268 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 46.77 -94.29 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.868 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -178.87 34.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.687 0.28 . . . . 0.0 111.156 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.29 -34.9 78.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.889 0.376 . . . . 0.0 110.412 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.26 68.57 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.342 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -140.28 95.95 8.12 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -43.6 133.44 7.39 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.989 2.459 . . . . 0.0 112.789 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.33 177.44 19.18 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.762 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -147.55 157.05 43.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.68 106.29 1.78 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 22.0 ptm -120.38 150.96 39.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.755 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.1 p -70.59 114.65 8.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 0.0 110.408 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.752 ' HB2' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -65.16 -21.54 66.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.89 -17.79 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.509 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.42 35.04 4.95 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.816 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.512 HD13 ' CD2' ' A' ' 107' ' ' LEU . 12.6 tp -62.5 125.7 24.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 139.5 54.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -15.76 61.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.395 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.94 -48.56 14.32 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.472 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -40.38 88.13 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.626 -179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.99 174.17 6.53 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.1 Cg_endo -76.18 130.26 11.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.263 1.975 . . . . 0.0 111.457 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.76 -14.5 17.87 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.886 2.391 . . . . 0.0 113.556 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -10.57 13.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.527 ' OD1' HD13 ' A' ' 82' ' ' LEU . 1.7 m-20 -134.99 45.43 2.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.765 0.317 . . . . 0.0 111.553 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.432 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.09 -49.38 7.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.2 Cg_exo -44.89 -36.74 11.33 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.455 2.103 . . . . 0.0 112.871 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.742 HG11 ' CD2' ' A' ' 84' ' ' PHE . 20.3 t -77.46 -51.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.984 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.586 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 10.7 mm -65.36 -32.1 56.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.8 -27.9 45.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.997 0.427 . . . . 0.0 110.725 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -48.49 13.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.509 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.0 tm? -78.04 -28.87 49.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.476 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.468 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.0 ttpp -55.5 -42.64 74.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.821 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.2 ttm-85 -69.96 -7.72 42.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.804 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.216 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.699 ' OP3' " H4'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.776 0.322 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -99.76 103.08 14.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -113.98 145.16 41.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.679 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.617 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.09 122.15 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -102.37 154.0 19.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.336 0.588 . . . . 0.0 111.869 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.4 mp -146.12 130.93 11.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.74 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.036 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.39 124.29 42.02 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -114.63 162.17 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.421 0.629 . . . . 0.0 111.913 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.464 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.54 106.01 0.43 Allowed Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.985 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.831 HG23 ' CG1' ' A' ' 18' ' ' ILE . 2.8 mp -70.29 100.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.694 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.14 126.51 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -96.42 140.61 30.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.504 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.554 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -107.88 -172.39 2.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.89 0.853 . . . . 0.0 112.666 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -69.26 -18.26 63.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.948 -1.478 . . . . 0.0 112.259 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.15 39.12 2.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.885 0.374 . . . . 0.0 110.891 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 47.17 28.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.556 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -106.6 145.42 31.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.328 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.831 ' CG1' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -106.7 127.19 62.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 0.0 111.872 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.73 ' N ' HD12 ' A' ' 18' ' ' ILE . 51.0 t80 -78.09 87.49 4.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.753 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.702 HD11 ' SD ' ' A' ' 105' ' ' MET . 1.2 pt -112.79 162.29 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 100' ' ' GLN . 14.2 p -82.48 114.23 20.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HA ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -138.76 103.75 4.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 111.109 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.896 ' CG ' ' HB1' ' A' ' 30' ' ' ALA . 6.6 mtp180 45.61 29.2 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 101' ' ' PRO . . . -106.63 35.2 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.258 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.831 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . . . -176.57 -69.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.162 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.15 147.54 47.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.077 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.39 -37.06 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.03 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -95.86 -45.23 7.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.06 43.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.816 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.896 ' HB1' ' CG ' ' A' ' 23' ' ' ARG . . . -72.89 -8.65 56.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.619 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -89.66 24.72 2.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.57 0.224 . . . . 0.0 111.565 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.28 26.16 10.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.89 0.376 . . . . 0.0 111.3 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 33' ' ' LEU . 6.6 tt -39.58 93.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.307 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 32' ' ' LYS . 3.1 tt0 -120.62 -168.88 1.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.913 0.387 . . . . 0.0 111.164 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.75 158.16 50.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.713 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.531 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 18.0 Cg_endo -58.17 167.83 4.23 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.513 2.809 . . . . 0.0 111.496 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.56 59.24 0.75 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.692 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.626 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -125.15 120.7 4.02 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 114.447 -0.876 . . . . 0.0 112.026 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 114.55 5.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.329 0.652 . . . . 0.0 111.751 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.036 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -58.8 -26.03 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.486 0.66 . . . . 0.0 110.733 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.543 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.31 -82.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.185 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 33.67 -86.35 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.507 0.504 . . . . 0.0 111.86 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.24 31.87 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.503 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.99 -175.64 4.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.809 0.338 . . . . 0.0 111.16 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.921 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.04 159.58 28.84 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.463 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.921 ' HD2' HG22 ' A' ' 45' ' ' THR . 7.0 Cg_endo -47.79 -24.44 4.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.628 2.218 . . . . 0.0 112.468 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -97.8 -47.45 5.57 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 4.8 mm-40 -80.13 -25.57 39.83 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.939 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -55.63 -47.54 76.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.809 0.337 . . . . 0.0 110.988 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.839 HG12 ' HB1' ' A' ' 7' ' ' ALA . 2.8 m -78.14 -45.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.194 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 47' ' ' GLU . 53.7 t -62.58 -35.79 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.449 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -78.31 -41.68 33.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.458 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.641 ' CB ' HG22 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -78.13 -26.23 47.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.318 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.961 HD23 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -57.57 -45.11 85.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 110.572 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -26.85 64.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.311 0.577 . . . . 0.0 109.489 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -77.11 -26.76 53.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.117 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -108.32 5.16 25.29 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 54' ' ' LEU . 1.3 t -134.78 -44.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.282 0.563 . . . . 0.0 109.603 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.6 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 59.78 0.48 1.0 Allowed Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.166 -0.925 . . . . 0.0 114.412 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.881 ' CG1' HG12 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -105.51 -173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 117.605 0.702 . . . . 0.0 110.375 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -114.55 88.04 15.28 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.374 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.574 ' HG2' ' HB3' ' A' ' 64' ' ' HIS . 98.3 Cg_endo -112.11 152.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.927 3.084 . . . . 0.0 113.478 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.423 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 35.5 mt-30 -74.76 78.67 2.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 103.433 -2.802 . . . . 0.0 103.433 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.961 ' CD2' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -111.19 120.25 41.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.555 -1.657 . . . . 0.0 112.089 -174.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -178.55 -148.19 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.99 161.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.163 0.506 . . . . 0.0 112.006 179.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 5.2 tt -125.31 116.98 22.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -76.54 -56.55 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 109.924 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mt-10 -172.05 131.66 0.65 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.171 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -117.38 132.01 56.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.987 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.603 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -117.78 134.67 54.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.5 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -120.4 109.87 15.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -126.24 153.05 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.522 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.09 133.91 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.52 . . . . 0.0 111.412 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -96.6 162.92 21.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.146 179.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 5.7 Cg_endo -47.6 80.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.166 2.577 . . . . 0.0 112.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' PHE . 5.0 t0 86.45 12.73 0.15 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.641 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.41 94.82 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.733 0.302 . . . . 0.0 111.112 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.426 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -74.84 109.31 8.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.751 0.31 . . . . 0.0 110.844 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -106.99 111.97 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 120.962 0.41 . . . . 0.0 111.029 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.55 125.71 51.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 71' ' ' LEU . 1.1 pp -126.45 114.88 18.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.69 0.281 . . . . 0.0 111.467 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -108.54 122.76 47.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 9.8 m-30 -101.67 121.0 41.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.91 0.386 . . . . 0.0 111.086 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.758 ' NE1' HG11 ' A' ' 50' ' ' VAL . 19.5 m95 -101.64 149.23 24.34 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 65' ' ' PHE . 26.1 tp -100.18 103.44 14.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.914 HG13 ' HA ' ' A' ' 64' ' ' HIS . 10.3 t -86.29 145.29 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.408 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -103.03 -32.83 9.51 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.26 165.5 26.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 118.49 0.586 . . . . 0.0 111.59 -179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.694 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.2 p90 -152.04 128.71 10.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.554 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -77.0 135.18 38.67 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.85 -125.84 20.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.431 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 1.4 tt0 -132.92 143.22 47.68 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.527 0.203 . . . . 0.0 110.864 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.668 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.7 Cg_exo -76.27 128.86 10.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.83 2.353 . . . . 0.0 111.408 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.6 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 57.7 p-90 -125.36 -61.26 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.179 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.26 -103.64 0.04 OUTLIER Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.04 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.27 38.39 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.556 0.217 . . . . 0.0 111.093 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -55.48 -41.73 73.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 110.79 -19.63 25.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.143 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.604 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -126.54 99.14 30.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.036 0.446 . . . . 0.0 111.477 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.831 ' HD2' ' HB2' ' A' ' 25' ' ' ALA . 57.8 Cg_exo -43.62 146.43 1.39 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.172 2.581 . . . . 0.0 112.663 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.12 177.39 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.758 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -143.21 157.17 44.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -74.08 106.39 5.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.702 ' SD ' HD11 ' A' ' 20' ' ' ILE . 4.1 ptm -120.42 163.0 18.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.937 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.95 114.89 23.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.814 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -64.32 -18.96 65.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.713 ' O ' HD21 ' A' ' 129' ' ' LEU . 12.0 p -54.44 -20.46 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.682 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.74 42.57 1.43 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.222 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.583 HD12 HD21 ' A' ' 107' ' ' LEU . 8.0 tt -62.94 150.29 42.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.806 0.303 . . . . 0.0 110.204 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -122.88 131.16 53.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.31 -14.84 61.85 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.36 -49.22 13.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.18 -38.82 86.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.887 0.375 . . . . 0.0 111.07 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.604 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.81 174.4 6.14 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.434 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 71.6 Cg_endo -75.21 127.76 10.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.176 1.917 . . . . 0.0 111.489 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.71 -15.0 39.31 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.667 2.245 . . . . 0.0 113.049 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.52 -9.76 57.48 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.583 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -122.64 28.67 7.22 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -70.64 -39.72 9.69 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -53.5 -42.19 67.57 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.988 1.792 . . . . 0.0 112.308 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -77.43 -51.36 18.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.423 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -64.31 -29.92 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.961 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -55.38 -34.3 64.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 110.432 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.17 -49.63 66.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.91 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' A' ' 68' ' ' PHE . 9.2 tp -78.19 -28.63 48.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.618 ' O ' HD12 ' A' ' 129' ' ' LEU . 17.2 tttt -57.08 -42.67 81.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.998 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -72.72 -5.09 35.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.983 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 108' ' ' VAL . 3.7 mp . . . . . 0 N--CA 1.457 -0.1 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.059 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.423 " O3'" ' CG1' ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.793 0.33 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.03 104.03 12.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 136.26 54.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.41 128.49 20.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.969 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.2 mt-30 -102.45 154.16 19.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.331 0.586 . . . . 0.0 111.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.434 ' HB ' HD23 ' A' ' 82' ' ' LEU . 38.2 mm -146.31 129.39 9.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.892 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.5 42.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.578 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.13 161.95 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.445 0.64 . . . . 0.0 111.972 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.04 121.43 1.19 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.642 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' HB ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -73.77 108.85 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.719 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.26 127.79 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 0.0 111.709 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.09 131.67 43.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.123 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.771 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.5 p-10 -87.8 -173.04 4.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.357 0.599 . . . . 0.0 111.909 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 22.1 tt0 -73.54 6.29 3.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.391 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 21.5 t-20 -130.33 45.06 2.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.048 -0.407 . . . . 0.0 112.052 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.9 p30 46.92 25.48 0.47 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.918 0.39 . . . . 0.0 111.369 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.509 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.53 161.61 18.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.661 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.3 144.37 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.058 0.456 . . . . 0.0 111.88 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.98 102.66 14.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.09 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.01 162.14 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.334 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.937 HG22 ' O ' ' A' ' 34' ' ' GLU . 10.1 t -84.65 139.61 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.328 . . . . 0.0 110.928 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -125.91 101.93 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.406 ' HG3' ' HB2' ' A' ' 30' ' ' ALA . 8.1 ttm-85 62.21 -104.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -175.86 -167.78 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.816 0.341 . . . . 0.0 111.066 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.37 -65.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.9 -51.64 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.965 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.43 147.93 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.096 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.31 -75.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -143.17 87.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HB2' ' HG3' ' A' ' 23' ' ' ARG . . . -72.06 -21.23 61.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.371 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t-20 -94.28 16.08 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.448 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -114.33 26.35 10.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 114' ' ' ASP . 2.2 tt -52.55 84.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.766 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.937 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -123.15 176.5 6.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 111.177 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.81 166.43 14.9 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.023 0.439 . . . . 0.0 112.075 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.4 Cg_endo -47.44 168.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.924 3.083 . . . . 0.0 112.628 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.64 59.46 0.75 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.099 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.68 112.09 1.15 Allowed Glycine 0 C--N 1.314 -0.68 0 CA-C-N 114.262 -0.969 . . . . 0.0 112.045 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 116.02 6.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.4 0.68 . . . . 0.0 111.853 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.013 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -55.06 -27.59 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.595 0.712 . . . . 0.0 110.271 179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.9 -80.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.206 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.3 mmm 38.64 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.355 0.41 . . . . 0.0 111.662 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.68 33.79 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.67 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.492 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -96.94 -170.26 2.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.65 0.262 . . . . 0.0 111.019 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.924 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.9 159.04 30.68 Favored Pre-proline 0 N--CA 1.455 -0.221 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.287 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.924 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.91 -24.66 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.777 2.318 . . . . 0.0 112.5 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -92.91 -58.1 2.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 8.0 pt20 -80.66 -4.88 55.9 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.795 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -63.16 -57.27 11.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.844 0.354 . . . . 0.0 111.013 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.617 HG22 HD13 ' A' ' 54' ' ' LEU . 1.4 p -78.78 -42.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.77 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.3 t -50.65 -35.65 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.203 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -78.21 -52.12 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.685 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.2 mm-40 -62.17 -20.09 63.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.625 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.9 HD11 ' NE2' ' A' ' 64' ' ' HIS . 2.1 tp -57.46 -44.67 85.0 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.575 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.93 -27.6 68.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.914 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.3 tm-20 -77.19 -30.4 54.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.282 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.49 6.4 26.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.912 HG12 HG13 ' A' ' 60' ' ' ILE . 43.4 t -133.43 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.78 -40.17 0.24 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.006 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.912 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.53 -177.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.06 0.457 . . . . 0.0 111.112 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.71 88.72 14.29 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.738 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.0 Cg_endo -111.55 146.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.404 2.736 . . . . 0.0 114.211 -177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.1 mt-30 -74.85 79.73 2.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.951 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.21 128.45 52.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.058 -176.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.11 -139.53 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.622 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.45 158.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.12 0.486 . . . . 0.0 111.85 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.594 HD21 ' HD3' ' A' ' 70' ' ' LYS . 5.6 tt -121.07 109.89 15.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.577 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.75 -43.39 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.977 0.418 . . . . 0.0 110.139 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt-10 -171.3 166.02 7.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.516 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.17 132.12 22.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.942 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.4 tp -117.4 124.55 49.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -122.28 110.16 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.649 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -140.67 153.16 45.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.686 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.25 140.22 48.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.296 0.569 . . . . 0.0 111.284 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.33 163.85 16.64 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.534 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 53.8 Cg_exo -41.58 81.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.458 2.772 . . . . 0.0 112.534 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' PHE . 10.3 t0 73.56 20.67 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.597 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 9.5 ttt180 -137.31 93.87 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.317 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.54 98.61 3.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.955 0.407 . . . . 0.0 110.94 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.62 111.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.98 133.83 43.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.771 HD13 HD21 ' A' ' 119' ' ' ASN . 32.1 mt -126.22 114.36 18.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.489 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.14 122.7 48.23 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.6 125.2 50.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.876 0.37 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.53 ' CE2' HG11 ' A' ' 50' ' ' VAL . 67.5 m95 -107.57 148.56 29.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.2 tp -98.97 103.01 14.92 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.326 0.584 . . . . 0.0 111.261 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.951 HG22 ' ND1' ' A' ' 64' ' ' HIS . 13.3 t -81.84 145.61 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.845 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -109.63 -35.34 6.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.56 165.66 25.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.843 0.747 . . . . 0.0 112.014 -178.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.771 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.5 p90 -151.02 130.76 13.16 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.6 139.67 40.73 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.815 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.43 -121.84 23.53 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.442 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.8 mt-10 -131.94 145.59 58.07 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.558 0.218 . . . . 0.0 110.835 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.63 128.71 10.4 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.841 2.361 . . . . 0.0 111.363 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.564 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.6 p-90 -133.34 -60.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.133 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.05 -100.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.001 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.56 32.85 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.61 0.243 . . . . 0.0 111.248 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.3 pt-20 -64.79 -27.04 68.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.834 0.35 . . . . 0.0 110.688 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.14 31.6 81.28 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.729 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 5.9 mm-40 -140.42 91.96 9.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.045 0.45 . . . . 0.0 111.253 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -43.6 126.51 5.53 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.025 2.483 . . . . 0.0 112.854 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.23 177.2 19.35 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.762 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.34 157.16 42.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -68.83 106.28 2.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.047 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 8.9 ptm -120.39 147.41 45.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.697 ' HB2' HG12 ' A' ' 108' ' ' VAL . 77.0 p -70.76 115.08 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.661 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -62.03 -18.65 61.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.909 ' HA ' HD21 ' A' ' 129' ' ' LEU . 12.1 p -59.02 -9.94 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.783 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.13 50.36 0.89 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.164 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.75 HD13 ' N ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -62.11 142.27 57.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 110.404 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.75 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -119.2 114.77 22.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.15 -15.27 61.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.242 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.94 -49.11 13.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.273 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.741 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -68.44 -33.43 74.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.768 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.06 174.03 6.63 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.406 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 64.4 Cg_endo -74.23 127.78 11.54 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.134 1.889 . . . . 0.0 111.387 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.86 -14.85 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.742 2.295 . . . . 0.0 113.285 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.4 -9.82 37.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.771 HD21 HD13 ' A' ' 82' ' ' LEU . 1.3 m-20 -130.16 37.82 3.85 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -72.19 -43.99 10.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 50.9 Cg_exo -54.78 -38.96 91.76 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.106 1.871 . . . . 0.0 112.169 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 69' ' ' GLU . 2.2 t -77.45 -51.31 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.01 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.522 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.36 -29.85 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.72 -31.06 57.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.924 0.393 . . . . 0.0 110.443 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -69.62 -52.43 25.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.705 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.7 tp -78.21 -19.53 53.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.585 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.41 -42.62 64.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.892 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -76.02 -3.65 36.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.131 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.813 0.34 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.56 104.25 13.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 132.76 56.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -138.38 128.06 25.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.3 mt-30 -102.48 154.19 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.275 0.559 . . . . 0.0 111.792 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.519 ' HB ' HD23 ' A' ' 82' ' ' LEU . 37.9 mm -146.33 129.04 8.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.923 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.013 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 124.54 42.41 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.573 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -124.43 162.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.339 0.59 . . . . 0.0 111.893 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.95 120.85 1.12 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.688 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -72.76 108.94 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.726 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.32 127.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.796 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -97.03 132.37 42.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.081 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.768 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 4.7 p-10 -88.95 -173.01 3.91 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 111.931 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 23.1 tt0 -73.29 5.8 3.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.391 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 19.7 t-20 -129.92 44.93 2.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.982 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.7 p30 46.76 25.61 0.46 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.427 . . . . 0.0 111.396 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 5.2 mt-10 -116.42 161.62 18.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.666 ' CG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -116.55 144.09 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.032 0.444 . . . . 0.0 111.828 -178.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -95.48 102.18 13.96 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.099 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' HB ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.14 162.08 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.362 179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.933 HG22 ' O ' ' A' ' 34' ' ' GLU . 11.0 t -85.71 137.58 32.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.981 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -123.94 101.46 7.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.806 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 63.17 -103.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.806 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -176.27 -168.6 0.26 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.854 0.359 . . . . 0.0 111.109 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.52 -64.07 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -105.89 -51.49 2.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -176.78 147.79 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.05 -74.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -143.11 87.06 1.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.53 -20.82 61.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.376 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.8 t-20 -94.99 16.24 16.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.412 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -114.41 26.32 10.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.744 HD12 ' HB3' ' A' ' 114' ' ' ASP . 2.2 tt -52.66 84.71 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.752 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.933 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -124.03 176.72 6.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 111.108 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.76 166.25 15.37 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.062 0.458 . . . . 0.0 112.014 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.5 Cg_endo -47.62 168.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.85 3.033 . . . . 0.0 112.527 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.54 59.47 0.75 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.112 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.84 110.33 0.95 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.252 -0.974 . . . . 0.0 112.039 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.627 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 118.14 4.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.344 0.658 . . . . 0.0 111.734 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.013 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -53.65 -27.91 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.561 0.696 . . . . 0.0 110.343 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.553 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -43.54 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.26 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 78.4 mmm 39.13 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.304 0.377 . . . . 0.0 111.586 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.67 33.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.702 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -96.92 -170.15 1.99 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.555 0.217 . . . . 0.0 111.055 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.915 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -104.55 158.97 30.85 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.915 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.4 Cg_endo -43.88 -24.71 0.86 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.902 2.402 . . . . 0.0 112.496 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -92.66 -58.29 2.4 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -80.72 -4.78 55.68 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.785 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.85 -57.24 11.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.792 0.329 . . . . 0.0 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.629 HG22 HD13 ' A' ' 54' ' ' LEU . 1.4 p -78.76 -42.75 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.783 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.2 t -50.66 -35.55 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.225 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -52.15 9.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.926 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.0 mm-40 -63.34 -19.84 64.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.693 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.923 HD11 ' HE2' ' A' ' 64' ' ' HIS . 2.7 tp -56.76 -44.68 82.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.071 0.462 . . . . 0.0 110.541 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.73 -27.02 68.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.899 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' LYS . 4.2 tm-20 -77.2 -30.63 54.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.23 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' CG ' ' HB3' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -108.44 6.69 26.47 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.914 HG12 HG13 ' A' ' 60' ' ' ILE . 43.8 t -133.48 -44.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.89 -40.1 0.25 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.951 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.914 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.46 -177.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.014 0.435 . . . . 0.0 111.095 -179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.55 88.7 13.85 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.996 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.742 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.8 Cg_endo -111.48 146.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 123.394 2.729 . . . . 0.0 114.219 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 14.8 mt-30 -74.74 79.64 2.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.956 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -120.94 128.64 52.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.006 -176.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 -177.04 -139.85 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.587 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 56.83 157.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.099 0.476 . . . . 0.0 111.86 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.558 HD21 ' HD3' ' A' ' 70' ' ' LYS . 5.3 tt -119.71 109.44 15.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.614 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.79 -43.54 36.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.151 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 2.7 mt-10 -171.24 165.66 7.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.624 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD3' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.15 132.11 22.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.882 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 tp -116.89 123.75 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -121.5 109.99 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.638 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -140.89 153.25 45.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -114.22 140.2 48.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.273 0.558 . . . . 0.0 111.307 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -103.75 163.84 16.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.475 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 54.1 Cg_exo -41.36 81.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.338 2.692 . . . . 0.0 112.554 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.6 t0 73.62 20.48 3.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.607 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 7.5 ttt180 -137.23 93.92 2.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.36 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -74.6 98.82 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 110.942 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.0 tt -99.64 111.87 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.887 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.52 133.76 44.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.661 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.787 HD13 HD21 ' A' ' 119' ' ' ASN . 35.1 mt -126.16 114.39 18.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.453 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.7 OUTLIER -110.08 122.66 48.13 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.485 ' HB3' ' HD1' ' A' ' 68' ' ' PHE . 3.1 m-85 -105.46 125.73 51.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.832 0.348 . . . . 0.0 111.269 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.551 ' HE1' ' HB1' ' A' ' 7' ' ' ALA . 67.6 m95 -107.86 148.5 29.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 65' ' ' PHE . 8.7 tp -98.74 102.81 14.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 111.332 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.956 HG22 ' ND1' ' A' ' 64' ' ' HIS . 13.9 t -81.5 145.65 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -109.53 -35.17 6.3 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.44 165.64 26.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.845 0.748 . . . . 0.0 112.017 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.768 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 1.4 p90 -151.47 130.54 12.63 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.572 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -76.35 140.87 41.62 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.16 -121.94 25.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.468 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.7 mt-10 -131.84 145.81 59.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.536 0.208 . . . . 0.0 110.779 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.4 Cg_exo -76.72 128.76 10.36 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.836 2.357 . . . . 0.0 111.362 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 55.8 p-90 -133.51 -60.75 0.83 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.124 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.84 -99.66 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.02 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 179.46 33.23 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.554 0.216 . . . . 0.0 111.278 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 57' ' ' GLU . 7.8 pt-20 -65.57 -26.81 68.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.794 0.33 . . . . 0.0 110.608 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.54 32.04 82.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.836 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 21' ' ' THR . 6.5 mm-40 -140.38 92.2 9.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.943 0.401 . . . . 0.0 111.216 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -43.57 126.37 5.38 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.091 2.527 . . . . 0.0 112.817 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.27 177.17 19.37 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.853 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.92 157.14 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -69.01 106.23 2.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.887 0.375 . . . . 0.0 110.031 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 9.6 ptm -120.47 148.12 44.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.036 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.686 ' HB2' HG12 ' A' ' 108' ' ' VAL . 77.4 p -70.89 114.97 9.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.058 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.666 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -61.41 -18.7 60.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.032 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.909 ' HA ' HD21 ' A' ' 129' ' ' LEU . 11.9 p -59.3 -9.63 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.836 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.45 49.62 0.92 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.276 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 111' ' ' ASN . 0.3 OUTLIER -62.22 142.11 57.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 110.42 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.734 ' N ' HD13 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -120.04 115.87 24.59 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.24 -15.16 61.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.211 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.02 -49.03 13.36 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.744 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -68.39 -33.51 74.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.76 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -83.14 174.02 6.64 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.394 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 63.5 Cg_endo -73.95 127.81 11.78 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.107 1.871 . . . . 0.0 111.363 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.02 -14.83 30.07 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.738 2.292 . . . . 0.0 113.266 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -9.75 39.58 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.787 HD21 HD13 ' A' ' 82' ' ' LEU . 1.3 m-20 -130.07 37.82 3.86 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.84 -43.87 11.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 111.528 0.195 . . . . 0.0 111.528 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.2 Cg_exo -54.76 -38.92 91.62 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.134 1.889 . . . . 0.0 112.244 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 2.3 t -77.55 -51.31 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.036 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.526 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -67.41 -29.87 47.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.027 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.66 -30.95 56.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.987 0.422 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -69.8 -52.52 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.868 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.695 ' O ' HD22 ' A' ' 129' ' ' LEU . 2.9 tp -78.16 -19.52 53.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 110' ' ' LEU . 18.1 ttpp -72.23 -42.74 65.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.114 0.483 . . . . 0.0 110.882 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -75.58 -3.92 37.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.176 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.909 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.882 0.372 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -86.91 136.15 33.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.51 121.94 19.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.833 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.629 HD11 " O3'" ' A' ' 131' ' ' 8OG . 2.6 pp -112.51 125.99 54.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.761 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 10.8 mt-30 -102.95 160.05 14.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.09 0.472 . . . . 0.0 111.482 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.615 HD12 ' CD1' ' A' ' 82' ' ' LEU . 39.8 mt -144.8 135.2 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.461 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.006 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.39 150.11 45.95 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -144.99 149.95 16.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.938 0.399 . . . . 0.0 111.143 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.6 111.35 0.5 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.723 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.09 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -81.13 109.62 15.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.743 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.6 OUTLIER -71.03 119.38 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.228 0.537 . . . . 0.0 111.82 -178.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 1.4 mmt85 -83.22 124.31 30.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.756 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.54 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -78.05 -172.92 2.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.528 178.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 tt0 -85.74 16.46 3.98 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.553 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -142.63 50.59 1.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.919 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.0 25.6 0.5 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.142 0.496 . . . . 0.0 111.217 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 105' ' ' MET . 39.4 mt-10 -120.54 161.47 21.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.09 HG21 HG22 ' A' ' 10' ' ' ILE . 13.0 mt -122.26 139.25 49.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.211 0.529 . . . . 0.0 111.356 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.9 OUTLIER -86.19 94.36 9.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.869 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -114.48 148.59 17.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.688 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.8 t -70.72 111.91 6.54 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.433 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.731 ' HD2' HD22 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -118.06 110.85 18.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.516 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 49.43 26.15 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.489 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 100' ' ' GLN . . . 48.96 -165.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 111.279 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.22 -29.77 31.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.014 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 p30 -104.84 -176.14 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.89 56.25 3.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.36 114.94 20.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.7 mmt 60.27 79.89 0.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.87 -11.19 59.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.619 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -96.67 29.46 2.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.349 . . . . 0.0 111.08 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -114.11 26.3 10.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.112 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.731 HD22 ' HD2' ' A' ' 22' ' ' ARG . 21.5 tp -64.04 70.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -118.37 178.08 4.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HB3' ' CG2' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.03 162.36 33.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.187 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 8.0 Cg_endo -48.02 169.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.941 3.094 . . . . 0.0 111.482 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.48 59.97 0.71 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.664 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -144.42 107.64 0.45 Allowed Glycine 0 C--N 1.313 -0.699 0 CA-C-N 114.222 -0.989 . . . . 0.0 111.67 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.96 -10.79 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.516 0.726 . . . . 0.0 110.513 -179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.006 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -43.75 -78.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.044 0.449 . . . . 0.0 110.961 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.625 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 5.38 -80.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.344 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttm 37.29 -133.43 0.1 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.378 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.32 14.81 5.6 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.033 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -71.09 -164.56 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.606 0.241 . . . . 0.0 110.805 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.872 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.62 154.41 37.49 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.872 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -44.29 -24.82 1.07 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -100.28 -47.97 4.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.99 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -80.37 -7.15 58.97 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -65.53 -55.62 16.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.565 0.221 . . . . 0.0 111.216 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.743 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.27 -40.76 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.06 179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.9 t -50.58 -35.4 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.432 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -42.76 31.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.457 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -67.26 -26.12 66.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.251 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.738 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.1 tp -52.55 -44.35 65.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.452 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.54 -33.08 74.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.1 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -77.36 -25.57 51.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.149 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 4.2 mm-40 -108.18 5.19 25.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 18.4 t -135.22 -44.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.319 0.581 . . . . 0.0 110.309 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.62 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.48 4.62 1.39 Allowed Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.604 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.07 -173.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 117.897 0.848 . . . . 0.0 110.831 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.9 p -113.72 87.48 12.24 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.545 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.754 ' HG3' HG11 ' A' ' 58' ' ' VAL . 9.1 Cg_endo -115.27 149.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.643 2.895 . . . . 0.0 114.22 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.02 79.82 2.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.05 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.3 t-160 -123.5 130.5 52.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.244 -175.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.55 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -177.86 -139.18 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.794 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.79 175.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 111.847 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.763 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -143.11 123.96 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.926 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.55 -44.61 34.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.498 . . . . 0.0 109.796 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -171.45 164.83 6.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.036 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 127.69 17.49 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 121' ' ' PRO . 48.7 tp -106.63 121.09 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.503 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -122.22 112.01 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -141.04 148.06 39.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.45 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -121.08 139.97 52.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.457 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -105.04 162.76 18.78 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.285 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.477 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 7.6 Cg_endo -49.72 82.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.099 2.533 . . . . 0.0 112.25 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 75' ' ' PHE . 9.2 m-20 87.74 11.35 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.595 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -137.28 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.726 0.298 . . . . 0.0 110.866 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -80.34 107.15 12.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 0.0 111.094 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.476 HD12 " O3'" ' A' ' 131' ' ' 8OG . 1.6 tt -100.42 111.74 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.71 135.11 42.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.924 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.823 HD21 ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -126.26 114.44 18.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.774 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -116.15 122.79 46.12 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.769 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 1.7 m-85 -113.6 113.44 25.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.877 0.37 . . . . 0.0 110.273 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.763 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 44.0 m95 -94.77 148.59 22.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.452 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 65' ' ' PHE . 50.4 tp -104.8 102.73 12.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.391 0.615 . . . . 0.0 111.251 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.05 HG22 ' CD2' ' A' ' 64' ' ' HIS . 12.6 t -80.88 145.8 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.291 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.77 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -161.78 165.52 27.82 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.868 0.758 . . . . 0.0 112.065 -178.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.743 ' HE3' HG22 ' A' ' 11' ' ' ILE . 2.1 p90 -149.84 131.49 14.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.489 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.53 136.38 33.87 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.73 -140.82 19.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.526 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.0 tt0 -115.1 129.82 24.75 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.383 0.135 . . . . 0.0 110.731 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.55 128.78 10.51 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.649 2.233 . . . . 0.0 111.721 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.62 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.1 p-90 -135.3 -57.74 0.8 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.866 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.51 -104.07 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.137 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 166.57 40.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -41.26 91.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.981 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.97 -104.03 0.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.932 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 19.7 mt-30 -92.95 120.61 66.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -43.62 146.14 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.066 2.511 . . . . 0.0 112.682 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.31 19.23 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.808 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.5 157.23 29.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.621 0.248 . . . . 0.0 110.735 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.1 m0 -60.39 106.87 0.58 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 110.426 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.8 OUTLIER -120.19 156.73 30.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.476 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 5.0 t -81.1 116.86 21.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.843 HD22 ' CD1' ' A' ' 18' ' ' ILE . 6.3 tp -72.66 -18.7 61.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 108' ' ' VAL . 21.6 t -49.67 -21.2 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.72 0.295 . . . . 0.0 111.452 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.23 50.51 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.886 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 107' ' ' LEU . 8.6 tt -62.12 150.31 38.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.686 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -104.11 101.22 10.97 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.19 -16.89 61.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.27 0.557 . . . . 0.0 110.083 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.51 -48.81 13.24 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.073 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -35.64 80.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.008 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.542 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.6 169.19 21.87 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.415 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 10.4 Cg_endo -54.63 131.8 47.81 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.55 2.167 . . . . 0.0 112.93 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.504 ' O ' ' CG ' ' A' ' 120' ' ' GLU . 55.6 Cg_endo -69.17 -14.07 37.27 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.072 2.515 . . . . 0.0 112.627 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -76.7 -9.04 58.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.823 ' OD1' HD21 ' A' ' 82' ' ' LEU . 1.7 m-20 -121.38 25.89 9.18 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -74.02 -38.84 3.94 Favored Pre-proline 0 N--CA 1.465 0.293 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 92.9 Cg_exo -44.82 -41.9 15.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.181 1.921 . . . . 0.0 113.204 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.769 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -77.42 -51.34 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.071 -179.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 115' ' ' PHE . 4.1 mm -65.37 -29.93 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.222 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.64 -32.23 63.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.13 0.49 . . . . 0.0 110.35 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -71.06 -48.58 51.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.212 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.835 HD23 ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.24 -30.8 48.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.157 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.835 ' N ' HD23 ' A' ' 126' ' ' LEU . 35.2 tttp -54.9 -42.64 72.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.974 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -67.16 -10.1 46.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.8 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.7 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.069 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.629 " O3'" HD11 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.832 0.348 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.99 103.05 11.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.79 131.88 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.801 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.5 pp -125.57 123.02 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.048 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.593 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 44.7 mt-30 -102.4 153.75 19.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.339 0.59 . . . . 0.0 111.658 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.732 HD11 " H4'" ' A' ' 131' ' ' 8OG . 89.3 mt -146.36 131.28 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.107 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.043 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.6 124.46 42.27 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.534 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.5 m -117.13 162.68 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.45 . . . . 0.0 111.697 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -144.46 115.0 0.83 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.606 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.757 HG22 HG13 ' A' ' 18' ' ' ILE . 1.5 mp -70.61 95.63 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.698 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.0 111.82 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.47 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.574 ' HB2' ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -85.51 136.26 33.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.046 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.652 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 23.5 p30 -105.94 -172.89 2.17 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.766 0.793 . . . . 0.0 112.687 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -68.21 -4.4 13.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.693 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 56.2 t30 -124.19 42.51 3.23 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.087 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 46.22 27.05 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.613 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB3' ' HA ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.8 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.867 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.85 146.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.378 0.608 . . . . 0.0 112.295 -178.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.557 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 20.1 t80 -90.04 95.79 10.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.86 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.867 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -108.34 162.19 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p -81.13 111.87 17.97 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.407 ' HG2' ' CG ' ' A' ' 23' ' ' ARG . 13.9 ttm180 -124.14 134.67 53.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.908 0.385 . . . . 0.0 111.383 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' NH1' ' HB1' ' A' ' 30' ' ' ALA . 2.4 mtt-85 48.56 27.31 1.42 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.404 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.09 -86.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.201 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.578 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . . . -144.49 -47.2 0.25 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.07 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -150.18 -50.45 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.016 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.9 120.39 16.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.182 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.06 -76.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.804 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.11 118.5 4.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.722 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' HB1' ' NH1' ' A' ' 23' ' ' ARG . . . -83.37 -25.24 31.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.485 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.68 19.23 10.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.374 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.5 26.18 10.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.717 0.294 . . . . 0.0 111.65 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.0 tt -54.15 83.71 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.757 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.78 -179.08 3.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.84 0.353 . . . . 0.0 111.412 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.534 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -120.0 160.98 40.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.648 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 29.0 Cg_endo -61.5 168.09 8.73 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.484 2.789 . . . . 0.0 111.528 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.45 59.34 0.75 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 119.806 -1.188 . . . . 0.0 113.98 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.94 121.02 3.43 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 114.777 -0.711 . . . . 0.0 112.05 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 115.02 6.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.382 0.673 . . . . 0.0 111.817 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.046 HD12 ' HB1' ' A' ' 49' ' ' ALA . 1.1 pt -58.24 -25.92 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.582 0.706 . . . . 0.0 110.573 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HB3' ' H ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -45.1 -85.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.24 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 38.29 -84.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.312 0.383 . . . . 0.0 111.615 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.57 32.68 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.541 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.7 mp0 -91.6 -176.46 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.86 0.362 . . . . 0.0 111.222 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.916 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -102.64 156.17 35.62 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.916 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.99 -24.77 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.797 2.331 . . . . 0.0 112.715 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.32 -48.27 5.39 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -80.27 -14.01 58.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.046 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.93 -52.97 62.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 111.073 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.821 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.1 m -77.93 -44.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 47' ' ' GLU . 46.6 t -57.77 -35.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.127 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -52.09 9.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.496 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.1 mm-40 -65.42 -24.21 67.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.839 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.029 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -52.2 -44.27 64.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.88 0.371 . . . . 0.0 110.345 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -36.6 78.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.86 -25.03 48.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.493 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.464 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 76.4 mm-40 -108.44 5.94 25.79 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.964 HG12 HG13 ' A' ' 60' ' ' ILE . 14.5 t -134.37 -44.12 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 110.543 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 60.59 5.29 4.88 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.623 -0.717 . . . . 0.0 114.353 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.964 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -122.5 -166.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 117.859 0.829 . . . . 0.0 110.852 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.601 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -112.57 88.08 10.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.813 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.4 Cg_endo -113.57 135.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.49 2.793 . . . . 0.0 114.462 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 27.8 mt-30 -74.65 79.39 2.01 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.029 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -113.04 132.9 55.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.684 -175.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.562 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -177.12 -143.1 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.829 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 2.1 m 52.14 171.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 112.245 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 67' ' ' LEU . 4.8 tt -134.24 114.48 13.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.452 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.565 ' HE1' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.49 -56.04 4.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.811 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -171.51 131.84 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.241 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -114.59 132.08 56.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.812 0.339 . . . . 0.0 110.893 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HB2' HG22 ' A' ' 122' ' ' VAL . 7.5 tp -107.34 141.44 38.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -131.32 109.72 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.683 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -141.02 138.25 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.296 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 8.3 pt-20 -107.41 140.11 40.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.262 0.553 . . . . 0.0 111.718 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -101.34 163.05 18.65 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.053 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 4.2 Cg_endo -46.6 81.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.196 2.598 . . . . 0.0 112.532 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 75' ' ' PHE . 8.3 m-20 85.61 11.87 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.689 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HG2' HD23 ' A' ' 4' ' ' LEU . 3.6 ttt180 -137.42 94.89 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 12.6 t-160 -74.84 97.92 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.0 tt -94.47 111.93 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.959 0.409 . . . . 0.0 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -107.03 129.43 54.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.822 HD13 ' OD1' ' A' ' 119' ' ' ASN . 11.4 mt -126.45 114.75 18.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.425 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.521 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -110.29 122.88 48.73 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.464 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 11.7 m-30 -103.22 113.08 26.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.735 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.9 m95 -95.07 148.86 21.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.548 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.2 tm? -90.9 102.87 15.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.225 0.536 . . . . 0.0 111.551 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.834 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.9 t -89.53 144.87 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 12' ' ' ARG . 4.7 pm0 -121.28 -13.5 8.47 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -160.94 160.05 30.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.044 1.293 . . . . 0.0 112.357 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.653 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -158.0 122.17 4.16 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.73 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.601 ' CB ' HG23 ' A' ' 61' ' ' THR . 1.5 mm-40 -83.33 117.98 23.37 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-O 120.882 0.372 . . . . 0.0 111.096 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.3 -125.61 8.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.531 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -128.13 136.12 28.56 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 110.577 -0.156 . . . . 0.0 110.577 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.676 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.99 128.91 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.766 2.311 . . . . 0.0 111.285 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.529 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 50.8 p-90 -140.95 -58.09 0.5 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.129 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 47.87 -93.28 0.01 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.501 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -171.93 33.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.787 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 99' ' ' GLY . 26.0 pt-20 -62.0 -47.09 86.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 99.46 -24.4 32.36 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.277 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -112.27 95.67 31.8 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.574 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.578 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 55.5 Cg_exo -43.5 146.14 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.173 2.582 . . . . 0.0 112.767 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.24 177.71 18.95 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.76 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.43 154.39 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.52 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.6 m0 -66.83 105.62 1.64 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.073 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.718 ' SD ' HD11 ' A' ' 20' ' ' ILE . 1.1 ptm -121.06 153.38 37.48 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.378 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.484 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 5.4 p -74.21 114.96 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.146 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.9 tm? -60.78 -24.45 65.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.685 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.5 t -55.49 -19.78 6.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.96 35.15 4.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.025 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 110' ' ' LEU . 10.8 tp -62.83 130.23 43.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.12 136.07 54.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.38 -15.43 61.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.657 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -78.85 -49.1 13.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.624 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -35.26 77.96 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.488 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -82.82 174.02 6.67 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.636 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 68.4 Cg_endo -74.75 127.99 11.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.256 1.971 . . . . 0.0 111.488 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.13 -14.74 25.03 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.774 2.316 . . . . 0.0 113.35 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.99 -9.9 25.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.822 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -131.86 41.0 3.31 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.78 0.324 . . . . 0.0 111.439 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.29 -46.3 7.85 Favored Pre-proline 0 N--CA 1.464 0.241 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.1 Cg_exo -47.83 -40.27 31.98 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.218 1.945 . . . . 0.0 112.816 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.3 t -77.52 -51.42 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.4 mm -65.45 -29.96 48.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.945 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.27 -31.61 63.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.987 0.423 . . . . 0.0 110.627 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -50.06 36.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.802 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -78.17 -26.39 47.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.297 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -58.25 -42.67 86.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 110.814 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.04 -8.6 46.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.779 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.004 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.732 " H4'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.773 0.321 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 113.86 26.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 121.92 13.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.671 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 78' ' ' ARG . 3.4 pp -100.36 121.02 40.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.751 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -102.61 151.32 22.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.204 0.526 . . . . 0.0 111.153 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.723 HD11 ' CD1' ' A' ' 4' ' ' LEU . 2.8 mp -140.06 139.0 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.486 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.964 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.78 140.8 52.6 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.525 HG11 ' CE1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -144.49 149.78 17.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.167 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.67 125.52 1.88 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.402 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.994 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -83.8 109.49 17.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.734 HG23 HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -71.16 121.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.157 0.503 . . . . 0.0 111.318 -178.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -85.94 120.06 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.129 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.511 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 27.5 p-10 -74.62 -171.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.914 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 8.3 tp10 -86.81 19.0 3.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.067 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -144.5 27.73 1.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.746 0.308 . . . . 0.0 111.663 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.61 3.86 4.72 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 1.5 mm-40 -100.76 159.89 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.994 HG21 HG22 ' A' ' 10' ' ' ILE . 7.0 mt -125.28 141.78 44.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 111.496 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -90.38 113.47 25.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.793 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.01 162.05 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.398 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 t -88.98 111.8 22.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.851 0.358 . . . . 0.0 110.315 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.612 ' HD2' HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -102.89 83.96 2.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.312 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' CG ' ' HA ' ' A' ' 30' ' ' ALA . 6.1 mtm180 50.95 23.54 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.536 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.832 ' HB2' ' HB3' ' A' ' 100' ' ' GLN . . . 47.59 27.73 1.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.715 0.293 . . . . 0.0 111.402 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 56.85 39.92 29.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.128 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 24' ' ' ALA . 3.1 p30 -134.56 -173.77 3.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.954 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.87 -161.67 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 71.48 -79.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -96.49 73.21 2.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.693 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . . . -85.3 -25.38 27.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.544 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.68 28.95 3.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.295 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -114.29 26.05 10.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.012 0.434 . . . . 0.0 111.515 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.612 HD11 ' HD2' ' A' ' 22' ' ' ARG . 1.1 tt -59.02 87.73 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -169.42 2.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.921 0.391 . . . . 0.0 111.526 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.765 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.95 165.44 17.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.792 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 8.6 Cg_endo -47.83 168.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.788 2.992 . . . . 0.0 111.844 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.737 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.15 59.84 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.249 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -138.92 109.44 0.66 Allowed Glycine 0 C--N 1.312 -0.761 0 CA-C-N 114.473 -0.864 . . . . 0.0 111.697 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 122.32 -8.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.463 0.705 . . . . 0.0 110.853 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.964 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -43.2 -65.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.256 0.55 . . . . 0.0 111.41 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -13.6 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.472 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 43.0 -94.0 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.598 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.23 18.11 0.09 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.579 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -79.55 -163.0 0.46 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.842 -0.211 . . . . 0.0 110.801 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.865 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.86 154.76 38.39 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.865 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.8 -24.86 0.85 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.702 2.268 . . . . 0.0 112.399 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.711 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.65 -52.22 4.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.015 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -80.51 -4.93 55.76 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -66.19 -57.01 8.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.101 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.738 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.32 -40.65 25.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 111.264 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 47' ' ' GLU . 58.7 t -50.46 -35.48 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.935 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -52.12 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.89 -25.59 67.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.65 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.682 HD13 ' CG2' ' A' ' 50' ' ' VAL . 2.1 tp -54.61 -44.43 73.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.576 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -27.41 67.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.734 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -77.14 -25.58 52.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.233 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 1.8 mp0 -108.42 5.74 25.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.918 HG12 HG13 ' A' ' 60' ' ' ILE . 16.4 t -134.53 -44.55 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.263 0.554 . . . . 0.0 110.286 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.636 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 56.79 3.41 0.7 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.577 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.918 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.75 -173.24 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 117.926 0.863 . . . . 0.0 110.392 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.2 p -113.96 87.5 12.87 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.901 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.755 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.9 Cg_endo -115.11 149.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 123.761 2.974 . . . . 0.0 113.924 -177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 83.2 mt-30 -74.81 79.62 2.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.907 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.57 127.57 49.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.061 -176.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.79 -136.98 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.776 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 56.6 163.26 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.219 0.533 . . . . 0.0 112.116 179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.5 tt -126.19 113.18 16.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.289 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.863 ' CE1' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.65 -53.24 8.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.293 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.714 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.41 131.68 0.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.418 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -125.11 132.07 53.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.728 0.299 . . . . 0.0 111.023 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.879 HD23 ' CG2' ' A' ' 122' ' ' VAL . 0.7 OUTLIER -106.54 159.34 16.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.666 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.0 tt0 -140.08 109.92 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.485 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -133.33 153.01 51.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.24 140.05 52.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 111.425 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -103.41 162.86 18.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.156 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.1 Cg_endo -45.8 80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.334 2.689 . . . . 0.0 112.815 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.5 t0 85.45 9.95 0.31 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.947 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.822 ' HG2' HD23 ' A' ' 4' ' ' LEU . 3.9 ttp-105 -137.39 101.39 4.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 111.087 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.0 m-70 -74.89 115.84 14.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.829 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 4' ' ' LEU . 1.1 tt -107.14 112.04 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.955 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.88 129.92 53.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.004 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.754 HD13 ' OD1' ' A' ' 119' ' ' ASN . 26.3 mt -126.37 114.43 18.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.146 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.8 m0 -111.95 122.43 47.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.044 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.714 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 3.4 m-30 -104.5 115.06 29.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.491 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.738 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 36.6 m95 -94.72 148.72 21.99 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.058 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.2 tm? -101.08 102.68 13.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.452 0.644 . . . . 0.0 111.361 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.907 HG22 ' CE1' ' A' ' 64' ' ' HIS . 11.5 t -82.11 145.77 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.658 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.97 -45.87 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.8 ptm85 -163.13 165.93 24.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.839 0.745 . . . . 0.0 112.383 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.662 ' HE3' HG22 ' A' ' 11' ' ' ILE . 8.4 p90 -139.59 136.19 34.13 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.68 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.35 108.72 19.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.35 -121.47 6.86 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.427 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.5 tt0 -135.08 135.06 22.18 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.467 0.175 . . . . 0.0 110.917 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.555 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.6 Cg_exo -76.47 128.73 10.54 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.796 2.331 . . . . 0.0 111.58 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.636 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.4 p-90 -133.47 -58.18 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.09 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.572 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 37.89 -92.39 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.257 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 95' ' ' TRP . 5.2 tmtm? 179.88 -69.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.812 0.339 . . . . 0.0 110.747 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER 42.21 26.06 0.05 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.605 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.21 -65.17 0.06 OUTLIER Glycine 0 CA--C 1.521 0.454 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.545 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.832 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 28.5 mt-30 -108.02 99.23 29.81 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.47 146.55 3.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.139 2.559 . . . . 0.0 112.469 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 169.04 21.4 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.189 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.84 157.62 25.31 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.83 106.36 3.11 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.609 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.401 ' CE ' ' NE ' ' A' ' 22' ' ' ARG . 2.6 mtp -120.87 164.11 17.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.384 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -70.75 116.96 11.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.339 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.548 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.83 -18.71 50.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.62 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.491 ' O ' HD21 ' A' ' 129' ' ' LEU . 21.2 t -57.12 -14.25 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.79 35.24 4.7 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.153 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 107' ' ' LEU . 11.5 tp -62.74 135.91 57.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.09 131.48 53.71 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.63 -15.3 61.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.975 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -78.71 -49.14 13.62 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.809 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -36.46 77.71 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.775 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.565 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -78.77 173.98 6.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.731 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.4 Cg_endo -76.46 137.17 18.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.358 2.039 . . . . 0.0 112.089 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 27.6 Cg_endo -62.01 -14.29 36.44 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.842 2.361 . . . . 0.0 113.202 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.3 -9.7 19.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.754 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -135.9 44.12 2.5 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.2 OUTLIER -76.05 -50.77 2.98 Favored Pre-proline 0 N--CA 1.463 0.186 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 79.6 Cg_exo -44.74 -38.02 12.26 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.447 2.098 . . . . 0.0 112.792 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.879 ' CG2' HD23 ' A' ' 71' ' ' LEU . 2.5 t -77.25 -49.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.611 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.565 HG13 ' CE2' ' A' ' 115' ' ' PHE . 11.3 mm -64.75 -29.97 48.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.747 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.05 -29.75 63.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 110.653 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.28 -48.52 15.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.629 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.863 HD23 ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -78.19 -30.25 48.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.815 0.34 . . . . 0.0 111.425 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HB2' HG22 ' A' ' 123' ' ' ILE . 12.0 ttpt -55.58 -42.47 74.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.022 0.439 . . . . 0.0 110.817 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -68.42 -7.47 31.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.639 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 108' ' ' VAL . 24.7 mt . . . . . 0 C--O 1.233 0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.073 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.713 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.855 0.36 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.09 131.75 54.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -126.93 141.89 51.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.4 pp -145.61 117.59 8.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.547 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.6 mt-30 -102.29 151.74 21.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.841 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.65 HD11 " O3'" ' A' ' 131' ' ' 8OG . 4.3 mt -142.68 128.28 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.869 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.099 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.54 124.68 42.78 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.536 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.7 m -115.39 162.18 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.283 0.563 . . . . 0.0 111.924 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -150.42 102.08 0.23 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.957 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.94 HG22 HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.91 110.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.606 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.55 115.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 120.688 0.28 . . . . 0.0 111.066 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 3.7 mmt85 -82.14 133.7 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.452 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 10.3 p-10 -84.17 -172.01 3.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 122.091 0.948 . . . . 0.0 113.062 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -56.61 -16.06 5.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.721 -1.581 . . . . 0.0 113.275 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -127.71 -83.0 0.6 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.16 17.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 111.687 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HB2' ' ND2' ' A' ' 13' ' ' ASN . 19.8 mt-10 -100.89 160.11 14.64 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.94 HD12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -135.08 145.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 111.997 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 14.0 t80 -84.48 89.63 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.79 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.895 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -113.29 162.17 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.038 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 34' ' ' GLU . 1.3 t -80.25 130.27 35.09 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 1.1 ptm180 -146.48 128.39 15.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 111.167 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 mpp_? 45.83 28.53 0.59 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 100' ' ' GLN . . . -99.99 32.8 2.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.175 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . -158.49 53.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.015 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -57.1 158.14 5.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 59.76 30.67 20.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.073 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -155.53 -55.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.02 108.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.03 -18.95 29.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.325 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.51 31.29 2.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.879 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.03 26.37 10.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.507 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HE1' ' A' ' 105' ' ' MET . 3.8 tt -57.74 77.37 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -108.58 -170.65 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.091 0.472 . . . . 0.0 111.636 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.9 154.13 55.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 11.1 Cg_endo -53.84 167.47 1.06 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.233 2.622 . . . . 0.0 111.677 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.01 59.25 0.77 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.137 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -128.06 117.04 2.48 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 114.84 -0.68 . . . . 0.0 112.059 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 3.5 tttt 115.76 4.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.322 0.649 . . . . 0.0 111.513 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.099 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -53.98 -27.61 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.569 0.699 . . . . 0.0 110.665 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.588 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.22 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.4 mmt 33.38 -85.62 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.558 0.537 . . . . 0.0 111.878 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -170.31 31.11 0.14 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.553 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.459 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 7.0 mp0 -91.61 -175.07 4.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -111.92 159.0 35.14 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.95 -24.65 0.88 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.904 2.403 . . . . 0.0 112.696 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -90.68 -58.08 2.61 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -80.4 -20.07 44.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.924 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.3 -49.76 73.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.833 0.349 . . . . 0.0 111.148 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.928 HG11 ' NE1' ' A' ' 85' ' ' TRP . 2.6 m -76.03 -46.86 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 47' ' ' GLU . 42.3 t -60.46 -35.85 65.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.087 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -70.91 -49.14 49.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.022 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.7 ' CB ' HG22 ' A' ' 40' ' ' ILE . 7.0 tp10 -71.33 -27.97 63.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.934 HD23 ' ND1' ' A' ' 64' ' ' HIS . 0.6 OUTLIER -55.06 -44.08 74.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.55 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -61.44 -35.09 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 0.0 109.816 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.53 -33.54 54.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.339 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 20.5 mm-40 -100.05 4.83 44.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.026 HG12 HG22 ' A' ' 60' ' ' ILE . 3.3 t -135.48 -43.37 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.115 0.483 . . . . 0.0 110.245 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.64 9.39 6.61 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.747 -0.661 . . . . 0.0 114.504 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.026 HG22 HG12 ' A' ' 58' ' ' VAL . 13.5 tt -115.88 162.42 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 117.46 0.63 . . . . 0.0 110.289 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.491 ' N ' HG12 ' A' ' 60' ' ' ILE . 1.5 p -98.82 88.44 0.72 Allowed Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.839 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 58.4 Cg_endo -113.31 156.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 124.236 3.291 . . . . 0.0 114.096 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -75.85 78.38 2.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.934 ' ND1' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -111.94 120.7 42.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.786 -173.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.535 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -177.95 -153.61 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.629 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m 59.56 154.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -118.39 120.02 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.437 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.71 -44.12 34.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.064 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 tt0 -171.44 162.81 6.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.187 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.576 ' HD2' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.53 132.16 22.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.449 ' HB2' HG22 ' A' ' 122' ' ' VAL . 34.5 tp -113.77 122.32 46.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.822 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -116.86 109.85 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.723 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.19 143.41 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.497 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.6 pt-20 -121.13 124.52 44.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.216 0.531 . . . . 0.0 111.547 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -85.24 163.23 46.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.089 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.2 Cg_endo -51.56 81.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.921 2.414 . . . . 0.0 112.225 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 90.54 11.61 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.53 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -137.29 93.78 2.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.772 0.32 . . . . 0.0 111.007 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -78.46 106.96 10.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.101 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.09 112.63 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -105.93 128.76 54.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.665 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.818 HD13 ' OD1' ' A' ' 119' ' ' ASN . 9.4 mt -126.34 114.64 18.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.723 0.297 . . . . 0.0 111.472 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -108.84 122.86 48.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.107 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.782 ' CD2' HG11 ' A' ' 122' ' ' VAL . 12.1 m-30 -103.43 112.04 24.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 0.0 110.888 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.928 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.9 m95 -95.12 149.23 21.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.437 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 65' ' ' PHE . 5.3 tp -106.3 103.18 12.59 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.862 HG13 ' HA ' ' A' ' 64' ' ' HIS . 11.3 t -82.63 145.45 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.326 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -102.84 -35.23 8.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.3 165.42 26.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.53 0.604 . . . . 0.0 112.0 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.716 ' HB2' HD13 ' A' ' 60' ' ' ILE . 9.2 p90 -138.93 157.96 45.08 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.289 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.764 ' C ' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -104.78 101.29 10.9 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.239 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.67 -115.02 5.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.065 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.5 tt0 -135.25 122.83 15.17 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.504 0.192 . . . . 0.0 111.432 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 3.0 Cg_exo -74.17 128.82 12.5 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.624 2.216 . . . . 0.0 110.794 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.547 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 20.8 p-90 -123.5 -60.85 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.09 0.471 . . . . 0.0 111.833 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 57.2 -117.79 10.69 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.261 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.54 37.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.06 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -53.82 -24.52 15.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.012 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.42 -15.03 39.07 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.315 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.779 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -140.06 105.38 6.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 111.392 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.56 143.77 2.44 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.006 2.471 . . . . 0.0 112.727 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.35 177.31 19.29 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.971 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.15 157.17 44.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.27 106.52 0.54 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.872 0.368 . . . . 0.0 110.177 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.553 ' HE1' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -120.53 139.57 52.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.027 179.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.574 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.8 p -59.66 114.77 2.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.352 . . . . 0.0 110.825 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.1 tm? -67.72 -24.49 65.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.095 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.574 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.5 p -57.73 -18.23 9.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.73 35.89 4.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.789 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.034 HD23 HD13 ' A' ' 123' ' ' ILE . 12.3 tp -62.8 135.52 57.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.22 133.41 54.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.36 -15.35 61.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.779 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.85 -49.29 13.16 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.742 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -30.6 69.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.386 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.731 ' CZ ' HG21 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -88.67 174.43 5.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.341 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 50.5 Cg_endo -69.61 127.97 15.49 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.968 1.779 . . . . 0.0 111.649 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.71 -14.81 45.06 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.643 2.228 . . . . 0.0 113.097 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.32 -9.79 44.52 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.818 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -124.21 27.22 7.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.475 0.179 . . . . 0.0 111.432 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' HA ' ' CG2' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -58.05 -49.07 95.71 Favored Pre-proline 0 N--CA 1.463 0.195 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 87.0 Cg_exo -46.86 -35.92 18.91 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.437 2.091 . . . . 0.0 113.176 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.782 HG11 ' CD2' ' A' ' 84' ' ' PHE . 21.3 t -77.54 -51.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.627 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.034 HD13 HD23 ' A' ' 110' ' ' LEU . 2.5 tp -68.07 -30.6 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.788 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.99 -26.99 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.877 0.37 . . . . 0.0 110.672 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -49.07 12.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.446 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -78.16 -29.53 48.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -56.04 -42.49 76.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.86 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.27 -3.9 29.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.892 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 108' ' ' VAL . 2.2 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.194 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.65 " O3'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tpp . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.807 0.337 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.26 102.9 12.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.38 143.41 53.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.798 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.939 HD11 " O3'" ' A' ' 131' ' ' 8OG . 3.6 pp -145.71 129.32 17.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.074 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.54 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.4 mt-30 -102.57 153.62 19.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.442 0.639 . . . . 0.0 112.342 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -146.48 132.37 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.671 178.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.042 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.26 124.97 43.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.469 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.579 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -117.86 162.55 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.406 0.622 . . . . 0.0 112.101 -179.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.08 114.29 0.63 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.851 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.087 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.25 107.27 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.2 mt -71.42 123.29 25.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.038 0.446 . . . . 0.0 111.676 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.674 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -83.61 119.97 25.39 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.829 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.552 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.8 t-20 -77.72 -172.32 2.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.766 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 59.6 tt0 -82.45 -2.99 54.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.583 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -131.95 40.61 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.802 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.6 9.29 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.506 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.726 ' C ' HD12 ' A' ' 18' ' ' ILE . 16.6 pt-20 -100.86 149.67 23.62 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.087 HG21 HG22 ' A' ' 10' ' ' ILE . 1.4 mp -115.11 141.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.238 0.542 . . . . 0.0 111.718 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CG ' ' HG2' ' A' ' 94' ' ' PRO . 26.7 t80 -80.65 99.9 8.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.758 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.13 162.12 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.446 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.564 HG21 ' OE2' ' A' ' 98' ' ' GLU . 3.6 p -82.23 112.01 18.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.551 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.93 114.71 29.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.37 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HD3' ' HB1' ' A' ' 30' ' ' ALA . 4.7 mtm180 56.55 20.83 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.557 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.94 -86.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.688 0.28 . . . . 0.0 111.407 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . . . -177.67 37.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.821 0.343 . . . . 0.0 111.1 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -164.9 -177.08 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.54 56.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -156.4 26.99 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.05 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -177.35 38.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.454 ' HB1' ' HD3' ' A' ' 23' ' ' ARG . . . -67.65 -22.02 65.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.473 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.84 21.48 7.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.274 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' HG2' ' O6 ' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -114.34 26.37 10.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.918 0.39 . . . . 0.0 111.423 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 1.5 tt -50.85 89.12 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE1' ' N2 ' ' A' ' 131' ' ' 8OG . 0.6 OUTLIER -119.94 -177.18 3.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.379 . . . . 0.0 111.234 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.765 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.74 160.76 41.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.734 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.29 168.43 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.813 3.008 . . . . 0.0 112.068 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 102.71 59.24 0.75 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.132 -1.032 . . . . 0.0 114.129 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.77 116.57 1.91 Allowed Glycine 0 C--N 1.315 -0.622 0 CA-C-N 114.71 -0.745 . . . . 0.0 112.097 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 119.13 4.49 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.517 0.727 . . . . 0.0 111.783 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.042 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -57.2 -26.06 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.515 0.674 . . . . 0.0 110.71 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.16 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.32 -179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.2 mtm 31.59 -86.79 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.455 0.472 . . . . 0.0 112.072 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -167.66 28.98 0.17 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.664 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.2 mp0 -92.43 -175.0 3.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.313 . . . . 0.0 111.101 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.864 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.71 154.94 38.94 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.864 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.92 -24.74 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.79 2.327 . . . . 0.0 112.601 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.719 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -94.44 -50.84 5.04 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.2 -22.03 42.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.899 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.58 -48.26 77.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.813 HG12 ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.02 -46.82 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -56.28 -35.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.958 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -76.96 -50.19 13.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.617 ' CB ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -65.63 -23.71 66.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.834 HD21 ' CE1' ' A' ' 64' ' ' HIS . 4.2 tp -52.88 -44.48 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -33.05 74.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.827 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 -24.85 50.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.197 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 4.0 mm-40 -108.66 5.5 24.94 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.915 HG12 HG13 ' A' ' 60' ' ' ILE . 38.8 t -134.74 -44.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.388 0.613 . . . . 0.0 109.944 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.692 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 57.46 4.16 1.22 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.119 -0.946 . . . . 0.0 115.038 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.915 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.55 -172.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.157 0.979 . . . . 0.0 110.46 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -112.82 87.94 10.9 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.664 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.5 Cg_endo -114.34 144.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 123.579 2.852 . . . . 0.0 114.24 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 30.6 mt-30 -75.02 80.04 2.21 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.834 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.78 126.05 50.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.947 -176.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.6 t80 177.37 173.25 0.51 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 92.12 148.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.855 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -97.71 137.13 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -103.07 -47.71 4.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.299 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -171.43 157.81 5.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.566 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.4 127.93 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.977 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.805 HD23 HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -127.25 124.47 38.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.497 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -116.91 118.11 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.755 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -137.37 136.37 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.685 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.13 120.38 42.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.147 0.498 . . . . 0.0 111.338 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.92 162.85 65.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.519 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.536 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 1.8 Cg_endo -41.74 82.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.655 2.903 . . . . 0.0 112.587 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' PHE . 2.9 t70 98.43 -27.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.19 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 75' ' ' PHE . 6.1 ttp180 -90.45 150.11 21.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.824 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -120.32 101.65 7.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.62 HD11 " O3'" ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -102.85 124.95 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.474 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -117.98 118.58 32.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.117 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.805 HD11 HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -126.14 114.99 19.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.085 0.469 . . . . 0.0 111.898 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.474 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.6 m0 -104.74 122.7 46.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.405 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 4.2 m-30 -95.38 109.63 21.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.486 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.727 ' NE1' HG11 ' A' ' 50' ' ' VAL . 28.6 m95 -96.78 148.63 22.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.109 0.481 . . . . 0.0 111.853 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.5 tm? -95.15 138.56 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.713 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.789 HG13 ' CB ' ' A' ' 64' ' ' HIS . 21.2 t -123.74 146.09 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.031 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.08 -22.04 9.15 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 3.9 tpp85 -162.48 160.51 26.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 119.018 0.826 . . . . 0.0 111.661 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.723 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.06 125.42 5.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.178 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.62 149.37 34.77 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.03 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.46 -127.13 44.18 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.598 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.0 mt-10 -129.57 141.91 43.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.431 0.157 . . . . 0.0 110.689 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.604 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.1 Cg_exo -76.6 128.59 10.35 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.766 2.311 . . . . 0.0 111.607 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.692 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 66.2 p-90 -125.87 -58.72 1.38 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.63 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 97' ' ' LYS . . . 49.86 -76.26 0.0 OUTLIER Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.806 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 95' ' ' TRP . 3.8 tptt 115.91 60.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.993 0.917 . . . . 0.0 110.488 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' OE2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -80.62 -33.32 35.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.71 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 123.17 -1.68 9.75 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.635 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -140.25 94.59 8.6 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 117.088 0.444 . . . . 0.0 111.45 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 57.6 Cg_exo -43.61 145.64 1.67 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.672 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.29 177.42 19.19 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.992 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.36 157.19 43.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.13 106.45 1.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.082 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 3.3 mtp -120.01 159.57 24.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.611 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.0 p -78.47 114.34 17.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.882 0.372 . . . . 0.0 110.809 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.673 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -80.5 -19.54 45.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.052 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG13 HD21 ' A' ' 129' ' ' LEU . 33.6 t -56.66 -18.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.622 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.63 50.5 0.8 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.792 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.766 HD22 HD12 ' A' ' 123' ' ' ILE . 6.4 tt -62.6 150.2 41.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.465 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -117.02 132.27 56.74 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.28 -15.17 61.9 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.448 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.6 -49.24 13.61 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.556 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.182 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.588 ' CE2' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -78.92 172.38 10.05 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.301 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 74.2 Cg_endo -75.76 128.15 10.69 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.327 2.018 . . . . 0.0 111.523 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.31 -14.69 16.46 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.777 2.318 . . . . 0.0 113.474 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.93 -11.47 18.83 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.713 HD21 HD22 ' A' ' 82' ' ' LEU . 1.4 m-20 -132.67 43.71 2.95 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.8 tt0 -76.07 -47.11 3.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 81.7 Cg_exo -45.83 -39.14 18.7 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.347 2.031 . . . . 0.0 112.837 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -77.27 -48.52 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.594 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.766 HD12 HD22 ' A' ' 110' ' ' LEU . 5.5 mm -65.18 -29.96 48.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.982 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.928 0.394 . . . . 0.0 110.485 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -46.24 16.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.47 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.2 tm? -78.17 -28.71 48.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 111.266 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 123' ' ' ILE . 10.4 ttpt -63.85 -42.28 97.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.416 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -64.07 -9.66 17.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.04 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.427 HD21 HG13 ' A' ' 108' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.088 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.939 " O3'" HD11 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.8 0.333 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -106.04 103.03 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.846 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? -89.04 135.45 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.1 127.05 14.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.472 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.1 mt-30 -102.69 154.99 18.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.216 0.532 . . . . 0.0 111.418 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.468 HD11 " O3'" ' A' ' 131' ' ' 8OG . 39.1 mm -146.2 127.43 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.006 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.059 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.38 124.59 42.68 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.288 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.668 HG11 ' OE2' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -129.8 162.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.178 0.513 . . . . 0.0 111.375 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 123.69 1.54 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.095 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.783 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -70.79 110.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.701 HG22 ' CE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.61 125.93 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.963 -178.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -93.0 126.83 38.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.346 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.469 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 5.9 t30 -89.5 -172.02 3.43 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.899 0.857 . . . . 0.0 112.088 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.79 -2.14 34.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.103 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -136.01 50.2 2.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.845 0.355 . . . . 0.0 111.283 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 p30 45.38 26.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.44 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HG3' ' CB ' ' A' ' 13' ' ' ASN . 11.5 pt-20 -112.36 150.29 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.85 ' CD1' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -121.99 144.76 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.447 0.642 . . . . 0.0 112.292 -178.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.441 ' CE1' ' CA ' ' A' ' 102' ' ' GLY . 36.3 t80 -82.5 91.5 6.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.127 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.85 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -98.9 162.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.497 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 100' ' ' GLN . 7.1 p -113.34 111.98 22.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.067 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HA ' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -87.5 83.58 7.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.476 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.734 ' HG3' ' HB3' ' A' ' 27' ' ' ALA . 28.4 tpt180 45.74 43.8 10.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.557 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 66.35 12.36 8.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.807 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 54.93 20.96 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.577 0.227 . . . . 0.0 111.49 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.55 93.46 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.833 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.734 ' HB3' ' HG3' ' A' ' 23' ' ' ARG . . . -162.45 -80.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.258 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m80 -176.76 -73.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.92 82.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -8.93 54.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.594 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.55 20.3 4.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.406 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.32 26.06 10.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.505 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 22' ' ' ARG . 17.0 tp -52.12 92.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.857 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.668 ' OE2' HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -128.54 -176.43 3.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.886 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.783 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.56 168.24 10.53 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.615 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 6.7 Cg_endo -47.5 168.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.602 2.868 . . . . 0.0 112.249 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.42 59.22 0.76 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.666 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -129.58 112.02 1.27 Allowed Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.23 -0.985 . . . . 0.0 112.384 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER 113.97 5.24 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.168 0.587 . . . . 0.0 112.096 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.059 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.22 -29.47 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.742 0.782 . . . . 0.0 110.148 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.98 -79.96 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.25 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.4 mmt 41.35 -85.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.539 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -177.27 33.22 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.762 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.1 OUTLIER -95.24 -169.19 1.93 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.673 0.273 . . . . 0.0 111.019 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.893 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -97.96 156.24 36.17 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.301 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.893 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.3 Cg_endo -44.01 -24.8 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.766 2.31 . . . . 0.0 112.465 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.9 mp0 -99.59 -48.34 4.78 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.912 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.32 -7.56 59.11 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.824 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -63.68 -56.98 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 0.0 110.864 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.779 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 1.4 p -78.3 -40.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.716 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 47' ' ' GLU . 59.2 t -50.67 -37.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.995 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.87 -52.38 8.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.306 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HB3' HG22 ' A' ' 40' ' ' ILE . 9.3 tm-20 -66.35 -19.92 65.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.694 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.729 HD11 ' CE1' ' A' ' 64' ' ' HIS . 14.1 tp -60.53 -44.41 96.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.728 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HA ' HG12 ' A' ' 58' ' ' VAL . 1.3 tm0? -71.58 -27.87 63.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.061 0.457 . . . . 0.0 110.029 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -69.07 -28.1 66.22 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.482 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.22 6.99 27.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.314 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.908 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -130.7 -44.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.997 0.427 . . . . 0.0 109.873 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 64.73 -35.66 0.1 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 115.058 0.783 . . . . 0.0 115.058 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.908 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -82.64 -174.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 116.929 0.364 . . . . 0.0 110.817 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.55 88.69 13.82 Favored Pre-proline 0 N--CA 1.445 -0.717 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.993 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.689 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.9 Cg_endo -110.68 143.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 123.312 2.675 . . . . 0.0 113.474 -178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 31.8 mt-30 -74.6 80.06 1.99 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 175.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.821 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.18 133.15 54.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.128 -175.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -179.77 -137.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.352 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.34 159.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.963 0.505 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.4 tt -122.26 110.68 16.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.418 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD1' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.68 -52.07 10.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.373 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.605 ' HB3' HG13 ' A' ' 122' ' ' VAL . 4.3 mt-10 -171.33 131.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -121.88 131.91 54.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.526 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.979 HD23 HG21 ' A' ' 122' ' ' VAL . 1.8 pp -114.45 158.67 21.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.957 0.408 . . . . 0.0 111.261 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.455 ' N ' HD12 ' A' ' 71' ' ' LEU . 9.0 tt0 -140.1 109.81 6.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.242 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -136.03 153.19 51.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.823 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -120.95 127.11 51.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.141 0.496 . . . . 0.0 111.353 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -91.68 163.89 26.3 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.417 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 50.5 Cg_exo -38.27 81.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.602 2.868 . . . . 0.0 112.886 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.59 21.24 3.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.061 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.31 93.83 2.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.239 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -74.91 99.97 3.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 111.152 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tt -102.55 111.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.734 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.79 133.22 44.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.468 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.618 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.13 114.48 18.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 111.468 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CZ3' HD11 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -110.82 125.55 53.7 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.618 ' CE1' HD12 ' A' ' 82' ' ' LEU . 2.4 m-85 -111.02 118.2 35.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.392 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.779 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 65.3 m95 -96.47 148.87 22.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.025 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.3 tm? -99.83 103.05 14.64 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.327 0.584 . . . . 0.0 111.34 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.821 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.2 t -80.65 145.87 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.665 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pm0 -113.29 -25.39 8.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 6.9 ttm180 -162.42 163.23 27.82 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.586 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.701 ' CE3' HG22 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -157.21 123.8 4.99 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.527 179.076 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -72.89 139.99 47.22 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.09 -121.7 26.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 60' ' ' ILE . 24.7 mt-10 -132.05 142.64 45.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.431 0.158 . . . . 0.0 110.775 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.541 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.15 128.8 11.66 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.719 2.279 . . . . 0.0 111.183 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.607 ' HE1' HG23 ' A' ' 60' ' ' ILE . 50.6 p-90 -126.83 -61.03 1.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 43.21 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.936 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt 177.99 35.15 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.703 0.287 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . 7.9 pt-20 -57.19 -37.79 72.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.88 0.371 . . . . 0.0 110.587 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.47 71.41 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.153 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 2.6 pm0 -140.16 93.29 9.2 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.28 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -43.61 138.82 5.29 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.056 2.504 . . . . 0.0 112.85 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' CA ' ' CE1' ' A' ' 19' ' ' PHE . . . -134.31 177.29 19.29 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.98 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -141.28 157.13 45.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -79.76 106.15 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.472 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.462 ' HG3' HD11 ' A' ' 20' ' ' ILE . 3.0 ptp -120.55 163.07 18.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.768 ' HB2' HG12 ' A' ' 108' ' ' VAL . 8.9 p -77.58 114.88 16.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.695 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.828 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.0 tm? -63.21 -18.91 64.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.768 HG12 ' HB2' ' A' ' 106' ' ' SER . 13.0 p -55.26 -20.83 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.464 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.18 35.05 4.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.812 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.71 HD22 HD21 ' A' ' 107' ' ' LEU . 10.7 tp -62.72 140.63 58.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.26 131.73 53.77 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.586 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.26 -15.51 61.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.414 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.79 -49.05 13.65 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.283 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.467 ' HB3' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -66.9 -40.08 87.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.599 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.63 174.16 6.5 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.404 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 61.5 Cg_endo -73.86 127.91 11.94 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.061 1.84 . . . . 0.0 111.509 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.97 -14.86 29.98 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.644 2.229 . . . . 0.0 113.122 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.98 -9.95 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.661 ' ND2' HD21 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -129.73 38.21 3.86 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.9 -47.36 15.35 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.068 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.6 Cg_exo -56.0 -35.28 94.29 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.336 2.024 . . . . 0.0 112.083 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.979 HG21 HD23 ' A' ' 71' ' ' LEU . 3.8 t -77.46 -51.38 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.082 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -69.79 -29.92 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.806 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -54.89 -27.53 43.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.905 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -53.34 12.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 68' ' ' PHE . 1.7 tp -78.46 -29.54 46.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.3 tttm -57.77 -42.6 84.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.014 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.519 ' C ' HD12 ' A' ' 129' ' ' LEU . 6.1 ttp180 -71.49 -5.55 33.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.937 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.731 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.139 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.253 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.629 " H3'" ' OP3' ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.838 0.352 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.32 125.71 47.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.712 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.33 38.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.949 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.719 HD21 ' HD3' ' A' ' 78' ' ' ARG . 3.0 pp -146.05 123.23 11.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -102.94 150.27 23.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.213 0.53 . . . . 0.0 111.258 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.596 ' HB ' HD22 ' A' ' 82' ' ' LEU . 8.5 mt -136.56 130.49 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.205 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.852 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.97 124.57 42.29 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.505 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -132.01 162.53 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.212 0.53 . . . . 0.0 111.658 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.44 121.51 1.22 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.915 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.912 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -70.83 109.97 3.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.696 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.07 125.48 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 120.976 0.417 . . . . 0.0 111.416 -178.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -92.21 133.13 36.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.956 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.629 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 29.6 p-10 -96.45 -172.13 2.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.86 0.838 . . . . 0.0 112.433 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.37 -0.88 16.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.071 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.433 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 20.6 t-20 -129.39 40.68 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 111.844 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 52.22 21.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -115.72 160.01 20.64 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.912 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -122.75 149.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.145 0.498 . . . . 0.0 111.922 -179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -89.49 101.65 14.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.041 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.908 HG23 ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.08 137.67 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.302 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.2 p -93.07 142.76 26.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.825 0.345 . . . . 0.0 110.943 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 2.9 ttt180 -106.82 83.65 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? 41.06 60.25 2.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.294 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 64.34 37.2 8.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.31 65.81 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.049 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 43.16 81.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.51 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.45 -33.4 6.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -161.07 -47.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 mtt -118.62 85.86 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.53 -9.05 52.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.73 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.61 11.31 13.1 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -114.52 26.24 10.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.535 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.696 HD21 ' HB ' ' A' ' 20' ' ' ILE . 4.8 tt -46.08 110.36 0.26 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.009 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -142.15 175.28 9.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.026 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.785 ' CD1' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.53 168.92 9.09 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.639 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.6 Cg_endo -46.66 169.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.693 2.929 . . . . 0.0 112.146 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.29 59.6 0.72 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.342 -0.933 . . . . 0.0 113.155 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.624 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.52 122.53 3.11 Favored Glycine 0 C--N 1.316 -0.582 0 CA-C-N 114.113 -1.044 . . . . 0.0 111.697 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 113.28 -7.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.28 0.632 . . . . 0.0 111.213 -179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.852 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -40.73 -57.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.389 0.614 . . . . 0.0 111.285 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -21.72 -80.43 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.252 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.5 mmt 41.83 -94.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.588 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -166.77 19.49 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.424 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -82.97 -165.71 1.14 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.529 0.205 . . . . 0.0 110.81 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.885 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.51 156.57 36.19 Favored Pre-proline 0 C--N 1.332 -0.156 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.885 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.5 -24.64 0.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.772 2.315 . . . . 0.0 112.362 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 51' ' ' VAL . 9.3 mm-40 -89.98 -59.97 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -80.89 -4.56 55.29 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -63.68 -57.08 11.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.593 0.235 . . . . 0.0 111.089 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.697 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -78.67 -41.77 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.354 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' GLU . 57.5 t -50.36 -35.36 12.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.342 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -52.15 9.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.49 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 10.2 mm-40 -70.1 -20.09 63.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 111.032 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.825 HD11 ' CE1' ' A' ' 64' ' ' HIS . 13.9 tp -58.18 -41.57 84.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.475 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.56 -26.96 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.1 tm-20 -72.12 -25.27 61.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.4 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -108.59 7.02 26.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.985 HG12 HG13 ' A' ' 60' ' ' ILE . 10.6 t -133.28 -43.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.191 0.52 . . . . 0.0 109.974 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 52.88 8.63 0.63 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.442 -0.799 . . . . 0.0 115.028 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.985 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.6 -174.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.026 0.913 . . . . 0.0 110.149 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 p -114.58 87.34 14.06 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.839 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.67 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.0 Cg_endo -115.5 145.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 123.664 2.909 . . . . 0.0 114.066 -177.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.82 79.93 2.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.825 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -122.64 133.33 54.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.409 -1.268 . . . . 0.0 111.329 -175.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.56 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER 178.04 -139.23 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.02 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 56.29 153.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.617 HD11 ' HG2' ' A' ' 70' ' ' LYS . 5.4 tt -116.78 111.21 19.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.386 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.56 ' CZ ' HG12 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -76.58 -54.14 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.195 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.623 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.0 mt-10 -171.28 131.7 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.438 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.617 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.27 126.6 39.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.692 0.282 . . . . 0.0 110.807 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 122' ' ' VAL . 1.2 pt? -113.84 136.67 52.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' HG21 ' A' ' 81' ' ' THR . 5.0 tt0 -121.67 109.94 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.706 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -131.05 152.2 50.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.528 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.5 pt-20 -121.13 139.58 53.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 111.381 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -103.23 162.67 19.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.133 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.1 Cg_endo -49.76 81.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.155 2.57 . . . . 0.0 112.344 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' PHE . 1.2 t70 89.28 10.2 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.595 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.719 ' HD3' HD21 ' A' ' 4' ' ' LEU . 3.2 tmm_? -137.34 93.94 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.731 0.3 . . . . 0.0 110.89 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 17.2 m80 -80.18 93.86 5.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.97 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 80' ' ' ILE . 15.4 tt -96.76 111.87 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -106.82 132.54 52.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.39 114.58 18.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.343 . . . . 0.0 111.422 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.454 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.1 m0 -109.34 125.53 52.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.226 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.646 ' CE1' HD12 ' A' ' 82' ' ' LEU . 1.8 m-85 -111.41 114.56 27.78 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.919 0.39 . . . . 0.0 110.932 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.542 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 61.3 m95 -94.73 148.83 21.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.56 ' O ' ' O ' ' A' ' 65' ' ' PHE . 14.6 tp -98.41 102.89 14.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 111.755 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.809 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.0 t -80.69 145.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.205 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 8.7 pt-20 -112.57 -26.96 8.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 3.9 mtt-85 -161.83 164.08 28.97 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.673 0.67 . . . . 0.0 111.428 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.696 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.67 123.59 4.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.551 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 152.95 32.51 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.1 -125.05 38.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.36 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -135.0 148.1 65.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.6 0.238 . . . . 0.0 110.956 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.636 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.48 128.8 10.58 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.933 2.422 . . . . 0.0 111.163 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' CE3' ' N ' ' A' ' 96' ' ' GLY . 66.8 p-90 -138.45 -58.56 0.63 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.749 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 41.38 -93.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.295 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER 175.12 32.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.28 . . . . 0.0 111.144 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' OE1' HG21 ' A' ' 21' ' ' THR . 4.1 pt-20 -68.05 -33.37 74.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.947 0.403 . . . . 0.0 110.256 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 32.12 52.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.05 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -140.35 91.65 9.69 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.093 0.473 . . . . 0.0 111.64 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.73 127.58 8.14 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.077 2.518 . . . . 0.0 112.602 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 19' ' ' PHE . . . -134.3 177.05 19.47 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.7 155.28 39.93 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.14 107.14 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 110.459 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -119.55 163.06 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.771 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.07 122.66 33.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.098 HD21 HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -79.97 -18.97 49.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.625 HG23 HD21 ' A' ' 129' ' ' LEU . 12.5 p -53.0 -21.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.862 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.69 45.42 1.13 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.038 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.098 HD22 HD21 ' A' ' 107' ' ' LEU . 11.6 tp -62.94 150.28 42.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.722 0.261 . . . . 0.0 110.378 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -117.46 131.8 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.2 -15.29 61.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.648 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -48.93 14.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.367 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.98 -39.02 87.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.945 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -81.11 171.43 12.26 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.324 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 57.2 Cg_endo -71.15 127.57 13.66 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.18 1.92 . . . . 0.0 111.875 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.64 -14.86 45.26 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.581 2.187 . . . . 0.0 112.84 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.84 -9.5 57.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' ND2' ' CZ ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER -124.01 34.33 5.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.714 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.57 -39.01 5.57 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.876 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 52.7 Cg_exo -53.07 -40.74 75.78 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.064 1.843 . . . . 0.0 112.699 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.72 HG21 HD22 ' A' ' 71' ' ' LEU . 2.3 t -77.47 -51.23 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.317 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 127' ' ' LYS . 0.7 OUTLIER -67.3 -30.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.303 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.28 -28.46 63.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.691 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -51.86 13.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.365 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.1 tp -78.12 -39.51 41.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 111.483 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.522 ' HB2' HG22 ' A' ' 123' ' ' ILE . 5.2 tttm -53.54 -42.56 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.282 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -72.06 -3.64 24.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.133 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 108' ' ' VAL . 5.6 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.011 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.613 ' OP1' " C3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.844 0.354 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -109.95 102.88 11.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.08 125.56 51.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.756 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.1 pp -125.24 139.05 54.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.065 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.583 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.7 mt-30 -102.46 155.41 18.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.805 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.699 HD11 " O3'" ' A' ' 131' ' ' 8OG . 30.2 mt -146.26 126.67 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.32 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.996 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.49 124.16 41.69 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.185 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.3 m -118.65 162.5 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.246 0.546 . . . . 0.0 111.875 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.34 117.19 1.19 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.934 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.911 ' CG2' HG21 ' A' ' 18' ' ' ILE . 4.7 mp -70.58 100.51 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.788 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -71.21 125.9 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -98.0 119.96 37.55 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.085 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.593 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.54 -172.93 0.84 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.019 0.438 . . . . 0.0 110.567 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 21.9 tt0 -81.28 12.83 3.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -133.92 34.9 3.34 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 5.32 2.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 111.503 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -100.95 161.76 13.37 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.911 HG21 ' CG2' ' A' ' 10' ' ' ILE . 6.7 mt -117.92 141.29 37.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.255 0.55 . . . . 0.0 111.665 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -93.02 92.77 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.254 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.853 HG13 HG22 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -107.97 162.07 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.206 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.429 HG21 ' OE1' ' A' ' 98' ' ' GLU . 5.0 p -87.36 119.11 27.29 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -136.68 119.81 16.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 111.21 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.824 ' HG3' ' HB1' ' A' ' 30' ' ' ALA . 0.9 OUTLIER 46.39 28.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.99 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 100' ' ' GLN . . . -98.45 29.43 3.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.278 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.73 -22.98 12.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.22 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 64.24 81.11 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 60.87 63.07 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.4 -76.82 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.93 79.58 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.824 ' HB1' ' HG3' ' A' ' 23' ' ' ARG . . . -87.16 -25.67 23.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.48 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -91.24 14.06 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.542 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HD3' ' N2 ' ' A' ' 131' ' ' 8OG . 1.4 mtpp -114.17 26.45 10.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 111.359 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.3 tt -40.34 117.07 0.75 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.222 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.728 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -158.3 -172.42 3.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.504 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CD2' HG23 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.37 163.08 28.88 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.879 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.52 ' HG3' HD11 ' A' ' 11' ' ' ILE . 6.2 Cg_endo -47.48 169.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.887 3.058 . . . . 0.0 112.314 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 103.05 59.32 0.73 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.449 -0.882 . . . . 0.0 113.349 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -132.13 109.04 0.82 Allowed Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.155 -1.022 . . . . 0.0 111.448 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 123.95 2.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.452 0.701 . . . . 0.0 111.176 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.996 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -51.43 -27.95 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 121.633 0.73 . . . . 0.0 110.571 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.591 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.333 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.3 mmt 32.36 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.458 0.474 . . . . 0.0 111.883 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -173.21 32.99 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.398 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.8 mp0 -89.72 -177.01 5.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.857 0.361 . . . . 0.0 111.263 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.887 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.03 154.89 37.1 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.887 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -43.96 -24.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.867 2.378 . . . . 0.0 112.596 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.8 mt-10 -102.43 -42.21 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.595 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -80.22 -10.35 59.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.951 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.6 -52.24 65.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.749 0.309 . . . . 0.0 111.201 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.747 ' O ' HD13 ' A' ' 54' ' ' LEU . 1.3 m -78.09 -46.6 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.7 t -52.61 -37.75 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -78.5 -52.17 8.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.677 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 40' ' ' ILE . 2.5 mm-40 -65.28 -25.98 67.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 50' ' ' VAL . 2.0 mp -54.05 -44.58 71.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.597 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -30.78 69.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 -31.07 52.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.393 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.585 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -108.76 7.0 26.12 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.969 HG12 HG13 ' A' ' 60' ' ' ILE . 4.7 t -133.32 -44.64 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 51.65 18.04 3.64 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.969 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.63 -170.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.871 0.836 . . . . 0.0 110.839 179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.819 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -115.28 87.09 15.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.91 179.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG3' HG11 ' A' ' 58' ' ' VAL . 10.6 Cg_endo -117.35 145.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.511 2.807 . . . . 0.0 115.177 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 89' ' ' ARG . 93.7 mt-30 -74.95 79.22 2.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 174.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.943 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -120.78 123.3 42.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.888 -175.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -176.68 -138.78 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.011 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m 53.19 169.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.245 0.545 . . . . 0.0 112.153 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.9 tt -128.87 109.56 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.374 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.778 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.59 -46.87 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 109.971 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 tt0 -171.67 155.56 4.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.338 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.83 132.1 21.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.599 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.635 HD22 ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.18 158.8 40.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 110.88 179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.448 ' N ' HD22 ' A' ' 71' ' ' LEU . 7.5 tt0 -140.04 128.31 22.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.947 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.5 p90 -141.0 147.62 38.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -121.08 132.26 54.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.256 0.551 . . . . 0.0 111.553 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -82.11 163.79 51.33 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.107 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.4 Cg_endo -49.64 82.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.185 2.59 . . . . 0.0 112.459 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.7 t70 94.37 16.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.524 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 3.0 ttt180 -137.45 150.16 47.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.741 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -121.57 116.31 24.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.942 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 73' ' ' TYR . 1.8 tt -122.34 121.22 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.788 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.07 134.62 50.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 71' ' ' LEU . 6.6 mt -125.64 114.26 18.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -109.21 122.49 47.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.37 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.4 m-30 -104.25 121.17 42.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.972 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.628 ' CE2' HG11 ' A' ' 50' ' ' VAL . 20.6 m95 -108.15 148.89 29.25 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.544 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 65' ' ' PHE . 46.3 tp -93.34 103.12 15.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.505 0.669 . . . . 0.0 111.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.943 HG22 ' ND1' ' A' ' 64' ' ' HIS . 17.4 t -88.71 145.59 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.654 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -102.2 -55.4 2.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -163.4 165.85 23.49 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.931 0.787 . . . . 0.0 112.854 -177.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.65 ' CE3' HG22 ' A' ' 11' ' ' ILE . 48.7 p90 -128.53 140.1 51.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.787 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.819 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.9 OUTLIER -93.07 85.48 5.1 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 120.903 0.382 . . . . 0.0 110.411 179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.57 -119.19 2.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.289 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 10.0 tt0 -135.12 131.12 19.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.434 0.159 . . . . 0.0 110.74 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 5.7 Cg_exo -77.07 128.87 10.15 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.895 2.397 . . . . 0.0 111.606 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.569 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 50.9 p-90 -142.19 -58.47 0.46 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.936 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 42.81 -96.13 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.017 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.08 39.34 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.761 0.315 . . . . 0.0 110.737 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE1' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -58.57 -47.64 83.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.03 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 139.74 -62.67 0.55 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.253 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 24' ' ' ALA . 3.4 pm0 -109.93 93.89 16.09 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 111.828 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.518 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 61.9 Cg_exo -43.82 125.92 5.49 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.017 2.478 . . . . 0.0 112.643 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -114.72 177.47 17.48 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.004 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' HE2' ' A' ' 105' ' ' MET . 70.9 tt0 -120.54 157.25 29.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.6 0.238 . . . . 0.0 110.631 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.401 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.1 m0 -61.04 106.9 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.399 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.608 ' HG3' HD12 ' A' ' 20' ' ' ILE . 8.1 ptp -120.2 163.19 18.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.241 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.661 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -83.94 131.93 34.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.952 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -76.09 -19.05 58.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.15 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.3 p -61.2 -13.61 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.936 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -119.71 38.95 2.62 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.109 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 107' ' ' LEU . 9.0 tp -70.55 140.54 51.8 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -123.16 134.8 54.15 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.25 -15.4 61.92 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.883 178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -49.12 13.48 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.559 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB2' ' CD1' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.74 -38.79 83.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.48 174.08 6.62 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.408 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 65.2 Cg_endo -74.15 127.85 11.67 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.258 1.972 . . . . 0.0 111.515 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.0 -14.82 29.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.658 2.239 . . . . 0.0 113.181 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.09 -9.79 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.1 38.23 3.81 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.713 0.292 . . . . 0.0 111.692 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.6 tt0 -71.17 -45.09 14.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.456 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 51.6 Cg_exo -54.88 -37.36 92.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.119 1.879 . . . . 0.0 112.271 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.45 -51.45 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.143 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.525 HG13 ' CE2' ' A' ' 115' ' ' PHE . 0.9 OUTLIER -68.59 -29.84 45.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.923 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.94 -28.69 53.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.975 0.417 . . . . 0.0 110.672 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.74 -49.19 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.065 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.778 HD22 ' CE2' ' A' ' 68' ' ' PHE . 9.7 tp -78.11 -27.51 48.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.272 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -58.86 -42.6 89.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.104 0.478 . . . . 0.0 110.914 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -74.51 -2.96 28.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.902 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 108' ' ' VAL . 3.3 mt . . . . . 0 N--CA 1.457 -0.118 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.162 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.699 " O3'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mtm . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.31 135.77 35.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.02 136.33 33.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.74 HD22 " O3'" ' A' ' 131' ' ' 8OG . 1.2 pp -138.18 138.56 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.43 ' O ' HD13 ' A' ' 6' ' ' ILE . 27.7 mt-30 -102.84 155.22 18.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.207 0.527 . . . . 0.0 111.312 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.473 HD11 " O5'" ' A' ' 131' ' ' 8OG . 39.7 mm -146.5 139.29 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.641 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.942 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.58 150.28 46.11 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.564 HG11 ' CE1' ' A' ' 84' ' ' PHE . 0.4 OUTLIER -145.45 148.86 17.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.906 0.384 . . . . 0.0 110.935 179.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 36' ' ' PRO . . . -151.57 107.37 0.33 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.886 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.676 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -72.41 103.87 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.802 HG21 ' CD2' ' A' ' 19' ' ' PHE . 1.2 tt -70.62 111.61 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.755 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.606 ' HG2' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -87.52 138.08 31.78 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.376 -179.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.76 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.3 p30 -90.52 -173.3 3.72 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.336 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 13.5 tp10 -78.24 0.91 23.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.326 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -122.38 40.33 3.69 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.97 21.35 2.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 111.576 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 22.1 mt-10 -113.85 161.94 16.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.676 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.25 135.79 58.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.92 0.391 . . . . 0.0 111.729 -178.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.802 ' CD2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -88.79 102.44 15.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.367 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -109.54 162.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.855 HG21 ' CD ' ' A' ' 98' ' ' GLU . 6.6 p -86.35 111.86 20.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.757 0.313 . . . . 0.0 110.608 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 7.7 ptt180 -127.4 131.64 50.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.001 0.429 . . . . 0.0 110.656 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 48.06 -107.5 0.2 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 169.75 -76.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.978 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -167.24 -51.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.014 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -93.93 -48.67 6.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -169.05 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.052 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 m80 51.79 -176.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.09 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.79 89.47 1.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.97 -8.97 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.569 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 3.01 53.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.416 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.33 26.36 10.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 111.398 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 33' ' ' LEU . 5.2 tt -45.23 93.55 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG3' ' HG3' ' A' ' 116' ' ' PRO . 0.3 OUTLIER -126.33 -179.97 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.16 0.505 . . . . 0.0 111.566 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.68 168.17 10.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.174 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 5.1 Cg_endo -46.95 168.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.276 2.65 . . . . 0.0 111.75 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.679 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.68 59.02 0.75 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.243 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -146.13 101.57 0.24 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.439 -0.88 . . . . 0.0 112.25 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.631 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 128.01 -9.83 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.374 0.67 . . . . 0.0 110.723 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.942 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -43.31 -74.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.618 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -8.22 -82.16 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.565 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 44.35 -93.36 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.505 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.58 17.21 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.485 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.89 -163.45 0.59 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.596 0.236 . . . . 0.0 110.807 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.909 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -106.73 155.82 38.3 Favored Pre-proline 0 N--CA 1.456 -0.162 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.909 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.82 -24.7 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.685 2.256 . . . . 0.0 112.442 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.719 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.7 mm-40 -94.33 -54.98 3.33 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.49 -4.98 55.89 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -65.4 -57.04 9.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.623 0.249 . . . . 0.0 110.974 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.726 ' CA ' HD12 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -78.37 -39.91 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.362 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 47' ' ' GLU . 56.7 t -50.68 -35.81 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -49.47 13.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.119 0.485 . . . . 0.0 110.422 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 40' ' ' ILE . 44.1 tp10 -64.41 -21.09 66.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.482 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.641 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.6 tp -57.02 -44.67 83.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -30.48 67.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.55 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.2 -26.27 64.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.027 0.442 . . . . 0.0 110.565 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.714 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.31 7.25 27.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.114 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.782 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -133.45 -44.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.161 0.505 . . . . 0.0 110.013 179.224 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.4 -40.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 114.519 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.782 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.59 -173.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.651 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -110.65 88.62 8.0 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.826 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 2.9 Cg_endo -111.12 152.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.706 0 C-N-CA 122.966 2.444 . . . . 0.0 114.555 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.494 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 42.8 mt-30 -74.66 80.06 2.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.033 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.2 t-160 -127.32 127.3 44.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.319 -176.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.13 -136.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.634 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 54.03 163.09 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.196 0.522 . . . . 0.0 112.358 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.608 ' O ' HD23 ' A' ' 67' ' ' LEU . 7.2 tt -125.14 110.34 13.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.74 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.98 -39.76 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.603 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -171.52 164.34 6.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.778 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 112.14 6.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.933 HD23 ' CD1' ' A' ' 82' ' ' LEU . 15.3 tp -99.53 128.0 45.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.35 . . . . 0.0 110.682 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -131.21 110.56 11.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.607 ' HE1' HD11 ' A' ' 82' ' ' LEU . 2.5 p90 -139.41 150.23 45.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.415 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.09 124.79 45.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.232 0.539 . . . . 0.0 111.613 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -73.65 163.3 69.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.233 179.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.1 Cg_endo -50.82 83.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.966 2.444 . . . . 0.0 112.144 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.3 m-20 94.29 16.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.342 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.5 148.7 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -120.76 97.35 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.446 HD12 HD11 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -102.97 111.89 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.743 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' ILE . 54.0 m -114.96 126.8 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.955 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.933 ' CD1' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -126.46 115.5 19.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.228 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.544 ' O ' HG13 ' A' ' 8' ' ' VAL . 12.5 m0 -94.6 122.87 37.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.186 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CE1' HG11 ' A' ' 8' ' ' VAL . 3.0 m-85 -99.68 109.78 22.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.777 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 61.5 m95 -95.72 148.53 22.46 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.573 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.6 tp -102.1 102.92 13.44 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.298 0.57 . . . . 0.0 112.034 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.033 HG22 ' CD2' ' A' ' 64' ' ' HIS . 12.8 t -80.52 145.56 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.649 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -111.83 -43.11 3.66 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.05 166.25 23.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.786 0.721 . . . . 0.0 112.377 -178.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.76 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 28.0 p90 -137.56 148.78 46.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.745 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.01 96.3 8.06 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.047 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 -138.49 14.84 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.779 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 6.4 tt0 -106.07 122.63 41.68 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 2.9 Cg_exo -76.3 129.02 10.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.898 2.399 . . . . 0.0 112.192 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.742 ' HE1' HG23 ' A' ' 60' ' ' ILE . 3.6 p-90 -126.2 -77.32 0.58 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.741 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.714 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 67.33 -66.96 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.856 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 0.7 OUTLIER 96.28 69.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.039 0.535 . . . . 0.0 110.811 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.855 ' CD ' HG21 ' A' ' 21' ' ' THR . 1.1 pp20? -83.36 -35.7 24.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.86 -52.13 0.16 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.001 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' O ' ' HB ' ' A' ' 21' ' ' THR . 3.6 mp0 -140.05 117.97 8.41 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.48 . . . . 0.0 111.621 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -43.72 144.87 2.09 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.923 2.415 . . . . 0.0 112.654 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.06 177.3 19.23 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.637 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -125.89 157.33 37.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.532 0.206 . . . . 0.0 110.603 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.486 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 2.0 m0 -60.89 105.81 0.51 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 3.3 ptm -120.76 154.21 35.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.542 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.5 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -72.36 124.64 25.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.027 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -80.06 -18.89 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.547 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.0 p -54.14 -18.34 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.48 41.47 1.72 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.179 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.024 HD12 HD21 ' A' ' 107' ' ' LEU . 3.1 tt -62.88 148.05 48.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.569 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -123.22 131.22 53.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -15.12 61.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.493 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.5 -49.28 13.67 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -67.12 -38.34 85.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.737 0.303 . . . . 0.0 111.092 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -78.97 173.6 7.46 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.293 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.9 Cg_endo -74.3 128.02 11.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.24 1.96 . . . . 0.0 111.678 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.97 -14.84 35.21 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.682 2.255 . . . . 0.0 113.175 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB2' ' H22' ' A' ' 131' ' ' 8OG . . . -66.78 -9.8 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.543 HD21 HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -128.76 37.72 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.808 0.337 . . . . 0.0 111.332 -179.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -76.08 -43.5 3.65 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.8 Cg_exo -45.2 -40.84 16.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.21 1.94 . . . . 0.0 113.166 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 71' ' ' LEU . 2.0 t -77.51 -51.27 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.209 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.635 HG22 ' HB2' ' A' ' 127' ' ' LYS . 1.5 mm -65.83 -33.69 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.467 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.92 -28.43 50.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.883 0.373 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.26 -53.15 8.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.682 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 129' ' ' LEU . 5.2 tp -78.52 -36.88 44.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.75 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.635 ' HB2' HG22 ' A' ' 123' ' ' ILE . 17.2 ttpt -53.76 -42.71 68.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.9 0.381 . . . . 0.0 111.126 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -7.65 25.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.808 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 126' ' ' LEU . 8.2 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.042 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.74 " O3'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ttm . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.806 0.336 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -110.05 102.98 11.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.027 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 133.3 38.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.736 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.656 HD11 HG13 ' A' ' 80' ' ' ILE . 3.0 pp -146.04 139.54 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 36.9 mt-30 -102.85 154.08 19.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.234 0.54 . . . . 0.0 111.881 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.626 HD11 " H4'" ' A' ' 131' ' ' 8OG . 40.0 mm -146.54 118.8 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.909 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.961 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.21 150.28 47.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.388 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -145.22 162.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.128 0.49 . . . . 0.0 111.472 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -136.79 114.81 1.18 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.203 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.955 HG22 HG21 ' A' ' 18' ' ' ILE . 1.5 mt -70.87 98.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.904 HG23 HG11 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.95 122.46 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.406 0.622 . . . . 0.0 112.276 -177.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -86.27 127.36 34.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.708 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 2.8 t-20 -73.24 -171.92 1.03 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 122.092 0.949 . . . . 0.0 112.692 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.69 -13.63 15.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.627 -1.624 . . . . 0.0 113.271 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -132.34 -82.93 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.799 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -149.82 14.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.71 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 1.8 pt-20 -100.72 160.39 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.955 HG21 HG22 ' A' ' 10' ' ' ILE . 6.1 mt -135.97 138.6 47.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 111.911 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -76.88 94.12 3.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.127 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.21 139.16 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.419 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.435 HG22 ' CD ' ' A' ' 98' ' ' GLU . 6.3 p -70.95 123.8 22.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.756 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.84 ' HG3' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -126.1 133.9 51.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.734 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.584 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.4 ptt-85 40.45 -104.64 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.315 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 166.5 -24.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.26 . . . . 0.0 111.223 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 79.93 35.17 0.15 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.901 0.381 . . . . 0.0 110.833 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -177.18 37.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.7 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.05 -167.19 1.02 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.083 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.71 -20.2 12.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.33 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.2 mtt -64.25 79.23 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.183 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.11 -9.1 56.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.528 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -96.21 31.42 2.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.002 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' GLU . 1.9 ttpp -110.6 26.06 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.84 HD13 ' HG3' ' A' ' 22' ' ' ARG . 17.2 tp -66.4 69.25 0.06 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.629 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -106.92 -168.64 1.43 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.945 0.402 . . . . 0.0 111.68 -179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.729 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.67 168.67 9.69 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.468 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 79.9 Cg_endo -80.11 169.3 17.81 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.459 3.44 . . . . 0.0 114.087 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 104.17 -1.63 43.91 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -62.14 161.66 29.04 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 117.565 0.682 . . . . 0.0 112.649 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.6 5.5 0.37 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.879 0.471 . . . . 0.0 111.792 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.961 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.5 pt -54.96 -25.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.588 0.708 . . . . 0.0 110.331 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.57 -80.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.391 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.1 mtp 32.12 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.502 0.501 . . . . 0.0 111.961 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -174.99 32.46 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.572 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.72 -172.07 3.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.911 0.386 . . . . 0.0 111.074 -179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.883 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -99.79 155.27 36.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.328 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.883 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.95 -24.96 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 112.596 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.7 mt-10 -101.65 -44.24 5.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.538 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -80.2 -6.1 57.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.925 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.28 -56.15 21.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.908 HG11 ' NE1' ' A' ' 85' ' ' TRP . 3.4 m -78.2 -45.3 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.303 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 47' ' ' GLU . 43.7 t -56.17 -39.27 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.501 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -78.36 -51.87 9.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.744 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 0.6 OUTLIER -68.98 -23.2 64.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.738 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -50.47 -44.28 55.65 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -33.92 65.43 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -77.72 -25.26 49.18 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.53 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.505 ' OE1' ' HA2' ' A' ' 37' ' ' GLY . 9.0 mp0 -108.43 5.09 25.01 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.979 HG12 HG13 ' A' ' 60' ' ' ILE . 8.6 t -134.82 -44.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.0 110.225 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.69 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 60.82 1.63 2.04 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.245 -0.889 . . . . 0.0 114.318 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.979 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.05 -172.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.695 0.748 . . . . 0.0 110.141 179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.1 p -113.38 87.89 12.1 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.618 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.722 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.0 Cg_endo -112.68 144.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.563 2.842 . . . . 0.0 113.9 -177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.452 ' HG3' ' HB3' ' A' ' 89' ' ' ARG . 4.8 pt20 -74.75 79.95 2.07 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.933 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.04 129.65 53.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.795 -175.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.606 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -176.66 -142.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.291 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.9 OUTLIER 57.28 154.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.231 0.539 . . . . 0.0 112.21 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.543 HD11 ' HG2' ' A' ' 70' ' ' LYS . 3.0 tt -117.83 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.5 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.622 ' HE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.49 -54.05 7.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 109.94 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.4 tt0 -171.58 145.81 2.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -136.79 117.99 14.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.321 . . . . 0.0 110.654 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.574 ' CD2' HG21 ' A' ' 122' ' ' VAL . 1.1 pp -98.58 147.05 25.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.093 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -133.22 112.07 11.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -137.75 128.95 27.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.75 118.62 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.052 0.453 . . . . 0.0 111.422 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -69.96 162.72 66.66 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.387 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 2.2 Cg_endo -44.96 81.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.438 2.759 . . . . 0.0 112.595 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 36.6 t0 104.08 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.103 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -94.87 150.26 20.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.872 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -121.75 93.82 4.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.679 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.656 HG13 HD11 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -93.17 135.71 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.985 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.3 118.91 22.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.513 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.534 ' HG ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -115.08 114.34 25.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 111.255 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.0 m0 -109.85 129.73 55.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 8' ' ' VAL . 9.0 m-30 -115.79 112.12 21.52 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.999 0.428 . . . . 0.0 110.798 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.908 ' NE1' HG11 ' A' ' 50' ' ' VAL . 43.6 m95 -94.9 149.32 21.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.461 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 65' ' ' PHE . 23.3 tp -97.71 102.8 14.65 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.54 0.686 . . . . 0.0 111.558 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.933 HG22 ' ND1' ' A' ' 64' ' ' HIS . 11.5 t -85.44 146.22 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.693 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -105.44 -39.4 6.14 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -162.85 165.43 25.27 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.96 0.8 . . . . 0.0 111.835 -178.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.672 ' HE3' HG22 ' A' ' 11' ' ' ILE . 3.3 p90 -147.6 128.49 14.43 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.714 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -77.35 113.19 14.88 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.54 -122.14 6.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.456 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 16.5 mt-10 -135.06 137.52 27.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.418 0.151 . . . . 0.0 110.825 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.564 ' CA ' HD11 ' A' ' 60' ' ' ILE . 4.5 Cg_exo -76.31 128.84 10.74 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.781 2.321 . . . . 0.0 111.395 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.69 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.8 p-90 -128.68 -59.22 1.15 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.901 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.514 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.02 -98.82 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.99 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 177.61 37.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.716 0.293 . . . . 0.0 111.171 -179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' CD ' HG22 ' A' ' 21' ' ' THR . 8.9 pt-20 -52.04 -41.92 62.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.639 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.82 -5.35 42.99 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.324 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -140.1 97.71 7.76 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.011 0.434 . . . . 0.0 111.457 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -43.49 145.09 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.073 2.516 . . . . 0.0 112.802 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.25 177.11 19.42 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -141.81 157.16 45.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -65.57 105.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.486 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.4 ptm -120.71 163.39 18.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.954 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.548 ' HB2' HG12 ' A' ' 108' ' ' VAL . 28.0 p -86.33 114.74 23.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.713 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.817 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -74.96 -18.85 60.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.202 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.3 p -54.22 -18.82 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.935 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.2 49.8 0.83 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.071 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 123' ' ' ILE . 8.3 tt -62.71 150.36 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.635 0.255 . . . . 0.0 110.427 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.04 131.65 55.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.13 -15.38 61.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.367 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.23 -46.66 17.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.232 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -71.9 -22.53 61.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.105 -179.073 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -97.35 174.53 3.17 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.7 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 115' ' ' PHE . 70.4 Cg_endo -75.3 136.02 19.26 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.277 1.985 . . . . 0.0 111.601 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.59 -14.36 35.1 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.901 2.401 . . . . 0.0 113.191 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -12.24 22.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.534 ' ND2' ' HG ' ' A' ' 82' ' ' LEU . 0.6 OUTLIER -130.87 37.96 3.74 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -76.06 -48.1 3.54 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.009 179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 57.4 Cg_exo -53.68 -38.29 84.47 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.371 2.047 . . . . 0.0 112.158 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.574 HG21 ' CD2' ' A' ' 71' ' ' LEU . 1.6 t -77.19 -51.05 19.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.666 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.48 HG13 ' CE2' ' A' ' 115' ' ' PHE . 1.0 OUTLIER -66.09 -29.98 48.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -55.13 -30.99 60.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.526 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -74.81 -52.0 12.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.429 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.622 HD13 ' HE2' ' A' ' 68' ' ' PHE . 2.3 tp -78.19 -19.73 53.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.641 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HB2' HG22 ' A' ' 123' ' ' ILE . 6.6 ttpp -80.38 -42.59 22.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.554 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -67.62 -8.8 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.907 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.557 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.761 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.626 " H4'" HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.752 0.311 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -101.0 103.0 14.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.44 121.97 32.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.79 HD13 " O3'" ' A' ' 131' ' ' 8OG . 3.9 pp -124.45 120.42 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -103.3 150.88 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.655 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.3 mp -141.92 134.38 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.48 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.708 ' O ' ' HA3' ' A' ' 37' ' ' GLY . . . -124.96 158.03 34.63 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.9 m -145.59 162.43 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.933 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.56 104.74 0.27 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.608 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.069 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.7 109.19 7.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.703 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -70.82 124.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.378 0.608 . . . . 0.0 112.323 -177.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.726 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.92 124.18 30.12 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.418 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.567 ' HA ' ' CZ3' ' A' ' 90' ' ' TRP . 19.8 t-20 -69.56 177.26 3.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.015 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tp10 -56.05 -18.65 10.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.6 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -121.19 -82.38 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.738 0.304 . . . . 0.0 111.519 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.97 15.56 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.711 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.537 ' C ' HD12 ' A' ' 18' ' ' ILE . 2.1 mp0 -100.83 160.51 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.069 HG21 HG22 ' A' ' 10' ' ' ILE . 3.8 mp -134.0 139.84 47.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.017 0.437 . . . . 0.0 111.167 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.512 ' HE2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -93.67 113.84 26.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.898 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.545 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -123.16 159.11 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.557 179.315 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.9 p -70.77 111.62 6.35 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HG3' ' CD1' ' A' ' 33' ' ' LEU . 1.9 ttt180 -124.47 110.6 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.96 0.41 . . . . 0.0 111.173 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 52.92 23.91 3.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.275 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . . . 49.79 -174.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.876 0.37 . . . . 0.0 111.212 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.03 -29.56 43.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -170.6 35.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.785 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . . . -99.23 -166.81 1.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.04 38.57 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.0 mtt -122.54 75.29 1.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.756 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.4 -26.18 24.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.38 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.8 11.03 21.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.425 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.46 26.3 10.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.747 0.308 . . . . 0.0 111.667 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 114' ' ' ASP . 1.4 tt -52.78 86.41 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.703 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.7 OUTLIER -122.09 179.8 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.239 0.542 . . . . 0.0 111.778 -179.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.95 166.59 14.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.736 -179.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 35' ' ' PHE . 7.6 Cg_endo -47.64 168.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.609 2.873 . . . . 0.0 111.461 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.24 59.78 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.75 -1.214 . . . . 0.0 114.209 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -133.42 103.14 0.49 Allowed Glycine 0 C--N 1.311 -0.861 0 CA-C-N 114.765 -0.718 . . . . 0.0 112.069 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 125.56 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.395 0.678 . . . . 0.0 111.525 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.668 HG21 ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -42.82 -46.16 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.494 0.664 . . . . 0.0 111.005 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.94 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.263 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 34.73 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -171.88 24.25 0.08 OUTLIER Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -90.04 -159.26 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.431 0.157 . . . . 0.0 110.747 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -100.72 152.74 37.92 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.64 -24.58 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.622 2.214 . . . . 0.0 112.192 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.94 -49.66 4.46 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -80.54 -8.82 59.72 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.651 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -66.98 -57.33 7.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.375 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.557 HG22 ' CD1' ' A' ' 54' ' ' LEU . 2.3 p -78.92 -35.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.459 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 47' ' ' GLU . 70.0 t -50.3 -35.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.333 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -34.82 47.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.501 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -76.95 -22.22 53.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.84 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.686 HD21 ' CG ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -55.42 -44.39 76.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.02 74.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.149 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.34 -27.61 52.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.459 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.9 mt-10 -108.22 5.47 25.78 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.986 HG12 HG13 ' A' ' 60' ' ' ILE . 17.0 t -134.5 -44.35 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.179 0.514 . . . . 0.0 110.369 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.653 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 55.22 18.04 12.53 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 114.744 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.986 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -128.38 -168.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 117.674 0.737 . . . . 0.0 110.676 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.685 HG23 ' HB3' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -116.28 86.73 18.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.923 179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.566 ' HG3' HG11 ' A' ' 58' ' ' VAL . 16.8 Cg_endo -117.18 139.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.745 0 C-N-CA 123.819 3.013 . . . . 0.0 114.532 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 89' ' ' ARG . 31.7 mt-30 -74.84 79.32 2.11 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 174.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.028 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.0 OUTLIER -114.22 126.72 55.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.142 -175.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -174.52 -150.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.846 -179.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.77 -177.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.903 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.6 pp -144.85 129.94 18.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.11 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.565 ' CE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -46.2 26.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.983 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.5 mt-10 -171.32 131.36 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.142 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.636 ' HE2' HD13 ' A' ' 67' ' ' LEU . 1.1 ptpm? -113.82 132.14 55.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.799 0.333 . . . . 0.0 111.006 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 122' ' ' VAL . 9.7 tp -112.24 137.68 50.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.653 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -129.42 109.91 11.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.675 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -140.51 149.14 42.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.562 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.19 140.05 52.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.254 0.549 . . . . 0.0 111.429 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -87.7 163.12 39.71 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.435 179.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.6 Cg_endo -52.52 82.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.004 2.469 . . . . 0.0 112.137 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 11.9 t0 97.08 13.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.187 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 75' ' ' PHE . 7.3 ttp-105 -137.34 150.34 47.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.627 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -123.79 96.96 5.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.871 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 4' ' ' LEU . 2.8 tt -100.73 111.88 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 110.984 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.76 131.73 45.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.408 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -125.78 114.27 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 2.3 m0 -112.89 122.8 48.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.179 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.632 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER -106.4 116.89 32.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 110.291 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 35.4 m95 -94.51 148.35 22.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.635 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.5 ' O ' ' O ' ' A' ' 65' ' ' PHE . 58.3 tp -102.87 102.9 13.03 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.319 0.58 . . . . 0.0 111.288 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.028 HG22 ' CD2' ' A' ' 64' ' ' HIS . 28.9 t -83.93 145.44 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.132 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.55 ' C ' ' HG2' ' A' ' 89' ' ' ARG . 8.1 pt-20 -115.8 -17.49 11.02 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -161.89 165.62 27.41 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.878 1.217 . . . . 0.0 112.185 -179.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.703 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -157.54 130.03 7.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.977 178.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.685 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -99.68 161.25 13.73 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 120.926 0.393 . . . . 0.0 111.197 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.12 -128.41 28.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.657 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.3 tt0 -127.12 127.88 24.23 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.525 ' HA ' HG12 ' A' ' 60' ' ' ILE . 4.2 Cg_exo -76.9 128.56 10.1 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.561 2.174 . . . . 0.0 112.69 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.653 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 7.8 p-90 -133.79 -62.5 0.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.061 0.458 . . . . 0.0 110.116 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.17 -67.45 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.789 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' TRP . 1.6 mmtt 81.45 43.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.966 0.412 . . . . 0.0 110.662 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.429 ' OE2' HG21 ' A' ' 21' ' ' THR . 0.6 OUTLIER -71.42 -29.31 64.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.806 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.72 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.794 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.546 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 3.9 mp0 -140.05 105.08 6.72 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.951 0.405 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -43.78 144.48 2.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.858 2.372 . . . . 0.0 112.388 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.2 169.64 22.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.93 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -115.21 157.31 23.87 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -66.74 106.05 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.581 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.1 ptm -120.56 163.25 18.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.797 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.6 t -72.87 114.86 11.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.668 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 18' ' ' ILE . 11.8 tp -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.314 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.56 -13.33 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.506 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.94 34.76 5.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.871 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 123' ' ' ILE . 11.7 tp -62.54 131.53 49.41 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 132.29 54.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.4 -15.42 61.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.285 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.78 -49.19 13.42 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.382 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.613 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -67.4 -38.34 84.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.674 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.89 174.06 6.7 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 62.4 Cg_endo -73.79 127.84 11.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.052 1.835 . . . . 0.0 111.355 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.53 -14.72 26.96 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.634 2.223 . . . . 0.0 113.289 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.75 -9.82 31.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.67 42.3 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 tt0 -73.22 -38.77 4.6 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 73.3 Cg_exo -51.17 -41.41 57.94 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.1 1.866 . . . . 0.0 113.033 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 71' ' ' LEU . 3.5 t -77.26 -51.32 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.405 . . . . 0.0 111.273 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.53 HG13 ' CE2' ' A' ' 115' ' ' PHE . 2.6 mm -65.97 -29.85 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.022 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 120' ' ' GLU . . . -56.47 -29.85 62.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.647 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -80.09 -46.56 16.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 68' ' ' PHE . 7.6 tp -78.14 -26.42 47.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.797 0.332 . . . . 0.0 111.257 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -58.4 -42.57 87.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.141 0.496 . . . . 0.0 110.648 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 1.5 tpp180 -71.12 -5.83 34.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.875 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.225 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.79 " O3'" HD13 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.88 0.371 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.59 127.22 41.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.01 132.59 49.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.548 HD13 HO3' ' A' ' 131' ' ' 8OG . 3.1 pp -140.94 129.72 22.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.853 ' O ' HD13 ' A' ' 6' ' ' ILE . 3.2 mt-30 -102.74 148.89 25.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.169 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.853 HD13 ' O ' ' A' ' 5' ' ' GLN . 24.0 mm -135.54 134.13 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.805 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 40' ' ' ILE . . . -124.94 125.19 43.54 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -131.63 155.7 41.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.251 0.548 . . . . 0.0 111.813 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.414 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -143.62 137.42 7.5 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.339 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.721 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -85.73 94.72 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.384 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.979 HG23 HG11 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -71.68 118.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.194 0.521 . . . . 0.0 111.351 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -103.66 140.96 36.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.262 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.621 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 7.4 p-10 -110.17 -173.52 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -45.99 -28.5 1.17 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 114.075 -1.42 . . . . 0.0 113.432 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -92.58 26.74 2.54 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.578 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.91 25.89 0.34 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.211 0.529 . . . . 0.0 110.51 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 17.2 pt-20 -114.22 160.16 19.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.212 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.75 HG12 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -112.15 135.96 49.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.347 0.594 . . . . 0.0 112.441 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 10.9 t80 -91.02 103.27 16.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.933 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.458 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.58 147.6 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.926 0.394 . . . . 0.0 110.863 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 98' ' ' GLU . 4.8 p -88.72 111.62 22.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.938 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 24.6 ptt-85 -113.92 172.19 7.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 111.096 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' MET . 16.4 mmm180 -74.8 57.25 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.3 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 49.2 -168.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.332 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.91 44.39 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.974 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -153.19 -44.13 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.057 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.62 173.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.389 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.86 30.67 3.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.962 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 6.6 mtt -140.84 38.39 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.772 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.71 -8.74 15.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.033 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 16.91 3.16 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 34' ' ' GLU . 4.0 mttt -114.36 26.01 10.6 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-O 120.962 0.41 . . . . 0.0 111.387 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -55.73 86.2 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.599 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.9 tt0 -106.89 -170.96 1.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.14 0.495 . . . . 0.0 111.741 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.668 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.86 166.04 16.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.44 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 61.1 Cg_endo -71.07 168.86 22.02 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.548 2.832 . . . . 0.0 111.708 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 103.43 59.36 0.72 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.601 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -127.44 120.02 3.4 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 114.118 -1.041 . . . . 0.0 111.527 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 119.05 -10.58 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.417 0.687 . . . . 0.0 110.727 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.915 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -37.78 -63.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.33 0.586 . . . . 0.0 111.358 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' N ' HG12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -15.41 -81.25 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.375 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 40.69 -93.27 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.696 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.6 22.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.447 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.6 -159.22 0.22 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.521 0.2 . . . . 0.0 110.884 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.901 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.44 155.61 37.68 Favored Pre-proline 0 N--CA 1.457 -0.082 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.901 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.0 Cg_endo -44.07 -24.83 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.781 2.321 . . . . 0.0 112.428 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.681 ' O ' HG23 ' A' ' 51' ' ' VAL . 6.0 mm-40 -100.0 -49.6 4.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.8 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -80.42 -4.58 54.21 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -64.61 -57.45 9.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.596 0.236 . . . . 0.0 111.214 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.51 ' N ' HD12 ' A' ' 40' ' ' ILE . 1.2 p -78.79 -40.86 23.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.494 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 47' ' ' GLU . 61.6 t -50.2 -35.22 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -52.16 9.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.212 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -67.51 -19.91 65.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.87 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.941 HD11 ' CE1' ' A' ' 64' ' ' HIS . 7.9 tp -56.61 -44.44 81.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.372 . . . . 0.0 110.459 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -26.78 68.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.836 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 97' ' ' LYS . 6.2 tm-20 -75.36 -26.77 58.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.396 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.97 6.82 25.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.978 HG12 HG13 ' A' ' 60' ' ' ILE . 8.2 t -131.46 -43.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.062 0.458 . . . . 0.0 110.395 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 57.46 7.34 2.9 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.751 -0.659 . . . . 0.0 114.679 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.978 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.9 -166.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 117.928 0.864 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.643 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -113.16 87.89 11.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.888 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.684 ' HG3' HG11 ' A' ' 58' ' ' VAL . 11.7 Cg_endo -113.51 133.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 123.792 2.995 . . . . 0.0 113.852 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 7.9 pt20 -74.75 79.22 2.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.941 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -112.16 130.02 56.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.539 -175.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -178.17 -142.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.053 -178.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 t 52.75 171.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.22 0.533 . . . . 0.0 112.16 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 67' ' ' LEU . 4.2 tt -131.31 105.65 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.404 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.64 -40.97 47.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.982 0.42 . . . . 0.0 110.121 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.8 tt0 -171.27 159.88 5.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.43 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -143.25 132.16 22.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.818 0.342 . . . . 0.0 110.965 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' A' ' 122' ' ' VAL . 5.5 tp -122.39 128.95 51.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.649 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.739 ' CD ' HG23 ' A' ' 81' ' ' THR . 1.1 tp10 -129.35 110.84 12.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.76 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.712 ' HE1' HD12 ' A' ' 82' ' ' LEU . 3.4 p90 -138.49 104.48 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.545 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 15.8 pt-20 -88.5 126.62 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.044 0.449 . . . . 0.0 111.526 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -70.08 163.55 60.4 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.934 179.138 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -38.75 -28.51 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.499 2.799 . . . . 0.0 113.103 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -140.6 -32.61 0.58 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.426 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 26.8 ttm180 -94.18 97.95 10.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.337 . . . . 0.0 111.61 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 9.4 m170 -78.97 100.21 7.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.693 0.282 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 tt -104.59 130.89 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.739 HG23 ' CD ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -121.44 132.01 54.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.465 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.911 HD13 ' OD1' ' A' ' 119' ' ' ASN . 22.2 mt -126.24 114.5 18.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 0.0 111.474 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -107.65 122.59 47.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.589 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.726 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -100.64 109.56 21.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.429 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.484 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 21.8 m95 -96.31 148.6 22.58 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.54 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.567 HD12 ' OE2' ' A' ' 88' ' ' GLU . 1.9 tm? -90.83 103.03 15.79 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.315 0.579 . . . . 0.0 111.35 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.979 HG11 HG23 ' A' ' 11' ' ' ILE . 18.9 t -90.5 145.3 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.567 ' OE2' HD12 ' A' ' 86' ' ' LEU . 1.7 mm-40 -113.85 -25.39 8.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.537 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 0.6 OUTLIER -163.5 165.86 23.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.105 1.32 . . . . 0.0 112.809 -178.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.684 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -157.12 124.5 5.28 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.623 178.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.643 ' CB ' HG23 ' A' ' 61' ' ' THR . 0.7 OUTLIER -80.06 117.99 21.38 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 120.801 0.334 . . . . 0.0 111.126 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.25 -123.34 6.97 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.445 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 66.8 mt-10 -129.46 137.78 31.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 122.952 -0.146 . . . . 0.0 110.63 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.608 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.8 Cg_exo -76.67 128.94 10.52 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.778 2.319 . . . . 0.0 110.969 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.54 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 51.1 p-90 -140.26 -58.99 0.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 48.55 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.578 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -179.37 32.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.628 0.252 . . . . 0.0 111.219 -179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.552 ' HG2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -63.96 -24.93 67.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.845 0.355 . . . . 0.0 110.57 179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.06 73.18 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.429 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.446 ' O ' ' HB ' ' A' ' 21' ' ' THR . 23.4 mt-30 -140.36 100.64 6.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -43.71 129.59 7.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.883 2.389 . . . . 0.0 112.385 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.429 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.09 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.14 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -153.27 157.13 39.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -71.59 105.69 3.75 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.824 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.464 ' C ' ' HB2' ' A' ' 17' ' ' GLU . 28.0 ptm -120.58 147.55 45.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.063 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.428 ' OG ' HG12 ' A' ' 108' ' ' VAL . 1.3 t -67.85 124.99 24.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.846 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.817 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.4 tm? -71.92 -20.76 61.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.225 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' A' ' 129' ' ' LEU . 11.7 p -55.13 -19.47 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.521 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.82 36.89 3.73 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.872 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 107' ' ' LEU . 10.6 tp -62.74 129.11 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.99 134.79 54.31 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.601 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -15.37 61.82 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.674 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -78.89 -49.25 13.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.772 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -30.31 68.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.652 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -88.45 173.97 5.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.621 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 72.3 Cg_endo -76.86 130.16 11.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.433 2.089 . . . . 0.0 111.596 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.58 -14.44 13.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.938 2.425 . . . . 0.0 113.728 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.71 -10.24 11.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.911 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -136.24 45.67 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.742 0.306 . . . . 0.0 111.465 -179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.52 -54.41 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.01 -33.09 7.24 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.396 2.064 . . . . 0.0 112.416 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.726 HG11 ' CD2' ' A' ' 84' ' ' PHE . 25.8 t -77.57 -51.03 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.668 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 16.6 mm -65.59 -29.77 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -30.4 56.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 110.626 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -47.44 14.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.449 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.769 ' O ' HD22 ' A' ' 129' ' ' LEU . 11.1 tp -78.18 -19.43 53.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.517 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 123' ' ' ILE . 3.8 ttpm? -71.14 -42.6 68.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 110.643 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -68.24 -9.46 47.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.004 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.125 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.623 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.604 ' P ' " H3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.828 0.346 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -93.83 135.47 35.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 145.94 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.645 ' CD1' HD11 ' A' ' 6' ' ' ILE . 2.8 pp -146.02 124.35 12.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.95 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.511 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 15.2 mt-30 -102.49 155.72 18.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.727 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.645 HD11 ' CD1' ' A' ' 4' ' ' LEU . 3.7 mp -146.16 132.29 13.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.503 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.065 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.4 124.74 43.0 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -126.79 162.12 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.259 0.552 . . . . 0.0 112.214 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.31 116.27 0.86 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.908 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.724 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -74.47 96.02 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.764 HG22 ' CG ' ' A' ' 64' ' ' HIS . 2.4 pt -79.35 111.68 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.164 0.507 . . . . 0.0 112.171 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.796 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.1 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.937 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.635 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.5 p-10 -125.34 -173.83 2.91 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -22.21 12.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.326 -1.307 . . . . 0.0 113.534 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -98.08 30.77 2.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.336 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.41 28.92 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.316 0.579 . . . . 0.0 110.264 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.7 mt-10 -117.71 160.34 21.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.957 HG21 HD23 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -114.62 136.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.045 0.45 . . . . 0.0 111.596 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.916 ' N ' HD13 ' A' ' 18' ' ' ILE . 44.5 t80 -87.88 93.68 9.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.619 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -114.68 162.2 12.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.621 HG21 ' CD ' ' A' ' 98' ' ' GLU . 27.9 p -71.72 129.65 39.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.93 128.45 42.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.775 0.321 . . . . 0.0 110.817 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 15.4 mtm180 54.6 -112.38 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.162 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . 172.98 176.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.882 0.372 . . . . 0.0 110.977 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB2' ' HG2' ' A' ' 101' ' ' PRO . . . -103.77 -30.89 10.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.988 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -111.08 -43.63 3.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -101.22 -176.01 3.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.028 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -84.09 -80.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.559 ' SD ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 53.21 38.32 27.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.018 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.96 97.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.318 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.88 20.84 9.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.204 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -114.49 26.47 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.602 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.651 HD21 HD12 ' A' ' 20' ' ' ILE . 2.5 tt -56.03 80.4 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.691 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -106.84 -168.31 1.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.945 0.402 . . . . 0.0 111.346 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.724 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.58 157.39 51.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.614 -179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.519 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 21.4 Cg_endo -60.06 167.37 7.45 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.216 2.61 . . . . 0.0 111.183 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.1 58.83 0.78 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.782 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.568 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -122.8 130.69 7.96 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 114.674 -0.763 . . . . 0.0 111.803 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 102.11 4.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.137 0.575 . . . . 0.0 111.695 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.065 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -54.95 -25.91 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.43 0.633 . . . . 0.0 110.547 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -44.28 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.965 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.1 mmm 35.49 -85.52 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.422 0.451 . . . . 0.0 111.807 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.42 30.63 0.15 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.385 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.5 mp0 -91.86 -178.27 4.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.872 0.368 . . . . 0.0 111.234 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.01 155.9 36.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.27 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.96 -24.78 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.847 2.365 . . . . 0.0 112.715 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.692 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.3 mt-10 -95.11 -49.38 5.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -80.21 -23.25 41.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.021 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.49 -48.43 77.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.952 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.818 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.1 -47.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.756 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.1 t -58.54 -35.73 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.036 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -74.89 -52.07 12.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.619 ' CB ' HG22 ' A' ' 40' ' ' ILE . 5.5 tp10 -68.98 -26.47 65.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.79 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 6.1 tp -51.94 -44.07 63.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.644 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.47 -31.19 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.158 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.1 -23.84 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.234 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.62 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 9.1 mm-40 -108.11 6.57 27.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.543 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.918 HG13 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -134.13 -45.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.167 0.508 . . . . 0.0 110.338 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 63.32 -27.32 0.08 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.934 1.133 . . . . 0.0 115.934 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.918 HD12 HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -93.94 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 117.771 0.786 . . . . 0.0 111.466 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.5 p -105.81 89.57 3.66 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.039 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 84.1 Cg_endo -109.57 137.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.438 2.759 . . . . 0.0 115.367 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 89' ' ' ARG . 70.9 mt-30 -75.55 79.46 2.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 174.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.771 ' HE2' ' HE3' ' A' ' 90' ' ' TRP . 1.8 m-70 -138.17 127.4 24.44 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.55 -173.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CE1' HG22 ' A' ' 51' ' ' VAL . 6.2 t80 173.5 173.72 0.14 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.028 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 5.4 t 106.14 154.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.736 0.814 . . . . 0.0 110.614 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.536 HD11 ' HE3' ' A' ' 70' ' ' LYS . 9.1 tt -106.75 146.88 30.31 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.675 ' HE2' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -117.13 -44.74 2.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.709 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.47 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -171.23 153.96 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.666 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE3' HD11 ' A' ' 67' ' ' LEU . 2.5 ptpp? -138.0 132.06 31.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.785 0.326 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 5.4 tp -118.01 124.39 48.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.737 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.82 109.88 17.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.538 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -134.42 153.22 52.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.648 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -114.89 140.13 49.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.291 0.567 . . . . 0.0 111.42 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -107.21 163.75 16.28 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.269 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 64.0 Cg_exo -39.26 81.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.457 2.772 . . . . 0.0 112.744 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER 72.02 20.53 4.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.431 ' NH1' HD23 ' A' ' 4' ' ' LEU . 2.8 tpt85 -137.32 93.88 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.357 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -74.79 101.13 4.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -100.15 114.73 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.979 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 128.2 54.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.76 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.86 HD13 ' OD1' ' A' ' 119' ' ' ASN . 24.8 mt -126.07 114.64 18.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.277 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 12.2 m0 -105.05 122.54 46.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.701 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.4 m-30 -99.41 109.86 22.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.038 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.788 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.2 m95 -99.69 148.16 24.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.033 0.444 . . . . 0.0 111.955 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 65' ' ' PHE . 6.8 tp -91.34 122.2 33.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.137 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.639 HG12 ' CA ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -124.06 145.4 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.921 -178.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 12' ' ' ARG . 10.7 tt0 -89.22 -69.78 0.69 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -162.51 166.08 25.3 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.19 0.519 . . . . 0.0 112.227 -177.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.771 ' HE3' ' HE2' ' A' ' 64' ' ' HIS . 47.8 p90 -115.78 163.01 16.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.254 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.67 72.27 0.95 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.72 0.295 . . . . 0.0 110.911 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 135.97 -115.97 1.41 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.637 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -134.18 118.77 14.14 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.554 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -75.74 128.97 11.3 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.836 2.357 . . . . 0.0 111.881 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.804 ' HE1' HG23 ' A' ' 60' ' ' ILE . 2.2 p-90 -121.86 -73.1 0.66 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.705 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.62 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 60.55 -68.63 0.01 OUTLIER Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.868 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' GLY . 40.7 tttm 96.95 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.212 0.605 . . . . 0.0 110.969 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.621 ' CD ' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -86.16 -31.31 21.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.625 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.3 -15.52 2.97 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.99 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -140.06 101.36 7.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.954 0.407 . . . . 0.0 111.373 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 54.3 Cg_exo -43.55 146.22 1.4 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.062 2.508 . . . . 0.0 112.623 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.428 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -133.24 177.37 19.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.888 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 13.8 tt0 -153.12 157.34 40.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.403 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -61.72 106.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.484 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.13 156.53 30.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.262 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.435 ' N ' ' HG2' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -67.12 114.54 5.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.87 179.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.957 HD23 HG21 ' A' ' 18' ' ' ILE . 3.0 tm? -78.4 -21.34 49.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.187 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.487 HG22 HD21 ' A' ' 129' ' ' LEU . 10.9 p -63.41 -12.53 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.547 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.15 40.87 2.02 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.891 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 110' ' ' LEU . 11.7 tp -62.64 134.13 55.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.02 137.73 54.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.29 -15.73 61.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.577 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.97 -49.25 13.06 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.58 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -39.22 87.64 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.47 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.563 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.94 173.91 6.94 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.454 ' O ' ' CZ ' ' A' ' 115' ' ' PHE . 73.9 Cg_endo -77.17 137.09 16.79 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.372 2.048 . . . . 0.0 111.916 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 20.1 Cg_endo -60.05 -14.09 26.58 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.901 2.401 . . . . 0.0 113.258 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.68 -9.81 10.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.86 ' OD1' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -138.91 47.52 1.92 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -70.36 -58.1 5.16 Favored Pre-proline 0 CA--C 1.531 0.231 0 O-C-N 122.214 -0.304 . . . . 0.0 111.389 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.46 ' HD3' ' HG3' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -44.73 -31.02 4.64 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.501 2.134 . . . . 0.0 112.522 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 84' ' ' PHE . 71.7 t -77.33 -50.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.59 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.668 HG22 ' HB2' ' A' ' 127' ' ' LYS . 26.8 mm -65.43 -31.54 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.58 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.76 -26.83 36.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 110.902 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -51.61 8.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.696 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.675 HD13 ' HE2' ' A' ' 68' ' ' PHE . 11.8 tp -78.09 -30.1 49.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.496 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.668 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.8 ttpt -56.71 -42.53 79.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -67.47 -8.85 36.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.762 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.487 HD21 HG22 ' A' ' 108' ' ' VAL . 10.7 mp . . . . . 0 C--O 1.232 0.145 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.902 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.508 " O3'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.833 0.349 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.75 102.91 12.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.973 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -104.91 144.62 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.6 pp -138.08 127.03 24.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.439 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 24.2 mt-30 -102.44 157.56 16.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.332 0.587 . . . . 0.0 111.869 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.507 ' HB ' HD12 ' A' ' 82' ' ' LEU . 73.1 mt -146.23 130.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.834 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.694 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.13 125.07 43.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -129.25 162.6 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.427 0.632 . . . . 0.0 111.925 -179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.433 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -148.11 113.55 0.64 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.428 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.766 HD12 ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -70.75 99.86 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.732 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.5 OUTLIER -71.26 119.57 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.275 0.56 . . . . 0.0 111.987 -178.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.63 141.79 28.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.883 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -100.12 -173.17 2.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.001 -179.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -73.75 -10.1 59.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.267 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.456 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 23.1 t-20 -111.89 30.91 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.63 11.39 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.545 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' HB2' HD21 ' A' ' 13' ' ' ASN . 0.0 OUTLIER -101.99 161.34 13.75 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.63 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -116.0 131.71 67.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 0.0 111.75 -178.396 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 7.0 t80 -82.92 107.63 15.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.524 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.486 HG13 HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -123.47 162.16 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 100' ' ' GLN . 4.3 p -79.18 111.74 15.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HG2' ' HG ' ' A' ' 33' ' ' LEU . 2.7 tmm_? -119.19 169.78 9.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.61 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -60.85 -14.64 23.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.204 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 80.86 -76.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.458 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' N ' ' HD3' ' A' ' 23' ' ' ARG . . . -164.3 -79.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.806 0.336 . . . . 0.0 111.265 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.27 34.73 3.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.989 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . -108.28 151.16 26.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.11 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -178.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.824 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mtt 59.92 72.36 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 23' ' ' ARG . . . -87.05 -27.5 23.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.406 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.29 22.16 7.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.386 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.53 25.95 10.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.928 0.394 . . . . 0.0 111.749 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.44 HD23 ' C ' ' A' ' 33' ' ' LEU . 3.3 tt -65.7 78.45 0.07 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.009 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.95 -171.9 2.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 0.0 111.403 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.766 ' CD2' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.86 156.48 54.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.766 -179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.493 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 8.9 Cg_endo -49.27 168.0 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.637 2.891 . . . . 0.0 111.831 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 102.34 59.21 0.76 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.033 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.711 ' C ' ' HG2' ' A' ' 39' ' ' LYS . . . -118.56 159.94 14.16 Favored Glycine 0 C--N 1.315 -0.617 0 CA-C-N 114.615 -0.793 . . . . 0.0 111.993 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.711 ' HG2' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 49.12 23.13 0.71 Allowed 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 111.561 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.049 HD12 ' HB1' ' A' ' 49' ' ' ALA . 0.5 OUTLIER -61.81 -30.96 49.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.704 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.19 -80.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.028 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.9 mmt 41.32 -84.03 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.381 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.29 33.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.682 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 mp0 -93.56 -174.33 3.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.7 0.286 . . . . 0.0 111.266 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.867 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -104.92 153.98 38.98 Favored Pre-proline 0 N--CA 1.457 -0.124 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.378 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.867 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.69 -24.66 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.958 2.439 . . . . 0.0 112.532 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.7 mt-10 -98.1 -48.71 5.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -80.42 -26.09 38.65 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.049 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -55.48 -47.38 76.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.33 -51.17 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.295 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.1 t -52.82 -36.56 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.512 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -78.24 -43.31 28.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.203 0.525 . . . . 0.0 109.925 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.59 ' HG2' HG22 ' A' ' 40' ' ' ILE . 10.8 tp10 -64.42 -27.37 68.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.289 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 64' ' ' HIS . 2.9 tp -56.57 -44.61 81.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.156 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -63.28 -35.41 80.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.322 0.582 . . . . 0.0 109.431 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.6 tm-20 -77.75 -26.13 49.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.477 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 36' ' ' PRO . 63.8 mm-40 -108.99 5.39 24.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.931 HG12 HG13 ' A' ' 60' ' ' ILE . 21.9 t -134.84 -44.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.316 0.579 . . . . 0.0 110.205 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.696 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 58.84 3.14 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.329 -0.85 . . . . 0.0 114.618 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.931 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -120.48 -173.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 117.907 0.853 . . . . 0.0 110.269 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.9 p -113.28 87.99 11.99 Favored Pre-proline 0 N--CA 1.438 -1.042 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.183 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.761 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.9 Cg_endo -113.23 145.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 123.612 2.875 . . . . 0.0 113.922 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.44 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 17.8 mt-30 -74.97 79.68 2.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 175.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.925 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -120.35 134.21 55.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.825 -176.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -179.3 -139.94 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.812 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 1.1 m 52.18 174.3 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.171 0.51 . . . . 0.0 112.111 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD11 ' CD ' ' A' ' 70' ' ' LYS . 6.1 tt -139.6 117.87 12.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.844 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.758 ' CE1' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.78 -55.61 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.221 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.614 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.1 mt-10 -171.13 131.38 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.441 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.762 ' CD ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.36 132.08 46.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.651 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.758 HD21 HG22 ' A' ' 122' ' ' VAL . 3.1 pp -140.56 161.95 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.93 0.395 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.666 ' HB2' HG23 ' A' ' 81' ' ' THR . 14.5 tt0 -125.69 124.1 40.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.851 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -120.88 152.71 38.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -120.76 120.9 36.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.151 0.5 . . . . 0.0 111.346 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -72.27 163.06 70.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.42 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.41 83.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.112 2.541 . . . . 0.0 112.316 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 16.8 m-20 95.29 15.2 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.57 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 8.2 tpp85 -137.44 150.14 47.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.7 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.7 105.6 10.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -111.36 154.31 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.666 HG23 ' HB2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -127.25 131.18 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.647 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.536 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 11.2 tp -126.32 114.56 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.289 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.568 ' CH2' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -110.26 135.64 50.69 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.718 0.294 . . . . 0.0 110.394 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.955 ' CD1' HG11 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -120.01 118.03 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.331 179.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.4 m95 -100.52 148.62 24.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.009 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.0 tp -96.6 102.89 14.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.46 0.648 . . . . 0.0 111.746 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.832 HG13 ' CB ' ' A' ' 64' ' ' HIS . 16.4 t -85.99 145.81 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.377 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.0 -39.77 5.65 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.8 ptp180 -163.24 165.67 24.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.837 0.744 . . . . 0.0 112.097 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.732 ' HE3' HG22 ' A' ' 11' ' ' ILE . 4.6 p90 -144.72 130.4 19.06 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.505 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.69 105.95 11.36 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.76 -122.82 7.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.446 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 15.0 mt-10 -134.97 137.07 26.3 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.401 0.143 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.594 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.9 Cg_exo -76.45 128.75 10.57 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.755 2.303 . . . . 0.0 111.502 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.696 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 65.2 p-90 -130.47 -57.2 1.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.959 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.521 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 45.15 -94.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.991 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' GLU . 3.4 mmtp 170.62 39.33 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 111.189 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -42.69 99.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.696 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.47 6.67 50.19 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.642 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 8.7 mp0 -140.2 99.12 7.34 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 117.31 0.555 . . . . 0.0 111.515 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -43.62 140.95 4.07 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.989 2.46 . . . . 0.0 112.668 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.17 177.05 19.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.768 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -147.96 157.18 43.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.545 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.2 m0 -61.86 105.92 0.62 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.114 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.2 ttm -120.55 159.81 24.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.277 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.547 ' HB2' HG12 ' A' ' 108' ' ' VAL . 5.2 p -83.93 123.85 30.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.746 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -80.01 -19.06 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.274 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.4 p -55.35 -19.82 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.18 45.8 1.11 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.076 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.608 HD12 ' CD2' ' A' ' 107' ' ' LEU . 7.6 tt -62.95 150.54 41.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.595 0.236 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -121.85 120.85 35.73 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.719 ' O ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.22 -14.71 61.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.834 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.93 -46.25 53.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.562 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.56 -13.56 58.97 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.719 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.61 175.71 3.86 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.59 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.559 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 68.6 Cg_endo -76.12 143.08 25.26 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 121.736 1.624 . . . . 0.0 110.949 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.449 ' HG2' ' N1 ' ' A' ' 131' ' ' 8OG . 25.5 Cg_endo -62.05 -14.27 36.49 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.483 2.122 . . . . 0.0 113.213 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.689 ' HB2' ' N3 ' ' A' ' 131' ' ' 8OG . . . -75.62 -9.37 58.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' OD1' ' O ' ' A' ' 116' ' ' PRO . 31.4 p-10 -124.48 32.74 5.41 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.522 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.51 -55.19 1.68 Allowed Pre-proline 0 N--CA 1.467 0.389 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.456 179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.95 -37.13 11.95 Favored 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.509 2.139 . . . . 0.0 112.889 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.955 HG11 ' CD1' ' A' ' 84' ' ' PHE . 2.4 t -77.6 -51.18 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.891 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.528 HD12 ' CD2' ' A' ' 110' ' ' LEU . 1.8 mm -68.3 -29.88 45.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.264 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.84 57.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.412 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -48.27 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.317 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.758 HD13 ' CE1' ' A' ' 68' ' ' PHE . 6.4 tp -78.21 -30.09 48.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.534 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -56.57 -42.87 79.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -75.59 -2.89 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.055 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.254 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.689 ' N3 ' ' HB2' ' A' ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_